Geneid,<2C (LG1),G1,S,G2M,>4C (GG2M),desc,class
Tb927.8.270,11625.0,11623.0,11625.0,11635.0,11527.0,variant surface glycoprotein  degenerate,G2M
Tb927.8.280,8578.0,6159.0,5637.0,6935.5,4680.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.8.290,3929.5,5104.5,5661.5,5470.0,3524.0,variant surface glycoprotein  degenerate,S
Tb927.8.300,8976.0,8809.0,7802.5,8454.0,6945.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.8.310,8537.5,7373.0,7736.0,7072.0,7788.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.8.320,8365.0,9248.0,9246.0,9173.0,6631.0,variant surface glycoprotein  degenerate,G1
Tb927.8.330,2357.5,2296.0,3514.5,3588.0,3033.0,variant surface glycoprotein  point mutation,G2M
Tb927.8.340,9886.0,8741.5,8253.0,9226.5,8006.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.8.350,8039.5,8167.5,8543.0,8328.0,5411.5,variant surface glycoprotein  point mutation,S
Tb927.8.360,4910.5,6101.0,6385.5,7859.5,3566.5,variant surface glycoprotein  degenerate,G2M
Tb927.8.370,2137.5,3552.0,4695.5,5168.5,1266.0,expression site-associated gene 3 (ESAG3)  degenerate,G2M
Tb927.8.380,1783.5,3625.0,3116.5,3463.5,2376.0,variant surface glycoprotein  degenerate,G1
Tb927.8.390,2598.0,867.5,743.0,862.0,697.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.8.400,4465.0,3008.5,3127.0,3492.0,4051.0,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.8.410,1460.0,413.0,471.5,464.0,213.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.8.420,1783.5,2429.0,1870.0,2506.5,3606.5,variant surface glycoprotein  frameshift,>4C (GG2M)
Tb927.8.430,2481.0,5896.0,6270.5,5481.5,4468.5,variant surface glycoprotein  degenerate,S
Tb927.8.440,4425.0,8031.0,7108.0,6129.0,9606.5,variant surface glycoprotein  frameshift,>4C (GG2M)
Tb927.8.443,5304.0,3273.5,2425.0,2725.0,1842.0,M4 ribosomal RNA,<2C (LG1)
Tb927.8.446,612.5,235.5,210.0,82.5,86.0,M6 ribosomal RNA,<2C (LG1)
Tb927.8.449,4389.0,2128.0,1771.5,2168.5,1010.0,M2 ribosomal RNA,<2C (LG1)
Tb927.8.450,2943.0,2402.0,1634.5,2302.0,2914.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.8.460,7421.0,2785.5,2226.5,2290.0,1944.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.8.470,8680.5,10408.0,10643.0,9661.0,10195.5,variant surface glycoprotein  degenerate,S
Tb927.8.480,7713.0,7285.5,7991.5,8505.0,9601.5,phosphatidic acid phosphatase protein  putative,>4C (GG2M)
Tb927.8.490,612.5,543.0,562.5,577.5,584.5,hypothetical protein,<2C (LG1)
Tb927.8.500,1783.5,6170.0,5512.0,5608.0,5841.5,hypothetical protein,G1
Tb927.8.510,1988.0,4928.0,3801.5,5470.0,4839.5,hypothetical protein,G2M
Tb927.8.520,9594.0,8587.5,8381.5,7540.0,5963.0,hypothetical protein,<2C (LG1)
Tb927.8.530,612.5,1536.0,2172.5,705.5,2389.0,leucine-rich repeat protein (LRRP)  point mutation,>4C (GG2M)
Tb927.8.540,11621.0,11612.0,11601.0,11627.0,11558.0,N-terminal region of Chorein  a TM vesicle-mediated sorter  putative,G2M
Tb927.8.550,5799.0,4481.0,3205.5,4598.0,5125.0,peptide methionine sulfoxide reductase  putative,<2C (LG1)
Tb927.8.560,6158.0,8611.0,8211.5,8000.5,7038.0,hypothetical protein  conserved,G1
Tb927.8.570,7558.5,5746.5,7165.0,8676.0,10232.5,proteasome regulatory non-ATP-ase subunit 10,>4C (GG2M)
Tb927.8.580,1460.0,5834.5,5981.0,5419.5,4096.5,MICOS complex subunit 40,S
Tb927.8.590,5063.0,10291.5,10360.5,10628.0,9872.5,carnitine O-palmitoyltransferase  putative,G2M
Tb927.8.595,6254.0,3625.0,3618.0,3503.0,2336.0,hypothetical protein,<2C (LG1)
Tb927.8.600,2930.5,2272.0,1623.0,2009.0,1860.5,Bucentaur or craniofacial development  putative,<2C (LG1)
Tb8.NT.8,612.5,279.5,336.0,273.5,287.0,Noncoding RNA  putative,<2C (LG1)
Tb927.8.610,11243.5,11173.5,10657.0,10671.5,10530.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.620,6324.5,5967.0,8896.0,6815.5,8360.5,KREPA3,S
Tb927.8.630,5286.0,4615.5,4130.5,4567.5,5953.5,lipoyltransferase  putative,>4C (GG2M)
Tb927.8.640,7923.0,5261.5,5129.0,3897.5,8273.0,Dpy-30 motif containing protein  putative,>4C (GG2M)
Tb927.8.650,10396.0,10778.0,10415.5,9634.0,9950.5,cation-transporting ATPase  putative,G1
Tb927.8.660,4527.5,738.5,1446.0,1187.5,5161.0,Sel1 repeat  putative,>4C (GG2M)
Tb927.8.670,6450.5,4553.0,4434.0,5050.5,3693.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.680,3328.5,5600.0,6664.0,7264.0,4429.0,KREPA5,G2M
Tb8.NT.9,6516.5,3499.5,2812.5,2956.0,3836.0,Noncoding RNA  putative,<2C (LG1)
Tb927.8.690,3078.5,2920.5,3308.0,5307.5,4411.5,peptidyl-prolyl cis-trans isomerase/rotamase  putative,G2M
Tb927.8.700,11005.0,11482.0,11466.5,11490.0,11248.0,DNA repair and recombination helicase protein PIF7,G2M
Tb927.8.710,7564.5,9124.0,10290.5,10000.5,9972.5,RNA-binding protein  putative,S
Tb8.NT.11,7496.0,3256.0,3148.0,4235.5,4276.5,Noncoding RNA  putative,<2C (LG1)
Tb927.8.720,9155.0,3579.0,2729.5,3878.0,4617.5,Cytosolic iron-sulfur protein assembly 2B  putative,<2C (LG1)
Tb927.8.730,7755.5,7184.0,5945.5,6779.5,6281.0,nucleolar RNA-binding protein  putative,<2C (LG1)
Tb927.8.740,612.5,2741.5,1510.5,2223.0,1304.5,nucleolar RNA-binding protein (fragment),G1
Tb927.8.750,6243.0,3336.0,3940.5,3588.0,4748.5,nucleolar RNA-binding protein  putative,<2C (LG1)
Tb927.8.760,612.5,2409.5,2764.5,2483.5,874.5,nucleolar RNA-binding protein,S
Tb927.8.770,8811.0,9899.0,9612.0,9653.5,8121.0,SUMO-interacting motif-containing protein,G1
Tb927.8.780,5006.5,9904.0,10142.0,9710.5,8575.0,hypothetical protein  conserved,S
Tb927.8.790,10679.0,11325.0,11292.0,11172.0,10955.5,hypothetical protein  conserved,G1
Tb927.8.800,10983.0,11330.0,11350.0,11347.0,11210.5,Domain of unknown function (DUF3437)  putative,S
Tb927.8.810,7532.5,7905.5,7526.5,7047.0,11236.5,radial spoke protein RSP9  putative,>4C (GG2M)
Tb927.8.820,1460.0,9475.0,9433.0,9140.5,8862.0,VID27 cytoplasmic protein  putative,G1
Tb927.8.830,9640.0,11137.0,11076.5,11111.0,10141.5,Protein of unknown function (DUF3608)  putative,G1
Tb927.8.840,9128.5,10597.5,10731.5,10669.5,10968.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.850,10660.5,9724.5,9457.0,9086.5,9087.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.860,2381.5,6992.5,7124.5,6909.0,6405.0,hypothetical protein  conserved,S
Tb927.8.870,11233.0,10704.5,10819.0,10839.0,10305.0,CAMK/CAMKL family protein kinase  putative,<2C (LG1)
Tb927.8.880,10939.0,9696.0,9717.0,9270.5,9589.0,hypothetical protein,<2C (LG1)
Tb927.8.890,6301.5,2011.0,1791.5,3557.0,5220.0,Ras-related protein Rab1A,<2C (LG1)
Tb8.NT.13,5241.5,1536.0,1041.5,1911.5,1622.5,Noncoding RNA  putative,<2C (LG1)
Tb927.8.900,10313.0,7985.5,7461.5,8219.0,9027.0,splicing factor TSR1,<2C (LG1)
Tb927.8.910,8702.0,10941.0,10412.5,10825.5,10152.0,hypothetical protein  conserved,G1
Tb927.8.920,612.5,2283.0,1831.0,1936.0,3386.5,ubiquitin-conjugating enzyme E2  putative,>4C (GG2M)
Tb927.8.930,9480.5,8192.0,8066.5,8309.0,7506.0,hypothetical protein,<2C (LG1)
Tb927.8.940,11397.0,11366.0,11486.5,11636.0,11705.0,Flagella connector protein 1,>4C (GG2M)
Tb927.8.950,9865.0,9939.0,9488.0,9686.5,9021.5,hypothetical protein,G1
Tb927.8.960,11420.0,11372.0,11471.0,11639.0,11706.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.970,9892.5,10204.5,10133.0,10020.5,8611.0,hypothetical protein,G1
Tb927.8.980,9016.0,9584.5,10073.5,9063.5,8563.0,phosphoacetylglucosamine mutase,S
Tb927.8.990,3358.0,5683.5,5759.5,5004.5,6392.5,RNA-binding protein 33 (RNA-binding motif protein 33),>4C (GG2M)
Tb927.8.1000,3882.5,10656.5,10907.0,10982.5,10905.0,hypothetical protein  conserved,G2M
Tb927.8.1010,1783.5,3973.5,4398.0,4112.0,3260.0,chaperone protein DnaJ  putative,S
Tb927.8.1020,11113.5,10664.0,10724.5,10532.0,10986.5,6-phosphofructo-2-kinase/fructose-2 6-biphosphatase  putative,<2C (LG1)
Tb927.8.1030,6787.5,9211.0,9363.5,9786.5,9254.0,chaperone protein DnaJ  putative,G2M
Tb927.8.1040,6381.5,6295.0,6577.0,6892.0,6328.0,protein phosphatase inhibitor  putative,G2M
Tb927.8.1050,11569.0,11276.0,11409.0,11360.0,10610.0,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.8.1060,7074.5,7967.5,7209.5,7422.0,5898.0,malonyl-CoA decarboxylase  mitochondrial precursor  putative,G1
Tb927.8.1070,10239.0,9387.5,9598.0,9489.5,7918.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1080,8516.5,5600.0,6480.0,7662.5,9423.0,centrin  putative,>4C (GG2M)
Tb927.8.1090,10104.5,7572.5,6460.5,6774.5,10396.0,NPAPL,>4C (GG2M)
Tb927.8.1100,10439.0,10783.0,10674.0,10093.0,9689.0,STE/STE11 serine/threonine-protein kinase  putative,G1
Tb927.8.1110,3822.0,1506.5,1886.0,1044.0,2089.0,40S ribosomal protein S9  putative,<2C (LG1)
Tb927.8.1120,2137.5,2701.5,2812.5,2577.5,1944.0,hypothetical protein  conserved,S
Tb927.8.1130,2658.5,11127.5,11217.5,11203.5,11131.5,protein phosphatase with EF-Hand domains  putative,S
Tb927.8.1140,4182.0,5841.0,7033.5,5782.0,7392.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.1150,6061.5,3552.0,3260.0,3332.5,3447.0,kinetoplastid kinetochore protein 9,<2C (LG1)
Tb927.8.1160,9375.0,9233.0,8596.0,7993.0,8067.0,vacuolar-type Ca2+-ATPase  putative,<2C (LG1)
Tb927.8.1170,4433.0,2964.5,1899.0,1779.5,3847.5,eukaryotic translation initiation factor 3 subunit h,<2C (LG1)
Tb927.8.1180,9546.0,10287.0,10021.5,10212.5,9095.5,vacuolar-type Ca2+-ATPase 1,G1
Tb927.8.1190,5167.5,3171.5,2182.5,1816.5,3847.5,eukaryotic translation initiation factor 3 subunit h,<2C (LG1)
Tb927.8.1200,9691.0,10986.0,10938.0,11033.0,10213.5,vacuolar-type Ca2+-ATPase 2,G2M
Tb927.8.1210,9400.0,10597.5,10502.0,10410.5,10009.5,hypothetical protein  conserved,G1
Tb927.8.1220,4104.0,7216.5,8523.0,7506.5,8297.5,hypothetical protein  conserved (pseudogene),S
Tb927.8.1230,7232.0,4072.5,4586.5,4126.5,4355.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1240,9960.5,9322.0,9181.0,9471.5,11062.0,electron transfer flavoprotein-ubiquinone oxidoreductase  putative,>4C (GG2M)
Tb927.8.1250,4894.5,6615.5,7869.0,5683.5,6216.5,Sel1 repeat  putative,S
Tb927.8.1260,10710.5,10784.0,10633.0,10317.0,10465.0,Nucleolar protein 112,G1
Tb927.8.1270,6033.5,5180.0,6089.5,5014.5,7649.5,Nucleolar protein 54,>4C (GG2M)
Tb927.8.1280,11191.0,11303.0,11327.0,11412.0,11301.0,hypothetical protein  conserved,G2M
Tb927.8.1290,11229.0,11463.0,11333.0,11339.5,11451.5,SUMO-interacting motif-containing protein,G1
Tb8.NT.18,6455.0,4790.0,5777.0,5050.5,3447.0,Noncoding RNA  putative,<2C (LG1)
Tb927.8.1300,9078.0,6223.5,6759.5,7611.0,5404.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1305,4057.5,4693.0,4372.0,4841.0,1691.0,hypothetical protein,G2M
Tb927.8.1310,10100.0,6471.5,7131.5,6914.5,4533.5,mitochondrial carrier protein,<2C (LG1)
Tb927.8.1320,9760.0,8137.5,9076.0,9126.5,6890.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1330,2795.5,260.0,507.0,444.5,584.5,60S ribosomal protein L7a  putative,<2C (LG1)
Tb927.8.1340,612.5,1536.0,1536.0,1044.0,721.5,60S ribosomal protein L7a  putative,G1
Tb927.8.1350,1460.0,6429.5,6302.0,5969.0,2016.0,hypothetical protein  conserved,G1
Tb927.8.1360,11455.0,11627.5,11637.0,11647.0,11626.0,Dynein heavy chain  N-terminal region 2  putative,G2M
Tb927.8.1370,612.5,3068.0,3009.0,2617.5,2016.0,hypothetical protein  conserved,G1
Tb927.8.1380,8684.5,8689.0,8741.5,8066.5,8486.0,hypothetical protein  conserved,S
Tb927.8.1381,7723.0,9367.5,8799.5,8159.0,8235.0,M5 ribosomal RNA,G1
Tb927.8.1382,7041.5,8955.0,8479.5,7864.5,7740.0,M5 ribosomal RNA,G1
Tb927.8.1383,7115.0,8923.5,8451.0,7931.0,8071.5,M5 ribosomal RNA,G1
Tb927.8.1384,7709.5,9270.5,8980.5,8061.0,8221.5,M5 ribosomal RNA,G1
Tb927.8.1385,7815.5,9408.5,9076.0,8348.5,8155.5,M5 ribosomal RNA,G1
Tb927.8.1386,7719.5,9423.5,8736.5,8205.0,7994.5,M5 ribosomal RNA,G1
Tb927.8.1387,7802.0,9314.0,8831.0,8089.5,8006.0,M5 ribosomal RNA,G1
Tb927.8.1388,8053.0,9231.5,8603.5,7979.5,8032.5,M5 ribosomal RNA,G1
Tb927.8.1389,5920.5,2864.5,3021.0,2656.5,3033.0,M5 ribosomal RNA (fragment),<2C (LG1)
Tb927.8.1390,9370.0,6148.5,6630.0,7016.0,6173.5,hypothetical protein  conserved  degenerate,<2C (LG1)
Tb927.8.1400,5148.5,3680.0,3410.0,3441.0,3006.0,hypothetical protein  conserved  degenerate,<2C (LG1)
Tb927.8.1410,2682.0,4770.5,5670.5,4542.0,3716.5,pre-rrna-processing protein tsr1 homolog,S
Tb927.8.1420,5673.0,9208.5,9319.0,10007.0,6259.0,acyl-CoA dehydrogenase  mitochondrial precursor  putative,G2M
Tb927.8.1430,2436.0,413.0,630.0,592.5,287.0,SSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.8.1440,612.5,5322.5,4046.5,4662.5,4533.5,maoC-like dehydratase  putative,G1
Tb927.8.1450,4698.0,3120.0,2827.0,3687.5,3271.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1460,9570.5,9463.0,9407.5,9454.0,8709.0,EamA-like transporter family  putative,<2C (LG1)
Tb927.8.1470,10681.0,8463.0,8101.5,7801.5,7806.0,Present in the outer mitochondrial membrane proteome 38,<2C (LG1)
Tb927.8.1480,11193.0,11349.0,11221.0,11191.0,9659.5,RAVE protein 1 C terminal  putative,G1
Tb927.8.1490,612.5,1018.0,1522.0,1922.5,1162.5,Protein of unknown function (DUF1674)  putative,G2M
Tb927.8.1500,7911.0,9431.0,10209.0,10739.0,11538.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.1510,5774.0,9293.5,9224.0,7993.0,9454.0,ATP-dependent RNA helicase DBP2B  putative,>4C (GG2M)
Tb927.8.1520,3510.0,7233.0,7850.5,7553.5,8606.5,NUDIX family hydrolase  putative,>4C (GG2M)
Tb927.8.1530,4978.5,3766.0,3987.0,3724.0,2834.5,Golgi pH regulator  putative,<2C (LG1)
Tb927.8.1540,11374.0,6708.5,6702.5,6626.0,10362.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1550,8796.5,9676.5,9281.5,10000.5,10937.5,paraflagellar rod component  putative,>4C (GG2M)
Tb927.8.1560,612.5,2187.0,2939.0,4019.0,9737.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.1570,4580.0,4806.0,4878.5,4070.5,3386.5,Uncharacterised protein family (UPF0172)  putative,S
Tb927.8.1580,11286.0,9220.5,9475.0,9185.0,8937.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1590,11082.0,11667.0,11631.0,11618.0,11690.0,ubiquitin-protein ligase  putative,>4C (GG2M)
Tb927.8.1600,2970.5,6397.0,7706.0,5862.5,7501.5,lysyl-tRNA synthetase  putative,S
Tb927_08_v4.snoRNA.0025,3341.5,886.5,1067.0,1031.0,1565.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0016,3041.5,543.0,658.5,592.5,797.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0006,2598.0,458.5,491.0,557.5,505.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0001,5099.5,2283.0,2172.5,2120.5,2125.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0026,3630.5,835.5,1078.0,1031.0,1325.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0017,3107.5,652.5,703.0,705.5,721.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0007,2552.0,426.0,313.0,444.5,531.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0002,4086.0,1143.0,1379.5,1003.0,1325.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0027,3630.5,999.0,980.0,957.5,1338.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0018,3179.0,709.0,596.0,610.5,915.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0008,2460.0,438.0,427.0,517.0,531.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0003,5120.0,2187.0,2510.5,2168.5,2065.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0028,3516.5,904.0,1137.0,839.0,1338.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0019,3078.5,690.0,615.0,592.5,744.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0009,2357.5,498.0,357.5,557.5,461.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0004,4027.5,1143.0,1179.5,1125.0,1253.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0029,3487.0,1059.5,1067.0,957.5,1422.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0020,3054.0,747.5,717.5,664.0,948.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0010,2481.0,345.0,448.0,352.0,397.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0005,4316.5,1609.0,1585.5,1451.5,1392.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0030,2619.0,518.0,668.5,687.0,836.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0021,2258.5,664.5,954.0,1202.5,1078.0,C/D snoRNA,<2C (LG1)
Tb927.8.1610,8462.5,9501.0,9411.0,9209.5,8765.5,MSP-B  putative,G1
Tb927.8.1620,9104.0,9828.0,10013.0,9507.0,9419.0,MSP-B  putative,S
Tb927.8.1630,9302.5,10072.0,10088.0,9662.0,9534.5,MSP-B  putative,S
Tb927.8.1640,9305.0,9897.0,9829.0,9690.5,9246.5,MSP-B  putative,G1
Tb927.8.1650,5330.0,7704.0,6900.0,7179.5,5499.0,Protein Associated with Differentiation  putative,G1
Tb927_08_v4.snoRNA.0011,2357.5,426.0,161.0,33.5,287.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0012,2047.0,484.0,547.0,334.5,461.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0031,2406.5,1313.5,954.0,1017.0,1120.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0015,2436.0,640.0,1021.0,610.5,637.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0033,2598.0,716.5,471.5,517.0,853.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0013,2047.0,1437.5,1522.0,1281.0,1304.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0032,3166.5,1482.5,1379.5,1363.5,1141.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0014,612.5,530.0,520.0,647.5,637.0,H/ACA-like snoRNA,G2M
Tb927.8.1660,6781.0,3579.0,4434.0,3367.5,2847.0,procyclin-associated gene (pseudogene)  putative,<2C (LG1)
Tb927.8.1665,6158.0,8632.5,9642.0,9275.0,5593.5,hypothetical protein,S
Tb927.8.1670,4086.0,7024.5,7297.0,7511.5,7518.0,Serine/threonine-protein kinase NEK14  putative,>4C (GG2M)
Tb927.8.1680,3589.5,1945.5,2692.0,2009.0,7494.0,kinetoplastid kinetochore protein 12,>4C (GG2M)
Tb927.8.1690,5511.0,4636.0,6417.0,5683.5,3681.5,Serine/threonine-protein kinase NEK14  putative,S
Tb927.8.1700,8598.0,7529.0,6730.0,6491.0,5487.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1710,10805.0,9091.5,9524.0,9005.5,7559.0,protein phosphatase 2A  regulatory subunit B  putative,<2C (LG1)
Tb927.8.1720,1460.0,8875.5,8582.5,7940.0,6712.0,phosphatidylglycerolphosphate synthase  mitochondrial,G1
Tb927.8.1730,612.5,4872.5,3858.5,4394.5,3524.0,hypothetical protein  conserved,G1
Tb927.8.1740,9461.5,5695.5,6527.5,5926.0,4266.0,Mitochondrial import inner membrane translocase subunit TIM62,<2C (LG1)
Tb927.8.1750,1460.0,1405.5,644.5,907.5,1047.0,Fe-S cluster assembly protein DRE2,<2C (LG1)
Tb927.8.1760,3922.5,799.5,1124.0,647.5,994.0,hypothetical protein,<2C (LG1)
Tb927.8.1770,11328.0,9476.5,9397.0,9885.5,9769.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1780,11523.0,11331.0,11279.5,11330.0,11205.0,STE/STE7 protein kinase  putative,<2C (LG1)
Tb927.8.1790,4321.0,1716.0,1870.0,2373.0,1304.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1800,8441.5,9387.5,9090.5,9755.5,9838.0,Eukaryotic membrane protein family  putative,>4C (GG2M)
Tb927.8.1810,8446.0,4305.0,4622.0,4433.0,5803.0,serine peptidase  Clan S-  family S54  putative,<2C (LG1)
Tb927.8.1820,5369.0,6211.0,7304.5,5728.5,4468.5,sterol carrier protein  putative,S
Tb927.8.1830,612.5,6838.5,7165.0,6688.0,7084.5,tRNA-methyl transferase  putative,S
Tb927.8.1840,10287.0,11024.5,11091.0,11152.5,11188.0,Sec7 domain containing protein  putative,>4C (GG2M)
Tb927.8.1850,9128.5,3353.0,4502.0,4790.0,7579.5,mitochondrial calcium uptake 1,<2C (LG1)
Tb927.8.1860,11318.0,11014.0,11003.0,10954.0,10699.0,pitrilysin-like metalloprotease,<2C (LG1)
Tb927.8.1870,8520.5,4950.0,3288.0,4894.5,2505.5,Golgi/lysosome glycoprotein 1,<2C (LG1)
Tb927.8.1880,8395.5,7297.5,8285.0,8397.0,6774.5,LSU ribosomal protein  mitochondrial  putative,G2M
Tb927.8.1890,8562.5,9793.0,9374.5,10080.0,10227.0,cytochrome c1  heme protein  mitochondrial  putative,>4C (GG2M)
Tb927.8.1900,3202.0,1101.5,1428.0,3168.0,1027.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.1910,3494.5,7073.0,6561.5,4711.5,6412.5,metallo-peptidase  Clan MH  Family M18,G1
Tb927.8.1920,5689.5,727.0,336.0,557.5,1676.0,histone-lysine n-methyltransferase,<2C (LG1)
Tb927.8.1930,612.5,235.5,189.5,159.0,287.0,Isy1-like splicing family  putative,<2C (LG1)
Tb927.8.1940,612.5,896.0,756.5,808.0,1213.5,endosomal integral membrane protein  putative,>4C (GG2M)
Tb927.8.1945,1460.0,1975.0,2103.5,2252.0,3596.5,hypothetical protein,>4C (GG2M)
Tb927.8.1950,1783.5,6039.0,4632.5,6637.0,7834.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.1960,612.5,5683.5,5771.0,5662.0,6581.0,CCR4-NOT transcription complex subunit 11,>4C (GG2M)
Tb927.8.1970,612.5,4719.0,5109.5,4951.0,6112.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.1980,612.5,6591.5,5808.0,5353.5,5220.0,Beta propeller protein 1,G1
Tb927.8.1990,4801.0,1940.0,2207.0,1642.5,1281.5,peroxidoxin,<2C (LG1)
Tb927.8.2000,6767.0,5706.5,7033.5,6558.5,6719.5,cyclophilin  putative,S
Tb927.8.2010,7224.0,4886.5,5696.5,5883.5,4005.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2020,2295.5,7362.0,6236.5,7021.5,8865.5,agmatinase  putative,>4C (GG2M)
Tb927.8.2030,10007.5,4486.5,5239.0,5517.5,8016.5,Posterior and Ventral Edge protein 1,<2C (LG1)
Tb927.8.2040,10495.5,9100.5,7994.5,8368.0,8893.0,Domain of unknown function (DUF1767)  putative,<2C (LG1)
Tb927.8.2050,4637.0,3397.0,4518.5,4542.0,4128.5,GDP-mannose pyrophosphorylase,<2C (LG1)
Tb927.8.2060,11637.0,11531.0,11599.0,11609.0,11576.0,Concanavalin A-like lectin/glucanases superfamily/Beige/BEACH domain containing protein  putative,<2C (LG1)
Tb927_08_v4.snoRNA.0022,5230.5,904.0,1179.5,1313.5,1472.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0035,5167.5,1266.0,2207.0,1609.0,2141.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0037,4086.0,811.0,925.0,989.0,1195.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0040,4211.5,716.5,795.0,687.0,1304.5,H/ACA-like snoRNA,<2C (LG1)
Tb927.8.2070,3606.0,2820.5,2750.5,2764.5,2178.0,Present in the outer mitochondrial membrane proteome 39-1,<2C (LG1)
Tb927_08_v4.snoRNA.0041,3252.5,759.0,808.5,862.0,1636.0,H/ACA-like snoRNA,<2C (LG1)
Tb927.8.2080,612.5,2920.5,3410.0,3978.5,5092.0,Fungal tRNA ligase phosphodiesterase domain containing protein  putative,>4C (GG2M)
Tb927_08_v4.snoRNA.0023,2658.5,2149.5,2122.5,2470.5,2609.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0036,3120.5,2051.0,1999.5,1980.0,2619.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0038,2137.5,2335.0,1945.0,2764.5,2819.0,C/D snoRNA,>4C (GG2M)
Tb927.8.2090,2481.0,4199.5,3167.0,5489.0,5600.5,cyclophilin type peptidyl-prolyl cis-trans isomerase  putative,>4C (GG2M)
Tb927.8.2100,3078.5,1991.5,2050.0,1003.0,433.0,vacuolar ATP synthase 16 kDa proteolipid subunit  putative,<2C (LG1)
Tb927.8.2110,2970.5,3827.0,3344.0,4112.0,3960.5,Alpha/beta hydrolase family  putative,G2M
Tb927.8.2120,11054.0,8211.5,7312.0,6969.0,8765.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2130,11073.5,8949.0,8281.5,8637.5,8353.5,cyclic nucleotide-binding domain containing protein  putative,<2C (LG1)
Tb927.8.2140,612.5,2714.5,1771.5,1936.0,2574.5,hypothetical protein  conserved,G1
Tb927.8.2150,2920.5,952.0,2103.5,1125.0,2819.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2160,10206.0,11133.5,10996.5,10905.0,10926.0,p-glycoprotein,G1
Tb927.8.2170,4594.0,3658.5,3108.5,2840.5,5044.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2180,2137.5,3164.5,2949.5,2290.0,3879.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2185,612.5,855.5,615.0,1044.0,1717.0,hypothetical protein,>4C (GG2M)
Tb927.8.2190,8027.0,1078.5,1041.5,1352.5,1392.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2200,7906.5,4703.0,3354.5,2940.5,2178.0,terbinafine resistance locus protein (yip1)  putative,<2C (LG1)
Tb927.8.2210,2598.0,3606.5,4462.5,4579.0,3861.0,pteridine reductase 1,G2M
Tb927.8.2220,10270.0,11085.0,11023.0,11137.5,10827.0,hypothetical protein  conserved,G2M
Tb927.8.2230,6069.0,3849.0,3364.5,3856.5,4231.5,Checkpoint protein HUS1  putative,<2C (LG1)
Tb927.8.2240,612.5,6550.5,6583.0,6940.5,5996.5,Tryptophanyl-tRNA synthetase 2,G2M
Tb927.8.2250,4449.5,8440.0,7983.0,8048.0,8121.0,Fungal tRNA ligase phosphodiesterase domain containing protein  putative,G1
Tb927_08_v4.snoRNA.0024,2658.5,449.0,336.0,313.5,584.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0034,2329.5,530.0,994.0,610.5,1213.5,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0039,3987.5,845.0,1149.5,1017.0,1253.0,C/D snoRNA,<2C (LG1)
Tb927_08_v4.snoRNA.0042,4074.0,727.0,471.5,773.0,1010.0,H/ACA-like snoRNA,<2C (LG1)
Tb927.8.2260,9796.0,8843.0,8160.5,8290.0,7426.0,Present in the outer mitochondrial membrane proteome 39-2,<2C (LG1)
Tb927_08_v4.snoRNA.0043,3191.0,458.5,578.5,334.5,721.5,H/ACA-like snoRNA,<2C (LG1)
Tb927.8.2270,4792.5,5128.0,4057.0,4587.0,3235.0,Present in the outer mitochondrial membrane proteome 39-3,G1
Tb927_08_v4.snoRNA.0044,3241.5,600.0,507.0,534.5,933.5,H/ACA-like snoRNA,<2C (LG1)
Tb927.8.2280,10311.5,9509.0,8892.5,9430.5,9131.0,Present in the outer mitochondrial membrane proteome 39-4,<2C (LG1)
Tb927.8.2290,7702.0,4560.0,4911.0,3168.0,4813.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2300,5876.5,5862.0,4990.5,6974.5,4571.0,hypothetical protein  conserved,G2M
Tb927.8.2310,5981.0,5474.0,5025.0,3596.5,4586.5,(H+)-ATPase G subunit  putative,<2C (LG1)
Tb927.8.2320,1460.0,3799.0,3560.0,3737.0,5199.0,hypothetical protein,>4C (GG2M)
Tb927.8.2330,3945.0,4155.5,3711.0,4818.5,6088.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2340,10456.0,7137.0,6401.0,7547.0,8032.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2350,1460.0,3842.0,5276.5,4662.5,3335.5,hypothetical protein  conserved,S
Tb927.8.2360,1460.0,1679.0,954.0,2907.5,721.5,mediator of rna polymerase ii transcription subunit 4,G2M
Tb927.8.2370,10165.0,10978.0,10704.5,10815.0,10156.0,dicer-like protein,G1
Tb927.8.2380,10729.5,10911.0,10998.5,10969.5,10839.0,ABC transporter  putative,S
Tb927.8.2390,10905.0,11172.0,10990.0,11111.0,11014.0,hypothetical protein  conserved,G1
Tb927.8.2395,612.5,1565.5,1771.5,1888.0,1407.5,hypothetical protein,G2M
Tb927.8.2400,9484.0,5136.0,3127.0,4057.0,1531.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2410,7528.0,9016.5,8994.0,9331.5,8690.5,amidase  putative,G2M
Tb927.8.2420,10564.0,8737.5,8430.5,8094.5,6038.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2430,5713.5,9945.0,10284.5,9979.5,10168.0,hypothetical protein  conserved,S
Tb927.8.2440,7794.5,4065.5,5704.5,6157.0,8146.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2450,1460.0,7237.5,7979.5,7762.0,5420.5,5'-AMP-activated protein kinase subunit beta,S
Tb927.8.2460,2295.5,2785.5,2564.5,2603.0,2786.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2470,4313.5,1904.5,1603.5,1071.0,818.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2480,5743.0,5446.5,3969.5,3888.5,2870.0,3-oxo-5-alpha-steroid 4-dehydrogenase-like  putative,<2C (LG1)
Tb8.NT.41,2406.5,398.0,668.5,334.5,721.5,Noncoding RNA  putative,<2C (LG1)
Tb927.8.2490,8748.0,6858.5,6556.0,6768.0,5916.5,SET domain containing protein  putative,<2C (LG1)
Tb927.8.2500,2258.5,7799.5,7562.5,8066.5,6864.5,ribosomal RNA methyltransferase  putative,G2M
Tb927.8.2510,612.5,7321.0,7183.5,7304.5,6270.0,hypothetical protein  conserved,G1
Tb927.8.2520,8800.5,6373.5,7365.0,6267.5,2243.5,acetyl-CoA synthetase  putative,<2C (LG1)
Tb927.8.2530,612.5,626.0,1446.0,1313.5,2268.0,Cytochrome c oxidase copper chaperone  related,>4C (GG2M)
Tb927.8.2540,9812.5,5867.5,6102.0,5037.0,6737.5,3-ketoacyl-CoA thiolase,<2C (LG1)
Tb927.8.2550,10461.5,10938.0,10902.5,10902.0,10452.0,mitochondrial DNA primase,G1
Tb927.8.2560,7320.0,4456.0,4868.0,5014.5,5664.0,spliceosomal U5 snRNP-specific protein  putative,<2C (LG1)
Tb927.8.2570,10352.5,9621.0,9653.5,9653.5,8228.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2580,10779.0,9226.5,9622.0,9249.5,7788.0,exocyst complex component Sec10  putative,<2C (LG1)
Tb927.8.2590,6867.0,5463.0,5109.5,5342.5,4664.5,Basal body protein,<2C (LG1)
Tb927.8.2600,5573.5,6301.5,7685.0,4301.0,5888.5,WD domain  G-beta repeat/BING4CT (NUC141) domain containing protein  putative,S
Tb8.NT.42,3142.5,1894.5,1945.0,1585.5,1239.0,Noncoding RNA  putative,<2C (LG1)
Tb927.8.2610,7948.0,4663.0,6883.0,5799.5,5432.0,5-methyltetrahydropteroyltriglutamate-homocysteine S-methyltransferase  putative,<2C (LG1)
Tb927.8.2620,3957.5,7176.5,8179.5,8348.5,11049.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.8.2630,3929.5,7962.0,6624.0,8211.5,11593.0,kinesin-C,>4C (GG2M)
Tb927.8.2640,6426.0,9512.0,9604.5,9559.0,10266.5,ubiquitin-activating enzyme E1  putative,>4C (GG2M)
Tb927.8.2650,10862.0,6334.0,7365.0,6919.5,6712.0,metallo-beta-lactamase-like protein  putative,<2C (LG1)
Tb927.8.2660,9720.0,11082.0,10780.0,10239.0,10763.0,Galactose oxidase  central domain containing protein  putative,G1
Tb927.8.2663,5379.0,2630.0,2586.5,2440.0,1422.0,tRNA Asparagine,<2C (LG1)
Tb927.8.2666,3394.0,1704.5,1831.0,1688.5,1828.0,tRNA Tryptophan,<2C (LG1)
Tb927.8.2670,612.5,2000.5,2092.5,1526.5,3399.5,Putative S-adenosyl-L-methionine-dependent methyltransferase  putative,>4C (GG2M)
Tb927.8.2680,10980.5,7447.5,8229.5,8368.0,6059.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2690,11181.0,10780.0,10803.5,10812.0,10201.0,SET domain containing protein  putative,<2C (LG1)
Tb927.8.2700,2729.0,2934.5,2144.5,2184.5,7453.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2710,9812.5,10741.5,11078.5,10932.0,10614.0,SET domain containing protein  putative,S
Tb927.8.2720,8721.5,8355.0,8683.0,8492.5,8012.5,Putative serine esterase (DUF676)  putative,<2C (LG1)
Tb927.8.2730,8185.5,8237.5,8600.5,7925.5,6836.0,hypothetical protein  conserved,S
Tb927.8.2740,1460.0,3799.0,5938.0,4531.5,2679.0,mitochondrial RNA binding protein,S
Tb927.8.2750,2047.0,5474.0,6034.5,4798.0,5880.0,hypothetical protein  conserved,S
Tb927.8.2760,8756.5,5689.0,7018.5,6035.0,1549.5,50S ribosome-binding GTPase  putative,<2C (LG1)
Tb927.8.2770,11483.0,11598.0,11627.0,11624.0,11571.0,inositol 1 4 5-trisphosphate receptor,S
Tb927.8.2780,3510.0,3813.5,2011.5,2072.5,3510.5,RNA-binding protein RBP10  putative,G1
Tb927.8.2790,1460.0,307.0,161.0,136.5,433.0,acetyl-CoA synthetase  truncated,<2C (LG1)
Tb927.8.2800,3224.0,4323.0,3551.5,4636.5,4947.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2810,9163.5,10878.0,10775.0,10652.0,10201.0,5'-3' exoribonuclease C,G1
Tb927.8.2820,3888.5,5829.5,5696.5,6381.0,6909.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2830,10606.5,9971.5,10312.5,9926.0,10134.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2840,5969.0,8881.5,6936.0,7953.0,7412.0,hypothetical protein  conserved,G1
Tb927.8.2850,1783.5,7128.5,5908.5,5899.5,7720.0,Poly(A)-specific ribonuclease PARN-1,>4C (GG2M)
Tb927.8.2851,2813.0,509.0,532.5,397.5,721.5,tRNA Isoleucine,<2C (LG1)
Tb927.8.2852,2795.5,260.0,271.5,419.0,761.5,tRNA Glutamine,<2C (LG1)
Tb927.8.2853,2460.0,413.0,507.0,248.0,964.0,tRNA Valine,<2C (LG1)
Tb927.8.2854,2535.5,709.0,778.0,788.5,1622.5,tRNA Lysine,<2C (LG1)
Tb927.8.2855,5844.5,3235.0,4271.0,2893.5,2834.5,small nuclear RNA,<2C (LG1)
Tb927.8.2856,4626.0,2592.5,3138.0,2671.0,2758.5,tRNA Glycine,<2C (LG1)
Tb927.8.2857,612.5,543.0,795.0,925.0,86.0,tRNA Leucine,G2M
Tb927.8.2858,612.5,823.0,1489.0,1299.0,994.0,tRNA Threonine,S
Tb927.8.2859,612.5,2551.0,3233.0,2541.0,1896.5,tRNA Arginine,S
Tb927.8.2861,1783.5,4486.5,2341.0,2506.5,3825.5,SRP RNA  7SL,G1
Tb927.8.2862,612.5,373.5,471.5,334.5,607.0,tRNA Lysine,<2C (LG1)
Tb927.8.2863,612.5,358.0,336.0,366.5,697.5,tRNA Arginine,>4C (GG2M)
Tb927.8.2864,612.5,999.0,1289.5,974.5,2692.0,small nuclear RNA,>4C (GG2M)
Tb927.8.2860,10623.5,9776.5,9569.0,9253.0,9032.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2870,9362.5,9062.0,9090.5,8374.0,8508.5,conserved protein,<2C (LG1)
Tb927.8.2880,7627.5,10692.0,10849.0,10988.5,10719.5,hypothetical protein  conserved,G2M
Tb927.8.2890,11687.0,10651.5,9150.0,9637.0,11212.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2900,7387.5,4199.5,4411.0,4126.5,4533.5,mannosyl-oligosaccharide 1 2-alpha-mannosidase IB  fragment,<2C (LG1)
Tb927.8.2910,7063.0,5765.0,6393.0,5307.5,6581.0,ER degradation-enhancing alpha-mannosidase-like protein 1  putative,<2C (LG1)
Tb927.8.2920,7041.5,7317.5,7023.5,6738.5,6183.0,ER degradation-enhancing alpha-mannosidase-like protein 2  putative,G1
Tb927.8.2930,8857.0,7518.0,7958.5,6748.5,8193.0,ER degradation-enhancing alpha-mannosidase-like protein 3  putative,<2C (LG1)
Tb927.8.2940,7306.5,6572.5,6838.0,6434.5,6511.5,ER degradation-enhancing alpha-mannosidase-like protein 4  putative,<2C (LG1)
Tb927.8.2950,9502.5,8081.0,6947.5,7314.0,7471.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.2960,6746.5,9975.0,10107.0,9955.5,10137.5,Probable methyltransferase BTM2 homolog,>4C (GG2M)
Tb927.8.2970,612.5,700.5,578.5,687.0,1120.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.2980,4170.0,6148.5,7718.5,5365.0,6690.0,Bis(5'-adenosyl)-triphosphatase  putative,S
Tb927.8.2990,1460.0,6380.0,6022.5,6313.0,4839.5,5-formyltetrahydrofolate cyclo-ligase family  putative,G1
Tb927.8.3000,4544.0,7203.0,7091.5,7592.5,8268.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.3010,6248.5,10310.0,10173.5,9831.0,10137.5,hook complex protein  conserved,G1
Tb927.8.3020,10597.5,11571.0,11524.0,11528.0,11492.0,hypothetical protein  conserved,G1
Tb927.8.3040,1460.0,1773.5,2351.5,2566.5,3524.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.3050,9370.0,9226.5,8219.5,8277.5,9978.5,Chitobiase/beta-hexosaminidase C-terminal domain containing protein  putative,>4C (GG2M)
Tb927.8.3060,3741.5,3881.5,3801.5,3815.5,4440.0,metallo-peptidase  Clan MF  Family M17,>4C (GG2M)
Tb927.8.3070,612.5,886.5,778.0,292.5,721.5,hypothetical protein  conserved,G1
Tb927.8.3080,10875.0,10116.5,10696.0,10657.0,11093.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.3090,612.5,5136.0,5044.5,5765.5,5153.5,hypothetical protein  conserved,G2M
Tb927.8.3100,8925.0,6626.0,5945.5,5662.0,8321.0,coronin  putative,<2C (LG1)
Tb927.8.3110,8408.0,3967.5,4550.5,3805.5,5135.5,Mitochondrial ribosomal protein S9,<2C (LG1)
Tb927.8.3120,6689.0,5151.5,5276.5,5109.5,5609.5,Uncharacterised protein family UPF0546  putative,<2C (LG1)
Tb927.8.3130,5477.5,3561.5,4887.0,4908.0,3144.5,S-adenosyl-methyltransferase mraW-like protein  putative,<2C (LG1)
Tb927.8.3140,612.5,9484.0,8831.0,8385.0,9092.5,SIR2-like protein 4  putative,G1
Tb927.8.3150,1460.0,222.0,1199.5,1526.5,8169.0,T-complex protein 1  gamma subunit  putative,>4C (GG2M)
Tb927.8.3160,3638.0,1716.0,2939.0,1504.0,1453.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3170,4713.5,8750.5,8420.5,7336.5,7177.5,kinetoplast ribosomal PPR-repeat containing protein 9,G1
Tb927.8.3180,8680.5,10517.0,10420.0,10379.5,8797.0,Protein of unknown function (DUF3250)  putative,G1
Tb927.8.3190,10076.0,6992.5,8157.5,9222.5,8727.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3200,9422.0,10831.0,10811.0,11047.0,11122.0,Rapamycin-insensitive companion of TOR2,>4C (GG2M)
Tb927.8.3210,8671.5,6874.5,7466.5,5353.5,6074.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3220,5349.0,7331.5,7696.5,7702.0,8294.5,Exodeoxyribonuclease 1,>4C (GG2M)
Tb927.8.3230,7448.5,7656.0,7076.5,6282.0,7098.5,hypothetical protein  conserved,G1
Tb927.8.3240,1783.5,4583.0,2919.0,3826.0,1703.0,lathosterol oxidase  putative,G1
Tb927.8.3250,2714.5,3367.5,2134.0,2290.0,10948.0,dynein heavy chain  putative,>4C (GG2M)
Tb927.8.3260,8389.5,7667.5,7850.5,8712.0,9668.5,YceI-like domain containing protein  putative,>4C (GG2M)
Tb927.8.3270,4490.0,3023.5,3354.5,4301.0,2376.0,hypothetical protein,<2C (LG1)
Tb927.8.3280,10807.5,8226.5,7756.0,7434.0,8575.0,Beta-lactamase superfamily domain containing protein  putative,<2C (LG1)
Tb927.8.3290,11363.0,11553.0,11498.0,11476.0,11075.5,DNA polymerase zeta catalytic subunit  putative,G1
Tb927.8.3300,9903.0,6626.0,7547.0,7506.5,4725.0,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.8.3310,7507.5,8835.0,8857.5,8597.5,7720.0,Elongator-like Protein 3b,S
Tb927.8.3320,1460.0,6620.0,7786.5,6796.5,6975.5,Mitochondrial ATP synthase subunit  putative,S
Tb927.8.3330,3241.5,8284.0,8446.0,8649.5,3981.5,mitochondrial carrier protein,G2M
Tb927.8.3340,8582.5,4711.5,4380.5,5228.0,5174.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3350,9440.0,10025.5,9867.5,10106.0,8657.0,DNA polymerase theta (helicase domain only)  putative,G2M
Tb927.8.3360,4159.0,787.5,578.5,974.5,397.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3370,6291.5,5816.0,5717.5,6322.0,5675.0,Ran-binding protein  putative,G2M
Tb927.8.3380,8434.0,7818.0,8028.5,7900.0,6857.0,succinate dehydrogenase iron-sulfur subunit,<2C (LG1)
Tb927.8.3390,5938.5,6229.5,5875.5,6397.5,7098.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.3400,9954.0,8872.0,8295.5,7486.0,6932.5,palmitoyl acyltransferase 12  putative,<2C (LG1)
Tb927.8.3410,8161.5,10640.0,10809.5,10769.5,11321.5,Inositol hexakisphosphate  putative,>4C (GG2M)
Tb927.8.3420,5851.5,7479.0,7274.0,6779.5,7662.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.3430,3419.0,867.5,448.0,382.0,461.5,Meckel syndrome type 1 protein  putative,<2C (LG1)
Tb927.8.3440,612.5,498.0,717.5,248.0,347.0,hypothetical protein  conserved,S
Tb927.8.3450,6867.0,5095.5,5808.0,6240.5,5898.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3460,10992.5,9974.0,9356.5,8704.5,8213.5,Ring finger domain containing protein  putative,<2C (LG1)
Tb927.8.3470,2747.5,3313.0,2453.0,3013.0,2758.5,Vesicle transport v-SNARE protein N-terminus  putative,G1
Tb927.8.3480,1460.0,3687.0,2092.5,1875.5,1929.5,hypothetical protein  conserved,G1
Tb927.8.3490,6724.5,9570.0,9460.5,9588.0,8754.0,Gryzun  putative trafficking through Golgi  putative,G2M
Tb927.8.3500,10969.0,8408.5,8340.0,8342.0,8000.0,mms19 nucleotide excision repair protein homolog,<2C (LG1)
Tb927.8.3510,7096.0,3579.0,4622.0,4126.5,3888.0,thymidylate kinase  putative,<2C (LG1)
Tb927.8.3520,6772.0,6115.0,6866.5,8011.5,7334.5,hypothetical protein  conserved,G2M
Tb927.8.3521,1914.0,1322.5,1347.5,737.0,461.5,hypothetical protein,<2C (LG1)
Tb927.8.3523,2813.0,543.0,491.0,517.0,531.0,tRNA Cysteine,<2C (LG1)
Tb927.8.3526,2747.5,626.0,471.5,557.5,761.5,tRNA Cysteine,<2C (LG1)
Tb927.8.3530,2855.0,2344.0,2440.5,2102.5,3669.0,glycerol-3-phosphate dehydrogenase [NAD+]  glycosomal,>4C (GG2M)
Tb927.8.3540,11598.0,11139.0,11096.5,11041.0,11426.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3550,6552.0,7561.5,7316.0,6909.0,6890.0,mitogen-activated protein kinase 3  putative,G1
Tb927.8.3560,10090.5,8165.5,9537.5,9550.0,10095.5,DNA repair and recombination helicase protein PIF5,>4C (GG2M)
Tb927.8.3570,9333.0,9245.0,8902.0,9390.5,10012.5,Zinc finger  C3HC4 type (RING finger)  putative,>4C (GG2M)
Tb927.8.3580,8154.5,7822.0,7359.5,7333.0,4947.0,mitochondrial chaperone BCS1  putative,<2C (LG1)
Tb927.8.3590,8475.0,7262.5,7782.0,6531.0,4028.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3600,4459.5,1530.0,1300.0,705.5,213.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3610,10562.5,9665.0,9622.0,10425.0,9032.0,AKAP7 2'5' RNA ligase-like domain containing protein  putative,<2C (LG1)
Tb927.8.3620,6123.0,9325.0,8980.5,8874.5,7484.5,folate transporter  putative,G1
Tb927.8.3630,5955.0,6958.5,7850.5,8511.5,5567.0,folate transporter  putative,G2M
Tb927.8.3640,1460.0,6403.5,7220.5,5917.0,8249.0,JAB1/Mov34/MPN/PAD-1 ubiquitin protease  putative,>4C (GG2M)
Tb927.8.3650,7153.0,8421.0,8375.5,8945.0,6757.0,folate transporter  putative,G2M
Tb927.8.3660,10446.0,9916.0,9798.5,9858.5,9071.5,protein transport protein SEC23,<2C (LG1)
Tb927.8.3680,10690.0,9372.5,9055.5,9557.0,8933.0,kinetoplastid kinetochore protein 4,<2C (LG1)
Tb927.8.3690,1460.0,9861.0,9786.0,10065.0,8173.5,isocitrate dehydrogenase [NADP]  mitochondrial precursor  putative,G2M
Tb927.8.3700,11326.0,11386.0,11334.5,11237.0,11218.5,hypothetical protein  conserved,G1
Tb927.8.3710,10920.0,9875.0,9827.0,9632.5,10128.0,3'-5' exonuclease,<2C (LG1)
Tb927.8.3720,7130.0,6282.5,7433.0,6796.5,7745.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.8.3730,5361.5,4429.5,4010.5,4981.0,3638.0,COPI associated protein  putative,<2C (LG1)
Tb927.8.3740,2574.5,3881.5,6055.5,5159.0,3658.5,pterin 4 alpha carbinolamine dehydratase  putative,S
Tb927.8.3750,2943.0,4653.0,4711.5,4647.0,2454.0,nucleolar protein 56,S
Tb927.8.3770,8654.5,8219.0,7958.5,8379.0,5499.0,Mitogen-activated protein kinase 10  putative,<2C (LG1)
Tb927.8.3780,8344.0,8923.5,7939.0,7987.5,7104.0,MORN repeat  putative,G1
Tb927.8.3790,8214.5,5045.5,4283.5,4542.0,6984.0,paraflagellar rod component  putative,<2C (LG1)
Tb927.8.3800,7385.0,9419.0,8536.5,8773.0,8338.0,guanosine diphosphatase  putative,G1
Tb927.8.3810,8209.5,7610.0,8348.0,8589.5,10662.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.3820,10208.5,8933.5,9873.0,9304.5,9749.0,Stress granule protein,<2C (LG1)
Tb927.8.3830,10252.5,10238.0,10021.5,10442.0,10736.0,mitochondrial,>4C (GG2M)
Tb927.8.3840,10873.5,8955.0,8664.5,9018.0,10777.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3850,7797.5,3956.5,4799.0,5728.5,8353.5,PSP1 C-terminal conserved region  putative,>4C (GG2M)
Tb927.8.3860,5834.0,2795.0,3215.0,3087.5,4893.5,cytosolic iron-sulfur protein assembly 1,<2C (LG1)
Tb927.8.3870,9755.0,9290.5,8087.5,7702.0,6328.0,Nucleolar protein 127,<2C (LG1)
Tb927.8.3880,5524.5,6561.0,5334.5,6018.0,3185.0,hypothetical protein  conserved,G1
Tb927.8.3890,5831.5,7834.5,6966.5,6322.0,4014.5,hypothetical protein  conserved,G1
Tb927.8.3900,5573.5,7362.0,7372.0,6996.5,4550.5,hypothetical protein  conserved,S
Tb927.8.3910,7173.0,5121.0,5153.5,5180.0,3125.5,thymidylate kinase  putative,<2C (LG1)
Tb927.8.3920,10080.0,6620.0,6893.0,7053.0,6216.5,mms19 nucleotide excision repair protein homolog,<2C (LG1)
Tb927.8.3930,5643.5,8625.5,8044.5,8402.5,8198.0,Gryzun  putative trafficking through Golgi  putative,G1
Tb927.8.3940,11266.0,7886.5,7076.5,7826.0,6195.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3950,11085.0,11046.0,10994.5,10603.5,10609.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3960,4767.5,6890.0,6910.5,6452.5,7740.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.3970,9465.5,8721.5,8217.0,7252.0,9017.0,oxidoreductase  putative,<2C (LG1)
Tb927.8.3980,10530.0,9651.0,10346.5,9862.5,9079.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.3990,5266.0,5236.0,4502.0,3029.0,1944.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4000,6154.5,7912.0,9298.0,8619.0,7792.5,ABC1 family  putative,S
Tb927.8.4010,1988.0,8662.0,7712.0,9086.5,9811.5,Flagellum adhesion protein 1,>4C (GG2M)
Tb927.8.4020,612.5,5322.5,4598.0,4872.5,5555.0,Zinc finger CCCH domain-containing protein 24,>4C (GG2M)
Tb927.8.4030,1460.0,3032.5,3092.0,2530.5,2834.5,class I transcription factor A  subunit 5a,S
Tb927.8.4040,6925.5,8317.0,7912.5,7891.0,7226.0,endonuclease G  putative,G1
Tb927.8.4050,11369.0,10931.0,10801.0,10781.0,9790.5,FLA1-binding protein,<2C (LG1)
Tb927.8.4060,6772.0,3120.0,3127.0,3965.5,11069.5,Flagellum adhesion protein 2  putative,>4C (GG2M)
Tb927.8.4070,1460.0,4188.5,3354.5,3950.5,4292.0,zinc finger protein family member  putative,>4C (GG2M)
Tb927.8.4080,1460.0,2429.0,2764.5,2617.5,2574.5,hypothetical protein  conserved,S
Tb927.8.4090,7134.5,9166.5,9133.5,9109.5,7806.0,endonuclease G  putative,G1
Tb927.8.4100,11225.0,10362.0,10179.0,10083.0,9173.5,FLA1-binding protein,<2C (LG1)
Tb927.8.4110,6741.5,2707.5,2987.0,3367.5,11110.0,Flagellum adhesion protein 3  putative,>4C (GG2M)
Tb927.8.4120,1460.0,5349.5,4767.5,4852.5,5332.5,zinc finger protein family member  putative,G1
Tb927.8.4130,612.5,1448.0,1932.0,1542.0,948.5,class I transcription factor A  subunit 5b,S
Tb927.8.4140,3570.5,4615.5,4010.5,3356.0,2442.5,Anaphase-promoting complex-associated protein AP3,G1
Tb927.8.4150,8204.5,6575.0,7098.0,5392.0,5713.5,rhomboid-like protein,<2C (LG1)
Tb927.8.4160,11699.0,11593.0,11564.0,11595.0,11529.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4170,1460.0,5338.5,4732.5,4045.0,6319.0,RNA-binding protein  putative,>4C (GG2M)
Tb927.8.4175,9383.5,7226.5,5500.5,5741.0,6522.5,hypothetical protein,<2C (LG1)
Tb927.8.4180,5111.0,2696.5,2919.0,3566.5,4770.5,tRNA-specific adenosine deaminase,<2C (LG1)
Tb927.8.4190,3272.0,6380.0,4990.5,6549.5,6112.5,hypothetical protein  conserved,G2M
Tb927.8.4200,9252.0,10612.5,10266.0,10874.0,10806.0,hypothetical protein  conserved,G2M
Tb927.8.4210,3726.5,5151.5,5325.5,5816.0,10297.0,basal body component  putative,>4C (GG2M)
Tb927.8.4220,8288.5,4194.0,5408.5,6531.0,4468.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4230,6604.5,10269.5,10256.5,9759.0,9868.5,hypothetical protein  conserved,G1
Tb927.8.4240,11655.0,11487.0,11486.5,11377.0,11459.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4250,8066.5,5941.5,6218.5,5981.0,3775.0,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,<2C (LG1)
Tb927.8.4260,1914.0,9676.5,9497.0,10037.0,9383.0,serine/threonine-protein kinase  putative,G2M
Tb927.8.4270,7317.0,8379.0,9292.0,8916.5,8103.5,hypothetical protein  conserved,S
Tb927.8.4280,5550.0,3245.0,2300.0,1688.5,2953.5,nuclear transport factor 2  putative,<2C (LG1)
Tb927.8.4290,612.5,5251.5,5744.0,5463.0,6870.5,Ribosome biogenesis protein Nop16  putative,>4C (GG2M)
Tb927.8.4300,4480.0,6578.0,6866.5,7662.5,6928.0,hypothetical protein,G2M
Tb927.8.4310,6381.5,7073.0,8621.0,8005.5,6749.5,hypothetical protein  conserved,S
Tb927.8.4320,2504.5,7223.0,7844.5,8168.5,8685.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.4330,6874.5,1727.5,1831.0,2311.0,2472.5,small GTP-binding protein Rab11,<2C (LG1)
Tb927.8.4340,7402.5,6782.5,7151.0,7065.0,7249.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4350,10396.0,11064.0,11206.5,11137.5,10037.0,hypothetical protein  conserved,S
Tb927.8.4360,8787.5,9402.5,10061.0,9876.5,7184.5,hypothetical protein  conserved,S
Tb927.8.4370,6636.0,10418.0,10646.5,10550.5,11055.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.4380,612.5,358.0,547.0,444.5,797.5,Archaic translocase of outer membrane 12 kDa subunit,>4C (GG2M)
Tb927.8.4390,7704.5,9779.0,9867.5,9673.5,8821.0,translation initiation factor eIF-2B subunit beta  putative,S
Tb927.8.4400,9192.5,7945.5,8741.5,9620.0,11489.5,Outer dynein arm docking complex protein 1  putative,>4C (GG2M)
Tb927.8.4410,5505.0,7362.0,8591.5,8181.0,6183.0,ARP2/3 complex subunit  putative,S
Tb927.8.4420,3179.0,2760.5,2310.0,2237.0,1816.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4430,6538.0,6824.0,6159.0,6138.0,3906.0,uridine phosphorylase,G1
Tb927.8.4440,6158.0,5746.5,3832.5,3826.0,4089.5,mitochondrial carrier protein,<2C (LG1)
Tb927.8.4450,10231.0,10218.0,10346.5,9908.5,10221.0,RNA-binding protein  putative,S
Tb927.8.4460,8173.5,9175.5,10041.0,9119.5,11252.0,Domain of Unknown Function (DUF1042)  putative,>4C (GG2M)
Tb927.8.4470,6212.5,4163.0,6672.5,5949.0,6472.5,chaperone protein DnaJ  putative,S
Tb927.8.4480,3468.5,3941.5,4815.0,5087.5,5548.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.4490,1460.0,867.5,1054.0,925.0,853.0,hypothetical protein,<2C (LG1)
Tb927.8.4500,9243.5,9378.0,9446.5,9408.5,8754.0,Eukaryotic translation initiation factor 4 gamma 5,S
Tb927.8.4510,4784.0,8137.5,8650.5,8391.0,9907.0,Nucleoside diphosphate kinase 4,>4C (GG2M)
Tb927.8.4520,3794.5,4145.5,4283.5,4940.5,4014.5,hypothetical protein  conserved,G2M
Tb927.8.4530,4505.5,7834.5,7393.0,7642.5,6712.0,hypothetical protein  conserved,G1
Tb927.8.4540,2180.0,2402.0,3239.0,4636.5,6596.5,PAB1-binding protein   putative,>4C (GG2M)
Tb927.8.4550,2552.0,4429.5,4904.5,4598.0,2834.5,Mitochondrial SSU ribosomal protein  putative,S
Tb927.8.4560,11041.0,8716.0,7151.0,7291.5,6048.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4570,9138.0,9144.0,10516.5,10204.0,9749.0,Zinc finger  C3HC4 type (RING finger)  putative,S
Tb927.8.4580,2180.0,1789.5,1574.0,2422.0,4480.5,Basal body protein,>4C (GG2M)
Tb927.8.4590,2047.0,3596.0,2876.5,2967.0,4014.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.4600,8680.5,6878.0,6288.0,6784.5,5092.0,Zinc finger  C3HC4 type (RING finger)  putative,<2C (LG1)
Tb927.8.4610,3848.5,2335.0,2778.0,1572.5,3413.5,Ras-related protein RabX1,<2C (LG1)
Tb927.8.4620,612.5,1747.5,1446.0,2373.0,2125.5,small GTP-binding protein Rab7  putative,G2M
Tb927.8.4630,4066.0,1629.0,562.5,1374.0,1896.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4640,6281.5,7996.5,6642.0,8567.5,10517.5,Component of motile flagella 19,>4C (GG2M)
Tb927.8.4650,612.5,3150.0,3288.0,2483.5,4199.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.4660,5573.5,7503.0,7359.5,6573.5,3994.5,hypothetical protein  conserved,G1
Tb927.8.4670,7786.5,7019.5,7259.5,6056.0,4179.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4680,7487.0,8574.5,8245.5,8391.0,7077.0,Spinocerebellar ataxia type 10 protein domain containing protein  putative,G1
Tb927.8.4690,6714.0,6251.0,6460.5,6962.0,6499.0,hypothetical protein  conserved,G2M
Tb927.8.4695,612.5,1520.0,2262.5,1922.5,3260.0,hypothetical protein,>4C (GG2M)
Tb927.8.4700,11002.5,11311.5,10947.5,11171.0,10635.0,amino acid transporter  putative,G1
Tb927.8.4710,10957.5,10455.0,9889.5,9762.5,9228.0,amino acid transporter  putative,<2C (LG1)
Tb927.8.4720,11444.0,11287.0,11014.5,10942.0,10383.0,amino acid transporter  putative,<2C (LG1)
Tb927.8.4730,11397.0,11177.5,10973.5,10799.0,10686.0,amino acid transporter  putative,<2C (LG1)
Tb927.8.4740,11445.0,11364.0,11223.0,11129.0,10884.0,amino acid transporter  putative,<2C (LG1)
Tb927.8.4750,10260.5,9536.0,9483.5,9448.5,9447.0,amino acid transporter  truncated,<2C (LG1)
Tb927.8.4760,9205.0,5941.5,7198.5,6827.0,4158.0,kinetoplastid kinetochore protein 20,<2C (LG1)
Tb927.8.4770,5167.5,4996.5,6429.5,6434.5,3214.5,small GTP-binding protein Rab18,G2M
Tb927.8.4780,3328.5,3138.5,3858.5,5551.0,11077.0,Flagellar Member 3,>4C (GG2M)
Tb927.8.4790,3013.5,2020.5,1650.0,1299.0,3199.5,Putative snoRNA binding domain containing protein  putative,>4C (GG2M)
Tb927.8.4800,2747.5,4331.5,4776.0,4598.0,6206.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.4810,6281.5,3304.0,2522.5,3228.0,1816.5,prohibitin 1,<2C (LG1)
Tb927.8.4820,6483.0,3932.0,3755.0,4346.0,3733.0,eukaryotic translation initiation factor 4 gamma 3,<2C (LG1)
Tb927.8.4830,7242.5,1394.5,2011.5,2252.0,1253.0,u1 small nuclear ribonucleoprotein 70 kDa,<2C (LG1)
Tb927.8.4840,2221.0,5918.5,7433.0,6501.0,6028.0,kinesin  putative,S
Tb927.8.4850,6797.0,6397.0,3930.5,5824.5,6679.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4860,6666.0,8154.5,8687.5,7897.5,7530.0,kinetoplast ribosomal PPR-repeat containing protein 10,S
Tb927.8.4870,1783.5,2069.5,3148.0,3194.5,8898.5,Component of motile flagella 6,>4C (GG2M)
Tb927.8.4880,11496.5,9266.0,10284.5,10568.5,10788.0,DNA polymerase alpha catalytic subunit,<2C (LG1)
Tb927.8.4890,5418.5,6139.5,5598.0,5628.0,6080.0,pol-associated gene 1,G1
Tb927.8.4895,5320.5,1866.5,1731.5,1154.5,1213.5,hypothetical protein,<2C (LG1)
Tb927.8.4900,9022.5,9002.0,8587.0,8682.5,7890.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4910,612.5,2760.5,1731.5,2347.0,7883.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.4920,1460.0,5185.0,6066.5,4790.0,5593.5,hypothetical protein  conserved,S
Tb927.8.4930,9268.0,5706.5,6078.5,6129.0,7861.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.4940,6220.0,7736.5,8120.5,6612.5,6878.5,hypothetical protein  conserved,S
Tb927.8.4950,5435.0,10111.0,9541.5,9982.5,9145.0,Kinesin Localized to the Ingressing Furrow,G1
Tb927.8.4960,9138.0,10038.0,9915.5,9390.5,8979.0,hypothetical protein  conserved,G1
Tb927.8.4970,3095.0,208.5,357.5,444.5,1062.5,Paraflagellar rod protein 2-1,<2C (LG1)
Tb927.8.4980,1988.0,176.5,161.0,248.0,915.0,Paraflagellar rod protein 2-2,<2C (LG1)
Tb927.8.4990,1914.0,235.5,99.0,204.0,915.0,Paraflagellar rod protein 2-3,<2C (LG1)
Tb927.8.5000,2047.0,96.0,161.0,159.0,895.5,Paraflagellar rod protein 2-4,<2C (LG1)
Tb927.8.5010,2137.5,413.0,427.0,534.5,874.5,Paraflagellar rod protein 2-5,<2C (LG1)
Tb927.8.5020,1460.0,5862.0,5962.0,5899.5,9628.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5030,612.5,3639.0,3116.5,2223.0,1944.0,transport protein particle (TRAPP) component  Bet3  putative,G1
Tb927.8.5040,3261.0,6538.5,5704.5,5042.5,3775.0,EMG1/NEP1 methyltransferase  putative,G1
Tb927.8.5050,8984.0,10109.0,10559.5,10352.0,7834.0,OTU-like cysteine protease  putative,S
Tb927.8.5060,4389.0,4531.5,4550.5,4962.5,2857.0,ADP-ribosylation factor-like protein 6,G2M
Tb927.8.5070,612.5,2093.5,2778.0,1654.0,4212.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5080,6822.0,10214.5,10438.0,10121.0,9589.0,fatty-acid amide hydrolase  putative,S
Tb927.8.5090,9213.0,8302.5,9429.5,8185.5,9716.5,DNA-directed RNA polymerase I largest subunit,>4C (GG2M)
Tb927.8.5100,10889.0,11258.0,11217.5,11068.5,10779.5,hypothetical protein  conserved,G1
Tb927.8.5110,8965.0,9918.5,10176.5,10513.5,9049.0,hypothetical protein  conserved,G2M
Tb927.8.5120,4248.0,3008.5,2238.0,3319.0,3353.0,cytochrome c,<2C (LG1)
Tb927.8.5130,1460.0,5521.0,5798.5,6001.0,6511.5,Present in the outer mitochondrial membrane proteome 41,>4C (GG2M)
Tb927.8.5140,8823.5,9670.0,8697.0,8948.5,9882.0,diacylglycerol kinase  putative,>4C (GG2M)
Tb927.8.5150,4544.0,2592.5,3323.5,3785.5,3648.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5160,11320.0,10765.5,10855.0,10823.0,10799.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5170,11559.0,11621.0,11616.0,11641.0,11432.0,hypothetical protein  conserved,G2M
Tb927.8.5180,7069.5,5561.5,4372.0,5069.5,3431.5,U6 snRNA-associated sm-like protein Lsm2,<2C (LG1)
Tb927.8.5190,5270.0,5301.5,5197.0,5628.0,4578.0,hypothetical protein  conserved,G2M
Tb927.8.5200,3241.5,8396.5,8973.5,8935.0,8489.5,Mitochondrial SSU ribosomal protein  putative,S
Tb927.8.5210,11475.0,10521.0,10238.0,10176.0,9843.0,cullin 3  putative,<2C (LG1)
Tb927.8.5220,3224.0,9983.5,9563.5,8909.5,10869.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5230,2137.5,3507.5,3205.5,2642.5,5317.0,peptidyl-prolyl cis-trans isomerase  putative,>4C (GG2M)
Tb927.8.5240,9294.5,8789.0,8513.5,7949.0,6038.0,Domain of unknown function DUF221  putative,<2C (LG1)
Tb927.8.5250,7622.0,2679.0,3009.0,3343.0,5585.0,delta-coat protein  putative,<2C (LG1)
Tb927.8.5260,612.5,543.0,471.5,292.5,505.0,60S ribosomal protein L39  putative,<2C (LG1)
Tb927.8.5270,612.5,3561.5,4485.5,2977.0,86.0,hypothetical protein  conserved,S
Tb927.8.5280,4972.0,8779.0,7756.0,6969.0,6917.0,mitochondrial ribosomal protein s34,G1
Tb927.8.5290,4956.5,7927.5,9350.5,7959.5,6909.5,WW domain containing protein  putative,S
Tb927.8.5300,5450.0,7266.0,7316.0,7090.5,3386.5,hypothetical protein  conserved,S
Tb927.8.5310,2137.5,5372.5,7151.0,6289.0,3144.5,Polyketide cyclase / dehydrase and lipid transport  putative,S
Tb927.8.5320,6883.0,3758.0,2630.0,3837.0,3100.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5330,8907.0,6813.0,6460.5,7212.0,5274.5,tyrosyl/methionyl-tRNA synthetase  putative,<2C (LG1)
Tb927.8.5340,10852.0,10310.0,10452.0,10690.5,10782.0,hypothetical protein,<2C (LG1)
Tb927.8.5345,612.5,2376.0,2679.5,3029.0,3044.5,tRNA Arginine,>4C (GG2M)
Tb927.8.5350,10072.0,9654.0,9238.0,9755.5,9043.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5360,612.5,1332.5,880.5,925.0,1453.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5370,6516.5,4331.5,5486.5,5148.0,6385.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5380,6750.0,2957.5,2827.0,2928.0,4525.5,ubiquitin fold modifier protein  putative,<2C (LG1)
Tb927.8.5390,10012.0,6084.5,5696.5,5476.5,6344.5,cdc2-related protein kinase 4  putative,<2C (LG1)
Tb927.8.5400,2956.5,4155.5,5034.0,6014.5,8719.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5410,5018.5,9516.5,9241.5,9438.0,4468.5,hypothetical protein  conserved,G1
Tb927.8.5420,1460.0,7741.5,6976.0,8126.5,6679.0,methyltransferase domain containing protein  putative,G2M
Tb927.8.5430,3524.0,2078.0,2465.5,1466.0,2364.5,Snf7  putative,<2C (LG1)
Tb927.8.5440,6324.5,4745.0,4200.5,5648.5,3413.5,flagellar calcium-binding 24 kDa protein,<2C (LG1)
Tb927.8.5450,11302.0,8392.0,8125.5,8454.0,8987.5,amino acid permease 24,<2C (LG1)
Tb927.8.5460,4849.5,3380.0,3179.5,3130.0,3431.5,Flagellar calcium-binding 44 kDa protein,<2C (LG1)
Tb927.8.5465,7558.5,5484.0,4304.0,4496.5,4121.5,flagellar calcium-binding 24 kDa protein,<2C (LG1)
Tb927.8.5470,7263.0,4268.0,4540.5,4183.0,3716.5,flagellar calcium-binding 24 kDa protein,<2C (LG1)
Tb927.8.5480,4691.0,4373.5,4722.5,3408.0,6631.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5490,612.5,4111.5,3877.5,4808.0,4222.5,Nucleolar protein Nop52  putative,G2M
Tb927.8.5500,2870.5,8322.5,8529.5,8567.5,7313.0,calcium/calmodulin-dependent protein kinase  putative,G2M
Tb927.8.5510,2047.0,3097.0,3215.0,2589.0,6398.5,apurinic/apyrimidinic endonuclease  putative,>4C (GG2M)
Tb927.8.5520,8961.5,7591.5,7909.5,8361.0,6799.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5530,6198.5,2913.5,6022.5,4367.0,3399.5,COP9 signalosome complex subunit 5  putative,<2C (LG1)
Tb927.8.5540,7741.0,6758.0,7718.5,6706.0,8563.0,Iron-sulfur assembly protein 1,>4C (GG2M)
Tb927.8.5550,2943.0,2671.0,3952.0,2893.5,1422.0,hypothetical protein  conserved,S
Tb927.8.5560,1914.0,3799.0,3452.0,3649.5,2794.5,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,G1
Tb927.8.5570,1460.0,4515.0,5025.0,4084.0,1703.0,transporter  putative,S
Tb927.8.5580,11688.0,11630.0,11618.0,11620.0,11550.0,N-terminal region of Chorein  a TM vesicle-mediated sorter/Integral peroxisomal membrane peroxin  putative,<2C (LG1)
Tb927.8.5590,2436.0,3561.5,2738.5,3978.5,1970.0,SH3-binding  glutamic acid-rich protein  putative,G2M
Tb927.8.5600,8229.0,5782.0,5661.5,6090.0,6535.5,transaldolase  putative,<2C (LG1)
Tb927.8.5610,3822.0,6107.0,6442.0,5908.5,7610.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5620,8494.0,10752.5,10729.5,10127.5,10888.0,ubiquitin carboxyl-terminal hydrolase  putative,>4C (GG2M)
Tb927.8.5630,10723.0,8156.5,9121.0,8863.5,7385.0,dihydroorotase  putative,<2C (LG1)
Tb927.8.5640,4333.5,4096.5,4559.5,4057.0,4988.5,putative succinate dehydrogenase subunit,>4C (GG2M)
Tb927.8.5650,10846.0,8970.5,9339.0,9627.0,8987.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5660,612.5,2701.5,3092.0,3658.0,6749.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5670,612.5,3367.5,4078.5,4699.5,4874.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.8.5680,11532.5,10562.5,10398.0,10625.0,10567.0,Pyridoxal-dependent decarboxylase conserved domain containing protein  putative,<2C (LG1)
Tb927.8.5690,2357.5,7981.0,7515.5,6357.5,7689.0,KREPB8,G1
Tb927.8.5700,5630.0,5675.0,4485.5,5249.5,3494.0,mitochondrial editosome-associated protein KREPB10,G1
Tb927.8.5710,5844.5,8647.0,8627.0,7040.5,6774.5,recombination initiation protein NBS1  putative,G1
Tb927.8.5720,2504.5,8528.5,7342.5,6501.0,5713.5,tRNA (guanine(37)-N1)-methyltransferase,G1
Tb927.8.5730,2637.5,3164.5,2275.0,1451.5,3260.0,STE20-like serine/threonine-protein kinase 1  putative,>4C (GG2M)
Tb927.8.5740,612.5,484.0,357.5,464.0,347.0,proteasome 26S non-ATPase subunit 9  putative,<2C (LG1)
Tb927.8.5750,10202.0,8594.0,9298.0,9775.5,10667.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5760,8764.0,9755.5,9956.5,10534.5,9895.5,Ankyrin repeats (many copies)/Alpha/beta hydrolase family  putative,G2M
Tb927.8.5770,5357.0,5494.5,5783.0,5873.0,6479.0,Elongator-like Protein 3a,>4C (GG2M)
Tb927.8.5780,3028.5,6089.0,6253.5,5365.0,3541.0,phosphatase of regenerating liver-type phosphatase  putative,S
Tb927.8.5790,8817.0,5488.5,4896.0,2554.0,874.5,hypothetical protein,<2C (LG1)
Tb927.8.5800,612.5,3747.5,4327.5,4894.5,4403.5,hypothetical protein  conserved,G2M
Tb927.8.5810,1460.0,3916.0,3609.0,3965.5,3669.0,mitochondrial carrier protein,G2M
Tb927.8.5820,5779.0,8365.5,8329.0,7577.0,7385.0,Las1-like  putative,G1
Tb927.8.5830,2137.5,2679.0,2551.0,1642.5,5442.5,SMP-30/Gluconolaconase/LRE-like region  putative,>4C (GG2M)
Tb927.8.5840,3662.5,1043.5,865.5,673.0,607.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5850,11645.0,11660.0,11642.0,11649.0,11600.0,hypothetical protein  conserved,G1
Tb927.8.5860,612.5,2034.0,1192.0,1403.5,761.5,mitochondrial ribosomal protein L17,G1
Tb927.8.5870,6220.0,1332.5,1909.5,2311.0,1422.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5880,6636.0,2367.5,1665.0,2373.0,86.0,eukaryotic translation initiation factor 1A  putative,<2C (LG1)
Tb927.8.5890,5611.0,345.0,210.0,366.5,797.5,histone chaperone ASF1B,<2C (LG1)
Tb927.8.5900,10762.5,7419.5,6942.5,5838.5,6836.0,Sedlin  N-terminal conserved region  putative,<2C (LG1)
Tb927.8.5910,8247.0,4357.5,5808.0,4421.5,4607.0,hypothetical protein,<2C (LG1)
Tb927.8.5920,1460.0,1506.5,1612.0,1329.0,461.5,hypothetical protein,S
Tb927.8.5930,9366.0,9776.5,9863.0,9029.5,8143.0,hypothetical protein,S
Tb927.8.5940,1914.0,2820.5,3599.5,3856.5,4257.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.5950,10390.5,11300.5,11226.5,11306.5,11228.5,mitogen-activated protein kinase kinase 4  putative,G2M
Tb927.8.5960,9215.5,4079.5,5164.0,4035.5,5686.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.5970,7340.0,10714.0,10250.5,10410.5,10237.0,Cullin 5  putative,G1
Tb927.8.5980,9343.0,10173.0,9295.0,9512.5,8454.0,TFIIH basal transcription factor complex helicase subunit  putative,G1
Tb927.8.5990,6422.0,8921.0,9604.5,8844.5,9142.0,NLE (NUC135) domain/WD domain  G-beta repeat  putative,S
Tb927.8.6000,612.5,5261.5,5396.5,6340.0,3271.5,fatty acid desaturase  putative,G2M
Tb927.8.6010,6816.5,4920.0,5182.0,3763.0,3794.0,Heme Response-1 protein  putative,<2C (LG1)
Tb927.8.6020,1460.0,4615.5,5670.5,5992.0,4560.5,hypothetical protein  conserved,G2M
Tb927.8.6030,612.5,1275.5,1402.0,1281.0,1860.5,60S ribosomal protein L12  putative,>4C (GG2M)
Tb927.8.6033,612.5,449.0,980.0,737.0,213.0,ribosomal protein L41  putative,S
Tb927.8.6036,612.5,373.5,832.0,628.0,86.0,ribosomal protein L41  putative,S
Tb927.8.6038,612.5,96.0,99.0,82.5,287.0,ribosomal protein L41  putative,<2C (LG1)
Tb927.8.6040,3726.5,1353.5,1030.5,974.5,1195.0,kinetoplast ribosomal PPR-repeat containing protein 11,<2C (LG1)
Tb927.8.6050,11197.0,9045.5,8578.0,7275.5,5135.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6060,9171.0,8782.0,7718.5,7747.0,5457.5,2-amino-3-ketobutyrate coenzyme A ligase,<2C (LG1)
Tb927.8.6070,6672.0,9085.0,10273.0,10727.5,11553.0,Trypanosome basal body component protein,>4C (GG2M)
Tb927.8.6080,1783.5,4806.0,4529.5,3847.5,2773.0,Glycerophosphoryl diester phosphodiesterase family  putative,G1
Tb927.8.6090,5251.5,6878.0,7763.5,8036.0,5813.0,ubiquitin-protein ligase  putative,G2M
Tb927.8.6100,11394.0,10834.0,10886.0,10690.5,9546.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6110,4122.5,5513.5,3233.0,4057.0,3871.0,3-hydroxy-3-methylglutaryl-CoA synthase  putative,G1
Tb927.8.6120,9523.0,5236.0,5174.5,6083.5,5034.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6130,2047.0,2402.0,2653.0,2404.0,1453.5,hypothetical protein  conserved,S
Tb927.8.6140,1914.0,1322.5,1402.0,1875.5,2079.5,Galactose oxidase  central domain/Kelch motif containing protein  putative,>4C (GG2M)
Tb8.NT.97,4170.0,279.5,391.5,334.5,86.0,Noncoding RNA  putative,<2C (LG1)
Tb927.8.6150,612.5,158.5,685.0,111.0,86.0,40S ribosomal protein S8  putative,S
Tb927.8.6160,612.5,40.5,427.0,111.0,86.0,40S ribosomal protein S8  putative,<2C (LG1)
Tb927.8.6170,7007.0,9567.5,9870.0,9951.0,10596.0,transketolase  putative,>4C (GG2M)
Tb927.8.6180,1460.0,130.0,271.5,159.0,761.5,60S ribosomal protein L26  putative,<2C (LG1)
Tb927.8.6190,2357.5,1924.0,2310.0,2321.5,1266.0,BolA-like protein  putative,<2C (LG1)
Tb927.8.6200,9368.0,9522.5,10541.5,9913.5,10756.5,tubulin folding cofactor D  putative,>4C (GG2M)
Tb927.8.6210,8673.5,10233.5,9911.5,10245.0,10806.0,phosphatidylinositol 3-kinase  putative,>4C (GG2M)
Tb927.8.6220,6787.5,9159.0,9502.5,8816.0,7909.0,Phosphorylated CTD interacting factor 1 WW domain containing protein  putative,S
Tb927.8.6230,2381.5,6319.0,4293.5,5168.5,7904.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.6240,2840.5,3615.5,3727.5,3588.0,3214.5,STOP axonemal protein,S
Tb927.8.6250,5844.5,9049.0,8869.5,9533.0,9275.0,Nucleoporin NUP76,G2M
Tb927.8.6260,11058.0,10466.0,10549.5,11003.0,11096.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.6270,1460.0,8601.0,9391.0,8611.5,9036.0,hypothetical protein  conserved,S
Tb927.8.6280,7140.0,4872.5,5531.5,3909.0,6448.5,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.8.6290,10033.5,10369.5,10241.5,10115.5,8483.0,hypothetical protein  conserved,G1
Tb927.8.6300,10424.5,7190.0,8411.5,7955.0,8383.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6310,612.5,1781.0,1679.0,1966.0,3375.0,chaperone protein DnaJ  putative,>4C (GG2M)
Tb927.8.6320,1460.0,5210.5,3475.0,5079.0,6059.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.6330,6538.0,10310.0,9298.0,10000.5,9686.0,WD domain  G-beta repeat/PFU (PLAA family ubiquitin binding)  putative,G1
Tb927.8.6340,9064.5,9737.0,9993.0,9722.5,8264.0,CYC2-like cyclin  putative,S
Tb927.8.6350,11131.0,10349.5,9644.5,10406.5,9435.5,CYC2-like cyclin  putative,<2C (LG1)
Tb927.8.6360,2795.5,7989.0,8873.5,8005.5,7192.0,SPRY domain containing protein  putative,S
Tb927.8.6370,5308.5,5706.5,5645.0,6482.0,4794.5,Flagellar pocket collar protein 4,G2M
Tb927.8.6380,4190.5,6109.0,6593.0,6491.0,6426.0,hypothetical protein  conserved,S
Tb927.8.6390,5897.5,6745.0,6417.0,7027.5,7192.0,lysophospholipase  putative,>4C (GG2M)
Tb927.8.6400,9349.5,7952.0,8523.0,8963.0,8188.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6410,5496.0,5205.5,6147.0,4962.5,5092.0,beta-ketoacyl-ACP reductase 3  putative,S
Tb927.8.6420,5082.5,6626.0,4990.5,4381.0,3169.5,beta-ketoacyl-ACP reductase 2,G1
Tb927.8.6430,3202.0,2128.0,1522.0,1763.5,397.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6440,5408.0,759.0,644.5,737.0,1828.0,RNA-binding protein  putative,<2C (LG1)
Tb927.8.6450,2460.0,1609.0,2219.0,1745.0,2427.0,inhibitor of cysteine peptidase,<2C (LG1)
Tb927.8.6460,3502.5,1384.0,1831.0,1805.5,2914.5,kinase binding protein CGI-121  putative,<2C (LG1)
Tb927.8.6470,4995.5,5454.0,4448.0,4126.5,2268.0,SET domain containing protein  putative,G1
Tb927.8.6480,11211.0,9832.0,9803.5,10142.0,9009.5,folate-binding protein YgfZ  putative,<2C (LG1)
Tb927.8.6490,8542.5,10208.0,10434.0,10355.0,10423.5,Basal body protein,S
Tb8.NT.99,6353.5,1602.5,1254.0,1745.0,1660.5,Noncoding RNA  putative,<2C (LG1)
Tb927.8.6500,8228.0,9737.0,9898.0,9245.5,9868.5,cell division cycle protein 20  putative,S
Tb927.8.6510,8998.0,6940.5,6288.0,6129.0,3144.5,ubiquitin-protein ligase  putative,<2C (LG1)
Tb927.8.6520,10293.0,9059.0,8931.5,8762.0,6706.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6530,6137.0,5585.0,4670.0,4882.0,4480.5,SET domain containing protein  putative,<2C (LG1)
Tb927.8.6540,11476.0,10389.5,10682.5,10655.0,9542.0,TFIIH basal transcription factor subunit,<2C (LG1)
Tb927.8.6550,5697.0,5552.5,5598.0,5816.0,5301.0,hypothetical protein  conserved,G2M
Tb927.8.6560,8278.0,5338.5,5182.0,4318.0,4800.5,SpoU rRNA Methylase family  putative,<2C (LG1)
Tb927.8.6562,612.5,498.0,507.0,382.0,486.0,tRNA Isoleucine,<2C (LG1)
Tb927.8.6564,2552.0,294.5,210.0,313.5,347.0,tRNA Leucine,<2C (LG1)
Tb927.8.6566,1988.0,222.0,161.0,33.5,213.0,tRNA Glutamine,<2C (LG1)
Tb927.8.6568,612.5,1087.5,893.0,1003.0,2322.0,tRNA Glutamine,>4C (GG2M)
Tb927.8.6572,612.5,1220.5,778.0,1154.5,2454.0,tRNA Isoleucine,>4C (GG2M)
Tb927.8.6570,3407.5,3842.0,4434.0,4772.5,2065.0,hypothetical protein  conserved,G2M
Tb927.8.6580,4826.0,9718.0,9113.5,9748.0,9433.5,Succinate dehydrogenase [ubiquinone] flavoprotein subunit  mitochondrial,G2M
Tb927.8.6590,6942.0,9007.0,8253.0,8460.0,7112.5,Outer mitochondrial membrane transport complex protein/Glutathione S-transferase  C-terminal domain containing protein  putative,G1
Tb927.8.6600,5042.0,7079.5,6185.0,6904.0,5713.5,Glutathione S-transferase  C-terminal domain containing protein  putative,G1
Tb927.8.6610,2970.5,4990.0,4181.0,3992.5,5585.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.6620,7096.0,7825.0,8420.5,8319.0,7274.5,hypothetical protein  conserved,S
Tb927.8.6630,3179.0,3991.5,5350.5,4951.0,5404.0,hypothetical protein,>4C (GG2M)
Tb927.8.6640,7226.0,9337.5,9506.5,8925.5,9772.5,Male sterility protein  putative,>4C (GG2M)
Tb927.8.6650,10675.0,10266.5,10180.5,9926.0,9419.0,RNA-binding protein  putative,<2C (LG1)
Tb927.8.6660,5770.5,1904.5,2949.5,2999.5,3606.5,paraflagellar rod component  putative,<2C (LG1)
Tb927.8.6670,11170.0,9532.5,9063.0,8812.0,10123.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6680,8817.0,7310.0,7706.0,7479.0,8093.5,clathrin assembly sigma-adaptin protein 3  putative,<2C (LG1)
Tb927.8.6690,10923.0,11033.0,11372.0,11300.0,11039.5,ATP-dependent DEAD/H DNA helicase recQ  putative,S
Tb927.8.6700,6055.0,5180.0,4411.0,4862.5,5174.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6710,5620.5,6423.0,6788.5,7161.0,5861.5,hypothetical protein  conserved,G2M
Tb927.8.6720,8588.0,10217.0,10207.5,10373.0,9716.5,hypothetical protein  conserved,G2M
Tb927.8.6730,11473.0,9469.5,9346.0,9164.5,10511.0,Enriched in surface-labeled proteome protein 24,<2C (LG1)
Tb927.8.6740,612.5,5746.5,5307.5,5673.5,3628.5,DNA repair protein  putative,G1
Tb927.8.6750,612.5,1766.0,2318.5,2530.5,3888.0,translationally controlled tumor protein (TCTP)  putative,>4C (GG2M)
Tb927.8.6760,5111.0,2795.0,3239.0,2977.0,778.5,translationally-controlled tumor protein homolog  putative,<2C (LG1)
Tb927.8.6770,4134.0,3625.0,2996.5,2541.0,1878.0,WD domain  G-beta repeat  putative,<2C (LG1)
Tb927.8.6780,3670.5,8059.5,8718.5,8682.5,7244.0,hypothetical protein  conserved,S
Tb927.8.6790,9619.0,10475.0,10593.5,10406.5,10543.5,hypothetical protein  conserved,S
Tb927.8.6800,10650.0,7179.5,8000.5,6706.0,7192.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6810,9190.0,8625.5,9604.5,9134.0,8898.5,STE/STE11 serine/threonine-protein kinase  putative,S
Tb927.8.6820,612.5,4235.0,4462.5,4496.5,4673.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.6830,11000.5,11122.0,11134.0,11188.5,10932.0,kinesin  putative,G2M
Tb927.8.6840,11249.0,8799.0,8334.0,8159.0,8012.5,mismatch repair protein MLH1,<2C (LG1)
Tb927.8.6850,9880.5,9550.5,8736.5,9206.0,6607.0,Zinc finger  C3HC4 type (RING finger)/EF-hand domain pair  putative,<2C (LG1)
Tb927.8.6860,8936.0,10658.0,10575.5,10494.0,10536.0,High-temperature-induced dauer-formation protein  putative,G1
Tb927.8.6870,8625.0,4967.0,5652.5,6322.0,6994.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.6880,10654.0,9623.5,9301.5,9361.0,8958.5,translation initiation factor IF-2  putative,<2C (LG1)
Tb927.8.6890,612.5,1807.0,925.0,1140.0,2870.0,putative succinate dehydrogenase subunit,>4C (GG2M)
Tb927.8.6900,1914.0,1362.5,1561.5,989.0,505.0,transport protein particle (TRAPP) component  putative,<2C (LG1)
Tb927.8.6910,5500.5,2272.0,4057.0,3178.5,5024.5,cyclophilin  putative,<2C (LG1)
Tb927.8.6920,8395.5,3827.0,2919.0,3319.0,10840.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.6930,7007.0,7331.5,6702.5,6501.0,5516.0,serine/threonine-protein kinase NRKB  putative,G1
Tb927.8.6940,1988.0,3097.0,4117.0,5129.0,11584.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.6950,7726.0,7626.5,5973.0,8334.0,11280.0,roadblock/LC7 family member,>4C (GG2M)
Tb927.8.6960,4040.0,6852.0,6527.5,6024.5,4490.0,NADH-ubiquinone oxidoreductase complex I subunit  putative,G1
Tb927.8.6970,10857.5,8809.0,9145.5,8660.0,7431.5,3-methylcrotonyl-CoA carboxylase alpha subunit  putative,<2C (LG1)
Tb927.8.6980,9821.0,9168.5,9385.5,8583.0,8315.0,Flagellum attachment zone protein 14,<2C (LG1)
Tb927.8.6990,1783.5,7105.0,7384.0,6612.5,6596.5,hypothetical protein  conserved,S
Tb927.8.7000,4470.5,4733.5,4529.5,4636.5,2413.0,E1-like ubiquitin-activating enzyme  putative,G1
Tb927.8.7010,5330.0,3665.0,3813.0,3205.5,4292.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.8.7020,7340.0,7009.0,7342.5,6909.0,5585.0,peptidase  putative,S
Tb927.8.7030,8748.0,7774.0,7865.5,6637.0,6452.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7040,4587.0,6705.5,6527.5,7553.5,7904.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.7050,612.5,4400.0,3464.5,4828.5,2336.0,mu-adaptin 4  putative,G2M
Tb927.8.7060,9131.0,10656.5,10479.5,10228.5,11298.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.7070,5441.0,4047.5,4670.0,3773.5,5686.0,Flagellum attachment zone protein 15,>4C (GG2M)
Tb927.8.7080,7602.5,6437.0,6102.0,7350.0,8826.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.7090,3543.0,9443.5,9227.0,9848.5,8489.5,Component of IIS longevity pathway SMK-1  putative,G2M
Tb927.8.7100,10959.5,10894.0,10890.5,10550.5,10090.0,acetyl-CoA carboxylase,<2C (LG1)
Tb927.8.7110,11301.0,8590.5,8402.0,8520.5,5054.0,Serine/threonine-protein kinase NEK12.1  putative,<2C (LG1)
Tb927.8.7120,9068.5,6176.0,5474.5,5683.5,4036.5,squalene synthase  putative,<2C (LG1)
Tb927.8.7130,8306.5,5876.0,6603.0,6612.5,4337.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7140,8340.5,8552.5,8424.5,9035.0,7139.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G2M
Tb927.8.7150,8766.5,9927.5,9792.5,10166.5,8143.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G2M
Tb927.8.7160,9415.0,8223.0,8000.5,8144.5,5145.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,<2C (LG1)
Tb927.8.7170,4756.0,7672.5,6687.5,7540.0,5220.0,inositol polyphosphate 1-phosphatase  putative,G1
Tb927.8.7180,6057.5,2908.0,2801.5,3075.0,1896.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7190,2295.5,5322.5,5379.0,4973.5,3185.0,hypothetical protein,S
Tb927.8.7200,1988.0,10272.5,10408.0,10212.5,9662.5,Region in Clathrin and VPS  putative,S
Tb927.8.7210,1783.5,959.0,1103.0,1202.5,2254.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.7220,7983.0,3367.5,4632.5,5375.0,4737.0,tousled-like kinase II,<2C (LG1)
Tb927.8.7230,9283.5,4276.0,2750.5,4496.5,2203.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7240,6405.5,9795.0,9374.5,9103.5,9798.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.7250,8334.0,8639.0,8642.5,7979.5,7811.5,repressor of RNA polymerase III transcription MAF1,S
Tb927.8.7260,11029.0,10848.0,10351.0,10322.5,9633.0,kinetoplast-associated protein  putative,<2C (LG1)
Tb927.8.7270,8804.0,9378.0,8714.0,7651.5,6557.0,Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC)/Endoplasmic reticulum vesicle transporter  putative,G1
Tb927.8.7280,3142.5,7844.5,6702.5,5832.0,6535.5,emp24/gp25L/p24 family/GOLD  putative,G1
Tb927.8.7290,10442.0,8392.0,8214.0,7826.0,6639.5,Regulator of chromosome condensation (RCC1) repeat  putative,<2C (LG1)
Tb927.8.7300,9031.5,6265.5,4235.0,5932.0,5702.0,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.8.7310,7246.5,9437.5,8407.5,8313.0,10271.0,hypothetical protein,>4C (GG2M)
Tb927.8.7320,4104.0,4684.0,4334.5,5285.0,5024.5,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.8.7330,9823.0,7939.0,8718.5,8628.5,8230.0,hypothetical protein,<2C (LG1)
Tb927.8.7340,10725.0,11351.0,11404.5,11405.0,11213.0,trans-sialidase  putative,G2M
Tb927.8.7350,10987.0,11244.0,11328.0,11283.5,10927.0,trans-sialidase  putative,S
Tb927.8.7360,9418.0,10019.5,9436.0,10415.5,10203.5,hypothetical protein  conserved,G2M
Tb927.8.7370,10160.0,8384.5,8295.5,9149.5,6764.0,hypothetical protein,<2C (LG1)
Tb927.8.7380,3437.5,5689.0,5358.0,3642.0,3681.5,dihydrolipoamide dehydrogenase  point mutation,G1
Tb927.8.7390,7210.5,9490.0,9587.5,10061.0,9937.0,protein phosphatase 1,G2M
Tb927.8.7400,5851.5,5561.5,5919.0,6525.0,9576.0,RNA polymerase IIA largest subunit,>4C (GG2M)
Tb927.8.7410,10387.0,9454.0,9644.5,8529.5,8543.0,calreticulin  putative,<2C (LG1)
Tb927.8.7420,2357.5,2942.5,4653.0,3216.0,11099.0,TerD domain containing protein  putative,>4C (GG2M)
Tb927.8.7430,612.5,1530.0,1989.5,1847.0,1213.5,ubiquinol-cytochrome c reductase  putative,S
Tb927.8.7440,5620.5,7440.0,9156.5,8709.5,6377.5,lipase  putative,S
Tb927.8.7450,7622.0,7470.5,7634.5,8023.0,7974.5,myosin heavy chain kinase A  putative,G2M
Tb927.8.7460,8689.5,8970.5,9286.5,9035.0,8213.5,zinc transporter  putative,S
Tb927.8.7470,8969.0,9276.0,9394.0,9309.0,7139.0,hypothetical protein  conserved,S
Tb927.8.7480,11004.0,10717.0,10604.5,10426.5,10229.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7490,8260.5,10956.5,11046.0,11063.0,11017.0,symplekin,G2M
Tb927.8.7500,7888.0,2714.5,4749.0,4882.0,3606.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7510,9247.0,3890.0,5091.5,4598.0,5526.5,p-nitrophenylphosphatase  putative,<2C (LG1)
Tb927.8.7520,4728.0,9317.5,10158.5,9588.0,10240.0,aminopeptidase  putative,>4C (GG2M)
Tb927.8.7530,7707.0,7676.5,8621.0,8432.0,6780.0,3 2-trans-enoyl-CoA isomerase  mitochondrial precursor  putative,S
Tb927.8.7540,10863.0,10259.0,10172.0,10147.0,9824.0,Flagella connector protein 3,<2C (LG1)
Tb927.8.7550,612.5,5144.5,4200.5,2589.0,5014.5,hypothetical protein,G1
Tb927.8.7560,6207.5,6834.5,6485.5,7789.5,6526.0,CorA-like Mg2+ transporter protein  putative,G2M
Tb927.8.7570,10373.0,7866.5,6322.0,6491.0,7602.0,tRNA-dihydrouridine synthase 1  putative,<2C (LG1)
Tb927.8.7580,9787.5,9709.0,9415.5,10174.0,10141.5,RING-variant domain containing protein  putative,G2M
Tb927.8.7590,9733.5,11456.0,11457.0,11451.0,11131.5,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.8.7600,9747.0,9171.0,10102.5,10171.5,9994.0,amino acid transporter  putative,G2M
Tb927.8.7610,7180.5,8955.0,8547.5,8334.0,7308.5,amino acid transporter 1  putative,G1
Tb927.8.7620,9338.5,10765.5,10677.5,10568.5,10527.5,amino acid transporter 1  putative,G1
Tb927.8.7630,9627.5,10732.5,10459.0,10500.5,10375.0,amino acid transporter 1  putative,G1
Tb927.8.7640,6163.0,7931.0,8044.5,7377.0,8282.5,amino acid transporter 1  putative,>4C (GG2M)
Tb927.8.7650,8957.5,7618.0,7562.5,7891.0,8198.0,amino acid transporter  putative,<2C (LG1)
Tb927.8.7660,5965.0,6488.0,6521.5,6738.5,4822.5,amino acid transporter (pseudogene)  putative,G2M
Tb927.8.7670,10101.5,10585.0,10916.5,10680.0,10409.0,amino acid transporter  putative,S
Tb927.8.7680,3394.0,8302.5,7540.5,7949.0,8575.0,amino acid transporter  putative,>4C (GG2M)
Tb927.8.7690,6069.0,7459.0,7879.0,8043.5,6270.0,amino acid transporter (pseudogene)  putative,G2M
Tb927.8.7700,3856.5,8905.0,8392.0,8402.5,9419.0,amino acid transporter  putative,>4C (GG2M)
Tb927.8.7710,3358.0,6714.5,7368.0,6626.0,6659.5,hypothetical protein  conserved,S
Tb927.8.7720,9624.5,8719.0,8075.5,8871.0,8943.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7730,6883.0,6587.0,6315.0,6996.5,4915.5,Sphingosine N-acyltransferase  putative,G2M
Tb927.8.7740,11352.0,10462.5,10270.0,9974.5,8662.0,amino acid transporter  putative,<2C (LG1)
Tb8.NT.128,612.5,3568.0,3521.5,3452.5,4022.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.8.7750,3741.5,10178.0,9876.5,10112.0,8618.5,hypothetical protein  conserved,G1
Tb8.NT.129,612.5,1679.0,1489.0,1558.5,853.0,Noncoding RNA  putative,G1
Tb927.8.7760,9908.0,10550.5,10735.5,10304.0,10494.0,hypothetical protein  conserved,S
Tb927.8.7770,10271.5,10093.5,10538.5,10456.5,10418.5,aldehyde dehydrogenase family  putative,S
Tb927.8.7780,9980.0,10526.0,10256.5,9953.0,10366.0,hypothetical protein  conserved,G1
Tb927.8.7790,9841.5,7642.0,7595.0,7662.5,6074.0,zinc finger domain  LSD1 subclass  putative,<2C (LG1)
Tb927.8.7800,9463.5,10689.5,10789.0,10339.5,10891.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.7810,1460.0,413.0,448.0,705.5,895.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.7820,10926.5,10605.0,10385.5,10500.5,7579.5,'Cold-shock' DNA-binding domain containing protein  putative,<2C (LG1)
Tb927.8.7830,9711.5,10997.5,10869.5,10518.0,10688.0,hypothetical protein  conserved,G1
Tb927.8.7840,4040.0,9200.0,9600.5,8735.0,9373.0,dynein heavy chain  cytosolic  putative,S
Tb927.8.7850,9681.0,9497.5,10158.5,10005.0,8781.0,hypothetical protein  conserved,S
Tb927.8.7860,11346.0,11611.0,11593.0,11615.0,11469.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb927.8.7870,11195.0,11588.0,11528.0,11575.0,11364.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.8.7880,4253.5,8447.5,8497.0,8749.0,8582.0,receptor-type adenylate cyclase GRESAG 4  fragment,G2M
Tb927.8.7890,11584.0,11585.0,11541.0,11587.0,11468.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb927.8.7900,10403.5,11344.0,11297.0,11213.0,10567.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.8.7910,11178.0,11383.0,11336.5,11389.0,11011.5,receptor-type adenylate cyclase GRESAG 4  frameshift,G2M
Tb927.8.7920,11015.5,11266.0,11220.0,11160.0,10892.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.8.7930,11283.0,11534.0,11525.0,11543.5,11381.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb927.8.7940,10761.0,11087.0,11009.0,10844.0,10589.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.8.7950,11600.0,11350.0,11410.0,11461.0,11498.5,Flagellar Member 4,<2C (LG1)
Tb927.8.7960,8542.5,9852.0,9246.0,9981.0,7459.5,hypothetical protein,G2M
Tb927.8.7970,7417.0,7447.5,6262.0,6626.0,4320.5,hypothetical protein,G1
Tb927.8.7980,11378.0,10823.5,11135.5,11052.5,10312.0,Pyrophosphate-energized vacuolar membrane proton pump 2  putative,<2C (LG1)
Tb927.8.7990,11587.0,11664.0,11662.0,11674.0,11620.0,Thioredoxin-like/Protein of unknown function (DUF3638)/Protein of unknown function (DUF3645)  putative,G2M
Tb927.8.8000,2436.0,4467.0,3832.5,3992.5,6712.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.8010,7587.0,8601.0,9918.0,8958.5,10480.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.8020,8152.5,5634.0,4518.5,4828.5,3981.5,monoglyceride lipase  putative,<2C (LG1)
Tb927.8.8030,1460.0,4503.0,3801.5,5159.0,2402.0,emp24/gp25L/p24 family/GOLD  putative,G2M
Tb927.8.8040,7440.5,7121.0,6518.0,7132.0,5442.5,kinetoplastid-specific phospho-protein phosphatase  putative,<2C (LG1)
Tb927.8.8050,9327.5,10367.5,10773.5,10125.0,10742.0,Nucleoporin NUP75,S
Tb927.8.8060,8676.0,8499.5,9238.0,9309.0,10073.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,>4C (GG2M)
Tb927.8.8070,10572.0,10067.5,10606.5,10358.5,8958.5,conserved protein,S
Tb927.8.8080,2258.5,2335.0,2318.5,2530.5,2268.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,G2M
Tb927.8.8090,3142.5,5213.5,3821.0,3773.5,3741.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.8.8100,4090.5,3775.5,4200.5,3815.5,4145.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,S
Tb927.8.8110,11465.0,10638.5,10756.5,10758.5,10278.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.8120,2137.5,2638.5,3727.5,3264.5,2747.0,hypothetical protein  conserved,S
Tb927.8.8130,9944.5,9615.0,9376.5,9595.5,9784.0,hypothetical protein  conserved,<2C (LG1)
Tb8.NT.138,3230.0,774.5,562.5,788.5,1047.0,Noncoding RNA  putative,<2C (LG1)
Tb927.8.8140,11162.0,11374.5,11445.5,11331.0,9519.5,small GTP-binding rab protein  putative,S
Tb927.8.8150,8282.0,5701.0,6288.0,4841.0,5834.5,C2 domain containing protein  putative,<2C (LG1)
Tb927.8.8160,9992.5,9110.0,8235.0,8853.5,8781.0,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.8.8170,9418.0,10968.5,10631.0,10954.0,10050.0,RNA editing mediator complex protein 5,G1
Tb927.8.8180,9187.0,9118.0,9292.0,8896.5,6420.0,RNA editing mediator complex protein 4,S
Tb927.8.8190,11126.5,10380.5,10044.5,9982.5,9641.5,hypothetical protein  conserved,<2C (LG1)
Tb927.8.8200,1460.0,1026.5,2275.0,1823.5,11402.5,Flagellar-associated protein 59  putative,>4C (GG2M)
Tb927.8.8210,3662.5,3256.0,3431.0,3168.0,3566.5,Cleavage stimulating factor 64  putative,<2C (LG1)
Tb927.8.8220,6659.5,8336.5,8931.5,8793.0,8000.0,amino acid transporter  putative,S
Tb927.8.8230,9073.0,10757.0,10536.0,10748.0,11095.0,amino acid transporter  putative,>4C (GG2M)
Tb927.8.8240,8218.0,8750.5,9475.0,9489.5,9095.5,amino acid transporter  putative,G2M
Tb927.8.8250,8058.0,10447.0,10308.5,10230.5,8505.0,amino acid transporter  putative,G1
Tb927.8.8260,7267.0,8770.0,8994.0,8767.5,8184.5,amino acid transporter  putative,S
Tb927.8.8270,5588.5,10904.0,10817.0,10318.5,8188.0,hypothetical protein  conserved,G1
Tb927.8.8280,7001.5,4276.0,3101.5,4137.0,4903.0,hypothetical protein  conserved,<2C (LG1)
Tb927.8.8290,8257.0,8503.5,7773.5,8348.5,6960.0,amino acid transporter AATP5,G1
Tb927.8.8300,2886.0,3336.0,2827.0,4183.0,5535.5,amino acid transporter  putative,>4C (GG2M)
Tb927.8.8310,8957.5,7851.5,7700.5,7179.5,4714.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.8.8320,10206.0,10482.0,10205.0,10600.0,10624.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.8.8330,3751.5,1190.0,1956.0,2252.0,9519.5,cysteine peptidase  putative,>4C (GG2M)
Tb927.8.8340,4040.0,4441.0,4653.0,5095.0,3726.5,CRAL/TRIO domain containing protein  putative,G2M
Tb927.8.8350,5673.0,5166.0,5025.0,4699.5,3335.5,Kinesin-13 4b  putative,<2C (LG1)
Tb927.8.8360,8979.5,8891.0,9162.5,8290.0,9049.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb10.v4.0160,2767.0,5128.0,3912.5,6313.0,7422.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0161,4544.0,4341.0,5512.0,5325.0,3110.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0162,4523.5,978.5,818.5,839.0,978.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0163,6372.0,1991.5,1977.0,1726.5,1984.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0164,7272.5,6324.0,6764.0,7448.0,4893.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0165,612.5,235.5,336.0,273.5,607.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0166,2714.5,5069.5,6568.5,7571.0,5174.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0167,1460.0,3723.5,4002.0,2840.5,3726.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0168,6556.0,3016.0,4189.0,5576.5,3345.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0169,612.5,3526.0,3858.5,2764.5,4320.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0170,7570.0,5225.5,5298.0,5969.0,6994.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0171,6803.5,5542.0,5001.0,5751.5,5174.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0172,6552.0,6494.5,5991.0,6219.5,4525.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0173,1460.0,2828.5,1945.0,1805.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0174,612.5,3211.5,2327.5,2716.0,2364.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0175,7552.5,3766.0,4653.0,4446.0,5675.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0176,4922.5,3367.5,3514.5,4221.0,4578.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0177,612.5,484.0,357.5,352.0,915.0,variant surface glycoprotein (point mutated fragment,>4C (GG2M)
Tb10.v4.0178,2329.5,9532.5,9660.0,9503.0,10116.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb10.v4.0179,1783.5,4983.0,4057.0,3796.5,2336.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0180,8654.5,3782.0,3832.5,3938.0,4957.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0181,6088.5,2544.5,1977.0,2456.5,2574.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb10.v4.0182,7778.0,1078.5,880.5,890.0,287.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0183,2813.0,5732.5,5460.5,5873.0,3235.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0184,9862.0,10005.0,10133.0,10624.0,10400.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0185,9169.0,10138.0,9811.0,9743.5,9755.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0186,4674.5,8974.5,8781.0,8892.5,9406.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0187,7646.5,3476.5,3092.0,2716.0,3596.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0188,5304.0,6525.5,6616.5,7783.5,5906.5,hypothetical protein,G2M
Tb10.v4.0189,612.5,518.0,491.0,628.0,347.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb10.v4.0190,10718.5,8680.5,8340.0,8100.0,9032.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0191,612.5,967.5,658.5,534.5,1984.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0192,612.5,4441.0,3697.0,4336.5,4051.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0193,5477.5,2149.5,2621.5,3102.5,2427.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.7.100,4569.0,727.0,471.5,577.5,744.5,variant surface glycoprotein (VSG)  putative (fragment),<2C (LG1)
Tb927.7.110,1783.5,927.5,313.0,737.0,964.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.7.120,1460.0,2272.0,2977.0,2977.0,2794.5,variant surface glycoprotein  degenerate,S
Tb927.7.130,2221.0,738.5,795.0,907.5,895.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.7.140,612.5,845.0,1164.0,2199.0,2454.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.7.150,1460.0,5277.0,4607.0,5004.5,8618.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.7.160,7581.5,8237.5,8869.5,9515.5,7826.5,expression site-associated gene 2 (ESAG2)  degenerate,G2M
Tb927.7.170,612.5,6368.0,7421.5,6240.5,6864.5,expression site-associated gene 9 (ESAG9) protein  putative,S
Tb927.7.180,5604.0,6124.0,6429.5,6381.0,6048.5,Trypanosomal VSG domain containing protein  putative,S
Tb927.7.190,1460.0,2592.5,2703.5,1980.0,347.0,thimet oligopeptidase  putative,S
Tb927.7.200,9890.0,8342.5,8472.5,8230.5,6799.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.210,10780.5,7338.0,7082.5,7675.5,5686.0,Proline dehydrogenase  mitochondrial,<2C (LG1)
Tb927.7.220,7387.5,7399.5,8470.0,8018.0,9046.0,CDP-DAG synthase,>4C (GG2M)
Tb927.7.230,7564.5,1565.5,1347.5,788.5,1162.5,40S ribosomal protein S33  putative,<2C (LG1)
Tb927.7.240,5001.5,1332.5,1311.0,1031.0,1338.5,40S ribosomal protein S33  putative,<2C (LG1)
Tb927.7.250,10714.5,10607.0,11027.0,10975.5,10509.0,zinc finger protein family member  putative,S
Tb927.7.260,3875.5,3787.0,3633.5,2988.5,4626.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.270,3701.5,5017.0,5460.5,6077.0,4320.5,Ribosome production factor 2 homolog,G2M
Tb927.7.280,8729.0,8651.5,8568.5,8282.5,8597.0,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.7.290,11248.0,11250.0,11257.0,11338.0,10213.5,leucine-rich repeat protein 1 (LRRP1)  putative,G2M
Tb927.7.300,11038.0,10405.0,10450.0,10743.0,9719.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb927.7.310,3407.5,3606.5,2949.5,3264.5,2679.0,Prostaglandin E synthase  putative,G1
Tb927.7.320,10000.0,10722.0,10596.5,10984.0,10983.0,RNA-binding protein 8,G2M
Tb927.7.330,612.5,3680.0,3431.0,2629.5,2079.5,Thioesterase-like superfamily  putative,G1
Tb927.7.340,1460.0,4790.0,5276.5,3924.0,3144.5,Alpha/beta hydrolase family  putative,S
Tb927.7.350,9934.5,9484.0,9405.0,9249.5,7226.0,hypothetical protein,<2C (LG1)
Tb927.7.360,9648.0,9208.5,8938.5,9478.0,8327.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.370,4459.5,3324.5,3727.5,4156.0,2914.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.380,8614.5,7585.5,7308.0,6428.5,6535.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.390,5908.0,5364.5,5408.5,6205.5,5624.0,hypothetical protein  conserved,G2M
Tb927.7.400,9546.0,9889.5,9185.0,9732.5,9071.5,hypothetical protein  conserved,G1
Tb927.7.410,5792.5,5229.0,5276.5,5407.5,4128.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.420,8913.0,8578.5,7923.5,8082.0,6820.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.430,6777.5,7179.5,7193.0,7072.0,5694.5,hypothetical protein  conserved,S
Tb927.7.440,7730.0,7663.0,7259.5,6465.0,7125.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.450,8773.0,9118.0,10170.0,10283.5,10326.5,Golgi complex component 7 (COG7)  putative,>4C (GG2M)
Tb927.7.460,8002.0,7331.5,6780.0,7725.0,8611.0,protein farnesyltransferase beta subunit,>4C (GG2M)
Tb927.7.470,8606.5,5985.5,5559.0,6157.0,6664.5,Enriched in surface-labeled proteome protein 14,<2C (LG1)
Tb927.7.480,10451.0,10279.5,10534.5,10327.0,9895.5,hypothetical protein  conserved,S
Tb927.7.490,10903.5,4642.5,5892.0,4981.0,2661.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.500,10041.0,11040.0,10920.5,10817.5,10998.0,hypothetical protein  conserved,G1
Tb927.7.510,3028.5,2510.5,2812.5,3045.0,3283.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.520,7577.0,4251.5,4421.0,4381.0,5379.5,cytochrome b5-like Heme/Steroid binding domain containing protein  putative,<2C (LG1)
Tb927.7.530,7115.0,10612.5,10832.5,10721.0,10105.0,FYVE zinc finger  putative,S
Tb927.7.540,1460.0,912.5,907.5,1329.0,1062.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.7.550,6811.0,9467.5,8938.5,10298.0,9938.5,WD domain  G-beta repeat  putative,G2M
Tb927.7.560,11083.0,10204.5,9573.0,9546.0,7154.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.570,8214.5,7844.5,8087.5,9107.0,9650.0,prefoldin  putative,>4C (GG2M)
Tb927.7.580,7951.5,9845.5,9898.0,9200.5,9463.5,GTP-binding protein  putative,S
Tb927.7.590,7783.5,8680.5,8746.5,9123.5,7478.0,hypothetical protein  conserved,G2M
Tb927.7.600,10293.0,9251.0,8825.5,8432.0,8738.5,mitochondrial DNA ligase homolog  LIG k-beta,<2C (LG1)
Tb927.7.610,612.5,855.5,980.0,957.5,2310.0,mitochondrial DNA ligase homolog  LIG k-alpha,>4C (GG2M)
Tb927.7.620,9725.5,6352.5,7442.5,6077.0,4365.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.630,612.5,3457.0,3551.5,2956.0,5362.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.640,4122.5,7373.0,7756.0,7517.0,7712.5,hypothetical protein  conserved,S
Tb927.7.650,11305.0,11177.5,11075.0,10934.0,10738.0,Nucleolar protein 105,<2C (LG1)
Tb927.7.660,8770.5,8951.5,10163.0,9946.5,9067.0,Cupin-like domain containing protein  putative,S
Tb927.7.670,10472.0,10854.0,10858.0,11135.0,10867.0,hypothetical protein  conserved,G2M
Tb927.7.680,10586.0,3336.0,2969.0,3577.5,5083.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.7.690,9049.0,8404.0,8831.0,9529.5,9293.0,zinc finger protein  putative,G2M
Tb927.7.700,7301.5,10484.5,10243.5,9786.5,10031.0,Nucleolar protein 74,G1
Tb927.7.710,5369.0,2241.5,2949.5,3658.0,1842.0,heat shock 70 kDa protein  putative,<2C (LG1)
Tb927.7.720,11671.0,11156.0,11245.0,11166.0,11360.0,conserved protein,<2C (LG1)
Tb927.7.730,1460.0,6842.0,6373.5,6845.5,9478.0,Component of motile flagella 49,>4C (GG2M)
Tb927.7.740,9226.0,9124.0,8299.5,7571.0,6307.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.7.750,10433.5,7032.0,6206.0,6567.0,6588.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.760,4459.5,6368.0,6616.5,6815.5,8454.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.770,5944.5,8245.0,8356.0,8773.0,9487.0,Ring finger domain containing protein  putative,>4C (GG2M)
Tb927.7.780,3957.5,8596.5,7474.5,7153.5,8198.0,RNA pseudouridylate synthase  putative,G1
Tb927.7.790,9272.0,7647.5,7242.0,8427.5,7896.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.800,9747.0,8274.5,8185.0,8454.0,8178.5,RNA editing mediator complex protein 3,<2C (LG1)
Tb927.7.810,10482.0,10635.0,10741.5,10881.5,11261.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.820,1460.0,1437.5,2827.0,1597.5,9472.0,dynein arm light chain  axonemal  putative,>4C (GG2M)
Tb927.7.830,11649.0,11658.0,11660.0,11653.0,11583.0,telomerase-associated protein  putative,S
Tb927.7.840,2658.5,3665.0,2577.0,2085.0,4145.0,Mitochondrial ATP synthase subunit  putative,>4C (GG2M)
Tb927.7.850,5897.5,3041.5,3503.0,2440.0,2268.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.860,11045.5,9580.5,9931.0,10355.0,8254.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.870,6185.5,6107.0,6513.5,4894.5,1141.0,hypothetical protein  conserved,S
Tb927.7.880,612.5,8020.5,8277.0,7599.5,9182.0,RNA-binding protein  putative,>4C (GG2M)
Tb927.7.890,3202.0,6813.0,6368.5,6475.5,2819.0,electron transfer protein  putative,G1
Tb927.7.900,1460.0,8863.0,8888.5,8904.0,8321.0,hypothetical protein  conserved,G2M
Tb927.7.910,612.5,8059.5,8563.0,7979.5,7890.5,hypothetical protein  conserved,S
Tb927.7.920,4153.0,3407.5,4181.0,4027.5,11312.0,Inner arm dynein 5-1,>4C (GG2M)
Tb927.7.930,5863.0,3397.0,1416.0,4301.0,4541.5,zinc finger CCCH domain containing protein 17,<2C (LG1)
Tb927.7.940,10798.0,10432.5,10137.5,10198.0,10733.5,protein kinase C substrate protein  heavy chain  putative,<2C (LG1)
Tb927.7.950,7511.5,10573.0,9829.0,10234.5,9530.0,Polycystin cation channel  putative,G1
Tb927.7.960,11019.0,10552.0,10986.0,11073.0,11192.0,CMGC/SRPK protein kinase  putative,>4C (GG2M)
Tb927.7.970,2295.5,5063.5,5856.5,4731.0,4179.0,NMD3 family  putative,S
Tb927.7.980,9406.0,6865.0,6687.5,5704.5,4490.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.990,6703.5,10225.5,10424.5,10237.5,8826.5,chaperone protein DnaJ  putative,S
Tb927.7.1000,7919.0,5909.5,6672.5,6562.0,7416.5,ATP-dependent DNA helicase-like PIF8,<2C (LG1)
Tb927.7.1010,612.5,2118.0,1446.0,1526.5,1789.5,hypothetical protein  conserved,G1
Tb927.7.1020,8845.5,7591.5,7204.0,7059.0,6623.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1025,5653.0,1034.0,1595.5,1125.0,2016.0,hypothetical protein,<2C (LG1)
Tb927.7.1030,9536.5,4886.5,4990.5,5850.0,7510.5,heat shock 70 kDa protein  putative,<2C (LG1)
Tb927.7.1040,1460.0,747.5,880.5,397.5,1099.0,40S ribosomal protein S16  putative,<2C (LG1)
Tb927.7.1050,612.5,130.0,373.5,204.0,287.0,40S ribosomal protein S16  putative,<2C (LG1)
Tb927.7.1060,5500.5,8107.0,7061.5,7560.5,9353.0,ISWI complex protein,>4C (GG2M)
Tb927.7.1070,6695.5,9730.0,8938.5,9386.0,7821.0,KREX1,G1
Tb927.7.1080,4480.0,5896.0,7249.5,8185.5,7023.0,hypothetical protein  conserved,G2M
Tb927.7.1090,10977.0,10444.0,9420.0,9100.0,9699.5,DNA repair protein RAD5  putative,<2C (LG1)
Tb927.7.1100,612.5,8421.0,7108.0,5569.0,8032.5,hypothetical protein  conserved,G1
Tb927.7.1110,3770.5,4079.5,4749.0,4928.5,3775.0,asparagine synthetase a  putative,G2M
Tb927.7.1120,3328.5,2392.5,2919.0,2881.0,3283.5,trypanothione/tryparedoxin dependent peroxidase 1  cytosolic,<2C (LG1)
Tb927.7.1130,6733.0,2138.5,2827.0,2506.5,4081.5,trypanothione/tryparedoxin dependent peroxidase 2,<2C (LG1)
Tb927.7.1140,4113.0,999.0,1585.5,1479.0,3906.0,trypanothione/tryparedoxin dependent peroxidase 3,<2C (LG1)
Tb927.7.1150,10442.0,11032.0,10972.0,11083.0,11053.5,hypothetical protein  conserved,G2M
Tb927.7.1160,612.5,4493.5,4448.0,3888.5,4081.5,hypothetical protein  conserved,G1
Tb927.7.1170,612.5,2571.5,4029.0,2988.5,3457.5,RNA-binding protein Y14,S
Tb927.7.1172,612.5,3000.5,3843.5,4057.0,3110.0,hypothetical protein,G2M
Tb927.7.1175,612.5,1574.5,1510.5,1299.0,1141.0,tRNA Glycine,G1
Tb927.7.1180,1460.0,2693.0,3079.0,2483.5,964.0,RNA-binding protein  putative,S
Tb927.7.1190,7421.0,10543.0,10622.5,10589.0,10584.0,regulator of chromosome condensation  putative,S
Tb927.7.1200,5266.0,7939.0,7756.0,7859.5,7084.5,Protein of unknown function (DUF525)  putative,G1
Tb927.7.1210,2913.0,7689.5,7741.0,7819.0,6270.0,regulator of chromosome condensation  putative,G2M
Tb927.7.1220,10484.5,11228.0,11181.0,11286.0,11023.0,hypothetical protein  conserved,G2M
Tb927.7.1230,11338.0,10701.5,10626.0,10544.0,10919.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1240,11135.0,11091.5,11199.5,10727.5,11099.0,Sphingosine kinase,S
Tb927.7.1250,6594.5,10394.0,10516.5,10799.0,10326.5,hypothetical protein  conserved,G2M
Tb927.7.1260,6389.5,7366.5,7076.5,7356.0,8553.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.1270,5546.0,10489.0,10672.5,10834.0,10351.0,hypothetical protein  conserved,G2M
Tb927.7.1280,4375.0,3941.5,4200.5,4981.0,5394.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.1290,4057.5,5757.0,6055.5,6927.5,4306.0,Protein of unknown function (DUF2012)  putative,G2M
Tb927.7.1300,2381.5,7444.0,7515.5,7681.5,8651.0,protein disulfide isomerase  putative,>4C (GG2M)
Tb927.7.1310,5799.0,6044.5,7044.5,7344.0,11605.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.1320,612.5,1635.5,1335.0,974.5,1489.0,10 kDa heat shock protein  putative,G1
Tb927.7.1330,1460.0,4838.0,3323.5,3992.5,6344.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.1340,612.5,1789.5,1650.0,941.0,2536.0,10 kDa heat shock protein  putative,>4C (GG2M)
Tb927.7.1350,612.5,4761.5,3767.5,3408.0,3794.0,Pentatricopeptide repeat protein (PPR)  putative,G1
Tb927.7.1360,612.5,1506.5,1402.0,1343.0,1047.0,hypothetical protein  conserved,G1
Tb927.7.1370,7148.0,8585.5,9038.5,8985.0,8674.0,spliced leader RNA PSE-promoter transcription factor  putative,S
Tb927.7.1380,8207.5,2851.5,3420.5,4446.0,2747.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1390,6963.5,4937.5,4857.0,5060.5,4365.0,RNA-binding protein  putative,<2C (LG1)
Tb927.7.1400,11258.0,8974.5,8909.5,9412.5,7782.5,Tripartite Attachment Complex Protein 60,<2C (LG1)
Tb927.7.1410,9800.5,8431.0,8697.0,8583.0,8213.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1420,10985.0,11480.0,11461.0,11478.0,11106.5,hypothetical protein  conserved,G1
Tb927.7.1430,3834.5,5896.0,6485.5,5249.5,8078.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.7.1440,8569.5,3499.5,4823.0,3950.5,4645.0,non-canonical poly (A) polymerase,<2C (LG1)
Tb927.7.1450,1460.0,2687.5,2849.0,3752.5,1582.0,Conserved hypothetical ATP binding protein  putative,G2M
Tb927.7.1460,9624.5,5542.0,6533.5,6540.5,6350.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1470,7671.0,4996.5,7274.0,6899.0,5972.0,Mitochondrial ATP synthase subunit c-3,<2C (LG1)
Tb927.7.1480,5725.0,9276.0,9551.5,9245.5,9178.5,hypothetical protein  conserved,S
Tb927.7.1490,8680.5,4937.5,5670.5,5445.5,4737.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1500,6563.5,4260.5,5969.0,5551.0,3033.0,Cytosolic Fe-S cluster assembly factor CFD1  putative,<2C (LG1)
Tb927.7.1510,9106.0,7672.5,6568.5,5695.0,7363.0,pseudouridylate synthase I  putative,<2C (LG1)
Tb927.7.1520,612.5,1384.0,966.5,941.0,1304.5,hypothetical protein  conserved,G1
Tb927.7.1530,10495.5,10159.5,10124.5,10101.0,10174.5,2OG-Fe(II) oxygenase superfamily  putative,<2C (LG1)
Tb927.7.1540,9250.0,6199.5,5256.0,6035.0,7834.0,Staphylococcal nuclease homologue  putative,<2C (LG1)
Tb927.7.1550,8083.0,6561.0,6803.5,6219.5,3871.0,KRET2,<2C (LG1)
Tb927.7.1560,8756.5,6977.5,8138.0,8765.0,9564.5,TPR repeat  putative,>4C (GG2M)
Tb927.7.1570,10680.0,8183.5,7005.5,7361.0,8213.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1580,8770.5,9682.0,10186.5,9977.0,10659.5,Vps52 / Sac2 family  putative,>4C (GG2M)
Tb927.7.1590,7413.5,8574.5,8610.0,8720.5,8151.0,mitotic cyclin,G2M
Tb927.7.1600,9499.5,9549.0,9954.0,10398.5,10088.0,C-1-tetrahydrofolate synthase  cytoplasmic  putative,G2M
Tb927.7.1610,10703.0,9501.0,8796.5,9114.0,6994.0,6-phosphofructo-2-kinase/fructose-2 6-biphosphatase  putative,<2C (LG1)
Tb927.7.1620,3570.5,1595.5,1665.0,1642.5,1489.0,Cleavage factor I 25 kDa subunit  putative,<2C (LG1)
Tb927.7.1630,612.5,2485.0,2564.5,2940.5,3021.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.1640,1914.0,4630.0,5678.5,5704.5,5342.0,ras-like small GTPase  putative,G2M
Tb927.7.1650,8456.0,9821.5,9573.0,9834.0,9279.0,hypothetical protein  conserved,G2M
Tb927.7.1660,7475.0,7561.5,8116.5,8245.0,4128.5,hypothetical protein  conserved,G2M
Tb927.7.1670,10505.0,3572.0,4327.5,4647.0,4770.5,Eukaryotic translation initiation factor 4E type 6,<2C (LG1)
Tb927.7.1680,3166.5,8770.0,8519.5,8647.5,4292.0,Uncharacterised conserved protein (DUF2305)  putative,G1
Tb7.NT.10,612.5,1684.5,2036.0,1823.5,2505.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.7.1690,2523.0,2609.5,2849.0,3452.5,2870.0,Silent information regulator 2 related protein 1,G2M
Tb927.7.1700,4995.5,5771.5,6016.0,6899.0,4617.5,hypothetical protein  conserved,G2M
Tb927.7.1710,7834.5,6946.0,6200.0,6626.0,3681.5,eukaryotic peptide chain release factor subunit 1  putative,<2C (LG1)
Tb927.7.1720,6301.5,1838.0,1721.5,2150.0,2268.0,NFU1 iron-sulfur cluster scaffold homolog  mitochondrial,<2C (LG1)
Tb927.7.1730,612.5,3016.0,2300.0,2506.5,1660.5,60S ribosomal protein L7  putative,G1
Tb927.7.1740,1460.0,279.5,189.5,313.5,213.0,60S ribosomal protein L7  putative,<2C (LG1)
Tb927.7.1750,612.5,307.0,980.0,221.5,347.0,60S ribosomal protein L7  putative,S
Tb927.7.1760,8853.0,4761.5,4695.5,5850.0,3271.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1770,10464.0,8872.0,9020.0,9005.5,9527.0,Mini-chromosome maintenance complex-binding protein,<2C (LG1)
Tb927.7.1780,4517.0,9093.5,8998.0,9055.5,9149.0,Adenine phosphoribosyltransferase  putative,>4C (GG2M)
Tb927.7.1790,4674.5,8284.0,8529.5,8296.5,7788.0,Adenine phosphoribosyltransferase  putative,S
Tb927.7.1800,5063.0,3900.0,4476.0,3965.5,3847.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.1810,10094.0,11034.0,10924.0,10915.0,11003.5,hypothetical protein  conserved,G1
Tb927.7.1820,5314.0,6504.5,5526.0,6024.5,4377.5,hypothetical protein  conserved,G1
Tb927.7.1830,8154.5,8926.5,8983.5,8881.5,8424.5,hypothetical protein  conserved,S
Tb927.7.1840,6563.5,9340.0,9856.5,8756.0,9467.0,zinc finger protein  putative,S
Tb927.7.1850,10263.0,11037.5,10916.5,11043.0,10995.0,hypothetical protein  conserved,G2M
Tb927.7.1860,5320.5,6223.5,5744.0,5939.0,4480.5,hypothetical protein  conserved,G1
Tb927.7.1870,8087.0,8936.5,8676.5,8239.5,8566.0,hypothetical protein  conserved,G1
Tb927.7.1880,6546.5,8978.5,9301.5,8144.5,9156.5,zinc finger protein  putative,S
Tb927.7.1890,1783.5,4235.0,6034.5,4336.5,4403.5,hypothetical protein  conserved,S
Tb927.7.1900,3456.5,7890.5,6866.5,4994.0,6088.5,cdc2-related protein kinase 7  putative,G1
Tb927.7.1910,8941.0,10726.5,10359.0,10794.0,9876.5,pyridoxal phosphate containing glycine decarboxylase  putative,G2M
Tb927.7.1920,10557.0,10693.0,10486.0,10895.0,10874.0,paraflagellar rod component  putative,G2M
Tb927.7.1930,3448.5,8176.0,8152.5,8211.5,7356.5,nucleoside diphosphatase  putative,G2M
Tb927.7.1940,7080.5,5521.0,5787.0,5917.0,5640.0,hypothetical protein,<2C (LG1)
Tb927.7.1950,11339.5,11405.0,11277.0,11324.5,10841.5,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.1960,11152.0,11569.0,11509.0,11547.0,11253.0,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.1970,11210.0,11429.0,11296.0,11275.5,10939.0,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.1980,11118.0,11455.0,11364.5,11350.0,11145.0,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.1990,10660.5,11357.0,11287.5,11312.0,10937.5,retrotransposon hot spot protein 7 (RHS7)  point mutation,G1
Tb927.7.2000,11206.0,11409.0,11359.5,11317.5,10917.5,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.2010,10696.5,10812.0,10694.0,10423.5,9879.5,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.2020,11447.0,11470.0,11438.5,11345.0,11042.5,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.2030,10042.5,11415.0,11188.0,11240.0,10708.0,retrotransposon hot spot protein 7 (RHS7)  putative,G1
Tb927.7.2040,7999.5,7389.5,5584.0,5307.5,7447.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2050,6783.5,8789.0,9510.0,8881.5,10145.0,R3H domain containing protein  putative,>4C (GG2M)
Tb927.7.2060,7023.5,8684.5,8038.5,8132.5,7725.5,DNA repair protein  putative,G1
Tb927.7.2070,9476.0,8796.0,8852.0,9229.5,10264.0,heat shock protein DNAJ  putative,>4C (GG2M)
Tb927.7.2080,7210.5,9217.0,9717.0,9523.5,8602.0,cap guanylyltransferase-methyltransferase 1,S
Tb927.7.2090,5199.5,4084.5,4283.5,3418.5,3896.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2100,8144.0,6745.0,6655.0,6927.5,6369.5,GMP synthase [glutamine-hydrolysing],<2C (LG1)
Tb927.7.2110,3734.0,543.0,731.0,757.5,1213.5,kinetoplastid kinetochore protein 11,<2C (LG1)
Tb927.7.2120,7696.0,2808.0,3821.0,3142.0,5803.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2130,1914.0,2128.0,2214.0,1745.0,2692.0,Uncharacterized conserved protein (DUF2036)  putative,>4C (GG2M)
Tb927.7.2140,3863.0,2069.5,3344.0,3393.5,2243.5,zinc finger protein family member  putative,<2C (LG1)
Tb7.NT.17,2357.5,471.5,448.0,557.5,797.5,Noncoding RNA  putative,<2C (LG1)
Tb927.7.2150,8832.5,10896.0,10692.0,10765.0,10006.0,SUMO-interacting motif-containing protein,G1
Tb927.7.2160,4159.0,2444.5,1956.0,2967.0,3693.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2170,7396.5,3827.0,3649.5,2775.0,5044.5,Nucleolar protein 168,<2C (LG1)
Tb927.7.2180,4887.0,6578.0,5798.5,7301.0,4121.5,T. brucei spp.-specific protein  T. brucei spp.-specific protein  putative,G2M
Tb927.7.2190,612.5,130.0,40.0,182.5,86.0,translocon-associated protein (TRAP)  alpha subunit  putative,<2C (LG1)
Tb927.7.2200,7800.0,2949.5,4038.0,2999.5,2819.0,mitochondrial import inner membrane translocase subunit tim9,<2C (LG1)
Tb927.7.2210,2047.0,3476.5,2703.5,3699.0,2268.0,hypothetical protein  conserved,G2M
Tb927.7.2220,7751.5,5847.0,5704.5,6035.0,6749.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2230,612.5,6066.5,4434.0,4841.0,7392.0,mitochondrial carrier protein  putative,>4C (GG2M)
Tb927.7.2240,612.5,2376.0,2075.5,1779.5,7439.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2250,5997.5,4983.0,5505.0,4790.0,6864.5,carnitine O-palmitoyltransferase II  putative,>4C (GG2M)
Tb927.7.2260,612.5,3723.5,4117.0,3965.5,4903.0,SEP domain containing protein  putative,>4C (GG2M)
Tb927.7.2270,1783.5,2384.0,1416.0,1745.0,797.5,hypothetical protein  conserved,G1
Tb927.7.2280,5006.5,2128.0,1909.5,2046.5,1374.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2290,5199.5,3367.5,4148.5,5206.5,4355.0,hypothetical protein  conserved,G2M
Tb927.7.2300,5120.0,3782.0,5070.5,4731.0,9573.0,Nucleoporin NUP132,>4C (GG2M)
Tb927.7.2310,5094.0,6329.5,6577.0,4962.5,5075.5,DNA primase small subunit  putative,S
Tb927.7.2320,9948.0,10499.0,10677.5,10570.0,10783.0,cyclic nucleotide-binding domain containing protein  putative,>4C (GG2M)
Tb927.7.2330,9031.5,10079.0,10724.5,11074.0,11637.0,Protein of unknown function (DUF1663)  putative,>4C (GG2M)
Tb927.7.2340,612.5,130.0,99.0,82.5,287.0,40S ribosomal protein S15  putative,<2C (LG1)
Tb927.7.2350,9725.5,11068.0,10887.0,11000.5,11559.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2360,10931.0,8525.0,8529.5,8834.0,8781.0,N-acetyltransferase  putative,<2C (LG1)
Tb927.7.2370,612.5,799.5,578.5,557.5,836.0,40S ribosomal protein S15  putative,>4C (GG2M)
Tb927.7.2380,612.5,759.0,427.0,1071.0,1392.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2390,2047.0,6852.0,7334.0,6366.5,5442.5,Tripartite attachment complex protein 102,S
Tb927.7.2400,5369.0,3515.0,5135.0,3228.0,4170.0,tyrosyl-tRNA synthetase  putative,<2C (LG1)
Tb927.7.2410,6563.5,9796.0,9846.5,10279.5,10310.0,Dynamin family  putative,>4C (GG2M)
Tb927.7.2420,5863.0,5876.0,6134.0,6582.5,8789.0,glycogen synthase kinase-3 alpha  putative,>4C (GG2M)
Tb927.7.2440,2995.0,3150.0,2134.0,1702.0,1062.5,pyrroline-5-carboxylate reductase  putative,G1
Tb927.7.2450,612.5,5463.0,4928.0,4928.5,5983.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.7.2460,5876.5,5391.0,4740.5,4454.5,8389.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2470,8551.0,10791.5,10790.0,10841.0,10869.0,GTPase activating protein  putative,>4C (GG2M)
Tb927.7.2480,9445.0,8839.0,7901.5,8617.0,8773.5,Parvulin 42,<2C (LG1)
Tb927.7.2490,4266.5,4287.0,3789.5,4193.5,3225.0,kinetoplast ribosomal PPR-repeat containing protein 15,G1
Tb927.7.2500,3314.5,967.5,1254.0,1763.5,1304.5,proteasome regulatory ATPase subunit 1,<2C (LG1)
Tb927.7.2510,7195.5,9734.0,9886.0,10035.0,8206.5,endoplasmatic reticulum retrieval protein  putative,G2M
Tb927.7.2520,7987.0,7656.0,8105.0,8036.0,8862.0,Uncharacterised protein family UPF0066  putative,>4C (GG2M)
Tb927.7.2530,612.5,4684.0,5570.5,5716.5,4158.0,N-acetyltransferase  putative,G2M
Tb927.7.2540,10799.0,9810.5,10466.5,10216.5,9557.0,ubiquitin-protein ligase  putative,<2C (LG1)
Tb927.7.2550,5604.0,2927.0,5777.0,7047.0,9425.0,proteasome regulatory ATPase subunit 5,>4C (GG2M)
Tb927.7.2560,2840.5,9254.0,9876.5,10267.5,10940.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2570,7851.0,6186.0,5298.0,6331.5,7008.5,guide RNA associated protein  GAP2,<2C (LG1)
Tb927.7.2580,5505.0,6631.0,7836.0,8554.0,6420.0,zinc finger protein family member  putative,G2M
Tb927.7.2590,612.5,2020.5,1634.5,1713.0,2609.5,prefoldin  putative,>4C (GG2M)
Tb927.7.2600,2780.5,1690.5,1561.5,1363.5,1179.0,class I transcription factor A  subunit 7,<2C (LG1)
Tb927.7.2610,4190.5,1894.5,2075.5,1688.5,1453.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2620,9073.0,2652.5,3560.0,2617.5,1660.5,SSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.7.2630,6967.0,9591.0,9306.5,9826.5,8883.5,50S ribosome-binding GTPase  putative,G2M
Tb927.7.2640,5588.5,7310.0,8138.0,7864.5,8093.5,cytoskeleton associated protein  putative,S
Tb927.7.2650,1460.0,1132.5,767.0,1391.5,8433.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2660,10703.0,10513.0,10420.0,10775.5,10817.0,zinc finger protein family member  putative,>4C (GG2M)
Tb927.7.2670,1988.0,4812.5,7601.0,5917.0,8125.0,zinc finger protein family member  putative,>4C (GG2M)
Tb927.7.2680,1460.0,4493.5,5590.5,4409.0,4760.0,zinc finger protein family member  putative,S
Tb927.7.2690,6883.0,6676.0,6166.0,5765.5,8297.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2700,8204.5,7137.0,6102.0,6289.0,4883.5,NADH-cytochrome b5 reductase  putative,<2C (LG1)
Tb927.7.2710,612.5,2178.5,2849.0,2858.5,3669.0,NADH-cytochrome b5 reductase  putative,>4C (GG2M)
Tb927.7.2720,9583.0,6727.5,7044.5,7172.0,5153.5,translation initiation factor SUI1  putative,<2C (LG1)
Tb927.7.2730,1783.5,978.5,865.5,1299.0,1027.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.7.2740,3979.5,3552.0,2638.5,1792.5,4468.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.2750,9078.0,5695.5,6315.0,4522.0,4065.0,calcium/calmodulin-dependent protein kinase  putative,<2C (LG1)
Tb927.7.2760,9031.5,5625.5,5808.0,6035.0,3235.0,Mitochondrial ribosomal protein L22,<2C (LG1)
Tb927.7.2770,9013.0,5568.0,4790.5,4504.5,5404.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2780,2504.5,2078.0,2593.5,2302.0,2178.0,hypothetical protein  conserved,S
Tb7.NT.24,612.5,5979.5,6278.0,6827.0,6969.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.7.2790,5697.0,10509.5,10733.5,10477.5,10900.0,Component of motile flagella 10,>4C (GG2M)
Tb927.7.2800,6245.5,4849.5,5246.5,5240.0,2000.0,Prp18 domain containing protein  putative,<2C (LG1)
Tb927.7.2810,4480.0,5421.5,5808.0,5517.5,3144.5,hypothetical protein  conserved,S
Tb927.7.2820,4384.0,1849.0,2703.5,3029.0,4645.0,histone H2A  putative,>4C (GG2M)
Tb927.7.2830,4806.0,2011.0,2564.5,3531.5,4597.5,histone H2A  putative,<2C (LG1)
Tb927.7.2840,4708.0,1894.5,2876.5,3463.5,5209.5,histone H2A  putative,>4C (GG2M)
Tb927.7.2850,5485.5,2149.5,2790.5,3965.5,5934.5,histone H2A  putative,>4C (GG2M)
Tb927.7.2860,4633.0,2187.0,3127.0,4084.0,5542.5,histone H2A  putative,>4C (GG2M)
Tb927.7.2870,4626.0,2062.0,2849.0,3699.0,4874.0,histone H2A  putative,>4C (GG2M)
Tb927.7.2880,4288.5,1506.5,2488.5,2756.0,4320.5,histone H2A  putative,>4C (GG2M)
Tb927.7.2890,4608.5,1934.0,2551.0,3513.0,5075.5,histone H2A  putative,>4C (GG2M)
Tb927.7.2900,4751.0,2214.5,2764.5,3254.5,5135.5,histone H2A  putative,>4C (GG2M)
Tb927.7.2910,4608.5,1875.5,2630.0,3503.0,4748.5,histone H2A  putative,>4C (GG2M)
Tb927.7.2920,6202.5,3922.5,5054.0,6138.0,7559.0,histone H2A  putative,>4C (GG2M)
Tb927.7.2930,4849.5,2296.0,3410.0,3763.0,5854.0,histone H2A  putative,>4C (GG2M)
Tb927.7.2940,4134.0,1690.5,2122.5,2893.5,3386.5,histone H2A  putative,<2C (LG1)
Tb927.7.2950,5997.5,8540.5,8646.5,10027.5,10177.5,ATPase family associated with various cellular activities (AAA)  putative,>4C (GG2M)
Tb927.7.2960,3380.0,5909.5,7790.0,7762.0,6432.5,Present in the outer mitochondrial membrane proteome 33,S
Tb927.7.2970,10614.0,11074.5,11173.5,11223.0,9334.0,ATP-dependent DEAD/H RNA helicase  putative,G2M
Tb927.7.2980,9736.0,6967.5,6429.5,7105.5,4849.5,Nitroreductase family  putative,<2C (LG1)
Tb927.7.2985,5413.5,2344.0,1278.5,1374.0,1162.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.2990,6939.5,4726.0,4643.0,4674.0,4770.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.7.3000,10961.0,11483.0,11490.5,11510.5,11419.0,kinesin  putative,G2M
Tb927.7.3010,4490.0,9526.5,10214.5,9793.5,10185.5,Nitrogen permease regulator 2  putative,S
Tb927.7.3020,9208.5,6001.5,5379.0,5789.5,3741.0,Nitroreductase family  putative,<2C (LG1)
Tb927.7.3025,4865.5,1378.0,907.5,826.5,637.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3030,6797.0,4703.0,5044.5,4367.0,4645.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3040,7153.0,8899.0,9639.5,10157.0,10728.0,F-box and WD40 domain containing protein,>4C (GG2M)
Tb927.7.3050,612.5,6676.0,6772.0,5789.5,2857.0,Mitochondrial SSU ribosomal protein  putative,S
Tb927.7.3060,8881.0,8832.5,8756.0,8536.0,7268.5,Tripartite Attachment Complex Protein 42,<2C (LG1)
Tb927.7.3070,7573.5,8939.0,9197.5,9031.5,9593.0,UAA transporter family  putative,>4C (GG2M)
Tb927.7.3080,3692.0,4975.5,5519.5,4612.5,2928.5,Kinetochore interacting protein 4,S
Tb927.7.3090,8578.0,9128.0,8775.5,8890.0,9570.5,Galactose oxidase  central domain containing protein  putative,>4C (GG2M)
Tb927.7.3100,10560.0,8176.0,7324.0,8974.0,8401.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3110,5989.0,6104.0,6744.5,5808.5,5368.0,transporter protein  putative,S
Tb927.7.3120,2619.0,1266.0,2931.0,2456.5,5542.5,small nuclear ribonucleoprotein SmD1,>4C (GG2M)
Tb927.7.3130,6649.0,8054.5,9342.5,8997.0,11608.0,Transition Zone Protein 103 kDa,>4C (GG2M)
Tb927.7.3140,10165.0,9067.5,9648.0,9561.5,7676.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3150,11451.5,9989.0,9581.5,10055.0,8826.5,CRAL/TRIO domain containing protein  putative,<2C (LG1)
Tb927.7.3160,11578.0,11675.0,11664.0,11675.0,11639.0,Cytoplasmic dynein 1 heavy chain (DYNC1H1)  putative,G1
Tb927.7.3170,6112.0,4866.0,5752.5,5655.5,4231.5,Beta-lactamase superfamily domain containing protein  putative,<2C (LG1)
Tb927.7.3180,8830.0,5521.0,7242.0,6381.0,7638.0,adaptor complex AP-1 medium subunit  putative,<2C (LG1)
Tb927.7.3190,6286.5,6650.5,4887.0,5489.0,5258.0,Pseudokinase  putative,G1
Tb927.7.3200,5766.5,6670.0,6159.0,4908.0,8651.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.3210,3579.5,6334.0,7840.0,8185.5,8559.0,Pseudokinase  putative,>4C (GG2M)
Tb927.7.3220,1783.5,6368.0,6095.5,6755.5,6614.5,ChaC-like protein  putative,G2M
Tb927.7.3230,9819.5,8966.5,9478.0,8779.5,6623.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3240,5291.5,7137.0,7450.0,6962.0,5442.5,Mitochondrial SSU ribosomal protein  putative,S
Tb927.7.3250,9634.0,7146.5,7727.5,7448.0,7936.0,expression site-associated gene 6 (ESAG6) protein  putative,<2C (LG1)
Tb927.7.3260,10383.0,9457.5,9682.0,9649.0,9409.5,expression site-associated gene 7 (ESAG7) protein  putative,<2C (LG1)
Tb927.7.3270,7106.5,7331.5,6624.0,6482.0,4957.5,hypothetical protein  conserved,G1
Tb927.7.3280,9767.0,11058.0,10884.0,10941.0,10920.5,translation initiation factor IF-2  putative,G1
Tb927.7.3290,5789.0,9065.0,8779.0,7391.0,7518.0,WD domain  G-beta repeat  putative,G1
Tb927.7.3300,9553.5,9824.0,9863.0,8909.5,10484.0,Flocculation protein FLO11-like,>4C (GG2M)
Tb927.7.3310,7086.0,8344.5,9371.5,8313.0,8888.5,Radial spoke head 1 homolog  putative,S
Tb927.7.3320,11218.0,8707.5,8949.5,8637.5,9021.5,ATG12/APG12  putative,<2C (LG1)
Tb927.7.3330,7944.5,9753.5,10170.0,10412.5,11309.5,Flagellar attachment zone protein 10,>4C (GG2M)
Tb927.7.3340,9826.5,9402.5,8942.5,9093.5,9046.0,Putative S-adenosyl-L-methionine-dependent methyltransferase  putative,<2C (LG1)
Tb927.7.3350,5799.0,7098.5,6672.5,6507.5,3006.0,palmitoyl acyltransferase 11  putative,G1
Tb927.7.3360,8403.5,7689.5,7165.0,6289.0,8433.5,farnesyl pyrophosphate synthase,>4C (GG2M)
Tb927.7.3370,6308.5,3499.5,4348.0,5037.0,10977.0,Intraflagellar transport protein 74  putative,>4C (GG2M)
Tb927.7.3380,2406.5,3515.0,3688.0,2956.0,3541.0,Ribosomal L28e protein family/Mak16 protein C-terminal region  putative,S
Tb927.7.3390,612.5,4047.5,4783.5,3531.5,3596.5,hypothetical protein  conserved,S
Tb927.7.3400,7646.5,7672.5,8028.5,7725.0,6581.0,MORN repeat  putative,S
Tb927.7.3410,4555.0,1384.0,1300.0,1382.0,6743.0,centrin-4,>4C (GG2M)
Tb927.7.3420,11202.0,10730.0,10953.5,11082.0,11518.0,peptidyl-prolyl cis-trans isomerase  putative,>4C (GG2M)
Tb927.7.3430,7524.0,1643.5,2612.0,2788.5,2639.5,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.7.3440,2943.0,759.0,615.0,444.5,4377.5,I/6 autoantigen,>4C (GG2M)
Tb927.7.3450,5343.5,438.0,644.5,737.0,1504.0,protein I/6,<2C (LG1)
Tb927.7.3460,10161.0,6719.5,5717.5,6669.5,8615.0,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.7.3470,1460.0,835.5,966.5,1085.0,2619.0,p22 protein precursor  putative,>4C (GG2M)
Tb927.7.3480,8863.0,10319.0,10046.0,10311.5,9948.0,hypothetical protein,G1
Tb927.7.3490,6792.5,10302.5,10273.0,10376.5,9559.0,synaptojanin  putative,G2M
Tb927.7.3500,612.5,3235.0,4139.5,3677.0,5499.0,Prostaglandin E synthase,>4C (GG2M)
Tb927.7.3510,10541.0,8443.0,8741.5,9093.5,6547.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.7.3520,8347.5,3467.5,3521.5,3687.5,3555.5,Mitochondrial pyruvate carrier 2,<2C (LG1)
Tb927.7.3530,2258.5,5469.0,5144.0,6276.5,4849.5,Vacuolar protein 14 C-terminal Fig4p binding  putative,G2M
Tb927.7.3540,6158.0,6763.0,5054.0,4973.5,6463.5,hypothetical protein  conserved,G1
Tb927.7.3550,2047.0,358.0,547.0,647.5,4748.5,cytoskeleton associated protein  putative,>4C (GG2M)
Tb927.7.3560,3078.5,2664.0,2399.5,2168.5,11046.0,Component of motile flagella 7,>4C (GG2M)
Tb927.7.3570,9833.5,8127.5,8650.5,9193.0,8396.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3580,5804.0,8436.5,8446.0,7979.5,9593.0,Serine/threonine-protein kinase NEK11  putative,>4C (GG2M)
Tb927.7.3590,4074.0,2241.5,2465.5,2566.5,3628.5,conserved protein,<2C (LG1)
Tb927.7.3600,1460.0,3273.5,4550.5,3950.5,2601.0,emp24/gp25L/p24 family/GOLD  putative,S
Tb927.7.3610,9835.5,6039.0,6759.5,7681.5,5824.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3620,8901.5,11186.0,10842.0,10400.5,11189.0,tyrosyl-tRNA synthetase,>4C (GG2M)
Tb927.7.3630,612.5,3890.0,3148.0,4011.0,5526.5,TPR-repeat-containing chaperone protein DNAJ  putative,>4C (GG2M)
Tb927.7.3640,5949.5,4560.0,5372.0,4309.5,4222.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3645,1783.5,1078.5,658.5,925.0,1622.5,hypothetical protein,<2C (LG1)
Tb927.7.3650,11370.0,10859.5,10703.0,10807.0,10828.0,STE/STE11 serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.7.3660,2406.5,4019.0,4411.0,2858.5,7069.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.3670,3120.5,3361.0,2764.5,2830.5,2914.5,TrkA-N domain containing protein  putative,G1
Tb927.7.3680,3692.0,576.5,615.0,757.5,637.0,ubiquitin/ribosomal protein S27a  putative,<2C (LG1)
Tb927.7.3690,4211.5,6587.0,5945.5,6676.5,8182.0,hypothetical protein,>4C (GG2M)
Tb927.7.3700,5530.5,5822.5,4356.5,5050.5,4306.0,hypothetical protein  conserved,G1
Tb927.7.3710,8524.0,6016.0,6803.5,7883.0,5906.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3720,4142.5,4675.5,4896.0,6077.0,6270.0,hypothetical protein,>4C (GG2M)
Tb927.7.3730,4333.5,5689.0,5704.5,6482.0,7169.5,RNA-binding protein  putative,>4C (GG2M)
Tb927.7.3740,10822.0,8779.0,9321.0,9523.5,10928.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.7.3750,612.5,322.0,210.0,221.5,461.5,TFIIF-stimulated CTD phosphatase  putative,<2C (LG1)
Tb927.7.3760,6274.5,6359.0,7027.5,6555.5,4135.5,phosphatidylserine synthase  putative,S
Tb927.7.3770,2523.0,6874.5,7049.5,6322.0,8597.0,Bifunctional NAD(P)H-hydrate repair enzyme,>4C (GG2M)
Tb927.7.3780,9798.5,9454.0,8878.5,9161.5,9225.0,Nuclear poly(A) polymerase 2,<2C (LG1)
Tb927.7.3790,7755.5,8696.5,8235.0,8547.5,7745.5,ras-like small GTPase  putative,G1
Tb927.7.3800,8886.5,5798.0,6102.0,5228.0,6363.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3810,2357.5,4203.5,4956.5,5648.5,2442.5,'Cold-shock' DNA-binding domain containing protein  putative,G2M
Tb927.7.3820,3179.0,7410.0,8697.0,7845.5,8927.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.3830,6344.5,11194.0,11369.0,11183.0,10993.5,kinesin K39  putative,S
Tb927.7.3840,1460.0,2646.0,1634.5,1352.5,1179.0,kinesin-like protein  fragment  putative,G1
Tb927.7.3850,7352.5,9680.0,9491.5,8963.0,8063.0,hypothetical protein  conserved,G1
Tb927.7.3860,4233.5,4711.5,5429.5,4828.5,4014.5,PQ loop repeat  putative,S
Tb927.7.3870,612.5,5216.5,4069.0,6192.0,4635.5,hypothetical protein  conserved,G2M
Tb927.7.3880,2047.0,2516.5,1860.0,3142.0,3510.5,Basal body protein,>4C (GG2M)
Tb927.7.3890,10521.0,5946.5,5670.5,5024.0,4345.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.3900,6487.5,2630.0,1217.0,1823.5,3100.5,vacuolar transporter chaperone  putative,<2C (LG1)
Tb927.7.3910,7334.0,8025.0,7520.5,7931.0,6903.0,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,G1
Tb927.7.3920,3394.0,4429.5,2939.0,3332.5,4560.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.3930,9982.0,10879.5,11142.0,10978.0,10984.0,hypothetical protein  conserved,S
Tb927.7.3940,10972.0,9463.0,9233.0,8728.0,9194.5,mitochondrial carrier protein,<2C (LG1)
Tb927.7.3950,5706.0,7065.5,7700.5,6428.5,5323.5,RNA-editing 3' terminal uridylyl transferase 1,S
Tb927.7.3960,1460.0,3639.0,4069.0,3596.5,3199.5,Mitochondrial ribosomal protein L16,S
Tb927.7.3970,7063.0,10091.5,9698.5,10142.0,10914.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.3980,10076.0,9552.0,9361.0,9563.5,8797.0,tc40 antigen-like,<2C (LG1)
Tb927.7.3990,8423.0,11389.0,11124.0,10972.0,11002.0,mitochondrial DNA polymerase I protein C,G1
Tb927.7.4000,9218.0,6423.0,6811.0,6706.0,8098.0,glutathione synthetase  putative,<2C (LG1)
Tb927.7.4010,4104.0,2296.0,1956.0,1833.5,2000.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4020,1783.5,3476.5,3138.0,4004.5,4320.5,protein phosphatase 2C  putative,>4C (GG2M)
Tb927.7.4030,5611.0,8196.5,9147.0,8508.0,6984.0,hypothetical protein  conserved,S
Tb927.7.4040,3095.0,8144.0,8911.5,7681.5,7681.5,hypothetical protein  conserved,S
Tb927.7.4050,8141.0,4294.5,5222.0,5476.5,4975.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4060,6417.5,4027.0,4493.5,4764.5,4459.5,cysteine peptidase  Clan CA  family C2  putative,<2C (LG1)
Tb927.7.4070,5534.0,4474.0,3755.0,5307.5,4429.0,cysteine peptidase  Clan CA  family C2  putative,<2C (LG1)
Tb927.7.4080,10396.0,9833.5,9780.0,9275.0,9412.5,DNA excision repair protein ERCC 6,<2C (LG1)
Tb927.7.4090,2535.5,8075.5,9142.0,8741.0,5978.5,CMGC/DYRK protein kinase  putative,S
Tb927.7.4100,8282.0,6329.5,6172.5,7361.0,9368.5,Domain of unknown function (DUF4201)  putative,>4C (GG2M)
Tb927.7.4110,10626.0,8616.5,8863.5,9671.0,7981.0,kinesin  putative,<2C (LG1)
Tb927.7.4120,9468.0,8949.0,8060.5,7617.5,6557.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4130,11674.0,11638.5,11661.0,11643.0,11611.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4140,1460.0,1886.0,1771.5,1329.0,2079.5,mitochondrial ribosomal protein L21,>4C (GG2M)
Tb927.7.4150,10352.5,10135.5,10294.0,9598.0,10602.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.4160,6066.0,2534.5,2858.0,1875.5,6385.5,Fatty acid elongase,>4C (GG2M)
Tb927.7.4170,5349.0,5368.5,5270.0,4193.5,2574.5,Fatty acid elongase,G1
Tb927.7.4180,1988.0,6386.5,7591.5,6996.5,6953.0,Fatty acid elongase,S
Tb927.7.4190,612.5,2540.0,1665.0,1993.5,2153.5,zinc finger domain  LSD1 subclass  putative,G1
Tb927.7.4200,5379.0,7338.0,7614.0,7391.0,5301.0,hypothetical protein  conserved,S
Tb927.7.4210,612.5,2785.5,2653.0,2223.0,2706.5,hypothetical protein  conserved,G1
Tb927.7.4220,9717.0,11007.5,11043.0,10721.0,9555.0,WD domain  G-beta repeat/Dip2/Utp12 Family  putative,S
Tb927.7.4230,6847.0,7459.0,8763.5,8198.0,7847.5,Enriched in surface-labeled proteome protein 12,S
Tb927.7.4240,7717.0,8240.5,8172.5,8573.5,7534.5,hypothetical protein  conserved,G2M
Tb927.7.4250,4594.0,7121.0,6923.0,7525.5,6749.5,hypothetical protein  conserved,G2M
Tb927.7.4260,9318.0,10278.0,9459.0,10180.0,9390.0,Enriched in surface-labeled proteome protein 13,G1
Tb927.7.4270,5006.5,6030.0,6119.5,5419.5,6463.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.4280,11303.0,8295.0,8942.5,9071.5,9404.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4290,1460.0,1180.5,832.0,925.0,3076.5,Nuclear distribution protein C homolog,>4C (GG2M)
Tb927.7.4300,10928.0,9713.0,9110.0,9460.5,9236.5,F-box domain containing protein  putative,<2C (LG1)
Tb927.7.4310,10101.5,7967.5,8305.5,7670.0,7896.5,pyridine nucleotide-disulphide oxidoreductase  putative,<2C (LG1)
Tb927.7.4320,6777.5,4806.0,6246.0,5917.0,2089.0,mRNA capping enzyme  beta chain  putative,<2C (LG1)
Tb927.7.4330,6145.5,8480.0,8578.0,8011.5,8327.5,Iguana/Dzip1-like DAZ-interacting protein N-terminal  putative,S
Tb927.7.4340,10254.0,10152.0,9348.5,8245.0,10721.5,Protein of unknown function (DUF1253)  putative,>4C (GG2M)
Tb927.7.4350,3013.5,1520.0,1808.5,1642.5,721.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4360,10233.5,6199.5,6788.5,5673.5,6123.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4370,11226.0,10723.0,11290.0,11382.0,11153.0,hypothetical protein  conserved,G2M
Tb927.7.4380,9420.5,7348.0,6759.5,7167.0,7230.5,Bromodomain  putative,<2C (LG1)
Tb927.7.4390,7923.0,8093.5,9055.5,8150.5,9027.0,threonine synthase  putative,S
Tb927.7.4400,10635.0,10717.0,10749.5,10660.5,9794.5,inositol hexakisphosphate kinase,S
Tb927.7.4410,6334.0,5841.0,6339.5,6598.5,4874.0,hypothetical protein  conserved,G2M
Tb927.7.4420,5068.5,2198.0,2703.5,2321.5,3006.0,proteasome alpha 3 subunit  putative,<2C (LG1)
Tb927.7.4430,1783.5,8020.5,7009.5,7144.0,7147.0,hypothetical protein  conserved,G1
Tb927.7.4440,3283.5,5454.0,5678.5,6120.5,7525.0,NAD dependent epimerase/dehydratase family  putative,>4C (GG2M)
Tb927.7.4450,612.5,5144.5,7165.0,7087.0,5577.5,SUMO-interacting motif-containing protein,S
Tb927.7.4460,4517.0,9688.5,9964.0,9993.5,11225.0,von Willebrand factor type A domain containing protein  putative,>4C (GG2M)
Tb927.7.4470,3341.5,3050.5,2238.0,2746.5,5457.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.4480,612.5,2093.5,1899.0,1626.0,2351.0,adenosine 5'-monophosphoramidase  putative,>4C (GG2M)
Tb927.7.4490,11222.0,10279.5,10268.5,10314.0,10128.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4500,6803.5,7799.5,8235.0,8663.0,7385.0,PX domain containing protein  putative,G2M
Tb927.7.4510,6628.0,3890.0,3260.0,4598.0,9194.5,Domain of unknown function (DUF4201)  putative,>4C (GG2M)
Tb927.7.4515,7540.5,3078.5,2510.5,2506.5,2773.0,Bardet-Biedl syndrome 18 protein,<2C (LG1)
Tb927.7.4520,5697.0,2820.5,2666.0,3452.5,3555.5,Thioredoxin-like  putative,<2C (LG1)
Tb927.7.4530,1460.0,7152.0,5792.5,5862.5,5161.0,hypothetical protein  conserved,G1
Tb927.7.4540,7974.0,5407.0,4938.0,3627.0,2243.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4550,5142.5,3293.0,2939.0,2801.0,1281.5,Mitochondrial ribosomal protein L7/L12,<2C (LG1)
Tb927.7.4560,612.5,2051.0,2238.0,2009.0,1392.5,Histone acetyltransferase 1,S
Tb927.7.4570,2295.5,2741.5,2164.5,2629.5,4065.0,inosine-guanine nucleoside hydrolase,>4C (GG2M)
Tb927.7.4580,6498.0,7482.5,7556.5,7696.0,8026.0,Cornifin (SPRR) family  putative,>4C (GG2M)
Tb927.7.4590,612.5,4467.0,3978.5,2850.5,4330.5,chaperone protein DnaJ  putative,G1
Tb927.7.4600,7948.0,6220.0,6587.5,5728.5,5927.0,Calponin homology (CH) domain containing protein  putative,<2C (LG1)
Tb927.7.4610,8347.5,6963.0,6236.5,6626.0,7319.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4620,1988.0,4203.5,3167.0,4070.5,5880.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.4630,6194.5,2903.5,2961.0,3168.0,3586.0,Miro-like protein  putative,<2C (LG1)
Tb927.7.4640,6167.5,3941.5,5229.5,4446.0,3474.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4645,6413.0,3179.0,3051.5,2988.5,3144.5,hypothetical protein,<2C (LG1)
Tb927.7.4650,9322.0,7479.0,6866.5,6205.5,6392.5,J Biosynthesis Protein 2,<2C (LG1)
Tb927.7.4660,612.5,3526.0,3697.0,3295.5,4051.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.4670,1783.5,335.0,2369.0,1110.5,721.5,ribosomal RNA processing protein 4,S
Tb927.7.4680,6999.0,6401.0,6315.0,6138.0,5362.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4690,6783.5,8349.5,8587.0,8264.5,8037.5,hypothetical protein,S
Tb7.NT.53,612.5,40.5,99.0,82.5,86.0,Noncoding RNA  putative,<2C (LG1)
Tb927.7.4700,2826.5,2687.5,1710.5,4070.5,6240.0,WD domain  G-beta repeat  putative,>4C (GG2M)
Tb927.7.4710,5001.5,2646.0,1848.0,2335.0,4096.5,Mitochondrial ribosomal protein L46,<2C (LG1)
Tb927.7.4720,8794.0,2772.5,4246.0,4818.5,4654.0,hypothetical protein,<2C (LG1)
Tb927.7.4730,2930.5,4830.0,4518.5,4612.5,3169.5,pumilio/PUF RNA binding protein 5,G1
Tb927.7.4740,6207.5,4207.5,3843.5,3194.5,3310.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4750,5477.5,4908.0,4510.0,5617.5,5542.5,hypothetical protein  conserved,G2M
Tb927.7.4760,8524.0,7083.5,7137.0,6647.5,8006.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4770,8012.0,5854.0,5379.0,4367.0,4377.5,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.7.4780,612.5,1171.5,865.5,1085.0,1195.0,conserved hypothetical protein  putative,>4C (GG2M)
Tb927.7.4790,5682.0,700.5,1254.0,2120.5,1078.0,proteasome beta 6 subunit,<2C (LG1)
Tb927.7.4800,4879.5,2011.0,1945.0,1823.5,1958.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4810,6344.5,4135.5,4139.5,3503.0,2661.5,HD domain containing protein  putative,<2C (LG1)
Tb927.7.4820,612.5,1371.5,1067.0,941.0,86.0,Trm112p-like protein  putative,G1
Tb927.7.4830,7292.0,3526.0,2673.0,3429.5,4693.0,kinesin  putative,<2C (LG1)
Tb927.7.4840,3741.5,5426.5,7061.5,6837.5,4635.5,hypothetical protein  conserved,S
Tb927.7.4850,6163.0,2062.0,2103.5,2184.5,1565.5,kinetoplastid kinetochore protein 5,<2C (LG1)
Tb927.7.4860,4817.0,4194.0,4670.0,4598.0,2977.5,kinetoplastid kinetochore protein 13,<2C (LG1)
Tb927.7.4870,8782.0,3492.0,3260.0,3837.0,3199.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4880,612.5,1807.0,1268.0,1558.5,1027.5,hypothetical protein  conserved,G1
Tb927.7.4890,7991.5,5822.5,5861.5,6147.0,3638.0,Present in the outer mitochondrial membrane proteome 34,<2C (LG1)
Tb927.7.4900,9937.5,9560.0,9083.5,9323.0,8026.0,5'-3' exoribonuclease A,<2C (LG1)
Tb927.7.4910,5195.0,4703.0,4529.5,4290.5,5888.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.4920,5181.0,6792.5,6147.0,6240.5,6344.5,hypothetical protein  conserved,G1
Tb927.7.4925,612.5,2106.0,2577.0,2697.5,1789.5,hypothetical protein,G2M
Tb927.7.4930,4298.5,2444.5,2577.0,2869.0,2454.0,ribonuclease H1,<2C (LG1)
Tb927.7.4940,612.5,7518.0,8257.5,6515.5,6074.0,serine peptidase  clan SC  family S9A-like protein,S
Tb927.7.4950,1460.0,4268.0,3801.5,4045.0,3836.0,NAD(P)-dependent steroid dehydrogenase protein  putative,G1
Tb927.7.4960,6842.0,4761.5,4944.0,4798.0,6112.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.4970,10639.0,9030.5,8206.5,8560.0,6975.5,glutamine synthetase  putative,<2C (LG1)
Tb927.7.4980,6270.5,2011.0,2075.5,1597.5,2336.0,Present in the outer mitochondrial membrane proteome 35,<2C (LG1)
Tb927.7.4990,2700.0,7533.5,7204.0,5704.5,5978.5,hypothetical protein  conserved,G1
Tb927.7.5000,612.5,373.5,471.5,273.5,287.0,60S ribosomal protein L19  putative,<2C (LG1)
Tb927.7.5010,612.5,4816.5,5164.0,4193.5,5499.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5020,1783.5,1068.5,1124.0,875.0,2389.0,60S ribosomal protein L19  putative,>4C (GG2M)
Tb927.7.5030,5154.5,4331.5,3987.0,3924.0,2427.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5040,6984.5,4072.5,5001.0,7571.0,10697.5,kinesin  putative,>4C (GG2M)
Tb927.7.5050,1783.5,919.5,189.5,687.0,9200.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5060,8423.0,5641.5,5902.5,5662.0,6602.0,CLN3 protein  putative,<2C (LG1)
Tb927.7.5070,5349.0,1635.5,1137.0,1261.0,3295.5,hypothetical protein,<2C (LG1)
Tb927.7.5080,6426.0,6992.5,6986.5,6626.0,4635.5,ATP-NAD kinase-like protein,G1
Tb927.7.5090,10315.0,9331.5,9353.5,9642.5,9386.5,condensin complex subunit 2  putative,<2C (LG1)
Tb927.7.5100,5330.0,3740.5,5044.5,4409.0,4480.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5110,9751.0,8463.0,9087.0,8688.0,10068.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5120,8559.0,5407.0,4632.5,5926.0,9095.5,SpoU rRNA Methylase family  putative,>4C (GG2M)
Tb927.7.5130,6220.0,8355.0,8060.5,7762.0,8597.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5140,1783.5,1817.5,2023.5,1779.5,933.5,hypothetical protein  conserved,S
Tb927.7.5150,10914.5,11077.0,10785.0,10796.5,8012.5,hypothetical protein  conserved,G1
Tb927.7.5160,4418.5,4251.5,5197.0,2919.0,4276.5,deoxyuridine triphosphatase  putative,S
Tb927.7.5170,2598.0,4111.5,5084.5,3102.5,2525.0,60S ribosomal protein L25,S
Tb927.7.5180,2747.5,498.0,615.0,737.0,797.5,60S ribosomal protein L23a  putative,<2C (LG1)
Tb927.7.5190,9898.5,10769.5,11140.0,11120.5,10797.0,hypothetical protein  conserved,S
Tb927.7.5200,8614.5,9927.5,10194.0,9693.0,9234.5,hypothetical protein  conserved,S
Tb927.7.5210,10393.0,10971.0,10635.5,10742.0,10235.0,Putative Phosphatase/Protein of unknown function DUF89  putative,G1
Tb927.7.5220,11217.0,10116.5,10247.0,10035.0,10550.0,Forkhead Kinase  putative,<2C (LG1)
Tb927.7.5230,10359.0,10877.0,10829.0,10925.0,10040.0,lanosterol synthase,G2M
Tb927.7.5240,7780.5,9954.5,10051.0,10080.0,10753.5,Flagellum attachment zone protein 21,>4C (GG2M)
Tb927.7.5250,8729.0,7642.0,7923.5,8637.5,8057.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5260,4397.0,3890.0,3779.5,4623.0,2857.0,Cytochrome c oxidase biogenesis protein Cmc1 like  putative,G2M
Tb927.7.5270,5291.5,2051.0,4316.5,3687.5,1062.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5280,10792.5,11524.0,11496.0,11479.5,11449.0,kinetoplast ribosomal PPR-repeat containing protein 19,G1
Tb927.7.5290,6426.0,8636.5,9016.0,8935.0,8657.0,hypothetical protein  conserved,S
Tb927.7.5300,5162.5,7252.5,7807.0,7592.5,9786.0,C2 domain/Ankyrin repeats (3 copies)  putative,>4C (GG2M)
Tb927.7.5310,9731.0,10116.5,10255.0,9666.0,10083.5,YEATS family  putative,S
Tb927.7.5320,8306.5,8831.0,8896.0,9060.0,4244.5,hypothetical protein  conserved,G2M
Tb927.7.5330,10406.5,9843.5,9598.0,9346.0,7745.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5340,10830.0,10559.0,10510.0,10322.5,10368.0,cAMP response protein 3,<2C (LG1)
Tb927.7.5350,6227.5,10230.0,10602.5,9919.5,9542.0,hypothetical protein  conserved,S
Tb927.7.5360,9073.0,4503.0,5661.5,4381.0,2977.5,Haemolysin-III related  putative,<2C (LG1)
Tb927.7.5370,10992.5,11328.0,11137.0,11346.0,11115.0,hypothetical protein  conserved,G2M
Tb927.7.5380,3478.0,3515.0,4662.5,4772.5,4014.5,Double RNA binding domain protein 12,G2M
Tb927.7.5390,2574.5,9683.0,10151.0,9885.5,10472.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5400,10528.0,9554.0,9402.5,10135.0,9110.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5410,9304.0,10098.0,10175.0,10368.0,9021.5,hypothetical protein  conserved,G2M
Tb927.7.5420,7606.5,8100.5,7274.0,7511.5,8063.0,hypothetical protein  conserved,G1
Tb927.7.5430,9325.5,10299.5,10405.5,10506.5,9440.0,hypothetical protein  conserved,G2M
Tb927.7.5440,11518.0,11368.0,11400.0,11358.0,11177.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5450,4233.5,7176.5,7220.5,7797.0,7325.0,lipin,G2M
Tb927.7.5460,4057.5,1530.0,2653.0,3429.5,4508.5,exosome-associated protein 3,>4C (GG2M)
Tb927.7.5470,5598.0,7422.5,7696.5,8110.0,6729.5,Present in the outer mitochondrial membrane proteome 36,G2M
Tb927.7.5480,10552.0,9910.5,9918.0,8963.0,7177.5,dihydrofolate reductase-thymidylate synthase,<2C (LG1)
Tb927.7.5490,1783.5,9536.0,8587.0,8560.0,6234.5,protein arginine n-methyltransferase 7,G1
Tb927.7.5500,10073.0,10711.5,10579.5,10723.0,9252.0,hypothetical protein  conserved,G2M
Tb927.7.5510,1460.0,6124.0,5286.0,4394.5,2016.0,hypothetical protein  conserved,G1
Tb927.7.5520,8033.0,8183.5,7813.0,7979.5,5972.0,peptidyl-tRNA hydrolase  putative,G1
Tb927.7.5530,9097.0,6023.5,4568.5,4872.5,3566.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5540,9318.0,9942.5,9573.0,9818.5,9507.0,2 4-dienoyl-coa reductase-like protein,G1
Tb927.7.5550,9003.5,8384.5,8299.5,9769.0,5963.0,TLD  putative,G2M
Tb927.7.5560,6000.5,8735.5,9483.5,9518.5,9957.0,glucosamine-fructose-6-phosphate aminotransferase  putative,>4C (GG2M)
Tb927.7.5570,7810.0,6813.0,5875.5,6598.5,6363.0,cell cycle associated protein MOB1-A,<2C (LG1)
Tb927.7.5580,9704.5,8818.5,9169.5,9435.0,8624.5,cell cycle associated protein MOB1-B,<2C (LG1)
Tb927.7.5590,9755.0,10982.0,11151.5,11092.0,10557.5,Domain of unknown function (DUF3883)  putative,S
Tb927.7.5600,7023.5,9703.0,9189.0,9129.0,9994.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb7.NT.62,1460.0,1211.0,1091.0,1416.5,1622.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.7.5610,10682.0,8531.0,9318.0,9448.5,11588.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5615,2180.0,1823.0,2887.5,2483.5,2928.5,hypothetical protein,>4C (GG2M)
Tb927.7.5620,3179.0,6079.5,5445.5,5969.0,8489.5,SET domain containing protein  putative,>4C (GG2M)
Tb927.7.5630,11514.0,10266.5,10036.5,10283.5,8245.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5640,5218.0,4928.0,5091.5,5551.0,6131.0,G-patch domain containing protein  putative,>4C (GG2M)
Tb927.7.5650,4817.0,8235.0,7426.0,7801.5,5301.0,kinesin  putative,G1
Tb927.7.5660,2855.0,1585.5,2453.0,2290.0,4345.5,Outer dynein arm docking complex protein 2  putative,>4C (GG2M)
Tb927.7.5670,1460.0,1303.5,1021.0,1875.5,2402.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5680,9393.5,6987.5,5577.5,5505.5,3748.5,deoxyribose-phosphate aldolase  putative,<2C (LG1)
Tb927.7.5690,3328.5,3150.0,3843.5,4097.0,8744.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.7.5700,6632.0,10009.0,9133.5,8672.5,7249.5,peripherally associated ATOM36,G1
Tb927.7.5710,4253.5,8857.0,9537.5,9119.5,9056.0,hypothetical protein  conserved,S
Tb927.7.5720,3875.5,7689.5,7986.5,7105.5,7392.0,hypothetical protein  conserved,S
Tb927.7.5730,11555.0,10838.5,10993.0,10923.5,11008.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5740,5737.5,9948.5,9783.5,9290.5,8241.0,conserved protein,G1
Tb927.7.5750,9176.5,8818.5,9725.0,9134.0,10421.0,Anaphase promoting complex-associated Protein AP2,>4C (GG2M)
Tb927.7.5760,1460.0,896.0,954.0,1466.0,6740.5,nuclear transport factor 2 protein  putative,>4C (GG2M)
Tb927.7.5770,2982.0,5095.5,3813.0,4355.5,4748.5,Nuclear Dbf2-related kinase,G1
Tb927.7.5780,10571.0,9382.0,9646.5,9766.0,8898.5,thioredoxin  putative,<2C (LG1)
Tb927.7.5790,4305.5,2416.5,1289.5,2120.5,2847.0,protein disulfide isomerase  putative,<2C (LG1)
Tb927.7.5795,6131.0,5953.5,5564.0,6582.5,6153.5,hypothetical protein,G2M
Tb927.7.5800,612.5,373.5,161.0,397.5,559.5,hypothetical protein,<2C (LG1)
Tb927.7.5810,10841.0,8192.0,8529.5,8942.5,8471.0,Protein of unknown function (DUF1637)  putative,<2C (LG1)
Tb927.7.5820,5734.0,7252.5,7137.0,7479.0,7988.0,Monooxygenase  putative,>4C (GG2M)
Tb927.7.5830,2460.0,774.5,907.5,1056.5,3021.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.5840,8218.0,7116.0,6556.0,7327.0,7541.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5850,4153.0,4172.0,5829.0,3588.0,1691.0,hypothetical protein  conserved,S
Tb927.7.5860,1460.0,2214.5,1623.0,1479.0,1958.0,hypothetical protein,G1
Tb927.7.5870,4601.0,2795.0,1783.0,2038.5,1504.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.5880,4872.5,4084.5,4749.0,5386.0,4468.5,cis-prenyltransferase-like protein,G2M
Tb927.7.5890,10540.0,10852.0,10632.0,10811.0,10245.0,hypothetical protein  conserved,G1
Tb927.7.5900,2714.5,6754.0,6211.0,7380.5,4975.5,Autophagy-related protein 8.1,G2M
Tb927.7.5910,8733.5,9358.5,9255.0,9420.5,8802.0,Autophagy-related protein 8.2,G2M
Tb927.7.5920,2094.5,8317.0,8825.5,8802.5,6932.5,mercaptopyruvate sulfurtransferase  putative,S
Tb927.7.5930,6870.5,7290.5,8108.5,7651.5,7566.0,Protein Associated with Differentiation 1,S
Tb927.7.5940,9056.5,8712.0,9255.0,8935.0,8393.5,Protein Associated with Differentiation,S
Tb927.7.5950,9506.0,3150.0,3578.0,4221.0,4451.0,protein associated with differentiation 3  putative,<2C (LG1)
Tb927.7.5960,7292.0,9492.5,9504.5,9527.5,10205.5,protein associated with differentiation 4  putative,>4C (GG2M)
Tb927.7.5970,6173.0,8770.0,8615.5,9134.0,8353.5,protein associated with differentiation 5  putative,G2M
Tb927.7.5980,8095.5,10396.0,10488.0,10246.5,10820.0,protein associated with differentiation 6  putative,>4C (GG2M)
Tb927.7.5990,6459.5,10138.0,9832.5,10477.5,9925.5,protein associated with differentiation 7  putative,G2M
Tb927.7.6000,9366.0,9845.5,10420.0,10566.5,9720.5,protein associated with differentiation 8  putative,G2M
Tb927.7.6010,10794.5,6911.5,7712.0,7132.0,9601.5,hypothetical protein,<2C (LG1)
Tb927.7.6020,6610.0,8163.5,8536.5,8036.0,7655.5,hypothetical protein,S
Tb927.7.6030,8562.5,2206.0,2778.0,2554.0,5761.0,hypothetical protein,<2C (LG1)
Tb927.7.6040,9333.0,11185.0,11241.0,11220.5,10804.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.7.6050,10850.0,11582.0,11572.0,11551.0,11364.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.7.6060,8853.0,11115.0,11171.0,11086.5,11015.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.7.6070,11272.0,11605.0,11589.0,11610.0,11551.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb927.7.6080,9718.5,10814.0,10910.5,10931.0,10497.5,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb927.7.6090,1783.5,1827.5,1623.0,2335.0,3386.5,eukaryotic translation initiation factor 3 subunit a,>4C (GG2M)
Tb927.7.6100,5697.0,7512.0,7324.0,7291.5,6123.0,hypothetical protein,G1
Tb927.7.6110,9243.5,7366.5,6178.5,6067.5,4597.5,Protein of unknown function (DUF3522)  putative,<2C (LG1)
Tb927.7.6130,4956.5,3711.5,3843.5,3029.0,2692.0,Protein of unknown function (DUF3522)  putative,<2C (LG1)
Tb927.7.6150,3437.5,5017.0,3167.0,3545.0,2870.0,Protein of unknown function (DUF3522)  putative,G1
Tb927.7.6170,8340.5,3658.5,2251.5,3205.5,3365.0,Protein of unknown function (DUF3522)  putative,<2C (LG1)
Tb927.7.6180,612.5,498.0,427.0,111.0,213.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.6190,4219.0,6650.5,5307.5,5799.5,6137.0,Ring finger domain containing protein  putative,G1
Tb927.7.6200,4894.5,6295.0,5474.5,6397.5,4703.5,chaperone protein DnaJ  putative,G2M
Tb927.7.6210,9832.0,8914.5,6664.0,8219.0,8738.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.6220,5718.0,8054.5,6616.5,8502.0,10021.5,calcium/calmodulin-dependent protein kinase  putative,>4C (GG2M)
Tb7.NT.76,4713.5,908.5,832.0,925.0,778.5,Noncoding RNA  putative,<2C (LG1)
Tb927.7.6230,7677.5,4521.5,4680.0,4146.0,3185.0,ADP-ribosylation factor  putative,<2C (LG1)
Tb927.7.6240,6546.5,8027.5,7457.0,8282.5,5509.0,hypothetical protein  conserved,G2M
Tb927.7.6250,2855.0,3579.0,3189.5,4699.5,5024.5,Centrosomal protein of 120 kDa  putative,>4C (GG2M)
Tb927.7.6260,4569.0,8340.0,8582.5,8094.5,7871.0,TPR repeat  putative,S
Tb927.7.6270,9792.5,9184.0,8596.0,8966.5,9231.5,peptidase t  putative,<2C (LG1)
Tb927.7.6280,4840.5,7518.0,7442.5,7377.0,7192.0,Domain of unknown function (DUF3508)  putative,G1
Tb927.7.6290,8606.5,10028.0,8994.0,9854.0,10875.5,kinesin  putative,>4C (GG2M)
Tb927.7.6300,6459.5,10805.5,10853.0,10744.5,10383.0,WD domain  G-beta repeat  putative,S
Tb927.7.6310,1914.0,2020.5,2092.5,3185.0,6190.0,polo-like protein kinase,>4C (GG2M)
Tb927.7.6320,7602.5,9781.5,8876.0,8440.0,9092.5,BTB/POZ domain/Regulator of chromosome condensation (RCC1) repeat  putative,G1
Tb927.7.6330,5174.0,1595.5,1446.0,2237.0,2050.0,hypothetical protein,<2C (LG1)
Tb927.7.6340,1783.5,6830.0,7304.5,8116.5,8602.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.6350,10668.0,7137.0,8012.0,7236.0,6564.5,NADH dehydrogenase [ubiquinone] flavoprotein 2  mitochondrial,<2C (LG1)
Tb927.7.6360,3013.5,799.5,980.0,1805.5,3310.5,histone H2A variant Z,>4C (GG2M)
Tb927.7.6370,4826.0,5002.0,4510.0,3666.5,3618.5,Zinc finger  C3HC4 type (RING finger)  putative,G1
Tb927.7.6380,2295.5,1087.5,1103.0,773.0,818.0,ssm4 protein  putative,<2C (LG1)
Tb927.7.6390,1460.0,5935.5,5981.0,4252.5,6420.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.7.6400,1783.5,2457.0,2399.5,1922.5,3169.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.6410,9764.0,9290.5,9771.5,9408.5,8883.5,hypothetical protein  conserved,S
Tb927.7.6420,3142.5,3023.5,2360.0,2237.0,2589.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.6430,1460.0,823.0,448.0,313.5,347.0,hypothetical protein,<2C (LG1)
Tb927.7.6440,6274.5,7597.0,8407.5,8904.0,7753.0,vesicle transport v-SNARE protein  putative,G2M
Tb927.7.6450,6251.5,6186.0,6744.5,4355.5,5824.0,tRNA-dihydrouridine synthase 3  putative,S
Tb927.7.6460,6470.0,10047.5,9041.0,9799.5,10042.0,Defective in exine formation 1 homolog  putative,G1
Tb927.7.6465,6357.5,4181.5,5537.0,3837.0,4145.0,hypothetical protein,<2C (LG1)
Tb927.7.6470,5393.5,6992.5,7856.0,6728.0,4403.5,metallo-peptidase  Clan MK  Family M67,S
Tb927.7.6480,4544.0,9004.5,9798.5,9499.0,7069.0,hypothetical protein  conserved,S
Tb927.7.6490,9380.5,9820.0,9956.5,9936.5,7347.5,hypothetical protein  conserved,S
Tb927.7.6500,11034.0,11340.0,11407.0,11385.0,10974.0,variant surface glycoprotein (VSG)  putative,S
Tb927.7.6510,612.5,1781.0,2092.5,2302.0,818.0,variant surface glycoprotein  degenerate,G2M
Tb927.7.6520,4865.5,3734.0,3503.0,3773.5,1472.0,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.7.6530,7258.0,4950.0,5109.5,4146.0,4988.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.7.6540,8643.5,3813.5,3745.0,3785.5,3006.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.7.6550,6828.0,11003.5,10817.0,11116.5,10245.0,hypothetical protein  conserved,G2M
Tb927.7.6560,9886.0,10962.5,10572.0,11071.0,9857.0,hypothetical protein  conserved,G2M
Tb927.7.6570,4776.0,5128.0,3668.5,4193.5,2692.0,Enriched in surface-labeled proteome protein 17,G1
Tb927.7.6580,10599.5,11188.0,11092.0,10873.0,10342.0,hypothetical protein,G1
Tb927.7.6590,9054.0,10034.0,10446.5,10429.5,8546.5,hypothetical protein  conserved,S
Tb927.7.6600,3711.5,6403.5,5696.5,5024.0,3825.5,hypothetical protein  conserved,G1
Tb927.7.6610,3341.5,8408.5,7399.0,7651.5,8553.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.6620,5542.0,9358.5,10110.0,9926.0,9699.5,Probable N6-adenine methyltransferase  putative,S
Tb927.7.6630,9994.0,7956.0,7622.5,7361.0,10457.0,Kinetochore interacting protein 5,>4C (GG2M)
Tb927.7.6640,10578.0,7981.0,8752.5,8607.5,10239.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.6650,10097.0,10360.0,11036.5,10815.0,10485.0,Colon cancer-associated protein Mic1-like  putative,S
Tb927.7.6660,1460.0,1661.5,1612.0,989.0,761.5,chaperone protein DnaJ  putative,G1
Tb927.7.6670,11596.0,11377.0,11330.0,11413.0,11334.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.6680,2504.5,5985.5,5848.5,4381.0,3413.5,STE/STE11 serine/threonine-protein kinase  putative,G1
Tb927.7.6690,9031.5,9869.5,9405.0,9043.0,10158.5,Trypanosoma specific protein  unknown function,>4C (GG2M)
Tb927.7.6700,7104.0,7741.5,7404.5,8498.5,4403.5,hypothetical protein,G2M
Tb927.7.6710,1460.0,3775.5,3801.5,4166.5,5034.5,hypothetical protein,>4C (GG2M)
Tb927.7.6720,612.5,5717.0,6495.5,6192.0,3431.5,hypothetical protein  conserved,S
Tb927.7.6730,5658.5,8312.5,8476.0,9068.5,6247.5,hypothetical protein  conserved,G2M
Tb927.7.6740,1914.0,3385.5,4148.5,5137.0,2389.0,ATPase family associated with various cellular activities (AAA)  putative,G2M
Tb927.7.6750,4298.5,8297.5,8907.0,6626.0,8762.0,hypothetical protein  conserved,S
Tb927.7.6760,5876.5,9205.5,8658.5,8974.0,6206.0,hypothetical protein  conserved,G1
Tb927.7.6770,1460.0,2877.0,2931.0,2940.5,2898.5,Acyl CoA binding protein  putative,G2M
Tb927.7.6780,6706.0,7095.5,7399.0,7625.0,5470.5,hypothetical protein,G2M
Tb927.7.6790,10525.5,9198.0,8466.5,8904.0,9621.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.6800,9519.5,7804.5,7797.5,6761.5,7029.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.7.6810,9838.0,11295.0,11343.0,11351.0,11037.0,EF-hand domain pair  putative,G2M
Tb927.7.6820,4617.0,952.0,1164.0,1391.5,874.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.6821,3295.0,2296.0,2036.0,2102.5,1717.0,tRNA Alanine,<2C (LG1)
Tb927.7.6822,4449.5,2160.0,2251.5,1726.5,1860.5,tRNA Serine,<2C (LG1)
Tb927.7.6823,6061.5,2561.0,2717.5,2456.5,3021.0,tRNA Aspartic acid,<2C (LG1)
Tb927.7.6824,6270.5,2490.5,2887.5,2237.0,3353.0,tRNA Aspartic acid,<2C (LG1)
Tb927.7.6825,4501.0,2198.0,2465.5,2223.0,1958.0,tRNA Serine,<2C (LG1)
Tb927.7.6826,3419.0,2319.0,1956.0,1654.0,1929.5,tRNA Alanine,<2C (LG1)
Tb927.7.6830,10216.0,9237.5,9940.5,8970.0,9708.0,trans-sialidase  putative,<2C (LG1)
Tb927.7.6840,6212.5,4041.5,5109.5,4654.5,6452.0,Centrosomal spindle body  CEP44  putative,>4C (GG2M)
Tb927.7.6845,7547.0,4111.5,4411.0,4301.0,5044.5,tRNA Lysine,<2C (LG1)
Tb927.7.6850,10800.0,11061.0,11138.5,10877.5,11027.5,trans-sialidase,S
Tb927.7.6855,3155.0,1043.5,865.5,890.0,874.5,hypothetical protein,<2C (LG1)
Tb927.7.6860,8444.0,8866.0,9110.0,8715.0,8738.5,expression site-associated gene 5 (ESAG5) protein  putative,S
Tb927.7.6863,2221.0,398.0,313.0,334.5,287.0,M2 ribosomal RNA,<2C (LG1)
Tb927.7.6866,4002.5,1602.5,1595.5,1626.0,1984.0,M6 ribosomal RNA,<2C (LG1)
Tb927.7.6869,5565.5,3380.0,2812.5,3687.5,3144.5,M4 ribosomal RNA,<2C (LG1)
Tb927.7.6870,9385.5,9342.5,9604.5,9509.5,9149.0,hypothetical protein  conserved,S
Tb927.7.6880,10971.0,11448.0,11519.0,11467.0,11269.0,hypothetical protein  conserved,S
Tb927.7.6881,11602.0,11538.0,11526.0,11446.5,11355.0,18S ribosomal RNA,<2C (LG1)
Tb927.7.6882,5667.0,4235.0,3789.5,3897.5,4533.5,5.8S ribosomal RNA,<2C (LG1)
Tb927.7.6883,10329.5,10929.0,10712.0,10645.5,9555.0,28S alpha ribosomal RNA,G1
Tb927.7.6884,5230.5,3225.0,2717.5,3319.0,3110.0,M1 ribosomal RNA,<2C (LG1)
Tb927.7.6885,10492.0,10241.0,9983.5,9834.0,8990.5,28S beta ribosomal RNA,<2C (LG1)
Tb927.7.6886,3589.5,1180.5,994.0,1031.0,1099.0,M2 ribosomal RNA,<2C (LG1)
Tb927.7.6887,4327.5,1781.0,2092.5,1993.5,1860.5,M6 ribosomal RNA,<2C (LG1)
Tb927.7.6888,4633.0,4474.0,3335.0,4542.0,3399.5,M4 ribosomal RNA,<2C (LG1)
Tb927.7.6890,7050.5,5771.5,4271.0,4908.0,6183.0,methyltransferase domain containing protein  putative,<2C (LG1)
Tb927.7.6900,6816.5,11065.5,10986.0,11243.0,11579.0,Sister chromatid cohesion protein 1,>4C (GG2M)
Tb927.7.6910,1783.5,2526.0,3821.0,4126.5,10170.5,Phosphatidylinositol 4-phosphate 5-kinase  putative,>4C (GG2M)
Tb927.7.6920,4305.5,7465.5,7498.5,7448.0,9334.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.6930,7662.5,10397.0,10158.5,10250.5,8821.0,ATPase  putative,G1
Tb927.7.6940,11528.5,10523.0,9928.5,9642.5,9576.0,glutaminyl cyclase  putative,<2C (LG1)
Tb927.7.6950,6949.5,8302.5,8404.0,8786.5,7963.5,hypothetical protein  conserved,G2M
Tb927.7.6960,5722.0,9026.5,8664.5,8825.5,7800.0,ubiquitin-conjugating enzyme E2  putative,G1
Tb927.7.6970,8871.5,7399.5,8392.0,9374.5,11259.0,paraflagellar rod protein  putative,>4C (GG2M)
Tb927.7.6980,9218.0,11072.0,11062.0,11239.0,11382.0,Mono-functional DNA-alkylating methyl methanesulfonate N-term/CPSF A subunit region  putative,>4C (GG2M)
Tb927.7.6990,5369.0,4400.0,4598.0,5148.0,2079.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.7000,8408.0,10328.0,10365.5,10434.0,10191.0,hook complex protein  conserved,G2M
Tb927.7.7010,8213.0,4823.5,5717.5,4464.5,5248.0,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.7.7020,612.5,3932.0,4130.5,4496.5,3939.5,hypothetical protein,G2M
Tb927.7.7030,9587.0,8647.0,8340.0,9405.0,11328.0,zinc-finger of a C2HC-type  putative,>4C (GG2M)
Tb927.7.7040,4425.0,8336.5,6642.0,7725.0,5972.0,methylthioadenosine phosphorylase  putative,G1
Tb927.7.7050,3214.5,7637.0,7706.0,7132.0,7904.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.7060,2504.5,2376.0,3138.0,3168.0,3669.0,Got1/Sft2-like family  putative,>4C (GG2M)
Tb927.7.7070,3272.0,4065.5,6041.0,5992.0,4365.0,MYND finger  putative,S
Tb927.7.7080,7902.0,4227.0,3205.5,5240.0,5457.5,mitochondrial glycoprotein-like protein,<2C (LG1)
Tb927.7.7090,7567.0,6643.5,4170.0,4908.0,3618.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.7100,10350.0,11346.5,11228.0,11150.5,10856.5,hypothetical protein,G1
Tb927.7.7110,10669.0,10194.5,10640.5,10717.0,10102.5,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.7.7120,7983.0,8517.5,10290.5,9609.5,9847.0,kinesin  putative,S
Tb927.7.7130,9176.5,8231.5,8372.0,8739.0,9279.0,S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase  putative,>4C (GG2M)
Tb927.7.7140,4834.5,6711.5,6262.0,6501.0,6851.5,Vta1 like  putative,>4C (GG2M)
Tb927.7.7150,10241.0,10577.5,10635.5,10389.5,10271.0,hypothetical protein  conserved,S
Tb927.7.7160,7652.5,9615.0,9870.0,10384.0,8703.0,kinetoplastid-specific dual specificity phosphatase  putative,G2M
Tb927.7.7170,3283.5,8774.5,8375.5,7789.5,9298.5,CYC2-like cyclin  putative,>4C (GG2M)
Tb927.7.7175,612.5,1115.5,966.5,1466.0,1816.5,tRNA Alanine,>4C (GG2M)
Tb927.7.7180,9914.0,9136.0,9988.5,9963.0,8973.0,leucine-rich repeat protein 1 (LRRP1)  putative,S
Tb927.7.7190,11467.0,11281.0,11167.0,11236.0,11108.0,hypothetical protein  conserved,<2C (LG1)
Tb927.7.7200,11376.0,10572.0,11095.0,11005.0,11658.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.7210,10309.0,5315.0,5631.0,6056.0,5780.5,Present in the outer mitochondrial membrane proteome 37,<2C (LG1)
Tb927.7.7220,8091.0,8361.5,8049.5,7495.5,6183.0,hypothetical protein  conserved,G1
Tb927.7.7230,612.5,6429.5,7505.5,7072.0,8643.0,nitroreductase,>4C (GG2M)
Tb927.7.7240,9430.0,10059.0,10370.0,10007.0,11218.5,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.7.7250,7310.0,10005.0,10564.0,10894.0,11622.0,Ankyrin repeats (3 copies)  putative,>4C (GG2M)
Tb927.7.7260,10396.0,6911.5,8241.5,8593.5,11288.0,kinesin  putative,>4C (GG2M)
Tb927.7.7270,5490.5,7781.0,8670.5,8268.0,9616.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.7.7280,8356.5,11062.5,11052.0,11188.5,10751.0,RNA-binding protein  putative,G2M
Tb927.7.7290,6422.0,8384.5,8627.0,9090.5,9472.0,COG4 transport protein  putative,>4C (GG2M)
Tb927.7.7300,4849.5,5612.5,5419.0,4205.5,4915.5,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.7.7310,612.5,2367.5,2172.5,2566.5,4451.0,hypothetical protein,>4C (GG2M)
Tb927.7.7320,4985.5,3158.0,3246.5,4336.5,3076.5,hypothetical protein  conserved,<2C (LG1)
Tb927.7.7330,7652.5,6643.5,6655.0,6748.5,7319.5,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,<2C (LG1)
Tb927.7.7340,2047.0,855.5,865.5,705.5,2870.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.7.7350,3770.5,3235.0,2894.5,2919.0,2000.0,hypothetical protein,<2C (LG1)
Tb927.7.7360,8815.0,7258.5,7588.0,7747.0,8182.0,cdc2-related kinase 2,<2C (LG1)
Tb927.7.7380,7467.5,4531.5,4258.0,4381.0,2773.0,u6 snrna-associated sm-like protein lsm3,<2C (LG1)
Tb927.7.7390,1988.0,1982.5,1899.0,1911.5,2029.5,hypothetical protein,>4C (GG2M)
Tb927.7.7400,2047.0,8325.5,7823.5,9473.5,11545.0,Basal body protein,>4C (GG2M)
Tb927.7.7410,6772.0,10403.0,10295.0,9946.5,9942.0,Trans-2-enoyl-ACP reductase 2  putative,G1
Tb927.7.7420,5863.0,8895.0,9150.0,8475.0,9027.0,ATP synthase F1  alpha subunit,S
Tb927.7.7430,5851.5,9548.0,9798.5,9350.5,9334.0,ATP synthase F1  alpha subunit,S
Tb927.7.7440,7819.0,10260.0,10441.5,10389.5,8226.0,hypothetical protein  conserved,S
Tb927.7.7450,3972.0,7578.5,4758.5,5050.5,2977.5,GTP-binding protein  putative,G1
Tb927.7.7460,2619.0,3429.0,2987.0,2422.0,2536.0,hypothetical protein  conserved,G1
Tb927.7.7470,8131.5,10410.5,10462.5,9911.0,9735.0,procyclic-enriched flagellar receptor adenylate cyclase 3,S
Tb927.7.7480,6698.5,10927.0,10806.0,10945.0,9922.0,trans-sialidase  putative,G2M
Tb927.7.7490,5673.0,9593.5,10532.0,10636.0,10690.0,Zinc finger  C3HC4 type (RING finger)  putative,>4C (GG2M)
Tb927.7.7495,612.5,3060.0,4476.0,3805.5,2574.5,hypothetical protein,S
Tb927.7.7500,10347.0,11317.5,11427.0,11444.0,10667.5,thymine-7-hydroxylase  putative,G2M
Tb927.7.7510,8635.5,7184.0,6437.0,6821.5,6006.0,hypothetical protein,<2C (LG1)
Tb07.30D13.180,6955.5,5479.0,6055.5,5883.5,6699.0,hypothetical protein  conserved (pseudogene),<2C (LG1)
Tb07.30D13.160,7944.5,7433.5,8116.5,7809.5,7592.0,hypothetical protein  conserved (pseudogene),S
Tb927.7.7520,10259.0,10964.0,11056.5,10974.0,11057.0,receptor-type adenylate cyclase GRESAG 4  putative,>4C (GG2M)
Tb07.30D13.130,7614.0,7157.0,7692.5,7391.0,8797.0,hypothetical protein  conserved (pseudogene),>4C (GG2M)
Tb07.30D13.110,4865.5,3201.0,3711.0,3380.5,3879.0,hypothetical protein  conserved (pseudogene),<2C (LG1)
Tb927.7.7530,8448.5,10961.0,10927.5,10921.0,11062.0,receptor-type adenylate cyclase GRESAG 4  putative,>4C (GG2M)
Tb07.30D13.80,6624.0,5992.0,6322.0,6784.5,7506.0,hypothetical protein  conserved (pseudogene),>4C (GG2M)
Tb07.30D13.60,7374.5,8776.5,8285.0,8198.0,7699.0,hypothetical protein  conserved (pseudogene),G1
Tb927.7.7540,11459.0,11637.0,11652.0,11652.0,11578.0,leucine-rich repeat protein 1 (LRRP1)  degenerate,S
Tb927.7.7550,2795.5,7167.0,7490.0,7859.5,7913.5,Protein of unknown function (DUF1181)  putative,>4C (GG2M)
Tb927.7.7560,5467.5,5421.5,5537.0,4828.5,5585.0,hypothetical protein,>4C (GG2M)
Tb927.4.100,10450.0,9680.0,9612.0,10273.0,9009.5,retrotransposon hot spot protein 1 (RHS1)  interrupted,<2C (LG1)
Tb927.4.110,8020.0,7952.0,7644.0,7670.0,6083.5,retrotransposon hot spot protein 1 (RHS1)  interrupted,<2C (LG1)
Tb927.4.120,11515.0,11506.0,11470.0,11521.0,11416.5,hypothetical protein,G2M
Tb927.4.130,11372.0,11511.0,11540.0,11550.0,11384.0,receptor-type adenylate cyclase GRESAG 4  pseudogene  putative,G2M
Tb927.4.140,4225.5,5166.0,5460.5,4973.5,4800.5,hypothetical protein,S
Tb927.4.150,3380.0,5664.0,6253.5,5365.0,4429.0,Protein of unknown function (DUF1181)  putative,S
Tb927.4.160,11316.0,11533.0,11577.0,11565.5,11438.0,leucine-rich repeat protein 1 (LRRP1)  frameshift,S
Tb927.4.170,7475.0,8118.0,7552.5,8935.0,8258.0,hypothetical protein,G2M
Tb927.4.180,6055.0,10328.0,9717.0,9614.0,8012.5,hypothetical protein,G1
Tb927.4.190,11704.0,11703.0,11699.0,11701.0,11673.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb927.4.200,11423.0,11589.0,11529.0,11540.0,11139.0,retrotransposon hot spot protein 1 (RHS1)  putative,G1
Tb927.4.210,11383.0,11421.0,11370.0,11459.0,11119.0,retrotransposon hot spot protein 2 (RHS2)  interrupted  degenerate,G2M
Tb927.4.220,9240.5,10120.0,10457.5,10421.5,9364.5,retrotransposon hot spot protein 2 (RHS2)  interrupted  degenerate,S
Tb927.4.230,10149.0,11129.0,11172.0,11238.0,10889.0,DNA-directed RNA polymerase III subunit  pseudogene  putative,G2M
Tb927.4.240,9951.0,11492.0,11449.0,11515.5,11375.5,retrotransposon hot spot protein 4 (RHS4)  degenerate,G2M
Tb927.4.250,6538.0,7252.5,7873.0,8356.0,6289.5,retrotransposon hot spot protein 5 (RHS5)  putative,G2M
Tb927.4.260,7915.5,9185.0,8787.0,9468.5,8888.5,retrotransposon hot spot protein 3 (RHS3)  putative,G2M
Tb927.4.270,9145.0,9290.5,9268.0,9499.0,8294.5,retrotransposon hot spot protein 3 (RHS3)  putative,G2M
Tb927.4.280,10027.0,10698.0,10312.5,10773.0,10158.5,retrotransposon hot spot protein 3 (RHS3)  putative,G2M
Tb927.4.290,10332.0,10651.5,10494.5,10714.5,10128.0,retrotransposon hot spot protein 3 (RHS3)  putative,G2M
Tb927.4.300,11441.0,11296.5,11206.5,11404.0,11216.0,retrotransposon hot spot protein 3 (RHS3)  putative,<2C (LG1)
Tb927.4.310,11668.0,11689.0,11674.0,11667.0,11629.0,SPRY domain/HECT-domain (ubiquitin-transferase)  putative,G1
Tb927.4.320,5915.0,6520.5,6134.0,7172.0,5640.0,Eukaryotic protein of unknown function (DUF914)  putative,G2M
Tb927.4.330,11040.0,8964.0,9129.5,8536.0,8460.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.340,9399.0,6023.5,4130.5,5525.5,3524.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.350,10198.5,6363.5,6648.5,6255.5,5153.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.360,2956.5,7943.5,8101.5,9123.5,8762.0,1 2-Dihydroxy-3-keto-5-methylthiopentene dioxygenase  putative,G2M
Tb927.4.370,6014.5,3304.0,2729.5,3102.5,3271.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.380,6616.5,5883.0,4928.0,5249.5,5675.0,WD domain  G-beta repeat  putative,<2C (LG1)
Tb927.4.390,3214.5,3615.5,4911.0,4742.5,4121.5,hypothetical protein  conserved,S
Tb927.4.400,7215.5,5378.0,4529.5,5342.5,8651.0,Double RNA binding domain protein 7,>4C (GG2M)
Tb927.4.410,5120.0,5200.5,5174.5,3418.5,5145.5,CAF 40,G1
Tb927.4.420,4930.5,10750.0,11072.5,10933.0,11325.5,phosphatidylinositol 4-kinase  putative,>4C (GG2M)
Tb927.4.430,2767.0,855.5,2144.5,2025.0,5420.5,proteasome beta 7 subunit,>4C (GG2M)
Tb927.4.440,4470.5,1190.0,925.0,849.0,1842.0,NADH:ubiquinone oxidoreductase  ESSS subunit  putative,<2C (LG1)
Tb927.4.450,2813.0,7098.5,7676.5,8699.5,10045.5,coatomer alpha subunit  putative,>4C (GG2M)
Tb927.4.460,4703.5,4450.0,4740.5,4918.5,2847.0,Alkylated DNA repair protein (alkB homolog)  putative,G2M
Tb927.4.470,6095.5,1275.5,2050.0,1416.5,2483.5,snoRNP protein GAR1  putative,<2C (LG1)
Tb927.4.480,6822.0,3639.0,3233.0,3627.0,3225.0,Cullin binding  putative,<2C (LG1)
Tb927.4.490,5697.0,8976.0,9880.5,9438.0,9027.0,hypothetical protein  conserved,S
Tb927.4.500,4480.0,5039.5,4868.0,5004.5,4377.5,FHA domain containing protein  putative,G1
Tb927.4.510,2047.0,2241.5,1999.5,1816.5,3110.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.520,3358.0,5095.5,5736.5,5799.5,4822.5,hypothetical protein  conserved,G2M
Tb927.4.530,1460.0,3932.0,4695.5,3888.5,3921.0,hypothetical protein  conserved,S
Tb927.4.540,5929.5,8235.0,7069.0,7854.0,2110.0,hypothetical protein  conserved,G1
Tb927.4.550,612.5,4693.0,4917.0,3699.0,4110.0,Zinc knuckle  putative,S
Tb927.4.560,6308.5,10351.5,10593.5,11343.5,11701.0,Cytoplasmic dynein 2 heavy chain (DYNC2H1)  putative,>4C (GG2M)
Tb927.4.570,7700.0,8642.5,9394.0,8985.0,7363.0,Replication factor-A C terminal domain containing protein  putative,S
Tb927.4.580,3328.5,3256.0,4421.0,4097.0,2758.5,hypothetical protein  conserved,S
Tb927.4.590,5120.0,7508.0,8145.5,8676.0,3225.0,PQQ-like domain/Protein of unknown function (DUF1620)  putative,G2M
Tb927.4.600,1988.0,1565.5,1831.0,1466.0,1549.5,Alpha/beta hydrolase family  putative,<2C (LG1)
Tb927.4.610,612.5,8634.5,7384.0,8230.5,9378.5,PX domain containing protein  putative,>4C (GG2M)
Tb927.4.620,8601.5,10581.5,10836.0,11203.5,11653.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.630,10055.5,8312.5,7986.5,7891.0,6006.0,MICOS complex subunit MIC34,<2C (LG1)
Tb927.4.640,9409.0,9701.5,10084.0,9775.5,9666.0,GRIP domain containing protein  putative,S
Tb927.4.650,6330.0,8412.5,8430.5,8239.5,8111.0,chaperone protein DnaJ  putative,S
Tb927.4.660,1460.0,1415.5,3239.0,3295.5,8303.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.670,7747.0,8552.5,9060.0,8820.5,8918.5,conserved protein  unknown function,S
Tb927.4.680,6945.5,3097.0,1966.5,2102.5,1622.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.690,5320.5,5585.0,4749.0,3737.0,3716.5,geranylgeranyl transferase type II beta subunit  putative,G1
Tb927.4.700,4930.5,7252.5,6981.5,6147.0,5209.5,hypothetical protein  conserved,G1
Tb927.4.710,4523.5,2908.0,3260.0,3142.0,797.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.720,2295.5,3561.5,2778.0,3065.5,5555.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.730,3179.0,1736.5,1886.0,1936.0,964.0,Peptidase family C78  putative,<2C (LG1)
Tb927.4.740,612.5,5251.5,6485.5,5101.5,3431.5,Rgp1  putative,S
Tb927.4.750,5834.0,6368.0,4680.0,4872.5,7285.5,50S ribosomal protein L7Ae  putative,>4C (GG2M)
Tb927.4.760,8820.5,7512.0,7433.0,6719.5,7834.0,AP-1 adapter complex gamma subunit  putative,<2C (LG1)
Tb927.4.770,9112.0,11324.0,11244.0,11193.5,11147.0,ubiquitin-protein ligase  putative,G1
Tb927.4.780,4086.0,3909.5,3323.5,4731.0,1732.0,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Y  putative,G2M
Tb927.4.790,5598.0,1344.0,1475.5,1861.0,1325.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.800,10466.5,11293.0,11320.0,11293.5,11415.0,target of rapamycin kinase 3  putative,>4C (GG2M)
Tb927.4.810,10705.0,11043.0,10905.5,11113.0,10860.5,expression site-associated gene 5 (ESAG5) protein  putative,G2M
Tb927.4.820,7974.0,8776.5,8977.5,9357.0,6719.5,TFIIF-stimulated CTD phosphatase  putative,G2M
Tb927.4.830,7246.5,3863.5,3902.0,3815.5,3541.0,cytochrome c oxidase assembly protein PET191  putative,<2C (LG1)
Tb927.4.840,4260.5,4188.5,2300.0,2716.0,3648.5,Histidine kinase-  DNA gyrase B-  and HSP90-like ATPase  putative,<2C (LG1)
Tb927.4.850,5697.0,4305.0,4950.0,4852.5,6485.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.860,612.5,1313.5,1909.5,1313.5,2589.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.870,3856.5,1807.0,2154.5,2967.0,8348.0,dynein heavy chain  putative,>4C (GG2M)
Tb927.4.880,10699.0,8699.5,9117.5,9588.0,9491.5,TPR-repeat-containing chaperone protein DNAJ  putative,<2C (LG1)
Tb927.4.890,7277.5,8779.0,6246.0,8205.0,10012.5,small nuclear ribonucleoprotein sm d3,>4C (GG2M)
Tb927.4.900,3241.5,10319.0,10363.5,10136.0,8933.0,hypothetical protein  conserved,S
Tb927.4.910,9923.5,10328.0,10127.0,10434.0,9805.0,hypothetical protein  conserved,G2M
Tb927.4.920,4354.0,3265.5,3179.5,4019.0,531.0,TPR repeat  putative,<2C (LG1)
Tb927.4.930,3295.0,5530.5,4104.0,3763.0,3861.0,Mitochondrial ribosomal protein L14,G1
Tb927.4.940,7706.0,5368.5,5991.0,5159.0,3960.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.950,9442.0,6587.0,6997.5,4808.0,7256.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.960,4879.5,7909.0,7393.0,7021.5,6479.0,WD domain  G-beta repeat  putative,G1
Tb927.4.970,3957.5,4547.5,3589.5,3752.5,1374.5,hypothetical protein  conserved,G1
Tb927.4.980,10459.0,10372.5,10107.0,10269.0,10198.5,actin  putative,<2C (LG1)
Tb927.4.990,9364.0,7385.5,6744.5,6407.5,7139.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1000,3834.5,9153.0,9545.0,9383.5,10467.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.1010,4094.5,1171.5,940.5,1243.0,1304.5,hypothetical protein,<2C (LG1)
Tb927.4.1020,4767.5,3060.0,2510.5,2470.5,1732.0,serine-palmitoyl-CoA transferase  putative,<2C (LG1)
Tb927.4.1030,3564.0,4199.5,4815.0,3441.0,4212.0,Protein of unknown function (DUF501)  putative,S
Tb927.4.1040,2047.0,2526.0,2036.0,2102.5,2991.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.1050,6578.5,2581.5,2440.5,1875.5,1227.0,inositol-pentakisphosphate 2-kinase,<2C (LG1)
Tb927.4.1060,8676.0,8160.0,9429.5,8652.5,9925.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.1070,3964.5,1285.0,980.0,1110.5,637.0,Mitochondrial ribosomal protein L13,<2C (LG1)
Tb927.4.1080,7446.5,8512.5,7989.5,7003.0,8193.0,V-type ATPase  A subunit  putative,G1
Tb927.4.1090,9116.5,6339.0,6860.0,6719.5,4284.0,endosomal integral membrane protein  putative,<2C (LG1)
Tb927.4.1100,612.5,130.0,99.0,82.5,818.0,ribosomal protein L21E (60S)  putative,>4C (GG2M)
Tb927.4.1110,7134.5,7561.5,7540.5,5969.0,7023.0,hypothetical protein  conserved,G1
Tb927.4.1120,2436.0,6471.5,4130.5,5407.5,5906.5,hypothetical protein  conserved,G1
Tb927.4.1130,3516.5,4624.0,5197.0,4598.0,2734.0,Complex 1 protein (LYR family)  putative,S
Tb927.4.1140,2729.0,8245.0,9279.0,8628.5,8618.5,phosphatidylinositol 4-kinase  putative,S
Tb927.4.1150,9407.5,8183.5,8902.0,7053.0,6575.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1160,6628.0,4895.5,5120.0,4731.0,5813.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1170,7140.0,7006.0,7115.5,7291.5,4391.0,ankyrin  putative,G2M
Tb927.4.1180,612.5,6107.0,5044.5,5228.0,4680.5,Programmed cell death protein 2  C-terminal putative domain containing protein  putative,G1
Tb927.4.1190,2295.5,576.5,491.0,687.0,836.0,LicD family  putative,<2C (LG1)
Tb927.4.1195,612.5,1087.5,940.5,444.5,978.0,tRNA Proline,G1
Tb927.4.1200,6883.0,7707.5,6417.0,7949.0,6749.5,expression site-associated gene 1 (ESAG1) protein  putative,G2M
Tb927.4.1210,8377.5,9089.5,8834.5,9060.0,8905.0,hypothetical protein,G1
Tb927.4.1213,612.5,1201.5,1054.0,957.5,1195.0,U6 small nuclear RNA,G1
Tb927.4.1216,612.5,1455.0,2011.5,875.0,818.0,tRNA Threonine,S
Tb927.4.1219,612.5,4079.5,3745.0,2085.0,2098.0,tRNA Tyrosine,G1
Tb927.4.1220,5120.0,7975.5,8008.5,8668.0,9071.5,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.4.1230,8783.0,8930.5,9121.0,9242.0,8987.5,hypothetical protein,G2M
Tb927.4.1240,3013.5,3499.5,2729.5,3045.0,3482.5,hypothetical protein,G1
Tb927.4.1250,5374.5,9826.0,10057.5,9699.0,9957.0,peroxisome biogenesis factor 1  putative,S
Tb927.4.1260,9694.0,6443.5,5898.0,6657.5,6432.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1270,4574.0,3961.0,3503.0,3815.5,3794.0,ruvB-like DNA helicase  putative,<2C (LG1)
Tb927.4.1280,5281.0,3109.0,3912.5,3205.5,1660.5,Tetratricopeptide repeat  putative,<2C (LG1)
Tb927.4.1290,612.5,1684.5,1091.0,1085.0,933.5,hypothetical protein  conserved,G1
Tb927.4.1300,3456.5,2609.5,3224.5,3295.5,8770.0,amidinotransferase  putative,>4C (GG2M)
Tb927.4.1310,7396.5,7270.0,6838.0,6909.0,8759.5,ZFP family member  putative,>4C (GG2M)
Tb927.4.1320,9233.5,9446.5,9072.5,8759.0,8578.0,hypothetical protein  conserved,G1
Tb927.4.1330,2870.5,1482.5,2226.5,2237.0,6016.5,DNA topoisomerase IB  large subunit,>4C (GG2M)
Tb927.4.1340,10896.0,4778.5,4695.5,3029.0,3065.0,Cleavage and polyadenylation specificity factor subunit,<2C (LG1)
Tb927.4.1350,9236.5,6429.5,5512.0,5690.0,6369.5,glyoxalase II,<2C (LG1)
Tb927.4.1360,7125.5,2751.5,2692.0,2237.0,2243.5,Glucose-6-phosphate 1-epimerase  putative,<2C (LG1)
Tb927.4.1370,8857.0,9663.5,9332.5,9715.0,6614.5,hypothetical protein  conserved,G2M
Tb927.4.1380,8137.0,8782.0,8953.0,8536.0,8416.0,D-Tyr-tRNA(Tyr) deacylase  putative,S
Tb927.4.1390,11499.0,11604.0,11552.0,11569.0,11325.5,hypothetical protein  conserved,G1
Tb927.4.1400,4505.5,7841.5,6866.5,7040.5,7968.5,vacuolar transport protein 4A  putative,>4C (GG2M)
Tb927.4.1410,9430.0,6508.5,6509.5,5079.0,5757.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1420,7125.5,5862.0,5765.5,5148.0,4737.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1430,10023.0,10147.0,9682.0,9823.5,10294.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.1440,2930.5,4111.5,4476.0,3194.5,2098.0,probable rRNA maturation factor YbeY  putative,S
Tb927.4.1450,7550.0,7934.0,7644.0,7631.5,4654.0,hypothetical protein  conserved,G1
Tb927.4.1460,2221.0,4653.0,4598.0,4662.5,6240.0,Zn-finger in ubiquitin-hydrolases and other protein  putative,>4C (GG2M)
Tb927.4.1470,1460.0,1143.0,1179.5,788.5,559.5,Domain of unknown function (DUF4379)  putative,<2C (LG1)
Tb927.4.1480,7840.0,10304.0,10471.0,10669.5,8831.5,DNA cross-link repair protein pso2/snm1,G2M
Tb927.4.1490,6047.5,6423.0,7916.5,6612.5,2029.5,hypothetical protein  conserved,S
Tb927.4.1500,10939.0,10919.0,10817.0,11035.5,10690.0,RNA editing associated helicase 2,G2M
Tb927.4.1510,10211.5,11148.5,11286.0,11230.0,11434.5,phospholipid-translocating ATPase  putative,>4C (GG2M)
Tb927.4.1520,2094.5,959.0,756.5,517.0,213.0,Simiate family protein  putative,<2C (LG1)
Tb927.4.1530,4555.0,8921.0,8362.5,7486.0,8893.0,hypothetical protein  conserved,G1
Tb927.4.1540,8794.0,8297.5,8722.0,9540.0,9107.0,NAD dependent epimerase/dehydratase family  putative,G2M
Tb927.4.1550,7496.0,8664.0,8568.5,8779.5,9419.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.1560,8692.5,4521.5,3727.5,4112.0,3794.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1570,2552.0,3129.0,2238.0,3168.0,2283.5,hypothetical protein  conserved,G2M
Tb927.4.1580,1460.0,4937.5,4069.0,4084.0,1304.5,WW domain containing protein  putative,G1
Tb927.4.1590,10990.0,8151.0,8094.5,9533.0,7313.0,Present in the outer mitochondrial membrane proteome 28,<2C (LG1)
Tb927.4.1600,7188.0,6998.0,7958.5,8691.0,7023.0,AAA domain containing protein  putative,G2M
Tb927.4.1610,5703.0,6581.5,6119.5,6024.5,7065.5,Tripartite attachment complex 40,>4C (GG2M)
Tb927.4.1620,4104.0,2964.5,2440.5,3393.5,2505.5,phosphatidylinositol phosphate kinase alpha,<2C (LG1)
Tb927.4.1630,10645.5,8982.0,9272.5,8935.0,8802.0,ribosomal RNA processing protein 6,<2C (LG1)
Tb927.4.1640,8446.0,2422.5,1870.0,2009.0,1338.5,Nucleotide sugar transporter 3,<2C (LG1)
Tb927.4.1650,6803.5,9755.5,10205.0,9885.5,8879.5,hypothetical protein  conserved,S
Tb927.4.1660,5339.5,8248.0,8138.0,6366.5,7821.0,mitochondrial carrier protein  putative,G1
Tb927.4.1670,612.5,2313.0,3452.0,2642.5,2364.5,cytochrome b5-like Heme/Steroid binding domain containing protein  putative,S
Tb927.4.1680,6145.5,5847.0,5120.0,5926.0,5813.0,ZFP family member  putative,<2C (LG1)
Tb927.4.1690,11675.0,10706.5,10762.0,10986.0,10644.5,Retinal Maintenance  putative,<2C (LG1)
Tb927.4.1700,7826.5,8408.5,7658.5,7535.0,4794.5,CK1/TTBK protein kinase  putative,G1
Tb927.4.1710,6088.5,7751.5,7979.5,7474.0,5824.0,rhodanese-like domain containing protein  putative,S
Tb927.4.1720,1460.0,5585.0,6010.0,4193.5,3510.5,Nucleoside diphosphate kinase 3,S
Tb927.4.1730,1460.0,967.5,756.5,610.5,1239.0,Nucleus and spindle associated protein 4,<2C (LG1)
Tb927.4.1740,5330.0,6148.5,6218.5,7304.5,6505.0,Component of motile flagella 41,G2M
Tb927.4.1750,8139.5,6437.0,6986.5,7434.0,7465.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1760,7391.5,8308.0,7393.0,6809.0,7602.0,hypothetical protein  conserved,G1
Tb927.4.1770,1460.0,3961.0,3962.5,4346.0,3888.0,hypothetical protein  conserved,G2M
Tb927.4.1780,612.5,3225.0,2790.5,2494.5,3960.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.1790,612.5,1285.0,1164.0,757.5,2898.5,ribosomal protein L3  putative,>4C (GG2M)
Tb927.4.1800,1460.0,1506.5,1561.5,890.0,3413.5,Mitochondrial ribosomal protein L3,>4C (GG2M)
Tb927.4.1810,2813.0,6115.0,7033.5,6768.0,6564.5,mitochondrial ribosomal protein L33,S
Tb927.4.1820,10229.5,10508.0,10591.0,10584.5,10016.5,selenocysteine-specific elongation factor  putative,S
Tb927.4.1830,3407.5,1690.5,2612.0,1702.0,1213.5,Urm1 (Ubiquitin related modifier)  putative,<2C (LG1)
Tb927.4.1840,4104.0,7252.5,7939.0,7460.5,7806.0,Carboxypeptidase-like protein,S
Tb927.4.1850,7550.0,3467.5,2465.5,1514.5,5634.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1860,4470.5,738.5,520.0,221.5,559.5,ribosomal protein S19  putative,<2C (LG1)
Tb927.4.1870,8925.0,4560.0,5214.5,6567.0,3748.5,Serine/threonine-protein phosphatase 2A catalytic subunit  putative,<2C (LG1)
Tb927.4.1880,10489.0,8170.0,8825.5,7891.0,9164.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.1890,1460.0,3855.5,5334.5,6837.5,4158.0,hypothetical protein  conserved,G2M
Tb927.4.1900,1460.0,3097.0,2764.5,2697.5,994.0,Methyltransferase domain/Methyltransferase involved in Williams-Beuren syndrome  putative,G1
Tb927.4.1910,1460.0,2975.0,4622.0,4940.5,3055.0,hypothetical protein  conserved,G2M
Tb927.4.1920,3131.5,4305.0,5631.0,4045.0,4403.5,GPI transamidase subunit 16  putative,S
Tb927.4.1930,5524.5,3863.5,4341.0,4852.5,5535.5,eukaryotic translation initiation factor 3 subunit g,>4C (GG2M)
Tb927.4.1940,10819.0,7927.5,8179.5,8743.5,7147.0,WD domain  G-beta repeat  putative,<2C (LG1)
Tb927.4.1950,5314.0,5104.5,6328.0,6271.5,6649.0,NADPH-dependent diflavin oxidoreductase 1,>4C (GG2M)
Tb927.4.1960,2598.0,6391.5,5519.5,6056.0,5577.5,hypothetical protein  conserved,G1
Tb927.4.1970,5834.0,8111.5,8097.5,7391.0,5135.5,Domain of unknown function DUF21  putative,G1
Tb927.4.1980,4260.5,6052.0,8176.5,8282.5,7419.5,hypothetical protein  conserved,G2M
Tb927.4.1990,10249.0,4583.0,5613.5,5120.0,5332.5,ATP-dependent RNA and DNA helicase  mitochondrial  putative,<2C (LG1)
Tb927.4.2000,612.5,484.0,848.5,1017.0,2758.5,ruvB-like DNA helicase  putative,>4C (GG2M)
Tb927.4.2010,612.5,1781.0,2289.5,2199.0,1355.0,acyl-CoA binding protein  putative,S
Tb927.4.2020,6594.5,8226.5,8356.0,8628.5,8348.0,AP-3 complex subunit mu  putative,G2M
Tb927.4.2030,8709.5,6901.5,7480.0,7599.5,7940.0,DNA/RNA-binding protein Alba 4,<2C (LG1)
Tb927.4.2040,3394.0,5867.5,4598.0,4057.0,9727.0,DNA/RNA-binding protein Alba 3,>4C (GG2M)
Tb927.4.2050,612.5,3397.0,2453.0,4252.5,11266.0,hypothetical protein,>4C (GG2M)
Tb927.4.2060,8340.5,3419.0,5025.0,6899.0,11589.5,Flagellum attachment zone protein 8,>4C (GG2M)
Tb927.4.2070,11548.0,11620.0,11606.0,11591.0,11474.0,antigenic protein  putative,G1
Tb927.4.2080,1460.0,322.0,373.5,534.5,4110.0,Coiled-coil and C2 domain-containing protein,>4C (GG2M)
Tb927.4.2090,6441.5,5664.0,4550.5,4742.5,3586.0,hypothetical protein,<2C (LG1)
Tb927.4.2100,7023.5,6554.5,6218.5,7605.5,7069.0,hypothetical protein,G2M
Tb927.4.2110,8667.0,5077.5,6373.5,5137.0,3812.0,protein phosphatase 2C  putative,<2C (LG1)
Tb927.4.2120,2047.0,3909.5,2477.5,2756.0,2647.0,hypothetical protein  conserved,G1
Tb927.4.2130,5099.5,6745.0,7572.0,7577.0,6066.5,hypothetical protein  conserved,G2M
Tb927.4.2140,2436.0,2772.5,4518.5,4267.0,10973.0,Component of motile flagella 8,>4C (GG2M)
Tb927.4.2150,2258.5,774.5,743.0,557.5,1828.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2160,2552.0,2170.0,2887.5,3075.0,5567.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2170,3155.0,4429.5,5486.5,4862.5,5702.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2180,612.5,1595.5,1237.5,839.0,1595.5,60S ribosomal protein L35a  putative,G1
Tb927.4.2190,1988.0,1249.0,2214.0,1491.0,5870.5,GTP-binding protein  putative,>4C (GG2M)
Tb927.4.2200,11055.0,10881.5,10443.0,10283.5,9918.5,Sec7 domain containing protein  putative,<2C (LG1)
Tb927.4.2210,10136.5,9580.5,9577.5,9793.5,8662.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2220,8984.0,5506.0,8927.5,10161.0,10271.0,TPR-repeat-containing chaperone protein DNAJ  putative,>4C (GG2M)
Tb927.4.2230,4211.5,6940.5,7532.5,7972.5,6690.0,dolichyl-P-Man:GDP-Man1GlcNAc2-PP-dolichyl alpha-1 3-mannosyltransferase  putative,G2M
Tb927.4.2240,7200.5,7622.0,7958.5,8925.5,8499.5,Aminotransferase class IV  putative,G2M
Tb927.4.2250,3054.0,1353.5,1536.0,2389.0,895.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2260,4480.0,1201.5,3028.0,4598.0,6607.0,centrin-1,>4C (GG2M)
Tb4.NT.19,4801.0,4357.5,3260.0,4522.0,2364.5,Noncoding RNA  putative,<2C (LG1)
Tb927.4.2265,2995.0,3385.5,2961.0,2072.5,5535.5,hypothetical protein,>4C (GG2M)
Tb927.4.2270,5485.5,7065.5,5962.0,5850.0,4915.5,Histone-like transcription factor (CBF/NF-Y) and archaeal histone  putative,G1
Tb927.4.2280,7690.5,8724.5,8658.5,7972.5,8865.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2290,4947.5,6626.0,6253.5,5981.0,2231.5,glucose transporter  putative,G1
Tb927.4.2300,1460.0,5765.0,5396.5,6598.5,5795.0,hypothetical protein  conserved,G2M
Tb927.4.2310,2460.0,7810.0,6561.5,6423.0,4586.5,asparaginyl-tRNA synthetase  putative,G1
Tb927.4.2320,612.5,6631.0,6929.5,6540.5,6369.5,hypothetical protein  conserved,S
Tb927.4.2330,612.5,5136.0,5728.0,4205.5,4783.5,hypothetical protein  conserved,S
Tb927.4.2340,1460.0,4413.0,3308.0,3605.5,5803.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2350,1914.0,6397.0,4956.5,5505.5,4292.0,twinfilin,G1
Tb927.4.2360,612.5,2723.0,2477.5,2046.5,2857.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2370,8601.5,8815.0,9520.0,8397.0,9727.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2380,3028.5,3507.5,3962.5,3102.5,2336.0,sarcoplasmic reticulum glycoprotein  putative,S
Tb927.4.2390,6052.0,7610.0,8190.0,8110.0,7226.0,ATP-dependent RNA helicase  putative,S
Tb927.4.2400,11429.0,9385.0,9843.0,10440.0,11610.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2410,8036.0,7591.5,7466.5,7940.0,8342.0,Glycosyl hydrolase family 65 central catalytic domain/Haloacid dehalogenase-like hydrolase  putative,>4C (GG2M)
Tb927.4.2420,8351.0,5883.0,5637.0,5159.0,6857.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2430,9608.5,5488.5,5452.0,4754.5,5174.5,Endonuclease/Exonuclease/phosphatase family  putative,<2C (LG1)
Tb927.4.2440,10461.5,7667.5,7662.0,8198.0,7847.5,SET domain containing protein  putative,<2C (LG1)
Tb927.4.2450,3358.0,5104.5,4540.5,5592.0,8232.5,protein disulfide isomerase 1,>4C (GG2M)
Tb927.4.2460,11157.0,11247.5,11029.0,11154.0,10792.0,kinatase  putative,G1
Tb927.4.2470,8883.0,10562.5,10588.5,10158.5,10264.0,hypothetical protein  conserved,S
Tb927.4.2480,8306.5,9150.5,10234.5,9027.0,8979.0,8-oxoguanine DNA glycosylase  putative,S
Tb927.4.2490,7617.0,7711.0,8309.5,7839.5,8437.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2500,9153.5,10821.5,10802.0,10852.5,10250.5,eukaryotic translation initiation factor 2-alpha kinase 2,G2M
Tb927.4.2510,9536.5,10109.0,10492.5,10230.5,10024.5,multidrug resistance-associated protein  putative,S
Tb927.4.2520,4734.5,6897.0,7380.5,6883.0,8998.0,Silent information regulator 2 related protein 3,>4C (GG2M)
Tb927.4.2530,8777.5,5765.0,4740.5,5148.0,3888.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2540,2357.5,1661.5,1091.0,1466.0,1281.5,Neural precursor cell-expressed  developmently downregulated 8,<2C (LG1)
Tb927.4.2550,7222.0,7399.5,8459.5,8547.5,9013.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2560,9366.0,6745.0,6166.0,7126.0,5725.5,cardiolipin synthetase,<2C (LG1)
Tb927.4.2570,6559.0,4745.0,5973.0,4146.0,3125.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2580,6033.5,7857.5,8730.5,8611.5,5135.5,hypothetical protein  conserved,S
Tb927.4.2590,8894.0,7651.5,8313.5,7819.0,8067.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2600,10768.0,10530.0,10950.0,10633.5,10460.0,SUMO-interacting motif-containing protein,S
Tb927.4.2610,4667.5,896.0,357.5,501.5,672.0,hypothetical protein,<2C (LG1)
Tb927.4.2620,7115.0,3680.0,2577.0,2335.0,3447.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2630,1783.5,3515.0,3902.0,2810.5,2178.0,ATP-dependent DEAD/H RNA helicase  putative,S
Tb927.4.2640,4190.5,6186.0,7354.5,7161.0,11522.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2650,5516.5,6044.5,5902.5,7153.5,6499.0,Regulator of chromosome condensation (RCC1) repeat  putative,G2M
Tb927.4.2660,4418.5,1736.5,2182.5,1861.0,2000.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2670,7046.0,4653.0,3116.5,4156.0,3494.0,pyroglutamyl-peptidase I  putative,<2C (LG1)
Tb927.4.2680,9790.5,10336.5,10073.5,10216.5,10837.0,Zeta toxin  putative,>4C (GG2M)
Tb4.NT.21,612.5,509.0,491.0,444.5,853.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.4.2700,7292.0,6079.5,6917.0,6761.5,5054.0,Hydroxymethylglutaryl-CoA lyase  mitochondrial  putative,<2C (LG1)
Tb927.4.2710,9038.0,7610.0,7813.0,7105.5,7693.5,ubiquitin-conjugating enzyme E2  putative,<2C (LG1)
Tb927.4.2720,9595.5,7406.5,7457.0,6475.5,5996.5,ATP dependent DEAD-box helicase,<2C (LG1)
Tb927.4.2730,4288.5,7642.0,7098.0,7567.0,5916.5,kinesin  putative,G1
Tb927.4.2740,6498.0,1953.0,1103.0,2404.0,3741.0,p25-alpha  putative,<2C (LG1)
Tb927.4.2750,9447.0,10800.0,10806.0,10916.0,10723.5,hypothetical protein  conserved,G2M
Tb927.4.2760,612.5,5416.0,5102.5,5087.5,4607.0,Protein of unknown function (DUF3808)  putative,G1
Tb927.4.2770,8582.5,6132.0,6315.0,7087.0,5420.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2780,10672.5,11117.0,11125.0,11075.0,11101.0,hypothetical protein  conserved,S
Tb927.4.2790,10549.0,8936.5,9945.5,9997.0,8480.0,kinetoplast ribosomal PPR-repeat containing protein 12,<2C (LG1)
Tb927.4.2800,8161.5,8122.5,7802.5,8656.5,8048.5,R3H-associated N-terminal domain containing protein  putative,G2M
Tb927.4.2810,612.5,1437.5,1595.5,1626.0,1744.5,hypothetical protein,>4C (GG2M)
Tb927.4.2820,3613.0,3984.0,6603.0,8985.0,11222.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2830,5139.0,5811.0,6114.0,6719.5,4783.5,hypothetical protein  conserved,G2M
Tb927.4.2840,1460.0,2544.5,3246.5,1526.5,287.0,hypothetical protein  conserved,S
Tb927.4.2850,9878.0,9697.0,9783.5,8668.0,9847.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2860,612.5,3284.0,3551.5,2237.0,1636.0,EAP30/Vps36 family  putative,S
Tb927.4.2870,7536.0,7578.5,6808.5,5939.0,3760.5,hypothetical protein  conserved,G1
Tb927.4.2880,4002.5,4790.0,5229.5,5862.5,7559.0,Nucleoporin NUP225,>4C (GG2M)
Tb927.4.2890,8595.0,6714.5,7622.5,7227.0,5135.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2900,7843.5,5494.5,8008.5,7469.0,6928.0,hypothetical protein  conserved,S
Tb927.4.2910,6689.0,10102.5,10241.5,10271.0,10480.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.2920,7581.5,10412.5,9838.5,8642.0,7847.5,hypothetical protein  conserved,G1
Tb927.4.2930,11216.0,9245.0,9055.5,9005.5,7731.5,OsmC-like protein  putative,<2C (LG1)
Tb927.4.2935,612.5,1635.5,3138.0,1805.5,1744.5,hypothetical protein,S
Tb927.4.2940,2406.5,1574.5,1268.0,925.0,697.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2950,6662.0,4429.5,4170.0,3992.5,3648.5,mitochondrial DNA polymerase I protein A  putative,<2C (LG1)
Tb927.4.2960,612.5,678.5,471.5,557.5,1407.5,mediator of rna polymerase ii transcription subunit 8,>4C (GG2M)
Tb927.4.2970,3314.5,4684.0,2858.0,3545.0,1549.5,chaperone protein DnaJ  putative,G1
Tb927.4.2980,2767.0,1553.5,2604.0,2290.0,1828.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.2990,6017.0,8317.0,7584.0,7126.0,7369.5,hypothetical protein  conserved,G1
Tb927.4.3000,10480.5,7146.5,7384.0,5751.5,5953.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3010,6999.0,2741.5,2477.5,2456.5,2647.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3020,8756.5,10392.0,10166.0,10291.0,10774.5,ATP-dependent DEAH-box RNA helicase  putative,>4C (GG2M)
Tb927.4.3030,2795.5,3187.0,3335.0,3254.5,2758.5,mediator of rna polymerase ii transcription subunit 2,S
Tb927.4.3040,612.5,1043.5,1347.5,1329.0,1047.0,Enriched in surface-labeled proteome protein 11,S
Tb927.4.3050,5635.5,4220.5,3452.0,4699.5,2203.5,hypothetical protein,<2C (LG1)
Tb927.4.3060,4074.0,2828.5,2839.0,2893.5,3185.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3070,8635.5,3397.0,5034.0,4686.5,1453.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3080,1783.5,2609.5,2939.0,1950.5,3465.5,Uncharacterised ACR  YggU family COG1872  putative,>4C (GG2M)
Tb927.4.3090,612.5,5159.5,4815.0,4496.5,7725.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.3100,5361.5,5454.0,6211.0,5962.0,5577.5,hypothetical protein  conserved,S
Tb927.4.3110,7886.0,7092.0,6664.0,5228.0,7437.0,tRNA-dihydrouridine synthase 4  putative,<2C (LG1)
Tb927.4.3120,5402.0,6683.5,6718.0,7119.0,8990.5,hook complex protein  conserved,>4C (GG2M)
Tb927.4.3130,612.5,1635.5,2251.5,2642.5,3716.5,Component of motile flagella 18,>4C (GG2M)
Tb927.4.3140,10358.0,8741.5,8502.5,9023.0,9903.0,Ribosome maturation protein SDO1,<2C (LG1)
Tb927.4.3150,7352.5,11098.5,11060.5,11228.0,10911.0,hypothetical protein  conserved,G2M
Tb927.4.3160,6179.5,11241.0,11166.0,10702.0,11084.0,dihydroxyacetone phosphate acyltransferase  putative,G1
Tb927.4.3170,9504.5,9722.0,9889.5,10234.5,10073.0,hypothetical protein  conserved,G2M
Tb927.4.3180,6190.5,7002.0,5973.0,6313.0,7406.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.3190,7677.5,2828.5,2551.0,2821.0,4244.5,ubiquitin-conjugating enzyme E2  putative,<2C (LG1)
Tb927.4.3193,4533.5,904.0,795.0,720.5,915.0,tRNA Valine,<2C (LG1)
Tb927.4.3196,612.5,738.5,808.5,592.5,397.5,tRNA Leucine,S
Tb927.4.3199,612.5,886.5,756.5,757.5,213.0,tRNA Methionine,G1
Tb927.4.3200,9697.0,6052.0,4502.0,5198.5,3970.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3210,4989.5,4950.0,6315.0,7252.0,5301.0,ESAG11-related protein  putative,G2M
Tb927.4.3220,5740.0,4928.0,5256.0,5908.5,3861.0,hypothetical protein  conserved,G2M
Tb927.4.3230,3662.5,7890.5,7930.0,8048.0,7551.5,ESAG11-related protein  putative,G2M
Tb927.4.3240,2658.5,3419.0,3116.5,4112.0,2758.5,hypothetical protein  conserved,G2M
Tb927.4.3250,3692.0,3827.0,3599.5,2801.0,4266.0,ESAG11-related protein  putative,>4C (GG2M)
Tb927.4.3260,1783.5,1670.0,1254.0,1542.0,4760.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.3270,3041.5,5871.0,3902.0,4156.0,1896.5,ESAG11-related protein  putative,G1
Tb927.4.3280,5314.0,5407.0,4577.0,5673.5,4687.0,expression site-associated gene 2 (ESAG2) protein  putative,G2M
Tb927.4.3290,6498.0,6792.5,6084.5,6626.0,7347.5,Trypanosomal VSG domain containing protein  putative,>4C (GG2M)
Tb927.4.3292,5542.0,2469.5,2564.5,2686.0,3871.0,tRNA Glutamic acid,<2C (LG1)
Tb927.4.3294,6264.0,3235.0,3066.0,3635.0,3906.0,tRNA Methionine,<2C (LG1)
Tb927.4.3296,5330.0,2062.0,1742.5,2422.0,2631.5,tRNA Serine,<2C (LG1)
Tb927.4.3298,5225.0,1492.5,1650.0,1491.0,2000.0,tRNA Valine,<2C (LG1)
Tb927.4.3300,3328.5,6572.5,6518.0,6192.0,8638.0,mitochondrial ATP-dependent zinc metallopeptidase  putative,>4C (GG2M)
Tb927.4.3310,2047.0,4886.5,4502.0,3965.5,5487.5,TPR repeat/SET domain containing protein  putative,>4C (GG2M)
Tb927.4.3320,612.5,1143.0,848.5,1017.0,287.0,uracil phosphoribosyltransferase  putative,G1
Tb927.4.3330,3013.5,2877.0,3051.5,3545.0,7295.0,EF-hand domain pair  putative,>4C (GG2M)
Tb927.4.3340,5863.0,4127.0,5340.0,4731.0,5788.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3350,2460.0,8512.5,8842.5,8735.0,8396.5,Carnosine N-methyltransferase  putative,S
Tb927.4.3360,1988.0,3606.5,3703.5,3744.5,2000.0,hypothetical protein  conserved,G2M
Tb927.4.3370,8830.0,3164.5,2919.0,2347.0,2720.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3380,2094.5,8857.0,6803.5,8547.5,8321.0,myosin IB heavy chain  putative,G1
Tb927.4.3390,1460.0,5407.0,6664.0,6340.0,6199.5,tuzin  putative,S
Tb927.4.3400,3848.5,7440.0,7399.0,7288.5,11125.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.3410,9566.0,10016.0,10562.0,10287.5,10615.0,selenoprotein  putative,>4C (GG2M)
Tb927.4.3420,9620.5,8081.0,7629.0,8802.5,8674.0,wee1-like protein kinase,<2C (LG1)
Tb927.4.3430,5718.0,4603.5,5631.0,5899.5,7796.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.3440,612.5,7028.5,7165.0,7517.0,5188.0,Basal body protein 50kDa,G2M
Tb927.4.3450,5450.0,3109.0,4434.0,4183.0,3576.5,Mitochondrial ATP synthase subunit  putative,<2C (LG1)
Tb927.4.3460,4916.5,3187.0,3431.0,2967.0,2631.5,ubiquitin-conjugating enzyme E2  putative,<2C (LG1)
Tb927.4.3470,11058.0,9520.5,9622.0,9445.0,9173.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3480,7490.5,6933.0,6788.5,7940.0,7385.0,hypothetical protein,G2M
Tb927.4.3490,2535.5,2093.5,2262.5,1966.0,5354.0,DNA-directed RNA polymerases II and III subunit RPB6  putative,>4C (GG2M)
Tb927.4.3500,7558.5,6301.5,7614.0,7333.0,7541.0,Amastin surface glycoprotein  putative,S
Tb927.4.3510,3041.5,2344.0,2653.0,2264.5,3960.5,DNA-directed RNA polymerase subunit  putative,>4C (GG2M)
Tb927.4.3520,2729.0,2510.5,2341.0,1922.5,2050.0,Amastin surface glycoprotein  putative,<2C (LG1)
Tb927.4.3530,8076.0,10679.0,10217.5,10546.5,10527.5,hypothetical protein  conserved,G1
Tb927.4.3540,4930.5,8118.0,6854.5,7275.5,8389.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.3550,1460.0,96.0,189.5,82.5,347.0,60S ribosomal protein L13a  putative,<2C (LG1)
Tb927.4.3560,4922.5,2887.5,1612.0,2134.5,3494.0,protein phoshatase 1  putative,<2C (LG1)
Tb927.4.3570,5960.5,6554.5,6166.0,6515.5,8943.0,translation elongation factor 1-beta  putative,>4C (GG2M)
Tb927.4.3580,4887.0,2170.0,1831.0,1504.0,1816.5,Transcription factor Pcc1  putative,<2C (LG1)
Tb927.4.3590,5989.0,6339.0,5902.5,6357.5,8645.5,translation elongation factor 1-beta  putative,>4C (GG2M)
Tb927.4.3600,4840.5,1455.0,1149.5,941.0,1120.5,Transcription factor Pcc1  putative,<2C (LG1)
Tb927.4.3610,7686.0,5251.5,5007.0,4552.0,6764.0,protein phosphatase 1  putative,<2C (LG1)
Tb927.4.3620,11691.0,11459.5,11310.0,11388.0,11487.0,serine threonine-protein phosphatase PP1  putative,<2C (LG1)
Tb927.4.3630,7611.5,7152.0,7777.5,7868.0,7290.0,serine threonine-protein phosphatase PP1  putative,G2M
Tb927.4.3640,10379.0,10141.0,10357.0,10467.0,10145.0,serine threonine-protein phosphatase PP1  putative,G2M
Tb927.4.3650,612.5,919.5,893.0,1403.5,6804.0,serine threonine-protein phosphatase PP1  putative,>4C (GG2M)
Tb927.4.3660,3063.5,1190.0,1324.0,1688.5,1162.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3670,4346.0,7778.5,7813.0,7465.0,8505.0,CBF/Mak21 family  putative,>4C (GG2M)
Tb927.4.3680,1460.0,5573.0,4493.5,5206.5,4170.0,protein phosphatase 2C  putative,G1
Tb927.4.3690,4153.0,5426.5,4271.0,5463.0,4391.0,Mitochondrial SSU ribosomal protein  putative,G2M
Tb927.4.3700,11494.0,9988.0,9634.0,10252.0,10095.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3710,6409.5,3419.0,3224.5,2928.0,5075.5,Predicted membrane protein  putative,<2C (LG1)
Tb927.4.3720,612.5,5309.0,3877.5,4045.0,2164.5,Uncharacterized conserved protein (DUF2039)  putative,G1
Tb927.4.3730,9451.0,7399.5,6206.0,6683.5,7699.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3740,4655.5,3138.5,4857.0,6183.0,11345.0,flagellar attachment zone protein 1,>4C (GG2M)
Tb927.4.3750,11438.0,11583.0,11483.0,11565.5,11380.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.4.3760,5713.5,6001.5,6084.5,4742.5,3295.5,hypothetical protein,S
Tb927.4.3770,10855.0,5904.0,4258.0,4126.5,6426.0,calcium/calmodulin-dependent protein kinase  putative,<2C (LG1)
Tb927.4.3780,3987.5,1536.0,954.0,1202.5,721.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3790,11468.5,9329.5,8600.5,8036.0,7566.0,ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb927.4.3800,7478.0,2505.5,1923.0,2311.0,2679.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3810,3131.5,5816.0,4977.5,5024.0,8321.0,DNA-directed RNA polymerase II subunit 2  putative,>4C (GG2M)
Tb927.4.3820,6847.0,8818.5,7457.0,8878.0,7274.5,hypothetical protein  conserved,G2M
Tb927.4.3830,612.5,2034.0,1818.0,2373.0,2351.0,hypothetical protein  conserved,G2M
Tb927.4.3840,7324.0,5867.5,4977.5,5168.5,6878.5,nucleolar protein  putative,<2C (LG1)
Tb927.4.3850,3314.5,4583.0,4767.5,3837.0,4330.5,NLE (NUC135) domain/WD domain  G-beta repeat  putative,S
Tb927.4.3860,11654.0,11618.0,11551.0,11604.0,11509.0,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.4.3870,11097.5,11404.0,11287.5,11105.0,11097.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.4.3880,10871.0,11133.5,11024.0,10980.0,10925.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.4.3890,10303.0,8709.5,8924.0,8511.5,8657.0,ATP-dependent RNA helicase  putative,<2C (LG1)
Tb927.4.3900,8023.5,9608.0,9730.0,9879.5,9404.5,hypothetical protein  conserved,G2M
Tb927.4.3910,9116.5,7487.0,8726.0,8287.0,9678.0,Kinesin-13 4a  putative,>4C (GG2M)
Tb927.4.3920,11412.0,10832.0,10788.0,11048.0,10809.5,CRAL/TRIO domain containing protein  putative,<2C (LG1)
Tb927.4.3930,8614.5,10523.0,10686.0,10701.0,8845.0,amino acid transporter  putative,G2M
Tb927.4.3940,7343.0,9057.0,8842.5,9396.0,6649.0,Calpain-like protein 2,G2M
Tb927.4.3950,5734.0,4950.0,4689.0,5206.5,6206.0,cytoskeleton-associated protein CAP5.5  putative,>4C (GG2M)
Tb927.4.3960,1783.5,1332.5,1402.0,1491.0,1717.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.3970,9128.5,10223.0,10148.0,10414.0,10393.0,hypothetical protein  conserved,G2M
Tb927.4.3980,612.5,6480.5,6046.5,6515.5,1944.0,chaperone protein DnaJ  putative,G2M
Tb927.4.3990,8627.5,9411.5,9464.0,9055.5,8454.0,amino acid transporter  putative,S
Tb927.4.4000,9307.5,10333.0,10380.0,10204.0,9178.5,amino acid transporter  putative,S
Tb927.4.4010,8712.0,9023.0,9246.0,8554.0,8048.5,amino acid transporter  putative,S
Tb927.4.4020,7267.0,7871.5,7124.5,6612.5,7226.0,amino acid transporter  putative,G1
Tb927.4.4030,8539.0,10146.0,10319.5,9974.5,8621.5,CCCH zinc finger in TRM13 protein/U11-48K-like CHHC zinc finger/Methyltransferase TRM13  putative,S
Tb927.4.4040,3543.0,2760.5,3364.5,2907.5,4365.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.4050,11259.0,9254.0,8111.0,7582.0,8393.5,glycosomal transporter (GAT1),<2C (LG1)
Tb927.4.4060,6937.0,10973.0,11043.0,11093.0,11250.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.4070,9608.5,6846.5,7749.0,7384.5,7177.5,mevalonate kinase  putative,<2C (LG1)
Tb927.4.4080,5817.0,3961.0,2996.5,3938.0,4212.0,C-5 sterol desaturase  putative,<2C (LG1)
Tb927.4.4090,5127.5,5765.0,5953.5,5325.0,7494.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.4100,3013.5,5546.5,6360.5,6663.0,4714.5,hypothetical protein  conserved,G2M
Tb927.4.4110,10332.0,9651.0,9666.0,9401.0,9454.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4120,5663.0,7321.0,6452.5,6105.5,9922.0,Cleavage stimulating factor 64  putative,>4C (GG2M)
Tb927.4.4130,8698.0,10032.5,9500.5,9854.0,11531.0,Flagellar-associated protein 59  putative,>4C (GG2M)
Tb927.4.4140,9426.5,10393.0,9758.5,10061.0,8519.0,hypothetical protein  conserved,G1
Tb927.4.4150,10390.5,9881.0,10073.5,9346.0,7762.5,mitochondrial RNA binding complex 1 subunit MRB4150,<2C (LG1)
Tb927.4.4160,11513.0,9685.0,9371.5,9512.5,9659.5,RNA editing mediator complex protein 5,<2C (LG1)
Tb927.4.4170,5792.5,8605.5,8775.5,8061.0,8477.5,rRNA methyltransferase  putative,S
Tb927.4.4180,10504.0,9936.0,9996.0,9255.0,10831.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.4.4190,7892.5,7776.0,8852.0,8668.0,3896.5,C2 domain containing protein  putative,S
Tb927.4.4200,6361.5,5537.5,5919.0,6515.5,4096.5,hypothetical protein  conserved,G2M
Tb927.4.4210,10152.0,8696.5,8898.5,8132.5,7130.5,ATP-dependent zinc metalloprotease AFG3-like  putative,<2C (LG1)
Tb927.4.4220,10354.0,8096.5,8484.5,7268.5,7551.5,small GTP-binding rab protein  putative,<2C (LG1)
Tb927.4.4230,11450.0,11007.5,11106.0,11130.5,10990.5,RNA-binding protein  putative,<2C (LG1)
Tb927.4.4240,4608.5,5647.0,5543.5,4221.0,3541.0,hypothetical protein  conserved,G1
Tb4.NT.41,7655.5,6611.5,5962.0,5673.5,6455.5,Noncoding RNA  putative,<2C (LG1)
Tb927.4.4250,10385.0,10966.0,10610.5,10714.5,10557.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.4260,4510.5,5052.5,5091.5,3627.0,2463.0,hypothetical protein  conserved,S
Tb4.NT.42,7698.5,6736.0,6406.5,6407.5,6938.5,Noncoding RNA  putative,<2C (LG1)
Tb927.4.4270,10180.5,9893.5,9388.5,9203.5,8961.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb927.4.4280,7524.0,8658.5,8871.5,8086.0,7377.0,hypothetical protein  conserved,S
Tb927.4.4290,9358.0,10133.5,10049.0,9568.5,9279.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.4300,3785.5,8835.0,9658.0,9782.5,9668.5,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,G2M
Tb927.4.4310,6055.0,9428.0,9508.0,8728.0,9355.5,Nucleoporin NUP64,S
Tb927.4.4320,3516.5,6306.5,5609.0,5981.0,3929.5,divalent cation tolerance protein  putative,G1
Tb927.4.4330,4721.0,2696.5,2820.0,2237.0,2413.0,kinetoplastid-specific phospho-protein phosphatase  putative,<2C (LG1)
Tb927.4.4340,8383.5,6758.0,7466.5,6138.0,7638.0,Domain of unknown function (DUF4498)  putative,<2C (LG1)
Tb927.4.4350,5393.5,6878.0,7411.0,6112.5,4975.5,emp24/gp25L/p24 family/GOLD  putative,S
Tb927.4.4360,9597.5,9334.0,9685.0,9930.5,9760.0,monoglyceride lipase  putative,G2M
Tb927.4.4370,11322.0,9495.0,9202.0,9109.5,9807.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4380,11058.0,10469.0,10772.0,10448.0,10595.0,Pyrophosphate-energized vacuolar membrane proton pump 1,<2C (LG1)
Tb927.4.4390,10644.0,10149.5,9740.5,9968.5,8480.0,hypothetical protein,<2C (LG1)
Tb927.4.4400,10860.0,10946.0,11032.0,10704.5,10320.0,hypothetical protein  conserved,S
Tb927.4.4410,11493.0,11471.0,11473.5,11421.0,11245.0,adenylyl cyclase,<2C (LG1)
Tb927.4.4420,11462.0,11346.5,11393.0,11383.0,11255.0,adenylyl cyclase  pseudogene  putative,<2C (LG1)
Tb927.4.4430,11243.5,11434.0,11462.0,11426.0,11366.0,adenylyl cyclase,S
Tb927.4.4440,11472.0,11528.0,11531.0,11515.5,11342.0,adenylyl cyclase,S
Tb927.4.4450,11294.0,11419.0,11440.0,11430.0,11282.5,adenylyl cyclase,S
Tb927.4.4460,11264.0,11507.0,11557.0,11506.0,11530.0,adenylyl cyclase,S
Tb927.4.4470,11209.0,11516.5,11482.0,11522.5,11368.0,adenylyl cyclase,G2M
Tb927.4.4480,8099.0,11255.5,11151.5,11130.5,10437.0,hypothetical protein  conserved,G1
Tb927.4.4490,11348.0,11422.0,11375.0,11270.5,11232.0,multidrug resistance protein E,G1
Tb4.NT.45,4691.0,3324.5,3578.0,2893.5,1281.5,Noncoding RNA  putative,<2C (LG1)
Tb927.4.4500,8380.5,9854.5,10426.5,10039.0,8724.0,hypothetical protein  conserved,S
Tb927.4.4510,11238.0,11428.0,11364.5,11366.0,11462.5,protein phosphatase 2C  putative,>4C (GG2M)
Tb927.4.4520,11285.0,9802.5,9471.5,9482.5,8835.5,'Cold-shock' DNA-binding domain containing protein  putative,<2C (LG1)
Tb927.4.4530,8152.5,5669.5,6159.0,6009.0,7431.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4540,6173.0,7385.5,6929.5,7053.0,6950.5,zinc finger domain  LSD1 subclass  putative,G1
Tb927.4.4550,10287.0,8292.0,8113.0,8427.5,7968.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4560,10436.0,9053.5,8771.5,7915.5,7655.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4570,9061.5,7813.5,7076.5,7702.0,5609.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4580,8231.0,10948.0,11162.0,10683.5,10185.5,hypothetical protein  conserved,S
Tb927.4.4590,11060.0,8208.0,8459.5,8043.5,9807.5,AGC family serine/threonine kinase  putative,<2C (LG1)
Tb927.4.4600,7337.0,7985.5,7498.5,7734.5,5451.0,mitochondrial ribosomal protein l43,G1
Tb927.4.4610,3314.5,5017.0,6108.0,6582.5,4231.5,LSU ribosomal protein  mitochondrial  putative,G2M
Tb927.4.4620,6297.5,3050.5,2703.5,2788.5,4028.0,cytochrome oxidase subunit VIII,<2C (LG1)
Tb927.4.4630,7162.5,1018.0,1402.0,1430.0,2563.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4640,5418.5,1747.5,2360.0,1352.5,915.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4650,8647.5,3572.0,2154.5,2764.5,3474.5,diphthine synthase  putative,<2C (LG1)
Tb927.4.4660,7964.5,5069.5,4840.5,4252.5,3541.0,Protein of unknown function DUF84  putative,<2C (LG1)
Tb927.4.4663,3822.0,935.5,1585.5,1542.0,1744.5,small RNA-76,<2C (LG1)
Tb927.4.4666,6075.0,1520.0,1831.0,1558.5,933.5,tRNA Valine,<2C (LG1)
Tb927.4.4670,9570.5,4460.5,5102.5,4731.0,3921.0,MYND finger  putative,<2C (LG1)
Tb927.4.4680,8443.0,8639.0,8697.0,8230.5,7161.5,DNA replication complex GINS protein PSF3,S
Tb927.4.4690,1460.0,6670.0,6236.5,6612.5,6216.5,hypothetical protein  conserved,G1
Tb927.4.4700,8211.5,5435.5,6544.0,6147.0,4051.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4710,7430.0,11269.0,11236.0,11334.0,11129.5,hypothetical protein  conserved,G2M
Tb927.4.4720,5779.0,7578.5,8441.0,7783.5,8111.0,kinetoplast ribosomal PPR-repeat containing protein 7,S
Tb927.4.4730,3524.0,3849.0,5670.5,5014.5,3494.0,amino acid transporter  putative,S
Tb927.4.4740,9739.5,8507.5,9627.5,8940.0,9450.5,Sphingosine N-acyltransferase  putative,<2C (LG1)
Tb927.4.4750,6381.5,6089.0,6152.5,5120.0,6890.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.4760,10298.0,9625.0,10273.0,10075.0,8519.0,Cullin 6  putative,<2C (LG1)
Tb927.4.4770,612.5,5349.5,5256.0,4409.0,4947.0,hypothetical protein,G1
Tb927.4.4780,612.5,727.0,808.5,737.0,461.5,hypothetical protein,S
Tb04.3I12.100,612.5,130.0,99.0,111.0,213.0,hypothetical protein,<2C (LG1)
Tb927.4.4790,4153.0,158.5,99.0,111.0,461.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4810,4159.0,1991.5,1536.0,2321.5,2734.0,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4815,10138.5,999.0,1008.5,1071.0,853.0,hypothetical protein,<2C (LG1)
Tb927.4.4820,9927.5,4895.5,5744.0,5463.0,5888.5,amino acid transporter 10  putative,<2C (LG1)
Tb927.4.4830,8945.0,9850.0,10056.0,9149.5,9558.0,amino acid transporter  putative,S
Tb927.4.4840,9102.0,5959.5,5808.0,5981.0,6270.0,amino acid transporter 7  putative,<2C (LG1)
Tb927.4.4850,8976.0,9886.5,9925.0,9233.0,9482.5,amino acid transporter  putative,S
Tb927.4.4860,8839.0,9358.5,9418.0,9729.5,9027.0,amino acid transporter 8  putative,G2M
Tb927.4.4870,10191.0,10605.0,10701.5,10440.0,9945.0,amino acid transporter  putative,S
Tb927.4.4880,11567.0,11012.0,11230.0,11132.5,11092.0,RING-variant domain containing protein  putative,<2C (LG1)
Tb927.4.4890,9247.0,8933.5,8960.0,8520.5,9194.5,CorA-like Mg2+ transporter protein  putative,<2C (LG1)
Tb927.4.4900,10309.0,7410.0,8060.5,7972.5,5535.5,hypothetical protein,<2C (LG1)
Tb927.4.4910,9338.5,9472.0,8960.0,8623.5,7416.5,3 2-trans-enoyl-CoA isomerase  mitochondrial precursor  putative,G1
Tb927.4.4920,9929.0,4135.5,4485.5,3452.5,4517.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.4930,7433.0,10788.0,10838.0,10384.0,10709.0,symplekin  putative,S
Tb927.4.4940,9665.0,7392.0,7480.0,8070.5,8338.0,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.4.4950,10538.5,10527.5,10792.5,10603.5,9576.0,Nucleolar protein 61,S
Tb927.4.4960,7511.5,6223.5,6811.0,7119.0,5470.5,zinc transporter  putative,<2C (LG1)
Tb927.4.4970,7837.5,7019.5,4341.0,6637.0,3482.5,myosin heavy chain kinase A  putative,<2C (LG1)
Tb927.4.4980,8060.0,5738.0,5838.5,5741.0,5451.0,NADH-ubiquinone oxidoreductase complex I subunit  putative,<2C (LG1)
Tb927.4.4990,612.5,4019.0,2738.5,4772.5,3929.5,ubiquinol-cytochrome c reductase  putative,G2M
Tb927.4.5000,2094.5,4199.5,3877.5,4183.0,10914.0,TerD domain containing protein  putative,>4C (GG2M)
Tb927.4.5010,9874.5,8341.0,8668.0,7372.5,8048.5,calreticulin  putative,<2C (LG1)
Tb927.4.5020,7761.5,7479.0,7283.5,7350.0,10652.0,DNA-directed RNA polymerase II subunit RPB1,>4C (GG2M)
Tb927.4.5030,4633.0,6714.5,6379.0,7258.0,5282.0,protein phosphatase 1,G2M
Tb927.4.5040,7847.5,5008.5,4577.0,3699.0,5240.0,dihydrolipoamide dehydrogenase,<2C (LG1)
Tb927.4.5050,7331.5,6443.5,6603.0,6165.0,2914.5,dihydrolipoamide dehydrogenase  pseudogene  putative,<2C (LG1)
Tb927.4.5060,7876.0,4785.0,3978.5,4327.5,2351.0,hypothetical protein,<2C (LG1)
Tb927.4.5070,10376.0,7760.5,7718.5,8793.0,8202.0,CRAL/TRIO domain containing protein  putative,<2C (LG1)
Tb4.NT.58,6308.5,4163.0,5164.0,5704.5,5765.5,Noncoding RNA  putative,<2C (LG1)
Tb927.4.5080,1460.0,1758.0,1612.0,1466.0,895.5,hypothetical protein  conserved,G1
Tb927.4.5090,7540.5,9479.5,9943.5,9075.5,9674.0,hypothetical protein,S
Tb927.4.5100,9491.5,8911.5,9329.5,9258.5,9454.0,Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC)/Endoplasmic reticulum vesicle transporter  putative,<2C (LG1)
Tb927.4.5110,3680.5,2516.5,2577.0,2389.0,2536.0,kinetoplastid kinetochore protein 8,<2C (LG1)
Tb927.4.5120,3621.0,9753.5,10054.0,9813.5,10704.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.5130,5127.5,3950.5,5298.0,5317.0,4737.0,KH domain/Domain of unknown function (DUF1771)/Smr domain containing protein  putative,G2M
Tb927.4.5140,5616.0,2170.0,1388.5,1281.0,2089.0,repressor of RNA polymerase III transcription MAF1,<2C (LG1)
Tb927.4.5150,6900.0,4089.5,3589.5,2940.5,2589.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.5160,4544.0,1201.5,1956.0,2275.5,1789.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.5170,6995.5,2306.5,2522.5,3737.0,2619.0,ribosomal protein L7/L12  putative,<2C (LG1)
Tb927.4.5180,4667.5,8651.5,8446.0,8966.5,7644.0,tousled-like kinase I,G2M
Tb927.4.5190,7421.0,10171.5,10228.5,9942.0,10597.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.5200,3394.0,1643.5,2440.5,2940.5,4440.0,Nucleoporin NUP62,>4C (GG2M)
Tb927.4.5210,1460.0,1313.5,966.5,1966.0,3169.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.4.5220,2714.5,4510.5,3658.5,5728.5,4222.5,hypothetical protein,G2M
Tb927.4.5230,2970.5,5612.5,4622.0,6067.5,5102.5,hypothetical protein  conserved,G2M
Tb927.4.5240,6405.5,10610.5,10558.0,10594.5,9208.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.5250,8242.0,9942.5,9670.0,9478.0,8093.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.5260,8079.5,9305.5,9342.5,9238.0,8754.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,S
Tb927.4.5270,8534.5,9479.5,9221.0,9350.5,8621.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.5280,9878.0,10277.0,10212.5,10022.5,10100.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.5290,9336.0,10294.0,10219.0,9984.5,9671.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.5300,9044.5,10238.0,9975.0,9793.5,9511.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb927.4.5310,8588.0,10875.0,10746.0,10750.0,8638.0,Repressor of differentiation kinase 2,G1
Tb927.4.5320,8481.5,11290.5,11151.5,10999.0,10095.5,Component of IIS longevity pathway SMK-1  putative,G1
Tb927.4.5330,10225.5,10782.0,9858.5,10254.5,10164.0,hypothetical protein,G1
Tb927.4.5335,8732.0,5979.5,6544.0,6452.5,6314.0,hypothetical protein,<2C (LG1)
Tb927.4.5340,10466.5,8664.0,8968.5,8319.0,8273.0,Flagellum attachment zone protein 11,<2C (LG1)
Tb927.4.5350,4533.5,4950.0,5829.0,5981.0,3093.0,3-methylcrotonyl-CoA carboxylase  pseudogene  putative (pseudogene),G2M
Tb04.24M18.150,2504.5,1924.0,1549.5,1585.5,1565.5,hypothetical protein  conserved,<2C (LG1)
Tb927.4.5360,2406.5,1838.0,1771.5,1585.5,2805.5,Cilia- and flagella-associated protein 44,>4C (GG2M)
Tb927.4.5370,9215.5,7465.5,5034.0,7547.0,11563.0,Component of motile flagella 39,>4C (GG2M)
Tb927.4.5380,2047.0,2785.5,3717.5,3492.0,11592.0,Cilia- and flagella-associated protein 43,>4C (GG2M)
Tb927.4.5390,5308.5,6347.0,4832.0,5949.0,6699.0,serine/threonine-protein kinase NrkA,>4C (GG2M)
Tb927.4.5400,612.5,4675.5,4607.0,4045.0,3482.5,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb927.4.5410,7409.5,6190.5,6211.0,6313.0,6259.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.4.5420,6842.0,5384.5,5604.5,6138.0,5411.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.4.5430,1460.0,3596.0,3821.0,3724.0,1195.0,variant surface glycoprotein (VSG  atypical)  putative,S
Tb927.4.5440,6277.5,4041.5,4868.0,4522.0,3906.0,hypothetical protein,<2C (LG1)
Tb927.4.5450,1783.5,2975.0,3891.5,2869.0,347.0,variant surface glycoprotein  degenerate,S
Tb927.4.5460,612.5,158.5,210.0,687.0,461.5,variant surface glycoprotein (VSG)  putative,G2M
Tb927.4.5470,4667.5,1018.0,1324.0,1374.0,1636.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5480,8932.0,7079.5,5419.0,6779.5,5274.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.4.5490,1460.0,358.0,357.5,557.5,761.5,variant surface glycoprotein  fragment  degenerate,<2C (LG1)
Tb927.4.5500,6141.0,3050.5,3767.5,3205.5,3915.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5510,5542.0,6804.5,7098.0,6549.5,7840.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.4.5520,3979.5,5172.5,5875.5,6768.0,4597.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  degenerate,G2M
Tb927.4.5530,2180.0,2062.0,2164.5,2335.0,1227.0,variant surface glycoprotein (VSG)  putative,G2M
Tb927.4.5540,612.5,1520.0,893.0,1805.5,948.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.4.5550,9276.5,8183.5,8012.0,7264.0,7169.5,variant surface glycoprotein  fragment  degenerate,<2C (LG1)
Tb927.4.5560,2406.5,4111.5,3148.0,2725.0,5323.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.4.5570,8408.0,6073.0,6815.5,5873.0,5567.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5580,9531.5,2272.0,2389.0,2775.0,2834.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.4.5590,9963.5,6587.0,7644.0,7336.5,9149.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5600,3462.5,1018.0,2909.0,1779.5,3310.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5610,8073.0,5904.0,5953.5,5673.5,3235.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5620,4792.5,6512.5,5286.0,5445.5,6836.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.4.5630,612.5,130.0,271.5,313.5,347.0,variant surface glycoprotein  fragment  degenerate,<2C (LG1)
Tb927.4.5640,2137.5,2723.0,1909.5,2085.0,4306.0,variant surface glycoprotein  point mutation,>4C (GG2M)
Tb927.4.5650,1783.5,774.5,644.5,773.0,1120.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5660,2094.5,2851.5,3678.5,3605.5,3896.5,expression site-associated gene 3 (ESAG3)  degenerate,>4C (GG2M)
Tb927.4.5670,3283.5,4653.0,4807.5,5120.0,4036.5,variant surface glycoprotein  fragment,G2M
Tb927.4.5680,1460.0,999.0,1030.5,1391.5,672.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5690,2295.5,7549.0,7103.5,7245.0,4337.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.4.5700,4767.5,978.5,596.0,1110.5,2039.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.4.5710,612.5,3467.5,3475.0,4798.0,1281.5,variant surface glycoprotein  degenerate,G2M
Tb927.4.5720,2658.5,1437.5,1522.0,1441.0,2125.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5730,9978.0,5210.5,5759.5,5628.0,6690.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.4.5740,9675.0,6386.5,5129.0,6120.5,6289.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.4.5750,2658.5,1362.5,865.5,1031.0,1828.0,variant surface glycoprotein  fragment  degenerate,<2C (LG1)
Tb927.4.5760,2552.0,4111.5,4316.5,5273.5,2706.5,variant surface glycoprotein  degenerate,G2M
Tb927.4.5770,9916.0,4135.5,3514.5,3888.5,2153.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.4.5780,3810.5,3734.0,3475.0,3642.0,4212.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.4.5790,5225.0,5854.0,5350.5,6728.0,6028.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G2M
Tb927.4.5800,1460.0,1026.5,907.5,1097.5,895.5,variant surface glycoprotein  truncated,<2C (LG1)
Tb927.5.100,612.5,1009.0,668.5,862.0,213.0,expression site-associated gene 9 (ESAG9)  degenerate,G1
Tb927.5.110,3711.5,8491.0,7850.5,7617.5,7077.0,variant surface glycoprotein (VSG)-related  putative,G1
Tb927.5.120,612.5,4220.5,5007.0,4156.0,5379.5,expression site-associated gene 9 (ESAG9) protein  putative,>4C (GG2M)
Tb927.5.130,612.5,398.0,313.0,444.5,1239.0,variant surface glycoprotein (VSG)-related  putative,>4C (GG2M)
Tb927.5.140,1783.5,4574.0,4928.0,5295.5,3335.5,hypothetical protein  conserved,G2M
Tb927.5.150,6088.5,4859.5,5034.0,4808.0,5694.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.160,5955.0,3842.0,4398.0,4504.5,4276.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb927.5.170,6636.0,4481.0,4917.0,4193.5,4988.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.180,10989.0,10840.0,10876.5,10640.0,11018.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.190,3478.0,1101.5,1692.0,1299.0,1141.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.200,8004.5,5136.0,5469.5,5992.0,7716.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.210,1460.0,1124.5,1091.0,1416.5,1266.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.5.220,1914.0,3890.0,4148.5,3282.0,6164.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.230,1460.0,2444.5,1428.0,1936.0,2574.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.5.240,7926.5,4950.0,4823.0,5120.0,6679.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.250,2357.5,235.5,161.0,366.5,86.0,variant surface glycoprotein  fragment  degenerate,<2C (LG1)
Tb927.5.260,1460.0,640.0,357.5,464.0,397.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.5.270,8520.5,8336.5,8568.5,8602.5,4517.5,variant surface glycoprotein  interrupted,G2M
Tb927.5.280,10787.0,11307.0,11312.0,11162.0,11263.0,retrotransposon hot spot protein 3 (RHS3)  interrupted  degenerate,S
Tb927.5.290,7540.5,9334.0,9035.5,9313.0,8883.5,galactose kinase  degenerate,G1
Tb927.5.300,4134.0,4056.0,3633.5,3699.0,2254.0,thymine-7-hydroxylase  putative,<2C (LG1)
Tb927.5.310,7980.5,8985.5,9276.0,8985.0,8516.0,invariant surface glycoprotein  putative,S
Tb927.5.285b,10625.0,9831.0,9556.0,9340.5,9203.0,expression site associated gene (ESAG) 4 protein  putative,<2C (LG1)
Tb927.5.286b,8115.5,7503.0,6997.5,6969.0,5725.5,adenosine transporter 1,<2C (LG1)
Tb927.5.287b,612.5,3941.5,4010.5,3666.5,2525.0,galactokinase (pseudogene),S
Tb927.5.288b,9724.0,9367.5,9988.5,9378.0,10342.0,ribulose-phosphate 3-epimerase  putative,>4C (GG2M)
Tb927.5.289b,5678.0,2358.5,2598.5,2956.0,2834.5,hypothetical protein,<2C (LG1)
Tb927.5.291b,8808.0,6413.0,6929.5,5751.5,6804.0,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.5.292b,3241.5,4872.5,5070.5,4367.0,3431.5,hypothetical protein,S
Tb927.5.293b,9041.0,10637.0,10738.0,10456.5,10216.5,hypothetical protein,S
Tb927.5.294b,3734.0,4726.0,4607.0,4279.5,4306.0,hypothetical protein,G1
Tb927.5.295b,9294.5,7975.5,8902.0,8597.5,8151.0,retrotransposon hotspot (RHS) protein 1,<2C (LG1)
Tb927.5.296b,6803.5,8214.0,8606.0,8342.0,7918.5,hypothetical protein,S
Tb927.5.297b,11470.0,11579.0,11554.0,11564.0,11501.0,hypothetical protein,G1
Tb927.5.300b,7402.5,5221.5,4662.5,4754.5,3541.0,2-oxoglutarate (2OG) and Fe(II)-dependent oxygenase superfamily protein  putative,<2C (LG1)
Tb927.5.309b,3328.5,6255.5,6192.0,6525.0,5290.5,invariant surface glycoprotein  putative,G2M
Tb927.5.320,10878.5,9638.0,9050.5,9320.0,9161.5,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.5.330,11289.0,11198.0,11101.0,11143.5,10360.0,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.5.340,1460.0,1807.0,2839.0,2150.0,4244.5,expression site-associated gene 5 (ESAG5) protein  putative,>4C (GG2M)
Tb927.5.350,8534.5,9740.0,9854.0,10057.0,9395.0,75 kDa invariant surface glycoprotein  putative,G2M
Tb927.5.360,8007.0,8547.0,9095.5,9081.5,8367.0,75 kDa invariant surface glycoprotein,S
Tb927.5.370,3645.5,2801.5,3101.5,3075.0,1010.0,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb927.5.380,10076.0,5421.5,5164.0,5419.5,4813.5,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb927.5.390,10184.5,9450.5,8953.0,8822.5,8428.5,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb927.5.400,6689.0,8959.0,9520.0,9503.0,8955.0,75 kDa invariant surface glycoprotein  putative,S
Tb927.5.410,8500.5,8011.0,7953.5,8454.0,7442.5,invariant surface glycoprotein  putative,<2C (LG1)
Tb927.5.420,5336.5,4531.5,5670.5,5551.0,6016.5,invariant surface glycoprotein  putative,>4C (GG2M)
Tb927.5.430,5643.5,5121.0,5315.0,4137.0,5880.0,invariant surface glycoprotein  putative,>4C (GG2M)
Tb927.5.440,8976.0,7615.0,7782.0,7441.5,6439.5,trans-sialidase  putative,<2C (LG1)
Tb927.5.445,612.5,130.0,40.0,33.5,213.0,tRNA Arginine,<2C (LG1)
Tb927.5.450,3543.0,7252.5,6712.5,6297.0,8334.5,NADH dehydrogenase [ubiquinone] flavoprotein 1  mitochondrial,>4C (GG2M)
Tb927.5.460,1460.0,458.5,448.0,577.5,1141.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.470,5262.5,5650.5,6609.5,6348.0,6066.5,riboflavin transporter,S
Tb927.5.480,3630.5,2723.0,2122.5,3087.5,2805.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.490,10246.5,10630.0,10378.5,10277.0,9772.5,methyltransferase  putative,G1
Tb927.5.500,10118.5,9492.5,9691.0,9340.5,8744.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.510,6572.0,8013.0,7831.0,7757.0,7816.0,putative succinate dehydrogenase subunit,G1
Tb927.5.520,11051.0,9540.0,9524.0,9423.5,9188.5,stomatin-like protein  putative,<2C (LG1)
Tb927.5.530,9283.5,9651.0,9820.0,9357.0,10393.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.540,4346.0,5017.0,5298.0,4951.0,4626.5,hypothetical protein,S
Tb927.5.550,9699.0,9118.0,8591.5,8715.0,8502.5,V-type proton ATPase subunit D  putative,<2C (LG1)
Tb927.5.560,6698.5,8536.5,8896.0,7586.5,5963.0,hypothetical protein  conserved,S
Tb927.5.570,8827.5,10287.0,11053.0,11402.0,11640.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.580,5989.0,3457.0,5345.0,6612.5,11445.0,prefoldin subunit  putative,>4C (GG2M)
Tb927.5.590,8981.5,5585.0,4977.5,7236.0,9650.0,protein phosphatase 1  regulatory subunit  putative,>4C (GG2M)
Tb927.5.600,612.5,1087.5,1361.0,1352.5,1078.0,hypothetical protein  conserved,S
Tb927.5.610,11719.0,11717.0,11718.0,11717.0,11718.0,acidic phosphatase  putative,<2C (LG1)
Tb5.NT.17,5709.5,4711.5,5153.5,4940.5,5470.5,Noncoding RNA  putative,<2C (LG1)
Tb927.5.620,1988.0,1520.0,2134.0,2671.0,3541.0,invariant surface glycoprotein  putative,>4C (GG2M)
Tb927.5.630,9495.0,7451.5,6997.5,8379.0,4988.5,acidic phosphatase  putative,<2C (LG1)
Tb927.5.640,11002.5,11143.0,11014.5,11104.0,10693.0,trans-sialidase  putative,G1
Tb927.5.650,7304.0,11173.5,11279.5,11127.0,10222.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.5.660,4375.0,7554.5,7634.5,8319.0,9548.5,Trypanosomal VSG domain containing protein  putative,>4C (GG2M)
Tb05.30F7.410,10396.0,10225.5,9996.0,10016.5,9039.5,hypothetical protein,<2C (LG1)
Tb927.5.670,4480.0,6115.0,5286.0,7268.5,5640.0,hypothetical protein  conserved,G2M
Tb927.5.680,2258.5,5757.0,7076.5,6515.5,6649.0,hypothetical protein  conserved,S
Tb927.5.690,2436.0,7939.0,7718.5,8061.0,7770.5,MICOS complex subunit MIC17,G2M
Tb927.5.700,6858.5,9883.0,9197.5,8809.5,8624.5,F-box-like  putative,G1
Tb927.5.710,10991.0,8818.5,8368.0,9052.5,5943.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.720,1988.0,6260.0,6114.0,6138.0,6048.5,hypothetical protein,G1
Tb927.5.730,3013.5,6636.5,7601.0,6452.5,6649.0,hypothetical protein,S
Tb927.5.740,8274.5,6754.0,7601.0,6755.5,6307.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.750,612.5,3023.5,3205.5,3356.0,2153.5,hypothetical protein  conserved,G2M
Tb927.5.760,9996.5,11397.5,11263.0,11446.5,11172.0,Cell cycle sequence binding phosphoprotein  putative,G2M
Tb927.5.770,10428.5,10070.0,10121.5,10032.5,6607.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.780,1988.0,8342.5,8332.5,8465.5,7890.5,hypothetical protein  conserved,G2M
Tb927.5.790,5643.5,5689.0,5625.0,7093.5,7055.0,casein kinase I isoform 1,G2M
Tb927.5.800,4104.0,4305.0,4334.5,4918.5,8132.0,casein kinase I  isoform 2,>4C (GG2M)
Tb927.5.810,3680.5,5196.0,3609.0,3837.0,5470.5,zinc finger CCCH domain containing protein 11,>4C (GG2M)
Tb927.5.820,8278.0,4913.5,3658.5,4394.5,4813.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.830,9128.5,9722.0,9339.0,9866.5,10177.5,Tripartite attachment complex protein 65,>4C (GG2M)
Tb927.5.840,9645.0,6772.0,6417.0,7220.0,8679.5,Nucleolar protein 111,<2C (LG1)
Tb927.5.850,7929.5,8581.5,8335.5,7469.0,9214.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.860,6014.5,9296.5,9142.0,8848.5,8643.0,Selenoprotein T  putative,G1
Tb927.5.890,9563.0,8417.0,8075.5,8663.0,8383.5,oligosaccharyl transferase subunit  putative,<2C (LG1)
Tb927.5.900,9086.5,8093.5,8463.0,8573.5,8618.5,oligosaccharyl transferase subunit  putative,<2C (LG1)
Tb927.5.910,11200.0,10283.0,10408.0,10222.5,10039.0,oligosaccharyl transferase subunit  putative,<2C (LG1)
Tb927.5.920,1783.5,7785.5,7399.0,7864.5,8522.5,rhodanese-like domain containing protein  putative,>4C (GG2M)
Tb927.5.930,6339.0,9266.0,10030.5,9959.0,9763.0,NADH-dependent fumarate reductase,S
Tb927.5.940,7405.5,8201.0,9286.5,8245.0,8093.5,NADH-dependent fumarate reductase  putative,S
Tb927.5.950,2329.5,3344.5,3452.0,3142.0,3413.5,monothiol glutaredoxin  putative,S
Tb927.5.960,3895.5,4950.0,4917.0,5782.0,3794.0,atpase family aaa domain-containing protein 1,G2M
Tb927.5.970,7023.5,6397.0,8019.0,7710.0,7290.0,class I transcription factor A  subunit 6,S
Tb927.5.980,11407.0,8792.5,7909.5,8313.0,6788.0,2OG-Fe(II) oxygenase superfamily  putative,<2C (LG1)
Tb927.5.990,612.5,1303.5,507.0,483.0,818.0,hypothetical protein  conserved,G1
Tb927.5.1000,1783.5,1068.5,3039.5,2919.0,9595.0,ubiquitin-conjugating enzyme E2  putative,>4C (GG2M)
Tb927.5.1010,10015.5,10391.0,10619.0,10589.0,11199.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.1020,1783.5,6329.5,7061.5,7535.0,7775.0,disulfide isomerase  putative,>4C (GG2M)
Tb927.5.1030,612.5,3187.0,2961.0,3075.0,4597.5,Iron-sulfur assembly protein 2,>4C (GG2M)
Tb927.5.1040,3380.0,1789.5,865.5,1542.0,853.0,hypothetical protein,<2C (LG1)
Tb927.5.1050,6198.5,8183.5,8324.5,8541.0,7484.5,hypothetical protein,G2M
Tb927.5.1060,7834.5,9211.0,9440.0,9370.5,10474.5,mitochondrial processing peptidase  beta subunit  putative,>4C (GG2M)
Tb927.5.1070,10912.0,10208.0,8983.5,9238.0,9496.0,OTU-like cysteine protease  putative,<2C (LG1)
Tb927.5.1080,1460.0,158.5,448.0,464.0,347.0,RNA-binding protein  putative,<2C (LG1)
Tb927.5.1090,10865.0,6007.0,6368.5,5850.0,6270.0,threonyl-tRNA synthetase  putative,<2C (LG1)
Tb927.5.1100,1783.5,4693.0,3801.5,4174.5,5735.0,peroxisome targeting signal 1 receptor,>4C (GG2M)
Tb927.5.1110,2795.5,1886.0,1909.5,1187.5,853.0,60S ribosomal protein L8  putative,<2C (LG1)
Tb927.5.1120,11708.0,11710.0,11708.0,11710.0,11699.0,Phage tail fibre repeat  putative,G1
Tb927.5.1130,9560.0,7736.5,7253.5,7434.0,7631.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1140,11202.0,10703.0,10759.5,10687.5,10207.0,choline/ethanolamine kinase,<2C (LG1)
Tb927.5.1145,8860.5,8322.5,8701.0,10294.0,7770.5,hypothetical protein,G2M
Tb927.5.1150,9134.0,6488.0,8081.5,6205.5,8466.5,RNA helicase Prp43,<2C (LG1)
Tb927.5.1160,5960.5,4540.5,4224.5,5004.5,3248.5,Degradation arginine-rich protein for mis-folding  putative,<2C (LG1)
Tb5.NT.35,10206.0,6922.5,6678.0,7925.5,3465.5,Noncoding RNA  putative,<2C (LG1)
Tb927.5.1170,3875.5,3476.5,3179.5,3282.0,1266.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1180,9835.5,10100.5,9846.5,9572.0,8230.0,hypothetical protein  conserved,G1
Tb927.5.1200,4153.0,4778.5,6200.0,4882.0,4928.5,exosome complex component CSL4,S
Tb927.5.1210,2137.5,5775.5,6788.5,6267.5,7573.0,short-chain dehydrogenase  putative,>4C (GG2M)
Tb927.5.1220,1988.0,3273.5,2369.0,2629.5,3248.5,hypothetical protein  conserved,G1
Tb927.5.1230,5902.5,5789.5,5077.0,5908.5,9957.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.1240,8128.5,5349.5,5848.5,4027.5,3994.5,LicD family  putative,<2C (LG1)
Tb927.5.1250,1460.0,8433.5,8815.5,8752.5,10037.0,GAF domain/TIP41-like family  putative,>4C (GG2M)
Tb927.5.1260,8667.0,7270.0,8038.5,8259.5,9491.5,Sulfate transporter N-terminal domain with GLY motif/Sulfate transporter family  putative,>4C (GG2M)
Tb927.5.1270,11124.0,8667.0,8536.5,9593.0,9467.0,Acidic leucine-rich nuclear phosphoprotein 32 family member,<2C (LG1)
Tb927.5.1280,10431.0,5568.0,5526.0,5850.0,7092.0,alanine racemase  putative,<2C (LG1)
Tb927.5.1290,8438.0,7847.5,8000.5,7925.5,7342.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1300,3510.0,9394.5,10011.0,9420.5,8129.0,V-type proton ATPase subunit a  putative,S
Tb927.5.1310,10454.0,8443.0,8472.5,9627.0,8826.5,protoheme IX farnesyltransferase  putative,<2C (LG1)
Tb927.5.1320,2460.0,7763.5,8066.5,8029.0,4822.5,Kinetochore interacting protein 2,S
Tb927.5.1330,11140.0,10314.0,9832.5,10493.0,9803.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1340,2637.5,5625.5,4740.5,4686.5,3399.5,pre-mRNA splicing factor  putative,G1
Tb927.5.1350,5450.0,6636.5,7269.0,8663.0,6820.0,hypothetical protein  conserved,G2M
Tb927.5.1360,10116.0,8066.0,8219.5,7605.5,8845.0,nucleoside 2-deoxyribosyltransferase,<2C (LG1)
Tb927.5.1370,2258.5,5221.5,5044.5,5765.5,5135.5,peptidyl-prolyl cis-trans isomerase  putative,G2M
Tb927.5.1380,2094.5,2198.0,2060.5,1688.5,1676.0,hypothetical protein,G1
Tb927.5.1390,3370.5,4227.0,4529.5,3605.5,2609.5,64 kDa invariant surface glycoprotein,S
Tb927.5.1400,4691.0,3390.0,2638.5,3677.0,2758.5,hypothetical protein,<2C (LG1)
Tb927.5.1410,5270.0,8003.5,6513.5,7586.5,4915.5,64 kDa invariant surface glycoprotein,G1
Tb927.5.1420,7413.5,6023.5,4977.5,6077.0,4266.0,hypothetical protein,<2C (LG1)
Tb927.5.1430,7206.0,6466.5,5744.0,5949.0,3970.0,64 kDa invariant surface glycoprotein,<2C (LG1)
Tb927.5.1440,9561.0,8583.5,7061.5,8250.0,7023.0,hypothetical protein,<2C (LG1)
Tb927.5.1450,8542.5,9463.0,9581.5,8645.0,7885.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.5.1460,1783.5,6480.5,6879.0,7132.0,8513.0,Possible lysine decarboxylase  putative,>4C (GG2M)
Tb927.5.1470,10266.0,9179.5,8587.0,9566.5,8754.0,NADH-cytochrome b5 reductase  putative,<2C (LG1)
Tb927.5.1480,3078.5,6272.5,6480.0,6205.5,5394.5,hypothetical protein,S
Tb927.5.1490,8998.0,7343.5,7404.5,7859.5,6519.0,Eukaryotic translation initiation factor 4 gamma 1,<2C (LG1)
Tb927.5.1500,8652.5,4373.5,4550.5,5317.0,3524.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1510,3957.5,2839.5,3108.5,3130.0,4938.0,Mitochondrial SSU ribosomal protein  putative,>4C (GG2M)
Tb927.5.1520,2840.5,7943.5,9449.5,8900.0,8449.0,ATP-dependent protease ATPase subunit HslU1,S
Tb927.5.1530,9514.0,7642.0,7861.0,7065.0,6511.5,Flavin-binding monooxygenase-like  putative,<2C (LG1)
Tb927.5.1540,5086.5,8208.0,9227.0,8816.0,8973.0,hypothetical protein  conserved,S
Tb927.5.1550,4170.0,7041.5,7634.5,6407.5,5854.0,mitochondrial carrier protein,S
Tb927.5.1560,10869.0,10221.0,9816.5,10445.5,10439.0,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb927.5.1570,10241.0,8073.0,6780.0,7474.0,7821.0,zinc finger CCCH domain containing protein 12,<2C (LG1)
Tb927.5.1580,10320.0,11466.0,11357.0,11409.5,11362.0,zinc finger CCCH domain containing protein 13,G1
Tb927.5.1590,3252.5,1789.5,2577.0,2858.5,1896.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1600,6080.5,5847.0,7165.0,6441.0,6439.5,hypothetical protein  conserved,S
Tb927.5.1610,1460.0,565.0,966.5,419.0,213.0,60S ribosomal protein L13a  putative,<2C (LG1)
Tb927.5.1620,5270.0,3561.5,3009.0,3815.5,2706.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1630,5036.5,4642.5,5182.0,4636.5,4145.0,hypothetical protein  conserved,S
Tb927.5.1640,5546.0,6019.0,6744.5,6147.0,5978.5,hypothetical protein  conserved,S
Tb927.5.1650,8932.0,9153.0,9255.0,8475.0,8810.5,CMGC/DYRK protein kinase  putative,S
Tb927.5.1660,8676.0,9007.0,9438.5,9313.0,8651.0,pyruvate dehydrogenase phosphatase  putative,S
Tb927.5.1670,2047.0,1143.0,2839.0,2102.5,2203.5,hypothetical protein  conserved,S
Tb927.5.1680,3524.0,11493.0,11472.0,11437.0,11495.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.1690,4282.0,6058.0,4868.0,4355.5,11534.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.1700,3341.5,1034.0,954.0,1243.0,505.0,replication Factor A 28 kDa subunit  putative,<2C (LG1)
Tb927.5.1710,4834.5,2358.5,2488.5,2735.0,3474.5,ATP synthase F(0) complex subunit B  mitochondrial  putative,<2C (LG1)
Tb927.5.1720,1783.5,7162.0,6352.5,7144.0,6924.0,hypothetical protein  conserved,G1
Tb927.5.1730,3856.5,7199.5,7143.0,6859.0,7038.0,Ecotin-like protein,G1
Tb927.5.1740,5981.0,6229.5,6028.0,7009.0,5988.0,hypothetical protein,G2M
Tb927.5.1750,2481.0,4567.5,5034.0,2686.0,5487.5,conserved protein  unknown function,>4C (GG2M)
Tb927.5.1760,9573.5,10389.5,10581.0,10580.0,10605.5,Isoprenylcysteine alpha-carbonyl methylesterase  putative,>4C (GG2M)
Tb927.5.1770,9533.5,9012.0,8290.5,8224.5,6764.0,RNA pseudouridylate synthase  putative,<2C (LG1)
Tb927.5.1780,10892.5,10879.5,11068.0,11140.0,9692.0,hypothetical protein  conserved,G2M
Tb927.5.1790,3456.5,9867.5,10079.0,9328.0,9188.5,Mitochondrial SSU ribosomal protein  putative,S
Tb927.5.1800,1783.5,6391.5,5577.5,6157.0,4355.0,hypothetical protein  conserved,G1
Tb927.5.1810,10641.0,11519.0,11605.0,11545.0,11547.0,lysosomal/endosomal membrane protein p67,S
Tb927.5.1820,3606.0,2118.0,1603.5,1875.5,1984.0,60S acidic ribosomal protein  putative,<2C (LG1)
Tb927.5.1830,9855.5,11353.0,11517.0,11393.0,11286.0,lysosomal/endosomal membrane protein p67,S
Tb927.5.1840,3630.5,5561.5,4848.5,4512.5,5657.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.1850,11048.0,11544.0,11561.0,11479.5,11207.0,hypothetical protein  conserved,S
Tb927.5.1860,5915.0,8459.0,8510.0,8342.0,8000.0,hypothetical protein  conserved,S
Tb927.5.1870,8917.0,9658.5,9649.5,8806.5,6780.0,Fidgetin  putative,G1
Tb927.5.1880,3487.0,1362.5,1254.0,1950.5,1392.5,inhibitor of serine peptidase (ISP)  putative,<2C (LG1)
Tb927.5.1890,11039.0,10127.5,10389.5,10342.0,10149.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1900,1914.0,5680.0,3920.5,6331.5,11089.0,Outer dynein arm docking complex protein 1  putative,>4C (GG2M)
Tb927.5.1910,5133.0,9836.5,9843.0,8589.5,7685.0,hypothetical protein  conserved,S
Tb927.5.1920,2329.5,4441.0,6504.5,4782.0,5054.0,hypothetical protein  conserved,S
Tb927.5.1930,612.5,3298.5,2876.5,3677.0,3861.0,signal peptidase subunit  putative,>4C (GG2M)
Tb927.5.1940,1460.0,1553.5,1977.0,2686.0,433.0,hypothetical protein  conserved,G2M
Tb927.5.1950,11549.0,11196.5,11294.0,11332.0,11060.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.1960,3456.5,2679.0,3668.5,3408.0,4292.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.1970,3120.5,2741.5,2075.5,2237.0,1472.0,hypothetical protein,<2C (LG1)
Tb927.5.1980,11100.0,7989.0,7526.5,7776.5,7377.0,Galactose oxidase  central domain/Kelch motif containing protein  putative,<2C (LG1)
Tb927.5.1990,6677.0,5280.5,5229.5,5004.5,4292.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2000,8905.5,7237.5,7023.5,6946.0,6764.0,hypothetical protein,<2C (LG1)
Tb927.5.2010,2137.5,4348.5,2465.5,3477.5,4533.5,hypothetical protein,>4C (GG2M)
Tb5.NT.46,1460.0,192.5,161.0,82.5,1266.0,Noncoding RNA  putative,<2C (LG1)
Tb927.5.2020,11591.0,11508.0,11545.0,11485.0,11429.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2030,8911.0,7500.5,7983.0,7034.0,4451.0,hypothetical protein  conserved,<2C (LG1)
Tb927_05_v4.snoRNA.0001,7227.5,3672.0,3891.5,4433.0,2647.0,C/D snoRNA,<2C (LG1)
Tb927.5.2040,4776.0,2526.0,3033.5,1875.5,6729.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.2050,1460.0,3374.0,4085.5,3013.0,2589.5,Putative methyltransferase  putative,S
Tb927.5.2060,10339.0,9762.0,9083.5,8997.0,9291.0,Cell division cycle 5-like protein,<2C (LG1)
Tb927.5.2070,9948.0,9646.5,9769.5,9550.0,10387.0,LSU ribosomal protein  mitochondrial  putative,>4C (GG2M)
Tb927.5.2080,4674.5,8011.0,8529.5,8155.0,9616.5,GMP reductase,>4C (GG2M)
Tb927.5.2090,8337.0,9916.0,10367.5,9533.0,11689.0,kinesin  putative,>4C (GG2M)
Tb927.5.2100,7063.0,6265.5,8054.5,6790.5,6547.5,RNA-binding protein  putative,S
Tb927.5.2110,612.5,5513.5,5808.0,5517.5,1878.0,G-patch domain containing protein  putative,S
Tb927.5.2120,7863.0,9372.5,9004.5,8656.5,8585.5,hypothetical protein  conserved,G1
Tb927.5.2130,6733.0,7685.0,7861.0,7448.0,7147.0,Lariat debranching enzyme  C-terminal domain containing protein  putative,S
Tb927.5.2140,9830.0,9411.5,9596.0,9357.0,5290.5,regulator of nonsense transcripts 1,<2C (LG1)
Tb927.5.2150,5673.0,6466.5,6678.0,7016.0,2834.5,hypothetical protein  conserved,G2M
Tb927.5.2160,5756.5,6205.5,7002.5,6790.5,5442.5,conserved protein,S
Tb927.5.2170,4784.0,2296.0,2858.0,2830.5,2164.5,conserved protein,<2C (LG1)
Tb927.5.2180,10222.5,9425.5,8756.0,8783.0,9957.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2190,10260.5,7331.5,5856.5,5628.0,7670.0,META domain/Domain of unknown function (DUF1935)  putative,<2C (LG1)
Tb927.5.2200,4940.0,2964.5,3410.0,2577.5,2773.0,META domain containing protein  putative,<2C (LG1)
Tb927.5.2210,10276.5,9214.0,8273.0,8573.5,9412.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2220,10426.5,7839.0,6172.5,6357.5,7800.0,META domain/Domain of unknown function (DUF1935)  putative,<2C (LG1)
Tb927.5.2230,4989.5,3086.5,3531.0,2494.5,2661.5,conserved protein,<2C (LG1)
Tb927.5.2240,10238.0,9036.5,8596.0,8479.5,9325.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2250,10423.0,7676.5,6328.0,6157.0,7602.0,META domain/Domain of unknown function (DUF1935)  putative,<2C (LG1)
Tb927.5.2260,5048.0,3916.0,4148.5,4567.5,4051.0,conserved protein,<2C (LG1)
Tb927.5.2270,2970.5,1492.5,1909.5,2184.5,2898.5,Component of motile flagella 44,<2C (LG1)
Tb927.5.2280,5973.5,6605.5,7076.5,7441.5,7545.5,acetyltransferase  putative,>4C (GG2M)
Tb927.5.2290,6811.0,9742.5,9545.0,9660.0,10770.0,ATP-dependent RNA helicase  putative,>4C (GG2M)
Tb927.5.2300,10693.0,9168.5,9020.0,8334.0,7988.0,formin  putative,<2C (LG1)
Tb927.5.2310,5582.0,8270.0,6322.0,7525.5,7890.5,Phosphorylated CTD interacting factor 1 WW domain containing protein  putative,G1
Tb927.5.2320,2180.0,9713.0,8655.5,8863.5,6938.5,Mak10 subunit  NatC N(alpha)-terminal acetyltransferase  putative,G1
Tb927.5.2325,5908.0,5305.5,4559.5,4381.0,4586.5,hypothetical protein,<2C (LG1)
Tb927.5.2330,11686.0,11624.0,11497.0,11197.5,11065.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2340,9766.0,9757.5,9617.5,9177.5,5624.0,hypothetical protein  conserved,<2C (LG1)
Tb927_05_v4.snoRNA.0003,1783.5,867.5,954.0,1154.5,874.5,C/D snoRNA,<2C (LG1)
Tb927_05_v4.snoRNA.0002,1460.0,2479.0,2300.0,3343.0,2050.0,C/D snoRNA,G2M
Tb927.5.2350,1460.0,6154.5,7490.0,6694.0,3185.0,glycosyltransferase (GlcNAc)  putative,S
Tb927.5.2360,9166.0,7290.5,8318.5,8150.5,9254.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.2370,612.5,6897.0,7193.0,6549.5,7334.5,hydrolase  alpha/beta fold family  putative,>4C (GG2M)
Tb927.5.2380,3429.0,1904.5,2011.5,2801.0,3365.0,hydrolase  alpha/beta fold family  putative,<2C (LG1)
Tb927.5.2390,2619.0,927.5,1067.0,1228.0,2029.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2400,11693.0,11541.0,11485.0,11450.0,11388.0,Peptidase C19  ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb927.5.2410,8450.5,9327.5,10003.0,11155.5,11687.0,kinesin  putative,>4C (GG2M)
Tb927.5.2420,3487.0,5625.5,5930.5,6728.0,3906.0,NOL1/NOP2/sun family  putative,G2M
Tb5.NT.60,2221.0,1773.5,1757.0,2038.5,2442.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.5.2430,9190.0,10305.5,9966.0,10321.0,9876.5,membrane transporter protein  putative,G2M
Tb5.NT.61,6233.5,6229.5,5625.0,6859.0,6270.0,Noncoding RNA  putative,G2M
Tb927.5.2440,5944.5,8674.0,8653.5,9829.0,9515.5,Centrosomal protein of 164 kDa  putative,G2M
Tb927.5.2450,11047.0,11123.0,11070.0,11086.5,10611.0,5'-3' exoribonuclease B  putative (pseudogene),G1
Tb927.5.2460,6750.0,8658.5,8034.0,8515.5,5463.0,hypothetical protein  conserved,G1
Tb927.5.2470,5799.0,9311.0,9730.0,9715.0,8918.5,hypothetical protein  conserved,S
Tb927.5.2480,2574.5,6132.0,5848.5,4567.5,5624.0,hypothetical protein  conserved,G1
Tb927.5.2490,9222.5,9078.5,9471.5,8858.5,9511.5,hypothetical protein  conserved  frameshift,>4C (GG2M)
Tb927.5.2500,10128.0,9965.5,8921.0,9390.5,9830.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2510,11223.0,10001.5,9709.5,9606.0,9208.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2520,6572.0,9100.5,7510.0,8036.0,9099.5,TPR repeat  putative,G1
Tb927.5.2530,8835.5,11146.0,11275.0,11168.0,10931.0,RNA cytidine acetyltransferase,S
Tb927.5.2540,3202.0,4348.5,3920.5,4686.5,4365.0,Organic solute transport protein 1  putative,G2M
Tb927.5.2550,1783.5,5008.5,5077.0,5215.5,3879.0,hypothetical protein  conserved,G2M
Tb927.5.2560,1460.0,530.0,808.5,273.5,347.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2570,612.5,2178.5,2103.5,3241.5,2141.5,eukaryotic translation initiation factor 3 subunit b,G2M
Tb927.5.2580,2956.5,4937.5,4568.5,3343.0,3648.5,hypothetical protein  conserved,G1
Tb927.5.2590,9377.0,4008.0,3697.0,3588.0,5003.0,Macro domain containing protein  putative,<2C (LG1)
Tb927.5.2600,10444.0,9767.5,9246.0,9507.0,8615.0,methyltransferase domain containing protein  putative,<2C (LG1)
Tb927.5.2610,6291.5,4895.5,4653.0,3616.5,2953.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2620,7690.5,9087.0,9423.0,9396.0,8401.0,hypothetical protein  conserved,S
Tb927.5.2630,6441.5,4450.0,3275.0,3837.0,4508.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2640,5167.5,1866.5,1254.0,1363.5,2495.0,nicotinamide/nicotinic acid mononucleotide adenylyltransferase,<2C (LG1)
Tb927.5.2650,7937.5,9007.0,8898.5,9304.5,8754.0,L-galactonolactone oxidase,G2M
Tb927.5.2660,9445.0,9393.0,10370.0,10174.0,9131.0,NUC130/3NT domain/SDA1  putative,S
Tb927.5.2670,6858.5,3041.5,1989.5,1403.5,2442.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2680,9455.5,8724.5,9685.0,9559.0,8471.0,hypothetical protein  conserved,S
Tb927.5.2690,6004.0,5967.0,7433.0,5561.5,6575.5,inositol-1(or 4)-monophosphatase 1  putative,S
Tb927.5.2700,4397.0,4733.5,4848.5,3596.5,3055.0,otubain cysteine peptidase  Clan CA  family C65  putative,S
Tb927.5.2710,10585.0,9667.5,8179.5,9319.0,9847.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2720,7396.5,6170.0,4398.0,4908.0,6328.0,zinc finger protein ZPR1,<2C (LG1)
Tb927.5.2730,8170.5,5309.0,6010.0,6366.5,6570.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2740,7490.5,5057.5,2750.5,4290.5,3353.0,Rab-GTPase-TBC domain containing protein  putative,<2C (LG1)
Tb927.5.2750,7080.5,6244.5,7143.0,6282.0,6059.0,Alpha/beta hydrolase family  putative,S
Tb927.5.2760,9195.5,5854.0,4304.0,4579.0,3465.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb927.5.2765,2295.5,2741.5,2750.5,2541.0,2525.0,tRNA Glutamic acid,S
Tb927.5.2770,1914.0,3109.0,2902.0,1713.0,3748.5,SET domain containing protein  putative,>4C (GG2M)
Tb927.5.2780,6973.0,5506.0,6044.5,6374.0,1772.5,mitochondrial DNA polymerase beta,<2C (LG1)
Tb927.5.2790,10232.0,6380.0,8113.0,6809.0,7861.0,mitochondrial DNA polymerase beta-PAK,<2C (LG1)
Tb927.5.2800,11282.0,11345.0,11298.0,11220.5,11039.5,Beta-lactamase superfamily domain containing protein  putative,G1
Tb927.5.2810,4826.0,6176.0,7873.0,7465.0,6890.0,hypothetical protein  conserved,S
Tb927.5.2820,10530.0,10501.0,10665.5,11035.5,10682.5,Serine/threonine-protein kinase NEK6  putative,G2M
Tb927.5.2830,612.5,999.0,893.0,1017.0,2231.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.2840,8431.0,2376.0,2226.5,1792.5,461.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2850,8066.5,3967.5,3994.5,4355.5,11113.0,radial spoke protein RSP2  putative,>4C (GG2M)
Tb927.5.2860,9704.5,7143.0,8368.0,8293.0,7913.5,Protein of unknown function (DUF2453)  putative,<2C (LG1)
Tb927.5.2870,7297.0,5077.5,5120.0,5240.0,8499.5,hypothetical protein,>4C (GG2M)
Tb927.5.2880,612.5,484.0,795.0,557.5,895.5,chaperone protein DnaJ  putative,>4C (GG2M)
Tb927.5.2890,11442.5,11606.0,11598.0,11590.0,11505.0,AAA domain (dynein-related subfamily)/von Willebrand factor type A domain containing protein  putative,G1
Tb927.5.2900,7868.0,9554.0,9092.0,9149.5,8530.0,histone deacetylase 4,G1
Tb5.NT.67,5148.5,5287.0,5551.5,6501.0,5348.0,Noncoding RNA  putative,G2M
Tb927.5.2910,5756.5,4008.0,3379.0,5031.5,2203.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.2920,5751.0,5008.5,5239.0,5551.0,4377.5,Ring finger domain containing protein  putative,<2C (LG1)
Tb927.5.2930,3502.5,3284.0,3877.5,4476.0,2110.0,Mitochondrial ATP synthase subunit  putative,G2M
Tb927.5.2940,1460.0,1945.5,1192.0,1654.0,2914.5,stress-induced protein sti1  putative,>4C (GG2M)
Tb927.5.2950,10733.0,11065.5,11070.0,11080.0,10608.0,Component of motile flagella 3,G2M
Tb927.5.2960,10437.5,9202.0,8420.5,8602.5,6455.5,phosphoribosylpyrophosphate synthetase  putative,<2C (LG1)
Tb927.5.2970,8105.0,9781.5,9554.0,8529.5,10224.0,suppressive immunomodulating factor,>4C (GG2M)
Tb927.5.2980,6649.0,10826.5,10752.0,10792.0,10617.0,Exocyst complex component Sec3  putative,G1
Tb927.5.2990,6202.5,3336.0,4462.5,3826.0,2178.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3000,5195.0,2319.0,3354.5,3616.5,3716.5,Thiopurine S-methyltransferase (TPMT)  putative,<2C (LG1)
Tb927.5.3010,612.5,2062.0,2410.5,1779.5,4199.0,Guide RNA binding complex protein 6,>4C (GG2M)
Tb927.5.3020,8547.0,6359.0,4887.0,4981.0,5675.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3030,3394.0,7726.5,8484.5,8935.0,11520.5,Intraflagellar transport protein 121,>4C (GG2M)
Tb927.5.3040,3945.0,652.5,668.5,907.5,531.0,MIX protein,<2C (LG1)
Tb927.5.3050,9377.0,8470.5,9279.0,8913.5,8968.5,poly(adp-ribose) polymerase,<2C (LG1)
Tb927.5.3060,1460.0,2851.5,2717.5,3513.0,3100.5,hypothetical protein  conserved,G2M
Tb927.5.3070,10371.0,10842.0,11130.5,10786.5,10527.5,Zinc finger  C3HC4 type (RING finger)  putative,S
Tb927.5.3080,6483.0,5579.0,4434.0,4476.0,5624.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3090,612.5,130.0,130.5,33.5,86.0,Mitochondrial ATP synthase subunit  putative,<2C (LG1)
Tb927.5.3100,10405.0,11162.5,11248.0,11357.0,10644.5,hypothetical protein,G2M
Tb927.5.3110,612.5,855.5,1091.0,875.0,933.5,Mitochondrial ribosomal protein L49,S
Tb927.5.3120,612.5,1940.0,1561.5,2311.0,744.5,eukaryotic translation initiation factor 2 beta subunit  putative,G2M
Tb927.5.3130,6658.0,8930.5,7844.5,7949.0,8727.5,hypothetical protein,G1
Tb927.5.3140,612.5,3050.5,5084.5,4908.0,6903.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.3150,10175.0,11271.0,11101.0,11100.0,10933.5,protein kinase   putative,G1
Tb927.5.3160,11280.0,11257.0,11307.0,11348.0,11215.0,CMGC/CLK family protein kinase  putative,G2M
Tb927.5.3170,8885.0,9958.5,9589.5,9740.5,9313.0,ribose-phosphate pyrophosphokinase  putative,G1
Tb927.5.3180,612.5,2335.0,2219.0,3241.5,2914.5,hypothetical protein  conserved,G2M
Tb927.5.3190,3680.5,1257.5,2164.5,2907.5,1896.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3200,6163.0,7399.5,6826.5,6774.5,7213.0,hypothetical protein  conserved,G1
Tb927.5.3210,5524.5,4145.5,4783.5,3699.0,4806.5,small ubiquitin-related modifier,<2C (LG1)
Tb927.5.3220,7324.0,4510.5,3813.0,3117.0,5725.5,signal peptidase type I  putative,<2C (LG1)
Tb927.5.3230,9849.5,10666.0,11119.0,11216.5,11142.0,hypothetical protein  conserved,G2M
Tb927.5.3240,5756.5,4420.5,4078.5,5799.5,5442.5,hypothetical protein  conserved,G2M
Tb927.5.3250,11009.0,10925.0,11089.0,10572.5,11042.5,hypothetical protein  conserved,S
Tb927.5.3260,9493.0,10863.0,10888.0,10241.0,10363.5,WD domain  G-beta repeat  putative,S
Tb927.5.3270,7115.0,10730.0,10857.0,10711.0,10060.5,Autophagy protein Apg6  putative,S
Tb5.NT.75,9908.0,6170.0,7227.5,6790.5,5988.0,Noncoding RNA  putative,<2C (LG1)
Tb927.5.3280,6004.0,7731.5,8318.5,7963.5,5499.0,Basal body protein,S
Tb927.5.3290,8835.5,10844.0,10792.5,10667.5,9957.0,Protein of unknown function  putative,G1
Tb927.5.3300,7148.0,5391.0,4632.5,3711.5,6557.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3310,5582.0,4761.5,4632.5,5407.5,6547.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.3320,11020.0,11193.0,11034.0,11362.0,11109.0,Pseudokinase  putative,G2M
Tb927.5.3330,11665.0,11650.0,11643.0,11650.0,11598.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3340,2637.5,652.5,373.5,483.0,2164.5,Mitochondrial import inner membrane translocase subunit 11,<2C (LG1)
Tb927.5.3350,2329.5,6408.0,7749.0,6989.0,5479.5,iron superoxide dismutase A  mitochondrial,S
Tb927.5.3360,10377.5,8942.0,9755.5,9775.5,7385.0,mitochondrial ribosomal protein L2,<2C (LG1)
Tb927.5.3370,612.5,6846.5,6678.0,6955.0,5888.5,hypothetical protein,G2M
Tb927.5.3380,612.5,3097.0,5015.0,4928.5,10890.0,ADG2  putative,>4C (GG2M)
Tb927.5.3390,4680.0,2887.5,2341.0,2928.0,2870.0,ADG1  pseudogene,<2C (LG1)
Tb927.5.3400,3875.5,10401.5,10178.0,10462.5,8719.5,calcium-translocating P-type ATPase,G2M
Tb927.5.3410,3191.0,2592.5,4977.5,3408.0,3169.5,Mitochondrial ribosomal protein L9,S
Tb927.5.3420,4834.5,2306.5,2876.5,2725.0,1162.5,ABC1 family  putative,<2C (LG1)
Tb927.5.3430,10659.0,10186.5,10130.0,10198.0,10655.0,ubiquitin-activating enzyme E1  putative,<2C (LG1)
Tb927.5.3440,5649.5,8803.0,9379.5,8952.0,7840.5,hypothetical protein  conserved,S
Tb927.5.3450,3996.0,5151.5,5229.5,5325.0,7753.0,eukaryotic translation initiation factor eIF2A  putative,>4C (GG2M)
Tb927.5.3460,8260.5,8850.5,8809.0,8892.5,10301.0,Flagellum attachment zone protein 16,>4C (GG2M)
Tb927.5.3470,3558.0,4886.5,3288.0,4496.5,3879.0,hypothetical protein  conserved,G1
Tb927.5.3480,4734.5,7351.0,6997.5,7344.0,6369.5,hypothetical protein  conserved,G1
Tb927.5.3490,3155.0,4456.0,4749.0,3909.0,2563.0,hypothetical protein  conserved,S
Tb927.5.3500,5330.0,8978.5,8752.5,9604.0,8303.5,SET domain containing protein  putative,G2M
Tb927.5.3510,9769.0,9770.0,9272.5,9454.0,8460.5,structural maintenance of chromosome 3   putative,G1
Tb927.5.3520,4122.5,2949.5,4010.5,2907.5,1099.0,queuine tRNA-ribosyltransferase  putative,<2C (LG1)
Tb927.5.3530,4965.0,6289.0,6485.5,7245.0,6392.5,hypothetical protein  conserved,G2M
Tb927.5.3540,5582.0,7766.0,8968.5,7264.0,4654.0,Meckelin (Transmembrane protein 67)  putative,S
Tb927.5.3550,9022.5,10457.5,11106.0,11290.0,10031.0,hypothetical protein  conserved,G2M
Tb927.5.3560,1460.0,3997.5,4057.0,5481.5,7826.5,vesicle-associated membrane protein  putative,>4C (GG2M)
Tb927.5.3570,10424.5,8714.0,7532.5,9270.5,9214.5,hypothetical protein  conserved,<2C (LG1)
Tb5.NT.81,612.5,2723.0,2275.0,2470.5,2203.5,Noncoding RNA  putative,G1
Tb927.5.3580,1460.0,4214.5,4117.0,4421.5,2977.5,phosphoglycerate mutase protein  putative,G2M
Tb927.5.3590,1988.0,5002.0,6159.0,4818.5,3970.0,Putative zinc finger motif  C2HC5-type/ASCH domain containing protein  putative,S
Tb927.5.3600,10186.0,11120.5,10871.0,10962.5,11371.0,ATP-dependent DEAD/H RNA helicase  putative,>4C (GG2M)
Tb927.5.3610,10751.0,10324.0,10411.0,10344.5,9149.0,adaptor complex protein (AP) 3 delta subunit 1  putative,<2C (LG1)
Tb927.5.3620,11066.0,10933.5,10614.0,11097.5,10112.0,kinetoplastid-specific dual specificity phosphatase  putative,G2M
Tb927.5.3630,1460.0,1653.5,3215.0,2840.5,2495.0,hypothetical protein  conserved,S
Tb927.5.3640,1460.0,1553.5,1311.0,875.0,86.0,Mitochondrial SSU ribosomal protein  putative,G1
Tb927.5.3650,8139.5,6255.5,5197.0,6098.5,4022.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3660,2767.0,5959.5,6288.0,6304.5,7936.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.3670,5809.5,9799.5,9953.0,10112.0,9173.5,DNA repair protein  putative,G2M
Tb927.5.3680,10723.0,8625.5,8892.5,9103.5,8952.0,GPI-GlcNAc transferase complex  PIG-H component  putative,<2C (LG1)
Tb927.5.3690,6874.5,4515.0,3551.5,5704.5,5585.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3700,6878.0,7079.5,6796.5,6690.0,7551.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.3710,8180.5,9651.0,9850.5,10119.0,9733.5,Inositol phosphosphingolipids phospholipase C,G2M
Tb927.5.3720,4190.5,2367.5,2453.0,2810.5,1878.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3730,3856.5,4745.0,4200.5,4852.5,6878.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.3740,612.5,2358.5,3138.0,2566.5,3431.5,RING-H2 zinc finger  putative,>4C (GG2M)
Tb927.5.3745,4364.5,6386.5,6624.0,5307.5,5354.0,ring-box protein  putative,S
Tb927.5.3750,5837.5,6449.5,6296.0,6414.0,3775.0,RNA-binding protein  putative,G1
Tb927.5.3760,2813.0,4127.0,4380.5,3463.5,4187.0,meiotic recombination protein SPO11  putative,S
Tb927.5.3770,5142.5,8803.0,9415.5,8515.5,8703.0,hypothetical protein  conserved,S
Tb927.5.3780,5876.5,1619.0,1489.0,1702.0,2786.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3790,8288.5,7373.0,8097.5,7099.5,7518.0,Tetraspanin family  putative,<2C (LG1)
Tb927.5.3800,9773.5,11100.0,10951.5,11078.5,11221.0,glutamine hydrolysing (not ammonia-dependent) carbomoyl phosphate synthase  putative,>4C (GG2M)
Tb927.5.3810,8113.5,3023.5,2036.0,2810.5,3939.5,orotidine-5-phosphate decarboxylase/orotate phosphoribosyltransferase  putative,<2C (LG1)
Tb927.5.3820,612.5,7839.0,8264.0,8460.0,4179.0,aspartate carbamoyltransferase  putative,G2M
Tb927.5.3830,7162.5,7036.0,7523.5,7441.5,7161.5,dihydroorotate dehydrogenase (fumarate),S
Tb927.5.3840,6710.0,9311.0,10211.0,9911.0,9811.5,hypothetical protein  conserved,S
Tb927.5.3850,6238.5,5463.0,4840.5,5398.5,5487.5,XRN 5'-3' exonuclease N-terminus  putative,<2C (LG1)
Tb927.5.3860,6528.0,10201.0,10156.0,10075.0,9840.0,tubulin tyrosine ligase  putative,G1
Tb927.5.3870,8473.5,8379.0,8825.5,9441.5,8445.0,LSU ribosomal protein  mitochondrial  putative,G2M
Tb927.5.3880,4354.0,6611.5,7433.0,7053.0,5174.5,hypothetical protein  conserved,S
Tb927.5.3890,3120.5,2772.5,2801.5,2869.0,2720.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.3895,7854.0,3849.0,3398.5,2775.0,4212.0,hypothetical protein,<2C (LG1)
Tb927.5.3900,1783.5,8365.5,8368.0,7204.5,9852.0,Galactose oxidase  central domain/Domain of unknown function (DUF4110)  putative,>4C (GG2M)
Tb927.5.3910,4339.5,4135.5,3475.0,1911.5,2495.0,small nuclear RNA-activating protein,<2C (LG1)
Tb927.5.3920,1460.0,9595.5,10070.5,9710.5,9889.0,Peroxisome biogenesis factor 6,S
Tb927.5.3930,7180.5,9829.5,9892.5,10069.0,10241.5,major facilitator superfamily  putative,>4C (GG2M)
Tb927.5.3940,9292.0,10142.5,10101.0,9831.0,9325.0,helicase  putative,G1
Tb927.5.3950,2481.0,5746.5,4493.5,3566.5,6385.5,2OG-Fe(II) oxygenase superfamily  putative,>4C (GG2M)
Tb927.5.3960,9259.5,7969.0,7027.5,7027.5,5634.5,arginine N-methyltransferase  type I,<2C (LG1)
Tb927.5.3970,5105.0,3922.5,2939.0,4097.0,6153.5,adenylate kinase  putative,>4C (GG2M)
Tb927.5.3980,5408.0,7173.5,7416.0,6821.5,6547.5,mitochondrial ribosomal protein L15,S
Tb927.5.3990,11090.0,11500.0,11527.0,11525.0,11311.0,variant surface glycoprotein (VSG  atypical)  putative,S
Tb927.5.4000,4751.0,4733.5,5981.0,3950.5,6377.5,hypothetical protein,>4C (GG2M)
Tb927.5.4010,612.5,3586.5,3388.5,3909.0,4533.5,Enriched in surface-labeled proteome protein 4,>4C (GG2M)
Tb927.5.4020,1460.0,3078.5,2858.0,2988.5,3981.5,hypothetical protein,>4C (GG2M)
Tb927.5.4030,4260.5,2335.0,2075.5,2046.5,3214.5,U6 snRNA-associated Sm-like protein LSm7p,<2C (LG1)
Tb927.5.4040,4433.0,8616.5,8878.5,8201.0,8327.5,Mitochondrial SSU ribosomal protein  putative,S
Tb927.5.4050,6434.5,2934.5,3589.5,2290.0,3125.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4060,10018.0,7998.5,8582.5,8132.5,7951.5,Nicastrin  putative,<2C (LG1)
Tb927.5.4070,2094.5,4305.0,2820.0,1993.5,1636.0,PrimPol-like protein 1,G1
Tb927.5.4080,10631.0,9391.5,10094.5,10314.0,9496.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4090,7313.5,4547.5,3092.0,3737.0,6679.0,FGR1 oncogene partner-like protein,<2C (LG1)
Tb927.5.4100,5938.5,4188.5,4448.0,4057.0,4110.0,WD domain  G-beta repeat  putative,<2C (LG1)
Tb927.5.4110,11278.0,8765.0,8556.0,8126.5,7325.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4120,612.5,5172.5,5564.0,5273.5,4199.0,LSU ribosomal protein  mitochondrial  putative,S
Tb927.5.4130,11251.0,10954.0,11226.5,11011.0,10149.5,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4140,6955.5,9367.5,9142.0,9229.5,8802.0,ZIP Zinc transporter  putative,G1
Tb5.NT.86,4190.5,3639.0,4568.5,3866.5,5824.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.5.4150,3380.0,4531.5,5334.5,5454.0,6570.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.4160,2180.0,3374.0,2717.5,3441.0,2427.0,hypothetical protein  conserved,G2M
Tb927.5.4170,4233.5,967.5,1860.0,1329.0,3638.0,histone H4  putative,<2C (LG1)
Tb927.5.4180,4248.0,1619.0,2251.5,2085.0,2389.0,histone H4  putative,<2C (LG1)
Tb927.5.4190,6498.0,3806.5,4966.0,3924.0,5861.5,histone H4  putative,<2C (LG1)
Tb927.5.4200,4411.0,1476.5,2410.5,2072.5,3169.5,histone H4  putative,<2C (LG1)
Tb927.5.4210,2406.5,307.0,893.0,826.5,1392.5,histone H4  putative,<2C (LG1)
Tb927.5.4220,5774.0,2469.5,3288.0,2919.0,4883.5,histone H4  putative,<2C (LG1)
Tb927.5.4230,4740.5,1747.5,2858.0,2707.0,3248.5,histone H4  putative,<2C (LG1)
Tb927.5.4240,3972.0,1553.5,2425.0,2357.0,2601.0,histone H4  putative,<2C (LG1)
Tb927.5.4250,3822.0,1249.0,1923.0,1572.5,2364.5,histone H4  putative,<2C (LG1)
Tb927.5.4260,3751.5,1766.0,3410.0,2603.0,3994.5,histone H4  putative,>4C (GG2M)
Tb927.5.4270,9016.0,9619.0,9394.0,9281.5,8513.0,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.5.4280,4074.0,1904.5,1502.0,2211.5,2483.5,Zinc finger  C3HC4 type (RING finger)  putative,<2C (LG1)
Tb927.5.4290,3929.5,7012.5,5435.0,4011.0,1099.0,hypothetical protein  conserved,G1
Tb927.5.4300,11271.0,10374.5,10383.0,10384.0,9383.0,prolyl oligopeptidase  putative,<2C (LG1)
Tb927.5.4310,8725.5,9638.0,9934.0,9043.0,8638.0,GTP-binding protein  putative,S
Tb927.5.4320,7524.0,8895.0,8621.0,8418.0,7494.0,Pre-mRNA polyadenylation factor FIP1,G1
Tb927.5.4330,8253.0,6039.0,6066.5,5583.5,4748.5,dihydrolipoamide branched chain transacylase  putative,<2C (LG1)
Tb927.5.4340,6990.0,7237.5,5531.5,6873.5,8933.0,basal body component  putative,>4C (GG2M)
Tb927.5.4350,3621.0,3542.5,3039.5,3185.0,2720.5,Nudix hydrolase 2,<2C (LG1)
Tb927.5.4360,5063.0,4879.0,4388.0,4070.5,5379.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.4370,5361.5,2934.5,3420.5,4146.0,2000.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4380,5435.0,9396.5,9263.0,9627.0,10274.5,Kinetoplastid-specific Protein Phosphatase 1,>4C (GG2M)
Tb927.5.4390,612.5,1275.5,865.5,925.0,2639.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.4400,612.5,4503.0,5345.0,5273.5,6814.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.4410,612.5,498.0,1475.5,1215.5,3704.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.5.4420,9123.0,6443.5,6352.5,6555.5,3794.0,nucleolar RNA helicase II  putative,<2C (LG1)
Tb927.5.4430,7413.5,7297.5,6767.0,8086.0,7363.0,calcium/calmodulin-dependent protein kinase  putative,G2M
Tb927.5.4440,5729.0,1068.5,630.0,849.0,933.5,dynein light chain  putative,<2C (LG1)
Tb927.5.4450,7830.0,4172.0,4928.0,5014.5,4938.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4460,8264.0,4770.5,4293.5,4808.0,3457.5,major vault protein  putative,<2C (LG1)
Tb927.5.4470,7593.5,9065.0,7404.5,8619.0,8679.5,hypothetical protein  conserved,G1
Tb927.5.4480,5822.0,2469.5,2969.0,3065.5,3283.5,paraflagellar rod component par4  putative,<2C (LG1)
Tb927.5.4490,4375.0,1415.5,1999.5,1833.5,2376.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4500,3621.0,1059.5,1041.5,907.5,2000.0,ras-like small GTPase  putative,<2C (LG1)
Tb927.5.4510,3041.5,398.0,491.0,419.0,818.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4520,6372.0,2485.0,3239.0,3272.5,5927.0,Kinetochore interacting protein 1,<2C (LG1)
Tb927.5.4530,5154.5,1257.5,818.5,839.0,1099.0,Long chain fatty acyl elongase,<2C (LG1)
Tb927.5.4535,612.5,1303.5,1595.5,1726.5,1676.0,hypothetical protein,G2M
Tb927.5.4540,10068.5,9823.0,9993.0,9732.5,8848.5,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.5.4550,9044.5,9190.0,9150.0,9071.5,7959.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.5.4560,2047.0,1716.0,1300.0,1329.0,2065.0,guanine deaminase  putative,>4C (GG2M)
Tb927.5.4570,4642.5,6846.5,6981.5,7605.5,11512.0,Flagellum adhesion protein 3,>4C (GG2M)
Tb927.5.4575,5620.5,1506.5,1710.5,1416.5,1896.5,hypothetical protein,<2C (LG1)
Tb927.5.4580,7074.5,8274.5,8160.5,8036.0,10823.0,Flagellum adhesion protein 3,>4C (GG2M)
Tb927.5.4590,7713.0,7285.5,6648.5,7398.5,7002.5,small GTP-binding rab protein  pseudogene  putative,<2C (LG1)
Tb927.5.4600,6759.0,5372.5,5526.0,5060.5,5713.5,expression site-associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb927.5.4610,3358.0,1585.5,2060.5,1875.5,2472.5,variant surface glycoprotein-related protein  frameshift,<2C (LG1)
Tb927.5.4620,8330.5,7041.5,6860.0,7350.0,5577.5,expression site-associated gene 9 (ESAG9) protein  putative,<2C (LG1)
Tb927.5.4630,5349.0,3787.0,2996.5,3545.0,4355.0,expression site-associated gene 1 (ESAG1) protein  putative,<2C (LG1)
Tb927.5.4640,5174.0,1758.0,1870.0,1416.5,1355.0,hypothetical protein  conserved,<2C (LG1)
Tb927.5.4650,9660.5,4983.0,6910.5,6267.5,4813.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.4660,2598.0,2170.0,1278.5,1171.0,1691.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.5.4670,4685.0,1914.0,2465.5,1966.0,3812.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.5.4680,612.5,260.0,233.5,182.5,86.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.4690,3579.5,2696.5,2919.0,3992.5,2914.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.5.4700,6381.5,3120.0,2969.0,3117.0,1516.0,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.5.4710,8351.0,3596.0,3821.0,4598.0,7624.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.4720,612.5,192.5,756.5,464.0,2463.0,expression site-associated gene 3 (ESAG3)  degenerate,>4C (GG2M)
Tb927.5.4730,5148.5,3429.0,2666.0,3057.0,2029.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.5.4740,1783.5,1257.5,1650.0,890.0,874.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.4750,7898.5,1437.5,1710.5,1343.0,1062.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.4760,5658.5,1827.5,1371.0,1626.0,347.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.5.4770,2221.0,2601.0,3260.0,2252.0,1392.5,variant surface glycoprotein (VSG)  putative,S
Tb927.5.4780,10218.0,11156.0,11074.0,10788.5,10472.5,variant surface glycoprotein  degenerate,G1
Tb927.5.4790,1460.0,1827.5,1909.5,2541.0,2773.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.4800,612.5,1293.5,1510.5,1950.5,2758.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.4810,6477.0,9248.0,8637.5,9304.5,9250.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.5.4820,612.5,1371.5,1561.5,1329.0,1531.5,variant surface glycoprotein  degenerate,S
Tb927.5.4830,6961.5,4103.5,4586.5,3815.5,6994.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.4840,1460.0,3179.0,3379.0,3909.0,2029.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.5.4850,3191.0,738.5,1091.0,737.0,531.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.4860,3502.5,3775.5,3902.0,3924.0,5640.0,expression site-associated gene 3 (ESAG3)  degenerate,>4C (GG2M)
Tb927.5.4870,2855.0,2839.5,1938.0,2264.5,1549.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.4880,612.5,6884.0,6718.0,6854.5,6066.5,variant surface glycoprotein  degenerate,G1
Tb927.5.4890,612.5,294.5,40.0,352.0,607.0,variant surface glycoprotein  truncated  degenerate,<2C (LG1)
Tb927.5.4900,612.5,700.5,410.0,483.0,86.0,variant surface glycoprotein  frameshift,G1
Tb927.5.4910,7329.0,7314.5,7790.0,7891.0,6131.0,variant surface glycoprotein  degenerate,G2M
Tb927.5.4920,5408.0,3615.5,3609.0,3429.5,5404.0,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.5.4930,5379.0,2609.5,2050.0,2483.5,3618.5,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.5.4940,8161.5,8445.0,8185.0,8611.5,6259.0,variant surface glycoprotein  frameshift,G2M
Tb927.5.4950,6890.5,2011.0,2510.5,2102.5,4607.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.5.4960,612.5,1115.5,1502.0,957.5,86.0,variant surface glycoprotein  degenerate,S
Tb927.5.4970,1460.0,1161.5,848.5,557.5,2631.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.4980,3358.0,1161.5,1561.5,1675.5,1531.5,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.5.4990,2901.0,912.5,818.5,419.0,637.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5000,4496.5,2581.5,3678.5,2252.0,3295.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5010,1460.0,3855.5,3066.0,2788.5,4377.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.5020,1988.0,1574.5,1428.0,1763.5,1758.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,<2C (LG1)
Tb927.5.5030,1460.0,96.0,40.0,82.5,287.0,variant surface glycoprotein  truncated,<2C (LG1)
Tb927.5.5040,5167.5,4983.0,5084.5,6098.5,4440.0,variant surface glycoprotein  point mutation,G2M
Tb927.5.5050,4305.5,235.5,130.5,136.5,505.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.5.5060,6389.5,2170.0,3821.0,3178.5,3235.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5070,612.5,279.5,40.0,159.0,347.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.5.5080,2658.5,2801.5,1757.0,1140.0,2505.5,variant surface glycoprotein (VSG)  putative,G1
Tb927.5.5090,4439.5,3526.0,3789.5,3477.5,4550.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.5100,5933.5,1220.5,1465.0,1313.5,1565.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5110,612.5,612.5,685.0,788.5,213.0,variant surface glycoprotein  degenerate,G2M
Tb927.5.5120,612.5,294.5,644.5,501.5,1239.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.5130,5423.5,4441.0,4388.0,4019.0,4635.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5140,4533.5,3293.0,2510.5,2756.0,2647.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,<2C (LG1)
Tb927.5.5150,10274.5,9916.0,9999.0,10497.5,10042.0,variant surface glycoprotein  degenerate,G2M
Tb927.5.5160,6888.0,4145.5,3978.5,4464.5,4292.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5170,5635.5,2138.5,2075.5,2038.5,2928.5,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.5.5180,7086.0,3652.5,3801.5,3307.0,4051.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,<2C (LG1)
Tb927.5.5190,3078.5,6278.5,6147.0,7227.0,5943.5,variant surface glycoprotein  degenerate,G2M
Tb927.5.5200,3979.5,1059.5,1595.5,1329.0,1565.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5210,5025.0,2392.5,2909.0,3154.0,3065.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.5.5220,612.5,2992.5,2453.0,2617.5,3021.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.5.5230,2180.0,3344.5,3116.5,2746.5,3510.5,expression site-associated gene (ESAG  pseudogene)  putative,>4C (GG2M)
Tb927.5.5240,1460.0,530.0,717.5,610.5,1958.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.5.5250,612.5,588.0,832.0,925.0,948.5,variant surface glycoprotein  fragment  degenerate,>4C (GG2M)
Tb927.5.5260,2094.5,1201.5,1091.0,849.0,397.5,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.5.5270,7185.0,2638.5,1300.0,1763.5,3871.0,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.5.5280,4721.0,1476.5,1818.0,1980.0,1281.5,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.5.5290,4019.5,1934.0,2103.5,3029.0,2125.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5300,2047.0,1095.0,1192.0,1110.5,964.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5310,4784.0,4745.0,4316.5,6313.0,4988.5,variant surface glycoprotein  frameshift,G2M
Tb927.5.5320,3951.0,799.5,685.0,557.5,1027.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5330,4721.0,3211.5,3858.5,3711.5,4212.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.5.5340,3711.5,1953.0,3021.0,2275.5,1717.0,expression site-associated gene (ESAG  pseudogene)  putative,<2C (LG1)
Tb927.5.5350,6047.5,6763.0,6533.5,5648.5,7566.0,variant surface glycoprotein  truncated,>4C (GG2M)
Tb927.5.5360,2137.5,678.5,731.0,1154.5,978.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5370,5989.0,3723.5,3260.0,4623.0,4607.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5380,3606.0,4975.5,5325.5,5087.5,6780.0,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb927.5.5390,3770.5,1437.5,1388.5,1441.0,2254.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5400,6762.5,4406.0,4130.5,5638.0,5761.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5410,5063.0,811.0,808.5,890.0,1896.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5420,612.5,612.5,448.0,974.5,2351.0,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb927.5.5430,3822.0,3639.0,3275.0,2940.5,2884.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5440,4784.0,2621.0,2360.0,2404.0,2268.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5450,9941.0,9367.5,9500.5,9979.5,8793.5,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5460,3964.5,4365.0,4246.0,4951.0,2953.5,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5470,3478.0,1034.0,1030.5,1140.0,1608.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5480,3394.0,1886.0,1371.0,989.0,1504.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5490,5432.0,3900.0,6166.0,3492.0,915.0,Variant Surface Glycoprotein  putative,S
Tb927.5.5500,4027.5,3256.0,3039.5,3642.0,4673.5,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb927.5.5510,612.5,2949.5,2075.5,1966.0,1099.0,Variant Surface Glycoprotein  putative,G1
Tb927.5.5520,612.5,3000.5,2453.0,3332.5,1622.5,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5530,1783.5,1492.5,1623.0,2134.5,2525.0,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb927.5.5540,1988.0,2416.5,2839.0,1713.0,2463.0,Variant Surface Glycoprotein  putative,S
Tb927.5.5550,7167.0,9465.0,8924.0,10042.5,8709.0,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5560,612.5,1437.5,1199.5,647.5,1162.5,Variant Surface Glycoprotein  putative,G1
Tb927.5.5570,1783.5,1595.5,1799.0,1899.5,1374.5,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5580,5291.5,9881.0,10024.5,10384.0,9153.5,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5590,6173.0,7083.5,7388.0,7301.0,6903.0,Variant Surface Glycoprotein  putative,S
Tb927.5.5600,612.5,498.0,507.0,592.5,584.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5610,4270.5,3298.5,3431.0,4464.5,3586.0,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5620,2329.5,927.5,893.0,788.5,1141.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5630,3606.0,1220.5,1289.5,1526.5,1078.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5640,4517.0,1653.5,1623.0,2102.5,1325.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5650,6381.5,2198.0,1103.0,1056.5,2991.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.5.5660,612.5,759.0,644.5,808.0,559.5,Variant Surface Glycoprotein  putative,G2M
Tb927.5.5670,612.5,554.5,685.0,705.5,1595.5,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb927.5.5680,612.5,1553.5,1335.0,1572.5,2079.5,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb927.5.5690,4533.5,2896.5,3260.0,3057.0,3541.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.9.100,8083.0,8279.5,9156.5,8834.0,9616.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.120,4248.0,5822.5,6339.5,6388.5,3888.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.130,5989.0,2093.5,2533.0,2311.0,2661.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.150,5593.5,7663.0,7091.5,7915.5,7304.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.160,5030.5,6458.5,6889.0,7486.0,7745.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.9.170,11241.0,11181.0,11194.0,10921.0,10996.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.9.180,2574.5,1807.0,1818.0,1597.5,3157.0,expression site-associated gene 3 (ESAG3)  fragment,>4C (GG2M)
Tb927.9.190,4389.0,4460.5,4398.0,4818.5,3541.0,variant surface glycoprotein (VSG)  putative,G2M
Tb927.9.200,5432.0,2384.0,1536.0,2058.5,1582.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.9.210,4608.5,3950.5,4029.0,4699.5,4967.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.220,4940.0,8031.0,7844.5,7441.5,8048.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.230,2047.0,4019.0,4966.0,3965.5,5240.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.240,2729.0,5546.5,3952.0,4674.0,2413.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.250,7631.0,3747.5,2341.0,3154.0,3648.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.260,11252.5,11424.0,11339.0,11224.0,11000.5,expression site-associated gene 3 (ESAG3)  fragment,G1
Tb927.9.270,11246.0,10133.5,9745.5,10275.5,8606.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.9.280,612.5,2224.0,2410.5,2264.5,3775.0,transferrin-binding protein  pseudogene,>4C (GG2M)
Tb927.9.290,9226.0,10665.0,10845.0,11023.5,10877.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.300,7674.0,4127.0,5197.0,4512.5,3199.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.310,6319.5,6480.5,6055.5,6979.0,4005.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.320,612.5,3419.0,2533.0,2404.0,2786.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.330,8756.5,9603.0,9702.5,9942.0,8674.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.340,7577.0,5765.0,5486.5,6482.0,4365.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.350,1460.0,7726.5,7644.0,8023.0,6903.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.360,8313.0,11156.0,11084.0,10884.5,10285.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.370,8863.0,4493.5,3568.0,3866.5,5209.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.380,1783.5,4127.0,3642.0,3492.0,3566.5,expression site-associated gene 3 (ESAG3)  pseudogene,G1
Tb927.9.390,612.5,5277.0,5358.0,3785.5,5788.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.400,612.5,2551.0,2036.0,2321.5,2231.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.410,6893.5,7277.5,6815.5,7931.0,7681.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.420,7863.0,9821.5,9332.5,9489.5,10068.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.430,10937.0,10345.0,10897.0,10211.0,9188.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.9.440,7063.0,8770.0,7484.0,8361.0,6328.0,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb927.9.450,3564.0,5953.5,5256.0,5260.5,5274.5,expression site-associated gene 3 (ESAG3)  fragment,G1
Tb927.9.460,3437.5,4027.0,2812.5,3142.0,4028.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.470,2381.5,5188.5,5325.5,4872.5,3879.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.480,612.5,626.0,391.5,647.5,461.5,expression site-associated gene 3 (ESAG3)  fragment,G2M
Tb927.9.490,6357.5,10576.0,10298.5,10561.5,9598.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.500,7282.0,6916.5,7588.0,7188.5,5342.0,variant surface glycoprotein  fragment,S
Tb927.9.510,9455.5,7395.0,6423.5,7670.0,7431.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.520,4057.5,6413.0,6218.5,6313.0,3775.0,variant surface glycoprotein  fragment,G1
Tb927.9.540,8820.5,2260.5,1679.0,1430.0,2110.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.550,2504.5,246.5,233.5,334.5,397.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.560,2795.5,3078.5,2969.0,3295.5,3021.0,expression site-associated gene 3 (ESAG3)  pseudogene,G2M
Tb927.9.570,4470.5,3171.5,4189.0,3228.0,3510.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.9.580,1460.0,1595.5,1742.5,2168.5,1407.5,variant surface glycoprotein (VSG)  putative,G2M
Tb927.9.590,612.5,158.5,293.0,382.0,213.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.9.600,4159.0,6928.5,6401.0,6098.5,7782.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.9.610,612.5,811.0,778.0,534.5,2079.5,hypothetical protein (pseudogene),>4C (GG2M)
Tb927.9.620,6568.0,2957.5,3092.0,3856.5,3474.5,expression site-associated gene 3 (ESAG3)  pseudogene,<2C (LG1)
Tb927.9.630,612.5,3313.0,3542.0,1597.5,1789.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.640,8485.0,6480.5,7061.5,6909.0,8315.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.650,6353.5,10233.5,10383.0,10428.0,9075.5,hypothetical protein (pseudogene),G2M
Tb927.9.660,9028.5,9457.5,9348.5,9808.5,8348.0,expression site-associated gene 1 (ESAG1) protein,G2M
Tb927.9.670,8327.0,3652.5,3706.5,3393.5,3295.5,hypothetical protein,<2C (LG1)
Tb927.9.680,10614.0,11474.0,11469.0,11541.0,11408.0,expression site-associated gene 9 (ESAG9)  pseudogene,G2M
Tb927.9.690,6061.5,3032.5,3978.5,4267.0,4179.0,variant surface glycoprotein (VSG  pseudogene)-related  putative,<2C (LG1)
Tb927.9.700,10622.0,9977.5,9730.0,10045.5,8416.0,hypothetical protein,<2C (LG1)
Tb927.9.710,9509.5,8818.5,9174.5,9401.0,7579.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.715,3095.0,2714.5,2318.5,1950.5,3235.0,hypothetical protein,>4C (GG2M)
Tb927.9.720,6586.0,6239.5,5848.5,5285.0,3399.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.730,4170.0,5144.5,5007.0,5899.5,3510.5,hypothetical protein  conserved,G2M
Tb927.9.740,6441.5,5822.5,5197.0,4940.5,4377.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.760,7667.0,8292.0,8779.0,7955.0,6048.5,hypothetical protein,S
Tb927.9.770,5275.5,3050.5,2931.0,3057.0,1984.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.780,10864.0,10210.0,10330.0,10054.0,10398.5,hypothetical protein,<2C (LG1)
Tb927.9.790,7203.5,7962.0,7424.0,8368.0,5188.0,hypothetical protein  conserved,G2M
Tb927.9.800,4922.5,4778.5,6102.0,5765.5,4550.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,S
Tb927.9.810,7096.0,6397.0,6970.5,7651.5,6519.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.820,6315.5,5811.0,5419.0,4446.0,7130.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.830,1460.0,7092.0,7115.5,7179.5,9373.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.840,612.5,2658.5,1489.0,1980.0,4839.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.850,3810.5,2034.0,2425.0,2801.0,3125.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.860,11631.0,11610.0,11613.0,11581.5,11523.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.9.870,2137.5,3304.0,3821.0,4057.0,4276.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.880,612.5,1078.5,1226.0,1491.0,964.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.890,11017.0,8946.0,8427.5,9278.0,9103.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.9.900,4617.0,4056.0,4002.0,5129.0,3185.0,variant surface glycoprotein (VSG)  putative,G2M
Tb927.9.910,2047.0,4493.5,4607.0,4084.0,5252.5,Trypanosome variant surface glycoprotein (A-type)  putative,>4C (GG2M)
Tb927.9.920,612.5,1362.5,1067.0,1003.0,505.0,hypothetical protein,G1
Tb927.9.930,2381.5,1285.0,1549.5,2058.5,1516.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.940,1460.0,5031.5,5054.0,3319.0,5479.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.950,1460.0,398.0,848.5,534.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.960,1783.5,867.5,1300.0,941.0,672.0,variant surface glycoprotein (VSG)  interrupted,<2C (LG1)
Tb927.9.970,8423.0,6494.5,6754.0,5608.0,5953.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.990,7960.5,919.5,1008.5,1514.5,559.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1000,1460.0,3542.5,3737.5,2686.0,3065.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.1010,6803.5,7277.5,6767.0,6555.5,6385.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.1030,2180.0,8436.5,7442.5,7410.0,4073.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.1040,2329.5,498.0,644.5,577.5,287.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1050,3358.0,6313.0,6838.0,6562.0,7740.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.9.1070,6397.5,6408.0,7227.5,7179.5,5834.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.1080,1783.5,4214.5,4799.0,4818.5,3994.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G2M
Tb927.9.1090,7971.0,6561.0,6352.5,6996.5,6938.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1100,5649.5,10013.0,9488.0,10406.5,9737.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.1110,6365.5,8270.0,7204.0,7789.5,8627.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.9.1120,3922.5,3658.5,3658.5,4654.5,2661.5,hypothetical protein  conserved,G2M
Tb927.9.1130,11171.0,9600.0,9259.0,9554.0,9406.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1140,9276.5,8782.0,8268.5,8440.0,9293.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.1150,3041.5,2664.0,2692.0,2940.5,2609.5,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb927.9.1160,1460.0,1619.0,1808.5,1847.0,1842.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.1170,6101.0,7916.5,7242.0,6331.5,4571.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.1180,6381.5,3734.0,4181.0,5014.5,5653.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1190,11392.0,11536.0,11580.5,11529.0,11386.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.1200,10162.0,3984.0,4002.0,3254.5,5188.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1210,1783.5,543.0,410.0,534.5,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1220,6838.0,5454.0,6006.0,6706.0,6917.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,>4C (GG2M)
Tb927.9.1230,1460.0,6834.5,5848.5,5981.0,6932.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.1240,1460.0,823.0,1054.0,875.0,1213.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.1250,2094.5,7006.0,6253.5,5932.0,7631.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.9.1280,9297.0,9608.0,9569.0,9294.0,10060.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.9.1340,10156.0,10334.5,10652.0,10622.0,11080.0,Myosin-like protein 2,>4C (GG2M)
Tb927.9.1350,1783.5,9040.0,8938.5,9600.0,8697.5,hypothetical protein  conserved,G2M
Tb927.9.1360,4713.5,6423.0,7091.5,7212.0,6945.5,hypothetical protein  conserved,G2M
Tb927.9.1365,8365.0,4019.0,4019.5,3356.0,5044.5,hypothetical protein,<2C (LG1)
Tb927.9.1380,11563.0,9889.5,9694.5,10214.0,8526.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.1390,1783.5,2118.0,2919.0,2389.0,213.0,CSL zinc finger  putative,S
Tb927.9.1400,10129.5,9781.5,9541.5,9620.0,8374.0,kynurenine 3-monooxygenase  putative,<2C (LG1)
Tb927.9.1410,9886.0,10830.0,10689.0,10652.0,10671.0,SUMO-interacting motif-containing protein,G1
Tb927.9.1420,7813.5,9272.0,7943.5,7915.5,7285.5,hypothetical protein  conserved,G1
Tb927.9.1440,3013.5,10843.0,10675.0,10645.5,11406.0,Paraquat-inducible protein A  putative,>4C (GG2M)
Tb927.9.1470,6973.0,3792.0,4928.0,4908.0,3669.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.1500,11092.0,11559.0,11603.0,11623.0,11524.0,Serine/threonine-protein kinase NEK15  putative,G2M
Tb927.9.1510,5074.0,8540.5,8775.5,8925.5,8006.0,D-ala D-ala ligase C-terminus/SET domain containing protein  putative,G2M
Tb927.9.1520,6397.5,6963.0,5350.5,7003.0,7484.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.1530,8706.0,10163.5,9658.0,9805.0,9169.0,hypothetical protein  conserved,G1
Tb927.9.1540,9424.0,7781.0,8547.5,7631.5,4839.5,protein phosphatase 2B  putative,<2C (LG1)
Tb927.9.1560,4122.5,8536.5,7246.0,7525.5,2928.5,DnaJ domain containing protein  putative,G1
Tb927.9.1570,1460.0,9762.0,9534.5,9543.0,8533.0,calcium/calmodulin-dependent protein kinase  putative,G1
Tb927.9.1590,5870.0,5159.5,5386.5,5949.0,5609.5,hypothetical protein  conserved,G2M
Tb927.9.1600,11585.0,11615.0,11595.0,11605.0,11369.0,hypothetical protein  conserved,G1
Tb927.9.1610,8431.0,5088.5,4848.5,4654.5,3847.5,CDP-diacylglycerol--inositol 3-phosphatidyltransferase  putative,<2C (LG1)
Tb927.9.1640,7516.0,4056.0,3033.5,3130.0,3310.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.1650,612.5,1553.5,1665.0,1154.5,531.0,hypothetical protein  conserved,S
Tb927.9.1660,3570.5,4331.5,4944.0,4290.5,6639.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.1670,10368.0,8658.5,9072.5,9222.5,10676.0,Aurora kinase 3  putative,>4C (GG2M)
Tb927.9.1680,612.5,3344.5,3626.0,2102.5,1266.0,Lys-63-specific deubiquitinase BRCC36  putative,S
Tb927.9.1700,4760.5,6052.0,5164.0,5024.0,4783.5,btb/poz domain containing protein  putative,G1
Tb927.9.1710,4411.0,6838.5,7813.0,7506.5,8927.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.1720,11367.0,10425.0,9993.0,9762.5,8409.5,peroxisomal membrane protein 4  putative,<2C (LG1)
Tb927.9.1730,11552.0,10918.0,11189.0,10929.0,10716.0,Primase zinc finger/Mcm10 replication factor  putative,<2C (LG1)
Tb927.9.1750,7442.0,6922.5,6718.0,7410.0,10812.5,Fibronectin type III domain containing protein  putative,>4C (GG2M)
Tb927.9.1770,11656.0,11622.0,11614.0,11606.0,11507.5,Zn-finger in Ran binding protein and others/SPRY domain/HECT-domain (ubiquitin-transferase)  putative,<2C (LG1)
Tb927.9.1780,8789.0,8408.5,7890.5,8179.5,10268.5,sec1 family transport protein  putative,>4C (GG2M)
Tb927.9.1790,2523.0,886.5,4304.0,2102.5,744.5,hypothetical protein  conserved,S
Tb927.9.1810,612.5,208.5,161.0,221.5,287.0,60S ribosomal protein L35  putative,<2C (LG1)
Tb927.9.1850,4965.0,1506.5,1623.0,1085.0,1281.5,60S ribosomal protein L35  putative,<2C (LG1)
Tb927.9.1880,10208.5,10419.0,9723.0,9478.0,9364.5,WD domain  G-beta repeat  putative,G1
Tb927.9.1910,8598.0,7512.0,7668.0,8881.5,8155.5,hypothetical protein  conserved,G2M
Tb927.9.1920,10769.0,10182.5,10543.0,10093.0,10071.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.1940,7804.5,11243.0,11382.0,11453.0,11163.5,hypothetical protein  conserved,G2M
Tb927.9.1950,612.5,3284.0,2399.5,1888.0,2310.0,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,G1
Tb927.9.1960,1783.5,3872.5,4304.0,3847.5,4783.5,nitrilase  putative,>4C (GG2M)
Tb927.9.1970,6767.0,10324.0,10554.0,10744.5,10179.5,syntaxin binding protein 1  putative,G2M
Tb927.9.1980,3179.0,8487.5,7069.0,7083.0,5258.0,hypothetical protein  conserved,G1
Tb927.9.2010,5729.0,9118.0,8012.0,8498.5,7676.5,kynureninase  putative,G1
Tb9.NT.6,612.5,471.5,293.0,352.0,1227.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.9.2020,612.5,1240.5,1149.5,1281.0,3365.0,60S ribosomal protein L38  putative,>4C (GG2M)
Tb927.9.2030,11705.0,10408.0,10245.0,10657.0,11123.0,Orc1-like protein,<2C (LG1)
Tb927.9.2050,5630.0,6239.5,6854.5,6683.5,7731.5,membrane protein YIP1  putative,>4C (GG2M)
Tb927.9.2055,7847.5,3407.5,4341.0,2850.5,1676.0,hypothetical protein,<2C (LG1)
Tb927.9.2060,6167.5,6881.0,6041.0,6271.5,7274.5,ADP-ribosylation factor family  putative,>4C (GG2M)
Tb927.9.2070,9297.0,9617.5,9996.0,9478.0,9478.0,hypothetical protein  conserved,S
Tb927.9.2075,11681.0,11651.0,11671.0,11660.0,11675.0,hypothetical protein,<2C (LG1)
Tb927.9.2080,612.5,40.5,40.0,33.5,86.0,invariant surface glycoprotein 100  point mutation,<2C (LG1)
Tb927.9.2100,10651.0,8704.0,9060.0,9340.5,8078.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2110,3895.5,6380.0,6072.0,6297.0,2884.5,hypothetical protein  conserved,G1
Tb927.9.2120,5241.5,5612.5,4928.0,5789.5,4036.5,hypothetical protein  conserved,G2M
Tb927.9.2130,10133.0,10890.0,10346.5,10766.5,10922.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.2140,9380.5,11045.0,11019.0,11059.0,10856.5,calcium/calmodulin-dependent protein kinase  putative,G2M
Tb927.9.2160,3283.5,1553.5,1831.0,2120.5,2442.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2210,7255.0,3284.0,3039.5,3117.0,3413.5,hypothetical protein,<2C (LG1)
Tb927.9.2220,9874.5,8684.5,8563.0,8287.0,8188.0,SUMO1/Ulp2  putative,<2C (LG1)
Tb927.9.2240,6167.5,8989.5,9044.0,9185.0,10050.0,Pseudokinase  putative,>4C (GG2M)
Tb927.9.2250,612.5,4590.5,3431.0,3805.5,3431.5,hypothetical protein  conserved,G1
Tb927.9.2260,2886.0,7380.0,7523.5,5228.0,4244.5,PQ loop repeat  putative,S
Tb927.9.2270,9290.0,10041.0,10135.5,9986.5,9564.5,hypothetical protein  conserved,S
Tb927.9.2280,4142.5,1827.5,2488.5,2725.0,1912.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2290,6274.5,5811.0,7411.0,7361.0,6270.0,hypothetical protein  conserved,S
Tb927.9.2310,2574.5,6881.0,7526.5,7819.0,7459.5,hypothetical protein  conserved,G2M
Tb927.9.2320,6470.0,10319.0,10337.0,10474.0,10278.0,methyltransferase domain containing protein  putative,G2M
Tb927.9.2340,612.5,398.0,615.0,483.0,818.0,tRNA Selenocysteine,>4C (GG2M)
Tb927.9.2350,10039.5,10962.5,11025.0,11268.0,10942.0,calcium/calmodulin-dependent protein kinase  putative,G2M
Tb927.9.2380,612.5,554.5,832.0,788.5,1717.0,tRNA Selenocysteine,>4C (GG2M)
Tb927.9.2390,8066.5,4281.0,4598.0,4686.5,4266.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2400,2406.5,7019.5,6142.0,7410.0,6793.5,hypothetical protein  conserved,G2M
Tb927.9.2420,10158.0,6776.5,6735.0,6591.5,6216.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2450,4745.5,4796.5,4632.5,5690.0,3669.0,electon transport protein SCO1/SCO2  putative,G2M
Tb927.9.2470,2406.5,823.0,778.0,1228.0,1970.0,nucleolar protein,<2C (LG1)
Tb927.9.2490,9863.5,1143.0,2949.5,3785.5,6780.0,nucleolar protein,<2C (LG1)
Tb927.9.2520,11721.0,11722.0,11722.0,11722.0,11722.0,microtubule-associated protein,G1
Tb927.9.2550,11576.0,11537.0,11542.0,11608.0,11129.5,Domain of unknown function (DUF4457)  putative,G2M
Tb927.9.2560,11430.0,11071.0,11063.0,11199.0,10560.5,TLC domain containing protein  putative,<2C (LG1)
Tb927.9.2580,1783.5,6052.0,7350.0,7506.5,7924.5,deoxyhypusine hydroxylase  putative,>4C (GG2M)
Tb927.9.2590,11457.0,10899.0,10859.0,10855.5,10523.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2600,5270.0,10251.0,10644.0,10453.0,8310.5,hypothetical protein  conserved,S
Tb927.9.2620,9333.0,9118.0,9087.0,9196.5,6614.5,Domain of unknown function (DUF4460)  putative,<2C (LG1)
Tb927.9.2630,11526.5,11596.0,11574.0,11556.0,11090.0,hypothetical protein  conserved,G1
Tb927.9.2650,11382.0,11230.0,11126.5,11081.0,10773.0,Present in the outer mitochondrial membrane proteome 2,<2C (LG1)
Tb927.9.2670,8368.5,10214.5,10743.5,10521.0,9914.5,Engulfment and cell motility domain-containing protein,S
Tb927.9.2700,7130.0,10077.5,10214.5,9464.5,7988.0,hypothetical protein  conserved,S
Tb927.9.2730,9100.0,11311.5,11254.5,11176.0,11220.0,hypothetical protein  conserved,G1
Tb927.9.2760,8099.0,10005.0,10308.5,9905.5,8268.0,EB1-like C-terminal motif containing protein  putative,S
Tb927.9.2780,6009.5,8091.0,6609.5,6927.5,5220.0,hypothetical protein  conserved,G1
Tb927.9.2800,6123.0,8265.0,8241.5,9213.0,8037.5,hypothetical protein  conserved,G2M
Tb927.9.2860,10400.0,10251.0,10328.5,10222.5,9818.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2811,8377.5,8274.5,8023.0,8515.5,8327.5,Domain of unknown function (DUF5075)  putative,G2M
Tb927.9.2815,10828.0,10559.0,10375.0,10484.0,9976.0,Domain of unknown function (DUF5075)  putative,<2C (LG1)
Tb927.9.2840,9968.0,9495.0,9457.0,9346.0,9220.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2845,9798.5,10114.0,9843.0,10045.5,9827.0,Domain of unknown function (DUF5075)  putative,G1
Tb927.9.2853,10293.0,9956.5,9667.5,9858.5,9716.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2855,9373.5,8891.0,8803.0,8881.5,8559.0,Domain of unknown function (DUF5075)  putative,<2C (LG1)
Tb927.9.2861,9201.0,9750.5,9761.0,9740.5,9696.5,Domain of unknown function (DUF5075)  putative,S
Tb927.9.2865,10876.0,10548.5,10526.0,10598.0,10054.5,Domain of unknown function (DUF5075)  putative,<2C (LG1)
Tb927.9.2871,10634.0,10344.0,10239.5,10149.0,9967.0,Domain of unknown function (DUF5075)  putative,<2C (LG1)
Tb927.9.2875,9779.0,9839.0,9810.0,9972.0,9079.0,Domain of unknown function (DUF5075)  putative,G2M
Tb927.9.2881,10437.5,10083.0,9886.0,9896.0,9781.0,Domain of unknown function (DUF5075)  putative,<2C (LG1)
Tb927.9.2885,8706.0,9701.5,9105.0,9323.0,9749.0,Domain of unknown function (DUF5075)  putative,>4C (GG2M)
Tb927.9.2891,7956.0,10754.5,10321.5,10586.5,9777.0,Domain of unknown function (DUF5075)  putative,G1
Tb927.9.2900,11571.0,11631.0,11621.0,11589.0,11596.0,U3 small nucleolar RNA-associated protein 10  putative,G1
Tb927.9.2910,1460.0,3273.5,2144.5,4097.0,1565.5,histone acetyltransferase subunit NuA4  putative,G2M
Tb927.9.2940,7956.0,10530.0,10465.0,10370.0,10507.0,hypothetical protein  conserved,G1
Tb09_snoRNA_0001,612.5,438.0,685.0,808.0,86.0,C/D snoRNA  TB9C1C1,G2M
Tb927_09_v4.snoRNA.0054,612.5,967.5,880.5,907.5,672.0,H/ACA-like snoRNA,G1
Tb927_09_v4.snoRNA.0046,2047.0,952.0,1465.0,890.0,853.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0107,612.5,40.5,99.0,33.5,287.0,H/ACA-like snoRNA,<2C (LG1)
Tb09_snoRNA_0005,612.5,413.0,731.0,534.5,672.0,C/D snoRNA  TB9C1C1,S
Tb927_09_v4.snoRNA.0055,612.5,690.0,1030.5,757.5,721.5,H/ACA-like snoRNA,S
Tb927_09_v4.snoRNA.0047,2295.5,1052.0,1347.5,925.0,874.5,H/ACA-like snoRNA,<2C (LG1)
Tb09_snoRNA_0008,612.5,40.5,99.0,33.5,86.0,H/ACA snoRNA  TB9Cs1H3,<2C (LG1)
Tb927.9.2980,7366.5,3150.0,2887.5,2707.0,3235.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.2990,612.5,4331.5,4010.5,3965.5,5258.0,hypothetical protein,>4C (GG2M)
Tb927.9.3000,6095.5,5546.5,4622.0,3978.5,5535.5,cytidine deaminase,<2C (LG1)
Tb927.9.3010,9870.5,5421.5,6678.0,6192.0,5282.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.3030,1914.0,1807.0,2122.5,1626.0,2720.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.3080,5148.5,4450.0,5439.0,6690.0,4429.0,hypothetical protein  conserved,G2M
Tb927.9.3100,2700.0,6239.5,6655.0,7434.0,5054.0,hypothetical protein  conserved,G2M
Tb927.9.3120,11101.0,11418.0,11396.0,11234.0,11392.0,STE/STE11 serine/threonine-protein kinase  putative,G1
Tb927.9.3130,10087.5,7656.0,8257.5,8191.0,9783.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.3170,9229.0,9759.5,8356.0,9728.0,10123.5,cytochrome oxidase subunit V,>4C (GG2M)
Tb927.9.3260,4667.5,9113.0,9047.0,9014.0,8165.0,hypothetical protein,G1
Tb927.9.3280,7690.5,3700.0,4776.0,3965.5,3125.5,exopolyphosphatase,<2C (LG1)
Tb927.9.3290,612.5,3596.0,2931.0,3367.5,3086.0,4F5 protein family  putative,G1
Tb927.9.3340,4449.5,4630.0,4462.5,3950.5,3704.0,hypothetical protein  conserved,G1
Tb927.9.3350,10108.5,7912.0,7833.0,8402.5,8590.5,pseudouridylate synthase  putative,<2C (LG1)
Tb927.9.3360,11267.5,10014.5,9520.0,10166.5,9922.0,N-acetyltransferase  putative,<2C (LG1)
Tb927.9.3370,3028.5,2934.5,4235.0,4994.0,2472.5,thioredoxin,G2M
Tb927.9.3390,2552.0,4711.5,4502.0,5228.0,10278.0,Calmodulin-binding  putative,>4C (GG2M)
Tb927.9.3400,11428.0,10672.5,10726.0,10490.5,10985.0,endo-beta-N-acetylglucosaminidase  putative,<2C (LG1)
Tb927.9.3410,612.5,3016.0,3902.0,3878.0,4110.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.3440,1460.0,3596.0,3589.5,4183.0,9930.5,cyclophilin type peptidyl-prolyl cis-trans isomerase  putative,>4C (GG2M)
Tb927.9.3460,7334.0,10618.0,11060.5,10946.0,11047.5,zinc finger protein family member  putative,S
Tb927.9.3470,1460.0,678.5,717.5,687.0,818.0,low molecular weight protein tyrosine phosphatase  putative,<2C (LG1)
Tb927.9.3480,2598.0,3086.5,4155.0,3605.5,3335.5,U5Cwc21 small nuclear ribonucleoprotein,S
Tb927.9.3490,10145.0,10615.5,10746.0,10329.0,10806.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.3530,2552.0,2034.0,1870.0,2422.0,3295.5,U6 snRNA-associated Sm-like protein LSm6p,>4C (GG2M)
Tb927.9.3540,4574.0,1797.0,1700.5,1899.5,3365.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.3550,3895.5,1384.0,2172.5,2840.5,6602.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.3560,3662.5,6992.5,6953.0,6946.0,5342.0,hypothetical protein  conserved,G1
Tb927.9.3580,10766.5,10688.0,10423.0,10537.5,10461.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.3590,5729.0,5896.0,6735.0,7525.5,5772.0,monothiol glutaredoxin  putative,G2M
Tb927.9.3600,9608.5,10580.0,10076.0,10456.5,9059.5,Glycosyl transferase family 11  putative,G1
Tb927.9.3620,9044.5,7902.0,7316.0,7883.0,6897.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.3630,3214.5,8127.5,7896.0,7670.0,6485.0,BSD domain containing protein  putative,G1
Tb927.9.3640,8780.5,10544.0,9903.0,10365.0,9099.5,LSU ribosomal protein  mitochondrial  putative,G1
Tb927.9.3650,11189.5,9270.5,8414.0,8853.5,9004.5,Kinesin-13 1,<2C (LG1)
Tb927.9.3670,11151.0,9906.5,10239.5,10163.0,10132.0,Endonuclease/Exonuclease/phosphatase family  putative,<2C (LG1)
Tb927.9.3680,11448.0,11290.5,10932.0,10884.5,10582.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.3750,5462.0,6538.5,6253.5,6205.5,6690.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.3760,6254.0,4859.5,6270.5,4772.5,3726.5,Nucleoporin GLE2,S
Tb927.9.3770,5241.5,927.5,1268.0,1044.0,1984.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.3780,612.5,3407.5,5637.0,4558.5,2706.5,Mitochondrial pyruvate carrier 1,S
Tb927.9.3800,8542.5,7804.5,7393.0,7314.0,6006.0,kinetoplastid kinetochore protein 18,<2C (LG1)
Tb927.9.3820,1988.0,8201.0,6744.5,6582.5,6479.0,syntaxin  putative,G1
Tb927.9.3840,1460.0,4393.0,4117.0,3154.0,3566.5,hypothetical protein  conserved,G1
Tb927.9.3850,3996.0,9583.0,9493.5,9879.5,9596.5,Protein of unknown function (DUF788)  putative,G2M
Tb927.9.3860,9281.0,9598.5,9909.0,9593.0,9662.5,Dyggve-Melchior-Clausen syndrome protein  putative,S
Tb927.9.3870,2381.5,4983.0,5604.5,5917.0,5870.5,hypothetical protein  conserved,G2M
Tb927.9.3880,6061.5,9391.5,8973.5,9666.0,7944.5,DNA polymerase beta thumb  putative,G2M
Tb927.9.3920,3570.5,1727.5,1237.5,1056.5,2991.5,ribosomal protein S7  putative,<2C (LG1)
Tb927.9.3930,10809.5,10845.5,10741.5,10965.0,11103.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.3970,10946.0,10719.0,10996.5,10851.0,10622.0,nicotinamidase  putative,S
Tb927.9.3990,1988.0,1602.5,1207.5,1352.5,3524.0,ribosomal protein S7  putative,>4C (GG2M)
Tb927.9.4000,8056.5,7529.0,8000.5,7940.0,9185.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.4040,10935.0,10735.5,10961.0,10827.5,10630.0,nicotinamidase  putative,S
Tb927.9.4050,10878.5,11401.0,11397.0,11423.0,11243.5,Ring finger domain/Zn-finger in ubiquitin-hydrolases and other protein  putative,G2M
Tb927.9.4080,11228.0,11341.0,11354.0,11398.0,10784.0,Stumpy formation signalling pathway protein  putative,G2M
Tb927.9.4130,9454.0,9421.5,9295.0,9872.5,9694.0,hypothetical protein  conserved,G2M
Tb927.9.4190,7713.0,9378.0,9863.0,9977.0,8327.5,fatty acyl CoA syntetase 1,G2M
Tb927.9.4200,10731.5,10684.0,10398.0,9811.0,8657.0,fatty acyl CoA synthetase 2,<2C (LG1)
Tb927.9.4207,4298.5,4553.0,4246.0,3577.5,2647.0,Noncoding RNA  putative,G1
Tb927.9.4210,10363.0,10936.0,11017.0,10704.5,9708.0,fatty acyl CoA synthetase 3,S
Tb927.9.4227,4403.5,4214.5,3885.0,3228.0,2805.5,Noncoding RNA  putative,<2C (LG1)
Tb927.9.4230,8023.5,10520.0,10920.5,10654.0,9383.0,fatty acyl CoA synthetase 4,S
Tb927.9.4250,5158.5,5442.5,5817.5,5704.5,2720.5,hypothetical protein  conserved,S
Tb927.9.4290,6037.5,7487.0,7685.0,8270.5,8409.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.4300,3579.5,5305.5,4695.5,4421.5,5609.5,PRP3  putative,>4C (GG2M)
Tb927.9.4310,7148.0,9750.5,9361.0,9822.0,9447.0,tricarboxylate carrier  putative,G2M
Tb927.9.4350,9946.0,11252.0,11299.0,11248.5,11155.0,hypothetical protein  conserved,S
Tb927.9.4360,2406.5,8746.0,8927.5,9671.0,9353.0,RNA-editing ligase 1  mitochondrial,G2M
Tb927.9.4370,3394.0,9040.0,8783.0,8486.0,9863.5,GTPase activating protein  putative,>4C (GG2M)
Tb927.9.4390,2913.0,4276.0,3531.0,3950.5,5404.0,DNA-damage inducible protein DDI1-like protein,>4C (GG2M)
Tb927.9.4420,5441.0,1727.5,2827.0,2252.0,10201.0,Beat-regulation protein,>4C (GG2M)
Tb927.9.4440,9226.0,10120.0,10210.0,10121.0,8590.5,Mitochondrial editosome-associated protein KREPB9,S
Tb927.9.4450,10801.0,10457.5,10980.5,11186.0,10500.0,hypothetical protein,G2M
Tb927.9.4500,10986.0,9524.5,9142.0,9245.5,6749.5,heat shock protein  putative,<2C (LG1)
Tb927.9.4520,10070.5,9877.5,9263.0,9281.5,10208.5,Mitochondrial-processing peptidase subunit beta,>4C (GG2M)
Tb927.9.4530,10952.5,10678.0,10609.0,10675.5,10079.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.4550,4734.5,5088.5,5460.5,5932.0,3386.5,SUMO-interacting motif-containing protein,G2M
Tb927.9.4560,9054.0,11251.0,11426.0,11269.0,10572.0,RBP32,S
Tb927.9.4570,4225.5,2652.5,2839.0,3393.5,1676.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.4620,6937.0,4816.5,6725.0,5538.5,5379.5,NEDD8 activating enzyme subunit  putative,<2C (LG1)
Tb927.9.4630,10914.5,10875.0,11027.0,10730.5,11074.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.4640,11590.0,11484.0,11504.0,11466.0,11154.0,Meckel syndrome type 6 protein  putative,<2C (LG1)
Tb927.9.4660,8825.5,7116.0,8709.0,7460.5,5854.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.4680,1460.0,774.5,685.0,557.5,1691.0,Eukaryotic initiation factor 4A-1,>4C (GG2M)
Tb927.9.4750,612.5,246.5,313.0,248.0,531.0,hypothetical protein,<2C (LG1)
Tb927.9.4755,4965.0,3225.0,2679.5,2038.5,1239.0,hypothetical protein,<2C (LG1)
Tb927.9.4760,612.5,9175.5,9758.5,9193.0,8559.0,Protein of unknown function (DUF3128)  putative,S
Tb927.9.4810,5844.5,9163.5,8375.5,8930.5,8193.0,hypothetical protein  conserved,G1
Tb927.9.4820,11265.0,11337.0,11183.0,11159.0,10908.5,calcium/potassium channel (CAKC)  putative,G1
Tb927.9.4840,3462.5,4540.5,4214.0,3605.5,5765.5,glucose transporter (pseudogene)  putative,>4C (GG2M)
Tb927.9.4850,10844.0,7385.5,8642.5,7327.0,5266.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.9.4900,8606.5,10420.5,10670.0,10683.5,10641.0,condensin subunit 1  putative,G2M
Tb927.9.4910,6088.5,8891.0,8497.0,8746.5,6938.5,3-phosphoinositide-dependent protein kinase 1  putative,G1
Tb927.9.4920,1783.5,5967.0,4807.5,7268.5,4222.5,hypothetical protein  conserved,G2M
Tb927.9.4930,6233.5,3492.0,4356.5,4156.0,2734.0,divalent cation transporter  putative,<2C (LG1)
Tb927.9.4940,2221.0,3526.0,3727.5,3452.5,4355.0,presenilin-like aspartic peptidase  putative,>4C (GG2M)
Tb927.9.4950,3534.0,7533.5,7013.5,7605.5,9863.5,radical SAM domain protein  putative,>4C (GG2M)
Tb927.9.4960,612.5,1875.5,1489.0,1228.0,672.0,hypothetical protein  conserved,G1
Tb927.9.4990,5361.5,4849.5,4316.5,4137.0,4292.0,DNA replication complex GINS protein PSF1,<2C (LG1)
Tb927.9.5000,9038.0,8642.5,9324.5,8844.5,9225.0,hypothetical protein  conserved,S
Tb927.9.5020,8601.5,9950.5,9975.0,9627.0,10507.0,HMG-box domain containing protein  putative,>4C (GG2M)
Tb927.9.5040,11185.0,11273.0,11313.0,11409.5,11481.5,cAMP-specific phosphodiesterase,>4C (GG2M)
Tb927.9.5100,9988.0,9906.5,9443.5,9123.5,10947.0,cAMP-specific phosphodiesterase,>4C (GG2M)
Tb927.9.5150,1460.0,787.5,596.0,687.0,1047.0,ribosomal protein S6  putative,<2C (LG1)
Tb927.9.5170,3261.0,4103.5,3021.0,3393.5,6655.5,phosphomevalonate kinase protein  putative,>4C (GG2M)
Tb927.9.5190,1914.0,4928.0,7712.0,7336.5,10179.5,proliferative cell nuclear antigen (PCNA)  putative,>4C (GG2M)
Tb927.9.5210,3341.5,3813.5,3832.5,4894.5,3606.5,glutaminyl-tRNA synthetase  putative,G2M
Tb927.9.5220,1460.0,3353.0,3475.0,2746.5,347.0,conserved protein,S
Tb927.9.5240,7903.5,10921.0,10827.0,10775.5,10306.5,mismatch repair protein MSH3  putative,G1
Tb927.9.5260,10700.0,9773.0,10016.5,9826.5,8380.0,ERAD-associated E3 ubiquitin-protein ligase HRD1  putative,<2C (LG1)
Tb927.9.5300,6516.5,10480.0,9594.5,9797.0,9852.0,kinetoplast ribosomal PPR-repeat containing protein 16,G1
Tb927.9.5320,1460.0,5789.5,6262.0,5190.5,8093.5,nucleolar RNA binding protein  putative,>4C (GG2M)
Tb927.9.5330,5500.5,8365.5,6886.5,6989.0,4065.0,Putative papain-like cysteine peptidase (DUF1796)  putative,G1
Tb927.9.5350,8257.0,8786.0,9687.5,9281.5,10137.5,actin related protein 3  putative,>4C (GG2M)
Tb927.9.5370,9604.0,7992.5,8791.0,8309.0,5870.5,2OG-Fe(II) oxygenase superfamily  putative,<2C (LG1)
Tb927.9.5380,9231.5,10539.0,10575.5,10542.5,9142.0,Rab-GTPase-TBC domain containing protein  putative,S
Tb927.9.5390,5876.5,6170.0,6278.0,6637.0,5003.0,hypothetical protein  conserved,G2M
Tb927.9.5410,10561.0,10305.5,10343.0,10556.5,9340.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.5440,4642.5,1068.5,1742.5,2919.0,8611.0,actin  putative,>4C (GG2M)
Tb927.9.5460,5779.0,9932.5,9823.0,10271.0,10802.0,Eukaryotic translation initiation factor 4 gamma 2,>4C (GG2M)
Tb927.9.5490,7819.0,10849.5,10325.5,10846.0,9185.0,cation transporter  putative,G1
Tb9.NT.32,6120.0,2808.0,1831.0,2211.5,5220.0,Noncoding RNA  putative,<2C (LG1)
Tb927.9.5520,11695.0,11634.0,11630.0,11617.0,11650.0,ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb927.9.5590,1460.0,8651.5,9315.0,8011.5,8826.5,DNA topoisomerase ii,S
Tb927.9.5620,11528.5,11355.0,11264.0,11043.0,11285.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.5630,6900.0,7554.5,6429.5,5445.5,4586.5,KREPB7,G1
Tb927.9.5650,3803.0,4441.0,5452.0,4433.0,4725.0,E2-like ubiquitin-conjugation enzyme  putative,S
Tb927.9.5680,11304.0,10785.0,10534.5,10509.0,10502.0,inositol/phosphatidylinositol phosphatase  putative,<2C (LG1)
Tb927.9.5690,1460.0,690.0,161.0,248.0,86.0,60S acidic ribosomal protein  putative,<2C (LG1)
Tb927.9.5700,11502.5,11657.0,11645.0,11655.0,11566.0,hypothetical protein  conserved,G1
Tb927.9.5710,4510.5,3211.5,2103.5,2617.5,2847.0,general transcription factor IIB,<2C (LG1)
Tb927.9.5730,6474.5,9240.0,9027.5,9755.5,9269.0,nucleosome assembly protein-like protein,G2M
Tb927.9.5770,6649.0,8051.0,7614.0,8100.0,8914.5,tryparedoxin peroxidase,>4C (GG2M)
Tb927.9.5800,4703.5,2444.5,2399.5,2520.5,2601.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.5860,8510.5,5775.5,5598.0,5295.5,7015.5,tryparedoxin peroxidase,<2C (LG1)
Tb927.9.5880,10703.0,9322.0,9379.5,9238.0,10125.0,pre-mRNA splicing factor  putative,<2C (LG1)
Tb927.9.5890,11067.5,10744.0,10476.5,10089.0,10208.5,solanesyl-diphosphate synthase  putative,<2C (LG1)
Tb927.9.5900,8863.0,10550.5,10989.0,10373.0,10821.0,glutamate dehydrogenase,S
Tb927.9.5960,4316.5,5669.5,6339.5,6397.5,7465.5,succinate dehydrogenase iron-sulfur subunit  putative,>4C (GG2M)
Tb927.9.6010,10717.0,10682.5,10827.0,10752.5,10895.5,DNA repair protein Rad9  putative,>4C (GG2M)
Tb927.9.6040,4253.5,7902.0,8160.5,8185.5,7871.0,E1-like ubiquitin-activating enzyme  putative,G2M
Tb927.9.6060,6163.0,8789.0,9169.5,9366.0,6729.5,ERV/ALR sulfhydryl oxidase domain-containing protein,G2M
Tb927.9.6070,5286.0,4719.0,3398.5,4243.0,4429.0,40S ribosomal protein S3  putative,<2C (LG1)
Tb927.9.6090,11324.0,11126.0,11180.0,11196.0,10817.0,PTP1-interacting protein  39 kDa,<2C (LG1)
Tb9.NT.34,5505.0,6255.5,5208.5,6192.0,6614.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.9.6100,10988.0,10836.0,10869.5,10944.0,10378.0,PTP1-interacting protein  39 kDa,<2C (LG1)
Tb927.9.6110,7830.0,10994.0,11010.0,11002.0,10174.5,Nucleus and spindle associated protein 2,S
Tb927.9.6130,10686.5,6538.5,7091.5,7963.5,11378.5,calmodulin  putative,>4C (GG2M)
Tb927.9.6150,10970.0,10289.5,10194.0,10536.0,9246.5,protein phosphatase 2A regulatory subunit  putative,<2C (LG1)
Tb927.9.6160,11355.0,11158.0,11233.0,11399.0,11351.5,hypothetical protein  conserved,G2M
Tb927.9.6210,8218.0,7395.0,9004.5,8940.0,9467.0,arginine kinase,>4C (GG2M)
Tb927.9.6250,7007.0,6458.5,7756.0,7687.0,8268.0,arginine kinase,>4C (GG2M)
Tb927.9.6270,8149.0,7572.5,8378.5,8829.0,7936.0,hypothetical protein  conserved,G2M
Tb927.9.6290,8144.0,8911.5,9940.5,9851.0,10803.0,arginine kinase,>4C (GG2M)
Tb927.9.6310,8892.0,9718.0,9475.0,9374.5,9302.5,ABC transporter  putative,G1
Tb927.9.6320,9585.5,8850.5,7668.0,8121.5,7525.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.6350,7277.5,7660.0,8809.0,8597.5,7213.0,inositol-1(or 4)-monophosphatase  putative,S
Tb927.9.6360,10151.0,10984.0,10994.5,10892.0,10787.0,hypothetical protein  conserved,S
Tb927.9.6370,8264.0,9514.5,9069.5,9609.5,8460.5,hypothetical protein  conserved,G2M
Tb927.9.6380,11018.0,10799.0,10851.0,10747.0,10743.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.6390,612.5,1904.5,1923.0,2120.5,3431.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.6410,11125.0,11535.0,11558.0,11568.0,11393.0,hypothetical protein  conserved,G2M
Tb927.9.6420,3283.5,7403.5,7350.0,6540.5,3775.0,hypothetical protein  conserved,G1
Tb927.9.6430,11149.0,9628.0,8455.5,8449.5,7778.0,Rab geranylgeranyl transferase component A  putative,<2C (LG1)
Tb927.9.6440,8534.5,7128.5,7171.5,6802.5,5567.0,dolichol phosphate-mannose biosynthesis regulatory protein (DPM2)  putative,<2C (LG1)
Tb927.9.6450,11558.0,10184.5,10051.0,10041.0,9584.5,peroxisomal membrane protein (Pex16)  putative,<2C (LG1)
Tb927.9.6460,10737.0,10680.5,10014.0,10050.0,11562.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.6470,8938.5,6858.5,6905.5,7692.0,7994.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.6510,11685.0,11491.0,11489.0,11530.0,11350.0,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.9.6530,7770.5,9524.5,9951.5,9489.5,8213.5,hypothetical protein,S
Tb927.9.6560,10848.0,7618.0,7905.5,8379.0,8165.0,NAK family pseudokinase  putative,<2C (LG1)
Tb927.9.6570,4449.5,5069.5,3978.5,4828.5,5054.0,hypothetical protein  conserved,G1
Tb927.9.6580,9526.5,8107.0,9024.0,8676.0,8165.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.6620,5565.5,8254.0,7727.5,8011.5,8310.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.6650,11562.0,11151.0,10979.0,11066.0,10854.5,tRNA synthetases class II (A)/Threonyl and Alanyl tRNA synthetase second additional domain containing protein  putative,<2C (LG1)
Tb927.9.6660,6961.5,9258.5,9402.5,9149.5,9438.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.6670,11709.0,11701.0,11701.0,11702.0,11692.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.6710,11390.5,11494.0,11597.0,11581.5,11494.0,kynurenine 3-monooxygenase  putative,S
Tb927.9.6720,9590.5,10644.5,10645.0,10406.5,9208.5,Putative methyltransferase  putative,S
Tb927.9.6730,9866.0,10916.5,11033.0,11179.5,11127.0,hypothetical protein  conserved,G2M
Tb927.9.6760,4740.5,2490.5,1300.0,1585.5,637.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.6830,11474.0,11633.0,11622.0,11642.0,11464.0,hypothetical protein,G2M
Tb927.9.6855,2460.0,3700.0,3568.0,3102.5,1860.5,hypothetical protein,G1
Tb927.9.6870,3028.5,4510.5,3157.0,4421.5,2203.5,RNA-binding protein  putative,G1
Tb927.9.6880,10399.0,9611.5,9361.0,9751.0,9911.0,cAMP-specific phosphodiesterase  putative,<2C (LG1)
Tb927.9.6890,7451.0,2020.5,2604.0,3029.0,584.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.6910,612.5,3552.0,3697.0,4623.0,4135.5,hypothetical protein  conserved,G2M
Tb927.9.6920,7195.5,8770.0,9798.5,9249.5,9138.0,hypothetical protein  conserved,S
Tb927.9.6940,9229.0,9516.5,10118.0,10303.0,9976.0,DNA topoisomerase type IB small subunit,G2M
Tb927.9.6960,5048.0,3032.5,2894.5,3521.5,5064.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.7000,9847.0,9991.5,9829.0,9217.5,10554.5,methyltransferase domain containing protein  putative,>4C (GG2M)
Tb927.9.7020,4010.5,7634.0,6803.5,5775.5,5988.0,hypothetical protein  conserved,G1
Tb927.9.7030,11386.0,11477.5,11520.0,11531.0,11317.0,hypothetical protein  conserved,G2M
Tb927.9.7040,9900.5,10922.5,10947.5,11007.0,11159.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.7060,8168.0,7689.5,6735.0,7194.0,7699.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7070,10494.0,8228.5,8502.5,7681.5,7236.5,exosome complex exonuclease RRP40,<2C (LG1)
Tb927.9.7080,612.5,1344.0,2318.5,1745.0,3006.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.7090,10165.0,9415.5,9743.5,9337.0,9934.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7100,4947.5,9183.0,9705.5,9786.5,9900.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.7110,7983.0,8392.0,8506.0,8607.5,7676.5,GRAM domain containing protein  putative,G2M
Tb927.9.7150,10684.0,11348.0,11436.0,11353.0,11033.0,RNA pseudouridylate synthase protein  putative,S
Tb927.9.7160,3394.0,5695.5,3801.5,3295.5,3812.0,hypothetical protein  conserved,G1
Tb927.9.7170,9470.5,8658.5,8152.5,8374.0,6588.5,Mitochondrial ribosomal protein L47,<2C (LG1)
Tb927.9.7180,9908.0,9836.5,9423.0,9457.0,11320.0,adenosine monophosphate deaminase  putative,>4C (GG2M)
Tb927.9.7190,4930.5,8477.5,7861.0,7642.5,7065.5,Trans-2-enoyl-ACP reductase 1  putative,G1
Tb927.9.7200,10593.0,6244.5,7177.0,7027.5,5943.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7210,10048.5,11104.5,11378.0,11291.0,10567.0,mitochondrial exoribonuclease DSS-1,S
Tb927.9.7230,6724.5,6824.0,6831.5,6009.0,7169.5,ADP-ribosylation factor-like protein  putative,>4C (GG2M)
Tb927.9.7250,1988.0,1394.5,1831.0,2483.5,1608.0,hypothetical protein  conserved,G2M
Tb927.9.7260,10945.0,10347.0,10146.5,10344.5,9884.0,phytanoyl-CoA dioxygenase (PhyH)  putative,<2C (LG1)
Tb927.9.7270,6689.0,11365.0,11273.0,11282.0,11169.0,hypothetical protein,G1
Tb927.9.7285,612.5,3109.0,2251.5,1675.5,347.0,hypothetical protein,G1
Tb927.9.7290,8752.0,9454.0,9379.5,8945.0,9766.5,variant surface glycoprotein (VSG)-related  putative,>4C (GG2M)
Tb927.9.7310,9142.5,8331.5,8185.0,8132.5,6195.0,variant surface glycoprotein (VSG  pseudogene)-related  putative,<2C (LG1)
Tb927.9.7320,10558.5,10523.0,10663.5,10716.0,10170.5,expression site-associated gene 11 (ESAG11) protein  putative,G2M
Tb927.9.7330,10053.0,9081.5,9513.0,9430.5,9755.5,expression site-associated gene 2 (ESAG2) protein  putative,<2C (LG1)
Tb927.9.7340,10250.5,9963.0,9353.5,9939.0,9847.0,expression site-associated gene 9 (ESAG9) protein  putative,<2C (LG1)
Tb927.9.7350,7755.5,9350.5,9388.5,9206.0,9062.0,expression site-associated gene 1 (ESAG1)  pseudogene,S
Tb927.9.7370,8811.0,7083.5,7676.5,8368.0,7959.5,expression site-associated gene 9 (ESAG9) protein  putative,<2C (LG1)
Tb927.9.7380,10415.0,10891.0,11143.0,11192.0,10748.5,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.9.7390,8499.0,8404.0,8627.0,8888.0,7670.0,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.9.7400,9064.5,9237.5,9230.5,9554.0,9160.0,expression site-associated gene 11 (ESAG11) protein  putative,G2M
Tb927.9.7410,7080.5,7879.0,8229.5,7959.5,8389.0,expression site-associated gene 2 (ESAG2) protein  putative,>4C (GG2M)
Tb927.9.7420,612.5,3353.0,2673.0,2290.0,1374.5,expression site-associated gene 9 (ESAG9) protein  putative,G1
Tb927.9.7430,11401.0,11479.0,11521.0,11507.5,11291.5,variant surface glycoprotein (VSG)-related  putative,S
Tb927.9.7470,7868.0,8035.5,8257.5,8668.0,6344.5,purine nucleoside transporter,G2M
Tb927.9.7480,10872.0,7059.0,7411.0,7902.5,7047.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7500,3224.0,1595.5,2144.5,2168.5,2141.5,hypothetical protein,<2C (LG1)
Tb927.9.7520,11284.0,6170.0,5848.5,6582.5,7262.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7540,11112.0,11267.0,11284.5,11400.5,10601.0,cysteine peptidase  Clan CA  family C2  putative,G2M
Tb927.9.7550,10963.5,11179.5,11035.0,11097.5,11261.0,adenylosuccinate lyase  putative,>4C (GG2M)
Tb927.9.7580,8294.0,8317.0,8815.5,9048.5,8511.0,hypothetical protein  conserved,G2M
Tb927.9.7590,612.5,640.0,578.5,610.5,1622.5,60S ribosomal protein L11  putative,>4C (GG2M)
Tb927.9.7620,612.5,565.0,731.0,628.0,1691.0,60S ribosomal protein L11  putative,>4C (GG2M)
Tb927.9.7650,5554.0,5397.5,4944.0,5454.0,8817.0,ADP-ribosylation factor  putative,>4C (GG2M)
Tb927.9.7670,2221.0,2042.0,1179.5,1745.0,2310.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.7690,8434.0,8379.0,9988.5,10243.5,11669.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.9.7700,7459.5,10231.0,10343.0,10305.5,9779.5,palmitoyl acyltransferase 1  putative,S
Tb927.9.7710,612.5,4365.0,3952.0,3307.0,3271.5,hypothetical protein  conserved,G1
Tb927.9.7720,6787.5,10855.0,11138.5,11391.5,11663.0,predicted tetratricopeptide repeat protein,>4C (GG2M)
Tb927.9.7740,8110.5,9745.0,9301.5,8981.0,9545.0,lipid-like atypical dual specificity phosphatase  putative,G1
Tb927.9.7760,9349.5,10763.0,10986.0,10769.5,10227.0,DENN (AEX-3) domain containing protein  putative,S
Tb927.9.7770,9109.0,6732.0,6504.5,7891.0,9289.0,spermidine synthase,>4C (GG2M)
Tb927.9.7800,5314.0,8568.0,8386.0,8427.5,7753.0,hypothetical protein  conserved,G1
Tb927.9.7810,612.5,3615.5,2909.0,2928.0,1647.0,hypothetical protein  conserved,G1
Tb927.9.7820,9440.0,10659.5,10528.5,10630.5,10524.5,hypothetical protein  conserved,G1
Tb927.9.7830,612.5,6488.0,5908.5,6192.0,4806.5,tRNA import complex component  putative,G1
Tb927.9.7850,7747.0,8926.5,8378.5,8793.0,8563.0,hypothetical protein  conserved,G1
Tb927.9.7860,11353.0,10711.5,10614.0,10861.0,9920.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7870,10356.5,10815.0,10699.5,10940.0,9208.5,hypothetical protein  conserved,G2M
Tb927.9.7880,6934.0,7258.5,6016.0,7398.5,6270.0,hypothetical protein  conserved,G2M
Tb927.9.7890,5604.0,10446.0,10502.0,10395.5,10016.5,hypothetical protein  conserved,S
Tb927.9.7900,10028.0,7806.5,7622.5,8593.5,7631.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7910,3904.5,1394.5,1721.5,1654.0,1047.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7920,6372.0,9670.0,8101.5,9366.0,9090.0,hypothetical protein  conserved,G1
Tb927.9.7930,9943.0,7825.0,7662.0,8573.5,7494.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7940,3957.5,1108.0,1679.0,2025.0,994.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.7950,7640.5,11390.0,11324.0,11452.0,11389.0,hypothetical protein,G2M
Tb927.9.7960,3054.0,10001.5,10188.0,10347.5,8088.0,hypothetical protein,G2M
Tb927.9.7980,5006.5,9466.0,8386.0,9189.5,9259.5,hypothetical protein  conserved,G1
Tb927.9.8000,8264.0,7430.0,7879.0,7959.5,9579.5,ubiquitin-protein ligase  putative,>4C (GG2M)
Tb927.9.8030,8556.5,9139.5,8362.5,8863.5,5765.5,hypothetical protein  conserved,G1
Tb927.9.8040,10535.5,10592.0,10691.0,10813.0,10462.5,hypothetical protein  conserved,G2M
Tb927.9.8050,8845.5,10939.0,11199.5,11167.0,10692.0,Protein of unknown function (DUF974)  putative,S
Tb927.9.8060,6389.5,9960.5,8446.0,9572.0,6848.5,WAHD domain of WASH complex  putative,G1
Tb927.9.8070,2574.5,307.0,189.5,204.0,461.5,QM-like protein,<2C (LG1)
Tb927.9.8100,5938.5,1371.5,2275.0,1558.5,1816.5,nascent polypeptide associated complex subunit  putative,<2C (LG1)
Tb927.9.8130,8575.5,2934.5,3224.5,3477.5,2977.5,nascent polypeptide associated complex subunit  putative,<2C (LG1)
Tb927.9.8160,2855.0,5573.0,4448.0,4994.0,4664.5,chaperone protein DnaJ  putative,G1
Tb927.9.8180,5722.0,9586.0,8676.5,10085.5,9766.5,hypothetical protein  conserved,G2M
Tb927.9.8190,10649.0,9476.5,10086.0,10443.0,10534.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8200,4713.5,9020.5,9286.5,7547.0,8703.0,Pescadillo N-terminus/BRCA1 C Terminus (BRCT) domain containing protein  putative,S
Tb927.9.8210,8173.5,9731.0,9653.5,9666.0,9807.5,Peptide deformylase 2,>4C (GG2M)
Tb927.9.8240,10182.5,9854.5,9615.5,10053.0,9496.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8250,7368.5,10956.5,10706.0,10456.5,8615.0,atypical dual specificity phosphatase  putative,G1
Tb927.9.8260,4418.5,9784.5,9117.5,9416.5,6903.0,rhomboid-like protein,G1
Tb927.9.8290,8614.5,6615.5,6953.0,7021.5,5624.0,mitochondrial ribosomal protein l30,<2C (LG1)
Tb927.9.8320,2658.5,4733.5,4148.5,4011.0,2203.5,hypothetical protein,G1
Tb927.9.8330,5393.5,8461.0,7069.0,7285.0,6535.5,hypothetical protein,G1
Tb927.9.8350,6101.0,7883.0,8071.0,9177.5,11674.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.8370,7255.0,5542.0,4790.5,4928.5,5301.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8380,9145.0,5251.5,5187.5,6157.0,7308.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8400,7437.0,10579.0,10383.0,10357.0,10756.5,predicted zinc finger protein,>4C (GG2M)
Tb927.9.8410,8105.0,8449.0,8718.5,8955.0,4893.5,chaperone protein DnaJ  putative,G2M
Tb927.9.8420,2406.5,176.5,313.0,182.5,761.5,QM-like protein,<2C (LG1)
Tb927.9.8450,5190.5,4294.5,4540.5,4686.5,2941.0,UMP/CMP kinase,<2C (LG1)
Tb927.9.8490,9016.0,6611.5,6568.5,5375.0,3185.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8500,10428.5,9939.0,9986.0,9905.5,7559.0,hypothetical protein,<2C (LG1)
Tb927.9.8510,11628.0,10773.0,10653.5,10830.5,10969.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8520,2552.0,8574.5,8200.0,8397.0,7670.0,hypothetical protein  conserved,G1
Tb927.9.8540,10301.0,11148.5,11117.5,10951.5,10873.0,Voltage-gated Chloride channel Like 1,G1
Tb927.9.8550,612.5,6339.0,6976.0,5981.0,8428.5,Domain of unknown function (DUF947)  putative,>4C (GG2M)
Tb927.9.8570,612.5,2839.5,3335.0,2357.0,2884.5,COPI associated protein  putative,S
Tb927.9.8580,3964.5,2198.0,1634.5,2999.5,1878.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8610,11595.0,11496.0,11450.0,11473.5,11358.5,Transcriptional repressor TCF25  putative,<2C (LG1)
Tb927.9.8620,11239.5,10356.0,10253.5,10488.5,7956.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8650,10588.0,8884.5,8668.0,9451.0,10109.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8655,612.5,1425.5,954.0,1187.5,1304.5,hypothetical protein,G1
Tb927.9.8670,10818.0,8503.5,8071.0,7434.0,7431.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8680,8033.0,4913.5,6334.0,6240.5,5083.0,cytochrome c oxidase assembly factor  putative,<2C (LG1)
Tb927.9.8700,10721.0,10353.5,9774.0,8997.0,7871.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.8710,5856.0,7243.0,7324.0,6219.5,7796.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.8720,3419.0,7622.0,8152.5,7617.5,4110.0,fructose-1 6-bisphosphatase,S
Tb927.9.8740,7391.5,9175.5,8206.5,8825.5,10885.0,Double RNA binding domain protein 3,>4C (GG2M)
Tb927.9.8760,11664.0,11655.0,11649.0,11680.0,11702.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.8780,3462.5,8020.5,7572.0,8116.5,6808.0,tRNA nucleotidyltransferase  putative,G2M
Tb927.9.8810,5074.0,5295.0,5091.5,5969.0,5841.5,hypothetical protein  conserved,G2M
Tb927.9.8815,6308.5,4886.5,6147.0,7258.0,6712.0,hypothetical protein,G2M
Tb927.9.8820,2047.0,1629.0,2499.0,2617.5,11284.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.8850,7242.5,7682.5,6123.0,8656.5,6670.0,actin A,G2M
Tb927.9.8880,8542.5,8096.5,6687.5,8853.5,7060.5,actin B,G2M
Tb927.9.8905,3142.5,7459.0,4840.5,5608.0,5745.0,hypothetical protein,G1
Tb927.9.8950,7358.0,7073.0,6561.5,6009.0,7285.5,metallo- peptidase  Clan M- Family M48,<2C (LG1)
Tb927.9.8990,8903.5,7059.0,6866.5,7264.0,8389.0,Ankyrin repeats (3 copies)  putative,<2C (LG1)
Tb927.9.9000,6912.5,9437.5,9310.0,9226.5,7994.5,isopentenyl-diphosphate delta-isomerase (type II),G1
Tb927.9.9010,9511.5,8843.0,8596.0,8871.0,8789.0,SAC3/GANP/Nin1/mts3/eIF-3 p25 family  putative,<2C (LG1)
Tb927.9.9020,8582.5,6115.0,6772.0,7361.0,2050.0,ribosome-interacting GTPase 2  putative,<2C (LG1)
Tb927.9.9030,7438.5,7679.5,8031.0,8482.5,5686.0,hypothetical protein  conserved,G2M
Tb927.9.9060,612.5,1231.0,1574.0,1792.5,2098.0,Lsm12 protein  putative,>4C (GG2M)
Tb927.9.9080,1460.0,5579.0,6211.0,7586.5,4355.0,Present in the outer mitochondrial membrane proteome 5,G2M
Tb927.9.9090,3295.0,7554.5,7887.0,7495.5,4403.5,WD domain  G-beta repeat  putative,S
Tb927.9.9100,612.5,1602.5,1078.0,2373.0,9254.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.9115,612.5,3284.0,2577.0,2456.5,5888.5,hypothetical protein,>4C (GG2M)
Tb927.9.9120,7310.0,6599.5,6142.0,6831.0,6826.5,tRNA (guanine-N(7)-)-methyltransferase  putative,<2C (LG1)
Tb927.9.9140,3230.0,5155.0,4990.5,4522.0,5479.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.9150,11344.0,8590.5,9181.0,8974.0,6975.5,GTP-binding protein  putative,<2C (LG1)
Tb927.9.9160,9575.5,9587.5,9669.0,9805.0,9295.5,hypothetical protein  conserved,G2M
Tb927.9.9170,8868.0,8270.0,7786.5,8036.0,8713.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.9180,6546.5,5979.5,6523.0,6591.5,7762.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.9190,10667.0,11394.0,11420.5,11527.0,11091.0,hypothetical protein  conserved,G2M
Tb927.9.9200,1914.0,8336.5,8949.5,8656.5,9182.0,alpha-1 2-mannosyltransferase  putative,>4C (GG2M)
Tb927.9.9210,612.5,1849.0,1054.0,1899.5,4014.5,60S ribosomal protein L37  putative,>4C (GG2M)
Tb927.9.9220,9174.5,9387.5,9960.0,10259.5,9633.0,ribonuclease P,G2M
Tb927.9.9230,4776.0,4163.0,3379.0,3566.5,3474.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.9260,9636.5,8574.5,8502.5,8264.5,8955.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.9270,9001.5,8522.0,9394.0,9445.0,9692.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.9280,11417.0,11381.0,11488.0,11457.5,11183.0,hypothetical protein  conserved,S
Tb927.9.9290,11076.0,10583.5,10855.0,10582.0,9524.0,polyadenylate-binding protein 1,<2C (LG1)
Tb927.9.9300,10329.5,9691.0,9604.5,9185.0,9269.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.9310,11593.0,11138.0,11300.0,11141.5,11138.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.9320,10345.0,10892.0,11072.5,11068.5,10871.5,MAPK/MAK/MRK overlapping kinase  putative,S
Tb927.9.9370,10782.0,10459.0,10303.5,10755.0,9530.0,PSP1 C-terminal conserved region  putative,<2C (LG1)
Tb927.9.9380,7180.5,8813.0,8741.5,8715.0,8848.5,sphingomyelin/ceramide phosphorylethanolamine synthase  bifunctional,>4C (GG2M)
Tb927.9.9390,9739.5,9918.5,9315.0,9751.0,8530.0,sphingomyelin/ceramide phosphorylethanolamine synthase  bifunctional,G1
Tb927.9.9400,8288.5,7016.0,6879.0,6694.0,5916.5,ceramide phosphorylethanolamine synthase,<2C (LG1)
Tb927.9.9410,9499.5,9861.0,9526.0,9601.5,8973.0,inositol phosphorylceramide synthase,G1
Tb927.9.9420,8477.5,9258.5,9169.5,9350.5,9616.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.9430,3063.5,10432.5,9860.0,10619.0,10121.5,Peroxisomal membrane protein PEX13.2,G2M
Tb927.9.9450,3558.0,9163.5,9292.0,10325.0,11601.0,zinc finger protein family member  putative,>4C (GG2M)
Tb927.9.9520,7854.0,9698.0,9875.0,9267.0,9686.0,zinc finger protein family member  putative,S
Tb927.9.9550,8244.5,5243.0,4485.5,5600.0,5209.5,conserved protein  unknown function,<2C (LG1)
Tb927.9.9580,4900.0,9266.0,10018.5,9598.0,10007.5,tubulin tyrosine ligase protein  putative,S
Tb927.9.9600,5408.0,8689.0,9133.5,8958.5,6096.5,DNA replication licensing factor MCM9  putative,S
Tb927.9.9610,612.5,2350.5,3288.0,2440.0,3248.5,hypothetical protein  conserved,S
Tb927.9.9620,5393.5,6846.5,7297.0,7003.0,6564.5,meiotic recombination protein DMC1  putative,S
Tb927.9.9630,5689.5,8075.5,8108.5,9170.5,9860.5,TPR repeat/Tetratricopeptide repeat  putative,>4C (GG2M)
Tb927.9.9640,7857.0,11265.0,11325.0,11442.0,11632.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.9660,4333.5,7427.0,6910.5,8076.5,6679.0,Mitochondrial import receptor subunit ATOM40,G2M
Tb927.9.9670,2729.0,1982.5,3697.0,5031.5,6844.5,proteasome alpha 1 subunit  putative,>4C (GG2M)
Tb927.9.9690,10530.0,8370.0,7793.5,8435.0,7104.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.9700,9089.0,10809.0,10250.5,10061.0,8703.0,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,G1
Tb927.9.9710,9060.0,8211.5,8000.5,8110.0,7981.0,Histidine phosphatase superfamily (branch 1)  putative,<2C (LG1)
Tb927.9.9720,8947.5,7736.5,7763.5,8018.0,4391.0,glucosidase II beta subunit-like protein  putative,<2C (LG1)
Tb927.9.9730,4364.5,1838.0,2440.5,2775.0,2550.0,Flagellar pocket protein FP45,<2C (LG1)
Tb927.9.9740,11692.0,10452.0,9812.5,11100.0,11644.0,AMP deaminase  putative,<2C (LG1)
Tb927.9.9750,4298.5,8333.0,7823.5,8164.0,7559.0,membrane- trafficking protein  putative,G1
Tb927.9.9780,7069.5,10511.0,10453.0,9353.0,10317.0,peptidyl-prolyl cis-trans isomerase (cyclophilin- 40)  putative,G1
Tb927.9.9810,6286.5,3991.5,4170.0,2671.0,5624.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.9820,8023.5,6538.5,5670.5,5824.5,6377.5,glyceraldehyde-3-phosphate dehydrogenase  putative,<2C (LG1)
Tb927.9.9840,612.5,5871.0,7354.5,6331.5,6526.0,lipoic acid containing carrier protein  putative,S
Tb927.9.9860,10783.0,8930.5,8839.0,8759.0,7816.0,170 kDa glucose-regulated protein  putative,<2C (LG1)
Tb927.9.9870,6883.0,7818.0,8101.5,8409.5,8071.5,Kinesin-13 6  putative,G2M
Tb927.9.9940,3621.0,7110.0,6373.5,6441.0,6969.5,parkin coregulated gene protein,G1
Tb927.9.9950,1460.0,5782.0,6942.5,6863.0,7125.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.9960,9314.5,3256.0,5135.0,5317.0,11423.0,katanin P80 subunit  putative,>4C (GG2M)
Tb927.9.9970,10433.5,10530.0,9816.5,10355.0,7606.0,Small nuclear RNA gene activation protein (SNAP) 50,G1
Tb927.9.9990,7732.0,8792.5,8863.5,8762.0,7731.5,kinetoplastid-specific dual specificity phosphatase  putative,S
Tb927.9.10000,4066.0,6655.0,5537.0,4409.0,7060.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.10010,10304.5,11213.5,11304.0,11241.5,10755.0,chaperone protein DnaJ  putative,S
Tb927.9.10040,1460.0,4902.5,4124.0,4433.0,2413.0,Pseudokinase  putative,G1
Tb927.9.10050,3283.5,3900.0,3189.5,2275.5,3157.0,60Kd inner membrane protein  putative,G1
Tb927.9.10060,4057.5,3187.0,3275.0,2716.0,2941.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.10070,3054.0,5144.5,5197.0,4720.5,7693.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.10080,7635.5,9302.5,8655.5,9066.0,7896.5,phosphatidylserine decarboxylase  putative,G1
Tb927.9.10100,11626.0,11315.0,11414.0,11387.0,10671.0,SET domain-containing protein  putative,<2C (LG1)
Tb927.9.10140,10111.0,9927.5,10298.5,10376.5,10648.0,Uncharacterised conserved protein  putative,>4C (GG2M)
Tb927.9.10150,2995.0,2992.5,3717.5,2290.0,4560.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.10160,5784.5,3672.0,1757.0,1726.5,5240.0,MICOS complex subunit MIC60,<2C (LG1)
Tb927.9.10170,2221.0,4975.5,2673.0,2456.5,744.5,anaphase-promoting complex subunit 11,G1
Tb927.9.10190,7794.5,6324.0,6328.0,6098.5,5451.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.10200,612.5,565.0,161.0,737.0,433.0,hypothetical protein  conserved,G2M
Tb927.9.10230,7487.0,9902.0,8905.0,8121.5,7610.5,Co-chaperone protein P23,G1
Tb927.9.10250,6949.5,3217.5,4732.5,4309.5,8303.5,small nuclear ribonucleoprotein Sm-F,>4C (GG2M)
Tb927.9.10280,10433.5,7533.5,5661.5,7153.5,8006.0,Zinc finger CCCH domain-containing protein 48,<2C (LG1)
Tb927.9.10300,4375.0,5625.5,6360.5,6171.5,7951.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.10310,5133.0,7919.0,7350.0,7172.0,7792.5,mitochondrial carrier protein 11,G1
Tb927.9.10340,8733.5,10009.0,9591.5,9328.0,9650.0,Polyamine transporter 1  putative,G1
Tb927.9.10350,4282.0,8470.5,8768.0,8676.0,8111.0,Snf7  putative,S
Tb927.9.10360,612.5,6260.0,7685.0,8076.5,10375.0,Cytosolic iron-sulfur protein assembly 2A  putative,>4C (GG2M)
Tb927.9.10370,8553.5,8961.5,9691.0,9843.5,11685.0,TAX-1,>4C (GG2M)
Tb927.9.10400,6151.5,7470.5,7901.5,7611.0,6143.5,hypothetical protein  conserved,S
Tb927.9.10430,9116.5,4251.5,5577.5,5992.0,4517.5,Zinc-binding domain containing protein  putative,<2C (LG1)
Tb927.9.10440,10802.0,11223.0,11546.0,11584.0,11439.0,DNA polymerase epsilon catalytic subunit  putative,G2M
Tb927.9.10450,8236.5,11098.5,11000.5,10556.5,9399.0,hypothetical protein  conserved,G1
Tb927.9.10470,9600.5,9010.0,8960.0,8928.5,9322.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.10490,10502.5,11208.5,11184.0,11417.0,10862.5,Component of motile flagella 56,G2M
Tb927.9.10500,9027.0,9053.5,8362.5,9035.0,8831.5,HAD hydrolase  TIGR01456 family/HAD hydrolase  family IIA  putative,G1
Tb927.9.10510,9109.0,7203.0,6495.5,5775.5,8546.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.10520,6604.5,4413.0,4614.0,3241.5,2747.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.10530,11077.0,10422.5,10130.0,10513.5,8460.5,Flagellum attachment zone protein 4,<2C (LG1)
Tb927.9.10550,4784.0,4027.0,5598.0,9627.0,11691.0,Spindle assembly abnormal protein 6 homolog,>4C (GG2M)
Tb927.9.10560,8091.0,6670.0,7308.0,7540.0,9415.0,Archaic Translocase of outer membrane 19 kDa subunit,>4C (GG2M)
Tb927.9.10570,9979.0,9781.5,9937.5,9753.0,10224.0,predicted zinc finger protein,>4C (GG2M)
Tb927.9.10580,9900.5,6568.0,4069.0,5765.5,6448.5,3-demethylubiquinone-9 3-methyltransferase  putative,<2C (LG1)
Tb927.9.10630,4094.5,6512.5,7652.5,7384.5,6774.5,hypothetical protein  conserved,S
Tb927.9.10640,7383.5,10952.0,10843.5,11175.0,11082.0,synaptojanin (N-terminal domain)  putative,G2M
Tb927_09_v4.snoRNA.0081,2682.0,1190.0,1041.5,1071.0,1422.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0065,5018.5,3256.0,2764.5,2671.0,3271.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0073,3142.5,1394.5,1278.5,1403.5,2000.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0057,3711.5,2260.5,2182.5,1911.5,2297.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0010,3922.5,1766.0,1799.0,1779.5,1744.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0036,2047.0,588.0,448.0,592.5,584.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0023,612.5,40.5,40.0,33.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0114,3945.0,2402.0,2638.5,2072.5,1374.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0100,3078.5,1190.0,1254.0,1085.0,1437.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0082,3155.0,935.5,940.5,1085.0,1355.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0066,4397.0,2707.5,2369.0,2168.5,2794.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0074,3202.0,959.0,1008.5,1215.5,1374.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0058,3380.0,1704.5,1848.0,1688.5,2178.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0011,3680.5,1866.5,1465.0,1966.0,1676.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0037,2137.5,588.0,471.5,610.5,744.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0024,612.5,40.5,40.0,33.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0108,4200.0,2498.0,2977.0,2554.0,2589.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0101,2552.0,1034.0,1067.0,1017.0,915.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0083,3107.5,886.5,994.0,849.0,1325.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0067,5018.5,2877.0,3039.5,2642.5,3510.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0075,3013.5,1415.5,1489.0,1228.0,1860.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0059,3810.5,2138.5,2122.5,2252.0,2550.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0012,4002.5,1690.5,2050.0,1805.5,1744.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0038,2258.5,640.0,410.0,534.5,672.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0025,612.5,40.5,40.0,33.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0109,3579.5,3225.0,3224.5,3545.0,3235.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0102,3107.5,1124.5,1124.0,1071.0,1489.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0084,2901.0,978.5,778.0,687.0,1453.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0068,4608.5,2526.0,2378.0,2373.0,2914.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0076,2970.5,959.0,880.5,1110.5,1660.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0060,3054.0,1670.0,1757.0,1466.0,2164.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0016,3107.5,1371.5,1268.0,1281.0,1227.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0039,2295.5,518.0,448.0,334.5,559.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0026,612.5,40.5,40.0,33.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0110,4200.0,2561.0,3148.0,2577.5,2525.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0103,2747.5,1220.5,1379.5,1085.0,1489.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0085,2767.0,1975.0,2060.5,1980.0,2941.0,C/D snoRNA,>4C (GG2M)
Tb927_09_v4.snoRNA.0069,4922.5,2992.5,2987.0,2566.5,3648.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0077,2956.5,1506.5,1217.0,1329.0,2190.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0061,3670.5,2272.0,2300.0,2150.0,2389.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0013,3762.0,1716.0,1536.0,1726.5,1842.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0040,2137.5,588.0,410.0,610.5,607.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0027,612.5,40.5,40.0,33.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0111,4142.5,2392.5,2961.0,2311.0,2336.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0104,2658.5,774.5,767.0,664.0,1047.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0086,3063.5,759.0,925.0,757.5,1355.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0070,4544.0,2516.5,2465.5,2199.0,2834.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0078,3380.0,1353.5,1300.0,1243.0,2125.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0062,3613.0,1894.5,2011.5,1779.5,2203.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0014,3904.5,1747.5,1848.0,1745.0,1489.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0041,2180.0,565.0,410.0,501.5,584.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0028,612.5,40.5,40.0,33.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0112,4801.0,3129.0,4093.0,3418.5,3335.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0105,3848.5,1602.5,1977.0,1936.0,2016.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0087,3191.0,835.5,658.5,757.5,1078.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0071,5611.0,5069.5,5286.0,4552.0,5803.0,C/D snoRNA,>4C (GG2M)
Tb927_09_v4.snoRNA.0079,2094.5,509.0,448.0,483.0,559.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0063,3904.5,1643.5,1634.5,1847.0,1919.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0015,3778.0,2313.0,2238.0,2566.5,2402.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0042,2357.5,345.0,293.0,352.0,347.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0029,3810.5,1492.5,1574.0,1154.5,818.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0113,3558.0,1211.0,1446.0,1542.0,1453.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0106,2436.0,904.0,668.5,890.0,1304.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0088,3063.5,886.5,848.5,808.0,778.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0072,5190.5,4441.0,4304.0,4137.0,4586.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0080,2180.0,208.5,271.5,111.0,397.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0064,3380.0,1153.5,1008.5,1202.5,1355.0,H/ACA-like snoRNA,<2C (LG1)
Tb09_snoRNA_0076,2780.5,4596.5,3877.5,3463.5,3055.0,H/ACA snoRNA  TB9Cs2H1,G1
Tb927.9.10650,1988.0,4719.0,5419.0,5808.5,3847.5,hypothetical protein,G2M
Tb927.9.10660,3358.0,2851.5,2858.0,3045.0,2601.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.10670,5369.0,7414.5,8038.5,7511.5,6195.0,bardet-biedl syndrome 1 protein,S
Tb927.9.10680,1988.0,4503.0,3441.0,3228.0,3065.0,RNA polymerase III RPC4  putative,G1
Tb927.9.10690,1914.0,6352.5,6718.0,6014.5,4748.5,Protein of unknown function (DUF2009)  putative,S
Tb927.9.10710,1783.5,7380.0,7324.0,7809.5,5963.0,hsp70 subfamily B suppressor 1,G2M
Tb927.9.10770,2870.5,2250.0,2196.0,2697.5,5034.5,polyadenylate-binding protein 2,>4C (GG2M)
Tb927.9.10790,9652.5,11262.0,11066.5,11125.5,9730.5,hypothetical protein,G1
Tb927.9.10820,9430.0,8843.0,9041.0,8198.0,8810.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.10830,3303.5,2296.0,2961.0,3029.0,2243.5,metal dependent 5'-nucleotidase,<2C (LG1)
Tb927.9.10840,5882.5,8454.0,8417.0,8958.5,9378.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.10850,612.5,426.0,410.0,204.0,86.0,Splicing factor 3B subunit 10 (SF3b10)  putative,<2C (LG1)
Tb927.9.10870,11477.0,11514.0,11385.0,11484.0,11080.0,hypothetical protein  conserved,G1
Tb927.9.10880,612.5,4574.0,4271.0,3752.5,3921.0,hypothetical protein  conserved,G1
Tb927.9.10890,1783.5,4079.5,4568.5,5832.0,11642.0,Regulatory subunit of type II PKA R-subunit  putative,>4C (GG2M)
Tb927.9.10920,4465.0,10583.5,10936.5,11146.0,11044.0,kinetoplastid kinetochore protein 3,G2M
Tb927.9.10930,2970.5,2510.5,2593.5,2554.0,1489.0,mediator of rna polymerase ii transcription subunit 7,<2C (LG1)
Tb927.9.10950,8871.5,10807.0,10930.0,10997.5,10978.0,chaperone protein DnaJ  putative,G2M
Tb927.9.10960,6695.5,9790.5,10027.5,10003.5,9737.5,ATP-dependent DEAD/H RNA helicase  putative,S
Tb927.9.10970,8481.5,8758.5,7813.0,8076.5,6965.5,Serine peptidase  Clan SC  Family S09X,G1
Tb927.9.11000,5225.0,7373.0,3930.5,6229.5,5765.5,ras-related protein RAB7  putative,G1
Tb927.9.11030,8791.5,9773.0,9080.5,9140.5,11161.0,cAMP-dependent protein kinase catalytic subunit 2,>4C (GG2M)
Tb927.9.11040,9398.0,7841.5,8392.0,7710.0,6173.5,mitochondrial carrier protein,<2C (LG1)
Tb927.9.11050,8529.0,10546.0,10376.5,10142.0,9264.5,4E-interacting protein  putative,G1
Tb927.9.11070,8641.0,10975.0,10961.0,10793.0,11078.0,predicted zinc finger protein,>4C (GG2M)
Tb927.9.11100,6238.5,8111.5,7767.5,8682.5,10928.5,cAMP-dependent protein kinase catalytic subunit 1,>4C (GG2M)
Tb927.9.11110,7956.0,10425.0,9983.5,9818.5,11425.0,U5 snRNA-associated splicing factor,>4C (GG2M)
Tb927.9.11120,9715.5,10271.0,10340.0,10471.0,9289.0,Chromosome passenger complex (CPC) protein INCENP N terminal  putative,G2M
Tb927.9.11130,1460.0,4675.5,5109.5,4504.5,6836.0,unc-50 related protein homolog,>4C (GG2M)
Tb927.9.11140,1460.0,2839.5,4493.5,4587.0,5379.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.11150,7528.0,8765.0,9385.5,8945.0,7573.0,hypothetical protein  conserved,S
Tb927.9.11220,9858.5,8728.0,8642.5,8000.5,7459.5,tRNA import complex component  putative,<2C (LG1)
Tb927.9.11230,7690.5,2250.0,2673.0,1688.5,2322.0,calmodulin-like protein  putative,<2C (LG1)
Tb927.9.11250,9519.5,9266.0,9108.0,8709.5,8141.0,predicted WD40 repeat protein,<2C (LG1)
Tb927.9.11260,9354.0,5585.0,4711.5,4940.5,5888.5,nucleoside diphosphate kinase  putative,<2C (LG1)
Tb927.9.11270,2767.0,944.0,1054.0,1504.0,7319.5,t- complex protein 1 (eta subunit)  putative,>4C (GG2M)
Tb927.9.11300,2329.5,1684.5,1164.0,808.0,4714.5,Mitochondrial ribosomal protein S17,>4C (GG2M)
Tb927.9.11330,6934.0,3639.0,3706.5,3752.5,3510.5,proteasome beta 2 subunit  putative,<2C (LG1)
Tb927.9.11350,7769.0,6605.5,7515.5,7368.0,8264.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.11360,612.5,5438.5,3441.0,4004.5,1407.5,hypothetical protein  conserved,G1
Tb927.9.11370,1460.0,700.5,578.5,248.0,994.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.11380,612.5,158.5,130.5,82.5,1120.5,60S ribosomal protein L23  putative,>4C (GG2M)
Tb927.9.11410,612.5,279.5,130.5,136.5,397.5,60S ribosomal protein L23  putative,<2C (LG1)
Tb927.9.11470,612.5,130.0,161.0,136.5,287.0,60S ribosomal protein L29,<2C (LG1)
Tb927.9.11480,8374.5,8204.5,7644.0,7967.5,7559.0,Enriched in surface-labeled proteome protein 9,<2C (LG1)
Tb927.9.11490,612.5,192.5,161.0,221.5,287.0,60S ribosomal protein L29,<2C (LG1)
Tb927.9.11500,10999.0,10669.0,10830.0,10849.0,10627.5,anaphase-promoting complex subunit 2,<2C (LG1)
Tb927.9.11510,10058.5,10089.0,9327.5,10164.5,9110.0,hypothetical protein  conserved,G2M
Tb927.9.11520,10136.5,9673.0,10316.0,9518.5,7951.5,hypothetical protein  conserved,S
Tb927.9.11540,6811.0,5031.5,6200.0,5883.5,6737.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.11560,3166.5,6443.5,7595.0,7398.5,4121.5,hypothetical protein  conserved,S
Tb927.9.11580,8610.5,8741.5,8116.5,8515.5,8933.0,glycosomal membrane protein,>4C (GG2M)
Tb927.9.11600,8984.0,5077.5,4815.0,3773.5,7161.5,glycosomal membrane protein,<2C (LG1)
Tb927.9.11640,9711.5,5625.5,5609.0,6219.5,5317.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.11660,8774.5,7919.0,8318.5,8340.0,7951.5,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,<2C (LG1)
Tb927.9.11670,10750.0,11420.0,11366.0,11395.0,11314.0,hypothetical protein  conserved,G1
Tb927.9.11690,10708.5,10047.5,10617.0,10283.5,9378.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.11700,4734.5,5069.5,5696.5,5024.0,4145.0,hypothetical protein  conserved,S
Tb927.9.11720,6662.0,4317.5,5109.5,4636.5,4306.0,Iron-sulfur cluster assembly protein,<2C (LG1)
Tb927.9.11740,2329.5,6052.0,5256.0,6815.5,6426.0,cyclophilin type peptidyl-prolyl cis-trans isomerase  putative,G2M
Tb927.9.11750,6787.5,6901.5,5861.5,5891.5,5499.0,methyltransferase domain containing protein  putative,G1
Tb927.9.11760,11616.0,11397.5,11436.0,11448.5,11404.0,DNA repair protein RAD2  putative,<2C (LG1)
Tb927.9.11770,7188.0,8297.5,9101.5,8205.0,7484.5,Fusaric acid resistance protein-like  putative,S
Tb927.9.11790,9359.0,10989.5,11076.5,11005.0,10946.0,membrane transporter protein  putative,S
Tb927.9.11800,10416.5,9358.5,9295.0,9703.0,9275.0,MATE efflux family protein  putative,<2C (LG1)
Tb927.9.11810,10628.0,7116.0,7823.5,7915.5,8032.5,membrane transporter protein  putative,<2C (LG1)
Tb927.9.11820,8340.5,8466.5,8145.5,8018.0,8057.5,CRAL/TRIO domain containing protein  putative,G1
Tb927.9.11830,10748.0,10541.5,10739.0,10381.0,11374.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.11840,4601.0,4531.5,2703.5,2440.0,2720.5,pre-rRNA-processing protein PNO1  putative,<2C (LG1)
Tb927.9.11850,6816.5,10644.5,10566.0,10785.0,11304.0,structural maintenance of chromosome 1  putative,>4C (GG2M)
Tb927.9.11870,8415.5,8512.5,9153.5,8303.0,7213.0,zinc finger protein  putative,S
Tb927.9.11880,4439.5,8328.5,7235.5,7216.0,6307.0,Mitochondrial SSU ribosomal protein  putative,G1
Tb927.9.11890,7310.0,10884.0,10749.5,10137.5,9674.0,hypothetical protein  conserved,G1
Tb927.9.11900,7185.0,7419.5,8351.0,8602.5,5624.0,acyl transferase-like protein,G2M
Tb927.9.11910,2682.0,9352.5,8927.5,9396.0,9350.0,peroxidase  putative,G2M
Tb927.9.11930,9816.5,10029.0,9854.0,9686.5,7981.0,DNA-repair protein  putative,G1
Tb927.9.11940,8610.5,6881.0,6577.0,6612.5,7501.5,replication factor A protein 3  putative,<2C (LG1)
Tb927.9.11960,10546.0,10903.0,11179.0,10871.5,9482.5,hypothetical protein  conserved,S
Tb927.9.11970,8875.5,8846.5,8902.0,8061.0,5713.5,hypothetical protein  conserved,S
Tb927_09_v4.snoRNA.0056,612.5,2241.5,2122.5,1125.0,1099.0,C/D snoRNA,G1
Tb927_09_v4.snoRNA.0009,5068.5,877.0,1254.0,1243.0,531.0,C/D snoRNA,<2C (LG1)
Tb927.9.12000,6918.0,6916.5,7767.5,6366.5,3044.5,LEM3 (ligand-effect modulator 3) family / CDC50 family  putative,S
Tb927.9.12030,4066.0,1670.0,1078.0,1642.5,1758.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.12040,10746.0,10809.0,10694.0,10771.0,10657.0,cap-specific 2'-O-methyltransferase,G1
Tb927.9.12070,8458.0,10253.0,10438.0,10757.0,11353.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.12080,6792.5,5494.5,4758.5,4084.0,6928.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.12090,11608.0,11575.0,11575.0,11558.0,11491.0,Putative death-receptor fusion protein (DUF2428)  putative,<2C (LG1)
Tb927.9.12100,10861.0,11237.0,11289.0,11164.5,10996.5,Tetrapyrrole (Corrin/Porphyrin) Methylases  putative,S
Tb927.9.12110,8124.5,8015.5,7137.0,7404.5,9305.0,6-phosphogluconate dehydrogenase  decarboxylating,>4C (GG2M)
Tb927.9.12140,11607.0,11477.5,11291.0,11416.0,10182.0,mitochondrial carrier protein,<2C (LG1)
Tb927.9.12150,2258.5,6012.0,5645.0,5741.0,4957.5,transport protein particle (TRAPP) subunit  putative,G1
Tb927.9.12160,5379.0,8994.0,8709.0,8863.5,8910.5,hypothetical protein  conserved,G1
Tb927.9.12170,9683.5,8905.0,8476.0,8789.0,9534.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.9.12200,2700.0,322.0,427.0,464.0,531.0,60S ribosomal subunit protein L31  putative,<2C (LG1)
Tb927.9.12240,4270.5,1585.5,1111.5,1466.0,1304.5,60S ribosomal subunit protein L31  putative,<2C (LG1)
Tb927.9.12280,5812.5,2093.5,925.0,1382.0,1929.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.12290,9702.0,3967.5,3167.0,2085.0,3693.0,Peroxin 19,<2C (LG1)
Tb927.9.12300,8218.0,7549.0,7466.5,6452.5,7720.0,replication factor C  subunit 3  putative,<2C (LG1)
Tb927.9.12310,9672.5,9848.5,9675.5,10308.0,11514.0,hypothetical protein  conserved,>4C (GG2M)
Tb09_snoRNA_0079,4219.0,2409.5,2226.5,2541.0,1374.5,C/D snoRNA  TB9C3C1,<2C (LG1)
Tb927_09_v4.snoRNA.0033,4205.0,3687.0,3767.5,4027.5,3323.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0043,612.5,40.5,40.0,33.5,86.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0030,612.5,40.5,40.0,33.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0006,3241.5,5798.0,5007.0,5617.5,5003.0,H/ACA-like snoRNA,G1
Tb09_snoRNA_0084,2357.5,600.0,491.0,628.0,559.5,C/D snoRNA  TB9C3C1,<2C (LG1)
Tb927_09_v4.snoRNA.0034,4019.5,1773.5,1612.0,2134.5,1660.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0044,612.5,40.5,40.0,33.5,86.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0031,612.5,96.0,40.0,82.5,86.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0007,3230.0,4770.5,4434.0,4731.0,4571.0,H/ACA-like snoRNA,G1
Tb09_snoRNA_0089,2574.5,518.0,520.0,419.0,637.0,C/D snoRNA  TB9C3C1,<2C (LG1)
Tb927_09_v4.snoRNA.0035,4019.5,1924.0,1692.0,1966.0,1860.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0045,612.5,40.5,40.0,33.5,86.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0032,2574.5,1266.0,1192.0,1243.0,1027.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0008,3131.5,1953.0,1757.0,2009.0,1703.0,H/ACA-like snoRNA,<2C (LG1)
Tb927.9.12320,7229.5,10864.0,10980.5,10869.0,10744.5,cystathione gamma lyase  putative,S
Tb927.9.12330,2855.0,222.0,1289.5,1466.0,397.5,thioredoxin  putative,<2C (LG1)
Tb9.NT.68,612.5,2913.5,2653.0,3649.5,2661.5,Noncoding RNA  putative,G2M
Tb927.9.12340,7804.5,8895.0,8994.0,9256.5,10160.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.12360,9723.0,10997.5,10840.5,10784.0,10554.5,RNA-binding protein  putative,G1
Tb927.9.12380,8898.5,7447.5,6879.0,6441.0,5725.5,Histidine phosphatase superfamily (branch 1)  putative,<2C (LG1)
Tb927.9.12390,6498.0,5789.5,5590.5,6525.0,8374.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.12400,11512.0,11444.0,11413.0,11510.5,11276.0,STE/STE11 serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.9.12430,1460.0,2326.0,2378.0,2373.0,2977.5,riboflavin kinase  putative,>4C (GG2M)
Tb927.9.12440,5981.0,9016.5,9816.5,10108.5,10012.5,hypothetical protein  conserved,G2M
Tb927.9.12450,3996.0,7679.5,7484.0,7434.0,7720.0,class I transcription factor A  subunit 2,>4C (GG2M)
Tb927.9.12470,6970.0,8699.5,9044.0,8554.0,8032.5,inositol polyphosphate multikinase,S
Tb927.9.12480,612.5,4684.0,5325.5,6183.0,11510.0,dynein light chain type 1  putative,>4C (GG2M)
Tb927.9.12490,10461.5,10768.0,10786.0,11034.0,10690.0,hypothetical protein  conserved,G2M
Tb927.9.12500,4510.5,6418.0,7124.5,7455.0,5780.5,Present in the outer mitochondrial membrane proteome 7,G2M
Tb927.9.12510,8257.0,6636.5,7086.0,6045.0,7125.0,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb927.9.12530,9785.5,10382.0,9786.0,10528.0,10646.5,DnaJ domain containing protein  putative,>4C (GG2M)
Tb927_09_v4.snoRNA.0048,4594.0,935.5,1021.0,1585.5,637.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0089,3107.5,1542.0,1124.0,1261.0,1304.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0017,4253.5,2581.5,1860.0,1936.0,1772.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0115,1914.0,246.5,336.0,248.0,531.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0001,3741.5,886.5,925.0,788.5,1213.5,H/ACA-like snoRNA,<2C (LG1)
Tb927.9.12550,8288.5,8996.0,8179.5,7651.5,9711.5,glycerol kinase  glycosomal,>4C (GG2M)
Tb927_09_v4.snoRNA.0095,2357.5,855.5,547.0,788.5,397.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0049,3579.5,1425.5,1388.5,1382.0,1549.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0091,2682.0,1553.5,1324.0,1044.0,1816.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0018,3589.5,1629.0,1465.0,1171.0,874.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0120,4887.0,3568.0,3487.0,3319.0,3981.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0002,3078.5,471.5,547.0,419.0,637.0,H/ACA-like snoRNA,<2C (LG1)
Tb927.9.12570,8441.5,8746.0,8138.0,7959.5,9794.5,glycerol kinase  glycosomal,>4C (GG2M)
Tb927_09_v4.snoRNA.0096,2357.5,678.5,373.5,517.0,397.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0050,3155.0,1132.5,1164.0,1031.0,1062.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0090,2901.0,1894.5,1623.0,1202.5,1717.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0019,4182.0,2601.0,2103.5,2223.0,1565.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0116,1460.0,413.0,410.0,313.5,531.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0003,3358.0,1087.5,832.0,826.5,1047.0,H/ACA-like snoRNA,<2C (LG1)
Tb927.9.12590,9300.0,8547.0,8172.5,7830.0,9169.0,glycerol kinase  glycosomal,<2C (LG1)
Tb927_09_v4.snoRNA.0097,2406.5,952.0,1137.0,925.0,1099.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0051,1460.0,1492.5,1679.0,1261.0,1691.0,C/D snoRNA,>4C (GG2M)
Tb927_09_v4.snoRNA.0092,2682.0,1161.5,703.0,757.5,1239.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0020,4449.5,2801.5,1999.5,1899.5,2079.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0117,2295.5,373.5,357.5,248.0,607.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0004,2619.0,518.0,313.0,292.5,853.0,H/ACA-like snoRNA,<2C (LG1)
Tb927.9.12610,9468.0,8451.5,8479.5,7734.5,9043.0,glycerol kinase  glycosomal,<2C (LG1)
Tb927_09_v4.snoRNA.0098,2258.5,626.0,448.0,592.5,397.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0052,4449.5,912.5,1111.5,1140.0,1120.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0093,3241.5,1344.0,994.0,989.0,1531.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0021,4544.0,2975.0,2144.5,2168.5,2110.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0118,2436.0,471.5,373.5,382.0,778.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0005,2574.5,652.5,491.0,517.0,637.0,H/ACA-like snoRNA,<2C (LG1)
Tb927.9.12630,9354.0,8735.5,8718.5,8361.0,9447.0,glycerol kinase  glycosomal,>4C (GG2M)
Tb927_09_v4.snoRNA.0099,2329.5,799.5,703.0,705.5,559.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0053,2047.0,1415.5,1335.0,1363.5,1595.5,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0094,2535.5,1190.0,954.0,957.5,1162.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0022,3929.5,3078.5,1999.5,2150.0,2336.0,C/D snoRNA,<2C (LG1)
Tb927_09_v4.snoRNA.0119,2460.0,358.0,391.5,382.0,637.0,C/D snoRNA,<2C (LG1)
Tb927.9.12650,8211.5,10496.0,10878.5,10750.0,11557.0,ubiquitin-activating enzyme E1  putative,>4C (GG2M)
Tb927.9.12670,4649.5,4830.0,4689.0,4636.5,2805.5,predicted zinc finger protein,G1
Tb927.9.12680,4956.5,5997.0,5408.5,5741.0,4490.0,hypothetical protein  conserved,G1
Tb927.9.12690,7797.5,5530.5,5439.0,5365.0,6491.0,prenyl protein specific carboxyl methyltransferase,<2C (LG1)
Tb927.9.12700,9600.5,11200.5,11202.0,10958.0,11069.5,phospholipase A1  putative,S
Tb927.9.12710,10138.5,9767.5,10310.5,10061.0,9895.5,hypothetical protein  conserved,S
Tb927.9.12720,8738.0,6048.0,3891.5,4205.5,1304.5,Ribonuclease D,<2C (LG1)
Tb927.9.12730,10593.0,10081.0,9786.0,10169.5,9943.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.9.12740,4104.0,8499.5,9612.0,8502.0,9173.5,Zeta toxin  putative,S
Tb927.9.12750,11235.0,11465.0,11379.0,11495.0,11336.0,hypothetical protein  conserved,G2M
Tb927.9.12770,10924.0,11439.0,11419.0,11497.0,11332.0,Kinetoplast polyadenylation factor 3,G2M
Tb927.9.12780,1460.0,9085.0,9105.0,8224.5,8543.0,Leucine carboxyl methyltransferase/Cupin-like domain containing protein  putative,S
Tb927.9.12790,9068.5,11049.5,11113.0,11272.0,11007.0,dolichol kinase  putative,G2M
Tb927.9.12800,11104.0,10144.0,10395.5,10666.0,10109.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.12810,8091.0,10216.0,10622.5,10909.0,10682.5,poly(ADP-ribose) glycohydrolase  putative,G2M
Tb927.9.12820,3328.5,1052.0,1124.0,1861.0,10711.5,dynein light chain  putative,>4C (GG2M)
Tb927.9.12830,8850.0,10861.0,10622.5,10733.0,11034.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.12850,4433.0,8370.0,7969.5,8820.5,5567.0,SpoU rRNA Methylase family  putative,G2M
Tb927.9.12870,3816.5,1904.5,1956.0,2589.0,1608.0,trafficking protein particle complex subunit 1  putative,<2C (LG1)
Tb927.9.12880,10994.0,10886.0,10778.5,10607.0,10128.0,STE20-like serine/threonine-protein kinase 2  putative,<2C (LG1)
Tb927.9.12890,9433.5,6260.0,5551.5,5087.5,5199.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.12900,10290.5,8328.5,7552.5,7281.5,7624.5,RNA polymerase-associated protein LEO1  putative,<2C (LG1)
Tb927.9.12930,6397.5,9305.5,9063.0,8699.5,8611.0,selenocysteine lyase,G1
Tb927.9.12950,10325.5,6286.0,6028.0,5583.5,7268.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.12960,8053.0,7041.5,7480.0,7065.0,5567.0,transporter  putative,<2C (LG1)
Tb927.9.12980,7977.5,10475.0,10530.0,10643.5,10567.0,Alpha/beta hydrolase family  putative,G2M
Tb927.9.12990,5105.0,7325.0,8402.0,8368.0,11460.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.13010,10887.0,10828.5,10902.5,10830.5,10330.0,50S ribosome-binding GTPase  putative,S
Tb927.9.13020,8761.0,6658.5,6016.0,6719.5,6190.0,Microtubule-associated protein Bicaudal-D  putative,<2C (LG1)
Tb927.9.13030,5538.0,3336.0,3503.0,4070.5,2427.0,QA-SNARE protein putative,<2C (LG1)
Tb927.9.13040,5241.5,8046.5,7328.5,8391.0,7994.5,hypothetical protein  conserved,G2M
Tb927.9.13050,2221.0,10157.0,10039.5,9905.5,9334.0,hypothetical protein  conserved,G1
Tb927.9.13060,7430.0,4388.5,5256.0,3924.0,4073.0,btb/poz domain containing protein  putative,<2C (LG1)
Tb927.9.13070,612.5,2436.0,3205.5,4243.0,4451.0,Heat shock factor binding 1 domain-containing protein,>4C (GG2M)
Tb927.9.13100,612.5,1249.0,2684.5,1713.0,1717.0,ankyrin repeat protein  putative,S
Tb927.9.13110,7686.0,8284.0,9763.5,8844.5,8694.5,hypothetical protein  conserved,S
Tb927.9.13120,4601.0,9960.5,10104.5,9666.0,8460.5,Present in the outer mitochondrial membrane proteome 8,S
Tb927.9.13130,11255.5,11431.0,11510.0,11481.0,11399.0,hypothetical protein  conserved,S
Tb927.9.13140,10323.0,10035.5,10349.5,9441.5,9609.5,hypothetical protein  conserved,S
Tb927.9.13150,3407.5,2871.5,2612.0,3087.5,5567.0,TFIIF-stimulated CTD phosphatase  putative,>4C (GG2M)
Tb927.9.13160,10176.0,11159.0,10884.0,11241.5,10824.5,hypothetical protein,G2M
Tb927.9.13200,5086.5,5612.5,3542.0,6045.0,4051.0,hypothetical protein,G2M
Tb09_tRNA_Gly_1,612.5,458.5,271.5,204.0,607.0,tRNA Glycine,<2C (LG1)
Tb927.9.13225,5851.5,3476.5,4732.5,4035.5,5117.5,hypothetical protein,<2C (LG1)
Tb927.9.13240,5209.5,5361.5,4722.5,4252.5,3447.0,hypothetical protein  conserved,G1
Tb927.9.13250,10785.5,7012.5,7388.0,7592.5,5165.5,NADPH--cytochrome P450 reductase  putative,<2C (LG1)
Tb927.9.13280,3841.0,2908.0,4057.0,2956.0,3076.5,Double RNA binding domain protein 9,S
Tb927.9.13290,4587.0,7905.5,7547.0,8126.5,6281.0,hypothetical protein  conserved,G2M
Tb927.9.13300,10001.0,9538.0,9541.5,9842.0,9487.0,Ring finger domain containing protein  putative,<2C (LG1)
Tb927.9.13310,5908.0,3194.0,3658.5,2642.5,213.0,Yos1-like  putative,<2C (LG1)
Tb927.9.13320,10790.0,10377.0,9255.0,9420.5,8968.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.13330,9404.0,11454.0,11399.0,11432.0,11454.0,hypothetical protein  conserved,G1
Tb927.9.13340,9844.5,10369.5,9379.5,9189.5,7363.0,Nop53 (60S ribosomal biogenesis)  putative,G1
Tb927.9.13350,10192.5,7626.5,7591.5,7384.5,7112.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.13360,11341.0,11499.0,11506.0,11486.0,11488.0,ubiquitin-protein ligase  putative,S
Tb927.9.13380,10662.5,9884.5,10137.5,9831.0,9573.0,Autophagy-related protein 24,<2C (LG1)
Tb927.9.13430,7108.5,9175.5,9335.5,9675.5,6699.0,ubiquitin carboxyl-terminal hydrolase  putative,G2M
Tb927.9.13440,11568.0,11167.0,11368.0,11367.0,11710.0,Flagellar Member 5,>4C (GG2M)
Tb927.9.13460,7609.5,7487.0,7884.0,7153.5,7566.0,Spt4/RpoE2 zinc finger  putative,S
Tb927.9.13470,7581.5,9994.5,10496.0,10389.5,9461.0,hypothetical protein  conserved,S
Tb927.9.13480,5653.0,7343.5,7668.0,7474.0,8533.0,Eukaryotic protein of unknown function (DUF1764)  putative,>4C (GG2M)
Tb927.9.13490,9898.5,10555.5,10681.0,11012.5,9647.0,metallo-peptidase  Clan MG  Family M24,G2M
Tb927.9.13510,8928.5,7585.5,8273.0,7611.0,8667.5,Poly(A)-specific ribonuclease PARN-3,<2C (LG1)
Tb927.9.13520,9307.5,9100.5,9617.5,9936.5,11633.0,Importin 1,>4C (GG2M)
Tb927.9.13530,8453.0,3129.0,4200.5,4612.5,5457.5,Stumpy formation signalling pathway protein  putative,<2C (LG1)
Tb927.9.13540,6945.5,8003.5,7532.5,7794.5,6729.5,hypothetical protein  conserved,G1
Tb927.9.13570,10908.0,8835.0,9246.0,9872.5,8063.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.13580,9806.5,6500.0,5808.0,6090.0,5092.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.13610,11421.0,11526.0,11473.5,11462.0,11427.0,helicase  putative,G1
Tb927.9.13620,9174.5,10340.0,10429.5,9919.5,8297.5,hypothetical protein  conserved,S
Tb927.9.13630,5496.0,7568.5,6616.5,6837.5,8770.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.13650,2886.0,2170.0,2182.5,1726.5,2550.0,ADP-ribosylation factor  putative,<2C (LG1)
Tb927.9.13655,3241.5,1201.5,1207.5,974.5,2322.0,ADP-ribosylation factor  putative,<2C (LG1)
Tb927.9.13680,3516.5,1344.0,1665.0,1044.0,3681.5,ADP-ribosylation factor  putative,>4C (GG2M)
Tb927.9.13710,3762.0,1415.5,1465.0,1017.0,2884.5,ADP-ribosylation factor  putative,<2C (LG1)
Tb927.9.13740,4527.5,2785.5,3275.0,3168.0,4199.0,ADP-ribosylation factor  putative,<2C (LG1)
Tb927.9.13770,7951.5,7871.5,7177.0,6183.0,5404.0,proteasome complex subunit Rpn13 ubiquitin receptor  putative,<2C (LG1)
Tb927.9.13780,6900.0,4388.5,5474.5,6056.0,3345.5,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.9.13785,2460.0,345.0,630.0,313.5,915.0,kinetoplastid membrane protein 11-5,<2C (LG1)
Tb927.9.13795,612.5,192.5,336.0,352.0,1253.0,kinetoplastid membrane protein 11-4,>4C (GG2M)
Tb927.9.13820,612.5,40.5,40.0,111.0,287.0,kinetoplastid membrane protein 11-3,<2C (LG1)
Tb927.9.13860,612.5,208.5,373.5,366.5,1179.0,kinetoplastid membrane protein 11-2,>4C (GG2M)
Tb927.9.13920,1460.0,96.0,130.5,136.5,994.0,kinetoplastid membrane protein 11-1,<2C (LG1)
Tb927.9.13970,10975.0,11044.0,10966.5,11095.0,10521.0,hypothetical protein  conserved,G2M
Tb927.9.13990,10198.5,10274.5,9915.5,10180.0,10007.5,RNA-binding protein  putative,G1
Tb927.9.14000,1460.0,2540.0,2499.0,2120.5,1239.0,60S ribosomal protein L12  putative,G1
Tb927.9.14030,2747.5,9251.0,8873.5,8543.5,8460.5,hypothetical protein  conserved,G1
Tb927.9.14040,8588.0,9709.0,10236.0,9869.5,10371.0,short-chain dehydrogenase  putative,>4C (GG2M)
Tb927.9.14050,10955.0,7184.0,7930.0,8023.0,2574.5,Lipase (class 3)  putative,<2C (LG1)
Tb927.9.14070,8157.0,6620.0,6886.5,6892.0,6607.0,short-chain dehydrogenase  putative,<2C (LG1)
Tb927.9.14080,9895.5,7498.0,6447.0,6276.5,8496.0,vesicle-associated membrane protein  putative,<2C (LG1)
Tb927.9.14100,3778.0,6908.5,7137.0,7078.5,6356.5,hypothetical protein  conserved,S
Tb927.9.14120,5812.5,8496.0,9055.5,9346.0,8416.0,NLI interacting factor-like phosphatase  putative,G2M
Tb927.9.14130,11108.0,10909.0,10709.5,11089.5,10310.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.14140,8053.0,7834.5,6929.5,6165.0,5624.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.14160,4010.5,2042.0,2075.5,2858.5,1958.0,rieske iron-sulfur protein  mitochondrial precursor,<2C (LG1)
Tb927.9.14170,10574.5,9634.5,9197.5,8414.0,7638.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.14180,5822.0,6813.0,7377.0,6854.5,4451.0,chaperone protein DnaJ  putative,S
Tb927.9.14190,11242.0,11609.0,11600.0,11597.0,11478.0,hypothetical protein  conserved,G1
Tb927.9.14200,612.5,7243.0,7235.5,7204.5,5301.0,methyltransferase domain containing protein  putative,G1
Tb927.9.14220,10068.5,9132.0,8125.5,7675.5,8877.0,metacaspase 5  putative,<2C (LG1)
Tb927.9.14230,7358.0,3535.0,4966.0,5883.5,2079.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.14240,3720.0,5180.0,5848.5,4987.0,8993.5,Nucleoporin NUP82,>4C (GG2M)
Tb927.9.14260,10954.0,10704.5,10808.0,10763.5,10519.5,hypothetical protein  conserved,<2C (LG1)
Tb927.9.14280,10949.5,11212.0,11169.5,11275.5,10257.0,hypothetical protein  conserved,G2M
Tb927.9.14290,8278.0,3476.5,4776.0,6297.0,11361.0,Cytokinesis initiation factor 2,>4C (GG2M)
Tb927.9.14300,4617.0,7802.5,8226.0,9177.5,11243.5,5-azacytidine-induced protein 1  putative,>4C (GG2M)
Tb927.9.14330,8632.5,7721.0,8023.0,7296.0,6472.5,mismatch repair protein PMS1  putative,<2C (LG1)
Tb927.9.14370,612.5,96.0,1103.0,610.5,2283.5,60S ribosomal protein L26  putative,>4C (GG2M)
Tb927.9.14400,6324.5,5057.5,4840.5,4742.5,4541.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.9.14410,3794.5,8823.0,7969.5,7635.5,7112.5,RNA 3'-terminal phosphate cyclase  putative,G1
Tb927.9.14420,9140.5,8654.5,9010.5,8623.5,10009.5,Peptidyl-prolyl cis-trans isomerase C  mitochondrial  putative,>4C (GG2M)
Tb927.9.14430,9109.0,9345.5,8976.0,9681.0,7624.5,Casein kinase II,G2M
Tb927.9.14440,11219.5,8196.5,7916.5,8406.5,9344.0,hypothetical protein,<2C (LG1)
Tb927.9.14470,11519.0,11211.0,11349.0,11378.0,10657.0,ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb927.9.14480,4113.0,2760.5,2289.5,3577.5,4975.5,dynein-associated protein  putative,>4C (GG2M)
Tb927.9.14530,5784.5,8063.0,8798.0,8642.0,6535.5,Protein of unknown function (DUF1181)  putative,S
Tb927.9.14540,11395.0,11599.0,11610.0,11577.0,11394.0,leucine-rich repeat protein (LRRP  pseudogene)  putative,S
Tb927.9.14570,11385.0,11095.0,10824.0,11227.0,10824.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.9.14600,9912.0,7105.0,7760.5,8100.0,7471.0,iron/ascorbate oxidoreductase family protein  putative,<2C (LG1)
Tb927.9.14630,3680.5,4531.5,3668.5,4137.0,3981.5,SL RNA,G1
Tb927.9.14650,11327.0,11442.0,11448.0,11411.0,11411.0,SLACS retrotransposable element (part)  putative (pseudogene),S
Tb927.9.14660,8606.5,10885.0,10697.5,10601.0,8321.0,SLACS reverse transcriptase  putative (pseudogene),G1
Tb927.9.14670,3589.5,1362.5,1054.0,1526.5,1504.0,SL RNA,<2C (LG1)
Tb927.9.14680,5882.5,4393.0,4411.0,4035.5,4893.5,SL RNA,<2C (LG1)
Tb927.9.14690,6904.0,6199.5,5938.0,6271.5,5898.0,SL RNA,<2C (LG1)
Tb927.9.14700,7242.5,6683.5,6066.5,6883.0,6164.0,SL RNA,<2C (LG1)
Tb927.9.14710,6949.5,7956.0,7607.0,8219.0,7478.0,SL RNA,G2M
Tb927.9.14720,7380.5,7277.5,6844.5,7434.0,6350.5,SL RNA,G2M
Tb927.9.14730,7027.0,6048.0,5777.0,6035.0,5757.0,SL RNA,<2C (LG1)
Tb927.9.14740,6677.0,6089.0,5526.0,6024.5,5880.0,SL RNA,<2C (LG1)
Tb927.9.14750,7169.0,6561.0,6126.5,6873.5,6323.0,SL RNA,<2C (LG1)
Tb927.9.14760,6733.0,5929.0,5486.5,5741.0,5906.5,SL RNA,<2C (LG1)
Tb927.9.14770,6955.5,5669.5,5435.0,5816.0,5311.0,SL RNA,<2C (LG1)
Tb927.9.14780,6397.5,3932.0,4462.5,4496.5,3950.0,SL RNA,<2C (LG1)
Tb927.9.14790,6822.0,6115.0,5559.0,5470.0,6028.0,SL RNA,<2C (LG1)
Tb927.9.14800,7050.5,5789.5,6406.5,6157.0,5870.5,SL RNA,<2C (LG1)
Tb927.9.14810,6656.0,5017.0,5120.0,4928.5,4867.0,SL RNA,<2C (LG1)
Tb927.9.14820,6762.5,5914.5,5270.0,5583.5,6066.5,SL RNA,<2C (LG1)
Tb927.9.14830,6967.0,6408.0,6055.5,6491.0,5906.5,SL RNA,<2C (LG1)
Tb927.9.14840,6487.5,4967.0,4944.0,4894.5,4893.5,SL RNA,<2C (LG1)
Tb927.9.14850,6906.5,6295.0,5609.0,6491.0,6153.5,SL RNA,<2C (LG1)
Tb927.9.14860,7622.0,6813.0,6044.5,7291.5,6281.0,SL RNA,<2C (LG1)
Tb927.9.14870,6212.5,4778.5,4758.5,4872.5,4403.5,SL RNA,<2C (LG1)
Tb927.9.14880,6504.0,6148.5,5728.0,6240.5,5996.5,SL RNA,<2C (LG1)
Tb927.9.14890,7013.0,5935.5,5652.5,5838.5,6183.0,SL RNA,<2C (LG1)
Tb927.9.14900,6590.0,5757.0,5500.5,5655.5,5585.0,SL RNA,<2C (LG1)
Tb927.9.14910,7046.0,5946.5,6126.5,6056.0,6153.5,SL RNA,<2C (LG1)
Tb927.9.14920,7200.5,6512.5,5930.5,6475.5,5752.5,SL RNA,<2C (LG1)
Tb927.9.14930,5257.0,4806.0,4722.5,5295.5,4654.0,SL RNA,G2M
Tb927.9.14940,9558.0,10025.5,10273.0,10171.5,10308.0,SLACS reverse transcriptase  putative,>4C (GG2M)
Tb927.9.14990,612.5,1201.5,756.5,610.5,1919.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.15000,612.5,6368.0,5953.5,5628.0,7624.5,proteasome complex subunit Rpn13 ubiquitin receptor  putative,>4C (GG2M)
Tb927.9.15010,5915.0,6702.5,6718.0,6626.0,6048.5,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,S
Tb927.9.15020,7219.0,7297.5,6735.0,7495.5,6706.0,hypothetical protein  conserved,G2M
Tb927.9.15030,9236.5,9817.0,10086.0,9961.0,7453.0,DNA polymerase epsilon subunit B  putative,S
Tb927.9.15040,7292.0,8671.0,9612.0,9933.0,9043.0,DTW domain containing protein  putative,G2M
Tb927.9.15050,612.5,845.0,562.5,2999.5,10338.0,nexin-dynein regulatory complex 4,>4C (GG2M)
Tb927.9.15060,612.5,1849.0,1989.5,2642.5,3794.0,rRNA processing protein  putative,>4C (GG2M)
Tb927.9.15070,11141.0,11210.0,11371.0,11420.0,11264.0,hypothetical protein  conserved,G2M
Tb927.9.15080,612.5,4493.5,4283.5,4367.0,6363.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.15090,2504.5,7844.5,6953.0,7027.5,6623.0,cytosolic coat protein  putative,G1
Tb927.9.15100,2406.5,8051.0,7165.0,7179.5,8578.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.15110,612.5,373.5,293.0,204.0,637.0,60S ribosomal protein L5  putative,>4C (GG2M)
Tb927.9.15170,612.5,626.0,391.5,204.0,637.0,60S ribosomal protein L5  putative,>4C (GG2M)
Tb927.9.15190,612.5,386.5,491.0,757.5,584.5,ribosomal protein L15  putative,G2M
Tb927.9.15210,2747.5,509.0,731.0,610.5,1422.0,ribosomal protein L36  putative,<2C (LG1)
Tb927.9.15230,8144.0,10166.5,10306.5,10099.0,10346.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.15240,3670.5,6516.5,6270.5,6001.0,7518.0,ATP11 protein  putative,>4C (GG2M)
Tb927.9.15260,6728.0,8594.0,7578.5,8230.5,8857.0,ubx domain containing protein  putative,>4C (GG2M)
Tb927.9.15270,3937.0,4227.0,3452.0,4267.0,3812.0,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,G2M
Tb927.9.15290,11484.0,11392.5,11433.0,11355.0,11124.0,CHAT domain containing protein  putative,<2C (LG1)
Tb927.9.15320,3041.5,6443.5,4938.0,5470.0,6048.5,hypothetical protein  conserved,G1
Tb927.9.15330,6516.5,6413.0,6616.5,7422.0,6808.0,U3 small nucleolar RNA-associated protein 6  putative,G2M
Tb927.9.15350,1460.0,4583.0,5736.5,5728.5,7545.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.9.15360,2137.5,2785.5,1956.0,1313.5,1896.5,40S ribosomal protein S6  putative,G1
Tb927.9.15380,9078.0,6987.5,7002.5,8293.0,5003.0,nadh-ubiquinone oxidoreductase 39 kda subunit,<2C (LG1)
Tb927.9.15400,11581.0,11625.0,11629.0,11633.0,11560.0,ankyrin-repeat protein  putative,G2M
Tb927.9.15420,5105.0,1153.5,778.0,808.0,1141.0,60S ribosomal protein L32,<2C (LG1)
Tb927.9.15450,10833.0,10440.0,10549.5,10541.0,10541.0,Domain of unknown function (DUF4205)  putative,<2C (LG1)
Tb927.9.15460,10959.5,10818.5,10733.5,10836.5,11313.0,calcium motive p-type ATPase  putative,>4C (GG2M)
Tb927.9.15470,7609.5,10302.5,10620.0,10825.5,10334.5,kinesin  putative,G2M
Tb927.9.15480,9652.5,8565.0,6788.5,8422.5,8161.0,hypothetical protein,<2C (LG1)
Tb927.9.15490,1783.5,5229.0,5678.5,6067.5,2794.5,ADP-ribosylation factor GTPase activating protein  putative,G2M
Tb927.9.15510,10224.0,9726.0,10009.0,10406.5,9542.0,BARP protein,G2M
Tb927.9.15520,10948.0,8647.0,8268.5,8205.0,7876.5,BARP protein,<2C (LG1)
Tb927.9.15530,6662.0,9576.0,9162.5,10183.5,10104.0,BARP protein,G2M
Tb927.9.15540,8992.0,8737.5,9060.0,9575.5,8282.5,BARP protein,G2M
Tb927.9.15550,9485.5,6951.0,7235.5,7296.0,6864.5,BARP protein,<2C (LG1)
Tb927.9.15560,11520.0,10565.0,10820.5,10706.0,10800.5,BARP protein,<2C (LG1)
Tb927.9.15570,5965.0,8616.5,8552.5,7902.5,6420.0,BARP protein,G1
Tb927.9.15580,10340.0,6977.5,7372.0,7517.0,7280.5,BARP protein,<2C (LG1)
Tb927.9.15590,10004.5,9198.0,9883.0,9846.0,7826.5,BARP protein,<2C (LG1)
Tb927.9.15600,9205.0,8317.0,9185.0,9378.0,8006.0,BARP protein,G2M
Tb927.9.15610,5058.0,9580.5,8902.0,9370.5,9283.0,BARP protein,G1
Tb927.9.15620,5477.5,3984.0,5345.0,5398.5,3921.0,BARP protein,<2C (LG1)
Tb927.9.15630,4826.0,7385.5,7540.5,8250.0,6890.0,BARP protein,G2M
Tb927.9.15640,5955.0,9276.0,8637.5,9646.5,9409.5,BARP protein,G2M
Tb927.9.15650,7320.0,8216.0,9346.0,9699.0,9727.0,hypothetical protein,>4C (GG2M)
Tb927.9.15660,9001.5,10055.5,10389.5,10327.0,10649.0,procyclic-enriched flagellar receptor adenylate cyclase 6,>4C (GG2M)
Tb927.9.15680,5485.5,2942.5,2673.0,2456.5,1099.0,transferrin receptor subunit,<2C (LG1)
Tb927.9.15700,8047.5,9033.5,9911.5,9919.5,9142.0,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.9.15710,4389.0,3734.0,3952.0,3216.0,3524.0,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.9.15720,10535.5,11037.5,11114.0,11222.0,10747.0,hypothetical protein  conserved,G2M
Tb927.9.15730,7671.0,5338.5,4485.5,3724.0,3741.0,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.9.15740,3972.0,2232.0,1848.0,2830.5,1355.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.15750,6586.0,9474.0,10140.0,9808.5,8161.0,hypothetical protein  conserved,S
Tb927.9.15760,3394.0,7351.0,6986.5,6465.0,7478.0,variant surface glycoprotein (VSG)-related  putative,>4C (GG2M)
Tb927.9.15770,4972.0,4103.5,4029.0,4433.0,2336.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.15780,5925.5,8951.5,9637.0,9366.0,8539.5,hypothetical protein  conserved,S
Tb927.9.15790,9679.0,10887.0,11040.5,11206.5,10594.0,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.9.15800,7997.0,8911.5,9306.5,9478.0,7416.5,hypothetical protein  conserved,G2M
Tb927.9.15810,4760.5,10105.5,9823.0,9401.0,7226.0,retrotransposon hot spot protein 3 (RHS3)  putative,G1
Tb927.9.15820,6464.5,5546.5,5246.5,5381.0,4170.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.15850,6945.5,2751.5,2389.0,2373.0,1970.0,hypothetical protein,<2C (LG1)
Tb927.9.15870,2329.5,1124.5,1278.5,1313.5,964.0,hypothetical protein,<2C (LG1)
Tb927.9.15890,2982.0,2106.0,3275.0,3013.0,5125.0,expression site-associated gene 5 (ESAG5) protein  putative,>4C (GG2M)
Tb927.9.15930,8622.5,3526.0,3503.0,4629.0,2805.5,small GTPase  putative,<2C (LG1)
Tb927.9.15940,1460.0,3380.0,3028.0,2335.0,1504.0,expression site-associated gene 3 (ESAG3) protein  putative,G1
Tb927.9.15950,7941.5,4331.5,5500.5,5505.5,5404.0,hypothetical protein,<2C (LG1)
Tb927.9.15980,8936.0,11274.0,11154.5,11183.0,10679.5,nucleoside transporter 1  putative,G1
Tb927.9.16010,8491.0,9093.5,9136.0,9222.5,8943.0,expression site-associated gene 4 (ESAG4  pseudogene)  putative,G2M
Tb927.9.16040,10925.0,11104.5,11086.0,11309.0,10862.5,leucine-rich repeat protein (LRRP)  degenerate fragment,G2M
Tb927.9.16050,9751.0,11238.0,11336.5,11361.0,10834.5,leucine-rich repeat protein (pseudogene)  putative,G2M
Tb927.9.16060,612.5,5883.0,3952.0,5095.0,3618.5,hypothetical protein,G1
Tb927.9.16070,10884.5,5600.0,4271.0,4962.5,6743.0,hypothetical protein,<2C (LG1)
Tb927.9.16080,4375.0,1924.0,1923.0,2025.0,2254.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16090,7511.5,2313.0,3275.0,3272.5,5266.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16100,6381.5,4276.0,3009.0,3319.0,3033.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16110,4792.5,4260.5,3599.5,3837.0,4330.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16130,4859.0,2272.0,3028.0,2735.0,2706.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16140,9497.0,1190.0,1311.0,1479.0,1504.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16150,7373.0,7184.0,6603.0,6989.0,5110.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16160,2714.5,2485.0,2612.0,2840.5,3474.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16170,7143.0,5322.5,5298.0,5824.5,9220.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16180,9452.5,2457.0,2440.5,2120.5,2647.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16190,7544.5,1530.0,1848.0,1665.0,2203.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb927.9.16200,7911.0,9488.0,9202.0,9745.5,9149.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.9.16210,3868.5,1866.5,2425.0,2058.5,1789.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb927.9.16220,10373.0,7834.5,7215.0,7161.0,5342.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16240,1783.5,1704.5,1742.5,989.0,1141.0,variant surface glycoprotein (VSG)  interrupted degenerate and frameshifted fragment,<2C (LG1)
Tb927.9.16250,9808.0,8358.5,8433.5,9390.5,9624.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.9.16260,3751.5,3385.5,3868.5,3087.5,2563.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,S
Tb927.9.16270,2901.0,4960.0,5445.5,3992.5,5702.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16280,612.5,2877.0,1757.0,1665.0,2110.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16290,612.5,279.5,1771.5,1763.5,1647.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16310,9954.0,11327.0,11503.0,11369.0,11214.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16320,4270.5,10284.0,9169.5,10886.5,10050.0,variant surface glycoprotein (VSG)  putative,G2M
Tb927.9.16330,1914.0,927.5,731.0,628.0,433.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16350,10370.0,8875.5,7901.5,8445.5,8789.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16360,2920.5,5656.0,4181.0,5437.0,4170.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16370,7606.5,7110.0,8123.0,8116.5,6535.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16380,612.5,4928.0,3066.0,2456.5,2483.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16390,2180.0,3407.5,3589.5,4235.5,4737.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16410,6349.0,6792.5,7297.0,8138.5,7861.0,hypothetical protein,G2M
Tb927.9.16430,612.5,2198.0,3079.0,2697.5,4560.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16440,11501.0,11602.0,11624.0,11548.0,11471.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16460,7797.5,8204.5,8637.5,9579.5,8638.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.9.16470,1460.0,4357.5,2703.5,2223.0,4036.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16480,3810.5,1171.5,427.0,1017.0,2050.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16490,10180.5,7721.0,7736.0,8303.0,7219.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.9.16500,9491.5,5963.0,7040.0,6706.0,7940.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.9.16510,2047.0,4163.0,3717.5,5137.0,3906.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16520,612.5,2896.5,3801.5,4464.5,4306.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16530,9514.0,8636.5,8372.0,8138.5,6499.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16540,4411.0,6480.5,4776.0,5716.5,4770.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16550,4594.0,7597.0,7662.0,7730.0,5567.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16560,9082.5,10169.5,10596.5,10786.5,10442.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16570,9465.5,6578.0,6844.5,5958.0,8188.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16580,3841.0,1924.0,2226.5,2373.0,1789.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb927.9.16590,4826.0,7173.5,5531.5,6171.5,6784.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16600,7405.5,7303.5,7227.5,6983.5,4022.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16610,3230.0,4181.5,4029.0,4798.0,2706.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16630,3613.0,2760.5,2499.0,2311.0,2297.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16640,4190.5,3293.0,3609.0,4327.5,3199.5,variant surface glycoprotein (VSG)  putative,G2M
Tb927.9.16650,4601.0,2646.0,2289.5,2716.0,3335.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16660,6792.5,9680.0,10252.0,10103.5,9524.0,variant surface glycoprotein (VSG)  frameshifted,S
Tb927.9.16670,3166.5,3138.5,3930.5,5317.0,5442.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16680,11169.0,7939.0,8235.0,7940.0,7161.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16690,2714.5,1635.5,1268.0,1441.0,697.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16700,1460.0,2652.5,2075.5,1823.5,2661.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,>4C (GG2M)
Tb927.9.16710,612.5,1448.0,2341.0,1430.0,672.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16720,2295.5,3086.5,5307.5,4267.0,6307.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16730,612.5,4041.5,3464.5,2821.0,2231.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16750,11683.0,11684.0,11683.5,11686.0,11630.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16770,3741.5,5039.5,5792.5,6719.5,5675.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16780,1783.5,260.0,99.0,182.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16790,4574.0,1161.5,2196.0,2617.5,2870.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16800,3589.5,3909.5,3767.5,4454.5,2351.0,hypothetical protein  conserved  degenerate,G2M
Tb927.9.16810,2780.5,8176.0,8277.0,7834.0,6307.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16820,5354.0,4034.0,4568.5,3724.0,3144.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16830,2619.0,4406.0,4966.0,4355.5,3386.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16840,4182.0,5243.0,5543.5,5180.0,2609.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,S
Tb927.9.16850,5048.0,4908.0,3260.0,4336.5,637.0,variant surface glycoprotein  truncated,<2C (LG1)
Tb927.9.16860,6838.0,4770.5,5044.5,4174.5,5934.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16870,2535.5,543.0,795.0,788.5,978.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16880,4894.5,3711.5,3711.0,4279.5,4664.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb927.9.16890,9812.5,7262.5,7246.0,7111.0,5209.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16900,5809.5,4996.5,5512.0,5014.5,6028.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16910,612.5,1405.5,1207.5,1363.5,915.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.16920,8356.5,8223.0,7652.5,8720.5,7299.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.16940,1783.5,2621.0,3398.5,2520.5,3510.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.16950,6353.5,2260.5,2011.5,3045.0,3716.5,hypothetical protein,<2C (LG1)
Tb927.9.16960,6708.5,3000.5,2488.5,3763.0,2773.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb927.9.16970,9890.0,7934.0,8968.5,8952.0,7855.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.16980,612.5,1565.5,1700.5,757.5,461.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.16990,612.5,2561.0,1623.0,2290.0,874.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.17010,5837.5,4540.5,3148.0,3521.5,3939.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17020,5994.0,5479.0,4695.5,4882.0,2402.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17030,3534.0,2785.5,1989.5,1847.0,2310.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17040,5308.5,7203.0,5792.5,6397.5,4187.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G1
Tb927.9.17050,6680.5,3256.0,3157.0,2764.5,3794.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.9.17060,9694.0,4450.0,3354.5,3588.0,4988.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17070,5349.0,4830.0,3850.0,4205.5,2914.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17080,7484.0,9628.0,9429.5,7979.5,2964.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.17090,11063.5,8463.0,8309.5,8385.0,8098.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17100,4288.5,438.0,685.0,664.0,213.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb927.9.17110,6291.5,3799.0,4529.5,4084.0,3431.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17120,10886.0,10095.0,9925.0,9993.5,9633.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17130,1460.0,5267.0,4139.5,3332.5,5432.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17140,7242.5,8297.5,7049.5,7662.5,8460.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.9.17160,6714.0,6027.5,6910.5,6018.0,4725.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.17170,5036.5,5765.0,5808.0,6045.0,6588.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17180,2221.0,158.5,233.5,221.5,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17190,11456.0,10157.0,9878.5,9997.0,8857.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17200,3437.5,1455.0,2351.5,2009.0,3110.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09_rRNA_1,8038.0,5798.0,4722.5,4367.0,3353.0,28S beta ribosomal RNA (fragment),<2C (LG1)
Tb09_rRNA_2,5844.5,4553.0,3542.0,3666.5,3413.5,M1 ribosomal RNA,<2C (LG1)
Tb09_rRNA_3,6636.0,8611.0,7905.5,7577.0,6547.5,28S alpha ribosomal RNA (fragment),G1
Tb927.9.17240,612.5,565.0,808.5,1713.0,1804.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17250,4080.0,3407.5,3388.5,4057.0,3775.0,variant surface glycoprotein (VSG)  point mutation (pseudogene),<2C (LG1)
Tb927.9.17260,6921.5,3457.0,5822.0,5538.5,4337.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17270,8306.5,2934.5,3092.0,3557.0,6432.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17280,7547.0,3973.5,4711.5,2881.0,6385.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17290,7696.0,7208.0,7979.5,7734.5,8278.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17310,9802.0,9584.5,9263.0,9816.0,8848.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17320,612.5,1553.5,1623.0,1403.5,697.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.17330,5204.5,7247.0,7171.5,7535.0,6319.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17340,4142.5,4816.5,5908.5,6083.5,4770.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G2M
Tb927.9.17350,5467.5,3711.5,2219.0,2850.5,2619.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17360,4480.0,7102.0,7540.5,7577.0,3693.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17370,2901.0,2241.5,1932.0,2223.0,2153.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17380,2682.0,6620.0,5919.0,7199.5,6463.5,Serum resistance-associated gene (SRA)  putative,G2M
Tb927.9.17390,10031.5,8451.5,7856.0,8185.5,7256.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17400,612.5,565.0,373.5,136.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17410,6052.0,9113.0,8819.5,9055.5,7060.5,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb927.9.17420,1914.0,7009.0,8441.0,7540.0,7406.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.17430,8641.0,5896.0,4348.0,5850.0,5824.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17440,3711.5,6676.0,7049.5,7040.5,8146.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17450,9675.0,9223.5,9324.5,9217.5,8437.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17460,4113.0,5469.0,5396.5,6045.0,4508.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17470,2855.0,2714.5,2289.5,3531.5,3775.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17480,1460.0,3476.5,2564.5,3045.0,2574.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.17490,10630.0,8632.5,9044.0,8449.5,8738.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17500,4019.5,2526.0,2790.5,3408.0,2898.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb927.9.17510,9172.0,10636.0,10340.0,10649.5,10054.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17520,8274.5,8930.5,9113.5,8783.0,5348.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.17530,5882.5,5854.0,5691.0,6129.0,4320.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17550,11136.5,11438.0,11412.0,11267.0,11062.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.17570,6291.5,7024.5,7568.0,8110.0,7861.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17580,8630.0,6154.5,6393.0,6331.5,7745.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17590,1460.0,130.0,233.5,82.5,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17600,5286.0,9505.5,9426.0,10035.0,9601.5,variant surface glycoprotein (VSG)  putative,G2M
Tb927.9.17610,2795.5,3179.0,3487.0,3805.5,4306.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17620,10019.0,9089.5,10190.0,9866.5,7412.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.17630,4465.0,999.0,685.0,875.0,994.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17640,10614.0,11532.0,11512.0,11468.0,11223.0,hypothetical protein  conserved,G1
Tb927.9.17660,3437.5,1143.0,1446.0,1922.5,3076.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17670,7558.5,4902.5,5239.0,6540.5,4490.0,hypothetical protein  conserved,<2C (LG1)
Tb927.9.17680,2826.5,4163.0,3568.0,3393.5,3929.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09_rRNA_4,1460.0,438.0,271.5,592.5,836.0,M2 ribosomal RNA,<2C (LG1)
Tb09_rRNA_5,5588.5,5454.0,5570.5,7486.0,4664.5,M6 ribosomal RNA,G2M
Tb09_rRNA_6,4544.0,1161.5,795.0,1261.0,964.0,M4 ribosomal RNA,<2C (LG1)
Tb927.9.17690,7191.0,4603.5,5386.5,5137.0,5916.5,hypothetical protein  conserved  frameshifted fragment,<2C (LG1)
Tb927.9.17700,5133.0,4034.0,3633.5,3837.0,6270.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17720,7793.0,2571.5,2214.0,2881.0,3055.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17730,7646.5,4823.5,3902.0,4522.0,3760.5,hypothetical protein,<2C (LG1)
Tb927.9.17740,5467.5,6301.5,6368.5,5600.0,7551.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17750,6095.5,7002.0,6917.0,7003.0,5664.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17760,7690.5,1108.0,717.5,839.0,1179.0,hypothetical protein,<2C (LG1)
Tb927.9.17770,1460.0,4056.0,1818.0,3013.0,3457.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.17780,10690.0,10653.5,10474.0,9161.5,8968.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17810,9415.0,10324.0,9454.0,10265.0,10639.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17820,612.5,4481.0,3487.0,3429.5,3431.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G1
Tb927.9.17830,7496.0,7923.0,7368.0,8440.0,9837.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.17850,6131.0,6776.5,7466.5,8338.0,8713.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.9.17870,4956.5,3353.0,2564.5,3185.0,3566.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17880,9784.0,9406.0,9480.0,9566.5,9142.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17890,8250.0,6605.5,6991.5,6067.5,4893.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17900,4354.0,8565.0,8668.0,8805.0,9914.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,>4C (GG2M)
Tb927.9.17910,2047.0,7303.5,7433.0,7119.0,8286.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.9.17930,10196.0,9851.0,9591.5,9751.0,9039.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17940,2598.0,1904.5,1783.0,1688.5,347.0,hypothetical protein,<2C (LG1)
Tb927.9.17950,6721.0,5251.5,4529.5,5060.5,6080.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17960,8330.5,8007.5,7368.0,6120.5,6649.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17970,1783.5,10174.0,10151.0,10271.0,6955.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.17980,9270.5,4413.0,3858.5,3878.0,3566.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.17990,612.5,2444.5,2164.5,1936.0,1266.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.18000,4196.0,877.0,630.0,1329.0,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.18010,8221.5,9812.5,9405.0,9540.0,9508.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.18040,7774.5,8073.0,7301.0,7059.0,7940.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.9.18050,7536.0,5929.0,5838.5,6647.5,3365.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.9.18070,7774.5,1875.5,2703.5,2603.0,2536.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.9.18080,9573.5,11326.0,11358.0,11248.5,11099.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.18100,4360.0,4624.0,4380.5,4699.5,3431.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.9.18110,2295.5,7076.5,7283.5,7416.5,7924.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.9.18120,5949.5,9337.5,9443.5,9374.5,8630.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.18130,9436.5,8709.5,9812.5,9536.5,9364.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.9.18140,11724.0,11724.0,11724.0,11724.0,11724.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.10,2574.5,1425.5,2300.0,2072.5,2065.0,variant surface glycoprotein VSG 10.1,<2C (LG1)
Tb927.10.20,11644.0,11641.0,11659.0,11630.0,11606.0,expression site-associated gene 1 (ESAG1) protein  putative,S
Tb927.10.30,4916.5,5664.0,6616.5,5608.0,5735.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.10.40,6185.5,2723.0,2902.0,1805.5,2297.5,hypothetical protein,<2C (LG1)
Tb927.10.60,4074.0,7049.5,6406.5,6157.0,5240.0,expression site-associated gene (ESAG)  putative,G1
Tb927.10.70,11093.0,11481.0,11513.0,11457.5,11133.0,retrotransposon hot spot (RHS)  putative  (fragment),S
Tb927.10.90,6145.5,6139.5,4966.0,5109.5,5713.5,hypothetical protein,<2C (LG1)
Tb927.10.100,7203.5,5095.5,5559.0,5569.0,4703.5,expression site-associated gene 2 (ESAG2)  degenerate,<2C (LG1)
Tb927.10.110,4642.5,2881.5,2902.0,3282.0,3447.0,retrotransposon hot spot protein 2 (RHS2)  pseudogene,<2C (LG1)
Tb927.10.120,10610.5,10135.5,9911.5,10899.0,9530.0,hypothetical protein,G2M
Tb927.10.130,2700.0,158.5,293.0,136.5,347.0,hypothetical protein,<2C (LG1)
Tb927.10.140,7898.5,6164.0,6518.0,5470.0,5675.0,hypothetical protein,<2C (LG1)
Tb927.10.150,1460.0,2232.0,2653.0,3616.5,4626.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.160,8050.0,8805.5,8809.0,9134.0,7207.5,Kinetoplast poly(A) polymerase 2,G2M
Tb927.10.170,612.5,3849.0,5460.5,4542.0,3431.5,pseudouridine synthase  Cbf5p,S
Tb927.10.180,612.5,2051.0,2425.0,1745.0,3413.5,ATP synthase F1 subunit gamma protein  putative,>4C (GG2M)
Tb927.10.190,612.5,678.5,795.0,313.5,2190.0,40S ribosomal protein S6  putative,>4C (GG2M)
Tb927.10.200,3711.5,1629.0,1324.0,1833.5,994.0,vacuolar ATP synthase  putative,<2C (LG1)
Tb927.10.210,4817.0,4745.0,4411.0,5381.0,3566.5,GPI transamidase component GAA1,G2M
Tb927.10.220,612.5,208.5,40.0,82.5,531.0,60S ribosomal protein L37a  putative,<2C (LG1)
Tb927.10.230,612.5,543.0,731.0,1504.0,1944.0,proteasome subunit alpha type-5  putative,>4C (GG2M)
Tb927.10.240,3166.5,5024.5,4510.0,5530.5,5274.5,peroxin 14  putative,G2M
Tb927.10.250,7496.0,8733.0,8513.5,9503.0,9952.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.260,612.5,612.5,336.0,136.5,213.0,BolA-like protein  putative,<2C (LG1)
Tb927.10.270,612.5,727.0,818.5,419.0,433.0,60S ribosomal protein L32  putative,S
Tb927.10.280,5199.5,3023.5,3116.5,3408.0,3494.0,cytochrome oxidase subunit VI,<2C (LG1)
Tb927.10.290,5053.5,2927.0,2551.0,3785.5,5102.5,proteasome alpha 2 subunit  putative,>4C (GG2M)
Tb927.10.300,6893.5,3535.0,4990.5,3897.5,5432.0,mitochondrial calcium uniporter,<2C (LG1)
Tb927.10.310,6628.0,9550.5,9585.5,9366.0,7377.0,pumillio/PUF RNA binding protein 3,S
Tb927.10.320,612.5,565.0,865.5,737.0,1595.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.330,612.5,4503.0,4662.5,3295.5,5188.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.340,9702.0,8658.5,9150.0,9374.5,8173.5,mitochondrial structure specific endonuclease I (SSE-1)  putative,<2C (LG1)
Tb927.10.350,7751.5,9853.0,9653.5,9430.5,9546.5,protein kinase PK4  putative,G1
Tb927.10.360,7148.0,7157.0,7975.5,8554.0,9117.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.370,5822.0,2319.0,2593.5,2746.5,4783.5,calcineurin B subunit  putative,<2C (LG1)
Tb927.10.380,2930.5,1303.5,717.5,862.0,1179.0,kinetoplast ribosomal PPR-repeat containing protein 5,<2C (LG1)
Tb927.10.390,8117.5,8499.5,7950.5,7850.0,7606.0,DUF2407 ubiquitin-like domain containing protein  putative,G1
Tb927.10.400,4887.0,3967.5,4840.5,4035.5,4145.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.410,6025.5,7493.5,5808.0,6706.0,5745.0,hypothetical protein  conserved,G1
Tb927.10.420,11165.0,8532.0,8582.5,8874.5,7047.0,Exocyst complex component EXO99,<2C (LG1)
Tb927.10.430,4034.5,3863.5,3521.5,3241.5,4903.0,peroxidase  putative,>4C (GG2M)
Tb927.10.440,3914.0,2128.0,2729.5,2697.5,1691.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.450,7206.0,4761.5,4823.0,4731.0,10836.0,Component of motile flagella 62,>4C (GG2M)
Tb927.10.460,612.5,8902.0,9024.0,9588.0,9415.0,NIMA-related protein kinase,G2M
Tb927.10.470,1460.0,7310.0,5618.5,6250.0,8396.5,choline dehydrogenase  putative,>4C (GG2M)
Tb927.10.480,8952.5,9658.5,9024.0,9023.0,10102.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.510,2180.0,2887.5,3335.0,3503.0,1636.0,Present in the outer mitochondrial membrane proteome 19,G2M
Tb927.10.520,10060.5,8689.0,8676.5,9052.5,8984.0,Mitochondrial ATP synthase subunit  putative,<2C (LG1)
Tb927.10.530,9890.0,9718.0,9991.0,9317.0,9704.0,Plasma-membrane choline transporter  putative,S
Tb927.10.540,5929.5,1492.5,1870.0,2440.0,2773.0,ATP-dependent RNA helicase SUB2  putative,<2C (LG1)
Tb927.10.550,6405.5,1405.5,1886.0,1980.0,2706.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.560,1783.5,130.0,210.0,382.0,397.5,40S ribosomal proteins S11  putative,<2C (LG1)
Tb927.10.570,9854.0,10219.0,10660.5,10803.0,10421.0,Sec8 exocyst complex component specific domain containing protein  putative,G2M
Tb927.10.580,612.5,2516.5,2060.5,2275.5,2619.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.590,6509.5,7544.0,8066.5,7873.5,8249.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.600,3341.5,8978.5,9411.0,9093.5,9246.5,Mitochondrial ribosomal protein L29,S
Tb927.10.610,10076.0,7844.5,8492.0,8066.5,7488.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.620,9338.5,8758.5,9528.0,9107.0,9786.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.630,7426.0,5277.0,4348.0,5741.0,5024.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.640,8134.5,10080.0,10545.0,10550.5,10858.0,arginine N-methyltransferase  type II,>4C (GG2M)
Tb927.10.650,3419.0,2505.5,2729.5,3642.0,10681.0,Component of motile flagella 17,>4C (GG2M)
Tb927.10.660,5120.0,4796.5,5120.0,6289.0,5323.5,2-oxoisovalerate dehydrogenase alpha subunit  putative,G2M
Tb927.10.670,612.5,3988.0,2717.5,2150.0,2243.5,hypothetical protein  conserved,G1
Tb927.10.680,2658.5,2871.5,2996.5,3142.0,5354.0,Protein of unknown function (DUF971)  putative,>4C (GG2M)
Tb927.10.690,4517.0,4653.0,4799.0,4754.5,3888.0,palmitoyl acyltransferase 3  putative,S
Tb927.10.700,9338.5,3542.5,4316.5,4636.5,4874.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.710,1460.0,40.5,99.0,33.5,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.720,9474.0,10189.5,9983.5,10318.5,11119.0,Flagellum attachment zone protein 24,>4C (GG2M)
Tb927.10.730,9418.0,10268.0,10306.5,10139.5,10398.5,ATP synthase  putative,>4C (GG2M)
Tb927.10.740,10645.5,10992.0,11000.5,11185.0,11217.0,structural maintenance of chromosome 4  putative,>4C (GG2M)
Tb927.10.750,4298.5,3324.5,3542.0,3154.0,5788.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.760,612.5,4493.5,5307.5,2858.5,3847.5,hypothetical protein  conserved,S
Tb927.10.770,3670.5,5778.0,5892.0,6240.5,6965.5,RF-1 domain containing protein  putative,>4C (GG2M)
Tb927.10.780,2357.5,1886.0,2060.5,2237.0,1595.5,Ring finger domain containing protein  putative,<2C (LG1)
Tb927.10.790,5756.5,3988.0,5208.5,6024.5,2495.0,vesicle-associated membrane protein  putative,G2M
Tb927.10.800,8356.5,5391.0,5838.5,5775.5,9496.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.810,6389.5,3097.0,4380.5,3272.5,1027.5,Pentatricopeptide repeat protein (PPR)  putative,<2C (LG1)
Tb927.10.820,3856.5,4733.5,4740.5,5129.0,6444.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.830,11362.0,10083.0,9528.0,10495.0,10449.5,adenylate kinase  putative,<2C (LG1)
Tb927.10.840,10167.5,11384.0,11340.0,11218.0,10903.0,Flagellum attachment zone protein 6,G1
Tb927.10.850,4298.5,9692.0,9286.5,8955.0,10449.5,hook complex protein  conserved,>4C (GG2M)
Tb927.10.870,4411.0,4163.0,3850.0,4711.5,11308.0,Furrow 1 protein,>4C (GG2M)
Tb927.10.880,5804.0,5322.5,6953.0,7517.0,9596.5,thymidine kinase,>4C (GG2M)
Tb927.10.890,11084.0,11543.0,11590.0,11594.0,11641.0,kinesin  putative,>4C (GG2M)
Tb927.10.900,3579.5,1313.5,1899.0,1745.0,1896.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.910,8663.5,7226.5,7505.5,6491.0,3960.5,DNA repair and recombination helicase protein PIF6,<2C (LG1)
Tb927.10.920,612.5,4761.5,4364.5,4084.0,4480.5,Ribosomal protein L1p/L10e family  putative,G1
Tb927.10.930,10356.5,9881.0,9050.5,9134.0,10369.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.940,2221.0,4567.5,4928.0,4862.5,5220.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.950,612.5,5172.5,5685.5,5004.5,5311.0,hypothetical protein  conserved,S
Tb927.10.960,6542.5,4719.0,2023.5,2928.0,4306.0,U4/U6-specific protein PRP4,<2C (LG1)
Tb927.10.970,3680.5,1437.5,1226.0,1491.0,11005.0,Tetratricopeptide repeat  putative,>4C (GG2M)
Tb927.10.980,9218.0,3984.0,5015.0,4636.5,2747.0,RNA polymerase III transcription factor (TF)IIIC subunit  putative,<2C (LG1)
Tb927.10.990,612.5,2306.5,1371.0,1526.5,1516.0,Enriched in surface-labeled proteome protein 6,G1
Tb927.10.1000,612.5,1727.5,1799.0,1558.5,1608.0,hypothetical protein,S
Tb927.10.1010,1460.0,912.5,161.0,941.0,213.0,hypothetical protein,<2C (LG1)
Tb927.10.1020,9963.5,10153.5,10394.0,10379.5,10027.0,hypothetical protein,S
Tb927.10.1030,4510.5,7184.0,7158.0,6989.0,3794.0,serine peptidase  Clan SC  Family S10,G1
Tb927.10.1040,5099.5,7041.5,7076.5,7059.0,3847.5,serine peptidase  Clan SC  Family S10,S
Tb927.10.1050,6990.0,7711.0,7879.0,8486.0,6535.5,serine peptidase  Clan SC  Family S10,G2M
Tb927.10.1060,612.5,1078.5,1164.0,1451.5,7579.5,T-complex protein 1  delta subunit  putative,>4C (GG2M)
Tb927.10.1070,10695.0,7726.5,7131.5,6331.5,6270.0,cdc2-related kinase 1,<2C (LG1)
Tb927.10.1080,612.5,373.5,233.5,82.5,744.5,40S ribosomal protein S23  putative,>4C (GG2M)
Tb927.10.1090,1783.5,498.0,210.0,221.5,1213.5,40S ribosomal protein S23  putative,<2C (LG1)
Tb927.10.1100,1460.0,40.5,40.0,82.5,86.0,60S ribosomal protein L9  putative,<2C (LG1)
Tb927.10.1110,10048.5,11316.0,11376.0,11343.5,10684.0,kinesin  putative,S
Tb927.10.1120,4784.0,4540.5,3410.0,4446.0,3541.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1130,4849.5,5192.0,6066.5,5476.5,9392.5,dynein arm light chain  axonemal  putative,>4C (GG2M)
Tb927.10.1140,6741.5,6044.5,7342.5,6647.5,6083.5,epsilon tubulin,S
Tb927.10.1150,10007.5,8477.5,7879.0,7819.0,6639.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1160,612.5,1661.5,1522.0,1713.0,2322.0,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,>4C (GG2M)
Tb927.10.1170,2943.0,3552.0,4235.0,4267.0,11224.0,intraflagellar transport protein 172,>4C (GG2M)
Tb927.10.1180,4649.5,5479.0,6609.5,6090.0,7453.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.1190,10745.0,8365.5,8451.0,9161.5,8083.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1200,6714.0,1945.5,2586.5,2707.0,3648.5,Programmed cell death protein 2  C-terminal putative domain containing protein  putative,<2C (LG1)
Tb927.10.1210,4721.0,4960.0,4224.5,4699.5,3981.5,katanin  putative,G1
Tb927.10.1220,10784.0,10758.5,10469.5,10699.0,10841.5,hypothetical protein,>4C (GG2M)
Tb927.10.1230,3358.0,3646.5,3560.0,3057.0,3310.5,Enriched in surface-labeled proteome protein 23,G1
Tb927.10.1240,1783.5,1394.5,1207.5,1585.5,3994.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.1250,1460.0,1849.0,3224.5,1504.0,2819.0,Aminoacyl-tRNA editing domain containing protein  putative,S
Tb927.10.1260,6033.5,9666.0,9478.0,9993.5,9514.0,aspartyl-tRNA synthetase  putative,G2M
Tb927.10.1270,11525.0,11562.0,11578.5,11571.5,11573.0,mismatch repair protein  putative,S
Tb927.10.1280,2658.5,5506.0,5678.5,5617.5,2589.5,Domain of unknown function (DUF4499)  putative,S
Tb927.10.1290,612.5,4214.5,4653.0,4243.0,1338.5,hypothetical protein  conserved,S
Tb927.10.1300,5048.0,7975.5,7887.0,7596.5,7256.0,hypothetical protein  conserved,G1
Tb927.10.1310,2137.5,9651.0,9971.5,9275.0,9017.0,Domain of unknown function (DUF4042)  putative,S
Tb927.10.1320,11212.0,7637.0,8484.5,9093.5,8709.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1330,8549.0,5331.5,6527.5,5198.5,2805.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1340,11408.0,9049.0,8424.5,8211.5,9753.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1350,7941.5,8396.5,8313.5,8628.5,7147.0,hypothetical protein  conserved,G2M
Tb927.10.1370,10227.0,7539.0,8414.0,7940.0,7072.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1380,10713.0,8677.0,7865.5,7921.0,7800.0,Serine/threonine-protein kinase NEK19  putative,<2C (LG1)
Tb927.10.1390,7032.0,4872.5,3420.5,3241.5,948.5,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,<2C (LG1)
Tb927.10.1400,4698.0,1476.5,1536.0,2009.0,895.5,hypoxanthine-guanine phosphoribosyltransferase,<2C (LG1)
Tb927.10.1410,5770.5,5364.5,6970.5,6219.5,2977.5,hypothetical protein  conserved,S
Tb927.10.1420,2137.5,4357.5,5930.5,5307.5,4418.5,metallo-peptidase  Clan MG  Family M24,S
Tb927.10.1430,4080.0,2983.5,4327.5,3596.5,4498.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.1440,1460.0,1766.0,1561.5,1665.0,697.5,hypothetical protein  conserved,G1
Tb927.10.1450,11532.5,11613.0,11633.0,11658.5,11337.0,plectin  putative,G2M
Tb927.10.1460,10013.5,9946.5,8787.0,8840.0,8409.5,NEK family Serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.10.1470,3945.0,4879.0,5652.5,5407.5,5332.5,hypoxanthine-guanine phosphoribosyltransferase,S
Tb927.10.1480,8659.5,6012.0,5222.0,5101.5,6596.5,hypothetical protein,<2C (LG1)
Tb927.10.1490,1914.0,4287.0,3092.0,1993.5,5102.5,Temperature dependent protein affecting M2 dsRNA replication  putative,>4C (GG2M)
Tb927.10.1500,3303.5,9913.0,9749.0,8602.5,8734.5,methionyl-tRNA synthetase  putative,G1
Tb927.10.1510,3261.0,9816.0,9545.0,10471.0,11619.0,CCR4-NOT transcription complex subunit 1,>4C (GG2M)
Tb927.10.1520,2747.5,2927.0,3578.0,4512.5,6623.0,ras-related protein Rab21  putative,>4C (GG2M)
Tb927.10.1530,3502.5,8484.5,7411.0,8076.5,9463.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.1540,8267.0,7500.5,6725.0,7776.5,7319.5,zinc finger protein family member  putative,<2C (LG1)
Tb927.10.1550,7236.5,5537.5,6119.5,7809.5,6764.0,proteasome regulatory non-ATP-ase subunit 5,G2M
Tb927.10.1560,5516.5,9519.0,7923.5,7752.0,5083.0,Nucleolar protein 91,G1
Tb927.10.1570,612.5,176.5,189.5,273.5,486.0,Mitochondrial ATP synthase subunit c-2,<2C (LG1)
Tb927.10.1580,3120.5,7041.5,6185.0,6340.0,5258.0,MICOS complex subunit MIC10-1,G1
Tb927.10.1590,2180.0,2416.5,2251.5,1726.5,2376.0,ribosomal protein L36  putative,G1
Tb927.10.1600,612.5,2975.0,4356.5,4918.5,287.0,hypothetical protein  conserved,G2M
Tb927.10.1610,4544.0,5469.0,6849.0,5992.0,6631.0,hypothetical protein  conserved,S
Tb927.10.1615,1460.0,978.5,1510.5,849.0,287.0,hypothetical protein,S
Tb927.10.1620,10149.0,9954.5,10198.5,9874.5,11141.0,phosphoserine/threonine/tyrosine-binding protein  putative,>4C (GG2M)
Tb927.10.1630,1460.0,3150.0,4293.5,3796.5,3681.5,atp-binding cassette sub-family e member 1,S
Tb927.10.1640,4956.5,5121.0,3952.0,3909.0,3836.0,hypothetical protein,G1
Tb927.10.1650,6101.0,6591.5,6114.0,7111.0,5813.0,hypothetical protein  conserved,G2M
Tb927.10.1660,3816.5,4323.0,3379.0,3649.5,2190.0,hypothetical protein  conserved,G1
Tb927.10.1670,6101.0,6429.5,6379.0,5437.0,6298.5,hypothetical protein,G1
Tb927.10.1680,5807.0,6480.5,6838.0,6001.0,7325.0,histone deacetylase 1,>4C (GG2M)
Tb927.10.1690,612.5,2534.5,1886.0,2102.5,1944.0,cytosolic Fe-S cluster assembly factor NBP35  putative,G1
Tb927.10.1700,9516.5,10159.5,10321.5,10254.5,9716.5,hypothetical protein  conserved,S
Tb927.10.1710,7761.5,8552.5,8568.5,8475.0,8690.5,DNA polymerase eta  putative,>4C (GG2M)
Tb927.10.1720,6459.5,8474.0,8172.5,7617.5,8125.0,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.10.1730,8905.5,9953.0,9358.5,10027.5,10249.0,Polyadenylation mediator complex protein PAMC3  putative,>4C (GG2M)
Tb927.10.1740,8368.5,4510.5,5197.0,2893.5,3888.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1750,4048.0,600.0,808.5,1187.5,744.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1760,7570.0,8512.5,8809.0,8211.5,7644.0,hypothetical protein,S
Tb927.10.1770,2930.5,5331.5,4104.0,3477.5,3921.0,hypothetical protein,G1
Tb927.10.1780,6909.0,5378.0,6078.5,6255.5,4915.5,hypothetical protein,<2C (LG1)
Tb927.10.1790,1783.5,588.0,520.0,444.5,584.5,hypothetical protein,<2C (LG1)
Tb927.10.1800,1460.0,3842.0,4293.5,3513.0,7494.0,methyltransferase domain containing protein  putative,>4C (GG2M)
Tb927.10.1810,612.5,700.5,832.0,826.5,1703.0,RING-H2 zinc finger  putative,>4C (GG2M)
Tb927.10.1820,612.5,678.5,994.0,647.5,2351.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.1830,5734.0,2964.5,5034.0,2686.0,3760.5,syntaxin  putative,<2C (LG1)
Tb927.10.1840,9858.5,7373.0,5144.0,5969.0,4128.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1850,2436.0,2571.5,2717.5,2735.0,1912.0,WD domain  G-beta repeat  putative,G2M
Tb927.10.1860,5703.0,8400.5,8436.5,8735.0,7219.5,hypothetical protein  conserved,G2M
Tb10.NT.18,1460.0,1285.0,1137.0,1526.5,3494.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.10.1870,612.5,565.0,532.5,826.5,1504.0,LSU ribosomal protein  mitochondrial  putative,>4C (GG2M)
Tb927.10.1880,10677.5,7634.0,5494.0,6883.0,3628.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1890,5190.5,2260.5,3127.0,4686.5,10723.5,cysteine peptidase  Clan CA  family C2  putative,>4C (GG2M)
Tb927.10.1900,7148.0,9867.5,8871.5,9495.5,8566.0,DNA topoisomerase IA  putative,G1
Tb927.10.1910,10701.0,11091.5,10778.5,10846.0,9647.0,STE/STE11 serine/threonine-protein kinase  putative,G1
Tb927.10.1920,5467.5,1201.5,1679.0,1558.5,2218.5,hypothetical protein,<2C (LG1)
Tb927.10.1930,7297.0,5416.0,5625.0,5168.5,4320.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.1940,3487.0,3766.0,3633.5,4267.0,3994.5,CAMK/CAMKL pseudokinase  putative,G2M
Tb927.10.1950,8099.0,9529.0,9383.5,8409.5,8606.5,leucine-rich repeat protein (LRRP)  putative,G1
Tb927.10.1960,8157.0,9505.5,10201.0,9572.0,10303.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.1970,9706.0,9522.5,9246.0,9896.0,11458.0,CHAT domain containing protein  putative,>4C (GG2M)
Tb927.10.1980,2729.0,8555.5,9268.0,9090.5,8602.0,hypothetical protein  conserved,S
Tb927.10.1990,10403.5,9737.0,10217.5,9416.5,8754.0,major vault protein  putative,<2C (LG1)
Tb927.10.2000,1988.0,3109.0,3560.0,3441.0,5044.5,actin-like protein  putative,>4C (GG2M)
Tb927.10.2010,612.5,1201.5,644.5,557.5,397.5,hexokinase,G1
Tb927.10.2020,1460.0,373.5,596.0,292.5,761.5,hexokinase,<2C (LG1)
Tb927.10.2030,5653.0,8176.0,8081.5,7734.5,6195.0,Pentatricopeptide repeat protein (PPR)  putative,G1
Tb927.10.2040,9240.5,9986.0,9765.5,10132.0,7510.5,STE group serine/threonine-protein kinase  putative,G2M
Tb927.10.2050,5678.0,2335.0,2050.0,1430.0,3939.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.2060,3613.0,8111.5,9383.5,9029.5,7585.5,hypothetical protein  conserved,S
Tb927.10.2070,612.5,664.5,1237.5,1140.0,3199.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2080,612.5,787.5,980.0,737.0,1281.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2090,8766.5,9428.0,8986.0,9420.5,8883.5,elongation factor 1-alpha,G1
Tb927.10.2100,7591.5,9195.0,8822.0,9550.0,9110.0,elongation factor 1-alpha,G2M
Tb927.10.2110,7873.0,8483.0,7215.0,7734.5,7871.0,elongation factor 1-alpha,G1
Tb927.10.2120,4879.5,4056.0,3398.5,1911.5,1828.0,U1 small nuclear ribonucleoprotein C  putative,<2C (LG1)
Tb927.10.2130,11582.0,10914.0,10831.0,11009.0,9760.0,Vps51/Vps67  putative,<2C (LG1)
Tb927.10.2140,2956.5,3068.0,3902.0,5137.0,5499.0,mitochondrial processing peptidase alpha subunit (pseudogene)  putative,>4C (GG2M)
Tb927.10.2150,612.5,1991.5,1808.5,2252.0,1213.5,mitochondrial calcium uniporter,G2M
Tb927.10.2160,2436.0,4436.0,4304.0,3295.5,6614.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2170,2523.0,588.0,596.0,577.5,486.0,hypothetical protein,<2C (LG1)
Tb927.10.2180,1460.0,3225.0,4085.5,3418.5,2857.0,Rtr1/RPAP2 family  putative,S
Tb927.10.2190,612.5,130.0,161.0,182.5,86.0,Protein of unknown function (DUF667)  putative,<2C (LG1)
Tb927.10.2200,6568.0,3615.5,2630.0,3978.5,5064.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.2210,8361.0,7610.0,7923.5,7525.5,6463.5,Peptidase C19  ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb927.10.2220,6173.0,10342.0,10365.5,10093.0,10248.0,PIWI-like protein,S
Tb927.10.2230,1783.5,8424.0,6986.5,8422.5,8845.0,NADPH:adrenodoxin oxidoreductase  mitochondrial  putative,>4C (GG2M)
Tb927.10.2240,4940.0,3561.5,3138.0,3452.5,4517.5,RNA binding protein,<2C (LG1)
Tb927.10.2250,6474.5,4220.5,4160.5,4742.5,5772.0,ubiquitin-conjugating enzyme variant Kua homologue  putative,<2C (LG1)
Tb927.10.2260,9426.5,10380.5,10803.5,10486.5,10519.5,Ubiquitin family  putative,S
Tb927.10.2270,11061.0,10581.5,10121.5,10112.0,8927.0,vacuolar protein sorting-associated protein 35  putative,<2C (LG1)
Tb927.10.2280,5209.5,5008.5,4904.5,4542.0,6851.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2290,6270.5,5017.0,4258.0,4598.0,5420.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.10.2300,3711.5,1758.0,1932.0,1805.5,2016.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.2310,6834.0,6698.0,5867.0,4636.5,6491.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.2320,8117.5,6740.0,6788.5,6067.5,6439.5,Nucleoporin NUP41,<2C (LG1)
Tb927.10.2330,9796.0,9744.0,10042.5,10504.0,9983.5,hypothetical protein  conserved,G2M
Tb927.10.2340,6594.5,2149.5,2909.0,2642.5,1912.0,SNARE domain containing protein  putative,<2C (LG1)
Tb927.10.2350,8318.0,7905.5,7498.5,8704.5,6826.5,pyruvate dehydrogenase complex E3 binding protein  putative,G2M
Tb927.10.2360,1460.0,600.0,562.5,517.0,948.5,hypothetical protein,<2C (LG1)
Tb927.10.2370,2258.5,988.5,1347.5,808.0,1489.0,Lupus La protein homolog  putative,<2C (LG1)
Tb927.10.2380,2047.0,4155.5,4316.5,5101.5,11409.0,Tetratricopeptide repeat  putative,>4C (GG2M)
Tb927.10.2390,4734.5,5847.0,5885.0,5060.5,4915.5,casein kinase I  putative,S
Tb10.NT.22,7236.5,5104.5,4559.5,5407.5,3981.5,Noncoding RNA  putative,<2C (LG1)
Tb927.10.2400,2598.0,3000.5,2378.0,2725.0,3915.0,hypothetical protein,>4C (GG2M)
Tb927.10.2410,9169.0,6073.0,7644.0,6452.5,5432.0,MSP-C  putative,<2C (LG1)
Tb927.10.2420,6883.0,7948.5,7005.5,7642.5,5394.5,hypothetical protein,G1
Tb927.10.2430,5908.0,6007.0,5350.5,5704.5,6535.5,receptor-type adenylate cyclase GRESAG 4  putative,>4C (GG2M)
Tb927.10.2440,3448.5,6272.5,4246.0,4301.0,5487.5,Metacaspase-4,G1
Tb927.10.2450,1460.0,3000.5,3706.5,3102.5,4915.5,hypothetical protein,>4C (GG2M)
Tb927.10.2460,4985.5,6229.5,7044.5,6974.5,4770.5,DnaJ domain containing protein  putative,S
Tb927.10.2470,9903.0,8534.5,8857.5,8672.5,6319.0,Cleft lip and palate transmembrane protein 1 (CLPTM1)  putative,<2C (LG1)
Tb927.10.2480,3741.5,4019.0,3542.0,4137.0,4306.0,hypothetical protein  conserved,>4C (GG2M)
Tb10.NT.27,612.5,652.5,615.0,1044.0,1608.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.10.2490,9707.5,8308.0,8097.5,8282.5,5795.0,glucose-6-phosphate 1-dehydrogenase,<2C (LG1)
Tb927.10.2500,8429.0,4467.0,5239.0,6205.5,3704.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.2510,6042.0,3766.0,4832.0,4421.5,6096.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2520,9742.0,5909.5,6352.5,9632.5,11479.5,PrimPol-like protein 2,>4C (GG2M)
Tb927.10.2530,612.5,1542.0,1388.5,577.5,213.0,adenylate kinase  putative,G1
Tb927.10.2540,8652.5,6694.5,6961.0,6854.5,7708.5,adenylate kinase  putative,<2C (LG1)
Tb927.10.2550,7923.0,9836.5,10068.5,10300.5,9347.0,malate dehydrogenase-related,G2M
Tb927.10.2560,10837.0,11000.0,10913.0,11152.5,10796.0,mitochondrial malate dehydrogenase,G2M
Tb927.10.2570,8606.5,10928.0,10874.0,10880.0,9350.0,lysosomal alpha-mannosidase precursor  putative,G1
Tb927.10.2580,8180.5,2896.5,3275.0,3343.0,3726.5,Nucleolar protein 12 (25kDa)  putative,<2C (LG1)
Tb927.10.2590,1914.0,3579.0,3801.5,3374.0,1472.0,methyltransferase domain containing protein  putative,S
Tb927.10.2600,7635.5,8684.5,9238.0,8615.0,6729.5,hypothetical protein  conserved,S
Tb927.10.2610,2995.0,5111.5,5962.0,5683.5,7610.5,Domain of unknown function (DUF1935)  putative,>4C (GG2M)
Tb927.10.2620,2870.5,3632.0,4703.0,4221.0,6463.5,CS domain containing protein  putative,>4C (GG2M)
Tb927.10.2630,4190.5,7059.0,8424.5,8168.5,7184.5,Regulator of Vps4 activity in the MVB pathway  putative,S
Tb927.10.2640,1460.0,759.0,1124.0,1491.0,7104.0,intraflagellar transport protein 81,>4C (GG2M)
Tb927.10.2650,5630.0,9055.5,9020.0,9617.0,11053.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2660,612.5,2820.5,4848.5,3441.0,5024.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2670,612.5,2679.0,2477.5,3557.0,9911.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2680,6264.0,10093.5,9251.0,9503.0,9757.5,pyridine nucleotide-disulphide oxidoreductase  putative,G1
Tb927.10.2690,1914.0,10590.5,10352.5,10445.5,10387.0,Trafficking protein Mon1  putative,G1
Tb927.10.2700,10123.5,4669.0,5919.0,5109.5,3628.5,predicted WD40 repeat protein,<2C (LG1)
Tb927.10.2710,612.5,2485.0,3464.5,2603.0,3021.0,ferredoxin  putative,S
Tb927.10.2720,1914.0,6719.5,8138.0,7560.5,7084.5,hypothetical protein  conserved,S
Tb927.10.2730,2329.5,4886.5,4758.5,4045.0,2125.5,START domain containing protein  putative,G1
Tb927.10.2750,8144.0,6758.0,6108.0,6423.0,5379.5,deoxyhypusine synthase,<2C (LG1)
Tb927.10.2760,1783.5,2498.0,1388.5,2025.0,1912.0,ATPase family associated with various cellular activities (AAA)  putative,G1
Tb927.10.2770,612.5,1095.0,1164.0,1299.0,287.0,eukaryotic translation initiation factor 5  putative,G2M
Tb927.10.2780,5330.0,10857.5,10862.0,10662.0,10494.0,DNA-directed RNA polymerase III subunit C1,S
Tb927.10.2790,6607.5,8998.5,9376.5,8682.5,6511.5,Conserved oligomeric complex COG6  putative,S
Tb927.10.2800,3904.5,3950.5,4304.0,4112.0,2991.5,mitochondrial ribosomal protein s6,S
Tb927.10.2810,11463.5,6538.5,5564.0,4654.5,7029.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.2820,11139.0,11371.0,11373.5,11251.5,11291.5,hypothetical protein  conserved,S
Tb927.10.2830,2870.5,2801.5,2289.5,3228.0,1842.0,hypothetical protein  conserved,G2M
Tb927.10.2840,612.5,96.0,99.0,111.0,86.0,ribosomal protein S25  putative,<2C (LG1)
Tb927.10.2850,3645.5,7561.5,8120.5,7582.0,5301.0,hypothetical protein,S
Tb927.10.2860,8842.5,3041.5,5077.0,5295.5,8690.5,POC1 centriolar protein homolog,<2C (LG1)
Tb927.10.2870,8966.5,8251.0,9215.5,9294.0,7525.0,hypothetical protein  conserved,G2M
Tb927.10.2880,8888.0,1727.5,1923.0,2321.5,11184.0,Voltage-dependent calcium channel subunit  putative,>4C (GG2M)
Tb927.10.2890,5994.0,3782.0,3642.0,3752.5,2898.5,enolase,<2C (LG1)
Tb927.10.2900,8056.5,3273.5,3658.5,3452.5,6216.5,importin beta-1 subunit  putative,<2C (LG1)
Tb10.NT.33,612.5,260.0,520.0,334.5,397.5,Noncoding RNA  putative,<2C (LG1)
Tb927.10.2910,612.5,2571.5,4235.0,3154.0,1213.5,splicing factor PTSR1 interacting protein,S
Tb927.10.2920,7929.5,8349.5,9159.5,8863.5,8078.0,SUMO-interacting motif-containing protein,S
Tb927.10.2930,5275.5,6664.0,7265.0,6768.0,7356.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2940,10856.0,9836.5,9948.5,10003.5,9790.5,Soluble NSF attachment protein  SNAP  putative,<2C (LG1)
Tb927.10.2950,5667.0,6963.0,8075.5,8164.0,11475.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.2960,8380.5,8274.5,6538.0,6534.5,5092.0,Translation factor GUF1  mitochondrial  putative,<2C (LG1)
Tb927.10.2970,7426.0,4521.5,2488.5,3856.5,4957.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.2980,8847.5,3615.5,3323.5,3254.5,2819.0,proteasome regulatory non-ATPase subunit 11,<2C (LG1)
Tb927.10.2990,7658.5,10412.5,10588.5,10048.0,9777.0,nuclear cap binding complex subunit CBP110,S
Tb927.10.3000,8481.5,10365.5,10408.0,10117.0,10875.5,Orofaciodigital syndrome 1-like protein  putative,>4C (GG2M)
Tb927.10.3010,11451.5,10838.5,10910.5,11040.0,10633.0,hook complex protein  conserved,<2C (LG1)
Tb927.10.3020,11697.0,11648.0,11641.0,11657.0,11654.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3030,8485.0,3385.5,2849.0,2869.0,2472.5,proteasome regulatory non-ATPase subunit 11,<2C (LG1)
Tb927.10.3040,5766.5,2881.5,3464.5,3666.5,4110.0,succinate dehydrogenase subunit,<2C (LG1)
Tb927.10.3050,5611.0,5834.5,3398.5,3393.5,1970.0,hypothetical protein,G1
Tb927.10.3070,9478.5,8692.5,8277.0,8100.0,8360.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3080,612.5,1161.5,1347.5,1154.5,1162.5,methionine biosynthetic protein  putative,S
Tb927.10.3090,7041.5,8499.5,8783.0,7740.5,8360.5,hypothetical protein  conserved,S
Tb927.10.3100,8372.0,7032.0,7916.5,7592.5,5516.0,glycerol-3-phosphate acyltransferase  putative,<2C (LG1)
Tb927.10.3110,3078.5,3441.5,2949.5,3380.5,2619.0,DNA primase large subunit  putative,G1
Tb927.10.3120,2180.0,3526.0,2764.5,3978.5,1239.0,cytochrome c oxidase assembly protein  putative,G2M
Tb927.10.3130,5148.5,6538.5,6803.5,6768.0,4440.0,myotubularin-associated protein  putative,S
Tb927.10.3140,9944.5,6458.5,7319.5,5240.0,5725.5,Basal body protein,<2C (LG1)
Tb927.10.3150,6483.0,4287.0,4559.5,4166.5,3033.0,N-acetyltransferase  putative,<2C (LG1)
Tb927.10.3160,4956.5,3855.5,4510.0,3477.5,2310.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3170,10344.0,6572.5,4722.5,5517.5,4468.5,ABC transporter  putative,<2C (LG1)
Tb927.10.3180,9068.5,10343.0,10381.0,10308.0,9337.5,zinc-finger of acetyl-transferase ESCO  putative,S
Tb927.10.3200,1460.0,4305.0,4632.5,3924.0,4860.0,U2 splicing auxiliary factor  putative,>4C (GG2M)
Tb927.10.3210,1783.5,3225.0,5500.5,3924.0,2941.0,delta-1-pyrroline-5-carboxylate dehydrogenase  putative,S
Tb927.10.3220,612.5,612.5,880.5,534.5,637.0,nucleolus protein  putative,S
Tb927.10.3230,4219.0,6329.5,7023.5,7078.5,7963.5,CMGC/MAPK protein kinase  putative,>4C (GG2M)
Tb927.10.3250,612.5,4745.0,4740.5,5538.5,1660.5,Mitochondrial SSU ribosomal protein  putative,G2M
Tb927.10.3260,7417.0,7146.5,7676.5,7455.0,7951.5,Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 5) (LACS 5)  putative,>4C (GG2M)
Tb927.10.3270,3407.5,6030.0,5710.5,6434.5,6596.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3280,612.5,130.0,99.0,33.5,86.0,60S ribosomal proteins L38  putative,<2C (LG1)
Tb927.10.3290,1460.0,2526.0,1371.0,2404.0,1338.5,hypothetical protein  conserved,G1
Tb927.10.3300,4449.5,8046.5,8152.5,7868.0,6631.0,Domain of unknown function (DUF4206)  putative,S
Tb927.10.3310,1460.0,279.5,2262.5,2716.0,10817.0,Component of motile flagella 76b,>4C (GG2M)
Tb927.10.3320,10727.0,9148.5,9241.5,9438.0,9564.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3330,5018.5,2313.0,2729.5,2603.0,3225.0,DDRGK domain containing protein  putative,<2C (LG1)
Tb927.10.3340,5969.0,9261.5,9436.0,9464.5,8898.5,CMGC/MAPK protein kinase  putative,G2M
Tb927.10.3350,10285.0,5862.0,4434.0,6129.0,6059.0,major facilitator superfamily  putative,<2C (LG1)
Tb927.10.3360,10350.0,9205.5,8857.5,8647.5,9004.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3370,3579.5,2664.0,2477.5,2038.5,2550.0,60S acidic ribosomal protein P2  putative,<2C (LG1)
Tb927.10.3380,4872.5,3265.5,3167.0,2919.0,4806.5,60S acidic ribosomal protein P2  putative,<2C (LG1)
Tb927.10.3390,9826.5,11019.5,11204.5,10992.5,10834.5,predicted TLD domain protein,S
Tb927.10.3400,10997.5,9641.0,7975.5,9027.0,9442.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3410,4211.5,799.5,756.5,705.5,1227.0,hypothetical protein,<2C (LG1)
Tb927.10.3420,7640.5,2913.5,3066.0,3521.5,3906.0,NADH-ubiquinone oxidoreductase c  putative,<2C (LG1)
Tb927.10.3430,10653.0,8887.5,9123.5,9297.0,8958.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3470,5933.5,8596.5,8867.5,7768.5,7334.5,Ankyrin repeats (3 copies)  putative,S
Tb927.10.3480,6194.5,3950.5,5717.5,4894.5,5092.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3490,10777.0,9322.0,9399.5,9075.5,7936.0,kinetoplastid-specific dual specificity phosphatase  putative,<2C (LG1)
Tb927.10.3500,4905.0,4663.0,5025.0,4454.5,3555.5,splicing factor u2af 65 kda subunit,S
Tb927.10.3510,11659.0,11225.5,11120.0,10917.5,11065.0,tRNA pseudouridine synthase D (TruD)  putative,<2C (LG1)
Tb927.10.3520,4698.0,1115.5,1217.0,1491.0,1744.5,protease regulatory ATPase subunit 4,<2C (LG1)
Tb927.10.3530,11359.0,10462.5,10340.0,10630.5,10744.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3540,4411.0,4056.0,4078.5,4629.0,5301.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3550,7741.0,9243.0,9080.5,8668.0,7662.5,DNA repair helicase  putative,G1
Tb927.10.3560,612.5,1716.0,1324.0,2085.0,637.0,arginine N-methyltransferase  putative,G2M
Tb927.10.3570,1783.5,4119.5,2673.0,3065.5,5470.5,RNA editing exonuclease 2,>4C (GG2M)
Tb927.10.3580,612.5,5144.5,5424.5,4612.5,6247.5,Mitochondrial SSU ribosomal protein  putative,>4C (GG2M)
Tb927.10.3590,10321.0,10264.0,9178.5,9523.5,9835.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3600,4661.0,5077.5,5559.0,6165.0,8235.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3610,3303.5,3855.5,4093.0,3545.0,6844.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3620,1783.5,3485.5,3371.5,4035.5,3283.5,Laminin-like protein  putative,G2M
Tb927.10.3630,7227.5,10730.0,10314.5,10638.0,10245.0,hypothetical protein  conserved,G1
Tb927.10.3640,4449.5,1886.0,2275.0,1665.0,2601.0,nuclear transmembrane protein  putative,<2C (LG1)
Tb927.10.3650,10857.5,11116.0,11128.5,10898.0,9983.5,NADH-dependent fumarate reductase,S
Tb927.10.3660,6339.0,6023.5,5044.5,4862.5,5780.5,aspartate aminotransferase,<2C (LG1)
Tb927.10.3670,10533.0,10024.0,10118.0,10289.0,8840.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3680,9908.0,3900.0,4148.5,5751.5,3716.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3690,10825.0,5862.0,6527.5,6531.0,5348.0,rRNA dimethyltransferase  putative,<2C (LG1)
Tb927.10.3700,10932.0,10181.0,10029.0,10572.5,10527.5,AMP-activated protein kinase  gamma regulatory subunit,<2C (LG1)
Tb927.10.3710,6004.0,4630.0,4711.5,4828.5,4266.0,proteasome activator protein PA26,<2C (LG1)
Tb927.10.3720,4375.0,3390.0,3205.5,4318.0,3169.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3730,1783.5,5397.5,5838.5,4962.5,7618.0,SET domain containing protein  putative,>4C (GG2M)
Tb927.10.3740,7868.0,6727.5,6084.5,7314.0,8918.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3750,11521.0,9314.0,9971.5,10027.5,8553.5,Endonuclease/Exonuclease/phosphatase family  putative,<2C (LG1)
Tb927.10.3760,9867.5,8328.5,7879.0,8492.5,7184.5,vacuolar ATP synthase subunit d  putative,<2C (LG1)
Tb927.10.3770,3570.5,3041.5,4680.0,4097.0,4654.0,predicted TPR repeat protein,S
Tb927.10.3780,8413.0,9487.0,9999.0,10049.0,9644.0,hypothetical protein  conserved,G2M
Tb927.10.3790,9482.5,10567.5,10194.0,9416.5,8254.5,hypothetical protein  conserved,G1
Tb927.10.3800,10652.0,8512.5,8257.5,8397.0,10153.5,predicted RING finger protein,<2C (LG1)
Tb927.10.3810,5938.5,7871.5,7965.0,7993.0,9103.5,Nucleoporin NUP65,>4C (GG2M)
Tb927.10.3820,9541.5,11195.0,11309.0,10829.0,10337.0,hypothetical protein  conserved,S
Tb927.10.3830,612.5,867.5,1111.5,875.0,1027.5,hypothetical protein,S
Tb927.10.3840,612.5,40.5,130.5,82.5,86.0,60S ribosomal protein L18a  putative,<2C (LG1)
Tb927.10.3850,8207.5,4294.5,3379.0,2956.0,4498.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3860,10918.0,6449.5,7393.0,6491.0,6289.5,SNF-7-like protein  putative,<2C (LG1)
Tb927.10.3870,5181.0,11205.5,10863.0,10870.0,10950.5,hypothetical protein  conserved,G1
Tb927.10.3880,5870.0,8417.0,9027.5,7377.0,9347.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3890,5235.0,7212.0,8733.5,8793.0,9447.0,phosphatidylinositol-4-phosphate 5-kinase  putative,>4C (GG2M)
Tb927.10.3900,7532.5,4207.5,4911.0,4940.5,2442.5,CAMK/CAMKL family protein kinase  putative,<2C (LG1)
Tb927.10.3910,2258.5,4393.0,5678.5,5891.5,4533.5,hypothetical protein  conserved,G2M
Tb927.10.3920,2700.0,3572.0,3678.5,3356.0,5394.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3930,3770.5,787.5,685.0,705.5,397.5,40S ribosomal protein S3A  putative,<2C (LG1)
Tb927.10.3940,2481.0,1991.5,1561.5,1044.0,1896.5,40S ribosomal protein S3A  putative,<2C (LG1)
Tb927.10.3950,6238.5,6670.0,8825.5,7216.0,8353.5,hypothetical protein  conserved,S
Tb927.10.3960,6641.0,6313.0,6200.0,6289.0,4783.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.3970,5139.0,6423.0,7724.0,9177.5,10975.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.3990,4211.5,1679.0,1054.0,1202.5,2857.0,DHH1,<2C (LG1)
Tb927.10.4000,2504.5,787.5,832.0,1031.0,1304.5,methylglutaconyl-CoA hydratase  mitochondrial precursor  putative,<2C (LG1)
Tb927.10.4010,7723.0,5104.5,6664.0,7301.0,3260.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4020,2221.0,1670.0,1416.0,1261.0,2065.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4030,612.5,235.5,130.5,182.5,559.5,hypothetical protein,<2C (LG1)
Tb927.10.4040,4569.0,6265.5,5792.5,5260.5,4244.5,3-keto-dihydrosphingosine reductase,G1
Tb927.10.4050,9911.0,6449.5,7328.5,6647.5,6950.5,serine palmitoyltransferase  putative,<2C (LG1)
Tb927.10.4060,2137.5,6359.0,5618.5,5899.5,7295.0,Ankyrin repeats (3 copies)  putative,>4C (GG2M)
Tb927.10.4070,3487.0,3068.0,4868.0,4662.5,2834.5,hypothetical protein  conserved,S
Tb927.10.4080,7596.5,10626.0,10404.0,10332.0,9983.5,hypothetical protein  conserved,G1
Tb927.10.4090,612.5,2178.5,1923.0,1792.5,1047.0,hypothetical protein  conserved,G1
Tb927.10.4100,9976.0,10406.0,10402.5,10250.5,10160.5,hypothetical protein  conserved,G1
Tb927.10.4110,1460.0,40.5,99.0,82.5,86.0,60S ribosomal protein L30,<2C (LG1)
Tb927.10.4120,612.5,1240.5,685.0,1056.5,1281.5,60S ribosomal protein L30,>4C (GG2M)
Tb927.10.4130,5441.0,7618.0,7442.5,7502.0,4451.0,NADH-ubiquinone oxidoreductase B13 subunit,G1
Tb927.10.4140,4010.5,208.5,336.0,248.0,433.0,Protein of unknown function (DUF1242)  putative,<2C (LG1)
Tb927.10.4160,6080.5,10212.5,10267.0,10384.0,9480.0,predicted zinc finger protein,G2M
Tb927.10.4170,11560.0,11502.5,11463.0,11507.5,11316.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4180,6126.5,6971.5,7033.5,7119.0,7806.0,TFIIF-stimulated CTD phosphatase  putative,>4C (GG2M)
Tb927.10.4190,1783.5,7591.5,6218.5,4818.5,6432.5,hypothetical protein,G1
Tb927.10.4200,4309.5,3687.0,4085.5,3752.5,5686.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4210,7267.0,2283.0,2226.5,2456.5,2706.5,Basal body protein,<2C (LG1)
Tb927.10.4220,612.5,3625.0,4334.5,4567.5,4517.5,hypothetical protein  conserved,G2M
Tb927.10.4230,4887.0,716.5,1311.0,1031.0,721.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4240,5582.0,935.5,1199.5,1816.5,461.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4250,3478.0,2350.5,2092.5,1665.0,1772.5,ADP-ribosylation factor-like 2  arl2,<2C (LG1)
Tb927.10.4260,4433.0,5876.0,7215.0,7819.0,8020.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4270,5036.5,4172.0,3521.5,3272.5,2550.0,coatomer subunit zeta  putative,<2C (LG1)
Tb927.10.4280,4956.5,8265.0,7399.0,7710.0,8821.0,ubiquinol-cytochrome c reductase complex 14 kda protein,>4C (GG2M)
Tb927.10.4290,4940.0,6220.0,6550.5,5758.0,6639.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4300,5573.5,6480.5,7461.5,7416.5,6679.0,Trk system potassium uptake protein,S
Tb927.10.4310,1988.0,1904.5,1226.0,1654.0,1472.0,prohibitin 2  putative,<2C (LG1)
Tb927.10.4320,8170.5,5634.0,4911.0,4623.0,5526.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4330,612.5,3526.0,3902.0,3737.0,3110.0,2-oxoisovalerate dehydrogenase beta subunit  mitochondrial precursor  putative,S
Tb927.10.4340,3063.5,1807.0,1848.0,1702.0,1660.5,hypothetical protein,<2C (LG1)
Tb927.10.4350,7991.5,6708.5,6759.5,5832.0,8835.5,hypothetical protein,>4C (GG2M)
Tb927.10.4360,612.5,322.0,40.0,419.0,86.0,hypothetical protein,<2C (LG1)
Tb927.10.4370,7967.5,6890.0,6509.5,6470.5,5317.0,expression site-associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb927.10.4380,8680.5,6664.0,6597.0,7628.5,4498.5,hypothetical protein,<2C (LG1)
Tb927.10.4390,4449.5,3235.0,2858.0,3897.5,2268.0,hypothetical protein,<2C (LG1)
Tb927.10.4400,4655.5,2062.0,2887.5,2775.0,3386.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4410,3456.5,2106.0,1956.0,1451.5,948.5,hypothetical protein,<2C (LG1)
Tb927.10.4420,2795.5,2260.5,2154.5,1966.0,3093.0,hypothetical protein,>4C (GG2M)
Tb927.10.4430,10377.5,5757.0,6429.5,5295.5,6339.0,pumillo RNA binding protein PUF1,<2C (LG1)
Tb927.10.4440,3979.5,3284.0,2226.5,2520.5,3760.5,predicted SAP domain protein,<2C (LG1)
Tb927.10.4450,2598.0,1704.5,1237.5,1558.5,2065.0,stress-inducible protein STI1-like  putative,<2C (LG1)
Tb927.10.4460,3142.5,4866.0,4868.0,5489.0,6259.0,leucine carboxyl methyltransferase  putative,>4C (GG2M)
Tb927.10.4470,6179.5,9598.5,10220.0,9123.5,9772.5,hypothetical protein  conserved,S
Tb927.10.4480,3191.0,6012.0,4956.5,5628.0,2991.5,DNA damage repair protein  putative,G1
Tb927.10.4490,5030.5,4636.0,4966.0,5505.5,7396.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4500,5635.5,3436.5,3051.5,2530.5,3541.0,cap guanine-N7 methyltransferase,<2C (LG1)
Tb927.10.4510,612.5,2983.5,2477.5,1911.5,2734.0,PUB domain containing protein  putative,G1
Tb927.10.4520,1460.0,3922.5,4327.5,2893.5,6240.0,6-phosphofructo-2-kinase/fructose-2 6-bisphosphatas  putative,>4C (GG2M)
Tb927.10.4530,612.5,6525.5,6447.0,6165.0,7177.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4540,612.5,3766.0,5365.5,3992.5,5735.0,ARP2/3 complex subunit  putative,>4C (GG2M)
Tb927.10.4550,3613.0,640.0,532.5,720.5,761.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4560,5789.0,7016.0,6406.5,7179.5,7478.0,elongation factor 2,>4C (GG2M)
Tb927.10.4570,6281.5,8651.5,7950.5,8825.5,8499.5,elongation factor 2,G2M
Tb927.10.4580,8750.0,4393.0,4868.0,5129.0,4411.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4590,7759.0,7427.0,6854.5,6768.0,6096.5,mitochondrial inner membrane signal peptidase  putative,<2C (LG1)
Tb927.10.4600,9325.5,5349.5,6022.5,6357.5,7002.5,predicted SET domain protein,<2C (LG1)
Tb927.10.4610,8529.0,5834.5,5752.5,5240.0,5457.5,dolicholphosphate-mannose synthase  putative,<2C (LG1)
Tb927.10.4620,2682.0,1095.0,925.0,907.5,1549.5,peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.10.4630,612.5,3441.5,4010.5,3796.5,5199.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4640,3510.0,1807.0,2341.0,2988.5,6259.0,eukaryotic translation initiation factor 3 subunit l,>4C (GG2M)
Tb927.10.4650,8201.5,9282.0,8701.0,7434.0,8647.0,hypothetical protein  conserved,G1
Tb927.10.4660,612.5,2198.0,2604.0,2881.0,287.0,Transcription factor S-II (TFIIS)  central domain containing protein  putative,G2M
Tb927.10.4670,6602.0,5513.5,4990.5,5741.0,6377.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4680,10827.0,5561.5,5144.0,5648.5,6298.5,Mutt-Nudix-related hydrolase 5  putative,<2C (LG1)
Tb927.10.4690,4233.5,845.0,1078.0,1504.0,7236.5,dynein light chain  putative,>4C (GG2M)
Tb927.10.4700,4010.5,3596.0,4019.5,4686.5,8674.0,dolicholphosphate-mannose synthase  putative,>4C (GG2M)
Tb927.10.4710,1460.0,988.5,1371.0,1526.5,3970.0,proteasome subunit beta type-2  putative,>4C (GG2M)
Tb927.10.4720,5812.5,8809.0,9165.5,9001.5,8067.0,Ankyrin repeats (many copies)  putative,S
Tb927.10.4730,4995.5,4365.0,4214.0,4346.0,2402.0,ribonuclease HII  putative,<2C (LG1)
Tb927.10.4740,1988.0,498.0,313.0,483.0,797.5,nucleolar RNA-binding protein  putative,<2C (LG1)
Tb927.10.4750,8481.5,10569.0,10226.5,10531.0,10218.5,hypothetical protein  conserved,G1
Tb927.10.4760,2481.0,2526.0,2902.0,3566.5,1516.0,Integral membrane protein DUF106  putative,G2M
Tb927.10.4770,612.5,7651.5,8436.5,7327.0,6994.0,phosphatidylinositol-4-phosphate 5-kinase  putative,S
Tb927.10.4780,8839.0,10124.0,10124.5,10127.5,7112.5,GPI inositol deacylase precursor,G2M
Tb927.10.4790,5742.0,5251.5,6302.0,6748.5,5745.0,hypothetical protein  conserved,G2M
Tb927.10.4800,7596.5,7128.5,8222.0,6540.5,6088.5,hypothetical protein  conserved,S
Tb927.10.4810,1460.0,3179.0,2801.5,2775.0,2190.0,hypothetical protein  conserved,G1
Tb927.10.4820,3407.5,2638.5,2440.5,2290.0,2065.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4830,7433.0,8773.0,8125.5,8440.0,7638.0,hypothetical protein  conserved,G1
Tb927.10.4840,3550.5,3324.5,2533.0,2554.0,2747.0,transcription factor IIa  putative,<2C (LG1)
Tb927.10.4850,1783.5,1455.0,2122.5,1391.5,2819.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4860,4563.0,2896.5,3952.0,3307.0,6557.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.4870,3734.0,7203.0,6961.0,6501.0,5145.5,tRNA-dihydrouridine synthase 2  putative,G1
Tb927.10.4880,1460.0,787.5,778.0,849.0,1141.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4890,6297.5,6452.5,8214.0,6802.5,6123.0,zinc-finger of a C2HC-type  putative,S
Tb927.10.4900,8403.5,7651.5,7934.5,8525.0,6788.0,TPR-repeat-containing chaperone protein DNAJ  putative,G2M
Tb927.10.4910,11458.0,10970.0,10924.0,11020.0,9153.5,mitochondrial carrier protein,<2C (LG1)
Tb927.10.4920,6018.5,3419.0,3398.5,3319.0,5664.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.4930,612.5,4127.0,2764.5,3909.0,1860.5,protein phosphatase 2C  putative,G1
Tb927.10.4940,4776.0,1448.0,1311.0,1243.0,994.0,Nuclear Dbf2-related kinase,<2C (LG1)
Tb927.10.4950,7306.5,1670.0,2341.0,2456.5,1213.5,U2 small nuclear ribonucleoprotein 16.5K,<2C (LG1)
Tb927.10.4960,2221.0,1132.5,1416.0,788.5,836.0,hypothetical protein,<2C (LG1)
Tb927.10.4970,612.5,2498.0,1831.0,1861.0,915.0,hypothetical protein  conserved,G1
Tb927.10.4980,612.5,4560.0,4189.0,2589.0,3871.0,ubiquitin-like protein DSK2  putative,G1
Tb927.10.4990,6447.0,2118.0,2949.5,3938.0,7139.0,cdc2-related kinase 3,>4C (GG2M)
Tb927.10.5000,612.5,1886.0,1549.5,2072.5,607.0,hypothetical protein  conserved,G2M
Tb927.10.5010,3407.5,9251.0,9121.0,9533.0,9552.5,Elongation factor G1  mitochondrial  putative,>4C (GG2M)
Tb927.10.5020,9963.5,7230.0,8164.0,8176.5,7968.5,Eukaryotic translation initiation factor 4E type 5,<2C (LG1)
Tb927.10.5030,612.5,774.5,832.0,673.0,761.5,ubiquitin/ribosomal protein S27a  putative,S
Tb927.10.5040,612.5,3235.0,3127.0,2440.0,1896.5,chaperone protein DnaJ  putative,G1
Tb927.10.5050,612.5,530.0,547.0,464.0,433.0,mitochondrial ATP synthase epsilon chain,<2C (LG1)
Tb927.10.5060,612.5,5057.5,5315.0,4318.0,4725.0,Protein of unknown function (DUF3592)  putative,S
Tb927.10.5070,3875.5,2093.5,2310.0,1391.5,1772.5,ribonuclease H  putative,<2C (LG1)
Tb927.10.5080,10120.5,8911.5,8424.5,7320.0,8353.5,GPI transamidase component Tta2,<2C (LG1)
Tb927.10.5090,612.5,1653.5,1721.5,1363.5,2089.0,Enriched in surface-labeled proteome protein 18,>4C (GG2M)
Tb927.10.5100,3670.5,2198.0,2389.0,2440.0,2283.5,hypothetical protein,<2C (LG1)
Tb927.10.5110,9903.0,8616.5,9207.5,9086.5,5102.5,KREPA4,<2C (LG1)
Tb927.10.5120,8380.5,2638.5,2790.5,1993.5,2647.0,KREPA6,<2C (LG1)
Tb927.10.5130,6216.0,7454.5,7018.5,7368.0,5653.0,Protein C21orf2 homolog  putative,G1
Tb927.10.5140,6578.5,8863.0,7055.0,8368.0,7328.5,Mitogen-activated protein kinase 6,G1
Tb927.10.5150,7911.0,6508.5,3717.5,4841.0,5125.0,zinc finger protein family member  putative,<2C (LG1)
Tb927.10.5160,3996.0,4383.0,3297.5,4057.0,5034.5,hypothetical protein,>4C (GG2M)
Tb927.10.5170,3803.0,4072.5,4104.0,4486.5,4345.5,XPC-binding domain containing protein  putative,G2M
Tb927.10.5180,5973.5,3753.5,3441.0,4841.0,4022.0,TPR-repeat-containing chaperone protein DNAJ  putative,<2C (LG1)
Tb927.10.5190,6101.0,7277.5,5497.5,6397.5,3365.0,Kinesin associated protein  putative,G1
Tb927.10.5200,2619.0,823.0,685.0,557.5,1027.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5210,4930.5,4317.5,3962.5,2881.0,3310.5,TFIIH basal transcription factor subunit,<2C (LG1)
Tb927.10.5220,6434.5,8902.0,9205.0,9097.0,9478.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.5230,9553.5,4305.0,4160.5,4567.5,4199.0,ADP-ribosylation factor-like protein 13  putative,<2C (LG1)
Tb927.10.5240,10290.5,8942.0,8484.5,9861.0,11695.0,cAMP binding protein  putative,>4C (GG2M)
Tb927.10.5250,6888.0,7866.5,7253.5,7883.0,9508.5,zinc finger protein family member  putative,>4C (GG2M)
Tb927.10.5260,1460.0,4859.5,6134.0,5850.0,11616.0,C2 domain containing protein  putative,>4C (GG2M)
Tb927.10.5270,2855.0,5295.0,5848.5,5398.5,2000.0,mitogen-activated protein kinase kinase 5,S
Tb927.10.5280,8947.5,7459.0,8507.5,8205.0,8137.0,pre-mRNA splicing factor ATP-dependent RNA helicase  putative,<2C (LG1)
Tb927.10.5290,4048.0,2416.5,1899.0,2102.5,1758.0,NFU3 iron-sulfur cluster scaffold homolog  mitochondrial,<2C (LG1)
Tb927.10.5300,4260.5,2772.5,3066.0,2656.5,3295.5,eukaryotic translation initiation factor 6 (eIF-6)  putative,<2C (LG1)
Tb927.10.5310,1783.5,4733.5,6270.5,5168.5,5916.5,SNF1-related protein kinases  putative,S
Tb927.10.5320,2658.5,8091.0,7342.5,7891.0,7968.5,RNA editing endoribonuclease,G1
Tb927.10.5330,612.5,576.5,391.5,352.0,1027.5,40S ribosomal protein S18  putative,>4C (GG2M)
Tb927.10.5340,612.5,576.5,233.5,592.5,347.0,40S ribosomal protein S18  putative,<2C (LG1)
Tb927.10.5350,2180.0,5625.5,7498.5,8164.0,11450.0,dynein heavy chain  putative,>4C (GG2M)
Tb927.10.5360,612.5,1068.5,1041.5,1171.0,213.0,40S ribosomal protein S10  putative,G2M
Tb927.10.5370,2047.0,588.0,668.5,334.5,1266.0,40S ribosomal protein S10  putative,<2C (LG1)
Tb927.10.5380,4200.0,4778.5,5153.5,5808.5,11257.0,intraflagellar transport protein 122,>4C (GG2M)
Tb927.10.5390,9377.0,9308.5,9306.5,8739.0,8536.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5400,612.5,7770.5,7209.5,7959.5,8137.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.5420,11492.0,10265.0,10586.0,10780.0,10331.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5430,5099.5,2983.5,2653.0,3013.0,3413.5,Flagellar C1a complex subunit C1a-32  putative,<2C (LG1)
Tb927.10.5440,6590.0,6787.5,7595.0,5782.0,5125.0,RNA editing endoribonuclease,S
Tb927.10.5450,10731.5,9440.5,9337.0,7768.5,10016.5,ISWI complex protein,<2C (LG1)
Tb927.10.5460,612.5,260.0,210.0,248.0,287.0,60S ribosomal protein L24  putative,<2C (LG1)
Tb927.10.5470,612.5,5024.5,3503.0,3521.5,1878.0,hypothetical protein  conserved,G1
Tb927.10.5480,612.5,192.5,189.5,182.5,213.0,60S ribosomal protein L24  putative,<2C (LG1)
Tb927.10.5490,7602.5,5841.0,6708.5,6604.0,6581.0,predicted HORMA domain protein,<2C (LG1)
Tb927.10.5500,10470.5,10083.0,10051.0,9627.0,9674.0,NADH-ubiquinone oxidoreductase complex I subunit  putative,<2C (LG1)
Tb927.10.5510,3142.5,4172.0,3697.0,3566.5,5432.0,endonuclease/exonuclease/phosphatase  putative,>4C (GG2M)
Tb927.10.5520,6931.5,8408.5,9324.5,9126.5,6770.5,AmmeMemoRadiSam system protein B  putative,S
Tb927.10.5530,9566.0,10042.0,9468.0,9869.5,9534.5,hypothetical protein  conserved,G1
Tb927.10.5540,7221.0,5024.5,5059.5,5561.5,5362.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5550,6750.0,3855.5,4448.0,4828.5,3794.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5560,7377.0,7092.0,6095.5,5419.5,8466.5,GPI alpha-mannosyltransferase III,>4C (GG2M)
Tb927.10.5570,7662.5,6804.5,5908.5,6669.5,6259.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5580,6441.5,7518.0,7947.5,8230.5,8083.5,hypothetical protein  conserved,G2M
Tb927.10.5590,9623.0,8491.0,7823.5,9781.0,7585.5,protein phosphatase 2C  putative,G2M
Tb927.10.5600,8835.5,6758.0,5153.5,5198.5,7689.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5610,612.5,1353.5,1956.0,1403.5,1531.5,40S ribosomal protein S9  putative,S
Tb927.10.5620,1460.0,2402.0,940.5,647.5,3283.5,fructose-bisphosphate aldolase  glycosomal,>4C (GG2M)
Tb927.10.5630,5247.5,8127.5,8285.0,8338.0,7566.0,hypothetical protein  conserved,G2M
Tb927.10.5640,8218.0,10194.5,10281.0,10502.0,10068.0,Gem-associated protein 2  putative,G2M
Tb927.10.5650,6381.5,6512.5,6593.0,6397.5,6975.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.5660,7348.0,6272.5,5077.0,6452.5,6356.5,heat shock protein  putative,<2C (LG1)
Tb927.10.5670,4972.0,8642.5,8709.0,8445.5,7974.5,N-acetyltransferase subunit Nat1  putative,S
Tb927.10.5680,5643.5,8379.0,8809.0,8215.5,6059.0,procyclin-associated gene 1 (PAG1) protein  putative,S
Tb927.10.5690,5725.0,3485.5,3737.5,3687.5,2679.0,procyclin-associated gene 2 (PAG2) protein  putative,<2C (LG1)
Tb927.10.5700,11262.5,8474.0,8392.0,8402.5,8848.5,Enriched in surface-labeled proteome protein 3,<2C (LG1)
Tb927.10.5710,10044.0,10001.5,9835.0,10389.5,10549.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.5720,5516.5,3819.0,3912.5,3837.0,6096.5,hypothetical protein,>4C (GG2M)
Tb927.10.5730,4010.5,5612.5,5379.0,6219.5,5209.5,hypothetical protein,G2M
Tb927.10.5740,4086.0,7795.5,7622.5,8235.0,8173.5,Protein of unknown function (DUF778)  putative,G2M
Tb927.10.5750,9460.0,9605.5,9087.0,9779.5,7871.0,Extradiol ring-cleavage dioxygenase  putative,G2M
Tb927.10.5760,1460.0,3792.0,2351.5,2389.0,5209.5,adenylate kinase  putative,>4C (GG2M)
Tb927.10.5770,1783.5,1108.0,1179.5,1202.5,3353.0,Valosin-containing protein,>4C (GG2M)
Tb927.10.5780,4649.5,7366.5,7319.5,7809.5,4179.0,amino acid tansporter  putative,G2M
Tb927.10.5790,8659.5,4620.0,3789.5,3992.5,3199.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5800,4859.0,426.0,293.0,221.5,213.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5810,4321.0,5542.0,5908.5,4112.0,4957.5,The ARF-like 2 binding protein BART  putative,S
Tb927.10.5820,6822.0,7602.0,6879.0,5949.0,6016.5,predicted RanGDP binding protein,G1
Tb927.10.5830,5582.0,7258.5,6664.0,6935.5,5404.0,hypothetical protein  conserved,G1
Tb927.10.5840,8389.5,652.5,954.0,788.5,86.0,translation elongation factor 1-beta  putative,<2C (LG1)
Tb927.10.5850,11614.0,11686.0,11697.0,11699.0,11677.0,N-terminal region of Chorein  a TM vesicle-mediated sorter  putative,G2M
Tb927.10.5860,6853.5,4636.0,5174.5,4764.5,4938.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.5870,1460.0,6750.5,6796.5,7416.5,6334.5,Flagellum attachment zone protein 25,G2M
Tb927.10.5880,6072.0,7711.0,8402.0,7789.5,7249.5,Proteophosphoglycan  putative,S
Tb927.10.5890,7819.0,3008.5,4598.0,5285.0,3586.0,Galactose oxidase  central domain containing protein  putative,<2C (LG1)
Tb927.10.5900,3834.5,8761.0,9709.5,9167.5,9079.0,hypothetical protein  conserved,S
Tb927.10.5910,11180.0,7380.0,7520.5,6676.5,5332.5,Basal body protein,<2C (LG1)
Tb927.10.5920,7702.0,10916.5,10298.5,10594.5,10289.0,hypothetical protein  conserved,G1
Tb927.10.5930,11107.0,10900.5,10682.5,10809.0,10283.5,NEK family Serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.10.5940,9383.5,10725.0,10579.5,10576.0,9820.5,NEK family Serine/threonine-protein kinase  putative,G1
Tb927.10.5950,5863.0,6373.5,6000.0,6297.0,4915.5,Serine/threonine-protein kinase NEK17  putative,G1
Tb927.10.5960,612.5,1095.0,994.0,1003.0,213.0,engulfment and cell motility domain 2  putative,G1
Tb927.10.5970,9199.0,6865.0,7108.0,7153.5,7447.5,predicted zinc finger protein,<2C (LG1)
Tb927.10.5980,6746.5,5935.5,5097.0,5569.0,7530.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.10.5990,4364.5,2609.5,3560.0,3374.0,2609.5,Centrosomal protein of 57 kDa  putative,<2C (LG1)
Tb927.10.6000,9688.0,6572.5,6593.0,6205.5,7944.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.6010,9178.5,8163.5,8206.5,8282.5,9447.0,Cohesin subunit SCC3  putative,>4C (GG2M)
Tb927.10.6020,7617.0,2283.0,1361.0,1805.5,2898.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.6030,612.5,811.0,940.5,1243.0,1374.5,proteasome subunit alpha type-1  putative,>4C (GG2M)
Tb927.10.6040,612.5,192.5,271.5,111.0,915.0,hypothetical protein,>4C (GG2M)
Tb927.10.6050,3107.5,935.5,1742.5,1110.5,1062.5,clathrin heavy chain,<2C (LG1)
Tb927.10.6060,612.5,855.5,391.5,534.5,505.0,universal minicircle sequence binding protein 2,G1
Tb927.10.6070,5611.0,1697.0,2238.0,1950.5,2364.5,universal minicircle sequence binding protein 1,<2C (LG1)
Tb927.10.6080,612.5,345.0,507.0,534.5,86.0,proteasome subunit beta type-5  putative,<2C (LG1)
Tb927.10.6090,9779.0,7781.0,6678.0,7692.0,5834.5,tRNA pseudouridine synthase A  putative,<2C (LG1)
Tb927.10.6100,6980.0,6132.0,6379.0,5454.0,5657.0,Protein of unknown function (DUF2419)  putative,<2C (LG1)
Tb927.10.6110,1460.0,3693.0,4670.0,3666.5,6281.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.6120,8586.0,4849.5,5808.0,4928.5,6183.0,Peptidase M76 family  putative,<2C (LG1)
Tb927.10.6130,4872.5,6516.5,5652.5,4731.0,6864.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.6140,6563.5,5935.5,5590.5,4367.0,5847.0,phosphatidylinositolN- acetylglucosaminyltransferase subunit c  putative,<2C (LG1)
Tb927.10.6150,10694.0,11485.0,11445.5,11439.0,11323.0,neurobeachin/beige protein  putative,G1
Tb927.10.6160,3606.0,7970.5,9012.5,8486.0,9855.0,Sec34-like family  putative,>4C (GG2M)
Tb927.10.6170,11276.0,10379.0,10717.0,10636.0,9870.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.6180,10143.5,6908.5,6469.0,6728.0,5199.0,FLA1-like protein,<2C (LG1)
Tb927.10.6190,11471.0,9501.0,8329.0,9256.5,4903.0,aldehyde dehydrogenase  putative,<2C (LG1)
Tb927.10.6200,1460.0,716.5,907.5,1726.5,721.5,hypothetical protein  conserved,G2M
Tb927.10.6210,3828.5,8404.0,9233.0,8422.5,7280.5,TPR repeat  putative,S
Tb927.10.6220,8814.0,7667.5,8019.0,7670.0,6814.0,5'-3' exoribonuclease D,<2C (LG1)
Tb927.10.6230,8762.0,9963.0,10538.5,10550.5,11152.0,MORN repeat containing protein,>4C (GG2M)
Tb927.10.6240,7736.5,8170.0,8196.5,7153.5,6334.5,ras-like small GTPase  putative,S
Tb927.10.6250,6822.0,9012.0,9038.5,8840.0,8360.5,hypothetical protein  conserved,S
Tb927.10.6260,3680.5,1520.0,1783.0,1875.5,2413.0,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb927.10.6270,612.5,96.0,40.0,82.5,287.0,hypothetical protein,<2C (LG1)
Tb927.10.6280,612.5,294.5,161.0,517.0,895.5,N-terminal glutamine amidase  putative,>4C (GG2M)
Tb927.10.6290,612.5,176.5,161.0,182.5,86.0,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb927.10.6300,8556.5,3693.0,3994.5,4205.5,3494.0,Mitochondrial ribosomal protein S5,<2C (LG1)
Tb927.10.6310,4242.0,7059.0,7411.0,7599.5,5379.5,major vault protein  putative,G2M
Tb927.10.6320,7046.0,7137.0,6695.5,6397.5,7308.5,CBF/Mak21 family  putative,>4C (GG2M)
Tb927.10.6330,1460.0,2498.0,4448.0,6452.5,10185.5,kinetoplastid kinetochore protein 1,>4C (GG2M)
Tb927.10.6340,4995.5,4886.5,5315.0,4731.0,9989.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.6350,1460.0,1466.5,717.5,1140.0,8812.0,trypanin,>4C (GG2M)
Tb927.10.6360,10412.5,9512.0,10170.0,9919.5,8709.0,FAZ-tip-localizing protein required for cytokinesis,<2C (LG1)
Tb927.10.6370,612.5,967.5,1465.0,705.5,86.0,60S ribosomal proteins L37  putative,S
Tb927.10.6380,9285.0,8259.5,7283.5,7227.0,7038.0,ring finger containing protein,<2C (LG1)
Tb927.10.6390,3888.5,5144.5,4904.5,4654.5,4065.0,hypothetical protein  conserved,G1
Tb927.10.6400,8400.5,9280.0,8610.0,8422.5,7369.5,chaperonin HSP60  mitochondrial precursor,G1
Tb927.10.6410,9642.5,11069.0,11213.0,11210.0,10817.0,DNA mismatch repair protein MSH6  putative,S
Tb10.NT.66,4587.0,1211.0,818.5,1187.5,584.5,Noncoding RNA  putative,<2C (LG1)
Tb927.10.6420,8250.0,6858.5,6360.5,4918.5,5988.0,hypothetical protein,<2C (LG1)
Tb927.10.6430,4698.0,3164.5,3344.0,2656.5,3169.5,hypothetical protein,<2C (LG1)
Tb10.NT.68,3762.0,2693.0,2499.0,2357.0,1099.0,Noncoding RNA  putative,<2C (LG1)
Tb927.10.6440,7069.5,7053.5,7457.0,7702.0,8083.5,phosphomannomutase,>4C (GG2M)
Tb927.10.6450,612.5,4515.0,2820.0,3441.0,948.5,2OG-Fe(II) oxygenase superfamily  putative,G1
Tb927.10.6460,1460.0,5732.5,4622.0,5981.0,5934.5,protein phosphatase 2B  putative,G2M
Tb927.10.6470,6401.0,6546.5,6152.5,5799.5,4687.0,hypothetical protein,G1
Tb927.10.6480,3856.5,4975.5,5652.5,3087.5,2268.0,hypothetical protein  conserved,S
Tb927.10.6490,3155.0,3211.5,2827.0,2642.5,2773.0,KIAA1430 homologue  putative,G1
Tb927.10.6500,10442.0,9826.0,10277.5,10609.0,9907.0,amino acid transporter  putative,G2M
Tb927.10.6510,7815.5,7956.0,7005.5,6755.5,6104.0,chaperonin HSP60  mitochondrial precursor,G1
Tb927.10.6520,1460.0,6636.5,7923.5,7404.5,5542.5,hypothetical protein  conserved,S
Tb927.10.6530,5635.5,7116.0,6360.5,6989.0,6844.5,dolichyl-P-Man:GDP-Man5GlcNAc2-PP-dolichyl alpha-1 3-mannosyltransferase  putative,G1
Tb927.10.6540,7810.0,5804.5,6495.5,5561.5,5282.0,kinetoplastid-specific phospho-protein phosphatase  putative,<2C (LG1)
Tb927.10.6550,612.5,2187.0,1634.5,1056.5,1489.0,Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region/Zinc-finger (CX5CX6HX5H) motif containing protein  putative,G1
Tb927.10.6560,3478.0,6798.0,6648.5,7845.5,6491.0,Protein of unknown function DUF72  putative,G2M
Tb927.10.6570,3063.5,4745.0,4917.0,4446.0,3482.5,TPR repeat  putative,S
Tb927.10.6580,4346.0,9655.5,8847.0,8809.5,7909.0,hypothetical protein,G1
Tb927.10.6590,4449.5,6870.0,6687.5,7245.0,5847.0,hypothetical protein  conserved,G2M
Tb927.10.6600,6649.0,6530.5,6185.0,5517.5,4693.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.6610,2780.5,3572.0,4057.0,2928.0,3093.0,chaperone protein DnaJ  putative,S
Tb927.10.6620,10140.5,7314.5,6986.5,7372.5,9103.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.6630,6504.0,2198.0,1199.5,1125.0,461.5,ATP-dependent RNA helicase DBP2A  putative,<2C (LG1)
Tb927_10_v5.snoRNA.0100,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927_10_v5.snoRNA.0101,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927_10_v5.snoRNA.0102,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927_10_v5.snoRNA.0103,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927.10.6640,612.5,1466.5,2440.5,3154.0,461.5,transmembrane emp24 domain-containing protein,G2M
Tb927_10_v5.snoRNA.0104,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927_10_v5.snoRNA.0105,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927_10_v5.snoRNA.0106,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927_10_v5.snoRNA.0107,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927.10.6650,3261.0,6016.0,6718.0,7065.0,6499.0,G10 protein homologue  putative,G2M
Tb927.10.6670,612.5,426.0,596.0,273.5,287.0,dynein light chain  putative,<2C (LG1)
Tb927.10.6680,11295.0,10826.5,11147.0,10876.0,10852.5,member of the NOL1/NOP2/sun family of proteins,<2C (LG1)
Tb927.10.6690,10608.0,10248.0,10276.0,10216.5,10213.5,protein tyrosine phosphatase 1,<2C (LG1)
Tb927.10.6700,3487.0,6458.5,8211.5,6854.5,8857.0,Kinetochore interacting protein 3,>4C (GG2M)
Tb927.10.6710,2094.5,5397.5,3902.0,3057.0,4597.5,hypothetical protein  conserved,G1
Tb927.10.6720,8520.5,8070.5,8863.5,8176.5,7447.5,Plasma-membrane choline transporter  putative,S
Tb927.10.6730,7348.0,6164.0,7061.5,6540.5,4276.5,Plasma-membrane choline transporter  putative,<2C (LG1)
Tb927.10.6740,10655.5,10427.0,10860.5,10693.0,9009.5,Plasma-membrane choline transporter  putative,S
Tb927.10.6750,9006.5,9190.0,9960.0,9572.0,8590.5,Plasma-membrane choline transporter  putative,S
Tb927.10.6760,7951.5,9718.0,10112.0,9627.0,8979.0,Plasma-membrane choline transporter  putative,S
Tb927.10.6770,9054.0,8245.0,7965.0,8303.0,7821.0,BRCA1 C Terminus (BRCT) domain containing protein  putative,<2C (LG1)
Tb927.10.6780,6173.0,6306.5,6480.0,5751.5,7334.5,vacuolar protein sorting-associated protein 45  putative,>4C (GG2M)
Tb927.10.6790,10775.0,10717.0,11021.0,10542.5,11433.0,Gamma-tubulin complex component 3-like protein,>4C (GG2M)
Tb927.10.6800,3803.0,8375.5,7652.5,7931.0,6216.5,developmentally regulated GTP-binding protein  putative,G1
Tb927.10.6810,2535.5,1609.0,1536.0,3013.0,1374.5,guanylate kinase  putative,G2M
Tb927.10.6820,1783.5,6170.0,7342.5,5690.0,5394.5,hypothetical protein  conserved,S
Tb927.10.6830,7409.5,4693.0,5025.0,4252.5,2427.0,bardet-biedl syndrome 4 protein,<2C (LG1)
Tb927.10.6840,612.5,4872.5,5584.0,4070.5,5282.0,hypothetical protein  conserved,S
Tb927.10.6850,7157.5,7262.5,7813.0,8056.0,8493.0,Mitochondrial ribosomal protein S18  putative,>4C (GG2M)
Tb10.NT.73,2747.5,3171.5,3987.0,3241.5,1842.0,Noncoding RNA  putative,S
Tb927.10.6860,5304.0,7825.0,7274.0,6647.5,5880.0,endonuclease v,G1
Tb927.10.6870,5925.5,8361.5,7912.5,8475.0,10131.0,short-chain dehydrogenase  putative,>4C (GG2M)
Tb927.10.6880,3741.5,6550.5,6636.5,5741.0,4664.5,glyceraldehyde 3-phosphate dehydrogenase  cytosolic,S
Tb927.10.6890,5090.0,6782.5,5618.5,5285.0,6028.0,hypothetical protein,G1
Tb927.10.6900,5308.5,9229.5,8451.0,8076.5,10092.0,base J-associated glucosyltransferase,>4C (GG2M)
Tb927.10.6910,7058.0,7672.5,6991.5,7144.0,6344.5,Sterol methyltransferase  putative,G1
Tb927.10.6920,2658.5,5315.0,6022.5,6157.0,4429.0,hypothetical protein,G2M
Tb927.10.6930,8485.0,8081.0,7418.5,8194.0,7184.5,Cullin family/Cullin protein neddylation domain containing protein  putative,<2C (LG1)
Tb927.10.6940,9781.5,10132.0,10457.5,10045.5,9820.5,Dipeptidyl-peptidase 8-like  putative,S
Tb927_10_v4.snoRNA.0045:snoRNA,3494.5,1653.5,1465.0,1688.5,2336.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0030:snoRNA,1460.0,335.0,391.5,313.5,778.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0057:snoRNA,612.5,386.5,596.0,292.5,744.5,term,>4C (GG2M)
Tb927_10_v4.snoRNA.0054:snoRNA,612.5,896.0,578.5,647.5,853.0,term,G1
Tb927_10_v4.snoRNA.0052:snoRNA,4480.0,1653.5,1361.0,1031.0,744.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0072:snoRNA,2381.5,294.5,210.0,273.5,213.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0046:snoRNA,2826.5,373.5,253.5,292.5,287.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0028:snoRNA,612.5,222.0,40.0,292.5,213.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0058:snoRNA,1783.5,373.5,161.0,248.0,347.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0056:snoRNA,612.5,1894.5,2275.0,2389.0,1099.0,term,G2M
Tb927.10.6950,6179.5,6324.0,6218.5,6676.5,5125.0,sterol 24-c-methyltransferase  putative,G2M
Tb927.10.6960,1783.5,5675.0,5856.5,6927.5,4411.5,hypothetical protein  conserved,G2M
Tb927.10.6970,9689.5,10254.0,10592.0,10045.5,10064.5,serine peptidase  Clan SC  Family S9B,S
Tb927_10_v4.snoRNA.0047:snoRNA,3645.5,1574.5,1650.0,1514.5,2550.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0029:snoRNA,612.5,294.5,427.0,397.5,531.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0059:snoRNA,612.5,449.0,507.0,444.5,933.5,term,>4C (GG2M)
Tb927_10_v4.snoRNA.0055:snoRNA,612.5,738.5,532.5,352.0,895.5,term,>4C (GG2M)
Tb927_10_v4.snoRNA.0053:snoRNA,7320.0,2609.5,2164.5,2520.5,1179.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0073:snoRNA,3863.0,626.0,743.0,628.0,433.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0048:snoRNA,3550.5,565.0,547.0,862.0,397.5,term,<2C (LG1)
Tb927.10.6980,10092.0,8677.0,9087.0,9748.0,8000.0,caltractin  putative,<2C (LG1)
Tb927.10.6990,4587.0,7317.5,7091.5,7327.0,4928.5,hypothetical protein  conserved,G2M
Tb927.10.7000,7292.0,4859.5,3599.5,4193.5,3144.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7010,6777.5,6139.5,7442.5,5600.0,4849.5,hypothetical protein  conserved,S
Tb927.10.7020,7148.0,4413.0,4019.5,3168.0,3794.0,acid phosphatase  putative,<2C (LG1)
Tb927.10.7030,2295.5,1858.0,1522.0,1215.5,1099.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7040,7898.5,7024.5,7601.0,6809.0,7268.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7050,1460.0,3467.5,4117.0,4221.0,5996.5,chromatin assembly factor 1 subunit B  putative,>4C (GG2M)
Tb927.10.7060,3785.5,4400.0,5144.0,7883.0,11344.0,Nucleoporin NUP96,>4C (GG2M)
Tb927.10.7070,3166.5,2149.5,2196.0,2199.0,3794.0,small nuclear RNA-activating protein,>4C (GG2M)
Tb927.10.7080,7471.5,6139.5,6708.5,5716.5,6690.0,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb927.10.7090,5025.0,4194.0,2440.5,2321.5,4703.5,Alternative oxidase  mitochondrial,<2C (LG1)
Tb927.10.7100,7324.0,6251.0,4928.0,5392.0,5003.0,delta-4 fatty acid desaturase,<2C (LG1)
Tb927.10.7110,3654.0,2409.5,3789.5,4394.5,2953.5,Myo-inositol 1-phosphate synthase,G2M
Tb927.10.7120,612.5,3256.0,3371.5,2603.0,6323.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7130,11022.0,9450.5,9080.5,9167.5,7484.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7140,9236.5,10422.5,10546.0,10305.5,10303.0,membrane-bound acid phosphatase 2,S
Tb927.10.7150,7104.0,5205.5,5419.0,5333.0,6048.5,hypothetical protein,<2C (LG1)
Tb927.10.7160,10302.0,10155.0,8596.0,9008.5,7731.5,procyclin-associated gene 1 (PAG1) protein  putative,<2C (LG1)
Tb927.10.7170,2637.5,6870.0,7552.5,6837.5,7412.0,hypothetical protein,S
Tb927.10.7180,11698.0,11289.0,11271.0,11037.0,11396.0,cysteine-rich  acidic integral membrane protein precursor,<2C (LG1)
Tb927.10.7190,9049.0,7681.0,6630.0,7547.0,4849.5,D-tyrosyl-tRNA deacylase  putative,<2C (LG1)
Tb927.10.7200,9564.0,6933.0,8015.5,8593.5,8273.0,TPR repeat  putative,<2C (LG1)
Tb927.10.7210,3314.5,2839.5,2551.0,2470.5,4005.5,Flagellum attachment zone protein 17,>4C (GG2M)
Tb927.10.7220,2504.5,6282.5,6838.0,5505.5,3669.0,hypothetical protein  conserved,S
Tb927.10.7230,10884.5,10748.0,11080.0,10611.5,10959.5,Flagellar Member 1,S
Tb927.10.7240,9125.5,7465.5,7890.5,8547.5,8213.5,kinetoplastid kinetochore protein 14,<2C (LG1)
Tb927.10.7250,612.5,7561.5,6826.5,6313.0,5634.5,hypothetical protein  conserved,G1
Tb927.10.7270,5689.5,8431.0,8746.5,9515.5,9652.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7280,9933.0,8917.0,9078.0,9018.0,10622.0,pre-mRNA splicing factor ATP-dependent RNA helicase  putative,>4C (GG2M)
Tb927.10.7290,9819.5,4913.5,5270.0,5617.5,5752.5,Flagellar Member 2,<2C (LG1)
Tb927.10.7300,1460.0,40.5,99.0,136.5,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7310,7709.5,8240.5,8222.0,7308.0,7112.5,terminal uridylyltransferase 3  putative,G1
Tb927.10.7320,2481.0,3457.0,3179.5,2120.5,1660.5,hypothetical protein  conserved,G1
Tb927.10.7330,612.5,192.5,336.0,334.5,213.0,40S ribosomal protein S24E  putative,<2C (LG1)
Tb927.10.7340,612.5,130.0,210.0,182.5,213.0,40S ribosomal protein S24E  putative,<2C (LG1)
Tb927.10.7350,4080.0,6007.0,5991.0,6067.5,10851.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7360,11110.0,10762.0,11104.0,10879.0,10021.5,ATP-binding cassette protein  putative,<2C (LG1)
Tb927.10.7370,612.5,8857.0,8831.0,8264.5,8852.5,hypothetical protein  conserved,G1
Tb927.10.7375,7210.5,2296.0,2522.5,2211.5,2141.5,hypothetical protein,<2C (LG1)
Tb927.10.7380,3868.5,4027.0,3464.5,3724.0,4617.5,LSU ribosomal protein  mitochondrial  putative,>4C (GG2M)
Tb927.10.7390,2535.5,518.0,448.0,647.5,559.5,PHF5-like protein  putative,<2C (LG1)
Tb927.10.7400,7532.5,9428.0,10035.0,9864.5,7792.5,predicted zinc finger protein,S
Tb927.10.7410,9391.0,8344.5,7629.0,7137.5,6344.5,succinyl-CoA ligase [GDP-forming] beta-chain  putative,<2C (LG1)
Tb927.10.7420,9443.0,7642.0,7124.5,7582.0,6864.5,bromodomain factor 2 protein  putative,<2C (LG1)
Tb927.10.7430,6822.0,9431.0,8803.0,8637.5,9903.0,GTP-binding protein  putative,>4C (GG2M)
Tb927.10.7440,5204.5,1866.5,2987.0,2907.5,672.0,ATP-dependent RNA helicase MTR4,<2C (LG1)
Tb927.10.7450,612.5,1817.5,1549.5,2869.0,2720.5,Ribosomal RNA processing protein 41A,G2M
Tb927.10.7460,6528.0,6124.0,6152.5,6706.0,5220.0,hypothetical protein,G2M
Tb927.10.7470,1460.0,2106.0,2425.0,2671.0,1717.0,RNA-binding protein  putative,G2M
Tb927.10.7480,1460.0,2957.5,3978.5,3866.5,3775.0,hypothetical protein  conserved,S
Tb927.10.7490,3142.5,5057.5,4577.0,3677.0,2550.0,cullin 2  putative,G1
Tb927.10.7500,5025.0,4540.5,3994.5,3826.0,3086.0,fibrillarin,<2C (LG1)
Tb10_snRNA_1:snRNA,8510.5,7716.0,6936.0,7687.0,7249.5,uRNA C,<2C (LG1)
Tb10_tRNA_Gly_1:tRNA,6906.5,5251.5,4398.0,4711.5,4498.5,tRNA Glycine,<2C (LG1)
Tb927.10.7510,1460.0,7230.0,8108.5,7072.0,7431.5,chromatin binding protein  putative,S
Tb927.10.7520,10487.0,9818.5,8847.0,9478.0,8345.0,folylpolyglutamate synthase  putative,<2C (LG1)
Tb927.10.7530,1783.5,1530.0,1091.0,757.5,86.0,hypothetical protein,<2C (LG1)
Tb927.10.7540,11033.0,10130.0,10522.0,10194.0,8443.0,VRR-NUC domain containing protein  putative,<2C (LG1)
Tb927.10.7550,9477.0,7660.0,6485.5,7034.0,7084.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7560,3848.5,5521.0,6302.0,6647.5,9065.0,methyltransferase domain containing protein  putative,>4C (GG2M)
Tb927.10.7570,8063.0,6546.5,6929.5,7710.0,5694.5,dihydrolipoamide acetyltransferase E2 subunit  putative,<2C (LG1)
Tb927.10.7580,11176.0,11147.0,11373.5,11374.0,10776.0,hypothetical protein  conserved,G2M
Tb927.10.7590,9195.5,6115.0,6976.0,6626.0,7098.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7600,612.5,3700.0,3487.0,3142.0,2734.0,Centrosomal protein POC5  putative,G1
Tb927.10.7610,8878.0,11213.5,11352.5,11336.0,11309.5,NADH-ubiquinone oxidoreductase complex I subunit  putative,S
Tb927.10.7620,1460.0,3979.0,4398.0,3282.0,4222.5,mitochondrial ATP-dependent zinc metallopeptidase  putative,S
Tb927.10.7630,1914.0,8560.5,8386.0,8615.0,10060.5,transportin2- like protein,>4C (GG2M)
Tb927.10.7640,612.5,2232.0,2207.0,1491.0,2351.0,hypothetical protein,>4C (GG2M)
Tb10_tRNA_Pro_2:tRNA,4339.5,867.5,1289.5,1125.0,531.0,tRNA Proline,<2C (LG1)
Tb10_tRNA_Thr_1:tRNA,612.5,886.5,703.0,849.0,584.5,tRNA Threonine,G1
Tb10_snRNA_2:snRNA,3550.5,1180.5,1757.0,1299.0,461.5,small nuclear RNA,<2C (LG1)
Tb927.10.7650,7421.0,7756.0,7856.0,7368.0,4938.0,hypothetical protein,S
Tb10_tRNA_Leu_1:tRNA,5158.5,4400.0,4807.5,4542.0,5024.5,tRNA Leucine,<2C (LG1)
Tb10_tRNA_Met_1:tRNA,3834.5,835.5,1030.5,773.0,1984.0,tRNA Methionine,<2C (LG1)
Tb10_tRNA_Pro_1:tRNA,3078.5,413.0,391.5,592.5,933.5,tRNA Proline,<2C (LG1)
Tb927.10.7660,3131.5,5236.0,5334.5,3763.0,4947.0,hypothetical protein,S
Tb927.10.7670,4728.0,5364.5,5670.5,5228.0,4391.0,Protein of unknown function (DUF2962)  putative,S
Tb927.10.7680,4375.0,3997.5,3755.0,3724.0,2164.5,GTPase activating protein  putative,<2C (LG1)
Tb927.10.7690,6216.0,9750.5,9649.5,8623.5,8662.0,Component of motile flagella 4,G1
Tb927.10.7700,9652.5,11354.0,11363.0,11390.0,10650.5,ATP-binding cassette protein subfamily G,G2M
Tb927.10.7710,7898.5,5213.5,5981.0,3380.5,4306.0,40S ribosomal protein S8  putative,<2C (LG1)
Tb927.10.7720,612.5,738.5,865.5,925.0,2720.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7730,5511.0,2723.0,2750.5,2264.5,2977.5,Domain of unknown function (DUF4496)  putative,<2C (LG1)
Tb927.10.7740,5402.0,7736.5,8606.0,7897.5,8380.0,protein transport protein SEC23,S
Tb927.10.7750,4375.0,6922.5,5584.0,6147.0,7213.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7760,7115.0,1595.5,2369.0,2237.0,1141.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7770,11296.5,9605.5,9698.5,8239.5,9832.0,hypothetical protein,<2C (LG1)
Tb927.10.7780,9061.5,5701.0,5164.0,4433.0,5772.0,Mitogen-activated protein kinase KFR1,<2C (LG1)
Tb927.10.7790,612.5,4096.5,3344.0,3295.5,2364.5,ubiquitin fusion degradation protein  putative,G1
Tb927.10.7800,4905.0,7789.0,6429.5,7426.5,7518.0,cop9 signalosome complex subunit  putative,G1
Tb927.10.7810,4894.5,10145.0,9630.5,9412.5,5675.0,Pre-rRNA-processing protein ESF1  putative,G1
Tb927.10.7820,2886.0,3235.0,3197.0,2252.0,1878.0,hypothetical protein  conserved,G1
Tb927.10.7830,9656.5,10825.0,10955.0,10840.0,10501.0,hypothetical protein  conserved,S
Tb927.10.7840,6862.0,2969.5,3028.0,3785.5,4975.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7850,612.5,3164.5,3514.5,2617.5,3125.5,protein-L-isoaspartate  putative,S
Tb927.10.7860,5074.0,3863.5,4732.5,4126.5,3413.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7870,7635.5,7939.0,8986.0,8023.0,7377.0,hypothetical protein  conserved,S
Tb927.10.7880,2970.5,1143.0,1149.5,1936.0,8590.5,Sperm tail/Sperm tail C-terminal domain containing protein  putative,>4C (GG2M)
Tb927.10.7890,3179.0,1838.0,2717.5,2357.0,3295.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7900,3448.5,4323.0,4887.0,3521.5,5354.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7910,612.5,1293.5,1217.0,1125.0,1355.0,RNA editing complex protein  putative,>4C (GG2M)
Tb927.10.7920,1914.0,3766.0,4170.0,4558.5,7545.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.7925,612.5,2069.5,2122.5,2456.5,3861.0,hypothetical protein,>4C (GG2M)
Tb927.10.7930,6479.5,5789.5,5044.5,5381.0,4391.0,2 3-bisphosphoglycerate-independent phosphoglycerate mutase,<2C (LG1)
Tb927.10.7940,8458.0,3711.5,4559.5,3658.0,4903.0,methyltransferase  putative,<2C (LG1)
Tb927.10.7950,612.5,5789.5,4776.0,5386.0,4257.0,hypothetical protein,G1
Tb927.10.7960,2047.0,2260.5,2369.0,2788.5,2679.0,hypothetical protein  conserved,G2M
Tb927.10.7970,9662.0,7293.5,6772.0,6366.5,7416.5,Organic solute transporter Ostalpha  putative,<2C (LG1)
Tb927.10.7980,8297.0,6664.0,6730.0,5969.0,6112.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.7985,612.5,192.5,668.5,273.5,86.0,hypothetical protein,S
Tb927.10.7990,8303.0,2479.0,3930.5,3805.5,1472.0,replication factor C subunit 3  putative,<2C (LG1)
Tb927.10.8000,1914.0,7053.5,7278.0,7940.0,10982.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.8010,3662.5,1415.5,1679.0,1726.5,2720.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8020,9292.0,10076.0,10155.0,9460.5,10447.0,prolyl endopeptidase,>4C (GG2M)
Tb927.10.8030,4563.0,2260.5,2612.0,1993.5,2536.0,Mitochondrial ATP synthase subunit 5,<2C (LG1)
Tb927.10.8040,5747.0,8557.5,9050.5,8132.5,10442.5,beta adaptin  putative,>4C (GG2M)
Tb927.10.8050,7435.0,9171.0,8882.5,8974.0,9234.5,TFIIF-stimulated CTD phosphatase  putative,>4C (GG2M)
Tb927.10.8060,11175.0,7065.5,8917.0,8348.5,5230.0,SET domain containing protein  putative,<2C (LG1)
Tb927.10.8070,7646.5,10632.5,10263.5,10198.0,9065.0,ATPase  putative,G1
Tb927.10.8080,4057.5,6792.5,7856.0,7308.0,6690.0,Uncharacterized conserved protein (DUF2042)  putative,S
Tb927.10.8090,3155.0,2975.0,3108.5,3295.5,1958.0,hypothetical protein  conserved,G2M
Tb927.10.8100,612.5,4227.0,3821.0,3796.5,4199.0,hypothetical protein  conserved,G1
Tb927.10.8110,9490.0,8300.0,7879.0,7072.0,9313.0,Protein of unknown function (DUF2453)  putative,<2C (LG1)
Tb927.10.8115,612.5,2479.0,1977.0,2058.5,3888.0,hypothetical protein,>4C (GG2M)
Tb927.10.8120,9250.0,8946.0,9095.5,9066.0,9911.0,RNA ligase/AAA domain containing protein  putative,>4C (GG2M)
Tb927.10.8130,612.5,2741.5,2075.5,3029.0,2141.5,hypothetical protein  conserved,G2M
Tb927.10.8140,612.5,3485.5,2541.5,1343.0,1958.0,EVE domain containing protein  putative,G1
Tb927.10.8150,7540.5,5083.0,6246.0,5939.0,5609.5,Bromodomain factor 1,<2C (LG1)
Tb927.10.8160,4930.5,2983.5,2214.0,2541.0,3606.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8170,4760.5,4823.5,6379.0,5407.5,7084.5,Nucleoporin NUP144,>4C (GG2M)
Tb927.10.8180,8380.5,8730.5,9197.5,8508.0,9220.5,hypothetical protein  conserved,>4C (GG2M)
Tb10.NT.91,612.5,2457.0,2638.5,3545.0,1338.5,Noncoding RNA  putative,G2M
Tb927.10.8190,1460.0,1817.5,2586.5,3627.0,10229.5,T-complex protein 1  theta subunit  putative,>4C (GG2M)
Tb927.10.8200,8800.5,7216.5,8094.5,6837.5,7055.0,Ribosomal protein L1p/L10e family  putative,<2C (LG1)
Tb927.10.8210,8800.5,8254.0,8060.5,7730.0,7689.0,KREPA2,<2C (LG1)
Tb927.10.8220,2460.0,7647.5,6648.5,5101.5,5567.0,hypothetical protein  conserved,G1
Tb927.10.8230,6498.0,6095.5,5991.0,5832.0,5266.5,protein disulfide isomerase 2,<2C (LG1)
Tb927.10.8240,6797.0,9072.0,9363.5,10630.5,11623.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.8250,8729.0,5946.5,5838.5,5600.0,4403.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8260,612.5,1190.0,1137.0,1097.5,1691.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.8270,2619.0,3217.5,2154.5,1805.5,1622.5,eukaryotic translation initiation factor 3 subunit c,G1
Tb927.10.8275,2381.5,2069.5,1757.0,2520.5,1047.0,hypothetical protein  conserved,G2M
Tb927.10.8280,3888.5,5921.5,4224.5,4798.0,5451.0,U1A small nuclear ribonucleoprotein,G1
Tb927.10.8290,2481.0,3552.0,2023.5,2085.0,1816.5,eukaryotic translation initiation factor 3 subunit c,G1
Tb927.10.8295,2094.5,1716.0,1603.5,2440.0,672.0,hypothetical protein  conserved,G2M
Tb927.10.8300,3468.5,4920.0,3789.5,4279.5,4928.5,U1A small nuclear ribonucleoprotein,>4C (GG2M)
Tb927.10.8310,6929.5,4823.5,3066.0,4301.0,5870.5,histone acetyltransferase,<2C (LG1)
Tb927.10.8320,9100.0,6772.0,6401.0,6357.5,5526.5,cytochrome oxidase subunit IX  putative,<2C (LG1)
Tb927.10.8330,2795.5,322.0,1402.0,1642.5,2991.5,S. cerevisiae PSP1 homologue  putative,>4C (GG2M)
Tb927.10.8340,1460.0,5992.0,4966.0,5517.5,5847.0,hypothetical protein,G1
Tb927.10.8350,9841.5,7934.0,7652.5,7979.5,6485.0,hypothetical protein,<2C (LG1)
Tb927.10.8360,8165.5,6413.0,6302.0,7220.0,5394.5,Poly(A)-specific ribonuclease PARN-2,<2C (LG1)
Tb927.10.8370,7971.0,4902.5,5239.0,4852.5,2786.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8375,5799.0,7325.0,7312.0,8543.5,6173.5,hypothetical protein,G2M
Tb927.10.8380,1783.5,222.0,130.5,204.0,531.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8390,9636.5,10726.5,11231.0,11025.0,11627.0,Concanavalin A-like lectin/glucanases superfamily/SPRY domain/HECT-domain (ubiquitin-transferase)  putative,>4C (GG2M)
Tb927.10.8400,1783.5,4778.5,4614.0,5765.5,4586.5,legume-like lectin  putative,G2M
Tb927.10.8410,9615.0,6295.0,6577.0,6441.0,6137.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8420,11620.0,11530.0,11479.5,11414.0,11431.0,Phosphatidylinositol 3-kinase tor1,<2C (LG1)
Tb927.10.8430,612.5,40.5,40.0,111.0,86.0,40S ribosomal protein S12  putative,<2C (LG1)
Tb10.NT.95,2729.0,2319.0,2112.5,2520.5,3283.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.10.8440,7892.5,6471.5,6334.0,6035.0,6928.0,glucose transporter 1B,<2C (LG1)
Tb927.10.8450,7177.0,5829.5,5598.0,5489.0,5555.0,glucose transporter 1E,<2C (LG1)
Tb927.10.8460,8520.5,6772.0,6270.5,6255.5,7219.5,glucose transporter  putative,<2C (LG1)
Tb927.10.8470,7573.5,6581.5,5765.5,6056.0,6764.0,glucose transporter  putative,<2C (LG1)
Tb927.10.8480,7568.0,7851.5,7767.5,7725.0,6104.0,glucose transporter  putative,G1
Tb927.10.8490,7859.5,6244.5,6772.0,6914.5,7290.0,glucose transporter  putative,<2C (LG1)
Tb927.10.8500,6552.0,5918.5,5408.5,6024.5,6190.0,glucose transporter  putative,<2C (LG1)
Tb927.10.8510,8044.5,7137.0,6966.5,7047.0,8360.5,glucose transporter  putative,>4C (GG2M)
Tb927.10.8520,9022.5,6676.0,6718.0,6366.5,8053.5,glucose transporter  putative,<2C (LG1)
Tb927.10.8530,8027.0,7216.5,6429.5,7469.0,7704.5,glucose transporter 2A,<2C (LG1)
Tb927.10.8540,2658.5,4733.5,5315.0,5060.5,2351.0,chaperone protein DnaJ  putative,S
Tb927.10.8560,612.5,3734.0,1574.0,2735.0,1622.5,small GTPase  putative,G1
Tb927.10.8570,11221.0,10888.5,10630.0,10709.0,10430.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8580,7041.5,2621.0,1700.5,2617.5,1816.5,ADP-ribosylation factor-like protein 3b  putative,<2C (LG1)
Tb927.10.8585,4872.5,2224.0,2207.0,2046.5,2574.5,hypothetical protein,<2C (LG1)
Tb927.10.8590,9966.0,9628.0,9335.5,9559.0,5996.5,flagellum transition zone component,<2C (LG1)
Tb927.10.8600,8137.0,9634.5,9215.5,9518.5,8374.0,Vps54-like protein  putative,G1
Tb927.10.8610,5036.5,6911.5,6192.0,6255.5,5526.5,hypothetical protein  conserved,G1
Tb927.10.8620,612.5,8223.0,9407.5,9075.5,6596.5,hypothetical protein  conserved,S
Tb927.10.8630,6973.0,3680.0,2653.0,2858.5,5266.5,Sucrase/ferredoxin-like  putative,<2C (LG1)
Tb927.10.8640,6389.5,4975.5,5497.5,5198.5,5824.0,Galactose oxidase  central domain containing protein  putative,<2C (LG1)
Tb927.10.8650,7215.5,7171.0,7188.5,7252.0,5404.0,ran binding protein  putative,G2M
Tb927.10.8660,6612.5,2416.5,2289.5,1993.5,3199.5,Fis1 C-terminal tetratricopeptide repeat  putative,<2C (LG1)
Tb927.10.8670,1460.0,4172.0,3344.0,3513.0,4703.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.8680,6680.5,2601.0,1999.5,2120.5,1565.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8690,3107.5,3561.5,3885.0,3605.5,5075.5,TIGR00269 family protein  putative,>4C (GG2M)
Tb927.10.8700,612.5,2106.0,2638.5,1140.0,1239.0,selenoprotein  putative,S
Tb927.10.8710,612.5,3245.0,2425.0,3978.5,4550.5,centrin-3,>4C (GG2M)
Tb927.10.8720,8516.5,9217.0,9948.5,9337.0,11025.0,CCR4-NOT transcription complex subunit 10  putative,>4C (GG2M)
Tb927.10.8730,4027.5,6708.5,4293.5,5273.5,4813.5,ABC1 family  putative,G1
Tb927.10.8740,612.5,3109.0,2750.5,3393.5,3896.5,hypothetical protein,>4C (GG2M)
Tb927.10.8750,612.5,2416.5,2262.5,1763.5,3323.0,GTPase activating protein  putative,>4C (GG2M)
Tb927.10.8760,612.5,3179.0,3410.0,3228.0,3794.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.8770,5369.0,7195.5,6423.5,5922.5,5282.0,disgorgin  putative,G1
Tb927.10.8780,9577.0,9097.0,9854.0,10788.5,11651.0,AAA domain containing protein  putative,>4C (GG2M)
Tb927.10.8790,4760.5,4950.0,4200.5,3677.0,3248.5,OTU-like cysteine protease  putative,G1
Tb927.10.8800,6990.0,6324.0,6849.0,6322.0,4365.0,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.10.8810,10276.5,10225.5,10323.0,10561.5,10494.0,hypothetical protein  conserved,G2M
Tb927.10.8820,8692.5,8154.5,9438.5,10300.5,11340.5,hook complex protein  conserved,>4C (GG2M)
Tb927.10.8830,3314.5,3060.0,1623.0,2566.5,8770.0,Flagellum attachment zone protein 5,>4C (GG2M)
Tb927.10.8840,5774.0,5454.0,4823.0,6045.0,6350.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.10.8850,8500.5,8966.5,9653.5,10125.0,8310.5,A distinct subfamily of CDD/CDA-like deaminases  putative,G2M
Tb927.10.8860,5792.5,8857.0,9126.0,8990.5,8697.5,hypothetical protein  conserved,S
Tb927.10.8870,3155.0,4383.0,4214.0,4686.5,6793.5,Myosin-like coiled-coil protein  putative,>4C (GG2M)
Tb927.10.8880,5908.0,6239.5,6302.0,7034.0,6377.5,RNA interference factor 4,G2M
Tb927.10.8890,9919.0,7697.5,7731.0,8488.5,8570.5,kinetoplast DNA-associated protein  putative,<2C (LG1)
Tb927.10.8900,10169.5,7760.5,6947.5,7258.0,8245.0,choline/ethanolamine phosphotransferase (CEPT),<2C (LG1)
Tb927.10.8910,8371.0,10790.0,10719.0,10513.5,10551.5,Nucleoporin NUP181,G1
Tb927.10.8920,4661.0,6740.0,6315.0,6090.0,6857.0,ras-like small GTPase  putative,>4C (GG2M)
Tb927.10.8930,9262.5,6967.5,7076.5,7967.5,8770.0,paraflagellar rod component  putative,<2C (LG1)
Tb927.10.8940,2221.0,498.0,795.0,826.5,3055.0,flagellum targeting protein kharon1  putative,>4C (GG2M)
Tb927.10.8950,4563.0,912.5,795.0,907.5,1338.5,kinetoplast-associated protein 4 isoform 1,<2C (LG1)
Tb927.10.8960,8242.0,5600.0,5494.0,5824.5,3794.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.8970,4533.5,1904.5,1742.5,2470.5,672.0,kinetoplast-associated protein 4 isoform 2,<2C (LG1)
Tb927.10.8980,9183.5,9228.0,8687.5,8752.5,8570.5,hypothetical protein  conserved,G1
Tb927.10.8990,8590.5,3932.0,4200.5,4962.5,3950.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9000,6925.5,9900.0,9483.5,9313.0,9859.0,Mitochondrial processome subunit 2,G1
Tb927.10.9010,5891.0,1009.0,980.0,1125.0,1531.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.10.9020,8827.5,5017.0,5771.0,5137.0,5014.5,Gcd10p family  putative,<2C (LG1)
Tb927.10.9025,612.5,260.0,795.0,628.0,213.0,hypothetical protein,S
Tb927.10.9030,4978.5,3313.0,4019.5,3796.5,3847.5,Mechanosensitive ion channel MscS  putative,<2C (LG1)
Tb927.10.9040,11500.0,11488.5,11455.0,11415.0,11428.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9050,9058.5,8305.5,8529.5,7710.0,8662.0,pseudouridine synthase TruD  putative,<2C (LG1)
Tb927.10.9060,6853.5,6186.0,6447.0,5816.0,5916.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9070,10194.5,10314.0,10638.0,10735.0,8188.0,hypothetical protein  conserved,G2M
Tb927.10.9080,9580.0,10706.5,10978.0,11063.0,10503.0,pteridine transporter  putative,G2M
Tb927.10.9090,10623.5,10289.5,10436.0,10295.5,9843.0,Cullin binding  putative,<2C (LG1)
Tb927.10.9100,612.5,4778.5,4057.0,4409.0,3271.5,hypothetical protein  conserved,G1
Tb927.10.9110,2682.0,3806.5,3452.0,3856.5,3169.5,hypothetical protein  conserved,G2M
Tb927.10.9120,1460.0,1240.5,1371.0,1526.5,2016.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.9130,9925.5,10646.0,10614.0,10850.0,10981.0,pre-mRNA splicing factor ATP-dependent RNA helicase  putative,>4C (GG2M)
Tb927.10.9140,6847.0,10112.0,9803.5,10279.5,9308.5,FAD dependent oxidoreductase  putative,G2M
Tb927.10.9150,4439.5,5205.5,5286.0,5079.0,6519.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.9160,2870.5,8127.5,8714.0,7728.0,6679.0,Cyclin 12  L-type,S
Tb927.10.9170,2574.5,1553.5,1489.0,773.0,1407.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9180,5286.0,2992.5,2112.5,2506.5,2351.0,PRA1 family protein  putative,<2C (LG1)
Tb10.NT.102,7834.5,2392.5,2275.0,2264.5,2495.0,Noncoding RNA  putative,<2C (LG1)
Tb927.10.9190,2956.5,279.5,233.5,273.5,797.5,isoleucyl-tRNA synthetase  putative,<2C (LG1)
Tb927.10.9200,11227.0,10989.5,11154.5,10949.5,10218.5,Nuclease-related domain containing protein  putative,<2C (LG1)
Tb927.10.9210,1988.0,6620.0,6253.5,6001.0,7098.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.9220,2840.5,4603.5,2961.0,3711.5,4560.5,hypothetical protein  conserved,G1
Tb927.10.9230,6137.0,8427.0,6893.0,6719.5,9801.5,beta adaptin  putative,>4C (GG2M)
Tb927.10.9240,1460.0,471.5,491.0,628.0,818.0,Tir chaperone protein (CesT) family  putative,<2C (LG1)
Tb927.10.9250,11043.0,6546.5,5187.5,5273.5,5983.0,adenylyl cyclase-associated protein  putative,<2C (LG1)
Tb927.10.9260,4225.5,6034.5,4758.5,5386.0,4306.0,hypothetical protein  conserved,G1
Tb927.10.9270,7503.5,2723.0,2564.5,2629.5,3199.5,emp24/gp25L/p24 family/GOLD  putative,<2C (LG1)
Tb927.10.9280,4642.5,3380.0,4139.5,3616.5,4022.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9290,612.5,3429.0,3033.5,3154.0,3413.5,Phosphoseryl-tRNA Kinase  putative,G1
Tb927.10.9300,3803.0,8279.5,8768.0,8704.5,6575.5,adiponectin receptor protein 1,S
Tb927.10.9310,1460.0,3344.5,3179.5,2603.0,2977.5,Haemolysin-III related  putative,G1
Tb927.10.9320,612.5,3476.5,3858.5,3168.0,6289.5,hypothetical protein  conserved,>4C (GG2M)
Tb10.NT.103,612.5,3150.0,3260.0,2988.5,3825.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.10.9330,10764.5,8015.5,7342.5,8150.5,5725.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9340,2406.5,1690.5,1237.5,1261.0,1062.5,hypothetical protein,<2C (LG1)
Tb927.10.9350,2094.5,6776.5,8318.5,4908.0,2050.0,hypothetical protein  conserved,S
Tb927.10.9360,6137.0,9936.0,9637.0,9334.0,8784.5,L-2-hydroxyglutarate dehydrogenase  mitochondrial  putative,G1
Tb927.10.9370,11067.5,9030.5,8540.5,8990.5,5752.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9380,11435.0,10949.5,11082.0,11292.0,10779.5,SEP domain/UBX domain containing protein  putative,<2C (LG1)
Tb927.10.9390,9449.0,8066.0,7706.0,7204.5,7988.0,Macrocin-O-methyltransferase (TylF)  putative,<2C (LG1)
Tb927.10.9400,7977.5,6295.0,8185.0,9116.5,9122.0,splicing factor 1,>4C (GG2M)
Tb927.10.9410,1460.0,1574.5,2425.0,1833.5,3033.0,Selenophosphate synthetase 2,>4C (GG2M)
Tb927.10.9420,4685.0,7102.0,7158.0,7087.0,5258.0,mitochondrial chaperone BCS1  putative,S
Tb927.10.9430,6120.0,6852.0,3843.5,3441.0,2243.5,phosphoribosylpyrophosphate synthetase  putative,G1
Tb927.10.9440,6487.5,9026.5,8949.5,8110.0,8241.0,NADH dehydrogenase,G1
Tb927.10.9445,612.5,471.5,507.0,444.5,86.0,hypothetical protein,<2C (LG1)
Tb927.10.9450,612.5,2540.0,1783.0,2404.0,5854.0,invariant surface glycoprotein  putative,>4C (GG2M)
Tb927.10.9465,612.5,2638.5,2036.0,2746.5,1531.5,hypothetical protein,G2M
Tb927.10.9470,5496.0,5287.0,5135.0,4841.0,4928.5,expression site-associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb927.10.9480,5519.0,6229.5,6460.5,6171.5,7573.0,expression site-associated gene 3 (ESAG3) protein  putative,>4C (GG2M)
Tb927.10.9490,1914.0,1823.0,2653.0,2456.5,2574.5,expression site-associated gene 3 (ESAG3)-like protein,S
Tb927.10.9500,2767.0,4227.0,4130.5,4808.0,3044.5,expression site-associated gene 3 (ESAG3) protein  putative,G2M
Tb927.10.9510,4170.0,3863.5,3503.0,3282.0,3825.5,hypothetical protein,<2C (LG1)
Tb927.10.9530,2221.0,8557.5,7350.0,7719.0,6712.0,hypothetical protein,G1
Tb927.10.9550,6264.0,1934.0,1757.0,1665.0,2402.0,hypothetical protein,<2C (LG1)
Tb927.10.9560,612.5,1018.0,427.0,974.5,637.0,oxidoreductase  putative,G1
Tb927.10.9570,11123.0,10299.5,10686.0,10881.5,11241.5,paraflagellar rod component  putative,>4C (GG2M)
Tb927.10.9590,9183.5,11102.0,11051.0,11026.0,10260.0,hypothetical protein  conserved,G1
Tb927.10.9600,4691.0,7770.5,6976.0,5273.5,8378.0,CMGC/DYRK protein kinase  putative,>4C (GG2M)
Tb927.10.9610,8300.0,5896.0,6142.0,5576.5,5861.5,hypothetical protein,<2C (LG1)
Tb927.10.9620,612.5,759.0,491.0,826.5,505.0,NADH-ubiquinone oxidoreductase c,G2M
Tb927.10.9630,612.5,40.5,233.5,182.5,397.5,hypothetical protein,<2C (LG1)
Tb927.10.9640,6828.0,5561.5,5598.0,4908.0,4145.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.9650,5127.5,3723.5,4653.0,5228.0,9811.5,Nucleoporin NUP152,>4C (GG2M)
Tb927.10.9660,11173.5,5166.0,4046.5,2311.0,3555.5,Splicing factor CRN  putative,<2C (LG1)
Tb927.10.9670,8497.0,9139.5,9066.5,8498.5,7534.5,ADP-ribosylation factor family  putative,G1
Tb927.10.9675,2523.0,3008.5,2586.5,1950.5,4860.0,hypothetical protein,>4C (GG2M)
Tb927.10.9680,5241.5,9843.5,9962.5,10057.0,9892.5,SET domain containing protein  putative,G2M
Tb927.10.9690,11539.0,11527.0,11484.0,11574.0,11349.0,predicted C2 domain protein,G2M
Tb927.10.9700,8632.5,10059.0,9153.5,9769.0,11540.0,Flagellum attachment zone protein 22,>4C (GG2M)
Tb927.10.9710,612.5,3467.5,2410.5,3408.0,7890.5,hypothetical protein,>4C (GG2M)
Tb927.10.9720,11564.0,10475.0,9637.0,10069.0,8590.5,RNA-editing-associated protein 1,<2C (LG1)
Tb927.10.9730,1460.0,2851.5,2961.0,2603.0,818.0,hypothetical protein  conserved,S
Tb927.10.9740,4040.0,4578.5,3850.0,4394.5,2029.5,Regulatory particle triple-A ATPase subunit 6,G1
Tb927.10.9750,10500.0,11169.0,10912.0,10766.5,10210.5,ubiquitin-protein ligase  putative,G1
Tb927.10.9760,8196.5,6352.5,6246.0,4894.5,2153.5,alternative oxidase,<2C (LG1)
Tb927.10.9770,5573.5,6062.5,6126.5,7859.5,11271.5,gamma-tubulin complex component 2,>4C (GG2M)
Tb927.10.9780,9969.5,10400.0,10201.0,9971.0,10377.0,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.10.9790,612.5,2679.0,3157.0,2541.0,2427.0,hypothetical protein  conserved,S
Tb927.10.9800,3834.5,2409.5,3246.5,3185.0,2574.5,60S ribosomal protein L22,<2C (LG1)
Tb927.10.9810,1460.0,2687.5,2499.0,3356.0,3648.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.9820,7520.5,5971.0,7896.0,5489.0,5609.5,mitochondrial intermediate peptidase,S
Tb927.10.9830,9360.5,6344.0,7365.0,7906.5,6153.5,Mitochondrial ATP synthase subunit  putative,<2C (LG1)
Tb927.10.9840,9169.0,5822.5,5543.5,6452.5,6112.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.10.9850,3770.5,7233.0,8494.0,7801.5,7834.0,amino acid transporter  putative,S
Tb927.10.9860,1783.5,3129.0,3101.5,3241.5,1789.5,Mitochondrial N(5)-glutamine methyltransferase MTQ1  putative,G2M
Tb927.10.9870,1460.0,5647.0,4586.5,5325.0,8125.0,Component of motile flagella 12,>4C (GG2M)
Tb927.10.9880,612.5,130.0,99.0,136.5,213.0,60S ribosomal protein L18  putative,<2C (LG1)
Tb927.10.9890,8957.5,9175.5,9981.0,9071.5,7392.0,hypothetical protein  conserved,S
Tb927.10.9900,4849.5,6058.0,7027.5,7220.0,6143.5,ABC1 protein  putative,G2M
Tb927.10.9910,10319.0,7474.5,9069.5,8619.0,8353.5,PSP1 C-terminal conserved region  putative,<2C (LG1)
Tb927.10.9920,3670.5,7996.5,8167.5,7245.0,6392.5,hypothetical protein  conserved,S
Tb927.10.9930,10167.5,9186.5,9259.0,8935.0,8226.0,PHD-zinc-finger like domain containing protein  putative,<2C (LG1)
Tb927.10.9940,6755.5,3194.0,2510.5,3463.5,5761.0,Predicted membrane protein  putative,<2C (LG1)
Tb927.10.9950,3534.0,8784.5,7490.0,8573.5,6890.0,hypothetical protein  conserved,G1
Tb927.10.9960,6867.0,6951.0,8152.5,7220.0,8690.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.9970,8516.5,11343.0,11322.0,11297.0,11134.5,hypothetical protein  conserved,G1
Tb927.10.9980,1460.0,3457.0,5479.0,3796.5,3861.0,hypothetical protein  conserved,S
Tb927.10.9990,8361.0,9103.5,8831.0,9826.5,10336.0,non-canonical purine NTP pyrophosphatase  RdgB/HAM1 family  putative,>4C (GG2M)
Tb927.10.10000,1783.5,5024.5,4783.5,3796.5,4617.5,hypothetical protein  conserved,G1
Tb927.10.10010,7570.0,4950.0,6556.0,4720.5,3693.0,mRNA turnover protein 4 homolog  putative,<2C (LG1)
Tb927.10.10020,6029.0,5378.0,6544.0,5295.5,5675.0,Rab5 GDP/GTP exchange factor (Rabex-5)  putative,S
Tb927.10.10030,6509.5,2731.0,3308.0,3367.5,5003.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10040,4574.0,5301.5,6695.5,6240.5,6314.0,hypothetical protein,S
Tb927.10.10050,4433.0,9877.5,8517.0,8948.5,7342.0,hypothetical protein  conserved,G1
Tb927.10.10070,7686.0,5273.0,5625.0,4841.0,6173.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10080,7956.0,4235.0,3767.5,3596.5,5702.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10090,11008.0,11073.0,10942.0,10449.5,10426.5,Component of motile flagella 14,G1
Tb927.10.10100,6198.5,9520.5,9625.5,9874.5,10602.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.10110,2504.5,1448.0,1091.0,1187.5,2243.5,PIG-P  putative,<2C (LG1)
Tb927.10.10120,3638.0,7247.0,7082.5,7227.0,5064.5,hypothetical protein  conserved,G1
Tb927.10.10130,8880.0,6911.5,7131.5,6240.5,5916.5,RNA editing mediator complex protein 1,<2C (LG1)
Tb927.10.10140,9148.0,5280.5,5102.5,6129.0,7655.5,paraflagellar rod component  putative,<2C (LG1)
Tb927.10.10150,8969.0,10338.5,9454.0,10024.0,10965.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.10160,8344.0,9069.5,8989.0,9637.0,8449.0,Kinetoplast polyadenylation factor 4,G2M
Tb927.10.10170,7766.0,10017.0,9737.5,9935.0,10095.5,pre-mRNA splicing factor 46  putative,>4C (GG2M)
Tb927.10.10180,8415.5,2319.0,3039.5,2999.5,3566.5,Miro-like protein  putative,<2C (LG1)
Tb927.10.10190,8510.5,10440.0,10820.5,10647.5,10642.0,Leucine-rich repeat domain containing protein,S
Tb927.10.10200,10944.0,9220.5,8863.5,8885.0,9013.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10210,10812.5,10149.5,10355.0,10736.5,10332.5,procyclin-associated gene 4 (PAG4) protein,<2C (LG1)
Tb927.10.10220,8638.0,6494.5,7124.5,7662.5,8838.5,procyclin-associated gene 2 (PAG2) protein,>4C (GG2M)
Tb927.10.10230,612.5,4199.5,3940.5,4318.0,5311.0,procyclin-associated gene 5 (PAG5) protein,>4C (GG2M)
Tb927.10.10240,7926.5,10462.5,10094.5,10010.5,10477.0,procyclin-associated gene 1 (PAG1) protein,>4C (GG2M)
Tb927.10.10250,5826.0,6992.5,7177.0,6434.5,6596.5,EP2 procyclin,S
Tb927.10.10260,9681.0,10534.5,10512.5,10729.0,10291.5,EP1 procyclin,G2M
Tb927.10.10270,7327.0,7776.0,8081.5,7455.0,8137.0,hypothetical protein,>4C (GG2M)
Tb927.10.10280,10684.0,11504.0,11568.0,11429.0,11519.0,microtubule-associated protein  putative,S
Tb927.10.10290,4205.0,5974.5,6041.0,5517.5,6743.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.10300,9641.0,9124.0,8441.0,9653.5,9275.0,hypothetical protein  conserved,G2M
Tb927.10.10310,10830.0,9305.5,9721.0,9346.0,7918.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10320,612.5,3060.0,2764.5,3752.5,2720.5,dynein light chain Tctex-type  putative,G2M
Tb927.10.10330,8183.5,6066.5,7354.5,8110.0,9637.5,Anaphase-promoting complex subunit CDC27,>4C (GG2M)
Tb927.10.10340,4333.5,4251.5,6114.0,5273.5,6472.5,structural maintenance of chromosome 2  putative,>4C (GG2M)
Tb927.10.10350,9411.0,9317.5,8683.0,7710.0,9328.0,STE/STE11 serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.10.10360,10158.0,10694.0,11158.5,10605.0,10470.0,Microtubule-associated repetitive protein,S
Tb927.10.10370,3856.5,6066.5,6172.5,5775.5,7219.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.10380,7496.0,8219.0,8676.5,7434.0,9579.5,ATP-dependent DEAD/H RNA helicase  putative,>4C (GG2M)
Tb927.10.10390,7507.5,6247.5,8034.0,6267.5,8221.5,trypanothione reductase,>4C (GG2M)
Tb927.10.10400,4751.0,3863.5,3832.5,6056.0,5420.5,Mitochondrial ribosomal protein S11,G2M
Tb927.10.10410,3394.0,4726.0,4653.0,1911.5,1622.5,DNA replication licensing factor MCM8  putative,G1
Tb927.10.10420,612.5,3447.0,2939.0,3241.5,4429.0,monothiol glutaredoxin  putative,>4C (GG2M)
Tb927.10.10430,1783.5,3687.0,3642.0,3577.5,3086.0,hypothetical protein  conserved,G1
Tb927.10.10440,5298.5,4331.5,4348.0,4267.0,3248.5,mitochondrial carrier protein,<2C (LG1)
Tb927.10.10445,3120.5,358.0,532.5,628.0,672.0,Core histone H2A/H2B/H3/H4  putative,<2C (LG1)
Tb927.10.10460,3095.0,1506.5,2207.0,1899.5,1078.0,histone H2B  putative,<2C (LG1)
Tb927.10.10470,2552.0,811.0,685.0,1654.0,1660.5,histone H2B  putative,<2C (LG1)
Tb927.10.10480,2574.5,626.0,893.0,849.0,915.0,histone H2B  putative,<2C (LG1)
Tb927.10.10490,2920.5,855.5,925.0,1228.0,1141.0,histone H2B  putative,<2C (LG1)
Tb927.10.10500,2682.0,1009.0,1361.0,1642.5,1338.5,histone H2B  putative,<2C (LG1)
Tb927.10.10510,3272.0,1231.0,1721.5,1441.0,1325.5,histone H2B  putative,<2C (LG1)
Tb927.10.10520,3120.5,1697.0,2541.5,2554.0,1489.0,histone H2B  putative,<2C (LG1)
Tb927.10.10530,3120.5,1201.5,1700.5,1430.0,1062.5,histone H2B  putative,<2C (LG1)
Tb927.10.10540,2180.0,235.5,391.5,444.5,397.5,histone H2B  putative,<2C (LG1)
Tb927.10.10550,3191.0,988.5,1091.0,1403.5,1027.5,histone H2B  putative,<2C (LG1)
Tb927.10.10560,2180.0,279.5,491.0,501.5,486.0,histone H2B  putative,<2C (LG1)
Tb927.10.10570,3155.0,944.0,1237.5,1299.0,797.5,histone H2B  putative,<2C (LG1)
Tb927.10.10580,2840.5,1448.0,1650.0,1833.5,1099.0,histone H2B  putative,<2C (LG1)
Tb927.10.10590,2913.0,747.5,966.5,1003.0,915.0,histone H2B  putative,<2C (LG1)
Tb927.10.10600,3041.5,1506.5,2238.0,2134.5,4244.5,ARP2/3 complex 16kDa subunit  putative,>4C (GG2M)
Tb927.10.10610,612.5,4823.5,5270.0,5824.5,5379.5,protein tyrosine phosphatase  putative,G2M
Tb927.10.10620,9649.0,8533.0,8540.5,7416.5,9242.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10630,3914.0,5287.0,5744.0,7301.0,3375.0,hypothetical protein  conserved,G2M
Tb927.10.10640,5886.0,2392.5,1679.0,1585.5,2389.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10650,10089.0,9713.0,9846.5,9885.5,10128.0,cytosolic Fe-S cluster assembly factor NAR1  putative,>4C (GG2M)
Tb927.10.10670,6227.5,8043.0,7291.0,6441.0,4391.0,kinetoplastid-specific dual specificity phosphatase  putative,G1
Tb927.10.10680,8269.5,4895.5,5070.5,5069.5,6104.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.10690,612.5,1619.0,1446.0,2184.5,1758.0,CEP19-like protein  putative,G2M
Tb927.10.10700,5218.0,3723.5,3148.0,2697.5,4128.5,splicing factor Prp31,<2C (LG1)
Tb927.10.10710,9886.0,9810.5,9717.0,10155.5,10299.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.10720,9507.5,10334.5,10554.0,10474.0,8445.0,Tetraspanin family  putative,S
Tb927.10.10730,11307.0,11231.0,11186.0,10995.0,10570.5,RNA Interference Factor 5,<2C (LG1)
Tb927.10.10740,3510.0,6897.0,3668.5,4070.5,2065.0,hypothetical protein  conserved,G1
Tb927.10.10750,8641.0,11042.0,10847.0,10865.0,10326.5,metallo-peptidase  Clan MC  Family M14  putative,G1
Tb927.10.10770,11213.5,6373.5,8714.0,7384.5,9500.0,Generative cell specific 1 protein  putative,<2C (LG1)
Tb927.10.10780,612.5,787.5,562.5,610.5,994.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.10790,1914.0,1034.0,907.5,1585.5,978.0,hypothetical protein,<2C (LG1)
Tb927.10.10800,7650.0,7092.0,6708.5,7078.5,5813.0,palmitoyl acyltransferase 2  putative,<2C (LG1)
Tb927.10.10810,1460.0,7297.5,7844.5,7692.0,8020.0,adenosine deaminase-like protein,>4C (GG2M)
Tb927.10.10820,612.5,3596.0,3487.0,3029.0,4664.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.10830,5891.0,5384.5,5808.0,5375.0,6123.0,RGG-containing protein 2,>4C (GG2M)
Tb927.10.10840,1783.5,6073.0,6550.5,6501.0,6984.0,Enriched in surface-labeled proteome protein 15,>4C (GG2M)
Tb927.10.10850,4501.0,9009.0,9047.0,9430.5,8955.0,Protein argonaute-1,G2M
Tb10_tRNA_Asn_1:tRNA,5667.0,2350.5,3167.0,2440.0,1422.0,tRNA Asparagine,<2C (LG1)
Tb10_tRNA_Ala_1:tRNA,3303.5,1466.5,1938.0,1626.0,1744.5,tRNA Alanine,<2C (LG1)
Tb10_tRNA_Arg_1:tRNA,2295.5,1482.5,685.0,907.5,853.0,tRNA Arginine,<2C (LG1)
Tb10_tRNA_Lys_1:tRNA,612.5,1344.0,1091.0,1154.5,1472.0,tRNA Lysine,>4C (GG2M)
Tb10_tRNA_Arg_2:tRNA,612.5,2118.0,1799.0,1805.5,1608.0,tRNA Arginine,G1
Tb927.10.10870,9739.5,4503.0,4372.0,4004.5,5470.5,CMGC family protein kinase  putative,<2C (LG1)
Tb927.10.10880,5673.0,4937.5,5429.5,3805.5,2550.0,ATP-binding cassette sub-family F member 1  putative,<2C (LG1)
Tb927.10.10890,4048.0,3979.0,2750.5,4686.5,4903.0,heat shock protein  putative,>4C (GG2M)
Tb927.10.10900,4972.0,3819.0,2593.5,4711.5,5199.0,heat shock protein  putative,>4C (GG2M)
Tb927.10.10910,3987.5,3499.5,2894.5,4542.0,4783.5,heat shock protein  putative,>4C (GG2M)
Tb927.10.10920,5965.0,4950.0,3649.5,6774.5,6183.0,heat shock protein  putative,G2M
Tb927.10.10930,3295.0,3097.0,2425.0,3677.0,3760.5,heat shock protein  putative,>4C (GG2M)
Tb927.10.10940,3848.5,3632.0,2425.0,4862.5,4737.0,heat shock protein  putative,G2M
Tb927.10.10950,3314.5,3552.0,2488.5,4612.5,4635.5,heat shock protein  putative,>4C (GG2M)
Tb927.10.10960,4057.5,3542.5,2522.5,4205.5,5174.5,heat shock protein  putative,>4C (GG2M)
Tb927.10.10970,4002.5,3361.0,2564.5,4381.0,4276.5,heat shock protein  putative,G2M
Tb927.10.10980,3785.5,3313.0,2564.5,4318.0,4199.0,heat shock protein 90  putative,G2M
Tb927.10.10990,4930.5,4996.5,6152.5,6892.0,8297.5,predicted WD40 repeat protein,>4C (GG2M)
Tb927.10.11000,6984.5,3211.5,3952.0,3013.0,3494.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11010,10015.5,5634.0,5298.0,6138.0,4377.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11020,7224.0,8127.5,7840.0,6647.5,7268.5,DNA mismatch repair protein MSH2  putative,G1
Tb927.10.11030,4887.0,6615.5,6192.0,6340.0,5161.0,Archaic translocase of outer membrane 11 kDa subunit,G1
Tb927.10.11040,8073.0,10686.5,10795.0,10680.0,10287.0,hypothetical protein  conserved,S
Tb927.10.11050,10255.5,6193.5,6417.0,5419.5,4508.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.10.11060,612.5,2214.5,2621.5,1993.5,2631.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.11070,6834.0,7795.5,7644.0,8056.0,3847.5,hypothetical protein  conserved,G2M
Tb927.10.11080,5744.0,10930.0,11064.0,11045.5,11391.0,paraflagellar rod protein,>4C (GG2M)
Tb927.10.11090,6811.0,7348.0,6000.0,5962.0,5411.5,hypothetical protein  conserved,G1
Tb927.10.11100,9604.0,4383.0,3551.5,2072.5,6844.5,deoxyribodipyrimidine photo-lyase  putative,<2C (LG1)
Tb927.10.11110,10535.5,10489.0,10186.5,9718.5,10182.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11120,6928.0,6727.5,7053.0,6491.0,5199.0,hypothetical protein  conserved,S
Tb927.10.11130,4501.0,8552.5,8730.5,8621.0,7847.5,SET domain containing protein  putative,S
Tb927.10.11140,8784.0,10561.0,10699.5,10474.0,9749.0,hypothetical protein  conserved,S
Tb927.10.11150,2700.0,4521.5,4887.0,4221.0,4525.5,hypothetical protein  conserved,S
Tb927.10.11160,1460.0,1520.0,3978.5,2869.0,2619.0,NFU2 iron-sulfur cluster scaffold homolog  mitochondrial,S
Tb927.10.11170,8004.5,11141.0,11210.0,11091.0,10360.0,hypothetical protein  conserved,S
Tb927.10.11180,8925.0,9314.0,9315.0,8930.5,7909.0,Ubiquitin-like modifier-activating enzyme ATG7  putative,S
Tb927.10.11190,6339.0,3672.0,2360.0,2520.5,1622.5,tRNA-splicing ligase RtcB  putative,<2C (LG1)
Tb927.10.11200,4517.0,1961.5,2196.0,1416.5,964.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11210,8572.5,7195.5,7283.5,7662.5,6398.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11220,9430.0,8474.0,6942.5,7072.0,3310.5,procyclic form surface phosphoprotein,<2C (LG1)
Tb927.10.11230,1783.5,9129.5,8451.0,8529.5,6339.0,Ras-induced vulval development antagonist  putative,G1
Tb927.10.11240,6254.0,1727.5,1054.0,808.0,1984.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11250,612.5,96.0,210.0,182.5,2268.0,Coiled-coil domain-containing protein 40 homolog,>4C (GG2M)
Tb927.10.11260,612.5,1914.0,743.0,1281.0,86.0,SSU ribosomal protein  mitochondrial  putative,G1
Tb927.10.11270,6308.5,3909.5,3885.0,4035.5,2631.5,RNA-binding protein  putative,<2C (LG1)
Tb927.10.11280,7313.5,8517.5,7943.5,8159.0,7015.5,hypothetical protein,G1
Tb927.10.11290,612.5,1425.5,1311.0,1097.5,213.0,hypothetical protein  conserved,G1
Tb927.10.11300,612.5,438.0,427.0,557.5,2125.5,paraflagellar rod component  putative,>4C (GG2M)
Tb927.10.11310,1460.0,2858.5,4680.0,6090.0,11071.0,intraflagellar transport protein 57/55,>4C (GG2M)
Tb927.10.11330,9346.0,5251.5,4200.5,5215.5,3065.0,EF-hand domain pair  putative,<2C (LG1)
Tb927.10.11340,10480.5,10314.0,10232.5,9755.5,10149.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11350,612.5,4486.5,4069.0,3241.5,3794.0,LSU ribosomal protein  mitochondrial  putative,G1
Tb927.10.11360,5190.5,4373.5,3599.5,4782.0,8526.5,protein phosphatase 2A regulatory subunit  putative,>4C (GG2M)
Tb927.10.11370,2995.0,1124.5,630.0,974.5,1595.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11380,612.5,5364.5,6055.5,7153.5,3541.0,hypothetical protein  conserved,G2M
Tb927.10.11390,612.5,40.5,161.0,111.0,213.0,60S ribosomal protein L6  putative,<2C (LG1)
Tb927.10.11400,9006.5,9540.0,9177.0,8409.5,6377.5,WD domain  G-beta repeat  putative,G1
Tb927.10.11410,7999.5,10044.0,9615.5,10089.0,10197.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.11420,6061.5,9383.5,8687.5,8239.5,10121.5,hypothetical protein  conserved,>4C (GG2M)
Tb927_10_v4.snoRNA.0036:snoRNA,612.5,413.0,532.5,419.0,1647.0,term,>4C (GG2M)
Tb927_10_v4.snoRNA.0025:snoRNA,612.5,279.5,253.5,221.5,486.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0049:snoRNA,612.5,176.5,99.0,159.0,287.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0022:snoRNA,1460.0,208.5,271.5,159.0,347.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0038:snoRNA,2357.5,759.0,980.0,1071.0,761.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0027:snoRNA,612.5,700.5,615.0,890.0,486.0,term,G2M
Tb927_10_v4.snoRNA.0050:snoRNA,612.5,208.5,40.0,136.5,347.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0023:snoRNA,612.5,130.0,189.5,111.0,397.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0039:snoRNA,2295.5,576.5,491.0,705.5,607.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0026:snoRNA,612.5,358.0,293.0,313.5,213.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0051:snoRNA,612.5,176.5,40.0,111.0,86.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0024:snoRNA,612.5,322.0,336.0,204.0,531.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0037:snoRNA,612.5,322.0,233.5,292.5,486.0,term,<2C (LG1)
Tb927.10.11430,612.5,1838.0,1603.5,2058.5,2016.0,hypothetical protein  conserved,G2M
Tb927.10.11440,3794.5,7721.0,7442.5,6974.5,6851.5,G1 cyclin CycE4  putative,G1
Tb927.10.11450,6264.0,8719.0,8206.5,8695.0,7342.0,TFIIF-stimulated CTD phosphatase  putative,G1
Tb927.10.11460,7736.5,7362.0,8241.5,8011.5,5624.0,hypothetical protein,S
Tb927.10.11470,10816.0,9495.0,9664.5,9209.5,9272.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11480,8657.0,4796.5,5584.0,5260.5,6897.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11500,1460.0,3693.0,3912.5,3168.0,2941.0,conserved protein,S
Tb927.10.11510,9931.5,11120.5,11112.0,11201.5,10678.0,hypothetical protein  conserved,G2M
Tb927.10.11520,612.5,4950.0,4434.0,3254.5,4110.0,mitochondrial import inner membrane translocase subunit tim13,G1
Tb927.10.11530,1460.0,3097.0,2275.0,1281.0,1489.0,hypothetical protein  conserved,G1
Tb927.10.11540,1783.5,222.0,253.5,334.5,213.0,40S ribosomal protein S3  putative,<2C (LG1)
Tb927.10.11550,612.5,4761.5,6759.5,6147.0,7177.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.11560,6483.0,4920.0,5246.5,5445.5,5772.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11570,3589.5,6239.5,6278.0,6276.5,3086.0,hypothetical protein  conserved,S
Tb927.10.11580,7767.5,9261.5,9483.5,8798.5,9433.5,predicted WD40 repeat protein,S
Tb927.10.11590,2930.5,2896.5,2551.0,2830.5,3760.5,nicotinate phosphoribosyltransferase  putative,>4C (GG2M)
Tb927.10.11600,10375.0,9235.0,9838.5,9499.0,9217.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11610,3762.0,2118.0,1475.5,1313.5,1549.5,SKP1-like protein,<2C (LG1)
Tb927.10.11620,8504.5,9225.0,9207.5,9300.0,8286.5,calcium-transporting ATPase  putative,G2M
Tb927.10.11630,10833.0,10754.5,10649.5,11039.0,10905.0,PSP1 C-terminal conserved region  putative,G2M
Tb927.10.11640,6528.0,5499.5,5991.0,6229.5,5188.0,Protein prenyltransferase alpha subunit repeat  putative,<2C (LG1)
Tb927.10.11650,5573.5,3997.5,4502.0,4027.5,4306.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11660,1460.0,4119.5,3755.0,3154.0,4586.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.11670,2901.0,3032.5,1595.5,2671.0,1717.0,hypothetical protein  conserved,G1
Tb927.10.11680,9509.5,10595.5,10783.0,10694.5,8539.5,Voltage-gated Chloride channel Like 2,S
Tb927.10.11690,11062.0,9354.0,9551.5,9328.0,8927.0,YEATS family  putative,<2C (LG1)
Tb927.10.11700,8144.0,3997.5,4462.5,3744.5,2125.5,guanylate kinase  putative,<2C (LG1)
Tb927.10.11710,5511.0,1034.0,1510.5,1097.5,287.0,hypothetical protein,<2C (LG1)
Tb927.10.11720,5561.0,3813.5,3354.5,2881.0,3669.0,CW-type Zinc Finger  putative,<2C (LG1)
Tb927.10.11730,10281.0,4276.0,4643.0,4126.5,3950.0,zinc finger protein family member  putative,<2C (LG1)
Tb927.10.11750,8347.5,5442.5,4293.5,3924.0,1984.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11760,4680.0,9352.5,9581.5,10174.0,10659.5,pumilio/PUF RNA binding protein 6,>4C (GG2M)
Tb927.10.11770,7292.0,3916.0,4767.5,6304.5,4135.5,succinate dehydrogenase cytochrome B subunit,<2C (LG1)
Tb927.10.11780,6672.0,7923.0,8799.5,8858.5,8744.0,hypothetical protein  conserved,G2M
Tb927.10.11800,2619.0,3138.5,3801.5,2764.5,3199.5,Axonemal inner arm dynein light chain  putative,S
Tb927.10.11810,4608.5,4072.5,3487.0,3154.0,2884.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11820,10913.0,8936.5,9373.0,9790.5,9112.0,kinetoplast ribosomal PPR-repeat containing protein 17,<2C (LG1)
Tb927.10.11830,612.5,7199.5,7227.5,7144.0,7708.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.11840,8073.0,8477.5,8280.0,8052.5,6143.5,WD domain  G-beta repeat  putative,G1
Tb927.10.11850,9941.0,9603.0,9761.0,9959.0,10587.5,WD domain  G-beta repeat  putative,>4C (GG2M)
Tb927.10.11860,6417.5,7518.0,6873.5,6669.5,7847.5,Cornifin (SPRR) family  putative,>4C (GG2M)
Tb927.10.11870,5554.0,4684.0,4956.5,5159.0,2991.5,Guide RNA binding complex protein 5,<2C (LG1)
Tb927.10.11880,9826.5,11017.0,11117.5,11023.5,10676.0,hypothetical protein  conserved,S
Tb927.10.11890,1914.0,2224.0,1721.5,2168.5,2805.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.11900,612.5,565.0,373.5,292.5,347.0,MICOS complex subunit MIC20,<2C (LG1)
Tb927.10.11910,3456.5,5315.0,5945.5,4918.5,5854.0,major facilitator superfamily  putative,S
Tb927.10.11920,8253.0,5331.5,6134.0,4612.5,7649.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11930,6967.0,5251.5,6826.5,5561.5,6123.0,beta-D-hydroxybutyrate dehydrogenase,<2C (LG1)
Tb927.10.11940,7763.5,5725.5,4304.0,5969.0,2550.0,ABC1 protein  putative,<2C (LG1)
Tb927.10.11950,6112.0,2851.5,2300.0,2440.0,2953.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.11960,6434.5,7069.5,5969.0,6177.5,5342.0,hypothetical protein  conserved,G1
Tb927.10.11970,10204.0,7697.5,6961.0,7776.5,7226.0,glutamine aminotransferase (GlnAT),<2C (LG1)
Tb927.10.11980,7843.5,7948.5,8348.0,7564.0,7351.0,QA-SNARE protein putative,S
Tb927.10.11990,6372.0,2772.5,2577.0,2211.5,2322.0,60S ribosome subunit biogenesis protein NIP7  putative,<2C (LG1)
Tb927.10.12000,4916.5,2469.5,2801.5,1816.5,2297.5,iron-sulfur cluster assembly protein  putative,<2C (LG1)
Tb927.10.12010,5199.5,2592.5,3475.0,3477.5,4693.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12020,6516.5,8287.5,8815.5,9129.0,7811.5,recA bacterial DNA recombination protein  putative,G2M
Tb927.10.12030,8221.5,3353.0,3092.0,3815.5,3929.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12040,9937.5,5355.0,4703.0,5454.0,5368.0,mitogen-activated protein kinase 11  putative,<2C (LG1)
Tb927.10.12050,612.5,4008.0,5358.0,3521.5,1195.0,LSU ribosomal protein  mitochondrial  putative,S
Tb927.10.12060,8173.5,10102.5,10003.0,9637.0,9683.5,hypothetical protein  conserved,G1
Tb927.10.12070,6649.0,3881.5,2812.5,3785.5,3006.0,hypothetical protein,<2C (LG1)
Tb927.10.12080,1988.0,5024.5,5991.0,5168.5,2218.5,hypothetical protein  conserved,S
Tb927.10.12090,7503.5,5732.5,5182.0,5530.5,7169.5,RNA-binding protein  putative,<2C (LG1)
Tb927.10.12100,7121.0,9258.5,8587.0,8834.0,8713.0,RNA-binding protein 7B,G1
Tb927.10.12110,7409.5,2429.0,1522.0,1833.5,1958.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12120,11601.0,11367.0,11403.0,11320.0,11045.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12130,5408.0,4703.0,6034.5,8005.5,11165.0,Ubiquitin family  putative,>4C (GG2M)
Tb927.10.12140,8458.0,8503.5,8476.0,7972.5,6229.0,hypothetical protein  conserved,G1
Tb927.10.12150,7287.5,7866.5,8917.0,7877.0,4541.5,hypothetical protein  conserved,S
Tb927.10.12160,6112.0,3179.0,3288.0,3773.5,2514.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12170,7215.5,7380.0,8038.5,7752.0,7606.0,RAB-interacting protein  putative,S
Tb927.10.12180,1783.5,8800.5,9324.5,10072.0,8151.0,hypothetical protein  conserved,G2M
Tb927.10.12190,612.5,3436.5,6000.0,6183.0,7880.5,RAB-interacting protein  putative,>4C (GG2M)
Tb927.10.12200,7285.0,7962.0,8193.5,8043.5,6614.5,hypothetical protein  conserved,S
Tb927.10.12210,6909.0,10816.0,10505.0,10817.5,8776.5,ribulose-5-phosphate 3-epimerase  putative,G2M
Tb927.10.12220,4219.0,4089.5,4246.0,4612.5,3260.0,hypothetical protein  conserved,G2M
Tb927.10.12230,6706.0,5896.0,6504.5,6761.5,7530.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.12240,612.5,498.0,644.5,352.0,397.5,3-ketoacyl-CoA reductase  putative,S
Tb927.10.12250,3516.5,5049.5,6550.5,5917.0,6960.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.12260,6572.0,8392.0,8697.0,8525.0,7782.5,cytosolic nonspecific dipeptidase  putative,S
Tb927.10.12270,2523.0,5834.5,4917.0,4522.0,5694.5,methyltransferase domain containing protein  putative,G1
Tb927.10.12280,3922.5,5049.5,5054.0,4504.5,4831.5,hypothetical protein,S
Tb927.10.12290,7870.5,4072.5,4258.0,4183.0,4036.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb927.10.12300,7329.0,8457.0,8130.5,7179.5,9027.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.12310,7001.5,9902.0,9137.5,8313.0,9788.5,helicase-like protein,G1
Tb927.10.12320,1914.0,5664.0,5892.0,5454.0,6808.0,hypothetical protein,>4C (GG2M)
Tb927.10.12330,4580.0,3138.5,4356.5,4433.0,6153.5,zinc finger protein family member  putative,>4C (GG2M)
Tb927.10.12340,8915.0,6443.5,5661.5,5728.5,7501.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12350,2637.5,1886.0,3205.5,2058.5,1213.5,hypothetical protein  conserved,S
Tb927.10.12360,5082.5,5695.5,5570.5,6250.0,6564.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.12370,6417.5,8176.0,7312.0,6873.5,7092.0,gamma-glutamylcysteine synthetase,G1
Tb927.10.12380,11343.0,10399.0,9951.5,10349.5,9901.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.10.12390,612.5,2581.5,3308.0,2686.0,3044.5,hypothetical protein  conserved,S
Tb927.10.12400,10517.0,8100.5,7712.0,7826.0,7201.0,membrane transporter protein  putative,<2C (LG1)
Tb927.10.12410,4142.5,2664.0,2389.0,3013.0,2039.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12420,1460.0,1953.0,1771.5,1833.5,3021.0,predicted S. cerevisiae Got1 homologue,>4C (GG2M)
Tb927.10.12430,7069.5,5521.0,5015.0,3065.5,3606.5,Noc2p family  putative,<2C (LG1)
Tb927.10.12440,7200.5,2069.5,2703.5,2893.5,5664.0,kinesin  putative,<2C (LG1)
Tb927.10.12450,3987.5,3672.0,2876.5,2347.0,2550.0,SNARE domain-containing protein  putative,<2C (LG1)
Tb927.10.12460,1460.0,2160.0,2638.5,2072.5,2483.5,Zinc finger  C3HC4 type (RING finger)  putative,S
Tb927.10.12470,3107.5,5664.0,8031.0,8005.5,6788.0,hypothetical protein  conserved,S
Tb927.10.12480,8712.0,8118.0,8049.5,8567.5,8918.5,UAA transporter family  putative,>4C (GG2M)
Tb927.10.12490,5195.0,8800.5,8917.0,8061.0,3323.0,kinesin  putative,S
Tb927.10.12500,7363.0,4990.0,5372.0,6407.5,6153.5,P-type H+-ATPase  putative,<2C (LG1)
Tb927.10.12510,9333.0,6251.0,6192.0,6090.0,8317.5,P-type H+-ATPase  putative,<2C (LG1)
Tb927.10.12520,1460.0,5600.0,5386.5,5592.0,3248.5,hypothetical protein  conserved,G1
Tb927.10.12530,612.5,1043.5,1416.0,773.0,1120.5,chaperone protein DnaJ  putative,S
Tb927.10.12540,8890.0,3652.5,4334.5,4019.0,2190.0,NADH-ubiquinone oxidoreductase complex I subunit  putative,<2C (LG1)
Tb927.10.12550,4176.0,5121.0,5494.0,5428.5,5199.0,hypothetical protein  conserved,S
Tb927.10.12560,612.5,40.5,40.0,248.0,559.5,hypothetical protein,<2C (LG1)
Tb927.10.12570,612.5,823.0,1379.5,1847.0,2442.5,hypothetical protein,>4C (GG2M)
Tb927.10.12580,4425.0,1716.0,1574.0,1451.5,3524.0,hypothetical protein,<2C (LG1)
Tb927.10.12590,6126.5,7875.0,8130.5,9258.5,11643.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.12600,6402.5,5592.5,6744.5,5180.0,6479.0,Small RNA 2'-O-methyltransferase,S
Tb927.10.12610,1460.0,2679.0,1475.5,2440.0,2773.0,hypothetical protein,>4C (GG2M)
Tb927.10.12620,11312.0,11338.0,11232.0,11148.5,11357.0,Protein of unknown function (DUF3648)  putative,>4C (GG2M)
Tb927.10.12630,3895.5,2106.0,3789.5,2541.0,9231.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.12640,8718.5,10100.5,9709.5,9686.5,7290.0,chaperone protein DnaJ  putative,G1
Tb927.10.12650,612.5,484.0,410.0,182.5,461.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12660,3468.5,3164.5,1886.0,1665.0,2870.0,pumilio/PUF RNA binding protein 2,<2C (LG1)
Tb927.10.12670,3202.0,3979.0,3626.0,5333.0,5972.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.12680,612.5,2429.0,2341.0,2440.0,1062.5,60S ribosomal protein L34  putative,G2M
Tb927.10.12690,1783.5,5063.5,5120.0,5180.0,5117.5,hypothetical protein  conserved,G2M
Tb927.10.12700,4751.0,2051.0,2144.5,2404.0,4664.5,pyruvate dehydrogenase E1 alpha subunit  putative,<2C (LG1)
Tb927.10.12710,4288.5,3164.5,3108.5,2735.0,5499.0,heat shock protein 110  putative,>4C (GG2M)
Tb927.10.12720,2094.5,7656.0,8245.5,9233.0,10822.0,Bait On Hook 1,>4C (GG2M)
Tb927.10.12730,4801.0,2296.0,1870.0,1936.0,347.0,hypothetical protein,<2C (LG1)
Tb927.10.12740,2886.0,5530.5,6288.0,5789.5,5841.5,Zinc finger CCCH domain-containing protein 35,S
Tb927.10.12750,5467.5,3390.0,3033.5,3205.5,3006.0,hypothetical protein,<2C (LG1)
Tb927.10.12760,7664.5,5738.0,7177.0,5538.5,6398.5,zinc finger protein family member  putative,<2C (LG1)
Tb927.10.12780,9092.5,7789.0,7668.0,7702.0,6649.0,Zinc finger CCCH domain-containing protein 37,<2C (LG1)
Tb927.10.12800,3828.5,5974.5,4493.5,5454.0,5647.5,Zinc finger CCCH domain-containing protein 38,G1
Tb927.10.12810,8806.0,7948.5,7668.0,7245.0,6314.0,cholinephosphate cytidylyltransferase A  putative,<2C (LG1)
Tb927.10.12820,5673.0,3284.0,2858.0,2223.0,5432.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.12830,8524.0,9776.5,8568.5,9862.5,10153.5,acetyltransferase  putative,>4C (GG2M)
Tb927.10.12840,8566.0,8547.0,8714.0,8440.0,4429.0,mitochondrial carrier protein,S
Tb927.10.12850,1460.0,2920.5,3051.5,3531.5,3794.0,ttaggg binding factor,>4C (GG2M)
Tb927.10.12860,2221.0,5573.0,6838.0,5592.0,9017.0,pre-RNA processing PIH1/Nop17  putative,>4C (GG2M)
Tb927.10.12870,8507.0,5904.0,5144.0,5716.5,6570.5,Basal body protein,<2C (LG1)
Tb927.10.12880,9445.0,6846.5,5256.0,6120.5,3335.5,SET domain containing protein  putative,<2C (LG1)
Tb927.10.12890,8714.0,6740.0,6211.0,4221.0,5362.5,bifunctional aminoacyl-tRNA synthetase  putative,<2C (LG1)
Tb927.10.12900,3543.0,1026.5,2510.5,2134.5,1027.5,Complex 1 protein (LYR family)  putative,<2C (LG1)
Tb927.10.12910,3856.5,8196.5,9534.5,9304.5,9395.0,hypothetical protein  conserved,S
Tb927.10.12920,6220.0,9190.0,9548.0,9919.5,9027.0,Flagellum attachment zone protein 18,G2M
Tb927.10.12930,2436.0,2526.0,2251.5,2102.5,2065.0,hypothetical protein  conserved,G1
Tb927.10.12940,6245.5,7303.5,7466.5,8682.5,7631.5,predicted zinc finger protein,G2M
Tb927.10.12950,4642.5,7746.5,7350.0,8296.5,10299.0,Basal body protein,>4C (GG2M)
Tb927.10.12960,612.5,2957.5,4868.0,3992.5,3065.0,Ras-related protein Rab5A,S
Tb927.10.12970,11544.5,9611.5,9807.0,10065.0,7077.0,AN1-like zinc finger  putative,<2C (LG1)
Tb927.10.12980,7391.5,6211.0,6114.0,5530.5,8857.0,Multisite-specific tRNA:(cytosine-C(5))-methyltransferase  putative,>4C (GG2M)
Tb927.10.12990,5018.5,3542.5,3902.0,5069.5,4586.5,predicted ankyrin repeat family protein,G2M
Tb927.10.13000,612.5,10448.5,10827.0,11136.0,10027.0,cAMP phosphodiesterase A  putative,G2M
Tb927.10.13010,6659.5,4111.5,5365.5,5180.0,5898.0,cAMP-dependent protein kinase catalytic subunit 3,<2C (LG1)
Tb927.10.13020,8033.0,5388.0,6288.0,6090.0,3970.0,Vacuolar protein sorting-associated protein 16 homolog  putative,<2C (LG1)
Tb927.10.13030,5620.5,8436.5,7235.5,8966.5,7753.0,cysteine peptidase  Clan CA  family C2  putative,G2M
Tb927.10.13040,10708.5,10442.0,10764.0,10395.5,10185.5,procyclic-enriched flagellar receptor adenylate cyclase 4,S
Tb927.10.13060,9424.0,10109.0,9531.0,9905.5,10064.5,hypothetical protein,G1
Tb927.10.13070,11572.0,10233.5,10798.5,10530.0,10531.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13080,5441.0,4590.5,3189.5,3102.5,4725.0,hypothetical protein,<2C (LG1)
Tb927.10.13090,10051.5,7212.0,7549.5,7410.0,5092.0,PhoD-like phosphatase  putative,<2C (LG1)
Tb927.10.13100,7371.0,6842.0,7909.5,7897.5,11190.5,Cytokinesis initiation factor 3,>4C (GG2M)
Tb927.10.13110,612.5,96.0,40.0,182.5,2283.5,Outer arm dynein light chain 7,>4C (GG2M)
Tb927.10.13120,612.5,5136.0,6346.0,5926.0,7060.5,mitochondrial carrier protein,>4C (GG2M)
Tb927.10.13130,8994.0,9435.5,9630.5,9695.5,8651.0,UTP-glucose-1-phosphate uridylyltransferase,G2M
Tb927.10.13140,1460.0,612.5,940.5,610.5,1099.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13150,1460.0,8724.5,9001.0,9334.0,10145.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.13160,4879.5,2820.5,3452.0,3356.0,3586.0,gpi mannosyltransferase 2,<2C (LG1)
Tb927.10.13170,612.5,2957.5,2778.0,2788.5,1984.0,hypothetical protein  conserved,G1
Tb927.10.13180,7029.0,11048.0,11058.0,10657.0,10626.0,Nrap protein  putative,S
Tb927.10.13190,1460.0,6727.5,6152.5,5365.0,6426.0,actin-related protein 2/3 complex subunit 1  putative,G1
Tb927.10.13200,8808.0,6798.0,7958.5,8029.0,6623.0,kinetoplast ribosomal PPR-repeat containing protein 4,<2C (LG1)
Tb927.10.13210,6538.0,3665.0,4283.5,3045.0,3812.0,dolichyl-P-Man:GDP-ManGlcNAc2-PP-dolichyl beta-1 4-mannosyltransferase  putative,<2C (LG1)
Tb927.10.13220,11384.0,10947.0,10735.5,10739.0,9872.5,cyclophilin type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.10.13230,612.5,5997.0,7873.0,6989.0,5420.5,hypothetical protein  conserved,S
Tb927.10.13240,9792.5,7124.0,8998.0,7314.0,7693.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13250,11638.5,11447.0,11533.0,11477.0,11397.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13260,7627.5,7533.5,7540.5,5608.0,8719.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.13270,4555.0,5592.5,5551.5,4476.0,4468.5,Periodic tryptophan protein 2 homolog  putative,G1
Tb927.10.13280,11574.0,11567.0,11566.0,11519.0,11278.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13290,8323.0,4096.5,3205.5,3241.5,2692.0,ethanolamine phosphotransferase (EPT),<2C (LG1)
Tb927.10.13300,612.5,1378.0,1254.0,1675.5,1636.0,Mitochondrial ribosomal protein S8,G2M
Tb927.10.13310,612.5,1969.0,767.0,1154.5,1772.5,DNA-directed RNA polymerase I subunit RPB5z  putative,G1
Tb927.10.13320,1460.0,2630.0,3658.5,4235.5,4541.5,DNA-directed RNA polymerase II/III subunit  putative,>4C (GG2M)
Tb927.10.13330,3734.0,9740.0,9988.5,10583.0,11210.5,paraflagellar rod component  putative,>4C (GG2M)
Tb927.10.13335,612.5,3758.0,4104.0,4598.0,5135.5,Zinc-finger of C2H2 type  putative,>4C (GG2M)
Tb927.10.13350,9627.5,9450.5,9436.0,9238.0,7356.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13360,612.5,6488.0,6702.5,5419.5,4770.5,Elongation factor Tu  mitochondrial,S
Tb927.10.13370,2658.5,612.5,578.5,1281.0,9438.0,dynein light chain Tctex-type  putative,>4C (GG2M)
Tb927.10.13380,8487.5,4610.5,5570.5,4318.0,6655.5,Origin recognition complex subunit 4-like protein,<2C (LG1)
Tb927_10_v4.snoRNA.0001:snoRNA,3358.0,1953.0,2226.5,1966.0,1338.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0060:snoRNA,3370.5,1553.5,1742.5,1626.0,1422.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0043:snoRNA,2795.5,345.0,427.0,366.5,778.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0015:snoRNA,3419.0,612.5,865.5,839.0,895.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0020:snoRNA,4219.0,1425.5,2036.0,1514.5,2661.5,term,<2C (LG1)
Tb10_snoRNA_0034:snoRNA,4760.5,1585.5,1791.5,1243.0,1141.0,term,<2C (LG1)
Tb927.10.13390,9220.5,9958.5,9388.5,9722.5,8273.0,hypothetical protein  conserved,G1
Tb927.10.13400,4496.5,8035.5,7023.5,8465.5,6112.5,Phosphatidic acid phostphatase  putative,G2M
Tb927_10_v4.snoRNA.0009:snoRNA,612.5,1553.5,1446.0,1329.0,721.5,term,G1
Tb927_10_v4.snoRNA.0002:snoRNA,2258.5,1052.0,880.5,647.5,672.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0061:snoRNA,3606.0,1052.0,1179.5,1403.5,637.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0041:snoRNA,3013.5,774.5,731.0,808.0,853.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0016:snoRNA,3013.5,518.0,357.5,557.5,672.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0021:snoRNA,2767.0,386.5,562.5,248.0,531.0,term,<2C (LG1)
Tb10_snoRNA_0041:snoRNA,3131.5,576.5,520.0,577.5,433.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0031:snoRNA,3272.0,294.5,99.0,248.0,86.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0040:snoRNA,3283.5,554.5,233.5,419.0,86.0,term,<2C (LG1)
Tb927.10.13410,3816.5,2283.0,1536.0,2072.5,1304.5,hypothetical protein,<2C (LG1)
Tb927.10.13420,612.5,3639.0,4038.0,3531.5,1141.0,hypothetical protein,S
Tb927.10.13430,4626.0,4373.5,5875.5,6289.0,4849.5,citrate synthase  putative,G2M
Tb927.10.13440,11509.0,10672.5,10872.0,10865.0,11085.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13450,11324.0,10440.0,10497.0,10833.0,9009.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13470,11542.0,10833.0,10764.0,10815.0,9969.0,PA26 p53-induced protein (sestrin)  putative,<2C (LG1)
Tb927.10.13480,1460.0,4145.5,2533.0,4097.0,2389.0,CAMK/CAMKL family protein kinase  putative,G1
Tb927.10.13490,6088.5,7087.5,7253.5,8402.5,6059.0,CAMK/CAMKL family protein kinase  putative,G2M
Tb927.10.13500,4321.0,2306.5,2931.0,2422.0,2322.0,60S ribosomal protein L10a,<2C (LG1)
Tb927.10.13510,9192.5,8594.0,8087.5,7072.0,5978.5,zinc metallopeptidase  putative,<2C (LG1)
Tb927.10.13513,612.5,3542.5,3323.5,3194.5,1691.0,Dpy-30 motif containing protein  putative,G1
Tb927.10.13517,612.5,3447.0,3877.5,4027.5,4065.0,40S ribosomal protein S27-like  putative,>4C (GG2M)
Tb927.10.13520,8871.5,7414.5,7786.5,6706.0,5803.0,Zn-finger in Ran binding protein and others/FYVE zinc finger  putative,<2C (LG1)
Tb927.10.13530,5218.0,1704.5,2425.0,1899.5,559.5,hypothetical protein,<2C (LG1)
Tb927.10.13540,3341.5,6643.5,5408.5,5648.5,4377.5,RNA-binding protein  putative,G1
Tb927.10.13550,6277.5,10809.0,11040.5,11108.0,11537.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.13560,7363.0,8639.0,7086.0,6240.5,8213.5,mevalonate-diphosphate decarboxylase,G1
Tb927.10.13570,4389.0,4703.0,6072.0,5419.5,6405.0,RNA-binding protein  putative,>4C (GG2M)
Tb927.10.13580,7352.5,8254.0,7588.0,7245.0,7177.5,major facilitator superfamily protein (MFS)  putative,G1
Tb927.10.13590,11095.0,10780.0,10723.0,10965.0,10531.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13600,4122.5,3932.0,3551.5,4567.5,5161.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.13610,11314.0,10720.5,10791.0,10979.0,10291.5,zinc-finger of a C2HC-type/Double zinc ribbon  putative,<2C (LG1)
Tb927.10.13620,6315.5,9179.5,8081.5,7752.0,6607.0,nadh-ubiquinone oxidoreductase 39 kda subunit,G1
Tb927.10.13630,10111.0,10351.5,10319.5,10300.5,9538.0,glucosidase  putative,G1
Tb927.10.13640,612.5,1858.0,1278.5,1542.0,2692.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.13650,1460.0,3336.0,4104.0,6728.0,6757.0,ADP-ribosylation factor-like protein 2-binding protein  putative,>4C (GG2M)
Tb927.10.13660,8477.5,8183.5,9192.0,8704.5,6814.0,Domain of unknown function DUF21  putative,S
Tb927.10.13670,612.5,4653.0,2876.5,4267.0,2550.0,serine/threonine protein phosphatase 5,G1
Tb927.10.13680,2094.5,3872.5,5256.0,3503.0,3399.5,lipase domain protein  putative,S
Tb927_10_v4.snoRNA.0003:snoRNA,3692.0,1945.5,2075.5,1597.5,1355.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0062:snoRNA,3468.5,999.0,1289.5,1243.0,1162.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0044:snoRNA,2855.0,398.0,578.5,382.0,697.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0017:snoRNA,3214.5,716.5,596.0,534.5,778.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0019:snoRNA,3407.5,498.0,615.0,464.0,744.5,term,<2C (LG1)
Tb10_snoRNA_0049:snoRNA,4182.0,1344.0,1561.5,957.5,697.5,term,<2C (LG1)
Tb927.10.13690,7830.0,9163.5,8329.0,9048.5,8020.0,hypothetical protein  conserved,G1
Tb927.10.13700,8083.0,3492.0,4130.5,4862.5,3741.0,phosphatidic acid phosphatase alpha  putative,<2C (LG1)
Tb927.10.13710,2795.5,5322.5,4529.5,5917.0,6339.0,Activator of Hsp90 ATPase  N-terminal/Activator of Hsp90 ATPase homolog 1-like protein  putative,>4C (GG2M)
Tb927.10.13720,1460.0,2118.0,980.0,1654.0,637.0,RNA-binding protein 29  putative,G1
Tb10.NT.148,2943.0,1849.0,1595.5,2275.5,2039.0,Noncoding RNA  putative,<2C (LG1)
Tb927.10.13730,612.5,2187.0,3487.0,3452.5,6028.0,60S ribosomal protein L7  putative,>4C (GG2M)
Tb927.10.13740,5320.5,3552.0,4928.0,4852.5,5943.5,synaptotagmin  putative,>4C (GG2M)
Tb927.10.13750,3429.0,5717.0,5059.5,5398.5,4760.0,hypothetical protein  conserved,G1
Tb927.10.13760,4849.5,6694.5,6730.0,7502.0,4306.0,hypothetical protein  conserved,G2M
Tb927.10.13770,4642.5,1858.0,1149.5,2335.0,1582.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13780,10845.0,8988.0,8226.0,9509.5,9816.0,Glycogen synthase kinase 3 short,<2C (LG1)
Tb927.10.13790,10390.5,9214.0,9792.5,9485.0,9399.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13800,8510.5,7433.5,6495.5,5958.0,6729.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13810,612.5,6164.0,4815.0,5190.5,5824.0,hypothetical protein  conserved,G1
Tb927.10.13820,7029.0,6714.5,6744.5,6540.5,5526.5,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.10.13830,10604.5,8100.5,8268.5,8290.0,6890.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.10.13840,6069.0,4521.5,5551.5,5704.5,4110.0,Domain of unknown function (DUF4475)  putative,<2C (LG1)
Tb927.10.13850,8879.0,9106.0,9315.0,9527.5,9194.5,ATP12 chaperone protein  putative,G2M
Tb927.10.13860,612.5,4027.0,4002.0,3343.0,3482.5,GPI-anchor transamidase subunit 8 (GPI8),G1
Tb927.10.13870,7765.0,8451.5,8632.5,9144.5,9319.0,tubulin tyrosine ligase protein  putative,>4C (GG2M)
Tb927.10.13880,9282.0,10738.5,11027.0,10890.5,10777.5,hypothetical protein  conserved,S
Tb927.10.13890,4309.5,8517.5,8627.0,8871.0,9164.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.13900,612.5,5506.0,5543.5,6946.0,8078.0,Nucleotide sugar transporter 1,>4C (GG2M)
Tb927.10.13910,4859.0,1585.5,1710.5,1374.0,948.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13920,4751.0,2760.5,1899.0,2940.5,2706.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.13930,6746.5,7585.5,8340.0,7625.0,8129.0,phosphatidic acid phosphatase  putative,S
Tb927_10_v4.snoRNA.0010:snoRNA,612.5,2078.0,1585.5,1466.0,1647.0,term,G1
Tb927_10_v4.snoRNA.0004:snoRNA,612.5,935.5,795.0,1071.0,697.5,term,G2M
Tb927_10_v4.snoRNA.0063:snoRNA,612.5,1257.5,1179.5,1430.0,1504.0,term,>4C (GG2M)
Tb927_10_v4.snoRNA.0042:snoRNA,1914.0,640.0,685.0,957.5,836.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0018:snoRNA,1914.0,176.5,130.5,111.0,86.0,term,<2C (LG1)
Tb10_snoRNA_0055:snoRNA,612.5,158.5,357.5,82.5,86.0,term,<2C (LG1)
Tb927.10.13950,4122.5,4056.0,6178.5,6183.0,4849.5,tubulin-specific chaperone  putative,G2M
Tb927.10.13960,1783.5,4268.0,5973.0,6940.5,11684.0,paralyzed flagella protein 20,>4C (GG2M)
Tb927.10.13970,612.5,3429.0,4550.5,5295.5,6984.0,uracil-DNA glycosylase  putative,>4C (GG2M)
Tb927.10.13980,612.5,3499.5,3101.5,2956.0,3214.5,btb/poz domain containing protein  putative,G1
Tb927.10.13990,612.5,4838.0,4117.0,3658.0,1453.5,Pentatricopeptide repeat protein (PPR)  putative,G1
Tb927.10.14000,11334.0,10996.0,10715.5,11120.5,10266.5,aconitase,<2C (LG1)
Tb927.10.14010,7037.0,6951.0,7061.5,7144.0,11251.0,tubulin cofactor C domain-containing protein RP2,>4C (GG2M)
Tb927.10.14020,5734.0,6458.5,7953.5,7617.5,7537.5,hypothetical protein  conserved,S
Tb927.10.14030,1460.0,2896.5,2399.5,2150.0,1582.0,hypothetical protein  conserved,G1
Tb927.10.14040,3720.0,1482.5,668.5,890.0,347.0,vacuolar ATP synthase subunit c  putative,<2C (LG1)
Tb927.10.14050,612.5,1758.0,1402.0,1261.0,86.0,hypothetical protein,G1
Tb927.10.14060,9747.0,10287.0,9958.0,10077.0,6975.5,hypothetical protein,G1
Tb927.10.14070,6145.5,8292.0,6533.5,5551.0,7518.0,mevalonate diphosphate decarboxylase,G1
Tb927.10.14080,3598.0,4830.0,6278.0,4940.5,6511.5,RNA-binding protein 27  putative,>4C (GG2M)
Tb927.10.14090,9958.0,7230.0,6844.5,5981.0,6432.5,transporter  putative,<2C (LG1)
Tb927.10.14100,9660.5,4990.0,5637.0,5517.5,4806.5,hypothetical protein  conserved,<2C (LG1)
Tb10.NT.154,3937.0,1394.5,1388.5,1491.0,1531.5,Noncoding RNA  putative,<2C (LG1)
Tb927.10.14110,2094.5,2969.5,3051.5,2211.5,3847.5,13 kDa deflagellation-inducible protein  putative,>4C (GG2M)
Tb927.10.14120,3028.5,2306.5,1137.0,1044.0,2834.5,hypothetical protein,<2C (LG1)
Tb927.10.14130,1988.0,1553.5,1021.0,1403.5,1789.5,SRP19 protein  putative,<2C (LG1)
Tb927.10.14140,6728.0,3672.0,2196.0,1261.0,1162.5,pyruvate kinase 1,<2C (LG1)
Tb927.10.14150,612.5,2864.5,2866.5,3367.5,3199.5,nuclear segregation protein  putative,G2M
Tb927.10.14160,1460.0,2772.5,1966.5,1823.5,86.0,Aquaglyceroporin 3,G1
Tb927.10.14170,2619.0,335.0,271.5,628.0,397.5,aquaglyceroporin 2,<2C (LG1)
Tb927.10.14180,5423.5,1619.0,1179.5,1017.0,1195.0,protein transport protein SEC13,<2C (LG1)
Tb927.10.14190,8592.5,9103.5,7572.0,6313.0,9430.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.14200,3380.0,5216.5,7411.0,6147.0,5624.0,syntaxin 5,S
Tb927.10.14210,2258.5,1220.5,1254.0,1352.5,797.5,TFIIH basal transcription factor subunit,<2C (LG1)
Tb927.10.14220,10410.0,4636.0,5892.0,6035.0,6511.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.14230,7558.5,10662.0,10370.0,10522.0,9983.5,hypothetical protein  conserved,G1
Tb927.10.14240,7577.0,8796.0,9238.0,8432.0,8125.0,N-myristoyltransferase,S
Tb927.10.14250,7481.0,6272.5,6123.0,6171.5,6131.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.14260,9751.0,5946.5,4476.0,2928.0,2977.5,AP-4 complex subunit sigma-1  putative,<2C (LG1)
Tb927.10.14270,8932.0,9317.5,8791.0,9973.0,8998.0,TFIIF-stimulated CTD phosphatase  putative,G2M
Tb927.10.14280,11232.0,9879.0,9577.5,9789.0,10345.0,mitochondrial carrier protein,<2C (LG1)
Tb927.10.14290,612.5,1866.5,3388.5,2506.5,3906.0,hypothetical protein,>4C (GG2M)
Tb927.10.14300,8395.5,9936.0,10881.0,10462.5,9616.5,MEKK-related kinase 1  putative,S
Tb927.10.14310,612.5,7828.0,8235.0,8633.0,4451.0,hypothetical protein  conserved,G2M
Tb927_10_v5.snoRNA.0108,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927.10.14320,9111.0,9387.5,9735.5,10335.0,11226.0,Flagellum attachment zone protein 9,>4C (GG2M)
Tb927.10.14330,7880.0,8899.0,8763.5,8786.5,8973.0,Utp14 protein  putative,>4C (GG2M)
Tb927.10.14340,7023.5,5344.0,6393.0,7047.0,11541.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.14350,612.5,386.5,1226.0,382.0,287.0,hypothetical protein  conserved,S
Tb927.10.14360,8131.5,7568.5,8164.0,7730.0,8553.5,U2 small nuclear ribonucleoprotein 40K,>4C (GG2M)
Tb927.10.14370,4940.0,1068.5,1124.0,1110.5,1374.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.14380,11380.0,10202.0,10121.5,10210.0,9775.0,Hsp70 protein  putative,<2C (LG1)
Tb927.10.14390,1460.0,4521.5,4632.5,6983.5,3726.5,FACT complex subunit POB3,G2M
Tb927.10.14400,9380.5,10937.0,10958.0,10820.5,10537.0,hypothetical protein  conserved,S
Tb927.10.14410,8590.5,6890.0,7013.5,6676.5,9772.5,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.10.14420,10265.0,11127.5,11261.0,10990.0,10741.0,Serine/threonine-protein kinase NEK16  putative,S
Tb927.10.14430,2747.5,9132.0,9763.5,9678.0,8449.0,hypothetical protein  conserved,S
Tb927.10.14440,5386.5,7539.0,6886.5,6802.5,7821.0,b9 domain-containing protein 1,>4C (GG2M)
Tb927.10.14450,2357.5,5442.5,4904.5,5228.0,6729.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.14460,10373.0,6977.5,5981.0,6604.0,4928.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.10.14470,1914.0,9290.5,10018.5,10763.5,11679.0,intraflagellar transport protein 140,>4C (GG2M)
Tb927.10.14480,10035.5,8875.5,9263.0,9642.5,11195.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.14490,5048.0,2927.0,1731.5,2422.0,3353.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.14500,8368.5,8235.0,7220.5,6863.0,8389.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.14510,3230.0,8446.0,6385.5,6748.5,5220.0,root hair defective 3 GTP-binding protein (RHD3)  putative,G1
Tb927.10.14520,612.5,4467.0,5182.0,5476.5,4800.5,Basal body protein,G2M
Tb927.10.14530,2180.0,2687.5,3877.5,3950.5,5898.0,19S proteasome non-atpase subunit 8,>4C (GG2M)
Tb927.10.14540,8936.0,5488.5,4485.5,5592.0,6788.0,hypothetical protein,<2C (LG1)
Tb927.10.14550,6632.0,3842.0,2866.5,3503.0,5054.0,ATP-dependent RNA helicase HEL67,<2C (LG1)
Tb927.10.14560,4817.0,6767.5,6636.5,6946.0,9746.0,TPR repeat  putative,>4C (GG2M)
Tb927.10.14570,5339.5,7285.5,5625.0,6738.5,8416.0,kinesin motor domain containing protein  putative,>4C (GG2M)
Tb927.10.14580,2329.5,774.5,644.5,182.5,1516.0,60S ribosomal protein L17  putative,<2C (LG1)
Tb927.10.14590,2329.5,952.0,1179.5,1171.0,1676.0,Protein of unknown function (DUF1279)  putative,<2C (LG1)
Tb927.10.14600,1460.0,999.0,1335.0,1140.0,1437.0,40S ribosomal protein S2  putative,<2C (LG1)
Tb927.10.14610,11454.0,11413.0,11278.0,11500.0,11628.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.10.14620,5384.0,6352.5,6028.0,6663.0,7871.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.14630,8860.5,6683.5,5315.0,5437.0,6016.5,fibrillarin  putative,<2C (LG1)
Tb927.10.14640,8231.0,7053.5,6587.5,7099.5,7610.5,Rtf2 RING-finger  putative,<2C (LG1)
Tb927.10.14650,612.5,6702.5,4904.5,6582.5,4135.5,hypothetical protein  conserved,G1
Tb927.10.14660,10171.5,6916.5,8193.5,7993.0,6229.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.14670,7847.5,1758.0,2378.0,1514.5,2065.0,hypothetical protein,<2C (LG1)
Tb927.10.14680,5713.5,6139.5,4148.5,3826.0,7342.0,ribosome biogenesis protein  putative,>4C (GG2M)
Tb927.10.14690,6546.5,6488.0,5187.5,5789.5,6270.0,syntaxin  putative,<2C (LG1)
Tb927.10.14700,612.5,2000.5,1679.0,1363.5,915.0,hypothetical protein  conserved,G1
Tb927.10.14710,612.5,530.0,448.0,397.5,531.0,40S ribosomal protein S2  putative,<2C (LG1)
Tb927.10.14720,2221.0,2760.5,3578.0,3477.5,5420.5,peroxin 13,>4C (GG2M)
Tb927.10.14730,4649.5,1727.5,2440.5,2085.0,3606.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.10.14740,4972.0,6818.5,6796.5,7327.0,8424.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.14750,6559.0,6858.5,6561.5,5683.5,6917.0,fibrillarin  putative,>4C (GG2M)
Tb927.10.14760,612.5,358.0,578.5,757.5,461.5,clathrin light chain  putative,G2M
Tb927.10.14770,7250.0,5909.5,7540.5,6996.5,8633.0,Associated kinase of Tb14-3-3,>4C (GG2M)
Tb927.10.14780,6441.5,9631.0,9123.5,9200.5,7201.0,Canertinib-binding protein kinase 1,G1
Tb927.10.14790,1783.5,9994.5,9593.0,9340.5,9527.0,metallo-peptidase  Clan MG  Family M24,G1
Tb927.10.14800,4580.0,3158.0,4139.5,5662.0,3716.5,mitogen-activated protein kinase 9  putative,G2M
Tb927.10.14810,612.5,2621.0,3452.0,3194.5,2773.0,multiprotein-bridging factor 1  putative,S
Tb927.10.14820,3734.0,6719.5,6754.0,7361.0,8202.0,Mitochondrial ADP/ATP carrier protein 5c,>4C (GG2M)
Tb927.10.14830,4163.5,6658.5,6923.0,7557.0,8173.5,Mitochondrial ADP/ATP carrier protein 5b,>4C (GG2M)
Tb927.10.14840,3142.5,6758.0,7193.0,7486.0,8213.5,Mitochondrial ADP/ATP carrier protein 5a,>4C (GG2M)
Tb927.10.14860,4276.0,4770.5,3275.0,3815.5,2692.0,NADH-ubiquinone oxidoreductase B14 subunit,G1
Tb927.10.14870,1460.0,3835.5,3551.5,4841.0,1531.5,hypothetical protein  conserved,G2M
Tb927.10.14880,6755.5,9293.5,9634.0,9579.5,9524.0,centrosomal protein of 104 kDa,S
Tb927.10.14890,7702.0,5295.0,4832.0,5551.0,6432.5,C-terminal motor kinesin  putative,<2C (LG1)
Tb927.10.14900,1783.5,6458.5,4434.0,4894.5,3847.5,hypothetical protein  conserved,G1
Tb927.10.14910,7863.0,9240.0,9999.0,10225.0,10075.5,Sarcalumenin  putative,G2M
Tb927.10.14920,3131.5,9026.5,9672.0,8816.0,9208.5,hypothetical protein  conserved,S
Tb927.10.14930,7741.0,7474.5,6900.0,7883.0,8979.0,Zinc finger CCCH domain-containing protein 39,>4C (GG2M)
Tb927.10.14950,9823.0,6124.0,4586.5,4894.5,5362.5,Zinc finger CCCH domain-containing protein 40,<2C (LG1)
Tb927.10.14960,5111.0,3787.0,4577.0,4433.0,2964.0,hypothetical protein,<2C (LG1)
Tb927.10.14980,1460.0,5216.5,3952.0,4994.0,10576.0,intraflagellar transport protein 52,>4C (GG2M)
Tb927.10.14990,3895.5,4653.0,4917.0,5325.0,11193.5,intraflagellar transport protein 80,>4C (GG2M)
Tb927.10.15000,11120.0,8992.0,8779.0,8825.5,9203.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15010,9470.5,9484.0,9687.5,9209.5,8137.0,lipoic acid synthetase  mitochondrial precursor  putative,S
Tb10.NT.166,612.5,896.0,615.0,464.0,721.5,Noncoding RNA  putative,G1
Tb927.10.15020,8684.5,9727.5,9315.0,9083.0,8454.0,CMGC/DYRK protein kinase  putative,G1
Tb927.10.15033,612.5,640.0,848.5,1140.0,895.5,hypothetical protein,G2M
Tb927.10.15040,3778.0,8133.5,7790.0,7740.5,8759.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15080,9181.0,2621.0,3609.0,3492.0,9099.5,WD40 Repeat 1,<2C (LG1)
Tb927.10.15090,2094.5,2741.5,3410.0,3029.0,1828.0,hypothetical protein  conserved,S
Tb927.10.15100,2137.5,565.0,756.5,1044.0,836.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15110,1783.5,294.5,313.0,628.0,874.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15120,612.5,1378.0,1278.5,974.5,2218.5,40S ribosomal protein S13  putative,>4C (GG2M)
Tb10.NT.168,1460.0,727.0,615.0,557.5,721.5,Noncoding RNA  putative,<2C (LG1)
Tb927.10.15130,8462.5,8601.0,8507.5,7864.5,8633.0,Vesicle-trafficking protein SEC22  putative,>4C (GG2M)
Tb927.10.15140,612.5,2436.0,3116.5,2671.0,5585.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15150,8988.0,4770.5,4398.0,3965.5,8103.5,DNA-directed RNA polymerase III subunit C11  putative,<2C (LG1)
Tb927.10.15160,9116.5,10958.0,10806.0,10692.0,9701.5,hypothetical protein  conserved,G1
Tb927.10.15170,3972.0,8466.5,7312.0,7656.5,6814.0,hypothetical protein  conserved,G1
Tb927.10.15180,2180.0,7572.5,8273.0,7967.5,7725.5,nucleosome assembly protein  putative,S
Tb927.10.15190,2481.0,9415.5,9541.5,10243.5,10479.0,Basal body protein,>4C (GG2M)
Tb927.10.15200,2747.5,7746.5,8164.0,6796.5,8353.5,Predicted coiled-coil domain-containing protein (DUF2360)  putative,>4C (GG2M)
Tb927.10.15210,612.5,7626.5,7474.5,7906.5,7471.0,nuclear cap binding complex subunit CBP30,G2M
Tb927.10.15220,5158.5,5876.0,5551.5,4221.0,5451.0,hypothetical protein  conserved,G1
Tb927.10.15230,3570.5,6159.0,4434.0,5662.0,5442.5,hypothetical protein  conserved,G1
Tb927.10.15240,6556.0,7956.0,8819.5,8385.0,8249.0,hypothetical protein  conserved,S
Tb927.10.15250,1460.0,612.5,685.0,1343.0,5499.0,paraflagellar rod component  putative,>4C (GG2M)
Tb10.NT.169,612.5,279.5,210.0,292.5,637.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.10.15260,1460.0,626.0,1268.0,1688.5,7834.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.10.15270,8173.5,7220.5,7018.5,6796.5,7762.5,metallo- peptidase  Clan MG  Family M24,<2C (LG1)
Tb927.10.15280,6024.0,5474.0,6262.0,5600.0,9647.0,Domain of Unknown Function (DUF1042)  putative,>4C (GG2M)
Tb927.10.15290,10759.5,10920.0,10672.5,10842.5,10964.0,tubulin binding cofactor c  putative,>4C (GG2M)
Tb927.10.15300,9771.5,10194.5,10373.5,9588.0,8012.5,Calcium/calmodulin-dependent protein kinase kinase  putative,S
Tb927.10.15310,8871.5,8167.5,7510.0,7987.5,5996.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15320,3314.5,3932.0,3626.0,3380.5,2016.0,hypothetical protein  conserved,G1
Tb927.10.15330,2767.0,3050.5,3323.5,3724.0,4170.0,CYTH domain containing protein  putative,>4C (GG2M)
Tb927.10.15340,1460.0,1313.5,1226.0,1466.0,2218.5,hypothetical protein,>4C (GG2M)
Tb927.10.15350,3429.0,4365.0,2790.5,4531.5,4498.5,histone H3 variant V,G2M
Tb927.10.15360,7884.0,10249.0,10455.5,10183.5,11065.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15370,612.5,3950.5,3066.0,2290.0,2805.5,DNA-directed RNA polymerases I and III subunit RPAC1  putative,G1
Tb927.10.15380,2436.0,1914.0,1886.0,1228.0,2631.5,U3 snoRNA-associated protein UTP11  putative,>4C (GG2M)
Tb927.10.15390,10734.5,9059.0,8736.5,8586.5,8715.5,Flagellum attachment zone protein 7,<2C (LG1)
Tb927.10.15400,10410.0,10251.0,10434.0,10516.5,9340.5,kinesin  putative,G2M
Tb927.10.15410,8820.5,5876.0,5645.0,5069.5,5153.5,glycosomal malate dehydrogenase,<2C (LG1)
Tb927.10.15420,8976.0,7493.5,7916.5,5583.5,7047.0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5  putative,<2C (LG1)
Tb927.10.15430,9722.0,7498.0,6803.5,6815.5,7494.0,Ankyrin repeats (3 copies)  putative,<2C (LG1)
Tb927.10.15440,3951.0,7561.5,8407.5,8094.5,8342.0,hypothetical protein  conserved,S
Tb927.10.15450,10997.5,10299.5,10527.0,10344.5,11442.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15460,612.5,5372.5,5386.5,3878.0,3386.5,EAP30/Vps36 family  putative,S
Tb927.10.15470,2295.5,4305.0,4448.0,2977.0,5555.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15480,7774.5,5822.5,6708.5,6540.5,7725.5,transporter  putative,<2C (LG1)
Tb927.10.15490,10647.5,9460.5,9600.5,9891.0,9777.0,GDP-mannose 4 6 dehydratase,<2C (LG1)
Tb927.10.15500,7074.5,4317.5,2812.5,3847.5,5034.5,SNARE protein  putative,<2C (LG1)
Tb927.10.15510,4580.0,4886.5,6429.5,4720.5,3235.0,hypothetical protein  conserved,S
Tb927.10.15520,8746.0,9688.5,9268.0,9281.5,9194.5,signal recognition particle protein  putative,G1
Tb927.10.15530,8400.5,9847.0,10062.5,9854.0,10811.0,ABC transport system ATP-binding protein  putative,>4C (GG2M)
Tb927.10.15540,10580.5,10588.5,10961.0,11022.0,10393.0,predicted VPS53-like domain protein,G2M
Tb927.10.15550,9327.5,10672.5,9943.5,10725.0,10477.0,hypothetical protein  conserved,G2M
Tb927.10.15570,5354.0,4838.0,6028.0,5249.5,6289.5,transcription factor IIa  putative,>4C (GG2M)
Tb927.10.15580,1460.0,1332.5,767.0,1430.0,1010.0,dynein light chain  putative,<2C (LG1)
Tb927.10.15590,612.5,4675.5,3891.5,3194.5,4883.5,macrophage infectivity potentiator  precursor  putative,>4C (GG2M)
Tb927.10.15600,11234.0,8187.5,8543.0,7868.0,7585.5,FKBP-type peptidylprolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.10.15610,4826.0,8671.0,9156.5,8863.5,6557.0,zinc finger protein  putative,S
Tb927.10.15620,3762.0,4331.5,3503.0,4097.0,3760.5,hypothetical protein,G1
Tb927.10.15640,7198.0,10525.0,10822.5,10438.0,9863.5,WD domain  G-beta repeat  putative,S
Tb927.10.15650,4826.0,5115.0,5386.5,5333.0,4199.0,Mitochondrial SSU ribosomal protein  putative,S
Tb927.10.15660,8427.5,7440.0,7474.5,8840.0,7662.5,hypothetical protein  conserved,G2M
Tb927.10.15670,5235.0,6466.5,6159.0,6262.0,5188.0,hypothetical protein  conserved,G1
Tb927.10.15680,11650.0,10689.5,10868.0,11014.0,11372.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15690,10258.0,4990.0,4380.5,4754.5,5411.5,anaphase promoting complex  subunit 10-like protein,<2C (LG1)
Tb927.10.15700,11463.5,11451.0,11423.0,11464.0,11569.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15710,6185.5,2887.5,2839.0,2589.0,1758.0,mitochondrial carrier protein,<2C (LG1)
Tb927.10.15720,4148.0,6636.5,8071.0,8720.5,8533.0,proteasome regulatory non-ATP-ase subunit 9,G2M
Tb927.10.15730,11713.0,11586.0,11580.5,11614.0,11556.0,SPRY domain/Ankyrin repeats (3 copies)  putative,<2C (LG1)
Tb927_10_v4.snoRNA.0074:snoRNA,1914.0,260.0,210.0,248.0,287.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0065:snoRNA,2329.5,358.0,189.5,292.5,584.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0005:snoRNA,2137.5,335.0,373.5,221.5,461.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0079:snoRNA,612.5,192.5,189.5,82.5,287.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0068:snoRNA,2995.0,335.0,271.5,221.5,836.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0032:snoRNA,2658.5,96.0,40.0,82.5,213.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0011:snoRNA,3904.5,1492.5,940.5,826.5,1374.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0075:snoRNA,3654.0,600.0,547.0,720.5,1195.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0066:snoRNA,3494.5,260.0,357.5,483.0,853.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0006:snoRNA,2180.0,260.0,471.5,352.0,433.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0080:snoRNA,1783.5,130.0,189.5,33.5,287.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0069:snoRNA,2920.5,192.5,336.0,292.5,672.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0033:snoRNA,2714.5,96.0,130.5,182.5,287.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0012:snoRNA,4066.0,1313.5,1091.0,773.0,1325.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0076:snoRNA,3437.5,727.0,562.5,757.5,1099.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0064:snoRNA,3063.5,886.5,596.0,941.0,874.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0007:snoRNA,2406.5,322.0,448.0,248.0,397.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0078:snoRNA,2886.0,518.0,471.5,419.0,347.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0070:snoRNA,2995.0,471.5,427.0,705.5,584.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0034:snoRNA,3534.0,96.0,161.0,182.5,86.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0013:snoRNA,3882.5,1009.0,954.0,517.0,797.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0077:snoRNA,3945.0,700.5,630.0,517.0,1099.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0067:snoRNA,3692.0,345.0,448.0,397.5,1062.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0008:snoRNA,1914.0,322.0,410.0,221.5,461.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0081:snoRNA,1783.5,96.0,189.5,33.5,213.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0071:snoRNA,2436.0,235.5,233.5,248.0,461.5,term,<2C (LG1)
Tb927_10_v4.snoRNA.0035:snoRNA,3214.5,40.5,130.5,136.5,86.0,term,<2C (LG1)
Tb927_10_v4.snoRNA.0014:snoRNA,3848.5,1201.5,717.5,577.5,933.5,term,<2C (LG1)
Tb10_snoRNA_0084:snoRNA,2795.5,1153.5,562.5,788.5,1304.5,term,<2C (LG1)
Tb927.10.15740,6772.0,6852.0,6780.0,7016.0,7177.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15750,9259.5,8507.5,8459.5,7111.0,8291.0,Tripartite attachment complex protein 197,<2C (LG1)
Tb927.10.15760,2535.5,222.0,448.0,313.5,213.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15770,3670.5,5331.5,6687.5,5120.0,3260.0,hypothetical protein  conserved,S
Tb927.10.15780,8318.0,7670.0,9087.0,7188.5,7052.0,hypothetical protein  conserved,S
Tb927.10.15790,9247.0,4079.5,4117.0,3785.5,4831.5,CHCH domain containing protein  putative,<2C (LG1)
Tb927.10.15800,1914.0,3324.5,4425.5,3724.0,3861.0,actin related protein 2  putative,S
Tb927.10.15810,5142.5,3909.5,3420.5,2554.0,2619.0,Fcf1  putative,<2C (LG1)
Tb927.10.15820,8423.0,6554.5,6218.5,6914.5,6439.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15830,10508.0,7059.0,6166.0,5437.0,7412.0,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.10.15840,7694.0,9694.0,9581.5,9445.0,8719.5,hypothetical protein  conserved,G1
Tb927.10.15850,6009.5,4745.0,2327.5,2821.0,5516.0,Peroxisome biogenesis factor 12,<2C (LG1)
Tb927.10.15860,612.5,3973.5,3179.5,3356.0,4320.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.10.15870,6656.0,3747.5,6262.0,4301.0,6173.5,RNA binding protein  putative,<2C (LG1)
Tb927.10.15880,4817.0,7358.5,7685.0,7635.5,7385.0,protein kinase  putative,S
Tb927.10.15890,10252.5,8346.5,7887.0,7535.0,8776.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15900,5557.5,345.0,253.5,248.0,607.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15910,6450.5,5641.5,6803.5,6919.5,3541.0,Glycerol uptake protein 1,G2M
Tb927.10.15920,3630.5,1313.5,1710.5,1609.0,1239.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.15930,5225.0,2469.5,2011.5,1572.5,3125.5,pdz domain containing protein  putative,<2C (LG1)
Tb927.10.15940,8036.0,8141.0,7969.5,7258.0,5526.5,cation transporter  putative,G1
Tb927.10.15950,5174.0,5397.5,5445.5,5014.5,4822.5,TATA-box-binding protein,S
Tb927.10.15960,7558.5,6865.0,7706.0,7642.5,7038.0,hypothetical protein  conserved,S
Tb927.10.15970,2180.0,2138.5,2060.5,2275.5,1179.0,Triglyceride lipase  putative,G2M
Tb927.10.15980,612.5,709.0,907.5,664.0,86.0,hypothetical protein,S
Tb927.10.15990,612.5,7857.5,7823.5,7762.0,6472.5,expression site-associated gene 4 (ESAG4)  pseudogene,G1
Tb927.10.16000,8712.0,8000.5,6905.5,7535.0,5725.5,expression site-associated gene 4 (ESAG4) protein  putative,<2C (LG1)
Tb927.10.16010,7851.0,8007.5,6095.5,6229.5,5379.5,hypothetical protein,G1
Tb927.10.16020,8418.5,8375.5,7749.0,7288.5,8367.0,pre-RNA processing PIH1/Nop17  putative,<2C (LG1)
Tb927.10.16030,6194.5,6211.0,6568.5,6417.5,5624.0,mitogen activated protein kinase 4  putative,S
Tb927.10.16040,8487.5,3552.0,4662.5,3965.5,4635.5,oxidoreductase-protein  putative,<2C (LG1)
Tb927.10.16050,4233.5,2260.5,2812.5,2422.0,2310.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.16060,8374.5,2731.0,2112.5,2470.5,2297.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.16070,5094.0,3639.0,2919.0,2764.5,1772.5,Eukaryotic translation initiation factor 4E-2,<2C (LG1)
Tb927.10.16080,8894.0,7751.5,6893.0,6919.5,6006.0,hypothetical protein  conserved,<2C (LG1)
Tb927.10.16090,7451.0,5488.5,3832.5,3785.5,4330.5,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.10.16100,612.5,3023.5,2593.5,3356.0,5927.0,FK506-binding protein (FKBP)-type peptidyl-prolyl isomerase  putative,>4C (GG2M)
Tb927.10.16110,3579.5,4838.0,4057.0,3773.5,5609.5,component of motile flagella 1,>4C (GG2M)
Tb927.10.16120,11565.0,10410.5,9979.5,9993.5,10902.0,inosine-5'-monophosphate dehydrogenase,<2C (LG1)
Tb927.10.16125,5450.0,2344.0,2310.0,1688.5,3248.5,hypothetical protein,<2C (LG1)
Tb927.10.16140,9351.0,4642.5,5077.0,3087.5,4081.5,Adenylate/guanylate cyclase  putative,<2C (LG1)
Tb927.10.16150,9028.5,5746.5,7363.0,5832.0,3248.5,ATP-dependent zinc metallopeptidase  putative,<2C (LG1)
Tb927.10.16160,7440.5,2283.0,2510.5,3087.5,3638.0,STE group serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.10.16170,3726.5,279.5,271.5,334.5,672.0,potassium voltage-gated channel  putative,<2C (LG1)
Tb927.10.16180,4792.5,1736.5,1585.5,1558.5,1772.5,hypothetical protein  conserved,<2C (LG1)
Tb927.10.16190,9156.5,9402.5,9235.0,9238.0,7244.0,procyclic-enriched flagellar receptor adenylate cyclase 2,G1
Tb10_rRNA_1:rRNA,2094.5,2469.5,1783.0,2642.5,2525.0,5.8S ribosomal RNA,G2M
Tb10_rRNA_2:rRNA,9816.5,10206.0,10015.0,9658.0,9159.0,28S alpha ribosomal RNA,G1
Tb927.10.16200,8053.0,9127.0,9971.5,8492.5,8998.0,Endonuclease-reverse transcriptase/Reverse transcriptase (RNA-dependent DNA polymerase)  putative,S
Tb927.10.16210,6145.5,2814.0,3589.5,2494.5,2364.5,hypothetical protein  conserved (pseudogene),<2C (LG1)
Tb927.10.16220,612.5,927.5,832.0,941.0,1162.5,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb927.10.16230,2357.5,1894.5,1783.0,2046.5,2218.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.10.16240,10549.0,11192.0,11344.0,10951.5,10878.0,Variant Surface Glycoprotein  putative,S
Tb927.10.16250,2047.0,4913.5,5419.0,4962.5,6780.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.10.16260,612.5,1362.5,1502.0,1243.0,1010.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.10.16270,1914.0,4693.0,4019.5,3938.0,5290.5,variant surface glycoprotein  fragment,>4C (GG2M)
Tb927.10.16280,5658.5,3535.0,3475.0,3924.0,6614.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.10.16290,7007.0,5210.5,5229.5,6348.0,4800.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16300,3202.0,2011.0,2621.5,1491.0,853.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.10.16310,10943.0,10991.0,11238.0,11016.0,10725.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.10.16320,7162.5,6711.5,6556.0,6083.5,6670.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16330,4703.5,678.5,1164.0,647.5,697.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16340,2700.0,835.5,668.5,941.0,1647.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,<2C (LG1)
Tb927.10.16350,2956.5,2679.0,2327.5,2168.5,1582.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16360,4094.5,2621.0,2036.0,1899.5,978.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16370,8716.0,3827.0,4283.5,3142.0,3939.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.10.16380,612.5,2283.0,2112.5,1899.5,1304.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.10.16390,3394.0,2741.5,3578.0,1558.5,3586.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.10.16400,1460.0,294.5,336.0,136.5,1179.0,variant surface glycoprotein,<2C (LG1)
Tb927.10.16410,9047.0,6690.5,6006.0,7252.0,7770.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16420,9166.0,8279.5,7457.0,7460.5,5342.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.10.16430,5933.5,1991.5,1207.5,1922.5,744.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16440,8932.0,7704.0,7269.0,7719.0,7782.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.10.16450,2795.5,2078.0,1650.0,2168.5,4703.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.10.16460,612.5,2592.5,3503.0,2821.0,637.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.10.16470,2658.5,4096.5,4703.0,4070.5,4687.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.10.16480,1988.0,2170.0,1886.0,1626.0,1896.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.10.16490,1783.5,2638.5,2801.5,705.5,1804.5,variant surface glycoprotein (VSG)  putative,S
Tb927.10.16500,612.5,2042.0,1679.0,1187.5,994.0,variant surface glycoprotein (VSG)  putative,G1
Tb927.10.16510,3979.5,3313.0,4104.0,4674.0,1565.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.10.16520,7455.5,4251.5,2778.0,3130.0,2819.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16530,612.5,664.5,630.0,1097.5,287.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.10.16540,6708.5,1595.5,1831.0,1215.5,3295.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.10.16550,8853.0,9157.5,9667.5,9854.0,9344.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.10.16560,1988.0,3723.5,3779.5,4662.5,1355.0,variant surface glycoprotein (VSG)  putative,G2M
Tb927.11.100,2658.5,2457.0,2154.5,1504.0,2734.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.105,8271.5,7851.5,8138.0,8121.5,8781.0,hypothetical protein,>4C (GG2M)
Tb927.11.110,612.5,40.5,40.0,33.5,86.0,expression site-associated gene 9 (ESAG9) (pseudogene),<2C (LG1)
Tb927.11.120,6230.5,7459.0,8888.5,8896.5,5600.5,variant surface glycoprotein-like (VSG-like)  pseudogene,G2M
Tb927.11.130,6925.5,2086.0,2812.5,2850.5,4345.5,expression site-associated gene (ESAG  pseudogene)  putative,<2C (LG1)
Tb927.11.140,10757.5,11222.0,11250.0,11261.0,10943.5,expression site-associated gene 4 (ESAG4) protein  putative,G2M
Tb927.11.150,10785.5,11300.5,11428.0,11433.5,10950.5,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb11.NT.1,7334.0,3441.5,3066.0,3045.0,2601.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.155,7652.5,2344.0,1870.0,1745.0,2413.0,hypothetical protein,<2C (LG1)
Tb927.11.160,612.5,3819.0,4732.5,5583.5,6412.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.164,2682.0,2592.5,1886.0,2603.0,1565.5,hypothetical protein,<2C (LG1)
Tb927.11.167,612.5,1982.5,2251.5,2707.0,1703.0,ribosome associated membrane protein RAMP4  putative,G2M
Tb927.11.170,8911.0,9097.0,9471.5,9523.5,9938.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.180,1460.0,9889.5,9903.0,10226.0,9534.5,electron transfer flavoprotein  putative,G2M
Tb927.11.190,2729.0,3194.0,2351.5,3117.0,2254.0,elongation factor  putative,G1
Tb927.11.200,2436.0,1982.5,2238.0,2373.0,4411.5,DNA-directed RNA polymerase I subunit  putative,>4C (GG2M)
Tb927.11.210,7915.5,3652.5,4271.0,4394.5,8042.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.220,2995.0,1303.5,3179.5,2422.0,3093.0,hypothetical protein  conserved,S
Tb927.11.230,10747.0,8507.5,9497.0,8767.5,10106.5,cleavage and polyadenylation specificity factor subunit 2,<2C (LG1)
Tb927.11.240,7396.5,9282.0,9399.5,9100.0,6975.5,hypothetical protein  conserved,S
Tb927.11.250,612.5,5273.0,5551.5,6867.5,1582.0,ubiquitin carboxyl-terminal hydrolase  putative,G2M
Tb927.11.260,4776.0,8077.5,9174.5,10112.0,11447.0,Putative intraflagellar transport protein F6,>4C (GG2M)
Tb927.11.270,2886.0,5273.0,3224.5,2928.0,874.5,mitochondrial carrier protein,G1
Tb927.11.280,11053.0,10605.0,10638.0,10832.0,10545.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.290,612.5,6732.0,7614.0,5891.5,4244.5,Phosphatase and tensin homolog  putative,S
Tb927.11.300,3261.0,1982.5,3542.0,2707.0,4345.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.310,7153.0,8908.0,8502.5,8756.0,3566.5,hypothetical protein  conserved,G1
Tb927.11.320,612.5,1520.0,832.0,1558.5,1816.5,dynein light chain 1  putative,>4C (GG2M)
Tb927.11.330,11130.0,10924.0,10881.0,10883.0,11539.0,Myosin-like protein 1,>4C (GG2M)
Tb927.11.340,7755.5,9097.0,9446.5,8728.0,7918.5,hypothetical protein  conserved,S
Tb927.11.350,1783.5,5904.0,4832.0,5908.5,9225.0,RNA-binding protein  putative,>4C (GG2M)
Tb927.11.360,2913.0,7966.0,7652.5,7093.5,4664.5,ATP-binding protein  putative,G1
Tb927.11.365,612.5,1953.0,1923.0,1779.5,1437.0,hypothetical protein,G1
Tb927.11.370,6470.0,6007.0,6910.5,5285.0,6448.5,repressor activator protein 1,S
Tb927.11.380,1460.0,130.0,507.0,182.5,213.0,B9 domain-containing protein 2,<2C (LG1)
Tb927.11.390,11144.0,10567.5,10839.0,10777.5,10433.0,SPRY domain containing protein  putative,<2C (LG1)
Tb927.11.400,5225.0,7389.5,8446.0,7940.0,8962.5,Protein of unknown function (DUF1308)  putative,>4C (GG2M)
Tb927.11.410,1460.0,3740.5,4586.5,4862.5,4783.5,hypothetical protein  conserved,G2M
Tb927.11.420,1914.0,5069.5,3801.5,4267.0,5240.0,Fcf2 pre-rRNA processing  putative,>4C (GG2M)
Tb927.11.430,3598.0,3561.5,2122.5,3763.0,3960.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.435,4425.0,3782.0,3779.5,4004.5,4673.5,hypothetical protein,>4C (GG2M)
Tb927.11.440,6578.5,9921.0,9721.0,10106.0,9601.5,conserved protein,G2M
Tb927.11.450,11427.0,10976.0,10957.0,10912.0,10715.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.460,9148.0,7597.0,6821.0,7199.5,7072.5,predicted WD40 repeat protein,<2C (LG1)
Tb927.11.470,8988.0,8149.5,7973.0,7525.5,5479.5,TFIIB-related factor BRF1,<2C (LG1)
Tb927.11.480,5030.5,6306.5,5885.0,5592.0,5653.0,small GTP-binding protein domain containing protein  putative,G1
Tb927.11.485,7767.5,1807.0,1966.5,1833.5,1984.0,hypothetical protein,<2C (LG1)
Tb927.11.490,3972.0,1087.5,1650.0,1626.0,2536.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.500,6870.5,6719.5,6078.5,6821.5,3970.0,RNA-binding protein  UBP1,<2C (LG1)
Tb927.11.510,9921.5,9675.0,8591.5,8482.5,9373.0,RNA-binding protein  UBP2,<2C (LG1)
Tb927.11.520,9452.5,9195.0,8658.5,9598.0,8327.5,hypothetical protein  conserved,G2M
Tb927.11.530,7734.0,7176.5,7183.5,8023.0,6820.0,RNA-binding protein  putative,G2M
Tb927.11.540,9599.0,8417.0,9246.0,8356.0,6499.0,ABC transporter  mitochondrial  putative,<2C (LG1)
Tb927.11.550,4397.0,3138.5,4271.0,3711.5,5044.5,Suppressor of clathrin deficiency 6  putative,>4C (GG2M)
Tb927.11.560,612.5,7016.0,6538.0,5751.5,7506.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.570,2137.5,4624.0,5822.0,5765.5,7285.5,DnaJ domain containing protein  putative,>4C (GG2M)
Tb927.11.580,612.5,5530.5,4722.5,4355.5,5188.0,lipid-like atypical dual specificity phosphatase  putative,G1
Tb927.11.590,8477.5,5725.5,6270.5,5353.5,4345.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.600,2995.0,5706.5,5543.5,4579.0,4645.0,Mitochondrial ATP synthase subunit  putative,G1
Tb927.11.610,612.5,835.5,562.5,1031.0,397.5,hypothetical protein  conserved,G2M
Tb927.11.620,11146.0,10536.0,10173.5,10039.0,10411.0,Regulatory-associated protein of TOR1,<2C (LG1)
Tb927.11.630,5148.5,7578.5,7388.0,7137.5,8367.0,RNA polymerase I second largest subunit,>4C (GG2M)
Tb927.11.640,612.5,6967.5,7744.5,7087.0,6870.5,Pentatricopeptide repeat protein (PPR)  putative,S
Tb927.11.650,612.5,799.5,1021.0,826.5,1392.5,mediator of rna polymerase ii transcription subunit 5,>4C (GG2M)
Tb927.11.660,7987.0,9331.5,9510.0,9512.5,9264.5,predicted zinc finger protein,G2M
Tb927.11.665,6308.5,5083.0,4485.5,5050.5,5266.5,hypothetical protein,<2C (LG1)
Tb927.11.670,4617.0,3016.0,2692.0,2881.0,1912.0,epsinR,<2C (LG1)
Tb927.11.680,2481.0,96.0,293.0,313.5,797.5,ribosomal protein L21E (60S)  putative,<2C (LG1)
Tb927.11.690,3816.5,4849.5,4518.5,4674.0,2884.5,hypothetical protein  conserved,G1
Tb927.11.700,4104.0,3775.5,2839.0,3013.0,1595.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.710,7219.0,5974.5,6346.0,6626.0,4988.5,SCAMP family  putative,<2C (LG1)
Tb927.11.715,612.5,652.5,685.0,483.0,2310.0,dynein light chain LC8  putative,>4C (GG2M)
Tb927.11.720,3638.0,908.5,778.0,907.5,1437.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.730,11088.0,11333.0,11454.0,11233.0,11196.5,hypothetical protein,S
Tb927.11.740,612.5,1034.0,357.5,483.0,287.0,eukaryotic translation initiation factor 5A,G1
Tb927.11.750,11468.5,11108.0,11031.0,11208.5,11009.0,DNA repair protein  putative,<2C (LG1)
Tb927.11.760,612.5,6058.0,6352.5,6669.5,6519.0,protein phosphatase 2C  putative,G2M
Tb927.11.770,5262.5,7945.5,7220.5,7333.0,5854.0,hypothetical protein  conserved,G1
Tb927.11.780,10211.5,10236.0,9776.5,10519.5,9925.5,hypothetical protein  conserved,G2M
Tb927.11.790,1460.0,5378.0,6485.5,5576.5,5834.5,AGC/RSK family serine/threonine kinase  putative,S
Tb927.11.800,3895.5,2241.5,2653.0,3013.0,7792.5,prefoldin subunit  putative,>4C (GG2M)
Tb927.11.810,7134.5,10055.5,10410.0,10649.5,10955.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.820,8941.0,6164.0,6417.0,6683.5,5978.5,hypothetical protein,<2C (LG1)
Tb927.11.830,10833.0,7539.0,8351.0,7996.5,8905.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.835,612.5,2402.0,2533.0,2642.5,3775.0,telomerase RNA component,>4C (GG2M)
Tb927.11.840,2598.0,8086.5,8113.0,8475.0,8338.0,sodium/hydrogen exchanger  putative,G2M
Tb927.11.850,2295.5,2149.5,2310.0,2671.0,6270.0,Atypical serine/threonine protein kinase BUD32  putative,>4C (GG2M)
Tb927.11.860,8943.5,9012.0,8676.5,9690.5,9390.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.11.870,8309.5,7890.5,6253.5,6045.0,2964.0,mitochondrial ribosomal protein l23,<2C (LG1)
Tb927.11.880,4849.5,3991.5,3697.0,4205.5,2870.0,cyclophilin a,<2C (LG1)
Tb927.11.890,9528.5,10494.0,10441.5,10801.5,10375.0,hypothetical protein  conserved,G2M
Tb927.11.900,5148.5,6095.5,7433.0,6728.0,3760.5,isocitrate dehydrogenase  putative,S
Tb927.11.910,7255.0,10386.0,10506.0,10480.5,8872.5,hypothetical protein  conserved,S
Tb927.11.920,8966.5,7262.5,5429.5,5307.5,7471.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.930,10609.0,10828.5,10975.0,10712.0,9621.0,hypothetical protein  conserved,S
Tb927.11.940,612.5,4560.0,4622.0,5004.5,4005.5,KREPB5,G2M
Tb927.11.950,2221.0,2160.0,1379.5,1261.0,2141.5,RNA-binding protein  putative,<2C (LG1)
Tb927.11.960,11070.0,10244.0,10516.5,10279.5,7918.5,ATPase  putative,<2C (LG1)
Tb927.11.970,7236.5,8196.5,7923.5,8091.5,7847.5,hypothetical protein  conserved,G1
Tb927.11.980,6828.0,5205.5,6226.5,5775.5,10687.0,Nucleoporin NUP158,>4C (GG2M)
Tb927.11.990,3524.0,4503.0,5919.0,5050.5,7244.0,autophagy protein APG9  putative,>4C (GG2M)
Tb927.11.1000,612.5,1143.0,1179.5,941.0,2794.5,kinetoplastid kinetochore protein 16,>4C (GG2M)
Tb927.11.1010,3303.5,5552.5,5015.0,4674.0,4607.0,chaperone protein DnaJ  putative,G1
Tb927.11.1020,4840.5,6842.0,6200.0,6946.0,6639.5,ribokinase  putative,G2M
Tb927.11.1030,1783.5,5454.0,8650.5,8840.0,11035.0,kinetoplastid kinetochore protein 7,>4C (GG2M)
Tb927.11.1040,10474.0,8803.0,9966.0,9540.0,9472.0,TFIIF-like transcription factor subunit 1,<2C (LG1)
Tb927.11.1050,612.5,3097.0,3051.5,3367.5,1565.5,ribosome production factor 1  putative,G2M
Tb927.11.1060,6381.5,7237.5,8340.0,7757.0,6655.5,Vasohibin  putative,S
Tb927.11.1070,2714.5,9694.0,9483.5,9155.0,7896.5,glycosomal transporter (GAT3)  putative,G1
Tb927.11.1080,6874.5,9732.0,10184.5,9701.0,9487.0,Nucleolar protein 60,S
Tb927.11.1090,4134.0,8211.5,8547.5,9666.0,11694.0,calpain-like protein  putative,>4C (GG2M)
Tb927.11.1100,2436.0,322.0,313.0,673.0,964.0,cysteine peptidase  Clan CA  family C2  putative,<2C (LG1)
Tb927.11.1110,3041.5,4754.0,3668.5,5398.5,11327.0,calpain  putative,>4C (GG2M)
Tb927.11.1130,11629.0,11666.0,11665.0,11681.0,11714.0,calpain-like cysteine peptidase  putative,>4C (GG2M)
Tb927.11.1150,4019.5,2505.5,2477.5,4166.5,9895.5,radial spoke protein 3,>4C (GG2M)
Tb927.11.1160,9410.0,11056.0,11110.0,11177.0,10405.0,Region in Clathrin and VPS  putative,G2M
Tb927.11.1170,10996.0,11378.0,11391.0,11475.0,11234.5,hypothetical protein  conserved,G2M
Tb927.11.1180,8813.0,5488.5,5396.5,4711.5,4839.5,cdc2-related kinase 6  putative,<2C (LG1)
Tb927.11.1190,7974.0,5847.0,5861.5,5751.5,4822.5,Ring finger domain/PHD-finger  putative,<2C (LG1)
Tb927.11.1200,4242.0,7905.5,7404.5,6738.5,7900.0,hypothetical protein  conserved,G1
Tb927.11.1210,6853.5,8223.0,8257.5,9617.0,10403.0,Domain of unknown function (DUF4470)/Domain of unknown function (DUF4471)  putative,>4C (GG2M)
Tb927.11.1220,6194.5,8753.5,9694.5,9547.5,11372.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.1230,8687.5,9565.5,9682.0,10065.0,9744.5,hypothetical protein  conserved,G2M
Tb927.11.1240,5908.0,6538.5,6630.0,6056.0,6799.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.1250,4982.0,9000.0,8989.0,9039.0,7624.5,Mitochondrial SSU ribosomal protein  putative,G2M
Tb927.11.1260,10215.0,9266.0,8714.0,7301.0,8962.5,copper-transporting ATPase-like protein  putative,<2C (LG1)
Tb927.11.1270,7180.5,5918.5,6328.0,6706.0,7501.5,Mitochondrial ATP synthase subunit  putative,>4C (GG2M)
Tb927.11.1280,3358.0,6818.5,7807.0,7525.5,7219.5,hypothetical protein  conserved,S
Tb927.11.1290,8303.0,7171.0,6687.5,6255.5,4654.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1300,612.5,3625.0,3649.5,4381.0,6472.5,UBA/TS-N domain containing protein  putative,>4C (GG2M)
Tb927.11.1310,5779.0,1924.0,3215.0,3452.5,2178.0,NADH-cytochrome b5 reductase  putative,<2C (LG1)
Tb927.11.1320,5467.5,4540.5,5519.5,4409.0,4145.0,NADH dehydrogenase [ubiquinone] iron-sulfur protein 7  mitochondrial,S
Tb11.NT.18,5393.5,2335.0,2378.0,2422.0,2454.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.1330,9097.0,7277.5,6504.5,7768.5,5972.0,Stress responsive A/B Barrel Domain  putative,<2C (LG1)
Tb927.11.1340,3013.5,8400.5,8637.5,9097.0,11119.0,Flagella connector protein 1,>4C (GG2M)
Tb927.11.1350,2137.5,5604.5,4510.0,4862.5,5953.5,calcium uniporter protein  mitochondrial,>4C (GG2M)
Tb927.11.1360,2870.5,7726.5,8519.5,8319.0,8334.5,zinc-finger of a C2HC-type  putative,S
Tb927.11.1370,612.5,307.0,313.0,352.0,672.0,Dithiol glutaredoxin 1,>4C (GG2M)
Tb927.11.1380,11646.0,11685.0,11680.0,11695.0,11665.0,Right handed beta helix region/Periplasmic copper-binding protein (NosD)  putative,G2M
Tb927.11.1390,7933.0,9308.5,9327.5,9209.5,9328.0,class I transcription factor A  subunit 1,>4C (GG2M)
Tb927.11.1400,11414.0,11118.5,10881.0,11281.0,10831.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1410,3794.5,2858.5,3767.5,4309.5,4783.5,class I transcription factor A  subunit 3,>4C (GG2M)
Tb927.11.1420,8226.5,9004.5,8034.0,8245.0,5813.0,hypothetical protein  conserved,G1
Tb927.11.1430,3272.0,10518.5,10032.5,10027.5,9792.5,Component of motile flagella 2,G1
Tb927.11.1440,5807.0,6095.5,5892.0,5949.0,7015.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.1450,8569.5,7270.0,4977.5,6452.5,5064.5,2-oxoglutarate dehydrogenase E1 component  putative,<2C (LG1)
Tb927.11.1460,10743.5,10575.0,10448.0,10613.0,10232.5,phosphatidylinositol (3 5) kinase  putative,<2C (LG1)
Tb927.11.1470,1460.0,7451.5,7930.0,7797.0,6472.5,65 kDa invariant surface glycoprotein-like protein,S
Tb927.11.1480,10545.0,11573.0,11573.0,11599.0,11515.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb927.11.1490,4276.0,3932.0,3297.5,3752.5,3365.0,receptor-type adenylate cyclase GRESAG 4  putative (fragment),<2C (LG1)
Tb927.11.1500,11575.0,11643.0,11639.0,11648.0,11638.0,leucine-rich repeat protein (LRRP)  putative  (fragment),G2M
Tb927.11.1510,10263.0,11294.0,11311.0,11263.5,11329.0,leucine rich repeat protein  putative,>4C (GG2M)
Tb927.11.1520,8309.5,8308.0,8687.5,8470.0,7826.5,expression site-associated gene 3 (ESAG3) protein  putative,S
Tb927.11.1530,10830.0,11024.5,10855.0,10969.5,10950.5,expression site-associated gene 3 (ESAG3) protein  putative,G1
Tb927.11.1540,10268.5,9139.5,9185.0,8961.0,9056.0,isovaleryl-CoA dehydrogenase,<2C (LG1)
Tb927.11.1550,9959.0,9235.0,9365.5,10027.5,10541.0,XRN 5'-3' exonuclease N-terminus  putative,>4C (GG2M)
Tb927.11.1560,2795.5,3265.5,2717.5,4011.0,5083.0,1 2-Dihydroxy-3-keto-5-methylthiopentene dioxygenase  putative,>4C (GG2M)
Tb927.11.1570,8698.0,9036.5,8756.0,8652.5,8731.0,hypothetical protein  conserved,G1
Tb927.11.1580,10406.5,10285.0,9895.0,9986.5,9640.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1590,6628.0,449.0,1665.0,808.0,4014.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1600,9391.0,6039.0,7474.5,5168.5,8178.5,tatD related deoxyribonuclease  putative,<2C (LG1)
Tb927.11.1610,9630.0,7810.0,8264.0,8172.5,9519.5,Exocyst complex component Sec6  putative,<2C (LG1)
Tb927.11.1620,6014.5,6664.0,5685.5,5168.5,6253.5,hypothetical protein  conserved,G1
Tb927.11.1630,9148.0,8259.5,9202.0,9001.5,7716.0,LSU ribosomal protein  mitochondrial  putative,S
Tb927.11.1640,1783.5,9884.5,9548.0,9294.0,8965.5,Stumpy formation signalling pathway protein  putative,G1
Tb927.11.1650,8368.5,5641.5,4529.5,3658.0,4244.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1660,5784.5,6437.0,5474.5,5932.0,6699.0,vesicular transport protein (CDC48 homologue)  putative,>4C (GG2M)
Tb927.11.1670,8915.0,8926.5,9471.5,8921.0,9392.5,cysteine desulfurase,S
Tb927.11.1680,11561.0,11165.0,11208.0,11232.0,11086.5,vesicular-fusion protein SEC18  putative,<2C (LG1)
Tb927.11.1690,6999.0,4276.0,4776.0,4290.5,3752.5,Emopamil binding protein  putative,<2C (LG1)
Tb927.11.1700,9861.0,10039.5,9858.5,9554.0,8744.0,hypothetical protein  conserved,G1
Tb927.11.1710,3448.5,1953.0,3138.0,3773.5,1141.0,guide RNA-binding protein of 21 kDa,G2M
Tb927.11.1720,9960.5,5695.5,6587.5,6669.5,5963.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1730,612.5,727.0,893.0,397.5,347.0,hypothetical protein,S
Tb927.11.1740,3630.5,3997.5,4832.0,6573.5,10019.0,intraflagellar transport protein 88,>4C (GG2M)
Tb927.11.1750,1460.0,5331.5,6236.5,5079.0,4867.0,hypothetical protein  conserved,S
Tb927.11.1760,8477.5,5600.0,6211.0,4940.5,3825.5,JmjC domain  hydroxylase  putative,<2C (LG1)
Tb927.11.1770,612.5,8118.0,9113.5,8597.5,6206.0,hypothetical protein  conserved,S
Tb927.11.1780,9016.0,9540.0,9008.0,9193.0,7319.5,protein phosphatase 2C  putative,G1
Tb927.11.1790,1914.0,1875.5,1831.0,2168.5,1239.0,histone H1,G2M
Tb927.11.1800,4667.5,1437.5,1067.0,1479.0,1227.0,histone H1,<2C (LG1)
Tb927.11.1810,6599.0,3457.0,4057.0,3045.0,5188.0,Ring finger domain containing protein  putative,<2C (LG1)
Tb927.11.1820,7528.0,6643.5,7607.0,6983.5,6479.0,translation initiation factor eIF2B delta subunit  putative,S
Tb927.11.1830,5357.0,6115.0,5584.0,5180.0,5153.5,hypothetical protein  conserved,G1
Tb927.11.1840,2460.0,3711.5,3215.0,3075.0,7308.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.1850,5074.0,1924.0,1945.0,2150.0,2268.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1860,2982.0,759.0,471.5,788.5,874.5,histone H1,<2C (LG1)
Tb927.11.1870,3621.0,588.0,685.0,705.5,1437.0,histone H1,<2C (LG1)
Tb927.11.1880,1914.0,3615.5,3189.5,5419.5,4849.5,histone H1,G2M
Tb927.11.1890,612.5,5454.0,6270.5,6009.0,7602.0,Serine-threonine kinase receptor-associated protein  putative,>4C (GG2M)
Tb927.11.1900,2357.5,1736.5,1510.5,1950.5,3310.5,T-complex protein 1  beta subunit  putative,>4C (GG2M)
Tb927.11.1910,612.5,3361.0,2604.0,4252.5,3335.5,cation transporter protein  putative,G2M
Tb927.11.1920,5604.0,10242.0,10027.5,10460.5,10057.5,hypothetical protein,G2M
Tb927.11.1930,9839.0,9932.5,10026.0,10449.5,10116.0,ubiquitin carboxyl-terminal hydrolase  putative,G2M
Tb927.11.1940,7581.5,4450.0,3994.5,5789.5,6857.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1950,9207.0,8811.0,8878.5,9380.0,8118.5,hypothetical protein  conserved,G2M
Tb927.11.1960,1460.0,1009.0,907.5,1363.5,2870.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.11.1970,2221.0,307.0,313.0,159.0,287.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.1980,10064.0,2975.0,3678.5,1140.0,1437.0,zinc finger protein family member  putative,<2C (LG1)
Tb927.11.1990,3863.0,6199.5,5625.0,5481.5,5230.0,arginyl-tRNA synthetase  putative,G1
Tb927.11.2000,8531.0,8857.0,8825.5,9582.5,9246.5,Cupin-like domain containing protein  putative,G2M
Tb927.11.2010,7262.0,7392.0,8295.5,6112.5,9062.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2020,7137.5,7019.5,8105.0,7830.0,7262.5,hypothetical protein  conserved,S
Tb927.11.2030,8549.0,2903.5,4614.0,3492.0,1970.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2040,5528.0,9192.5,7209.5,8056.0,4770.5,STE/STE11 serine/threonine-protein kinase  putative,G1
Tb927.11.2050,1914.0,176.5,233.5,273.5,433.0,60S acidic ribosomal protein P0  putative,<2C (LG1)
Tb927.11.2060,3922.5,1220.5,1192.0,1416.5,933.5,60S acidic ribosomal protein P0  putative,<2C (LG1)
Tb927.11.2070,5925.5,3120.0,2389.0,3441.0,1772.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2080,1783.5,7539.0,7372.0,7967.5,6864.5,hypothetical protein  conserved,G2M
Tb927.11.2090,8069.5,6824.0,6185.0,5617.5,5075.5,choline kinase,<2C (LG1)
Tb927.11.2100,10739.0,10468.0,10190.0,10365.0,10543.5,Divergent AAA domain containing protein  putative,<2C (LG1)
Tb927.11.2110,9254.0,5592.5,6055.5,4764.5,3628.5,Snf7  putative,<2C (LG1)
Tb927.11.2120,9923.5,5959.5,5025.0,4011.0,6038.0,CBF/Mak21 family  putative,<2C (LG1)
Tb927.11.2130,2747.5,4413.0,4938.0,6475.5,8241.0,proteasome regulatory non-ATP-ase subunit 3,>4C (GG2M)
Tb927.11.2140,5635.5,8872.0,9531.0,9242.0,11261.0,cyclic nucleotide-binding domain containing protein  putative,>4C (GG2M)
Tb927.11.2150,9212.0,9840.0,9662.0,10320.0,9461.0,hypothetical protein  conserved,G2M
Tb927.11.2160,2870.5,3711.5,3877.5,4598.0,4508.5,hypothetical protein  conserved,G2M
Tb927.11.2170,4425.0,9750.5,9537.5,9489.5,9340.5,hypothetical protein  conserved,G1
Tb927.11.2180,3303.5,2358.5,2378.0,1526.5,2953.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2190,5251.5,5494.5,5930.5,4598.0,4831.5,MICOS complex subunit MIC10-2,S
Tb11.NT.26,612.5,1115.5,1268.0,1702.0,3335.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.11.2200,4872.5,5778.0,5246.5,5228.0,5593.5,DNA-directed RNA polymerase II  putative,G1
Tb11.NT.27,8462.5,2319.0,2103.5,2150.0,3465.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.2210,6666.0,9801.0,9664.5,9926.0,9122.0,diacylglycerol acyltransferase  putative,G2M
Tb927.11.2220,1914.0,1124.5,1522.0,1745.0,1744.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2230,5418.5,7258.5,7457.0,6940.5,7770.5,carnitine O-acetyltransferase  putative,>4C (GG2M)
Tb927.11.2235,612.5,845.0,717.5,687.0,1717.0,hypothetical protein,>4C (GG2M)
Tb927.11.2240,5174.0,3723.5,4848.5,3531.5,1984.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2245,3621.0,484.0,271.5,419.0,86.0,hypothetical protein,<2C (LG1)
Tb927.11.2250,2381.5,1716.0,2717.5,3102.5,2661.5,conserved protein  unknown function,G2M
Tb927.11.2260,7690.5,5083.0,4670.0,4808.0,5451.0,Eukaryotic translation initiation factor 4E-1,<2C (LG1)
Tb927.11.2270,1783.5,2187.0,1848.0,2223.0,8303.5,inner dynein arm I1 intermediate chain  axonemal,>4C (GG2M)
Tb927.11.2280,5756.5,4373.5,4057.0,4221.0,6890.0,BRO1-like domain/ALIX V-shaped domain binding to HIV  putative,>4C (GG2M)
Tb927.11.2290,5766.5,10261.0,10711.0,10370.0,10483.0,hypothetical protein  conserved,S
Tb927.11.2300,1460.0,4886.5,3779.5,3909.0,4377.5,eukaryotic peptide chain release factor subunit 1  putative,G1
Tb927.11.2310,10220.0,8370.0,7696.5,8704.5,7866.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2320,9867.5,10307.0,10303.5,10528.0,8927.0,Hereditary spastic paraplegia protein strumpellin  putative,G2M
Tb927.11.2330,7080.5,6216.5,7242.0,7531.5,8078.0,molybdopterin synthase sulphurylase protein  putative,>4C (GG2M)
Tb927.11.2340,8777.5,8881.5,8847.0,8779.5,10653.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2350,5616.0,4642.5,4104.0,4409.0,5963.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2360,10664.5,9601.0,8977.5,7416.5,9164.5,phenylalanyl-tRNA synthetase (beta subunit)  putative,<2C (LG1)
Tb927.11.2370,11105.5,6955.0,4878.5,6366.5,10486.5,mRNA export factor MEX67,<2C (LG1)
Tb927.11.2380,11199.0,10622.0,10476.5,10630.5,10486.5,phosphoglycerate kinase  putative,<2C (LG1)
Tb927.11.2390,612.5,4879.0,3952.0,5592.0,4081.5,Tubulin-tyrosine ligase family  putative,G2M
Tb927.11.2400,11524.0,11638.5,11628.0,11628.0,11542.0,Flabarin-like protein,G1
Tb927.11.2410,5298.5,5002.0,5218.0,5375.0,5943.5,Flabarin  putative,>4C (GG2M)
Tb927.11.2420,10020.0,9276.0,8044.5,9270.5,9930.5,Tubulin-tyrosine ligase family  putative,<2C (LG1)
Tb927.11.2430,4767.5,6655.0,7622.5,8728.0,11254.0,Cytoplasmic dynein 2 heavy chain (DYNC2H2)  putative,>4C (GG2M)
Tb927.11.2440,9728.0,7223.0,6796.5,8029.0,9220.5,Tubulin cofactor C domain-containing protein 1,<2C (LG1)
Tb927.11.2460,6893.5,5407.0,4130.5,4394.5,7501.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2465,8698.0,2479.0,3678.5,3938.0,3748.5,hypothetical protein,<2C (LG1)
Tb927.11.2470,3951.0,7810.0,7076.5,7372.5,8155.5,metallo-peptidase  Clan MF  Family M17,>4C (GG2M)
Tb927.11.2480,3751.5,1690.5,1371.0,1642.5,1647.0,hypothetical protein,<2C (LG1)
Tb927.11.2490,6878.0,10803.5,10176.5,10886.5,10769.0,Unc104-like kinesin  putative,G2M
Tb927.11.2500,9604.0,9065.0,9076.0,9386.0,9361.0,Metallocarboxypeptidase 1,<2C (LG1)
Tb927.11.2510,7528.0,8908.0,9105.0,9071.5,7994.5,NUC173 domain containing protein  putative,S
Tb927.11.2520,9086.5,9062.0,9162.5,9116.5,8888.5,UDP-n-acetylglucosamine pyrophosphorylase,S
Tb927.11.2530,10271.5,9971.5,10086.0,10202.0,9957.0,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.11.2540,4148.0,2457.0,3514.5,5454.0,9071.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2550,1460.0,4383.0,4411.0,4112.0,3586.0,recombinase rad51  putative,S
Tb927.11.2560,4698.0,3586.5,4476.0,4035.5,3879.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2570,10936.0,9591.0,10066.0,10506.5,10317.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2580,2714.5,2283.0,1502.0,1911.5,2218.5,Present in the outer mitochondrial membrane proteome 11,<2C (LG1)
Tb927.11.2590,10236.5,8494.0,8836.5,8334.0,7319.5,Flagellum attachment zone protein 12,<2C (LG1)
Tb927.11.2600,8161.5,9349.0,9207.5,9837.0,10099.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2610,1460.0,2429.0,1999.5,2347.0,3323.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2620,6095.5,10631.0,10752.0,11060.0,10268.5,hypothetical protein  conserved,G2M
Tb927.11.2630,9333.0,8658.5,8217.0,8709.5,9527.0,diphthamide biosynthesis enzyme Dph1/Dph2 domain containing protein  putative,>4C (GG2M)
Tb927.11.2640,10684.0,10332.0,9510.0,9748.0,8597.0,Nucleolar protein 53,<2C (LG1)
Tb927.11.2650,9415.0,7549.0,6288.0,6515.5,7177.5,heat shock protein 84  putative,<2C (LG1)
Tb927.11.2660,11413.0,9829.5,9934.0,9027.0,10817.0,Golgi reassembly stacking protein (GRASP homologue)  putative,<2C (LG1)
Tb927.11.2670,6792.5,3109.0,2692.0,3102.5,3260.0,Nucleoporin NUP59,<2C (LG1)
Tb927.11.2680,8716.0,10184.5,10524.0,9946.5,10490.5,ATP synthase regulation protein NCA2  putative,S
Tb927.11.2690,10512.5,10577.5,10230.5,10686.0,10060.5,Succinyl-CoA:3-ketoacid coenzyme A transferase  mitochondrial,G2M
Tb927.11.2700,11404.0,11076.0,11059.0,11102.5,10439.0,Basal body protein,<2C (LG1)
Tb927.11.2710,3013.5,4251.5,4019.5,3837.0,4330.5,Cell division cycle 45,>4C (GG2M)
Tb927.11.2720,6434.5,1353.5,1665.0,1585.5,2834.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2730,4740.5,4960.0,4887.0,3065.5,2589.5,UDP-galactose 4-epimerase,G1
Tb927.11.2740,10642.0,10746.0,10455.5,10484.0,9472.0,hypothetical protein  conserved,G1
Tb927.11.2750,2870.5,6373.5,6772.0,7119.0,8315.0,Present in the outer mitochondrial membrane proteome 12,>4C (GG2M)
Tb927.11.2760,6714.0,7591.5,7749.0,7227.0,7551.5,hypothetical protein  conserved,S
Tb927.11.2770,5490.5,5579.0,5197.0,6388.5,5479.5,hypothetical protein  conserved,G2M
Tb927.11.2780,6422.0,10870.5,10945.5,10857.0,10917.5,hypothetical protein  conserved,S
Tb927.11.2790,1914.0,3997.5,4093.0,5273.5,4849.5,Solute carrier (proton/amino acid symporter)  TRAMD3 or PAT1  putative,G2M
Tb927.11.2800,8516.5,5287.0,2790.5,3950.5,3994.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2810,7960.5,5295.0,3930.5,4346.0,4266.0,Protein of unknown function (DUF3773)  putative,<2C (LG1)
Tb927.11.2820,11030.0,7985.5,8749.5,8645.0,8489.5,hypothetical protein  conserved,<2C (LG1)
Tb11.NT.31,4940.0,1240.5,615.0,1966.0,948.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.2825,612.5,1466.5,940.5,989.0,1078.0,Presenilin enhancer-2 subunit of gamma secretase  putative,G1
Tb927.11.2830,5960.5,7098.5,9020.0,8368.0,8905.0,hypothetical protein  conserved,S
Tb927.11.2840,1460.0,4990.0,4388.0,5407.5,4429.0,magnesium-dependent phosphatase-1/HAD phosphatase  family IIIC  putative,G2M
Tb927.11.2850,2813.0,3032.5,2465.5,3130.0,2351.0,hypothetical protein  conserved,G2M
Tb927.11.2860,9985.5,8254.0,9625.5,9100.0,7139.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2870,612.5,1344.0,1008.5,1071.0,895.5,hypothetical protein,G1
Tb927.11.2880,1914.0,5706.5,8200.0,9323.0,11231.0,kinesin  putative,>4C (GG2M)
Tb927.11.2890,8161.5,7355.0,7297.0,7350.0,8420.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2900,8297.0,5416.0,4990.5,4674.0,559.5,HIT zinc finger  putative,<2C (LG1)
Tb927.11.2910,1783.5,7939.0,6883.0,7448.0,7161.5,phosphoglycerate mutase  putative,G1
Tb927.11.2920,10268.5,8003.5,8960.0,8254.5,8454.0,glycerolphosphate mutase  putative,<2C (LG1)
Tb11.NT.33,6004.0,3158.0,3388.5,4252.5,3353.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.2930,10771.0,9557.0,7727.5,10241.0,9482.5,membrane-associated protein  putative,<2C (LG1)
Tb927.11.2940,4019.5,5359.5,6000.0,6120.5,6826.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2950,3241.5,4373.5,4643.0,5375.0,9065.0,Nucleoporin NUP89,>4C (GG2M)
Tb927.11.2960,4490.0,1231.0,1502.0,2009.0,2310.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.2970,10220.0,8818.5,8885.0,8925.5,10969.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.2980,6594.5,6508.5,6780.0,5789.5,6535.5,hypothetical protein  conserved,S
Tb927.11.2990,4910.5,8992.0,8947.0,8224.5,7699.0,KREPB4,G1
Tb927.11.3000,612.5,1670.0,1731.5,1352.5,1622.5,60S ribosomal protein L37  putative,S
Tb927.11.3010,6057.5,3129.0,4069.0,4235.5,3906.0,ribonuclease P,<2C (LG1)
Tb927.11.3020,1460.0,9043.0,9768.0,10191.5,9004.5,hypothetical protein  conserved,G2M
Tb927.11.3030,10483.0,8823.0,7652.5,6809.0,7745.5,phosphoribosylpyrophosphate synthetase  putative,<2C (LG1)
Tb927.11.3040,2913.0,1211.0,2453.0,1833.5,584.5,hypothetical protein,<2C (LG1)
Tb927.11.3050,4134.0,3073.0,4069.0,3194.5,2413.0,hypothetical protein,<2C (LG1)
Tb927.11.3060,10543.0,7883.0,7227.5,7967.5,5110.5,Phosphate transport (Pho88)  putative,<2C (LG1)
Tb927.11.3070,5756.5,6702.5,6744.5,5333.0,6028.0,ribosome assembly protein RRB1  putative,S
Tb927.11.3080,612.5,3900.0,2919.0,3102.5,4284.0,vesicular protein trafficking mediator  putative,>4C (GG2M)
Tb927.11.3090,5795.0,7076.5,5752.5,7083.0,5526.5,LisH domain-containing protein FOPNL  putative,G2M
Tb927.11.3100,4872.5,8211.5,8991.0,8699.5,7518.0,Present in the outer mitochondrial membrane proteome 13,S
Tb927.11.3110,5981.0,7095.5,7526.5,6859.0,8754.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3120,8526.5,8590.5,8407.5,7132.0,8232.5,nucleolar GTP-binding protein 1,G1
Tb927.11.3130,10812.5,6865.0,5792.5,5751.5,7712.5,glycosomal transporter (GAT2),<2C (LG1)
Tb927.11.3140,5477.5,4441.0,3551.5,3356.0,4988.5,dual specificity tyrosine-phosphorylation-regulated kinase 2  putative,<2C (LG1)
Tb927.11.3150,10891.0,10489.0,10617.0,9840.0,10622.0,conserved protein,<2C (LG1)
Tb927.11.3160,7037.0,7128.5,6772.0,6962.0,9056.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3170,7967.5,3652.5,3978.5,5206.5,4635.5,Der1-like family  putative,<2C (LG1)
Tb927.11.3180,9963.5,5128.0,4799.0,4828.5,6153.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.3190,10805.0,9747.0,9399.5,9782.5,11274.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3200,5120.0,7454.5,7433.0,7762.0,4199.0,Histone methylation protein DOT1  putative,G2M
Tb927.11.3210,7374.5,8692.5,8568.5,8164.0,8852.5,hypothetical protein,>4C (GG2M)
Tb927.11.3220,7013.0,9220.5,9286.5,8573.5,8165.0,metacaspase,S
Tb927.11.3230,1460.0,130.0,336.0,366.5,213.0,60S ribosomal protein L44,<2C (LG1)
Tb927.11.3240,2180.0,727.0,596.0,826.5,5593.5,T-complex protein 1  zeta subunit  putative,>4C (GG2M)
Tb927.11.3250,2258.5,3542.5,4448.0,4235.5,9934.5,dynein heavy chain  putative,>4C (GG2M)
Tb927.11.3260,9694.0,11339.0,11126.5,10890.5,10413.5,mitochondrial DNA polymerase I protein D  putative,G1
Tb927.11.3270,4354.0,4908.0,5537.0,5551.0,6164.0,squalene monooxygenase  putative,>4C (GG2M)
Tb927.11.3280,8012.0,8719.0,8235.0,8720.5,11504.0,Kinesin-13 5  putative,>4C (GG2M)
Tb927.11.3290,5784.5,8305.5,8615.5,6761.5,3566.5,Tripartite attachment complex protein 166,S
Tb927.11.3300,10334.0,8669.0,8980.5,9609.5,10585.5,Spindle assembly abnormal 4,>4C (GG2M)
Tb927.11.3310,7490.5,3016.0,3521.5,3168.0,3494.0,ubiquitin-conjugating enzyme  putative,<2C (LG1)
Tb11.NT.40,4872.5,2444.5,1799.0,2357.0,2164.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.3320,2258.5,471.5,391.5,577.5,486.0,ras-like small GTPase  putative,<2C (LG1)
Tb927.11.3330,2747.5,9889.5,10151.0,9891.0,9264.5,hypothetical protein  conserved,S
Tb927.11.3340,2258.5,9296.5,8931.5,9658.0,9824.0,RNA-binding protein 34  putative,>4C (GG2M)
Tb927.11.3350,10037.5,10052.0,10283.0,9797.0,9633.0,phospholipid-transporting ATPase 1-like protein  putative,S
Tb927.11.3360,2258.5,6124.0,7342.5,6465.0,10639.5,Component of motile flagella 22,>4C (GG2M)
Tb927.11.3370,7277.5,10198.5,9883.0,10152.5,9344.0,hypothetical protein,G1
Tb927.11.3380,2795.5,3700.0,3658.5,3815.5,3283.5,Ran-binding protein 1  putative,G2M
Tb927.11.3390,11037.0,11580.0,11596.0,11626.0,11707.0,Concanavalin A-like lectin/glucanases superfamily/SPRY domain/HECT-domain (ubiquitin-transferase)  putative,>4C (GG2M)
Tb927.11.3400,612.5,3436.5,5001.0,3393.5,6491.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3410,3794.5,10014.5,10317.0,9710.5,10299.0,hypothetical protein  conserved,S
Tb927.11.3420,2920.5,7923.0,5787.0,6935.5,8590.5,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.11.3430,2381.5,3723.5,2533.0,2671.0,3586.0,hypothetical protein  conserved,G1
Tb927.11.3440,6339.0,5301.5,6460.5,6549.5,5379.5,hypothetical protein  conserved,G2M
Tb927.11.3450,4930.5,9399.5,9928.5,9653.5,7442.5,hypothetical protein  conserved,S
Tb927.11.3460,4321.0,5166.0,6544.0,5551.0,5772.0,hypothetical protein  conserved,S
Tb927.11.3470,1783.5,5579.0,7151.0,6873.5,4617.5,endosomal integral membrane protein  putative,S
Tb927.11.3480,4425.0,3881.5,3697.0,5662.0,4883.5,Sin-like protein conserved region  putative,G2M
Tb927.11.3490,6620.5,9643.0,8253.0,9196.5,10281.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3500,1460.0,7818.0,6302.0,7040.5,11248.0,Dpy-30 motif containing protein  putative,>4C (GG2M)
Tb927.11.3510,8621.0,8204.5,8888.5,7553.5,7944.5,hypothetical protein  conserved,S
Tb927.11.3520,5902.5,1249.0,2275.0,2184.5,2351.0,Acyl CoA binding protein  putative,<2C (LG1)
Tb927.11.3530,6190.5,4726.0,4421.0,4381.0,5772.0,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,<2C (LG1)
Tb927.11.3540,3202.0,2000.5,3066.0,2940.5,3100.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.3550,4253.5,4460.5,5365.5,6001.0,5290.5,XPA-interacting protein  putative,G2M
Tb927.11.3560,8780.5,8914.5,8615.5,7635.5,6216.5,hypothetical protein,G1
Tb927.11.3570,9536.5,7989.0,9679.0,8990.5,9103.5,metallo-peptidase  Clan MA(E) Family M1,S
Tb927.11.3580,5643.5,2696.5,1710.5,1779.5,4783.5,Thiamin pyrophosphokinase  vitamin B1 binding domain containing protein  putative,<2C (LG1)
Tb927.11.3590,612.5,738.5,313.0,313.5,287.0,40S ribosomal protein S4  putative,G1
Tb927.11.3600,612.5,799.5,293.0,292.5,213.0,40S ribosomal protein S4  putative,G1
Tb927.11.3610,8537.5,6984.0,7588.0,6845.5,6909.5,nucleobase/nucleoside transporter 8.1,<2C (LG1)
Tb927.11.3620,9669.5,8839.0,8819.5,9642.5,8694.5,nucleobase/nucleoside transporter 8.2,<2C (LG1)
Tb927.11.3630,6033.5,5200.5,7193.0,7132.0,5145.5,nucleobase/nucleoside transporter 8.3,S
Tb927.11.3640,10346.0,8978.5,9948.5,9695.5,9561.0,Mitochondrial ribosomal protein L27,<2C (LG1)
Tb927.11.3650,6762.5,6437.0,7334.0,7710.0,5342.0,adenylosuccinate synthetase  putative,G2M
Tb927.11.3660,612.5,640.0,743.0,974.5,1047.0,dynein light chain Tctex-type  putative,>4C (GG2M)
Tb927.11.3670,6714.0,5854.0,6616.5,4301.0,4607.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.3680,1914.0,2078.0,1938.0,1745.0,1392.5,calmodulin  putative,G1
Tb927.11.3690,10610.5,7897.5,8763.5,8100.0,6452.0,Alpha/beta hydrolase family  putative,<2C (LG1)
Tb927.11.3700,4810.5,3842.0,3755.0,3408.0,5694.5,Uncharacterised ACR  YagE family COG1723  putative  unspecified product,>4C (GG2M)
Tb927.11.3705,612.5,2326.0,3148.0,2686.0,2125.5,DNA-directed RNA polymerases I  II  and III subunit RPABC5  putative,S
Tb927.11.3710,9391.0,11162.5,11272.0,11277.0,11351.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3720,11490.0,10037.0,9426.0,9703.0,9741.5,Ring finger domain containing protein  putative,<2C (LG1)
Tb927.11.3730,7267.0,7597.0,7532.5,6452.5,7104.0,leucyl-tRNA synthetase  putative,G1
Tb927.11.3740,1460.0,3032.5,3288.0,3029.0,2110.0,proteasome regulatory ATPase subunit 2,S
Tb927.11.3750,1783.5,6583.5,7662.0,8816.0,7334.5,NADH-cytochrome b5 reductase  putative,G2M
Tb927.11.3760,7478.0,5088.5,3885.0,4567.5,5686.0,hypothetical protein,<2C (LG1)
Tb927.11.3770,6878.0,5985.5,5239.0,6120.5,11413.5,Dpy-30 motif containing protein  putative,>4C (GG2M)
Tb927.11.3780,9387.0,10714.0,10941.0,10971.0,10164.0,subtilisin peptidase,G2M
Tb927.11.3790,612.5,5600.0,5129.0,3687.5,6969.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3810,4375.0,2561.0,2360.0,1993.5,2050.0,hypothetical protein,<2C (LG1)
Tb927.11.3820,6759.0,4583.0,3560.0,5095.0,1732.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.3830,2619.0,4653.0,4283.5,3178.5,1325.5,hypothetical protein  conserved,G1
Tb927.11.3840,10030.0,10398.0,10595.0,10988.5,9467.0,hypothetical protein  conserved,G2M
Tb927.11.3850,6620.5,10467.0,10569.0,10246.5,9504.0,AMP deaminase  putative,S
Tb927.11.3860,10022.0,5725.5,5424.5,6157.0,6994.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.3870,9268.0,8196.5,7393.0,7495.5,7328.5,katanin  putative,<2C (LG1)
Tb927.11.3880,4617.0,2903.5,3297.5,2746.5,10109.5,actin  putative,>4C (GG2M)
Tb927.11.3890,9473.0,9514.5,9883.0,8578.5,10157.0,N(2)  N(2)-dimethylguanosine tRNA methyltransferase  putative,>4C (GG2M)
Tb927.11.3900,2574.5,738.5,1179.5,737.0,744.5,glycosyltransferase family-like protein  putative,<2C (LG1)
Tb927.11.3910,9519.5,9893.5,9662.0,10125.0,9208.5,hypothetical protein  conserved,G2M
Tb927.11.3920,10791.0,10282.0,10224.0,9963.0,7847.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.3930,1783.5,5355.0,6678.0,5873.0,1912.0,hypothetical protein  conserved,S
Tb927.11.3940,6179.5,6475.0,7009.5,7391.0,8776.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3950,5357.0,4967.0,6078.5,5505.5,6984.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.3960,7884.0,7032.0,7865.5,6056.0,7304.0,btb/poz domain containing protein  putative,<2C (LG1)
Tb927.11.3970,10476.5,4719.0,4896.0,5317.0,4081.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.3980,10599.5,6458.5,6550.5,6219.5,6463.5,metallo-peptidase  Clan ME  Family M16,<2C (LG1)
Tb927.11.3990,7380.5,7317.5,7033.5,6854.5,8667.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.4000,9796.0,10105.5,10301.0,9871.0,10511.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.4010,10412.5,10208.0,10290.5,10421.5,10387.0,hypothetical protein  conserved,G2M
Tb927.11.4020,1460.0,1018.0,448.0,647.5,895.5,Complex1_LYR-like  putative,<2C (LG1)
Tb927.11.4030,8231.0,11423.0,11493.0,11543.5,11354.0,hypothetical protein  conserved,G2M
Tb927.11.4040,6521.5,4540.5,3843.5,2893.5,4179.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4050,3987.5,4365.0,4372.0,2940.5,2679.0,hypothetical protein  conserved,S
Tb927.11.4060,612.5,6494.5,6385.5,6728.0,5516.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.11.4070,8857.0,3680.0,3531.0,3924.0,3812.0,hypothetical protein,<2C (LG1)
Tb927.11.4080,3875.5,1415.5,1192.0,1597.5,1062.5,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.11.4090,11056.0,6599.5,6379.0,6669.5,5125.0,hypothetical protein,<2C (LG1)
Tb927.11.4100,4826.0,2864.5,4155.0,3295.5,4355.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.4120,1460.0,7818.0,8455.5,7839.5,8278.5,leucine-rich repeat protein (LRRP)  putative,S
Tb927.11.4130,4027.5,8141.0,8945.5,8829.0,6857.0,ubiquitin-like protein  putative,S
Tb927.11.4140,612.5,3515.0,4398.0,4808.0,4525.5,hypothetical protein  conserved,G2M
Tb927.11.4150,1783.5,5717.0,6744.5,5569.0,5220.0,hypothetical protein  conserved,S
Tb927.11.4160,11403.0,10534.5,10509.0,10395.5,10467.0,predicted C2 domain protein,<2C (LG1)
Tb927.11.4170,6921.5,7766.0,7731.0,7617.5,7038.0,kinetoplastid-specific dual specificity phosphatase  putative,G1
Tb927.11.4180,9863.5,9858.0,11096.5,11214.0,10213.5,PSP1 C-terminal conserved region  putative,G2M
Tb927.11.4190,8344.0,4785.0,5519.5,5180.0,3775.0,Metallopeptidase family M24  putative,<2C (LG1)
Tb927.11.4200,11351.0,10527.5,10450.0,10861.0,9824.0,mannose-specific lectin  putative,<2C (LG1)
Tb927.11.4210,11071.0,11081.0,11210.0,11216.5,11202.0,U-box domain containing protein  putative,G2M
Tb927.11.4220,10797.0,10638.5,10847.0,10415.5,10966.5,palmitoyl acyltransferase 6  putative,>4C (GG2M)
Tb927.11.4230,10752.5,11183.0,11267.0,11128.0,10383.0,hypothetical protein  conserved,S
Tb927.11.4240,2619.0,2436.0,2692.0,2788.5,213.0,hypothetical protein  conserved,G2M
Tb927.11.4250,6075.0,5612.5,6410.0,6927.5,797.5,hypothetical protein  conserved,G2M
Tb927.11.4260,7854.0,5746.5,5953.5,6950.5,5499.0,mitochondrial calcium uniporter,<2C (LG1)
Tb927.11.4270,612.5,3813.5,3431.0,3429.5,1355.0,hypothetical protein  conserved,G1
Tb927.11.4280,10502.5,11023.0,11036.5,11018.0,10894.0,hypothetical protein  conserved,S
Tb11.NT.54,5086.5,4669.0,5408.5,6001.0,4714.5,Noncoding RNA  putative,G2M
Tb927.11.4290,1783.5,5711.0,6055.5,6883.0,4860.0,40S ribosomal protein S12,G2M
Tb927.11.4300,612.5,235.5,130.5,159.0,347.0,60S ribosomal protein L18  putative,<2C (LG1)
Tb927.11.4310,6225.0,1727.5,2378.0,720.5,818.0,hypothetical protein,<2C (LG1)
Tb927.11.4320,9420.5,9300.0,10198.5,9290.5,10241.5,Uncharacterized ACR  COG1678  putative,>4C (GG2M)
Tb927.11.4330,4905.0,959.0,925.0,501.5,287.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4340,5891.0,9818.5,9041.0,8445.5,8260.0,SUMO-interacting motif-containing protein,G1
Tb927.11.4350,6620.5,9924.0,8676.5,9582.5,10260.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.11.4360,9916.0,9685.0,9713.0,9595.5,8797.0,Protein of unknown function (DUF1014)  putative,<2C (LG1)
Tb927.11.4370,6666.0,7157.0,4689.0,4798.0,3628.5,hypothetical protein  conserved,G1
Tb927.11.4380,10555.5,11279.0,11198.0,10967.5,11029.0,ATP-dependent RNA helicase  putative,G1
Tb927.11.4390,8532.0,7162.0,7115.5,7275.5,3447.0,Histidine phosphatase superfamily (branch 1)  putative,<2C (LG1)
Tb927.11.4400,8192.5,9460.5,9968.5,9658.0,8927.0,hypothetical protein  conserved,S
Tb927.11.4420,6455.0,7839.0,7055.0,7571.0,7861.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.4430,8800.5,10845.5,10508.0,10577.5,10664.0,ferric reductase transmembrane protein  putative,G1
Tb927.11.4440,7368.5,3419.0,2987.0,3408.0,5647.5,hypothetical protein,<2C (LG1)
Tb927.11.4450,4849.5,2232.0,2327.5,1363.5,4187.0,ALBA-Domain Protein,<2C (LG1)
Tb927.11.4460,6075.0,4413.0,3051.5,3477.5,6836.0,ALBA-Domain Protein,>4C (GG2M)
Tb927.11.4470,8300.0,8086.5,7958.5,8164.0,10164.0,ULK family serine/threonine-protein kinase  putative,>4C (GG2M)
Tb927.11.4480,3579.5,747.5,1067.0,1261.0,6137.0,Flagellar radial spoke protein 4/6,>4C (GG2M)
Tb927.11.4490,7391.5,3429.0,5479.0,3938.0,5898.0,long-chain-fatty-acid-CoA ligase  putative,<2C (LG1)
Tb927.11.4500,11317.0,11239.0,11085.0,10987.0,10589.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4510,11368.0,11187.0,11130.5,11088.0,11072.5,Sister chromatid cohesion C-terminus  putative,<2C (LG1)
Tb927.11.4520,11183.0,11254.0,11383.0,11333.0,10095.5,hypothetical protein  conserved,S
Tb927.11.4530,6274.5,5683.5,3987.0,4193.5,6547.5,N-acetyltransferase subunit ARD1,>4C (GG2M)
Tb927.11.4540,7297.0,2664.0,2134.0,2038.5,10317.0,Nucleoporin NUP48,>4C (GG2M)
Tb927.11.4550,2920.5,1679.0,2949.5,1861.0,9504.0,Domain of unknown function (DUF4200)  putative,>4C (GG2M)
Tb927.11.4560,3202.0,3941.5,4815.0,4235.5,1896.5,hypothetical protein  conserved,S
Tb927.11.4570,9106.0,6664.0,6417.0,5249.5,4391.0,Ras-related protein Rab5B,<2C (LG1)
Tb927.11.4590,5181.0,4503.0,5631.0,5365.0,6016.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.4610,3214.5,4331.5,3745.0,3724.0,7023.0,protein kinase A regulatory subunit,>4C (GG2M)
Tb927.11.4620,1460.0,1087.5,925.0,1085.0,915.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4630,3914.0,4019.0,5829.0,5782.0,4051.0,hypothetical protein  conserved,S
Tb927.11.4640,3770.5,7343.5,7652.5,7308.0,7592.0,calpain-like protein  putative,S
Tb927.11.4650,7723.0,11136.0,11262.0,11173.5,10750.0,Mitochondrial ribosomal protein L52  kinetoplast ribosomal PPR-repeat containing protein 13,S
Tb927.11.4660,7125.5,8361.5,8081.5,8682.5,5567.0,Kinesin-13 2,G2M
Tb927.11.4670,5565.5,4251.5,3560.0,2264.5,2898.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4680,3370.5,1858.0,1818.0,1558.5,2110.0,SURF1 family  putative,<2C (LG1)
Tb927.11.4690,11580.0,11027.0,10273.0,10790.5,11083.0,mitochondrial DNA polymerase I protein B,<2C (LG1)
Tb927.11.4700,7528.0,5941.5,4607.0,3185.0,3541.0,prostaglandin f synthase,<2C (LG1)
Tb927.11.4710,1460.0,6676.0,6873.5,5981.0,4800.5,hypothetical protein  conserved,S
Tb927.11.4720,3996.0,1018.0,1111.5,647.5,1027.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4730,4104.0,5953.5,7744.5,6854.5,7431.5,hypothetical protein  conserved,S
Tb927.11.4740,6330.0,8484.5,8547.5,8904.0,7244.0,paraflagellar rod component  putative,G2M
Tb927.11.4750,7013.0,10011.0,10163.0,9287.5,9589.0,hypothetical protein,S
Tb927.11.4760,11365.0,11288.0,11123.0,11299.0,10940.5,hypothetical protein,<2C (LG1)
Tb927.11.4770,11624.0,11603.0,11587.0,11579.0,11405.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb927.11.4780,2930.5,4145.5,4117.0,4486.5,1549.5,pyruvate dehydrogenase (lipoamide) kinase  putative,G2M
Tb927.11.4790,612.5,1313.5,1268.0,1451.5,1195.0,hypothetical protein,G2M
Tb11.NT.60,612.5,1043.5,1347.5,1466.0,721.5,Noncoding RNA  putative,G2M
Tb927.11.4800,5432.0,7430.0,7741.0,8465.5,9723.0,clathrin coat assembly protein  putative,>4C (GG2M)
Tb927.11.4810,1460.0,130.0,99.0,136.5,287.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4820,612.5,96.0,40.0,501.5,86.0,60S ribosomal protein L17  putative,<2C (LG1)
Tb927.11.4830,6870.5,7610.0,7916.5,7099.5,5240.0,hypothetical protein  conserved,S
Tb927.11.4840,1460.0,6611.5,6893.0,5407.5,6960.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.4850,6797.0,7373.0,8615.5,7153.5,9017.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.4860,8124.5,9106.0,9832.5,9405.0,9475.5,Ring finger domain containing protein  putative,S
Tb927.11.4870,1914.0,1773.5,2919.0,2629.5,2254.0,hypothetical protein  conserved,S
Tb927.11.4880,1914.0,4260.5,5396.5,5608.0,7401.0,Calmodulin-binding  putative,>4C (GG2M)
Tb927.11.4890,8842.5,6516.5,5765.5,4421.5,5624.0,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,<2C (LG1)
Tb927.11.4900,7329.0,3916.0,3189.5,4057.0,7708.5,WD40/YVTN repeat-like-containing protein,>4C (GG2M)
Tb927.11.4910,5094.0,8096.5,8543.0,8492.5,7290.0,predicted ankyrin repeat family protein,S
Tb927.11.4920,4922.5,3855.5,3578.0,2470.5,3323.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4930,4242.0,1059.5,1091.0,1187.5,1744.5,Phosducin  putative,<2C (LG1)
Tb927.11.4940,11342.0,11395.0,11111.0,11212.0,10892.5,AAA ATPase  putative,G1
Tb927.11.4950,11350.0,11012.0,10945.5,10985.0,11027.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.4960,612.5,1068.5,880.5,1313.5,3510.5,transcription elongation factor s-II  putative,>4C (GG2M)
Tb927.11.4970,8150.5,5159.5,3364.5,4290.5,6385.5,predicted WD40 repeat protein,<2C (LG1)
Tb927.11.4980,9771.5,10801.5,10740.0,10324.0,9749.0,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.11.4990,8192.5,10912.0,10622.5,10734.0,10650.5,kinetoplastid-specific phospho-protein phosphatase  putative,G1
Tb927.11.5000,1460.0,1609.0,1268.0,3441.0,10731.5,Dynein intermediate chain 1  axonemal,>4C (GG2M)
Tb927.11.5010,5826.0,6007.0,5372.0,6205.5,10790.5,TFIIF-stimulated CTD phosphatase  putative,>4C (GG2M)
Tb927.11.5020,11293.0,10933.5,10959.0,10615.5,10274.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5030,4784.0,6767.5,7450.0,7194.0,4377.5,hypothetical protein  conserved,S
Tb927.11.5040,4872.5,2592.5,4104.0,5101.5,4525.5,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.11.5050,5516.5,2551.0,3658.5,4221.0,3271.5,fumarate hydratase  class I,<2C (LG1)
Tb927.11.5060,10274.5,10367.5,9795.0,9390.5,9021.5,Mitochondrial small ribosomal subunit Rsm22  putative,G1
Tb927.11.5070,10126.5,8525.0,7220.5,6491.0,7154.5,GPI ethanolamine phosphate transferase 3  putative,<2C (LG1)
Tb927.11.5080,6649.0,7399.5,7676.5,7845.5,7974.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.5090,5262.5,6804.5,7377.0,7448.0,5499.0,aspartate aminotransferase  mitochondrial,G2M
Tb927.11.5100,11274.0,11227.0,10492.5,11038.0,11105.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5110,10070.5,9075.0,8398.0,9304.5,8643.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5120,10401.0,10849.5,10983.0,10868.0,10587.5,TPR repeat/SET domain containing protein  putative,S
Tb927.11.5130,2956.5,8176.0,6970.5,8086.0,6729.5,hypothetical protein  conserved,G1
Tb927.11.5140,1460.0,4560.0,4327.5,3666.5,3033.0,ubiquitin carboxyl-terminal hydrolase  putative,G1
Tb927.11.5150,7250.0,7518.0,7884.0,8215.5,6570.5,hypothetical protein  conserved,G2M
Tb927.11.5160,11113.5,10228.5,10277.5,10540.0,10933.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5170,9669.5,6587.0,7198.5,6192.0,7806.0,ubiquitin activating enzyme  putative,<2C (LG1)
Tb927.11.5180,6752.5,9490.0,9263.0,9157.5,9117.0,hypothetical protein  conserved,G1
Tb927.11.5190,7444.0,9789.0,9604.5,10497.5,11567.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.11.5200,7807.5,2896.5,2621.5,3699.0,3541.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5210,4094.5,3397.0,4038.0,3102.5,3861.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5220,9611.5,10072.0,10454.0,10598.0,9560.0,chaperone protein DnaJ  putative,G2M
Tb927.11.5230,3028.5,5435.5,4540.5,4346.0,2679.0,hypothetical protein  conserved,G1
Tb927.11.5240,6586.0,7751.5,7498.5,6809.0,5034.5,Methyltransferase TRM13  putative,G1
Tb927.11.5250,11086.5,11019.5,10898.5,11056.5,10719.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5260,8120.0,9655.5,9311.5,8853.5,7047.0,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein  putative,G1
Tb927.11.5270,6672.0,10856.0,10971.0,10664.0,11103.5,ubiquitin carboxyl-terminal hydrolase  putative,>4C (GG2M)
Tb927.11.5280,612.5,4460.5,3717.5,3228.0,5199.0,Mitochondrial ATP synthase subunit c-1,>4C (GG2M)
Tb927.11.5290,7340.0,8152.5,8087.5,8978.0,6844.5,mitochondrial carrier protein,G2M
Tb927.11.5300,10658.0,9802.5,9920.0,9846.0,9328.0,Kinesin-13 3  putative,<2C (LG1)
Tb927.11.5310,9669.5,9939.0,9966.0,10275.5,9229.0,PPPDE putative peptidase domain containing protein  putative,G2M
Tb927.11.5330,5774.0,8547.0,8200.0,7567.0,9138.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.5340,8601.5,10479.0,10583.0,10959.5,11075.5,Cell division protein kinase  putative,>4C (GG2M)
Tb927.11.5350,11570.0,9927.5,9677.0,10168.0,9099.5,myo-inositol/proton symporter (MIT),<2C (LG1)
Tb927.11.5360,11418.0,10769.5,10759.5,10907.5,10081.5,aldo/keto reductase  putative,<2C (LG1)
Tb927.11.5365,612.5,988.5,1008.5,1056.5,531.0,hypothetical protein,G2M
Tb927.11.5370,6599.0,7857.5,7498.5,8296.5,3044.5,hypothetical protein  conserved,G2M
Tb927.11.5380,4680.0,4305.0,5153.5,5981.0,4480.5,Protein of unknown function (DUF523)  putative,G2M
Tb927.11.5390,2767.0,5757.0,5197.0,5004.5,6216.5,mitochondrial import inner membrane translocase subunit  putative,>4C (GG2M)
Tb927.11.5400,10025.0,7697.5,7943.5,7040.5,5927.0,signal recognition particle 54 kDa,<2C (LG1)
Tb927.11.5410,6202.5,8942.0,8559.5,8348.5,9279.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.11.5420,3662.5,7427.0,8241.5,8052.5,7038.0,hypothetical protein  conserved,S
Tb927.11.5430,5298.5,7766.0,8071.0,8116.5,7676.5,DNA repair and recombination protein RAD54  putative,G2M
Tb927.11.5440,11250.0,7539.0,7510.0,7111.0,7369.5,NADP-dependent malic enzyme  cytosolic,<2C (LG1)
Tb927.11.5450,8630.0,8240.5,9099.5,8904.0,7847.5,malic enzyme,S
Tb927.11.5460,612.5,4251.5,4990.5,4433.0,3618.5,hypothetical protein  conserved,S
Tb927.11.5470,2714.5,5971.0,6603.0,6738.5,4849.5,hypothetical protein  conserved,G2M
Tb927.11.5480,1914.0,5416.0,5618.5,5617.5,6588.5,phosphotransferase  putative,>4C (GG2M)
Tb927.11.5490,11522.0,9734.0,10355.0,10020.5,9264.5,Polyphosphoinositide phosphatase  putative,<2C (LG1)
Tb927.11.5500,11298.0,11017.0,10721.5,10992.5,10348.5,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.11.5510,4266.5,2198.0,2477.5,2184.5,8872.5,dynein light chain p28  axonemal  putative,>4C (GG2M)
Tb927.11.5520,5225.0,3304.0,2075.5,1888.0,4440.0,triosephosphate isomerase,<2C (LG1)
Tb927.11.5530,10025.0,4450.0,5452.0,4798.0,6780.0,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.5540,2767.0,4383.0,3101.5,4235.5,6307.0,emp24/gp25L/p24 family/GOLD  putative,>4C (GG2M)
Tb927.11.5550,5190.5,3827.0,5044.5,4841.0,3726.5,DNA polymerase theta,<2C (LG1)
Tb927.11.5560,1460.0,6278.5,5867.0,5437.0,11167.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.5570,5598.0,6095.5,7986.5,6598.5,7092.0,DNA replication licensing factor MCM5,S
Tb927.11.5580,11032.0,9705.5,7668.0,9014.0,7029.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5590,8670.0,9421.5,10044.5,9896.0,5442.5,Anaphase-promoting complex-associated protein AP1,S
Tb927.11.5600,7277.5,4227.0,3813.0,4754.5,5735.0,Archaic Translocase of outer membrane 14 kDa subunit,<2C (LG1)
Tb927.11.5610,612.5,1781.0,1650.0,1491.0,1970.0,Rab-GTPase-TBC domain containing protein  putative,>4C (GG2M)
Tb927.11.5620,8131.5,6030.0,6368.5,5342.5,6664.5,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.11.5630,10233.5,9863.5,10114.0,9888.5,4860.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5640,9755.0,10708.5,10544.0,10773.0,9786.0,hypothetical protein  conserved,G2M
Tb927.11.5650,6230.5,9543.5,10332.0,9891.0,8006.0,replication factor C  subunit 1  putative,S
Tb927.11.5660,6556.0,4830.0,5460.5,4782.0,2805.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5670,1460.0,5344.0,5286.0,5295.5,7579.5,Mnd1 family  putative,>4C (GG2M)
Tb927.11.5680,612.5,235.5,615.0,826.5,8543.0,dynein light chain 1  axonemal,>4C (GG2M)
Tb927.11.5690,8411.5,9509.0,9914.0,9690.5,9487.0,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily-related  putative,S
Tb927.11.5700,9514.0,10986.0,11014.5,10938.5,10848.5,hypothetical protein  conserved,S
Tb927.11.5710,9583.0,6244.5,6509.5,6962.0,5713.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.11.5720,5218.0,4056.0,3658.5,4221.0,2218.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5730,10133.0,9367.5,8882.5,9593.0,9208.5,pre-mRNA-splicing factor ATP-dependent RNA helicase  putative,<2C (LG1)
Tb927.11.5740,9775.0,9030.5,9221.0,9637.0,7262.5,formin-like protein,<2C (LG1)
Tb927.11.5750,3078.5,6408.0,6917.0,7744.5,11602.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.11.5760,9034.5,7373.0,7578.5,7320.0,9178.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.5770,6649.0,11028.0,11247.0,11251.5,10260.0,hypothetical protein  conserved,G2M
Tb927.11.5780,10976.0,9814.5,9468.0,9868.0,10653.5,DNA-directed RNA polymerase  mitochondrial,<2C (LG1)
Tb927.11.5790,5018.5,5506.0,4170.0,4433.0,3510.5,hypothetical protein  conserved,G1
Tb927.11.5800,6528.0,11029.5,11038.5,11017.0,10477.0,hypothetical protein  conserved,S
Tb927.11.5810,1460.0,3245.0,2738.5,3492.0,6224.0,Surfeit locus protein 6  putative,>4C (GG2M)
Tb927.11.5820,10788.0,7830.5,6513.5,7384.5,7904.0,Inhibitor of apoptosis-promoting Bax1  putative,<2C (LG1)
Tb927.11.5830,6538.0,5641.5,6393.0,6904.0,6247.5,YL1 nuclear protein  putative,G2M
Tb927.11.5840,1460.0,3217.5,3633.5,5069.5,818.0,Protein translation factor SUI1 homolog  putative,G2M
Tb927.11.5850,3358.0,4503.0,4643.0,4446.0,3760.5,RNA-binding protein 38  putative,S
Tb927.11.5855,2855.0,5656.0,4758.5,4097.0,4418.5,hypothetical protein,G1
Tb927.11.5860,10734.5,4596.5,4990.5,4882.0,5834.5,AGC/RSK family serine/threonine kinase  putative,<2C (LG1)
Tb927.11.5870,7511.5,8219.0,8497.0,9119.5,8522.5,hypothetical protein  conserved,G2M
Tb927.11.5880,8337.0,10365.5,10656.0,10265.0,8416.0,LSU ribosomal protein  mitochondrial  putative,S
Tb927.11.5890,5625.5,5442.5,5256.0,5353.5,5585.0,Domain of unknown function (DUF4505)  putative,<2C (LG1)
Tb927.11.5900,6021.5,8447.5,8791.0,8185.5,8291.0,hypothetical protein  conserved,S
Tb927.11.5910,10179.0,9597.0,9776.5,9489.5,8719.5,WASH complex subunit 7  N-terminal/WASH complex subunit 7/WASH complex subunit 7  C-terminal  putative,<2C (LG1)
Tb927.11.5920,6429.5,9254.0,9483.5,9577.0,10004.0,conserved protein,>4C (GG2M)
Tb927.11.5940,10842.0,9072.0,9774.0,9378.0,8667.5,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.11.5950,4517.0,1466.5,1510.5,1056.5,1622.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5960,7019.5,4056.0,4434.0,4301.0,4571.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.5970,8282.0,7331.5,5808.0,6112.5,5600.5,phosphoinositide-specific phospholipase C,<2C (LG1)
Tb927.11.5980,2574.5,2942.5,2604.0,3013.0,3365.0,conserved protein,>4C (GG2M)
Tb927.11.5990,9307.5,6095.5,6518.0,7599.5,7002.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.6000,612.5,3984.0,5135.0,4940.5,5803.0,mitochondrial ribosomal protein L4,>4C (GG2M)
Tb927.11.6010,3579.5,4294.5,5685.5,5249.5,2079.5,conserved protein  unknown function,S
Tb927.11.6020,612.5,588.0,1347.5,610.5,2773.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.NT.73,8673.5,5057.5,6236.5,6515.5,7098.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.6030,612.5,4155.5,4029.0,4221.0,2661.5,ras-like small GTPase  putative,G2M
Tb927.11.6040,2574.5,6804.5,6328.0,6604.0,5713.5,Nodulin-like  putative,G1
Tb927.11.6050,7826.5,8525.0,8305.5,8668.0,11681.0,Flagellar-associated PapD-like  putative,>4C (GG2M)
Tb927.11.6060,2995.0,9100.5,7418.5,8219.0,4748.5,major facilitator superfamily  putative,G1
Tb927.11.6070,3762.0,4084.5,2729.5,2671.0,1929.5,hypothetical protein  conserved,G1
Tb927.11.6080,3078.5,5407.0,5590.5,4433.0,8221.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6090,612.5,2283.0,2327.5,1847.0,2847.0,tatD related deoxyribonuclease  putative,>4C (GG2M)
Tb927.11.6100,612.5,2078.0,1416.0,1665.0,1636.0,hypothetical protein  conserved,G1
Tb927.11.6120,10774.0,11319.0,11282.0,11310.5,9519.5,ABC transporter  putative,G1
Tb927.11.6130,1783.5,8063.0,6587.5,8379.0,7834.0,SKP1-like protein,G2M
Tb927.11.6140,612.5,518.0,703.0,557.5,1253.0,40S ribosomal protein S15A  putative,>4C (GG2M)
Tb927.11.6150,2920.5,4521.5,4586.5,4454.5,1472.0,60Kd inner membrane protein  putative,S
Tb927.11.6160,612.5,3881.5,2011.5,2389.0,1531.5,eukaryotic release factor 3  putative,G1
Tb927.11.6170,3803.0,5273.0,5519.5,5716.5,7201.0,protein transport protein SEC31  putative,>4C (GG2M)
Tb927.11.6180,612.5,279.5,161.0,159.0,287.0,60S ribosomal protein L28  putative,<2C (LG1)
Tb927.11.6190,6582.0,5701.0,5919.0,5129.0,3775.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.6200,612.5,208.5,99.0,82.5,213.0,60S ribosomal protein L28  putative,<2C (LG1)
Tb927.11.6210,9597.5,10491.5,10953.5,10675.5,8310.5,Lanosterol 14-alpha demethylase,S
Tb927.11.6220,11013.0,10384.5,10420.0,10177.5,8727.5,Palmitoyl acyltransferase 7,<2C (LG1)
Tb927.11.6230,3987.5,3273.5,3224.5,3282.0,2110.0,protein transport protein SEC61 subunit alpha  putative,<2C (LG1)
Tb927.11.6240,5611.0,5941.5,5777.0,4987.0,3825.5,hypothetical protein  conserved,G1
Tb927.11.6250,9092.5,6792.5,7334.0,6219.5,3836.0,Mitochondrial ATP synthase subunit  putative,<2C (LG1)
Tb927.11.6260,7173.0,10047.5,10521.0,10234.5,8278.5,hypothetical protein  conserved,S
Tb927.11.6270,1460.0,5612.5,4476.0,5600.0,6655.5,inositol-1 4 5-trisphosphate (IP3) 5-phosphatase  putative,>4C (GG2M)
Tb927.11.6280,3726.5,5725.5,7433.0,7993.0,8409.5,pyruvate phosphate dikinase,>4C (GG2M)
Tb927.11.6290,4449.5,3956.5,4586.5,3866.5,4571.0,HIT zinc finger  putative,S
Tb927.11.6300,3589.5,1275.5,1347.5,1171.0,1860.5,40S ribosomal protein S5  putative,<2C (LG1)
Tb927.11.6310,612.5,158.5,954.0,382.0,2065.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6320,2813.0,2457.0,2969.0,3117.0,3447.0,MRB1-associated protein,>4C (GG2M)
Tb927.11.6330,10973.5,10448.5,10221.5,10137.5,10366.0,6-phosphogluconolactonase,<2C (LG1)
Tb927.11.6340,8177.0,8884.5,9622.0,8958.5,6328.0,PUB domain containing protein  putative,S
Tb927.11.6350,9816.5,11392.5,11434.0,11376.0,10630.0,AAA ATPase  putative,S
Tb927.11.6360,10017.0,6916.5,6780.0,6755.5,7592.0,60S ribosomal protein L24  putative,<2C (LG1)
Tb927.11.6370,9388.5,5397.5,5892.0,4828.5,2928.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.11.6380,2137.5,4620.0,6976.0,5673.5,4110.0,hypothetical protein  conserved,S
Tb927.11.6390,5181.0,4990.0,2839.0,3492.0,1392.5,START domain containing protein  putative,<2C (LG1)
Tb11.NT.81,3341.5,959.0,743.0,366.5,964.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.6400,5291.5,8667.0,8687.5,8273.5,5996.5,kinesin  putative,S
Tb927.11.6410,11434.0,11430.0,11234.0,11339.5,11140.0,regulator of nonsense transcripts 2,<2C (LG1)
Tb927.11.6420,9709.0,9300.0,9749.0,8018.0,9911.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6430,7090.5,8346.5,9581.5,9766.0,11287.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6440,2436.0,3086.5,3755.0,3393.5,8204.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6450,612.5,9670.0,9780.0,10089.0,7618.0,Serine incorporator (Serinc)  putative,G2M
Tb927.11.6460,10580.5,8477.5,8476.0,9167.5,8570.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.6470,612.5,5656.0,5875.5,6129.0,7201.0,MICOS complex subunit MIC16,>4C (GG2M)
Tb927.11.6480,10873.5,7981.0,5645.0,7199.5,7855.0,FHA domain containing protein  putative,<2C (LG1)
Tb927.11.6490,6538.0,5717.0,5570.5,5551.0,7447.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6500,1460.0,130.0,210.0,111.0,287.0,40S ribosomal protein S21  putative,<2C (LG1)
Tb927.11.6510,1460.0,176.5,161.0,136.5,213.0,40S ribosomal protein S21  putative,<2C (LG1)
Tb927.11.6520,5965.0,8336.5,7442.5,7167.0,5003.0,hypothetical protein  conserved,G1
Tb927.11.6530,2094.5,6139.5,4568.5,5489.0,8431.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6540,8952.5,10609.0,10628.5,10426.5,10042.0,hypothetical protein  conserved,S
Tb927.11.6550,10601.5,9572.0,8561.0,9423.5,7736.0,PUF nine target 1,<2C (LG1)
Tb927.11.6560,5565.5,4181.5,4857.0,5561.5,7981.0,Centriole protein POC11  putative,>4C (GG2M)
Tb927.11.6565,9292.0,8827.5,7359.5,7955.0,7930.5,hypothetical protein,<2C (LG1)
Tb11.NT.84,7671.0,7857.5,6664.0,7422.0,7689.0,Noncoding RNA  putative,G1
Tb927.11.6570,4859.0,10297.0,10253.5,10261.0,9976.0,Nodulin-like  putative,G1
Tb927.11.6580,1460.0,2138.5,1402.0,1430.0,1141.0,hypothetical protein  conserved,G1
Tb927.11.6590,7813.5,7914.5,8264.0,8150.5,7351.0,metallo-peptidase  Clan MF  Family M17,S
Tb927.11.6600,11677.0,11467.0,11466.5,11497.0,11502.0,conserved protein  unknown function,<2C (LG1)
Tb927.11.6610,7635.5,6104.0,6672.5,6582.5,8948.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6620,7585.0,5513.5,4680.0,5325.0,6994.0,Nucleolar protein 47,<2C (LG1)
Tb927.11.6630,5565.5,7700.5,8091.5,7517.0,5745.0,3-methylcrotonoyl-CoA carboxylase beta subunit  putative,S
Tb927.11.6640,4751.0,5732.5,4977.5,5808.5,1676.0,cytochrome b5  putative,G2M
Tb927.11.6650,9134.0,10698.0,10836.0,10419.5,10643.0,hypothetical protein,S
Tb927.11.6660,7671.0,9124.0,9020.0,8418.0,7762.5,Tex-like protein N-terminal domain/Helix-hairpin-helix motif containing protein  putative,G1
Tb927.11.6670,9202.5,9941.0,10047.5,10198.0,10605.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6680,5450.0,9258.5,9420.0,8259.5,8158.5,amino acid permease/transporter  putative,S
Tb927.11.6690,3095.0,4145.5,4002.0,3856.5,1878.0,NEK family Serine/threonine-protein kinase  putative,G1
Tb927.11.6700,612.5,5172.5,5044.5,5031.5,5509.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6710,612.5,1716.0,2219.0,2907.5,7047.0,predicted tetratricopeptide repeat (TPR) protein,>4C (GG2M)
Tb927.11.6720,8087.0,7830.5,8054.5,7949.0,6975.5,mRNA cap guanine-N7 methyltransferase  putative,<2C (LG1)
Tb927.11.6730,6995.5,6023.5,5838.5,5375.0,6270.0,hypothetical protein,<2C (LG1)
Tb927.11.tRNA_Gly_1,612.5,40.5,40.0,33.5,86.0,tRNA Glycine,<2C (LG1)
Tb927.11.6740,7210.5,9722.0,9937.5,9023.0,9704.0,pumilio/PUF RNA binding protein 10  putative,S
Tb927.11.6750,3558.0,7837.0,7529.0,6927.5,6240.0,DNA ligase  putative,G1
Tb927.11.6760,5441.0,6352.5,5759.5,6229.5,5713.5,leucine-rich repeat protein (LRRP)  putative,G1
Tb927.11.6770,8507.0,8674.0,9575.0,9157.5,6153.5,hypothetical protein  conserved,S
Tb927.11.6780,9892.5,7508.0,7061.5,7009.0,4703.5,regulator of chromatin condensation  putative,<2C (LG1)
Tb927.11.6790,3314.5,6001.5,6504.5,4579.0,8536.0,Nucleolar protein 89,>4C (GG2M)
Tb927.11.6800,612.5,426.0,448.0,557.5,964.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6810,10851.0,6890.0,8345.0,7236.0,9056.0,tubulin-tyrsoine ligase-like protein  putative,<2C (LG1)
Tb927.11.6820,3456.5,2828.5,3127.0,1993.5,2065.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.6830,2258.5,8059.5,6636.5,6331.5,4222.5,Domain of unknown function(DUF2779)  putative,G1
Tb927.11.6840,6853.5,8455.5,8081.5,7854.0,8905.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6850,9936.0,7152.0,8145.5,8981.0,7534.5,Optic atrophy 3 protein (OPA3)  putative,<2C (LG1)
Tb927.11.6860,612.5,3225.0,2477.5,2907.5,8088.0,hypothetical protein,>4C (GG2M)
Tb927.11.6870,3120.5,640.0,644.5,773.0,2991.5,14-3-3 protein 2,<2C (LG1)
Tb927.11.6890,10583.5,9946.5,10226.5,10009.0,9834.0,DNA repair and recombination helicase protein PIF1,<2C (LG1)
Tb927.11.6900,11260.0,11387.0,11341.5,11323.0,11412.0,DNA repair and recombination helicase protein PIF2,>4C (GG2M)
Tb927.11.6910,3214.5,8765.0,8701.0,7776.5,8103.5,hypothetical protein  conserved,G1
Tb927.11.6920,4940.0,7028.5,6687.5,5799.5,10245.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.6930,4801.0,1991.5,1595.5,1572.5,4096.5,Sec20  putative,<2C (LG1)
Tb927.11.6940,6223.5,1945.5,3009.0,2150.0,4128.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.6950,612.5,988.5,1475.5,1171.0,1489.0,hypothetical protein,>4C (GG2M)
Tb927.11.6960,1460.0,2526.0,3167.0,1763.5,2472.5,ATG16/SAP18/CVT11/APG16  putative,S
Tb927.11.6970,8110.5,8827.5,7989.5,7567.0,7930.5,NADH-cytochrome b5 reductase-like protein,G1
Tb927.11.6980,7786.5,6736.0,6538.0,6738.5,4947.0,Phosphoenolpyruvate carboxykinase  related,<2C (LG1)
Tb927.11.6990,7751.5,10387.0,10684.0,10677.0,10574.5,Calcium/calmodulin-dependent protein kinase kinase  putative,S
Tb927.11.7000,4708.0,2335.0,1428.0,1299.0,2991.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7010,9158.0,9286.0,8556.0,8874.5,8078.0,Calcium/calmodulin-dependent protein kinase kinase  putative,G1
Tb927.11.7020,6372.0,2422.5,1818.0,2422.0,3618.5,proteasome alpha 7 subunit  putative,<2C (LG1)
Tb927.11.7030,11045.5,8728.0,8907.0,9134.0,7685.0,Rad51  putative,<2C (LG1)
Tb927.11.7040,10236.5,7343.5,7198.5,7153.5,6570.5,pterin-4-alpha-carbinolamine dehydratase  putative,<2C (LG1)
Tb927.11.7045,5557.5,4745.0,5270.0,5505.5,5713.5,hypothetical protein,>4C (GG2M)
Tb927.11.7050,8901.5,5612.5,6826.5,6482.0,4320.5,PA domain containing protein  putative,<2C (LG1)
Tb927.11.7060,7016.5,7721.0,7802.5,7979.5,6639.5,acidocalcisomal pyrophosphatase,G2M
Tb927.11.7070,6612.5,10595.5,10547.5,10013.0,9930.5,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.11.7080,4242.0,8630.5,8670.5,8942.5,8539.5,acidocalcisomal pyrophosphatase,G2M
Tb927.11.7090,612.5,509.0,373.5,248.0,697.5,mediator of rna polymerase ii transcription subunit 6,>4C (GG2M)
Tb927.11.7100,2840.5,5552.5,5325.5,4464.5,6074.0,cytoplasmic translation machinery associated protein  putative,>4C (GG2M)
Tb927.11.7110,3680.5,9790.5,10192.0,9775.5,8000.0,myotubularin-associated protein  putative,S
Tb927.11.7120,9092.5,9195.0,9488.0,9300.0,7800.0,hypothetical protein  conserved,S
Tb927.11.7130,9895.5,7440.0,8375.5,7212.0,8098.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7140,612.5,5683.5,4966.0,4754.5,5870.5,cell cycle sequence binding phosphoprotein (RBP33)  putative,>4C (GG2M)
Tb927.11.7150,5133.0,8959.0,8888.5,8563.5,6664.5,NGG1 interacting factor 3-like,G1
Tb927.11.7160,9402.0,4127.0,3599.5,3856.5,6444.5,cdc2-related kinase 8  putative,<2C (LG1)
Tb927.11.7170,8657.0,6538.5,6759.5,6077.0,7459.5,seryl-tRNA synthetase,<2C (LG1)
Tb927.11.7180,11636.0,9276.0,9227.0,10164.5,9644.0,MORN repeat  putative,<2C (LG1)
Tb927.11.7190,5298.5,5159.5,5717.5,5419.5,6463.5,hypothetical protein,>4C (GG2M)
Tb927.11.7200,10006.0,10052.0,9608.5,9732.5,7055.0,GRIP domain containing protein  putative,G1
Tb927.11.7210,8497.0,8056.5,7188.5,7258.0,6234.5,eukaryotic translation initiation factor 2-alpha kinase 1  putative,<2C (LG1)
Tb927.11.7211,4776.0,5918.5,6328.0,5180.0,6412.5,SNF2 DNA repair protein  putative,>4C (GG2M)
Tb927.11.7212,6714.0,2646.0,3092.0,3130.0,3335.5,NADH-ubiquinone oxidoreductase complex I subunit  putative,<2C (LG1)
Tb927.11.7213,9721.0,6012.0,4722.5,5608.0,5064.5,Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC)/Endoplasmic reticulum vesicle transporter  putative,<2C (LG1)
Tb11.02.5090,1460.0,664.5,703.0,444.5,86.0,trimethylguanosine synthase,<2C (LG1)
Tb927.11.7214,3314.5,2731.0,1870.0,2199.0,1622.5,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5105,3241.5,4761.5,3568.0,4433.0,3431.5,Present in the outer mitochondrial membrane proteome 15,G1
Tb927.11.7216,2180.0,612.5,596.0,397.5,347.0,origin recognition complex subunit 1 (ORC1)  putative,<2C (LG1)
Tb927.11.7218,3914.0,3120.0,3464.5,2422.0,3323.0,mitochondrial edited mRNA stability factor 1 subunit,<2C (LG1)
Tb927.11.7220,5418.5,10547.0,10783.0,10900.5,10826.0,neurobeachin/beige protein  putative,G2M
Tb927.11.7230,4375.0,1875.5,2586.5,2237.0,2773.0,palmitoyl acyltransferase 8  putative,<2C (LG1)
Tb927.11.7240,2094.5,952.0,940.5,1187.5,9423.0,nexin-dynein regulatory complex 2,>4C (GG2M)
Tb927.11.7250,8079.5,6782.5,7692.5,7009.0,8784.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.7260,612.5,260.0,630.0,292.5,1099.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.7270,5384.0,1716.0,2399.5,2821.0,3413.5,proteasome beta 3 subunit  putative,<2C (LG1)
Tb927.11.7280,3904.5,554.5,795.0,517.0,3681.5,DNA-direcetd RNA polymerase II  subunit 9  putative,<2C (LG1)
Tb927.11.7290,8961.5,8741.5,9113.5,9005.5,9217.5,pantothenate kinase subunit  putative,>4C (GG2M)
Tb927.11.7300,6459.5,4902.5,4703.0,5148.0,6253.5,major facilitator superfamily  putative,<2C (LG1)
Tb927.11.7310,9278.5,6946.0,6725.0,6423.0,4903.0,RNA binding protein  putative,<2C (LG1)
Tb927.11.7320,3692.0,5315.0,4327.5,5517.5,4377.5,dual specificity phopshatase  putative,G2M
Tb927.11.7330,612.5,449.0,391.5,501.5,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7340,10933.0,10540.0,9940.5,10310.0,9593.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7350,612.5,600.0,966.5,687.0,1355.0,Histone H2B variant V,>4C (GG2M)
Tb927.11.7360,7677.5,5378.0,5120.0,4808.0,5311.0,palmitoyl acyltransferase 9  putative,<2C (LG1)
Tb927.11.7370,9324.0,7931.0,8642.5,9170.5,7876.5,haloacid dehalogenase hydrolase  putative,<2C (LG1)
Tb927.11.7380,3443.0,4103.5,3755.0,4579.0,6649.0,glycerol-3-phosphate dehydrogenase (FAD-dependent)  mitochondrial,>4C (GG2M)
Tb927.11.7390,7997.0,4693.0,5246.5,5437.0,3950.0,NADH-ubiquinone oxidoreductase complex I  21 kDa subunit  putative,<2C (LG1)
Tb927.11.7400,1914.0,5612.5,4904.5,6077.0,4244.5,hypothetical protein  conserved,G2M
Tb927.11.7410,5251.5,7002.0,6648.5,6883.0,6511.5,MSP-A  putative,G1
Tb927.11.7420,6831.5,6905.5,6527.5,7296.0,6028.0,phosphoadenosine phosphosulfate reductase-like protein,G2M
Tb927.11.7430,1460.0,2571.5,3066.0,4318.0,2819.0,hypothetical protein  conserved,G2M
Tb927.11.7440,1460.0,2949.5,3379.0,2840.5,2164.5,hypothetical protein  conserved,S
Tb927.11.7450,7596.5,5854.0,5744.0,5240.0,4645.0,Component of motile flagella 71,<2C (LG1)
Tb11.02.5360,8692.5,6313.0,5598.0,5789.5,6016.5,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5370,5863.0,4065.5,4380.5,4205.5,4170.0,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5380,5643.5,4785.0,3767.5,3992.5,5110.5,exosome complex exonuclease RRP44p homologue,<2C (LG1)
Tb11.02.5390,8069.5,7162.0,6866.5,5638.0,8103.5,Guide RNA binding complex protein 4,>4C (GG2M)
Tb11.02.5400,8017.5,4065.5,4598.0,5215.5,6602.0,cystathionine beta-synthase  putative,<2C (LG1)
Tb11.NT.94,3662.5,811.0,448.0,382.0,2297.5,Noncoding RNA  putative,<2C (LG1)
Tb11.02.5410,612.5,426.0,410.0,352.0,994.0,ubiquitin activating enzyme (E1) subunit Aos1  putative,>4C (GG2M)
Tb11.02.5420,10062.5,7751.5,7143.0,6573.5,6289.5,NADPH-cytochrome p450 reductase  putative,<2C (LG1)
Tb11.02.5430,8325.5,5552.5,6134.0,6935.5,5290.5,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5440,2047.0,7630.5,7831.0,7819.0,7840.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.11.7460,8943.5,4754.0,3288.0,4782.0,6038.0,luminal binding protein 1 (BiP)  putative,<2C (LG1)
Tb927.11.7470,8774.5,3799.0,3891.5,3272.5,3055.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7475,5863.0,4406.0,4421.0,4764.5,4783.5,AN1-like Zinc finger containing protein  putative,<2C (LG1)
Tb927.11.7480,3448.5,1180.5,1428.0,1097.5,1944.0,vacuolar type h+ ATPase subunit  putative,<2C (LG1)
Tb11.NT.96,5582.0,1679.0,2275.0,1441.0,2454.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.7490,2574.5,6034.5,5208.5,5683.5,6679.0,Protein of unknown function (DUF423)  putative,>4C (GG2M)
Tb11.NT.97,612.5,1643.5,1721.5,1329.0,994.0,Noncoding RNA  putative,S
Tb927.11.7500,612.5,4703.0,3832.5,4346.0,2914.5,Protein of unknown function (DUF423)  putative,G1
Tb927.11.7510,9322.0,5521.0,3475.0,5437.0,6369.5,luminal binding protein 1 (BiP)  putative,<2C (LG1)
Tb927.11.7520,3638.0,3766.0,3688.0,4512.5,3093.0,hypothetical protein  conserved,G2M
Tb927.11.7530,5068.5,7630.5,7802.5,7577.0,8905.0,long-chain-fatty-acid-CoA ligase  putative,>4C (GG2M)
Tb927.11.7540,4626.0,6066.5,4799.0,3878.0,4760.0,electron-transfer-flavoprotein  alpha polypeptide  putative,G1
Tb927.11.7550,4601.0,6062.5,6315.0,6946.0,7963.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.7560,3272.0,8043.0,8414.0,8361.0,10599.0,Component of motile flagella 15,>4C (GG2M)
Tb927.11.7570,9585.5,9536.0,9823.0,9561.5,8826.5,ATP-grasp domain containing protein  putative,S
Tb927.11.7580,11400.0,6782.5,6616.5,6348.0,7125.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7590,9322.0,7700.5,8578.0,8110.0,6412.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7600,7657.0,2479.0,1710.5,1875.5,1595.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7610,10200.5,9611.5,10261.0,10027.5,8193.0,gp63-1 surface protease homologue  pseudogene,S
Tb927.11.7620,3922.5,8440.0,7393.0,8978.0,10507.0,MSP-A  putative,>4C (GG2M)
Tb927.11.7630,3868.5,4188.5,4258.0,6024.5,5003.0,Gp63-1 surface protease homolog  putative,G2M
Tb927.11.7640,7345.5,3194.0,4246.0,5273.5,3076.5,Gp63-1 surface protease homolog  putative,<2C (LG1)
Tb927.11.7650,3957.5,5159.5,3952.0,4290.5,5075.5,hypothetical protein,G1
Tb927.11.7660,4505.5,4429.5,4643.0,4336.5,3457.5,hypothetical protein,S
Tb927.11.7670,1460.0,2561.0,2876.5,2456.5,4096.5,Cornifin (SPRR) family  putative,>4C (GG2M)
Tb927.11.7675,612.5,40.5,40.0,248.0,86.0,ribosomal protein S10p/S20,<2C (LG1)
Tb927.11.7680,5784.5,9106.0,8942.5,9203.5,7974.5,hypothetical protein  conserved,G2M
Tb927.11.7685,612.5,96.0,161.0,182.5,86.0,ribosomal protein S10p/S20,<2C (LG1)
Tb927.11.7690,4517.0,5771.5,7308.0,7179.5,5411.5,hypothetical protein,S
Tb927.11.7695,5496.0,2723.0,2738.5,2821.0,2231.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7700,3701.5,2000.5,2144.5,2357.0,3093.0,hypothetical protein,<2C (LG1)
Tb927.11.7702,612.5,398.0,253.5,273.5,531.0,U6 snRNA-associated Sm-like protein LSm5,<2C (LG1)
Tb927.11.7705,612.5,246.5,293.0,159.0,433.0,ribosomal protein S11  putative,<2C (LG1)
Tb927.11.7707,1460.0,307.0,233.5,397.5,1141.0,Tctex-1 family  putative,<2C (LG1)
Tb927.11.7710,6000.5,4908.0,5164.0,5037.0,4222.5,Gp63-1 surface protease homolog  putative,<2C (LG1)
Tb927.11.7720,7911.0,6984.0,6218.5,6219.5,4345.5,Gp63-1 surface protease homolog  putative,<2C (LG1)
Tb927.11.7740,6349.0,2335.0,2425.0,2850.5,4498.5,dynein light chain  putative,<2C (LG1)
Tb927.11.7750,8247.0,11118.5,11214.5,11096.0,10990.5,MSP-A  putative,S
Tb927.11.7760,3419.0,4823.5,4214.0,3194.5,2203.5,MSP-A  putative,G1
Tb927.11.7770,5856.0,8746.0,8637.5,8460.0,7422.5,oxidoreductase-like protein,G1
Tb927.11.7780,1783.5,6397.0,5777.0,6657.5,6917.0,Mitochondrial import receptor subunit ATOM46,>4C (GG2M)
Tb927.11.7790,5006.5,2138.5,1465.0,1847.0,1804.5,Mitochondrial ribosomal protein S16,<2C (LG1)
Tb927.11.7800,612.5,6073.0,7253.5,7016.0,5548.5,hypothetical protein  conserved,S
Tb927.11.7810,612.5,2498.0,1966.5,1713.0,2773.0,hypothetical protein,>4C (GG2M)
Tb927.11.7820,11337.0,11205.5,11087.5,11078.5,11134.5,endonuclease/exonuclease/phosphatase  putative,<2C (LG1)
Tb927.11.7830,11065.0,9593.5,9464.0,10186.5,9612.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7840,612.5,2106.0,2341.0,3837.0,6131.0,ribonucleoside-diphosphate reductase large chain,>4C (GG2M)
Tb927.11.7850,9919.0,8039.5,6702.5,6909.0,8973.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.7860,11308.0,10760.5,11020.0,10835.0,11030.0,DNA replication licensing factor MCM2,<2C (LG1)
Tb927.11.7870,6324.5,8201.0,7614.0,8391.0,6607.0,hypothetical protein  conserved,G2M
Tb927.11.7880,1460.0,3284.0,4462.5,4928.5,4915.5,hypothetical protein  conserved,G2M
Tb927.11.7890,5418.5,7585.5,8381.5,8802.5,8155.5,zinc finger CCCH domain containing protein 44,G2M
Tb927.11.7900,9939.0,7470.5,6860.0,7891.0,6749.5,mitochondrial RNA binding protein 16,<2C (LG1)
Tb927.11.7910,3868.5,2581.5,2729.5,2707.0,3760.5,hypothetical protein,<2C (LG1)
Tb927.11.7920,6586.0,7568.5,8392.0,7921.0,5342.0,SUMO-interacting motif-containing protein,S
Tb927.11.7930,612.5,855.5,547.0,890.0,874.5,RNA polymerase B subunit RPB8  putative,G2M
Tb927.11.7940,1914.0,919.5,925.0,1526.5,2164.5,calmodulin  putative,>4C (GG2M)
Tb927.11.7950,4995.5,5985.5,5350.5,5600.0,6757.0,kinetoplastid-specific dual specificity phosphatase  putative,>4C (GG2M)
Tb927.11.7960,8988.0,9841.5,9560.0,8482.5,6356.5,kinetoplast poly(A) polymerase 1,G1
Tb927.11.7970,5703.0,6500.0,7259.5,7553.5,4967.0,hypothetical protein  conserved,G2M
Tb927.11.7980,4674.5,1293.5,1149.5,1228.0,1944.0,hypothetical protein,<2C (LG1)
Tb927.11.7990,1783.5,9300.0,8803.0,8402.5,9126.5,hypothetical protein,G1
Tb927.11.8000,9697.0,6176.0,7342.5,6612.5,7130.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8010,4826.0,6626.0,6936.0,7275.5,6206.0,DNA repair protein  putative,G2M
Tb927.11.8020,7915.5,3932.0,4316.5,5079.0,3981.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8030,10448.0,8466.5,8381.5,8418.0,6183.0,hypothetical protein  conserved,<2C (LG1)
Tb11.NT.99,612.5,2306.5,2196.0,2566.5,2110.0,Noncoding RNA  putative,G2M
Tb927.11.8040,1460.0,1332.5,1192.0,1779.5,1636.0,LSU ribosomal protein  mitochondrial  putative,G2M
Tb927.11.8050,4354.0,8875.5,8268.5,6784.5,6173.5,Sas10/Utp3/C1D family/Sas10 C-terminal domain containing protein  putative,G1
Tb927.11.8060,7487.0,6466.5,5945.5,5592.0,5567.0,SNARE associated Golgi protein  putative,<2C (LG1)
Tb927.11.8070,9675.0,8068.5,7934.5,7227.0,5841.5,Domain of unknown function (DUF4539)  putative,<2C (LG1)
Tb927.11.8080,11050.0,6295.0,5429.5,5273.5,4244.5,btb/poz domain containing protein  putative,<2C (LG1)
Tb927.11.8090,8204.5,11184.0,11162.0,11301.0,11335.0,protein phosphatase 1  putative,>4C (GG2M)
Tb927.11.8100,6492.0,6124.0,5059.5,5295.5,6631.0,Ankyrin repeats (3 copies)  putative,>4C (GG2M)
Tb927.11.8110,3564.0,6235.0,5537.0,4454.5,5457.5,hypothetical protein  conserved,G1
Tb927.11.8120,5298.5,7886.5,7823.5,7161.0,5713.5,protein transport protein SEC13  putative,G1
Tb927.11.8130,9302.5,6650.5,4956.5,4973.5,7274.5,ATP synthase subunit H  putative,<2C (LG1)
Tb927.11.8140,8619.0,6211.0,5613.5,5673.5,5420.5,ER lumen retaining receptor protein  putative,<2C (LG1)
Tb927.11.8150,11347.0,10341.0,10221.5,10492.0,10405.0,ULK family pseudokinase  putative,<2C (LG1)
Tb927.11.8160,2886.0,5280.5,4643.0,4711.5,11410.0,dynein heavy chain  putative,>4C (GG2M)
Tb927.11.8165,3794.5,5647.0,7568.0,8277.5,7930.5,hypothetical protein,G2M
Tb927.11.8170,6353.5,6946.0,6664.0,6240.5,5003.0,Mitogen-activated protein kinase 8  putative,G1
Tb927.11.8180,8446.0,9296.5,8839.0,8554.0,6984.0,hypothetical protein  conserved,G1
Tb927.11.8185,5725.0,3078.5,2919.0,2764.5,3716.5,Zinc finger  C3HC4 type (RING finger) containing protein  putative,<2C (LG1)
Tb927.11.8190,6915.5,7697.5,7861.0,8086.0,7597.5,DNA repair protein RAD51,G2M
Tb927.11.8200,7417.0,471.5,40.0,248.0,86.0,ribosomal protein S26  putative,<2C (LG1)
Tb927.11.8210,10113.0,11041.0,10665.5,10863.0,10227.0,RAD50 DNA repair-like protein,G1
Tb927.11.8220,2930.5,3835.5,3021.0,4782.0,11281.0,aurora B kinase,>4C (GG2M)
Tb927.11.8230,2840.5,3863.5,2764.5,4852.5,7169.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.8240,6842.0,10138.0,9705.5,9233.0,9364.5,TPR repeat  putative,G1
Tb927.11.8250,4260.5,3792.0,4493.5,3605.5,672.0,hypothetical protein  conserved,S
Tb927.11.8260,4806.0,8481.5,7969.5,8356.0,7060.5,carbonic anhydrase-like protein,G1
Tb927.11.8270,3370.5,9678.0,9685.0,9690.5,9711.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.8280,6990.0,8189.5,8726.0,8752.5,7662.5,hypothetical protein  conserved,G2M
Tb927.11.8290,7819.0,9694.0,9446.5,9503.0,8475.0,DIS3-like exonuclease  putative,G1
Tb927.11.8300,10452.0,9577.5,9918.0,9963.0,8697.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8310,7029.0,6870.0,7676.5,7398.5,7038.0,class I transcription factor A  subunit 4,S
Tb927.11.8320,9041.0,8712.0,7490.0,8554.0,7484.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8330,612.5,6813.0,5564.0,5569.0,7342.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.8340,6568.0,2283.0,1977.0,1779.5,1878.0,hypothetical protein,<2C (LG1)
Tb927.11.8350,8113.5,5499.5,5919.0,7910.0,10203.5,katanin p60 ATPase containing subunit A  putative,>4C (GG2M)
Tb927.11.8360,1460.0,2444.5,1977.0,1861.0,2336.0,hypothetical protein,G1
Tb927.11.8370,9268.0,9051.5,9627.5,10139.5,10731.5,Nucleus and spindle associated protein 1,>4C (GG2M)
Tb927.11.8380,4496.5,5216.5,5174.5,4928.5,3169.5,NADPH--cytochrome P450 reductase  putative,G1
Tb927.11.8390,4601.0,3361.0,1956.0,4742.5,2834.5,hypothetical protein  conserved,G2M
Tb927.11.8400,3543.0,4761.5,4046.5,3737.0,4065.0,Mitochondrial RNA processing endonuclease 1 (mRPN1),G1
Tb927.11.8410,3914.0,8424.0,6811.0,7320.0,7518.0,hypothetical protein  conserved,G1
Tb927.11.8420,612.5,877.0,907.5,1572.5,1828.0,DnaJ domain containing protein  putative,>4C (GG2M)
Tb927.11.8430,10881.5,9490.0,8935.0,9745.5,9090.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8440,3380.0,2687.5,1710.5,2102.5,1437.0,haloacid dehalogenase-like hydrolase  putative,<2C (LG1)
Tb927.11.8450,8957.5,8470.5,7572.0,7662.5,7262.5,Amastin surface glycoprotein  putative,<2C (LG1)
Tb927.11.8460,2258.5,5929.0,7676.5,6706.0,6793.5,amastin-like protein,S
Tb927.11.8470,7409.5,9023.0,8398.0,8052.5,6788.0,zinc finger protein family member  putative,G1
Tb927.11.8480,10706.5,9771.0,9227.0,9715.0,8877.0,DNA polymerase kappa  putative,<2C (LG1)
Tb927.11.8490,10475.0,8243.0,7484.0,8138.5,7401.0,DNA polymerase kappa  putative,<2C (LG1)
Tb927.11.8500,9794.0,8970.5,9101.5,8993.5,8493.0,DNA polymerase kappa  putative,<2C (LG1)
Tb927.11.8510,8494.0,9350.5,8852.0,9290.5,9046.0,DNA polymerase kappa  putative,G1
Tb927.11.8520,8909.0,9231.5,9306.5,8970.0,8071.5,DNA polymerase kappa  putative,S
Tb927.11.8530,8099.0,6658.5,6642.0,6147.0,7816.0,DNA polymerase kappa  putative,<2C (LG1)
Tb927.11.8580,10021.0,7277.5,6695.5,7834.0,6799.5,DNA polymerase kappa  putative,<2C (LG1)
Tb927.11.8680,6767.0,5675.0,5551.5,5728.5,4586.5,DNA polymerase kappa  putative,<2C (LG1)
Tb927.11.8700,10025.0,8547.0,7840.0,7577.0,8578.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8710,8890.0,8417.0,8857.5,8541.0,7597.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8720,3692.0,5435.5,6192.0,5899.5,4874.0,Leishmanolysin-like peptidase  putative,S
Tb927.11.8730,8650.5,5552.5,6417.0,5190.5,7008.5,Cell division control protein 48  putative,<2C (LG1)
Tb927.11.8740,4397.0,4603.5,4653.0,3194.5,6104.0,Protein of unknown function (DUF423)  putative,>4C (GG2M)
Tb927.11.8750,1460.0,2671.0,2666.0,2671.0,3214.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.8760,9262.5,7651.5,7304.5,6996.5,7602.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8770,2406.5,4268.0,4832.0,4084.0,3006.0,ATP-dependent RNA helicase FAL1  putative,S
Tb927.11.8775,612.5,1293.5,1091.0,1466.0,1266.0,hypothetical protein,G2M
Tb927.11.8780,1460.0,4960.0,5625.0,5891.5,5516.0,hypothetical protein  conserved,G2M
Tb927.11.8790,7715.0,8384.5,7151.0,8520.5,8206.5,target SNARE  putative,G2M
Tb927.11.8800,9256.0,7972.0,8591.5,8105.0,6557.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8810,10603.0,9986.0,10104.5,9086.5,9542.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.8820,5550.0,8412.5,8281.5,8637.5,7876.5,glutathionylspermidine synthetase  putative,G2M
Tb927.11.8830,9519.5,8496.0,9110.0,8303.0,7256.0,Enriched in surface-labeled proteome protein 2,<2C (LG1)
Tb927.11.8840,4751.0,7297.5,7515.5,7448.0,8241.0,hypothetical protein,>4C (GG2M)
Tb927.11.20730,7444.0,3855.5,5771.0,6129.0,5916.5,glycerophosphoryl diester phosphodiesterase  putative,<2C (LG1)
Tb927.11.8850,612.5,130.0,161.0,82.5,213.0,Uncharacterised protein family (UPF0220)  putative,<2C (LG1)
Tb927.11.8860,1460.0,6139.5,4790.5,5617.5,7788.0,CEP76 C2 domain containing protein  putative,>4C (GG2M)
Tb927.11.8870,7104.0,7952.0,8226.0,7850.0,6112.5,DEAD-box ATP-dependent RNA helicase  mitochondrial,S
Tb927.11.8880,7677.5,9784.5,10121.5,9939.0,10430.5,tRNA threonylcarbamoyl adenosine modification protein  Sua5/YciO/YrdC/YwlC family  putative,>4C (GG2M)
Tb927.11.8890,5528.0,3485.5,3737.5,3216.0,2964.0,DNA-dependent RNA polymerases  putative,<2C (LG1)
Tb927.11.8900,1460.0,7741.5,8049.5,8303.0,7256.0,DPCD protein family  putative,G2M
Tb927.11.8910,4057.5,7422.5,7634.5,8287.0,6826.5,NADH-ubiquinone oxidoreductase B16.6 subunit,G2M
Tb927.11.8920,8582.5,8100.5,7421.5,8043.5,4760.0,Centrosomal protein of 120 kDa  putative,<2C (LG1)
Tb927.11.8930,1460.0,5115.0,6078.5,5576.5,2525.0,D123  putative,S
Tb927.11.8940,7956.0,8240.5,6953.0,7834.0,8765.5,protein lipid droplet kinase (LDK),>4C (GG2M)
Tb927.11.8950,5048.0,6073.0,5286.0,4818.5,6623.0,leucine rich repeat,>4C (GG2M)
Tb927.11.8960,8201.5,11047.0,10905.5,11061.0,10864.0,hypothetical protein  conserved,G2M
Tb927.11.8970,6783.5,4560.0,2612.0,4711.5,3794.0,ribose 5-phosphate isomerase  putative,<2C (LG1)
Tb927.11.8980,10754.0,7444.0,7986.5,7789.5,5593.5,Elongation factor G 2  mitochondrial  putative,<2C (LG1)
Tb927.11.8990,2729.0,5771.5,5445.5,5437.0,8570.5,cation transporter  putative,>4C (GG2M)
Tb927.11.9000,11371.0,11400.0,10963.0,10680.0,10767.0,cation transporter  putative,G1
Tb927.11.9010,10544.0,10728.0,10059.5,9807.0,10033.0,cation transporter  putative,G1
Tb927.11.9020,9287.0,9505.5,8299.5,8191.0,7981.0,cation transporter  putative,G1
Tb927.11.9030,6477.0,5888.5,5246.5,5004.5,5735.0,cation transporter  putative,<2C (LG1)
Tb927.11.9040,7780.5,1437.5,2653.0,2211.5,2389.0,conserved protein,<2C (LG1)
Tb927.11.9050,5897.5,7561.5,7545.0,7040.5,9167.0,p21-C-terminal region-binding protein  putative,>4C (GG2M)
Tb927.11.9060,5336.5,8196.5,9230.5,8699.5,7369.5,DnaJ domain containing protein  putative,S
Tb927.11.9070,8427.5,7414.5,6401.0,6348.0,6088.5,palmitoyl acyltransferase 4  putative,<2C (LG1)
Tb927.11.9080,10606.5,10445.0,10727.0,9485.0,7909.0,Nucleolar protein 136,S
Tb927.11.9090,8549.0,9342.5,9426.0,9544.5,10624.5,Putative methyltransferase  putative,>4C (GG2M)
Tb927.11.9100,1783.5,1078.5,1278.5,1003.0,433.0,Domain of unknown function (DUF4586)  putative,<2C (LG1)
Tb927.11.9110,612.5,6272.5,6226.5,6171.5,2550.0,C-terminal motor kinesin  putative,G1
Tb927.11.9120,9998.5,10067.5,10144.0,9854.0,9860.5,SNF2 family N-terminal domain/Ring finger domain containing protein  putative,S
Tb927.11.9130,4205.0,3693.0,5867.0,6035.0,6444.5,Replication factor A protein 1,>4C (GG2M)
Tb927.11.9140,6990.0,5625.5,6206.0,5285.0,4725.0,Guide RNA binding complex protein 7,<2C (LG1)
Tb927.11.9150,10619.5,9952.0,10337.0,10183.5,10634.0,Mitochondrial processome subunit 1,>4C (GG2M)
Tb927.11.9160,1460.0,1322.5,2075.5,2746.5,1472.0,ATPase-like protein  putative,G2M
Tb927.11.9170,9543.5,9673.0,10372.0,9653.5,9298.5,DNA topoisomerase III  putative,S
Tb927.11.9180,4403.5,7162.0,6495.5,6690.0,8709.0,ADP-ribosylation factor GTPase activating protein  putative,>4C (GG2M)
Tb927.11.9190,8582.5,9148.5,10265.0,9762.5,10109.5,Serine/threonine-protein kinase VPS15,S
Tb927.11.9200,8720.0,8823.0,9276.0,8834.0,7029.5,methyltransferase domain containing protein  putative,S
Tb927.11.9210,9954.0,10620.0,10444.5,10938.5,9156.5,NOL1/NOP2/sun family  putative,G2M
Tb927.11.9220,1460.0,1362.5,3578.0,2404.0,2794.5,proteasome regulatory non-ATP-ase subunit 2,S
Tb927.11.9230,8871.5,8528.5,8658.5,6105.5,6897.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.9240,6047.5,10795.5,11093.5,10965.0,11671.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.9250,3191.0,6286.0,7274.0,6357.5,5248.0,hypothetical protein  conserved,S
Tb927.11.9260,9913.0,10149.5,9983.5,10208.0,10416.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.9270,612.5,6698.0,6084.5,6809.0,7422.5,differentiation inhibitory kinase,>4C (GG2M)
Tb927.11.9280,1914.0,7325.0,8152.5,7996.5,6356.5,hypothetical protein  conserved,S
Tb927.11.9290,10445.0,9787.5,9207.5,9464.5,10897.5,Flagellum attachment zone protein 20,>4C (GG2M)
Tb927.11.9295,4321.0,3909.5,3092.0,3978.5,3431.5,hypothetical protein,<2C (LG1)
Tb927.11.9300,4090.5,5979.5,5372.0,5932.0,7192.0,Domain of unknown function (DUF3342)  putative,>4C (GG2M)
Tb927.11.9310,10298.0,10943.0,10563.0,10418.0,9796.0,tRNA pseudouridine synthase  putative,G1
Tb927.11.9320,4449.5,7190.0,6708.5,6105.5,3929.5,hypothetical protein  conserved,G1
Tb927.11.9330,8871.5,9425.5,10281.0,9675.5,10916.0,helicase-like protein,>4C (GG2M)
Tb927.11.9340,9760.0,9166.5,9506.5,9337.0,8404.5,Galactose oxidase  central domain containing protein  putative,<2C (LG1)
Tb927.11.9350,612.5,1797.0,2673.0,2199.0,1422.0,phosphonopyruvate decarboxylase-like protein  putative,S
Tb927.11.9360,9882.5,6977.5,6900.0,7188.5,6505.0,prenyltransferase  putative,<2C (LG1)
Tb927.11.9370,5393.5,8491.0,7595.0,7099.5,4794.5,hypothetical protein  conserved,G1
Tb927.11.9380,5078.5,5407.0,6078.5,5873.0,7084.5,hypothetical protein,>4C (GG2M)
Tb927.11.9390,612.5,6001.5,5765.5,5850.0,4928.5,Octanoyltransferase  putative,G1
Tb927.11.9400,1460.0,9242.0,9698.5,8000.5,9681.0,hypothetical protein  conserved,S
Tb927.11.9405,2535.5,1437.5,1237.5,1056.5,1062.5,hypothetical protein,<2C (LG1)
Tb927.11.9410,4327.5,518.0,391.5,397.5,287.0,hypothetical protein,<2C (LG1)
Tb927.11.9420,612.5,4493.5,4139.5,3418.5,4128.5,ATP synthase  putative,G1
Tb927.11.9425,5709.5,3324.5,2858.0,2440.0,3576.5,hypothetical protein,<2C (LG1)
Tb927.11.9430,7741.0,5229.0,5962.0,6067.5,3812.0,TFIIH basal transcription factor subunit,<2C (LG1)
Tb927.11.9440,10087.5,8918.5,8190.0,7776.5,7762.5,Component of motile flagella 63,<2C (LG1)
Tb927.11.9450,5521.0,2000.5,1989.5,2389.0,1266.0,cyclophilin type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.11.9460,9134.0,6039.0,5315.0,5695.0,4571.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.9470,5673.0,7338.0,6838.0,5638.0,7488.5,ADP-ribosylation factor GTPase activating protein  putative,>4C (GG2M)
Tb927.11.9480,1783.5,1492.5,1886.0,2009.0,397.5,tubulin binding cofactor c  putative,G2M
Tb927.11.9490,9082.5,7069.5,7421.5,5168.5,1804.5,CobW/HypB/UreG  nucleotide-binding domain containing protein  putative,<2C (LG1)
Tb927.11.9500,1783.5,3324.5,3531.0,2389.0,4081.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.9510,6790.0,6216.5,4868.0,5969.0,3888.0,nucleic acid binding protein  putative,<2C (LG1)
Tb927.11.9520,3701.5,8905.0,9063.0,8560.0,6793.5,DNA topoisomerase III  putative,S
Tb927.11.9530,3502.5,576.5,547.0,647.5,6356.5,14-3-3 protein 1,>4C (GG2M)
Tb927.11.9540,7631.0,7634.0,8052.0,8916.5,10646.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.9550,6021.5,5746.5,4904.5,5992.0,6199.5,replication factor C  subunit 4  putative,>4C (GG2M)
Tb927.11.9560,9870.5,6690.5,5656.5,5454.0,2941.0,oxidoreductase  putative,<2C (LG1)
Tb927.11.9570,7944.5,9906.5,9642.0,8011.5,8770.0,hypothetical protein  conserved,G1
Tb927.11.9580,4253.5,8689.0,8787.0,8273.5,7638.0,hypothetical protein  conserved,S
Tb927.11.9590,6692.5,10967.0,11164.0,11208.5,10774.5,S-adenosylhomocysteine hydrolase  putative,G2M
Tb927.11.9600,7834.5,3256.0,5197.0,5240.0,4831.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.9610,2813.0,5088.5,3678.5,4057.0,3915.0,eukaryotic translation initiation factor 3 subunit i,G1
Tb927.11.9620,5789.0,4823.5,5856.5,6165.0,6048.5,hypothetical protein  conserved,G2M
Tb927.11.9630,612.5,3961.0,3246.5,3773.5,4597.5,Snf7  putative,>4C (GG2M)
Tb927.11.9640,10956.0,10383.0,10140.0,10072.0,11143.5,glycyl-tRNA synthetase  putative,>4C (GG2M)
Tb927.11.9650,11147.0,9276.0,7896.0,8589.5,6770.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.9660,6864.5,10470.5,10039.5,10440.0,10320.0,Zinc finger  C3HC4 type (RING finger)  putative,G1
Tb927.11.9665,612.5,130.0,578.5,974.5,433.0,hypothetical protein,G2M
Tb927.11.9670,2813.0,6154.5,6178.5,6417.5,3248.5,aminomethyltransferase  mitochondrial  putative,G2M
Tb927.11.9680,612.5,9644.0,9531.0,9068.5,8979.0,hypothetical protein  conserved,G1
Tb927.11.9690,11306.0,10168.0,10337.0,10367.0,10220.0,Spindle pole body protein 1,<2C (LG1)
Tb927.11.9700,4617.0,690.0,795.0,647.5,761.5,transcription factor BTF3  putative,<2C (LG1)
Tb927.11.9710,1460.0,919.5,253.5,221.5,721.5,60S ribosomal protein L10a  putative,<2C (LG1)
Tb927.11.9720,2137.5,158.5,271.5,292.5,853.0,40S ribosomal protein S27  putative,<2C (LG1)
Tb927.11.9730,612.5,307.0,615.0,273.5,287.0,60S ribosomal protein L34  putative,S
Tb927.11.9740,612.5,2086.0,3727.5,2134.5,607.0,tRNA intron endonuclease  catalytic C-terminal domain containing protein  putative,S
Tb927.11.9750,2901.0,10257.0,9332.5,9451.0,8633.0,Protein of unknown function (DUF498/DUF598)  putative,G1
Tb927.11.9760,1988.0,738.5,2011.5,720.5,607.0,hypothetical protein  conserved,S
Tb927.11.9770,7313.5,9512.0,8709.0,9468.5,7319.5,hypothetical protein  conserved,G1
Tb927.11.9780,9003.5,9871.5,9955.0,10402.5,8513.0,Nucleoporin NUP119,G2M
Tb927.11.9790,5058.0,6655.0,6469.0,7486.0,5761.0,calmodulin  putative,G2M
Tb927.11.9800,2094.5,3799.0,4510.0,5159.0,2619.0,hypothetical protein  conserved,G2M
Tb927.11.9810,1460.0,3579.0,3246.5,3418.5,4089.5,NUDIX hydrolase 3  putative,>4C (GG2M)
Tb927.11.9820,7751.5,8396.5,8574.0,8668.0,8877.0,TZ ciliopathy protein (tectonic)  putative,>4C (GG2M)
Tb927.11.9830,4104.0,2714.5,3431.0,3545.0,2203.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.9840,10369.0,10623.5,10387.0,11027.5,10303.0,hypothetical protein  conserved,G2M
Tb927.11.9850,612.5,40.5,99.0,136.5,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.9860,1460.0,130.0,161.0,111.0,287.0,EF-hand domain pair  putative,<2C (LG1)
Tb927.11.9870,1783.5,9932.5,10066.0,9805.0,10294.0,Telomere-associated protein 1,>4C (GG2M)
Tb927.11.9880,6504.0,7760.5,8130.5,7605.5,5526.5,Protein of unknown function (DUF2009)  putative,S
Tb927.11.9890,10576.0,10894.0,10415.5,10228.5,10396.0,signal recognition particle receptor alpha subunit  putative,G1
Tb927.11.9900,11164.0,9423.5,8008.5,8293.0,9633.0,phytoene synthase  putative,<2C (LG1)
Tb927.11.9910,612.5,3353.0,3531.0,3477.5,4975.5,Domain of unknown function (DUF3846)/TPR repeat  putative,>4C (GG2M)
Tb927.11.9920,7074.5,5368.5,6192.0,6802.5,6547.5,polyubiquitin  putative,<2C (LG1)
Tb927.11.9930,4496.5,2306.5,2196.0,3075.0,1179.0,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,<2C (LG1)
Tb927.11.9940,7363.0,6676.0,4643.0,3441.0,7956.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.9950,5298.5,8565.0,8309.5,8086.0,10245.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.9960,10870.0,9111.0,9072.5,9173.0,8922.5,Protein of unknown function (DUF2870)  putative,<2C (LG1)
Tb927.11.9970,1460.0,3835.5,3952.0,3013.0,2898.5,Small acidic protein family  putative,S
Tb927.11.9980,8738.0,10161.0,10167.0,9779.5,9386.5,2-oxoglutarate dehydrogenase E1 component  putative,S
Tb927.11.9990,10878.5,7756.0,7235.5,6867.5,7120.0,glycosyl transferase-like protein,<2C (LG1)
Tb927.11.10000,2258.5,1332.5,2036.0,1597.5,2089.0,Charged multivesicular body protein 3  putative,<2C (LG1)
Tb927.11.10010,8356.5,10601.0,10281.0,10265.0,11036.0,vacuolar sorting-associated protein-like  putative,>4C (GG2M)
Tb927.11.10020,612.5,7799.5,6302.0,6381.0,8496.0,short-chain dehydrogenase  putative,>4C (GG2M)
Tb927.11.10025,612.5,176.5,161.0,111.0,531.0,60S ribosomal protein L29  putative,<2C (LG1)
Tb927.11.10030,1460.0,208.5,210.0,182.5,797.5,60S ribosomal protein L29  putative,<2C (LG1)
Tb927.11.10040,4569.0,2078.0,1347.5,1950.5,978.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10050,2357.5,1953.0,2510.5,1993.5,397.5,LSU ribosomal protein  mitochondrial  putative,S
Tb927.11.10060,612.5,1975.0,2092.5,2746.5,3125.5,Biotin--acetyl-CoA-carboxylase ligase  putative,>4C (GG2M)
Tb927.11.10070,612.5,3324.5,2465.5,3635.0,2178.0,Bromodomain  putative,G2M
Tb927.11.10075,612.5,3293.0,1742.5,2150.0,2884.5,hypothetical protein,G1
Tb927.11.10080,4834.5,3245.0,2598.5,1861.0,3566.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.10090,1460.0,6339.0,6718.0,6604.0,5463.0,hypothetical protein  conserved,S
Tb927.11.10100,8020.0,9688.5,8909.5,9043.0,6216.5,hypothetical protein  conserved,G1
Tb927.11.10110,612.5,4806.0,4643.0,4486.5,8546.5,actin-like protein  putative,>4C (GG2M)
Tb927.11.10120,2598.0,3842.0,3364.5,2603.0,7385.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10130,7426.0,6884.0,5386.5,7511.5,7614.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10140,4034.5,2214.5,1510.5,1847.0,4199.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10150,10569.0,9567.5,9117.5,10149.0,9637.5,Enoyl-CoA hydratase/isomerase family  putative,<2C (LG1)
Tb927.11.10160,1460.0,130.0,391.5,352.0,1179.0,60S ribosomal protein L22  putative,<2C (LG1)
Tb927.11.10170,612.5,2630.0,1549.5,1187.5,2884.5,Mitochondrial ribosomal protein L20,>4C (GG2M)
Tb927.11.10180,9809.5,8317.0,7601.0,6927.5,7693.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10190,9941.0,11029.5,11122.0,11173.5,10574.5,telomerase reverse transcriptase,G2M
Tb927.11.10200,3095.0,5862.0,6583.0,6192.0,9887.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10210,8334.0,9311.0,9698.5,9637.0,10759.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10220,3534.0,4145.5,2977.0,3168.0,1703.0,hypothetical protein  conserved,G1
Tb927.11.10230,1988.0,3273.5,2750.5,2967.0,559.5,RNA polymerase-associated protein CDC73  putative,G1
Tb927.11.10240,6095.5,6429.5,6072.0,6706.0,5542.5,ATP-dependent protease subunit HslV,G2M
Tb927.11.10250,11536.0,8881.5,8152.5,8414.0,5161.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10260,6029.0,4761.5,5479.0,4279.5,4005.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10270,8979.5,4711.5,4019.5,2470.5,4928.5,Golgi SNAP receptor complex member 1  putative,<2C (LG1)
Tb927.11.10280,9803.0,11160.0,11133.0,11162.0,11038.0,metallo-peptidase  Clan MC  Family M14  putative,G2M
Tb927.11.10300,5298.5,2942.5,1771.5,2335.0,2786.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10320,8565.0,8396.5,8847.0,8822.5,7342.0,TatD related DNase  putative,S
Tb927.11.10330,11556.0,11691.0,11695.0,11694.0,11662.0,regulator of chromosome condensation 1-like protein,S
Tb927.11.10340,11526.5,9986.0,8235.0,9079.0,8143.0,Serine/threonine-protein phosphatase PGAM5  mitochondrial  putative,<2C (LG1)
Tb927.11.10350,3328.5,4950.0,3658.5,4790.0,9792.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10360,6803.5,7802.5,7578.5,7839.5,7631.5,hypothetical protein  conserved,G2M
Tb927.11.10370,8952.5,10122.0,9850.5,9584.0,9225.0,glycosyl hydrolase-like protein,G1
Tb927.11.10380,8199.5,10257.0,10182.0,10155.5,9945.0,hypothetical protein  conserved,G1
Tb927.11.10390,3120.5,7167.0,6055.5,5908.5,3716.5,hypothetical protein  conserved,G1
Tb927.11.10400,2329.5,1940.0,1989.5,1031.0,933.5,SSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.10410,2574.5,2326.0,1818.0,1374.0,1896.5,Cornichon protein  putative,<2C (LG1)
Tb927.11.10420,3841.0,2820.5,3108.5,3393.5,3465.5,DNA-directed RNA polymerase I subunit  putative,<2C (LG1)
Tb927.11.10430,1460.0,4967.0,4462.5,5454.0,10418.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10440,2970.5,1619.0,1757.0,2199.0,3681.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10450,3095.0,4806.0,6695.5,6192.0,4498.5,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase  putative,S
Tb927.11.10460,1914.0,4065.5,5991.0,5428.5,6066.5,dna replication complex gins protein psf2,>4C (GG2M)
Tb927.11.10470,8053.0,9932.5,10168.0,9955.5,9532.0,hypothetical protein  conserved,S
Tb927.11.10480,6025.5,10262.5,10298.5,10297.0,9623.0,PQQ-like domain/WD domain  G-beta repeat/Utp21 specific WD40 associated putative domain containing protein  putative,S
Tb927.11.10490,4048.0,6313.0,5829.0,6549.5,3929.5,hypothetical protein  conserved,G2M
Tb927.11.10500,9745.0,5929.0,6278.0,5765.5,5054.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10510,612.5,6958.5,5396.5,5129.0,1253.0,ubiquinone biosynthesis methyltransferase  putative,G1
Tb927.11.10520,10211.5,7338.0,10102.5,9759.0,10329.0,kinetoplastid kinetochore protein 2,>4C (GG2M)
Tb927.11.10530,612.5,7721.0,6322.0,6904.0,5379.5,hypothetical protein  conserved,G1
Tb927.11.10540,2047.0,5935.5,5604.5,5648.5,7262.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10550,9830.0,10240.0,10424.5,10516.5,10323.0,hypothetical protein  conserved,G2M
Tb927.11.10560,11583.0,11078.0,11173.5,11187.0,11424.0,eukaryotic translation initiation factor 4 gamma 4,<2C (LG1)
Tb927.11.10570,7101.5,5454.0,5452.0,5273.5,4626.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.10580,11543.0,10125.5,10305.0,10456.5,9491.5,COG (conserved oligomeric Golgi) complex component  COG2/Domain of unknown function (DUF3510)  putative,<2C (LG1)
Tb927.11.10590,7157.5,3150.0,3051.5,1980.0,5024.5,Glutathione S-transferase  C-terminal domain containing protein  putative,<2C (LG1)
Tb927.11.10600,9116.5,7818.0,8318.5,6112.5,7207.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10610,9580.0,10494.0,10376.5,10523.5,10580.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10620,612.5,2658.5,3379.0,3332.5,3169.5,hypothetical protein  conserved,S
Tb927.11.10630,11122.0,11360.0,11494.0,11315.0,10237.0,hypothetical protein  conserved,S
Tb927.11.10640,5844.5,3068.0,1886.0,2520.5,4187.0,DNA-(apurinic or apyrimidinic site) lyase  putative,<2C (LG1)
Tb927.11.10650,10332.0,10648.5,10296.0,10219.5,8888.5,Adaptor protein complex AP-3 subunit beta-3,G1
Tb927.11.10660,11690.0,11627.5,11640.0,11638.0,11666.0,Basal body protein,<2C (LG1)
Tb927.11.10670,11049.0,10866.0,10814.5,10947.5,9373.0,glycosyl hydrolase  putative,<2C (LG1)
Tb927.11.10690,6372.0,5407.0,5848.5,6573.5,5199.0,hypothetical protein  conserved,G2M
Tb927.11.10700,4674.5,5188.5,6442.0,7099.5,7712.5,glucosidase II beta subunit-like protein  putative,>4C (GG2M)
Tb927.11.10710,11424.5,10098.0,9478.0,9771.5,7618.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10720,11198.0,11320.0,11195.0,11433.5,11296.0,hypothetical protein  conserved,G2M
Tb927.11.10730,8192.5,8805.5,9150.0,8868.0,10255.0,SWI/SNF-related helicase  putative,>4C (GG2M)
Tb927.11.10740,3166.5,2367.5,1909.5,2120.5,4883.5,vacuolar sorting-associated protein-like  putative,>4C (GG2M)
Tb927.11.10750,8177.0,9574.5,9630.5,9759.0,10389.5,pre-mRNA-splicing factor CWC22  putative,>4C (GG2M)
Tb927.11.10760,9289.0,9705.5,9798.5,10253.0,11151.0,kinesin-D,>4C (GG2M)
Tb11.NT.122,4260.5,3078.5,2378.0,1993.5,1772.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.10770,3487.0,6520.5,7896.0,7486.0,8441.0,VHS domain containing protein  putative,>4C (GG2M)
Tb927.11.10780,612.5,192.5,189.5,248.0,213.0,Voltage-dependent anion channel  putative,<2C (LG1)
Tb927.11.10790,612.5,1115.5,1522.0,1451.5,2016.0,40S ribosomal protein SA  putative,>4C (GG2M)
Tb927.11.10800,5068.5,5008.5,4857.0,6045.0,3861.0,Domain of unknown function (DUF4496)  putative,G2M
Tb927.11.10810,9714.0,9440.5,8676.5,9323.0,8682.5,pumillio/PUF RNA binding protein 11,<2C (LG1)
Tb927.11.10820,5538.0,6977.5,7265.0,7099.5,7988.0,Casein kinase II subunit beta  putative,>4C (GG2M)
Tb927.11.10830,6116.5,6306.5,6322.0,6388.5,7313.0,hypothetical protein,>4C (GG2M)
Tb927.11.10840,7473.0,4260.5,3452.0,4464.5,4903.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10850,612.5,5804.5,5898.0,5662.0,6499.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10860,5565.5,9806.0,9221.0,8853.5,8979.0,20S-pre-rRNA D-site endonuclease NOB1,G1
Tb927.11.10870,3241.5,5057.5,5229.5,5273.5,4915.5,32 kDa ER-associated protein,G2M
Tb927.11.10880,10742.0,10470.5,10392.5,11066.0,10442.5,hypothetical protein  conserved,G2M
Tb927.11.10890,7191.0,7167.0,5637.0,5024.0,4597.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.10900,2637.5,1629.0,1416.0,2373.0,7649.5,Component of motile flagella 9,>4C (GG2M)
Tb927.11.10910,1914.0,1293.5,1149.5,1542.0,2231.5,40S ribosomal protein SA  putative,>4C (GG2M)
Tb927.11.10920,5915.0,3658.5,4832.0,4409.0,5996.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10930,8440.0,7121.0,8615.5,8185.5,10086.0,tubulin delta chain,>4C (GG2M)
Tb927.11.10940,2574.5,6352.5,7033.5,7794.5,9833.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.10950,10803.0,7474.5,6527.5,7236.0,7008.5,DnaJ domain containing protein  putative,<2C (LG1)
Tb11.01.2730,11586.0,11690.0,11683.5,11678.0,11645.0,hypothetical protein  conserved,G1
Tb927.11.10960,10300.0,8073.0,9251.0,8695.0,6757.0,2OG-Fe(II) oxygenase superfamily  putative,<2C (LG1)
Tb927.11.10970,8044.5,5625.5,4029.0,4146.0,4451.0,RWD domain/Uncharacterized protein family UPF0029  putative,<2C (LG1)
Tb927.11.10980,2481.0,9036.5,9142.0,9946.5,9305.0,Got1/Sft2-like family  putative,G2M
Tb927.11.10990,1460.0,4111.5,4069.0,3228.0,4365.0,methylthioribose-1-phosphate isomerase  putative,>4C (GG2M)
Tb927.11.11000,10418.0,10602.0,10468.0,10349.5,10717.0,Calponin homology (CH) domain containing protein  putative,>4C (GG2M)
Tb927.11.11010,612.5,5625.5,6262.0,6357.5,9589.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.11020,9583.0,10714.0,10752.0,10752.5,9814.0,hypothetical protein  conserved,G2M
Tb927.11.11030,3419.0,5088.5,3578.0,4183.0,3295.5,exosome-associated protein 4,G1
Tb927.11.11040,2574.5,3179.0,2738.5,3102.5,3169.5,hypothetical protein  conserved,G1
Tb927.11.11050,4122.5,7425.0,8081.5,7404.5,4883.5,hypothetical protein  conserved,S
Tb927.11.11060,6893.5,8459.0,6953.0,7635.5,6131.0,hypothetical protein,G1
Tb927.11.11075,5094.0,4041.5,3379.0,2422.0,3896.5,hypothetical protein,<2C (LG1)
Tb927.11.11080,6286.5,5391.0,5930.5,5608.0,7670.0,Nucleoporin NUP149,>4C (GG2M)
Tb927.11.11090,3295.0,4268.0,5752.5,6482.0,10954.0,Nucleoporin NUP140,>4C (GG2M)
Tb927.11.11100,5042.0,7266.0,6735.0,6407.5,6206.0,glucosamine 6-phosphate N-acetyltransferase,G1
Tb927.11.11110,9461.5,10291.5,10659.0,10471.0,9612.5,Serine/threonine-protein kinase NEK20  putative,S
Tb927.11.11120,8386.5,3171.5,3335.0,3029.0,4244.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.11130,2913.0,787.5,1522.0,875.0,1355.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.11135,3295.0,2457.0,2638.5,2821.0,3704.0,hypothetical protein,>4C (GG2M)
Tb927.11.11140,9916.0,10353.5,9803.5,9666.0,9882.0,hypothetical protein,G1
Tb927.11.11150,6477.0,8985.5,8771.5,7967.5,8724.0,U5 snRNP-specific 40 kDa protein,G1
Tb927.11.11160,1783.5,8522.0,8692.5,8853.5,7974.5,Low-affinity phosphate transporter PHO91 (fragment),G2M
Tb927.11.11170,612.5,4684.0,5945.5,6719.5,4626.5,hypothetical protein  conserved,G2M
Tb927.11.11180,612.5,176.5,99.0,33.5,213.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.11200,5949.5,6339.0,7450.0,6837.5,2376.0,oligomeric golgi complex component 8  putative,S
Tb927.11.11210,8903.5,7830.5,7724.0,7696.0,7002.5,paraflagellar rod component  putative,<2C (LG1)
Tb927.11.11220,4122.5,5725.5,6754.0,8586.5,11686.0,dynein heavy chain  putative,>4C (GG2M)
Tb927.11.11230,612.5,40.5,161.0,111.0,86.0,60S ribosomal protein L14  putative,<2C (LG1)
Tb927.11.11240,4276.0,5077.5,6636.5,5249.5,7924.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.11250,5142.5,6295.0,6815.5,6331.5,6123.0,cytosolic malate dehydrogenase,S
Tb927.11.11260,8271.5,8985.5,8741.5,8445.5,10145.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.11270,7467.5,6763.0,5298.0,7434.0,6878.5,conserved protein,<2C (LG1)
Tb927.11.11280,7167.0,8046.5,8907.0,9039.0,9934.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.11290,1914.0,5469.0,4722.5,5883.5,5813.0,heat shock protein 70  putative,G2M
Tb927.11.11300,612.5,2051.0,1388.5,890.0,86.0,hypothetical protein  conserved,G1
Tb927.11.11310,2729.0,1797.0,2262.5,3307.0,1860.5,hypothetical protein  conserved,G2M
Tb927.11.11320,2221.0,3950.5,4767.5,4818.5,5332.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.11330,2930.5,4770.5,4069.0,4894.5,2679.0,heat shock protein 70,G2M
Tb927.11.11340,6918.0,6818.5,7685.0,7809.5,8471.0,gamma-tubulin complex component 3,>4C (GG2M)
Tb927.11.11350,11208.0,7602.0,6475.0,6979.0,6463.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.11360,2767.0,2592.5,3297.5,2184.5,2164.5,receptor for activated C kinase 1,S
Tb927.11.11370,2221.0,1466.5,1909.5,1313.5,2322.0,receptor for activated C kinase 1,>4C (GG2M)
Tb927.11.11380,4282.0,8287.5,7813.0,7642.5,8441.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.11.11385,4027.5,4357.5,4944.0,4522.0,4654.0,Ubiquitin-like autophagy protein Apg12  putative,S
Tb927.11.11390,7944.5,7970.5,7235.5,7517.0,5499.0,2OG-Fe(II) oxygenase superfamily  putative,G1
Tb927.11.11400,9711.5,10450.0,10042.5,10581.0,9402.5,hypothetical protein,G2M
Tb927.11.11410,11609.0,11204.0,11329.0,11408.0,11163.5,trans-sialidase  putative,<2C (LG1)
Tb927.11.11420,10979.0,10913.0,10713.5,11021.0,10174.5,hypothetical protein,G2M
Tb927.11.11425,1460.0,886.5,925.0,788.5,637.0,hypothetical protein,<2C (LG1)
Tb927.11.11430,10826.0,11079.0,11038.5,11247.0,10363.5,cullin 1  putative,G2M
Tb927.11.11435,2295.5,4703.0,5174.5,5159.0,11116.5,dynein light chain type 1  putative,>4C (GG2M)
Tb927.11.11440,1460.0,1817.5,3767.5,4754.5,4081.5,A/G-specific adenine glycosylase  putative,G2M
Tb927.11.11450,10621.0,9235.0,8650.5,8000.5,9409.5,Galactose oxidase  central domain containing protein  putative,<2C (LG1)
Tb927.11.11460,8661.5,8611.0,9215.5,9129.0,6588.5,Mitochondrial import receptor subunit ATOM69,S
Tb927.11.11470,9925.5,5205.5,4046.5,5365.0,6405.0,kinetoplast ribosomal PPR-repeat containing protein 14,<2C (LG1)
Tb927.11.11475,4594.0,3206.5,2902.0,2357.0,2964.0,ribosomal protein S14p/S29e,<2C (LG1)
Tb927.11.11480,10926.5,10416.5,10552.0,10188.5,10497.5,Trichohyalin  putative,<2C (LG1)
Tb927.11.11490,6009.5,10541.5,10583.0,10694.5,10560.5,2 3-bisphosphoglycerate-independent phosphoglycerate mutase-like protein  putative,G2M
Tb927.11.11500,6538.0,8540.5,8470.0,7987.5,9378.5,cyclin dependent kinase-binding protein  putative,>4C (GG2M)
Tb927.11.11510,8047.5,5088.5,4632.5,3228.0,4187.0,hd phosphohydrolase family protein,<2C (LG1)
Tb927.11.11520,4276.0,3872.5,3618.0,4522.0,778.5,glycosomal membrane protein,G2M
Tb927.11.11530,10903.5,11110.0,11204.5,11265.0,11190.5,histone acetyltransferase  putative,G2M
Tb927.11.11550,11021.0,11286.0,11169.5,11225.0,11114.0,DNA topoisomerase II alpha  putative,G1
Tb927.11.11560,11605.0,11432.0,11423.0,11470.0,11348.0,DNA topoisomerase II beta  putative,<2C (LG1)
Tb927.11.11570,11255.5,10818.5,10151.0,10363.0,10174.5,Translation initiation factor eIF-2B subunit epsilon  putative,<2C (LG1)
Tb927.11.11580,11634.0,11083.0,10927.5,11125.5,11267.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.11590,5604.0,6223.5,5365.5,5862.5,4028.0,Eukaryotic translation initiation factor 3 subunit E,G1
Tb927.11.11600,11366.0,11646.0,11669.0,11616.0,11648.0,hypothetical protein  conserved,S
Tb927.11.11610,6563.5,8601.0,8185.0,7891.0,8111.0,Cactus-binding C-terminus of cactin protein  putative,G1
Tb927.11.11620,7544.5,8039.5,7450.0,7525.5,7618.0,hypothetical protein  conserved,G1
Tb927.11.11630,7173.0,1690.5,1771.5,1466.0,1691.0,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.11640,11409.0,7171.0,9368.0,8259.5,8667.5,DNA replication licensing factor MCM6,<2C (LG1)
Tb927.11.11650,1783.5,9419.0,9780.0,9801.0,10253.0,Centrosomal protein of 164 kDa  putative,>4C (GG2M)
Tb927.11.11660,1460.0,5798.0,5691.0,6014.5,4783.5,conserved protein,G2M
Tb927.11.11670,6516.5,7544.0,7433.0,7776.5,7184.5,dolichyl-lipid chaperone  putative,G2M
Tb927.11.11680,6945.5,3979.0,4316.5,4084.0,2589.5,2-oxoglutarate dehydrogenase E2 component  putative,<2C (LG1)
Tb927.11.11690,3882.5,5407.0,6401.0,6482.0,6229.0,Vacuolar proton pump subunit B  putative,G2M
Tb927.11.11700,9274.0,9608.0,9126.0,8454.0,9998.5,nucleotidyl transferase  putative,>4C (GG2M)
Tb927.11.11710,8497.0,5822.5,5070.5,5260.5,5379.5,Putative serine esterase (DUF676)  putative,<2C (LG1)
Tb927.11.11720,9395.0,7266.0,7718.5,8374.0,6164.0,FG-GAP repeat protein  putative,<2C (LG1)
Tb927.11.11725,3063.5,208.5,189.5,159.0,778.5,ribosomal protein S14p/S29e,<2C (LG1)
Tb927.11.11730,9372.0,7962.0,8455.5,8520.5,9769.5,MRP protein  putative,>4C (GG2M)
Tb927.11.11740,8313.0,10091.5,10003.0,9823.5,8582.0,membrane-bound acid phosphatase  putative,G1
Tb927.11.11750,8267.0,10019.5,9900.5,9681.0,8807.5,membrane-bound acid phosphatase  putative,G1
Tb927.11.11760,1460.0,5656.0,3308.0,4579.0,4915.5,hypothetical protein  conserved,G1
Tb927.11.11770,8030.5,5904.0,5875.5,5476.5,4947.0,Eukaryotic translation initiation factor 4E-3,<2C (LG1)
Tb927.11.11780,9739.5,6940.5,8692.5,6397.5,5600.5,acyl-CoA dehydrogenase  putative,<2C (LG1)
Tb927.11.11790,9549.5,9240.0,8206.5,7687.0,8486.0,R3H domain containing protein  putative,<2C (LG1)
Tb927.11.11800,11153.0,9965.5,9807.0,9722.5,8496.0,DNA repair and recombination helicase protein PIF3,<2C (LG1)
Tb927.11.11810,3914.0,8895.0,9055.5,8728.0,7655.5,hypothetical protein  conserved,S
Tb927.11.11820,1460.0,192.5,233.5,33.5,213.0,40S ribosomal protein S17  putative,<2C (LG1)
Tb927.11.11830,612.5,2149.5,2196.0,1654.0,1325.5,40S ribosomal protein S17  putative,S
Tb927.11.11840,2504.5,2808.0,2551.0,2554.0,1582.0,hypothetical protein  conserved,G1
Tb927.11.11850,2221.0,8839.0,9279.0,8691.0,10391.0,splicing factor 3B subunit 1  putative,>4C (GG2M)
Tb927.11.11860,8553.5,6480.5,7657.0,7877.0,5509.0,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.11.11870,2436.0,7247.0,7498.5,7340.5,5609.5,ADP-ribosylglycohydrolase  putative,S
Tb927.11.11880,8582.5,9305.5,9803.5,9565.0,10454.0,conserved protein,>4C (GG2M)
Tb927.11.11900,6921.5,4849.5,5512.0,5638.0,9082.0,Coatomer subunit gamma,>4C (GG2M)
Tb927.11.11910,8890.0,4135.5,4928.0,3343.0,6059.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.11920,7581.5,9623.5,9895.0,8773.0,8645.5,molybdenum cofactor biosynthesis protein  putative,S
Tb927.11.11930,9977.0,7760.5,8736.5,7902.5,8057.5,SelR domain containing protein  putative,<2C (LG1)
Tb927.11.11940,10484.5,8765.0,7736.0,7327.0,5772.0,protein phosphatase 2A  putative,<2C (LG1)
Tb927.11.11950,612.5,6824.0,7334.0,6177.5,4664.5,cytochrome oxidase assembly protein  putative,S
Tb927.11.11960,11158.0,8982.0,8733.5,7987.5,9668.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.11965,2943.0,7087.5,6860.0,7474.0,6048.5,cytoskeleton-associated protein  putative,G2M
Tb927.11.11970,2295.5,6732.0,6123.0,6297.0,5516.0,hypothetical protein,G1
Tb927.11.11975,2637.5,8204.5,7850.5,7819.0,6412.5,cytoskeleton-associated protein  putative,G1
Tb927.11.11980,2795.5,5463.0,5526.0,5648.5,4480.5,cytoskeleton-associated protein 15,G2M
Tb927.11.11990,612.5,5251.5,7685.0,6465.0,7249.5,hypothetical protein,S
Tb927.11.12000,2901.0,4008.0,4680.0,4951.0,3065.0,hypothetical protein  conserved,G2M
Tb927.11.12010,4113.0,3313.0,3308.0,2881.0,3125.5,hypothetical protein,<2C (LG1)
Tb927.11.12020,9604.0,8035.5,7466.5,7448.0,4664.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12030,5891.0,7459.0,6609.5,6388.5,6960.0,hypothetical protein  conserved,G1
Tb927.11.12040,612.5,3646.5,3179.5,4818.5,3399.5,Cytochrome c oxidase component  putative,G2M
Tb927.11.12045,3448.5,1838.0,2036.0,2686.0,2819.0,hypothetical protein,<2C (LG1)
Tb927.11.12050,2481.0,2571.5,3308.0,2541.0,2914.5,hypothetical protein  conserved,S
Tb927.11.12060,10133.0,4653.0,5429.5,4156.0,5145.5,Peroxisomal biogenesis factor 11 (PEX11)  putative,<2C (LG1)
Tb927.11.12070,3534.0,6458.5,7601.0,7065.0,7753.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.12080,612.5,896.0,1361.0,1097.5,1141.0,N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase,S
Tb927.11.12090,2460.0,2701.5,3197.0,3216.0,2483.5,endonuclease III  putative,G2M
Tb927.11.12100,2767.0,2913.5,2251.5,2422.0,1304.5,RNA-binding protein  putative,G1
Tb927.11.12110,7797.5,9285.0,8536.5,8475.0,7385.0,RNA helicase  putative,G1
Tb927.11.12120,6233.5,2444.5,2919.0,3596.5,3494.0,RNA-binding protein  putative,<2C (LG1)
Tb927.11.12130,2658.5,3734.0,4398.0,4962.5,5044.5,hypothetical protein,>4C (GG2M)
Tb927.11.12140,612.5,1875.5,2182.5,2840.5,1141.0,hypothetical protein,G2M
Tb11.NT.146,612.5,413.0,471.5,419.0,213.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.12150,612.5,130.0,253.5,419.0,721.5,flagellar pocket cytoskeletal protein bilbo1,>4C (GG2M)
Tb927.11.12160,5658.5,5935.5,5164.0,4818.5,2692.0,hypothetical protein  conserved,G1
Tb927.11.12170,6955.5,4975.5,5325.5,5728.5,6607.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12180,9659.0,9081.5,8664.5,8379.0,8539.5,kinesin  putative,<2C (LG1)
Tb927.11.12190,9346.0,6971.5,6288.0,5824.5,3994.5,FHA domain containing protein  putative,<2C (LG1)
Tb927.11.12200,5428.0,5573.0,5787.0,4381.0,6066.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.12210,3863.0,5200.5,5256.0,5060.5,3365.0,Domain of unknown function (DUF4586)  putative,S
Tb927.11.12220,7405.5,8936.5,9080.5,8816.0,6994.0,catalytic subunit of the vacuolar transporter chaperone 4,S
Tb927.11.12230,8224.0,8578.5,9520.0,9718.5,7885.0,ATP-dependent protease ATPase subunit HslU2,G2M
Tb927.11.12240,10348.0,11096.0,11144.0,11162.0,10514.0,cysteine peptidase  Clan CA  family C19  putative,G2M
Tb927.11.12250,5477.5,11003.5,11203.0,10937.0,10959.5,DNA replication licensing factor MCM4,S
Tb927.11.12260,4905.0,8846.5,9311.5,8878.0,8169.0,hypothetical protein  conserved,S
Tb927.11.12270,612.5,6538.5,6166.0,6779.5,5161.0,drug resistence protein  putative,G2M
Tb927.11.12280,6459.5,4967.0,5325.5,6802.5,5788.5,hypothetical protein  conserved,G2M
Tb927.11.12290,1914.0,1043.5,1324.0,1202.5,1489.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12300,2870.5,1991.5,767.0,1125.0,1549.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12310,6151.5,10364.0,9767.0,10093.0,9373.0,cdc2-related kinase 12,G1
Tb927.11.12320,7337.0,10594.0,10401.0,10389.5,10696.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.12330,612.5,4056.0,4130.5,3295.5,2747.0,hypothetical protein  conserved,S
Tb927.11.12340,8766.5,9118.0,8768.0,8728.0,8943.0,predicted Zinc finger  C3HC4 type (RING finger) protein,G1
Tb927.11.12350,8168.0,7128.5,8372.0,6591.5,6016.5,DNA photolyase  putative,S
Tb927.11.12360,5837.5,4119.5,5064.5,4987.0,3510.5,ankyrin repeat protein  putative,<2C (LG1)
Tb927.11.12365,7363.0,7195.5,6744.5,6845.5,7236.5,hypothetical protein,<2C (LG1)
Tb927.11.12370,8460.0,6159.0,5783.0,5908.5,6535.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12380,612.5,4770.5,3148.0,4221.0,7782.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.12390,10035.5,8388.5,8600.5,8116.5,6491.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12400,9362.5,7770.5,7807.0,7915.5,8103.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12410,6397.5,4034.0,4703.0,6001.0,10383.0,kinetoplastid kinetochore protein 10,>4C (GG2M)
Tb927.11.12420,4792.5,7549.0,6917.0,6821.5,9763.0,kinetoplastid kinetochore protein 19,>4C (GG2M)
Tb927.11.12430,2813.0,6858.5,6986.5,8066.5,4578.0,cell division cycle phosphatase 14  putative,G2M
Tb927.11.12440,6227.5,3397.0,4485.5,3566.5,3541.0,Plus-3 domain/Zinc finger  C3HC4 type (RING finger)  putative,<2C (LG1)
Tb927.11.12450,7054.5,7355.0,6385.5,6381.0,6664.5,Bardet-Biedl syndrome 8 protein,G1
Tb927.11.12460,6281.5,9150.5,9411.0,8921.0,8546.5,hypothetical protein  conserved,S
Tb927.11.12470,11299.0,11473.0,11380.0,11406.0,11473.0,hypothetical protein  conserved,G1
Tb927.11.12480,2729.0,6211.0,7562.5,7179.5,8042.0,Kinetochore interacting phosphatase 7,>4C (GG2M)
Tb927.11.12490,7994.5,6698.0,7770.5,8268.0,6112.5,hypothetical protein  conserved,G2M
Tb927.11.12500,2714.5,3457.0,3940.5,2977.0,6112.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.12510,4459.5,8384.5,8615.5,9023.0,10591.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.12520,2357.5,6905.5,4189.0,6540.5,6289.5,hypothetical protein  conserved,G1
Tb927.11.12530,4364.5,3792.0,4304.0,4841.0,4560.5,Flagellum attachment zone protein 3,G2M
Tb927.11.12540,10337.0,10787.0,11002.0,11124.0,10290.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.11.12560,7137.5,11000.0,10914.5,10903.0,11233.0,hypothetical protein,>4C (GG2M)
Tb927.11.12570,3095.0,4806.0,3503.0,3545.0,2336.0,kinetoplastid-specific dual specificity phosphatase  putative,G1
Tb927.11.12580,3314.5,8118.0,8621.0,8048.0,6969.5,hypothetical protein  conserved,S
Tb927.11.12590,5408.0,2510.5,2075.5,2422.0,1860.5,Der1-like family  putative,<2C (LG1)
Tb927.11.12600,3380.0,6650.5,8484.5,6738.5,6909.5,ATP-dependent DNA helicase  putative,S
Tb927.11.12610,5441.0,7605.0,7426.0,8100.0,7029.5,cyclin 1,G2M
Tb927.11.12620,7348.0,9358.5,10599.0,10075.0,8835.5,Glucosidase II beta subunit-like  putative,S
Tb927.11.12630,10158.0,9806.0,9491.5,8773.0,8857.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12640,7863.0,9229.5,9691.0,8773.0,9430.5,PH domain containing protein  putative,S
Tb927.11.12650,9173.0,7146.5,6577.0,7486.0,6639.5,palmitoyl acyltransferase 5  putative,<2C (LG1)
Tb927.11.12660,11453.0,10198.5,9698.5,9297.0,9996.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12670,612.5,6546.5,7943.5,7495.5,9250.5,Methyltransferase TYW3  putative,>4C (GG2M)
Tb927.11.12680,1460.0,1313.5,1634.5,1329.0,2427.0,prefoldin subunit 2  putative,>4C (GG2M)
Tb927.11.12690,8383.5,4866.0,5505.0,5808.5,2336.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12700,612.5,260.0,1149.5,737.0,1047.0,hypothetical protein  conserved,S
Tb927.11.12710,11530.0,11196.5,11151.5,11256.5,10462.5,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.11.12720,7880.0,2138.5,3116.5,2252.0,2514.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12730,6582.0,2026.5,2122.5,1542.0,2125.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12740,6990.0,6763.0,6346.0,6558.5,6740.5,tRNA import complex component  putative,<2C (LG1)
Tb927.11.12750,612.5,565.0,848.5,705.5,1842.0,cleavage and polyadenylation specificity factor 30 kDa subunit,>4C (GG2M)
Tb927.11.12760,8250.0,4305.0,3288.0,4126.5,4760.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12770,11516.0,9787.5,9892.5,9468.5,7880.5,ubiquitin ligase  putative,<2C (LG1)
Tb927.11.12780,5320.5,3526.0,3589.5,4193.5,9194.5,ribonucleoside-diphosphate reductase small chain  putative,>4C (GG2M)
Tb927.11.12790,6179.5,4928.0,6334.0,5808.5,9753.0,ribonucleoside-diphosphate reductase small chain,>4C (GG2M)
Tb927.11.12800,9156.5,5479.0,5590.5,6105.5,10216.5,ribonucleoside-diphosphate reductase small chain,>4C (GG2M)
Tb927.11.12810,6248.5,5953.5,6480.0,5958.0,10273.0,ribonucleoside-diphosphate reductase small chain,>4C (GG2M)
Tb927.11.12820,7516.0,6199.5,6624.0,7105.5,10170.5,ribonucleoside-diphosphate reductase small chain,>4C (GG2M)
Tb927.11.12830,6248.5,9667.5,10151.0,9673.5,8734.5,acyl-CoA binding protein  putative,S
Tb927.11.12840,3314.5,10648.5,11049.5,10867.0,11672.0,Domain of unknown function (DUF4486)  putative,>4C (GG2M)
Tb927.11.12850,10965.0,8578.5,7823.5,6507.5,9916.5,oligopeptidase b,<2C (LG1)
Tb927.11.12860,5856.0,5888.5,6095.5,4928.5,4212.0,cAMP response protein  putative,S
Tb927.11.12870,6409.5,7923.0,7520.5,6748.5,7753.0,hypothetical protein  conserved,G1
Tb927.11.12880,6106.5,9406.0,9576.0,9233.0,8765.5,Present in the outer mitochondrial membrane proteome 17,S
Tb927.11.12910,2329.5,2118.0,1634.5,2275.5,2125.5,prefoldin subunit  putative,<2C (LG1)
Tb927.11.12920,9611.5,9767.5,9368.0,9412.5,8821.0,hypothetical protein  conserved,G1
Tb927.11.12930,9178.5,9814.5,9569.0,9206.0,7670.0,DEAD-box helicase  putative,G1
Tb927.11.12940,10597.5,10142.5,10110.0,9797.0,9242.0,Uncharacterised protein family (UPF0160)  putative,<2C (LG1)
Tb927.11.12950,3914.0,2224.0,1371.0,2494.5,2141.5,ras-like small GTPase  putative,<2C (LG1)
Tb927.11.12960,8470.0,5757.0,5197.0,4742.5,3847.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12970,8866.5,5287.0,4448.0,4782.0,4783.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.12980,10518.0,9443.5,10325.5,9968.5,10315.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13000,7267.0,11215.0,11318.0,11141.5,11170.0,phospholipid-transporting ATPase  putative,S
Tb927.11.13003,1460.0,1249.0,1217.0,1056.5,1896.5,ubiquitin-60S ribosomal protein L40,>4C (GG2M)
Tb927.11.13007,612.5,158.5,271.5,248.0,287.0,ubiquitin-60S ribosomal protein L40,<2C (LG1)
Tb927.11.13010,1460.0,3572.0,3388.5,3978.5,2964.0,hypothetical protein,G2M
Tb927.11.13020,612.5,1161.5,1149.5,1416.5,5442.5,calmodulin,>4C (GG2M)
Tb927.11.13030,612.5,208.5,373.5,483.0,3825.5,calmodulin,>4C (GG2M)
Tb927.11.13040,612.5,322.0,373.5,720.5,4128.5,calmodulin,>4C (GG2M)
Tb927.11.13050,612.5,373.5,336.0,737.0,4947.0,calmodulin,>4C (GG2M)
Tb927.11.13060,10614.0,10429.5,10889.0,10836.5,10593.0,translation-associated element 2  putative,S
Tb927.11.13070,7929.5,9532.5,9653.5,9609.5,9681.0,O-phosphoseryl-tRNA(Sec) selenium transferase  putative,>4C (GG2M)
Tb927.11.13080,2137.5,8517.5,9174.5,8460.0,9964.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.13090,7741.0,6418.0,5930.5,7380.5,10562.0,elongation factor 1 gamma  putative,>4C (GG2M)
Tb927.11.13100,612.5,5331.5,4038.0,4126.5,4440.0,hypothetical protein  conserved,G1
Tb927.11.13110,5784.5,6488.0,7115.5,7078.5,3888.0,hypothetical protein  conserved,S
Tb11.NT.158,4544.0,2138.5,3902.0,4962.5,5092.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.11.13120,7677.5,4135.5,3009.0,2775.0,2661.5,PUB domain containing protein  putative,<2C (LG1)
Tb927.11.tRNA_His_1,612.5,690.0,578.5,419.0,1789.5,tRNA Histidine,>4C (GG2M)
Tb927.11.tRNA_Glu_1,612.5,543.0,336.0,419.0,347.0,tRNA Glutamic acid,<2C (LG1)
Tb927.11.tRNA_Phe_1,3564.0,3120.0,2801.5,2199.0,2178.0,tRNA Phenylalanine,<2C (LG1)
Tb927.11.13125,7599.0,4615.5,4540.5,5060.5,4110.0,cytochrome oxidase subunit X,<2C (LG1)
Tb927.11.13130,10839.0,9729.0,8986.0,8105.0,7900.0,membrane-bound acid phosphatase 1 precursor,<2C (LG1)
Tb927.11.13140,7573.5,4754.0,4388.0,4828.5,4096.5,cytochrome oxidase subunit X,<2C (LG1)
Tb927.11.13150,5457.5,3693.0,3487.0,3408.0,3214.5,UEV domain/Zinc finger  C3HC4 type (RING finger)  putative,<2C (LG1)
Tb927.11.13160,9686.5,9560.0,9725.0,9736.5,9555.0,hypothetical protein,G2M
Tb927.11.tRNA_Ala_1,612.5,40.5,40.0,33.5,86.0,tRNA Alanine,<2C (LG1)
Tb927.11.tRNA_Arg_1,2381.5,1797.0,2075.5,1154.5,1078.0,tRNA Arginine,<2C (LG1)
Tb927.11.tRNA_Phe_2,5025.0,4188.5,3678.5,2735.0,2190.0,tRNA Phenylalanine,<2C (LG1)
Tb927.11.13170,8491.0,4610.5,5229.5,5648.5,5647.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13180,11136.5,10951.0,10904.0,10907.5,10401.5,Present in the outer mitochondrial membrane proteome 10,<2C (LG1)
Tb927.11.13190,6755.5,5738.0,4799.0,6647.5,10467.0,elongation factor 1 gamma  putative,>4C (GG2M)
Tb927.11.13200,8470.0,8414.0,9268.0,9031.5,9903.0,LEM3 (ligand-effect modulator 3) family / CDC50 family  putative,>4C (GG2M)
Tb927.11.13210,4956.5,3941.5,3987.0,2506.5,4212.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13220,5209.5,2839.5,2692.0,2085.0,4498.5,phospholipid:diacylglycerol acyltransferase-like protein,<2C (LG1)
Tb927.11.13230,6047.5,8231.5,6682.5,6748.5,4794.5,VAMP-associated protein  putative,G1
Tb927.11.13240,4019.5,6066.5,6016.0,4720.5,3994.5,RNA polymerase subunit  putative,G1
Tb927.11.13250,4122.5,5992.0,5691.0,5148.0,5432.0,eukaryotic translation initiation factor 2 gamma  putative,G1
Tb927.11.13260,8060.0,8352.5,8964.5,8475.0,8116.0,hypothetical protein  conserved,S
Tb927.11.13270,10433.5,7851.5,7923.5,8563.5,7023.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13280,4810.5,3586.5,3542.0,3356.0,1582.0,Guide RNA binding protein 25,<2C (LG1)
Tb927.11.13290,6858.5,4227.0,5386.5,3950.5,5420.5,mitochondrial import inner membrane translocase subunit tim17,<2C (LG1)
Tb927.11.13300,3179.0,2858.5,3079.0,4486.5,8226.0,Intraflagellar transport protein 25,>4C (GG2M)
Tb927.11.13310,6677.0,4474.0,3962.5,3588.0,5230.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13320,5697.0,9518.0,9129.5,9840.0,9753.0,hypothetical protein  conserved,G2M
Tb927.11.13330,2795.5,8583.5,8249.5,7662.5,8624.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.13340,8150.5,10330.5,10268.5,10602.0,10334.5,hypothetical protein  conserved,G2M
Tb927.11.13350,6207.5,7909.0,8687.5,7586.5,5854.0,hypothetical protein  conserved,S
Tb927.11.13360,11163.0,9040.0,8989.0,9609.5,8611.0,AAA ATPase  putative,<2C (LG1)
Tb927.11.13370,1460.0,3313.0,2849.0,2775.0,2495.0,hypothetical protein  conserved,G1
Tb927.11.13380,11160.0,10372.5,10024.5,9722.5,10850.0,ATP-dependent helicase  putative,<2C (LG1)
Tb927.11.13390,3741.5,1875.5,2453.0,2264.5,1141.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13400,1460.0,6940.5,4799.0,6388.5,8178.5,Bromodomain  putative,>4C (GG2M)
Tb927.11.13410,612.5,3245.0,5469.5,4629.0,6164.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.13420,6137.0,6830.0,5584.0,6147.0,7213.0,PPPDE putative peptidase domain containing protein  putative,>4C (GG2M)
Tb927.11.13440,9785.5,3336.0,4928.0,4327.5,3065.0,mitochondrial carrier protein,<2C (LG1)
Tb927.11.13450,612.5,235.5,233.5,610.5,505.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13460,8919.5,9673.0,7377.0,7845.5,10027.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.13470,3711.5,3336.0,3344.0,3029.0,2268.0,PPPDE putative peptidase domain containing protein  putative,<2C (LG1)
Tb927.11.13480,1783.5,4590.5,4046.5,3531.5,3541.0,SUMO-interacting motif-containing protein,G1
Tb927.11.13490,612.5,3429.0,3994.5,2977.0,3199.5,hypothetical protein  conserved,S
Tb927.11.13500,11126.5,9020.5,9449.5,9331.5,8026.0,par1,<2C (LG1)
Tb927.11.13510,5247.5,927.5,1585.5,1125.0,933.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13520,10741.0,10817.0,11108.0,10773.0,10702.0,hypothetical protein  conserved,S
Tb927.11.13530,1460.0,4348.5,6393.0,5673.5,4429.0,hypothetical protein  conserved,S
Tb927.11.13540,10843.0,7128.5,8026.5,7404.5,7762.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13550,7054.5,9181.5,9838.5,9334.0,9665.0,hypothetical protein  conserved,S
Tb927.11.13560,612.5,4567.5,4104.0,2999.5,5735.0,SET domain containing protein  putative,>4C (GG2M)
Tb927.11.13570,1460.0,1817.5,2887.5,2102.5,2758.5,hypothetical protein  conserved,S
Tb927.11.13580,4617.0,6520.5,6953.0,7179.5,6848.5,ubiquinone biosynthesis protein-like protein,G2M
Tb927.11.13590,2840.5,5757.0,5930.5,5353.5,5044.5,hypothetical protein  conserved,S
Tb927.11.13600,1460.0,3390.0,4093.0,3531.5,3555.5,DnaJ domain containing protein  putative,S
Tb927.11.13610,3828.5,3723.5,3952.0,3635.0,3494.0,rhodanese-like domain containing protein  putative,S
Tb927.11.13620,8850.0,3367.5,2465.5,1875.5,2857.0,rhodanese-like domain containing protein  putative,<2C (LG1)
Tb927.11.13630,8698.0,8208.0,9350.5,9523.5,8984.0,hypothetical protein  conserved,G2M
Tb927.11.13640,2982.0,8758.5,8060.5,8840.0,5323.5,J-binding protein,G2M
Tb927.11.13650,4288.5,5355.0,4944.0,5101.5,3006.0,cytochrome b5  putative,G1
Tb927.11.13660,612.5,358.0,161.0,221.5,287.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13670,7840.0,10821.5,10976.5,10905.0,9500.0,hypothetical protein  conserved,S
Tb927.11.13680,9809.5,8370.0,8578.0,8505.0,9322.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13690,6955.5,7433.5,6730.0,7605.5,8493.0,Radial spoke protein 11,>4C (GG2M)
Tb927.11.13700,6853.5,2877.0,4117.0,7065.0,10470.0,Basal body protein,>4C (GG2M)
Tb927.11.13710,612.5,2093.5,3308.0,2830.5,6570.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.13720,1783.5,3775.5,4703.0,4699.5,2098.0,hypothetical protein,S
Tb927.11.13730,7125.5,3120.0,2977.0,2577.5,2203.5,ornithine decarboxylase,<2C (LG1)
Tb927.11.13740,2826.5,5816.0,5109.5,5569.0,5803.0,procyclic-enriched flagellar receptor adenylate cyclase 5,G1
Tb927.11.13750,612.5,96.0,99.0,182.5,287.0,Ras-related protein Rab4,<2C (LG1)
Tb927.11.13760,612.5,158.5,685.0,366.5,287.0,hypothetical protein  conserved,S
Tb927.11.13770,2094.5,2020.5,2453.0,1950.5,505.0,LEM3 (ligand-effect modulator 3) family / CDC50 family  putative,S
Tb927.11.13780,5450.0,5128.0,4069.0,5050.5,3638.0,profilin,<2C (LG1)
Tb927.11.13785,7937.5,4849.5,4425.5,4579.0,4377.5,hypothetical protein,<2C (LG1)
Tb927.11.13790,9580.0,6568.0,5439.0,6138.0,5713.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13800,2637.5,919.5,2425.0,2520.5,836.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13810,5643.5,7102.0,7124.5,6914.5,8063.0,ATP- dependent RNA helicase  putative,>4C (GG2M)
Tb927.11.13820,612.5,5585.0,5798.5,4156.0,5898.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.13830,7824.5,5287.0,2717.5,2603.0,3413.5,DnaJ domain containing protein  putative,<2C (LG1)
Tb927.11.13840,10328.0,7474.5,7614.0,7740.5,8433.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13850,9458.5,6951.0,6854.5,6815.5,5943.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13860,5686.0,4260.5,4356.5,5470.0,4005.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.13870,8168.0,6079.5,6538.0,6397.5,8471.0,uncharacterized protein  PH0010 family/AmmeMemoRadiSam system protein A  putative,>4C (GG2M)
Tb927.11.13880,10726.0,9214.0,9735.5,9267.0,9427.0,kinetoplastid-specific protein tyrosine phosphatase  putative,<2C (LG1)
Tb927.11.13890,11184.0,6605.5,6034.5,7327.0,6706.0,AKAP7 2'5' RNA ligase-like domain containing protein  putative,<2C (LG1)
Tb927.11.13900,9140.5,6139.5,5991.0,6647.5,6903.0,Centrin-5,<2C (LG1)
Tb927.11.13910,9951.0,7303.5,6815.5,7340.5,6006.0,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,<2C (LG1)
Tb927.11.13920,6324.5,10968.5,10983.0,10913.0,10953.0,kinesin-II 85 Kd subunit  putative,S
Tb927.11.13930,612.5,2051.0,1886.0,2357.0,2870.0,U3 small nucleolar ribonucleoprotein protein IMP3  putative,>4C (GG2M)
Tb927.11.13940,3951.0,4603.5,4029.0,5489.0,5943.5,ubiquitin-conjugating enzyme E2  putative,>4C (GG2M)
Tb927.11.13950,9551.0,7879.0,8484.5,8816.0,9399.0,Mut7-C RNAse domain containing protein  putative,<2C (LG1)
Tb927.11.13960,612.5,130.0,1207.5,826.5,86.0,U6 snRNA-associated Sm-like protein LSm4p,S
Tb927.11.13970,5485.5,4207.5,5551.5,6374.0,3335.5,Pab1p-dependent poly(A) ribonuclease subunit  putative,G2M
Tb927.11.13980,612.5,6334.0,6102.0,6205.5,10435.0,Outer row dynein-assembly protein 7,>4C (GG2M)
Tb927.11.13990,5891.0,6319.0,5396.5,6090.0,5174.5,GDP-L-fucose synthetase,G1
Tb927.11.14000,1460.0,1153.5,1886.0,1202.5,347.0,nuclear RNA binding domain 1,S
Tb927.11.14010,10421.0,9118.0,8309.5,9512.5,8445.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.14020,1460.0,1322.5,2541.5,1215.5,86.0,nuclear RNA binding domain 2,S
Tb927.11.14030,3598.0,1303.5,1164.0,1044.0,3076.5,cyclin 9,<2C (LG1)
Tb927.11.14040,8526.5,10245.0,9569.0,9813.5,10425.0,RIC1  putative,>4C (GG2M)
Tb927.11.14050,2406.5,6084.5,7312.0,6983.5,8409.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.14060,9677.5,6719.5,6754.0,6962.0,4957.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.14070,11133.0,11084.0,11004.0,11254.0,10667.5,Repressor of differentiation kinase 1,G2M
Tb927.11.14080,5320.5,5530.5,5710.5,6837.5,4284.0,cyclin 2,G2M
Tb927.11.14090,612.5,1275.5,1799.0,2335.0,3310.5,Double RNA binding domain protein 18,>4C (GG2M)
Tb927.11.14100,4182.0,5039.5,6616.5,6077.0,7377.0,Double RNA-binding domain containing protein 4,>4C (GG2M)
Tb927.11.14110,6741.5,6745.0,7215.0,7167.0,4110.0,TFIIH basal transcription factor subunit,S
Tb927.11.14120,3358.0,3881.5,3009.0,3545.0,2125.5,phenylalanyl-tRNA synthetase alpha chain  putative,G1
Tb927.11.14130,1460.0,96.0,161.0,136.5,347.0,ribosomal protein L18  putative,<2C (LG1)
Tb11.NT.176,3478.0,1101.5,1041.5,1441.0,1772.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.14140,7016.5,6538.5,7319.5,6845.5,4725.0,ethanolamine-phosphate cytidylyltransferase,S
Tb927.11.14150,612.5,1849.0,1536.0,1281.0,2039.0,pre-mRNA splicing factor  putative,>4C (GG2M)
Tb927.11.14160,3120.5,4806.0,5537.0,4699.5,3353.0,Alpha/beta hydrolase family  putative,S
Tb927.11.14165,9224.0,9873.0,8476.0,9270.5,8508.5,hypothetical protein,G1
Tb927.11.14170,9658.0,7414.5,7474.5,8874.5,6153.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.14180,9159.5,9762.0,9433.0,9642.5,9353.0,CLASP N terminal  putative,G1
Tb927.11.14190,10947.0,11067.0,10890.5,11169.0,10706.5,Staphylococcal nuclease homologue/Tudor domain containing protein  putative,G2M
Tb927.11.14200,5225.0,4155.5,4411.0,2810.5,3021.0,ubiquitin-conjugating enzyme CDC34,<2C (LG1)
Tb927.11.14210,4019.5,4703.0,4917.0,6845.5,11293.0,conserved protein,>4C (GG2M)
Tb927.11.14220,7383.5,8712.0,8185.0,7949.0,8026.0,Regulator of ESAG9-1,G1
Tb927.11.14230,5181.0,5104.5,5704.5,4166.5,5266.5,Vps23 core domain containing protein  putative,S
Tb927.11.14240,9826.5,10662.0,10966.5,10659.0,11303.0,WD domain  G-beta repeat  putative,>4C (GG2M)
Tb927.11.14250,2221.0,4348.5,3618.0,4019.0,10957.0,T-complex protein 1  epsilon subunit  putative,>4C (GG2M)
Tb927.11.14260,8877.0,8322.5,8523.0,8259.5,7029.5,atypical dual specificity phosphatase  putative,<2C (LG1)
Tb927.11.14270,7977.5,10198.5,10373.5,9977.0,8952.0,STE group serine/threonine-protein kinase  putative,S
Tb927.11.14280,6976.5,3109.0,2679.5,2869.0,2805.5,septum formation protein MAF homologue  putative,<2C (LG1)
Tb927.11.14290,4956.5,6027.5,5728.0,5024.0,5535.5,vacuolar sorting protein  putative,G1
Tb927.11.14300,3558.0,1201.5,1021.0,1187.5,7396.5,Dynein intermediate chain  axonemal,>4C (GG2M)
Tb927.11.14310,612.5,4531.5,2586.5,3142.0,4800.5,small nuclear ribonucleoprotein Sm-G,>4C (GG2M)
Tb927.11.14320,612.5,5049.5,5908.5,5949.0,5870.5,hypothetical protein  conserved,G2M
Tb11.NT.178,2295.5,279.5,731.0,737.0,433.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.14330,3295.0,6834.5,8091.5,5789.5,9678.0,HECT-domain (ubiquitin-transferase)  putative,>4C (GG2M)
Tb927.11.14340,8224.0,9062.0,8217.0,9715.0,9727.0,exportin 1,>4C (GG2M)
Tb927.11.14350,612.5,2760.5,2533.0,3513.0,6596.5,mitochondrial carrier protein,>4C (GG2M)
Tb927.11.14360,5653.0,6032.5,6495.5,6205.5,6917.0,mitochondrial carrier protein,>4C (GG2M)
Tb927.11.14370,7115.0,11017.0,11157.0,10820.5,10979.0,Microtubule-associated protein 103 kDa,S
Tb927.11.14380,5722.0,6437.0,8130.5,8224.5,5161.0,kinetoplast polyadenylation/uridylation factor 2,G2M
Tb927.11.14390,5938.5,4796.5,6655.0,5148.0,6903.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.NT.179,3155.0,774.5,685.0,687.0,761.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.14400,9776.5,6834.5,7510.0,6796.5,5451.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.14410,9528.5,9906.5,10293.0,10432.0,10428.5,Ankyrin repeats (3 copies)  putative,G2M
Tb927.11.14420,2574.5,3775.5,3727.5,4346.0,4403.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.14430,5291.5,4745.0,5001.0,5109.5,6006.0,proteasome regulatory non-ATP-ase subunit,>4C (GG2M)
Tb927.11.14440,8423.0,7203.0,6102.0,6348.0,9504.0,Pentatricopeptide repeat protein (PPR)  putative,>4C (GG2M)
Tb927.11.14450,5477.5,8601.0,9211.5,9736.5,9126.5,hypothetical protein  conserved,G2M
Tb927.11.14460,10045.5,7195.5,7108.0,6892.0,7313.0,ADP-ribosylation factor GTPase activating protein 1  putative,<2C (LG1)
Tb927.11.14470,8763.0,8248.0,8852.0,9154.0,6581.0,Bardet-Biedl syndrome 9 protein,G2M
Tb927.11.14480,10672.5,10149.5,9740.5,10191.5,10195.5,ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb927.11.14490,4170.0,6508.5,7291.0,6322.0,8715.5,RNA polymerase subunit  putative,>4C (GG2M)
Tb927.11.14495,612.5,1849.0,1757.0,1171.0,1453.5,hypothetical protein,G1
Tb927.11.14500,3972.0,3086.5,3891.5,3194.5,3100.5,Pseudokinase  putative,<2C (LG1)
Tb927.11.14510,4002.5,716.5,743.0,313.5,86.0,hypothetical protein,<2C (LG1)
Tb927.11.14520,2658.5,1679.0,2360.0,1713.0,584.5,Polypeptide deformylase 1,<2C (LG1)
Tb927.11.14530,5199.5,8027.5,6997.5,7547.0,6870.5,WLM domain containing protein  putative,G1
Tb927.11.14540,2180.0,2026.5,2465.5,2085.0,5290.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.14550,3214.5,5017.0,5486.5,5120.0,1789.5,PPPDE putative peptidase domain containing protein  putative,S
Tb927.11.14560,8900.0,10866.0,10030.5,10291.0,11289.0,Cleavage and polyadenylation specificity factor CPSF160  putative,>4C (GG2M)
Tb927.11.14570,9629.0,3407.5,5015.0,3878.0,2847.0,LicD family  putative,<2C (LG1)
Tb927.11.14580,5697.0,6936.0,7165.0,7564.0,7401.0,Bifunctional Monophosphate RNA Kinase/RNA guanylyltransferase,G2M
Tb927.11.14590,6198.5,6301.5,3189.5,6304.5,6143.5,G5-interacting protein,G2M
Tb927.11.14595,8661.5,8421.0,8931.5,8765.0,8282.5,hypothetical protein,S
Tb927.11.14600,5457.5,8443.0,8913.5,9317.0,7866.0,procyclin-associated gene 2-like protein  putative,G2M
Tb927.11.14610,6167.5,6767.5,6849.0,7377.0,6780.0,procyclin-associated gene 4 (PAG4) protein  putative,G2M
Tb927.11.14620,1988.0,9108.5,9272.5,9614.0,10004.0,expression site-associated gene 2 (ESAG2) protein  putative,>4C (GG2M)
Tb11.01.6240,6838.0,2469.5,2827.0,3477.5,2472.5,expression site-associated gene 2 (ESAG2) protein  putative,<2C (LG1)
Tb11.01.6250,10835.0,11313.0,11274.0,11364.0,11051.0,expression site-associated gene 11 (ESAG11) protein  putative,G2M
Tb927.11.14630,10066.5,9202.0,8839.0,9575.5,8872.5,ATP-dependent DNA DEAD/DEAH box helicase  putative,<2C (LG1)
Tb927.11.14640,4360.0,6772.0,6236.5,5576.5,5788.5,hypothetical protein  conserved,G1
Tb927.11.14650,9433.5,10043.0,9556.0,9951.0,9052.0,SUMO-interacting motif-containing protein,G1
Tb927.11.14660,2436.0,3060.0,2551.0,3205.5,2647.0,hypothetical protein  conserved,G2M
Tb927.11.14670,9202.5,8086.5,8081.5,8988.0,6928.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.14680,11166.0,11520.0,11544.0,11431.0,11520.5,phosphatidylinositol 3-related kinase  putative,S
Tb927.11.14690,612.5,1858.0,2638.5,1228.0,637.0,Microtubule-binding protein MIP-T3  putative,S
Tb927.11.14700,6701.0,10777.0,10428.0,10096.5,9723.0,hypothetical protein  conserved,G1
Tb927.11.14705,612.5,345.0,130.5,159.0,213.0,hypothetical protein,<2C (LG1)
Tb927.11.14710,2886.0,2118.0,2621.5,2422.0,3169.5,rRNA processing  putative,>4C (GG2M)
Tb927.11.14720,612.5,2078.0,2238.0,2058.5,1804.5,hypothetical protein  conserved,S
Tb927.11.14730,8702.0,8322.5,8290.5,7940.0,7478.0,Metalloprotease M41 FtsH  putative,<2C (LG1)
Tb927.11.14740,612.5,10221.0,9560.0,9968.5,8582.0,YqaJ-like viral recombinase domain containing protein  putative,G1
Tb927.11.14750,10062.5,4642.5,4823.0,6262.0,4783.5,PSP1 C-terminal conserved region  putative,<2C (LG1)
Tb927.11.14760,9120.5,9705.5,9737.5,9396.0,6173.5,Clustered mitochondria/Translation initiation factor eIF3 subunit 135  putative,S
Tb927.11.14770,5630.0,7716.0,7450.0,7258.0,5230.0,hypothetical protein  conserved,G1
Tb927.11.14780,9488.0,8279.5,8038.5,8277.5,6588.5,phosphomannose isomerase,<2C (LG1)
Tb927.11.14790,2870.5,4967.0,3323.5,4290.5,2928.5,DNA repair and recombination helicase protein PIF4,G1
Tb927.11.14800,9341.5,8704.0,9429.5,9850.0,9863.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.14810,2523.0,2020.5,2790.5,3254.5,1099.0,hypothetical protein  conserved,G2M
Tb927.11.14820,4685.0,9638.0,9792.5,9304.5,9283.0,hypothetical protein  conserved,S
Tb927.11.14830,612.5,5634.0,5408.5,5932.0,8103.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.14840,2619.0,5552.5,6262.0,6567.0,6814.0,chromosomal passenger complex 2,>4C (GG2M)
Tb927.11.14850,6703.5,10019.5,9679.0,9066.0,9807.5,hypothetical protein  conserved,G1
Tb927.11.14860,10250.5,10747.0,10642.0,11356.0,11533.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.14870,11419.0,7962.0,7143.0,7547.0,8630.0,NAD+ synthase  putative,<2C (LG1)
Tb927.11.14880,1460.0,2306.5,3233.0,3711.5,6793.5,Paraflagellar Rod Proteome Component 9  putative,>4C (GG2M)
Tb11.NT.185,6243.0,2051.0,1549.5,1966.0,3100.5,Noncoding RNA  putative,<2C (LG1)
Tb927.11.14890,7054.5,4008.0,2738.5,2810.5,5927.0,DNA polymerase alpha/epsilon subunit B  putative,<2C (LG1)
Tb927.11.14900,4947.5,4726.0,3877.5,4235.5,3271.5,coatomer subunit epsilon,<2C (LG1)
Tb927.11.14910,4200.0,6928.5,7749.0,7525.5,5411.5,protein phosphatase 2C  putative,S
Tb927.11.14920,9566.0,11458.0,11394.0,11231.0,10971.5,hypothetical protein  conserved,G1
Tb927.11.14930,8395.5,10559.0,10355.0,9911.0,8865.5,hypothetical protein  conserved,G1
Tb927.11.14940,10447.0,8107.0,8632.5,7897.5,7753.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.14950,4555.0,1773.5,1446.0,2102.5,2601.0,zinc finger protein 2,<2C (LG1)
Tb927.11.14960,5393.5,8528.5,8730.5,8303.0,6984.0,pumilio/PUF RNA binding protein 7  putative,S
Tb927.11.14970,7306.5,6504.5,7947.5,7883.0,6298.5,hypothetical protein  conserved,S
Tb927.11.14980,9270.5,6001.5,6010.0,6407.5,2941.0,mitochondrial ribosomal protein L38,<2C (LG1)
Tb927.11.14990,1914.0,6205.5,6630.0,5969.0,8437.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.14995,5209.5,2260.5,3531.0,3531.5,5174.5,hypothetical protein,<2C (LG1)
Tb927.11.15000,5257.0,3201.0,4224.5,4558.5,5745.0,survival of motor neuron (SMN)-like protein,>4C (GG2M)
Tb927.11.15010,4288.5,9663.5,9679.0,9705.0,10294.0,Serine/threonine-protein kinase NEK21  putative,>4C (GG2M)
Tb927.11.15020,3762.0,4460.5,6262.0,4542.0,4051.0,iron superoxide dismutase,S
Tb927.11.15030,3295.0,7726.5,7994.5,8432.0,8026.0,small GTPase,G2M
Tb927.11.15040,6004.0,9634.5,10286.5,9919.5,8842.5,Chaperonin HSP60  mitochondrial,S
Tb927.11.15050,8180.5,5612.5,5981.0,5799.5,5757.0,Cation efflux family  putative,<2C (LG1)
Tb927.11.15060,1460.0,640.0,1324.0,808.0,2758.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15070,10140.5,8355.0,8746.5,7762.0,8914.5,Basal body protein,<2C (LG1)
Tb927.11.15080,8466.0,4615.5,3697.0,5050.5,6903.0,Transmembrane proteins 14C  putative,<2C (LG1)
Tb927.11.15090,5053.5,5924.5,7115.5,5353.5,5054.0,hypothetical protein  conserved,S
Tb927.11.15100,2094.5,1068.5,1742.5,1261.0,6247.5,Tb5.20,>4C (GG2M)
Tb927.11.15110,7963.0,7053.5,7718.5,8138.5,7213.0,Vitamin B6 photo-protection and homoeostasis  putative,G2M
Tb927.11.15120,7229.5,6750.5,7183.5,7314.0,3847.5,hypothetical protein  conserved,G2M
Tb927.11.15130,3494.5,7605.0,8356.0,6867.5,11011.5,DnaJ homolog  putative,>4C (GG2M)
Tb927.11.15140,1783.5,7098.5,8398.0,7740.5,5841.5,bilobe region protein  putative,S
Tb927.11.15150,8706.0,2772.5,1909.5,3102.5,1842.0,1-acyl-sn-glycerol-3-phosphate acyltransferase  putative,<2C (LG1)
Tb927.11.15160,3468.5,9156.0,9156.5,9185.0,8146.5,hypothetical protein  conserved,G2M
Tb927.11.15170,4397.0,4620.0,3755.0,3752.5,2794.5,ribosome biogenesis protein TSR3  putative,G1
Tb927.11.15180,6281.5,6044.5,4271.0,5824.5,8303.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15190,2047.0,5221.5,4977.5,5476.5,11003.5,Domain of unknown function (DUF4200)  putative,>4C (GG2M)
Tb927.11.15200,5706.0,6475.0,6236.5,6927.5,7447.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15210,9436.5,9865.0,10079.0,9507.0,9892.5,TLR4 regulator and MIR-interacting MSAP  putative,S
Tb927.11.15220,612.5,4294.5,4356.5,5024.0,6298.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15230,2504.5,4235.0,4170.0,4126.5,3214.5,cytosolic coat protein  putative,G1
Tb927.11.15240,612.5,664.5,336.0,720.5,5470.5,Ras-related protein RAB2B  putative,>4C (GG2M)
Tb927.11.15250,7050.5,5031.5,4950.0,5249.5,347.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.15255,612.5,3542.5,3642.0,3205.5,4664.5,hypothetical protein,>4C (GG2M)
Tb927.11.15270,6202.5,4119.5,5197.0,4647.0,1531.5,phosphopantetheine adenylyltransferase  putative,<2C (LG1)
Tb927.11.15280,8124.5,6089.0,7797.5,7275.5,4714.5,tRNA-sepcific adenosine deaminase,<2C (LG1)
Tb927.11.15290,9222.5,5521.0,6134.0,7161.0,8958.5,eRF1 methyltransferase catalytic subunit  putative,<2C (LG1)
Tb927.11.15300,10469.0,8970.5,8513.5,8560.0,8389.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.15310,7058.0,9564.0,10130.0,9604.0,9482.5,hypothetical protein  conserved,S
Tb927.11.15320,9312.0,8827.5,9145.5,9381.5,9301.0,hypothetical protein,G2M
Tb927.11.15330,10752.5,10875.0,10866.0,10683.5,9876.5,phosphatidylinositol 3-kinase catalytic subunit  putative,G1
Tb927.11.15340,5751.0,7190.0,7890.5,6250.0,7510.5,hypothetical protein  conserved,S
Tb927.11.15350,612.5,5045.5,5717.5,5295.5,6975.5,RNA-binding protein  putative,>4C (GG2M)
Tb927.11.15360,5643.5,8025.0,8960.0,8888.0,7412.0,hypothetical protein  conserved,S
Tb927.11.15370,2258.5,4872.5,6211.0,5249.5,3960.5,Importin subunit beta-4  putative,S
Tb927.11.15375,612.5,2149.5,2488.5,2404.0,1027.5,hypothetical protein,S
Tb927.11.15380,3272.0,7470.5,5744.0,6784.5,6224.0,hypothetical protein,G1
Tb927.11.15390,3272.0,9764.5,9749.0,9990.5,9134.5,hypothetical protein,G2M
Tb927.11.15400,11433.0,11150.0,11201.0,11055.0,11175.0,synaptobrevin  putative,<2C (LG1)
Tb11.NT.192,612.5,158.5,99.0,82.5,213.0,Noncoding RNA  putative,<2C (LG1)
Tb927.11.15410,2481.0,2534.5,2778.0,2456.5,3906.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15420,6131.0,2034.0,2226.5,1966.0,3733.0,eukaryotic translation initiation factor 3 subunit k,<2C (LG1)
Tb927.11.15430,9844.5,7270.0,6744.5,6549.5,5870.5,U5 small nuclear ribonucleoprotein component  putative,<2C (LG1)
Tb927.11.15440,7500.5,5680.0,5064.5,5392.0,5174.5,NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit  putative,<2C (LG1)
Tb927.11.15450,11670.0,11711.0,11710.0,11712.0,11712.0,Basal body protein,G2M
Tb927.11.15460,9449.0,9160.5,9838.5,9048.5,9779.5,ATP-dependent DEAD/H RNA helicase  putative,S
Tb927.11.15470,4633.0,3775.5,3987.0,3752.5,3861.0,methionyl-tRNA formyltransferase,<2C (LG1)
Tb927.11.15480,6042.0,3016.0,3727.5,4367.0,2941.0,heat shock protein Hsp20  putative,<2C (LG1)
Tb927.11.15490,4134.0,4357.5,3138.0,3168.0,5555.0,Tb-291 membrane associated protein  putative,>4C (GG2M)
Tb927.11.15500,9645.0,4145.5,4411.0,4309.5,3693.0,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.11.15510,7741.0,5397.5,5479.0,7090.5,4626.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.15520,8321.0,8520.0,7994.5,7212.0,8173.5,hypothetical protein  conserved,G1
Tb927.11.15530,6315.5,6282.5,5505.0,6683.5,5188.0,C-14 sterol reductase  putative,G2M
Tb927.11.15540,2221.0,5344.0,5091.5,4772.5,7762.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15550,7536.0,5789.5,6642.0,5419.5,6564.5,NADH-cytochrome b5 reductase  putative,<2C (LG1)
Tb927.11.15560,8663.5,2526.0,1999.5,1140.0,7002.5,Nucleoporin NUP53a,<2C (LG1)
Tb927.11.15570,6220.0,7529.0,8206.5,8303.0,8042.0,Pentatricopeptide repeat protein (PPR)  putative,G2M
Tb927.11.15580,2221.0,4242.0,3920.5,4309.5,3125.5,TFIIF-like transcription factor subunit 2,G2M
Tb927.11.15590,9022.5,7770.5,8610.0,7949.0,7319.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.15600,7857.0,7406.5,7177.0,6407.5,7161.5,histone deacetylase 2,<2C (LG1)
Tb927.11.15610,5678.0,10384.5,9608.5,9843.5,9259.5,hypothetical protein  conserved,G1
Tb927.11.15620,9781.5,9897.0,9925.0,9946.5,9584.5,hypothetical protein  conserved,G2M
Tb927.11.15630,6838.0,9059.0,8692.5,8695.0,6659.5,NOL1/NOP2/sun family  putative,G1
Tb927.11.15640,4170.0,8491.0,7474.5,7801.5,8522.5,mitochondrial RNA binding complex 1 subunit,>4C (GG2M)
Tb927.11.15650,1460.0,2621.0,3127.0,3168.0,2734.0,terminal uridylyltransferase 4,G2M
Tb927.11.15660,612.5,855.5,1416.0,1514.5,2178.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15675,612.5,130.0,99.0,111.0,86.0,hypothetical protein,<2C (LG1)
Tb927.11.15680,6409.5,3680.0,2499.0,3117.0,3271.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.15690,10246.5,8035.5,7291.0,7320.0,7959.5,U5 snRNP-associated 102 kDa protein  putative,<2C (LG1)
Tb927.11.15700,4346.0,4420.5,4799.0,3826.0,4158.0,hypothetical protein  conserved,S
Tb927.11.15710,5018.5,7373.0,7629.0,6974.5,6690.0,mediator of rna polymerase ii transcription subunit 1,S
Tb927.11.15720,3570.5,2864.5,2275.0,2589.0,3044.5,hypothetical protein,<2C (LG1)
Tb927.11.15730,2329.5,9043.0,9221.0,8479.5,7806.0,cyclic nucleotide-binding domain containing protein  putative,S
Tb927.11.15740,7500.5,5612.5,5396.5,5353.5,7918.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15750,11186.0,6578.0,5783.0,6669.5,10090.0,AMP deaminase  putative,<2C (LG1)
Tb927.11.15760,4887.0,3313.0,4214.0,2629.5,607.0,GPI transamidase subunit Tta1,<2C (LG1)
Tb927.11.15770,4153.0,9469.5,8815.5,9313.0,8441.0,hypothetical protein  conserved,G1
Tb927.11.15780,1460.0,727.0,703.0,419.0,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.15790,2357.5,3097.0,3323.5,2483.5,3214.5,hypothetical protein  conserved,S
Tb927.11.15800,2901.0,1492.5,2327.5,2347.0,11116.5,Cytokinesis initiation factor 1,>4C (GG2M)
Tb927.11.15810,8455.0,8384.5,7840.0,7547.0,8793.5,NADH-ubiquinone oxidoreductase B22 subunit,>4C (GG2M)
Tb927.11.15820,5829.0,7465.5,7354.5,7016.0,6048.5,iron superoxide dismutase C  mitochondrial,G1
Tb927.11.15830,10917.0,10374.5,10259.0,9816.0,8679.5,RNA methyltransferase  putative,<2C (LG1)
Tb927.11.15840,2460.0,9108.5,8847.0,8829.0,5555.0,L-Lysine transport protein  putative,G1
Tb927.11.15850,5667.0,9856.0,10081.0,9799.5,10252.0,kinteoplast poly(A) polymerase complex 1 subunit,>4C (GG2M)
Tb927.11.15855,612.5,935.5,1030.5,907.5,1374.5,hypothetical protein,>4C (GG2M)
Tb927.11.15860,2619.0,7825.0,7873.0,7506.5,5362.5,L-Lysine transport protein  putative,S
Tb927.11.15870,5882.5,7561.5,8277.0,7391.0,6557.0,hypothetical protein  conserved,S
Tb927.11.15880,1783.5,690.0,507.0,313.5,397.5,60S ribosomal protein L27  putative,<2C (LG1)
Tb927.11.15890,4298.5,8857.0,8130.5,8743.5,8872.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.15900,2995.0,1220.5,1254.0,1085.0,2016.0,60S ribosomal protein L27  putative,<2C (LG1)
Tb927.11.15910,8066.5,9927.5,10036.5,10376.5,10413.5,iron superoxide dismutase,>4C (GG2M)
Tb927.11.15920,3720.0,2011.0,1977.0,1609.0,2283.5,glutathione peroxidase  putative,<2C (LG1)
Tb927.11.15930,612.5,2671.0,3727.5,3658.0,3524.0,Sybindin-like family  putative,S
Tb927.11.15940,11544.5,11446.0,11495.0,11503.0,11440.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.15950,5111.0,9893.5,10230.5,10412.5,8905.0,amino acid transporter  putative,G2M
Tb927.11.15960,7898.5,4663.0,4010.5,4994.0,2941.0,amino acid transporter  putative,<2C (LG1)
Tb927.11.15970,10029.0,11012.0,10701.5,10417.0,10661.0,Guanine nucleotide exchange factor in Golgi transport N-terminal/Sec7 domain containing protein  putative,G1
Tb927.11.15980,5747.0,9641.0,9139.0,8536.0,7638.0,hypothetical protein  conserved,G1
Tb927.11.15990,1914.0,4590.5,4722.5,4754.5,8012.5,Nucleoporin NUP109,>4C (GG2M)
Tb927.11.16000,7558.5,9146.0,8794.5,9167.5,9843.0,exonuclease  putative,>4C (GG2M)
Tb927.11.16010,8752.0,7647.5,7869.0,8735.0,9049.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.16020,10897.0,10691.0,10898.5,10783.0,10959.5,RNA-binding protein  putative,>4C (GG2M)
Tb927.11.16030,1914.0,2658.5,2510.5,3744.5,2747.0,proteasome regulatory non-ATP-ase subunit 7,G2M
Tb927.11.16040,7532.5,10039.5,9502.5,9588.0,8383.5,prefoldin subunit  putative,G1
Tb927.11.16050,10911.0,8827.5,7793.5,8328.0,8221.5,CS domain/TPR repeat  putative,<2C (LG1)
Tb927.11.16060,7250.0,5804.5,5685.5,5628.0,5634.5,zinc finger protein  putative,<2C (LG1)
Tb927.11.16070,612.5,1886.0,2251.5,2252.0,1304.5,TFIIH basal transcription factor subunit,G2M
Tb927.11.16080,1460.0,1143.0,994.0,1391.5,2029.5,Soluble NSF attachment protein  SNAP  putative,>4C (GG2M)
Tb927.11.16090,5908.0,1969.0,2996.5,3319.0,9840.0,Outer dynein arm docking complex protein 2  putative,>4C (GG2M)
Tb927.11.16100,10416.5,10587.0,10577.5,10614.0,10283.5,ubiquitin carboxyl-terminal hydrolase  putative,G2M
Tb927.11.16110,6365.5,10188.0,10537.0,10339.5,10920.5,integrin alpha chain protein  putative,>4C (GG2M)
Tb927.11.16120,11189.5,10870.5,10668.0,10893.0,10564.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16130,8752.0,4849.5,3868.5,3888.5,2734.0,nucleoside diphosphate kinase,<2C (LG1)
Tb927.11.16140,4384.0,5151.5,5064.5,5662.0,5420.5,DNA replication licensing factor MCM7,G2M
Tb927.11.16150,612.5,845.0,1923.0,2168.5,5600.5,tubulin binding cofactor A  putative,>4C (GG2M)
Tb927.11.16160,5538.0,1394.5,994.0,1416.5,2834.5,ATP binding protein-like protein,<2C (LG1)
Tb927.11.16170,6018.5,1924.0,1634.5,1702.0,1970.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16180,4027.5,3991.5,5182.0,5608.0,5102.5,hypothetical protein,G2M
Tb927.11.16190,9025.5,9211.0,9178.5,9144.5,9200.0,hypothetical protein,G1
Tb927.11.16200,612.5,3849.0,2510.5,3241.5,2631.5,cytoskeleton-associated protein 17,G1
Tb927.11.16210,10549.0,10404.0,10610.5,10314.0,10764.5,cAMP response protein 1  putative,>4C (GG2M)
Tb927.11.16220,4667.5,4400.0,3420.5,3773.5,4158.0,Cytochrome b-c1 complex subunit  putative,<2C (LG1)
Tb927.11.16230,9760.0,10198.5,10183.0,10103.5,10685.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.16240,8744.0,7642.0,8559.5,8633.0,8987.5,RING-variant domain containing protein  putative,>4C (GG2M)
Tb927.11.16250,5902.5,9435.5,8726.0,9060.0,9511.5,PIN domain containing protein  putative,>4C (GG2M)
Tb927.11.16260,11706.0,11672.0,11657.0,11668.0,11647.0,SPRY domain/HECT-domain (ubiquitin-transferase)  putative,<2C (LG1)
Tb927.11.16270,9259.5,6946.0,8351.0,5873.0,6547.5,TFIIH basal transcription factor complex helicase XPB subunit  putative,<2C (LG1)
Tb927.11.16280,612.5,1078.5,1217.0,862.0,1027.5,60S ribosomal protein L8  putative,S
Tb927.11.16290,6227.5,5876.0,6942.5,5240.0,4257.0,AUT2/APG4/ATG4 cysteine peptidase  putative,S
Tb927.11.16300,9412.5,4317.5,4130.5,3992.5,2164.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16310,5658.5,10074.5,10003.0,10083.0,9564.5,Unconventional myosin,G2M
Tb927.11.16320,3654.0,3900.0,4029.0,3649.5,4145.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.16330,8742.0,10030.0,10016.5,10123.0,9898.5,hypothetical protein  conserved,G2M
Tb927.11.16340,6850.0,8902.0,9769.5,9290.5,8483.0,Importin-beta N-terminal domain/HEAT-like repeat  putative,S
Tb927.11.16350,7783.5,7770.5,6744.5,6626.0,2857.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16360,7037.0,5641.5,5526.0,5899.5,5125.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16370,1460.0,9621.0,8005.5,9181.5,7154.5,SHQ1 protein  putative,G1
Tb927.11.16380,8236.5,4642.5,4010.5,4598.0,2574.5,TPR repeat  putative,<2C (LG1)
Tb927.11.16390,7255.0,4493.5,4181.0,3649.5,5230.0,cyclin dependent kinases regulatory subunit  putative,<2C (LG1)
Tb927.11.16400,1460.0,6683.5,7249.5,6035.0,6247.5,kinetoplast-associated protein 3  putative,S
Tb11.NT.208,612.5,1455.0,1585.5,1899.5,2483.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.11.16410,612.5,5689.0,4622.0,5004.5,7060.5,enolase  putative,>4C (GG2M)
Tb927.11.16420,7130.0,3723.5,3431.0,3992.5,2964.0,Methyltransferase TYW3  putative,<2C (LG1)
Tb927.11.16430,5199.5,4474.0,4364.5,3087.5,3365.0,18 kDa ER-associated protein,<2C (LG1)
Tb927.11.16440,4305.5,4268.0,4653.0,3616.5,1355.0,Transmembrane protein 18  putative,S
Tb927.11.16450,1914.0,2000.5,1757.0,2389.0,1374.5,hypothetical protein  conserved,G2M
Tb927.11.16460,10317.5,9641.0,8646.5,7625.0,7406.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16470,6542.5,9808.0,9927.0,10376.5,11416.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.11.16480,3929.5,8160.0,8386.0,8502.0,7592.0,enoyl-CoA hydratase/isomerase family protein  putative,G2M
Tb927.11.16490,9123.0,8590.5,8318.5,8470.0,8657.0,Methyltransferase-associated protein,<2C (LG1)
Tb927.11.16500,9650.0,9363.5,10082.5,9233.0,9972.5,hypothetical protein  conserved,S
Tb11.NT.210,612.5,1838.0,1475.5,1071.0,607.0,Noncoding RNA  putative,G1
Tb927.11.16510,612.5,690.0,471.5,687.0,607.0,hypothetical protein  conserved,G1
Tb927.11.16520,612.5,3120.0,2996.5,2788.5,994.0,hypothetical protein  conserved,G1
Tb927.11.16530,10281.0,10460.0,10541.5,10556.5,9782.0,hypothetical protein  conserved,G2M
Tb927.11.16540,612.5,664.5,313.0,534.5,461.5,Roadblock/LC7 domain containing protein  putative,G1
Tb927.11.16550,9751.0,10993.0,10444.5,10577.5,10232.5,Zinc finger protein  C3H1 type-like,G1
Tb927.11.16560,7977.5,9448.0,10062.5,8940.0,9442.5,Nucleotide sugar transporter 2,S
Tb927.11.16570,3437.5,6561.0,6379.0,6077.0,5702.0,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.11.16575,3751.5,2214.5,1603.5,2311.0,2402.0,hypothetical protein,<2C (LG1)
Tb927.11.16580,7516.0,9077.0,8436.5,7776.5,8282.5,hypothetical protein  conserved,G1
Tb927.11.16590,4048.0,5757.0,4878.5,5824.5,5675.0,RNA-binding protein  putative,G2M
Tb927.11.16600,7180.5,2949.5,3388.5,2404.0,3225.0,exosome-associated protein 2,<2C (LG1)
Tb927.11.16610,10338.0,10641.0,10761.0,10665.0,10617.0,zinc-finger of a C2HC-type  putative,S
Tb927.11.16615,612.5,640.0,271.5,366.5,486.0,Protein of unknown function (DUF2638)  putative,G1
Tb927.11.16620,8627.5,8254.0,8785.0,8529.5,7559.0,hypothetical protein  conserved,S
Tb927.11.16630,8808.0,10377.0,10556.5,10464.5,10854.5,major facilitator superfamily  putative,>4C (GG2M)
Tb927.11.16640,5218.0,4886.5,3779.5,5037.0,3006.0,Uncharacterised protein family UPF0564  putative,<2C (LG1)
Tb927.11.16650,11411.0,9175.5,9589.5,9627.0,8921.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16660,11309.0,11521.0,11468.0,11441.0,11453.0,Dopey  N-terminal  putative,G1
Tb927.11.16670,10756.0,8127.5,8752.5,7906.5,5145.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16680,3380.0,7116.0,5645.0,5551.0,7015.5,tRNA pseudouridine synthase D (TruD)  putative,G1
Tb927.11.16690,11215.0,9526.5,9594.5,8806.5,9114.5,Voltage-gated Chloride channel Like 3,<2C (LG1)
Tb927.11.16700,8165.5,10648.5,10719.0,10875.0,9624.5,hypothetical protein  conserved,G2M
Tb927.11.16710,5697.0,3787.0,3323.5,2642.5,2671.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16720,6381.5,3596.0,4181.0,6683.5,6104.0,mitotic cyclin 6,G2M
Tb927.11.16730,10314.0,10085.5,10207.5,9649.0,8965.5,dihydrolipoyl dehydrogenase,<2C (LG1)
Tb927.11.16740,10177.5,7962.0,8568.5,8589.5,8979.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.11.16750,5573.5,6148.5,6452.5,5392.0,6074.0,hypothetical protein  conserved,S
Tb927.11.16760,4027.5,1542.0,3101.5,2373.0,6307.0,T-complex protein 1  alpha subunit  putative,>4C (GG2M)
Tb927.11.16770,8403.5,5650.5,6561.5,6056.0,5824.0,glucosamine-6-phosphate isomerase  putative,<2C (LG1)
Tb927.11.16780,9300.0,7578.5,7209.5,7719.0,8606.5,hypothetical protein,<2C (LG1)
Tb927.11.16790,2886.0,7290.5,7578.5,6612.5,6938.5,mitogen-activated protein kinase,S
Tb927.11.16800,11236.0,10979.0,10968.0,10741.0,10789.0,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16810,612.5,4214.5,2961.0,5765.5,8937.5,dynein light intermediate chain D1bLIC  putative,>4C (GG2M)
Tb927.11.16820,7987.0,9797.5,8722.0,9898.0,9378.5,hypothetical protein  conserved,G2M
Tb927.11.16830,3957.5,4663.0,7198.5,4951.0,9496.0,Rab-like 5  small G protein,>4C (GG2M)
Tb927.11.16840,10217.0,8989.5,8290.5,8892.5,8993.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.16850,7790.0,10090.0,9740.5,9736.5,9972.5,Golgi transport complex subunit 5  putative,G1
Tb927.11.16860,10123.5,8228.5,8152.5,7752.0,6950.5,Guide RNA binding complex protein 3,<2C (LG1)
Tb927.11.16870,6733.0,4034.0,3560.0,4279.5,5593.5,NADH-ubiquinone oxidoreductase B8 subunit,<2C (LG1)
Tb927.11.16880,10535.5,7561.5,8277.0,8985.0,10045.5,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.11.16890,9787.5,9431.0,9321.0,9588.0,11536.0,Tetratricopeptide-like helical domain containing protein,>4C (GG2M)
Tb927.11.16900,9858.5,7277.5,8510.0,8172.5,11068.0,hypothetical protein,>4C (GG2M)
Tb927.11.16910,9686.5,10615.5,10524.0,10406.5,10852.5,Serine hydrolase (FSH1)/RWD domain/50S ribosome-binding GTPase/GTPase of unknown function C-terminal  putative,>4C (GG2M)
Tb927.11.16915,612.5,1520.0,1623.0,1504.0,1179.0,hypothetical protein,S
Tb927.11.16920,6575.5,7736.5,8430.5,8076.5,6814.0,VSG exclusion protein 1,S
Tb927.11.16930,7837.5,9078.5,9399.5,9213.0,7855.0,ABC transporter of the mitochondrion  putative,S
Tb927.11.16940,8857.0,7465.5,6360.5,6205.5,6240.0,MIZ/SP-RING zinc finger  putative,<2C (LG1)
Tb927.11.16950,612.5,413.0,210.0,366.5,637.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.16960,3904.5,8857.0,8935.0,8460.0,8342.0,SUMO-interacting motif-containing protein,S
Tb927.11.16970,10366.0,10272.5,9788.0,10208.0,9664.0,protein phosphatase 4  putative,<2C (LG1)
Tb927.11.16980,2258.5,3457.0,3779.5,3699.0,6247.5,chaperone protein DnaJ  putative,>4C (GG2M)
Tb927.11.16990,10107.0,7152.0,7962.5,7398.5,7447.5,50S ribosome-binding GTPase  putative,<2C (LG1)
Tb927.11.17000,5667.0,1781.0,1886.0,2302.0,8254.5,AIR9-like protein,>4C (GG2M)
Tb927.11.17010,4490.0,2741.5,2679.5,1713.0,3970.0,Rab5-interacting protein (Rab5ip)  putative,<2C (LG1)
Tb927.11.17015,612.5,158.5,253.5,182.5,86.0,Cytochrome c oxidase assembly factor 6 homolog  putative,<2C (LG1)
Tb927.11.17020,2870.5,5811.0,6603.0,4674.0,5657.0,hypothetical protein  conserved,S
Tb927.11.17040,10197.0,11335.0,11212.0,11270.5,10879.5,procyclic-enriched flagellar receptor adenylate cyclase 1,G1
Tb927.11.rRNA_1,2295.5,3632.0,2692.0,3635.0,3555.5,5.8S ribosomal RNA,G2M
Tb927.11.rRNA_2,8017.5,8486.0,8466.5,8254.5,6631.0,28S alpha ribosomal RNA (fragment),G1
Tb927.11.17050,5490.5,5592.5,4316.5,4636.5,4480.5,variant surface glycoprotein (VSG)  pseudogene,G1
Tb927.11.17060,5550.0,3225.0,3260.0,3531.5,2178.0,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.17070,5127.5,1553.5,2060.5,1299.0,1213.5,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.17080,6666.0,5924.5,5286.0,4994.0,4036.5,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.17090,1460.0,845.0,818.5,628.0,1437.0,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.17100,5042.0,3265.5,3755.0,3737.0,2427.0,variant surface glycoprotein (VSG  pseudogene)  fragment,<2C (LG1)
Tb927.11.17110,2460.0,2178.5,2214.0,1352.5,1472.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.17120,8650.5,3827.0,3297.5,2389.0,1472.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.17130,1460.0,6176.0,6034.5,5463.0,7585.5,variant surface glycoprotein (VSG) degenerate and franmeshifted,>4C (GG2M)
Tb927.11.17140,612.5,2498.0,2876.5,2102.5,5847.0,variant surface glycoprotein (VSG)  degenerate and frameshifted,>4C (GG2M)
Tb927.11.17150,4608.5,747.5,717.5,875.0,1860.5,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb927.11.17160,612.5,759.0,848.5,1125.0,1472.0,variant surface glycoprotein (VSG)  degenerate and frameshifted,>4C (GG2M)
Tb927.11.17170,612.5,1344.0,1207.5,1261.0,1758.0,variant surface glycoprotein (VSG)  degenerate,>4C (GG2M)
Tb927.11.17180,2295.5,1643.5,1347.5,1745.0,2065.0,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,<2C (LG1)
Tb927.11.17190,5111.0,3881.5,3599.5,4019.0,4284.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.17200,1914.0,530.0,596.0,248.0,697.5,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,<2C (LG1)
Tb927.11.17210,612.5,2149.5,3487.0,1665.0,672.0,variant surface glycoprotein (VSG)  frameshifted and degenerate,S
Tb927.11.17220,7121.0,5561.5,6489.0,6591.5,6298.5,variant surface glycoprotein (VSG)  degenerate and frameshifted,<2C (LG1)
Tb927.11.17230,7157.5,1344.0,907.5,720.5,1010.0,variant surface glycoprotein (VSG)  point mutation,<2C (LG1)
Tb927.11.17240,2295.5,2457.0,1489.0,2589.0,1027.5,variant surface glycoprotein (VSG)  fragment  degenerate,G2M
Tb927.11.17250,5402.0,4937.5,4950.0,5530.5,4036.5,variant surface glycoprotein (VSG)  degenerate,G2M
Tb927.11.17260,1460.0,322.0,233.5,221.5,213.0,variant surface glycoprotein (VSG)  fragment  degenerate,<2C (LG1)
Tb927.11.17270,612.5,1322.5,2341.0,1343.0,2563.0,variant surface glycoprotein (VSG)  frameshifted and point mutation,>4C (GG2M)
Tb927.11.17280,6151.5,7893.5,7777.5,7719.0,8182.0,variant surface glycoprotein (VSG)  point mutation,>4C (GG2M)
Tb927.11.17290,4298.5,2992.5,4069.0,4205.5,3248.5,variant surface glycoprotein (VSG)  point mutation,<2C (LG1)
Tb927.11.17300,5944.5,2384.0,2196.0,2725.0,5555.0,variant surface glycoprotein (VSG)  frameshifted and point mutated pseudogene,<2C (LG1)
Tb927.11.17310,2137.5,2250.0,2341.0,2335.0,1758.0,hypothetical protein  conserved  point mutation,S
Tb927.11.17320,4425.0,2409.5,3079.0,2642.5,4654.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.17330,4010.5,5914.5,6475.0,5992.0,6784.5,variant surface glycoprotein (VSG)  degenerate,>4C (GG2M)
Tb927.11.17340,1988.0,5355.0,5265.0,4542.0,5394.5,expression site-associated gene 3 (ESAG3)  frameshifted and degenerate,>4C (GG2M)
Tb927.11.17350,1988.0,4967.0,4002.0,2858.5,3185.0,variant surface glycoprotein (VSG)  frameshifted and degenerate,G1
Tb927.11.17360,7096.0,5221.5,4476.0,3711.5,3693.0,variant surface glycoprotein (VSG)  degenerate,<2C (LG1)
Tb927.11.17370,612.5,1653.5,1054.0,1171.0,1582.0,variant surface glycoprotein (VSG)  putative,G1
Tb927.11.17380,2901.0,1975.0,3167.0,2775.0,1010.0,variant surface glycoprotein (VSG)  frameshifted and interrupted,S
Tb927.11.17390,6649.0,7121.0,7342.5,7617.5,8927.0,expression site-associated gene 3 (ESAG3)  frameshifted and degenerate,>4C (GG2M)
Tb927.11.17400,9341.5,6804.5,6000.0,7469.0,6945.5,variant surface glycoprotein (VSG)  fragment,<2C (LG1)
Tb927.11.17410,6656.0,6386.5,6417.0,6647.5,6623.0,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb927.11.17420,1988.0,2864.5,3410.0,3130.0,4517.5,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted fragment,>4C (GG2M)
Tb927.11.17430,4728.0,4008.0,4680.0,3866.5,4459.5,variant surface glycoprotein (VSG)  fragment,<2C (LG1)
Tb927.11.17440,1914.0,3225.0,2866.5,4301.0,1717.0,variant surface glycoprotein (VSG)  degenerate,G2M
Tb927.11.17450,4985.5,8020.5,7975.5,7762.0,5795.0,variant surface glycoprotein (VSG)  frameshifted and degenerate,G1
Tb927.11.17460,6741.5,9543.5,9809.0,8783.0,8559.0,variant surface glycoprotein (VSG)  frameshifted and interrupted,S
Tb927.11.17470,1914.0,1344.0,658.5,1281.0,1636.0,variant surface glycoprotein (VSG)  frameshifted and degenerate fragment,<2C (LG1)
Tb927.11.17480,3214.5,1009.0,1347.5,1558.5,584.5,variant surface glycoprotein (VSG)  degenerate,<2C (LG1)
Tb927.11.17490,612.5,3535.0,3542.0,3711.5,4391.0,variant surface glycoprotein (VSG)  point mutation,>4C (GG2M)
Tb927.11.17500,4713.5,4754.0,4476.0,4928.5,5870.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.17510,1460.0,4172.0,4896.0,4872.5,3760.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.17520,6533.5,4305.0,4246.0,4782.0,1407.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.17530,6106.5,1190.0,1041.5,890.0,1422.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.17540,9354.0,10632.5,10737.0,10191.5,9945.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.17550,9151.0,10515.5,9774.0,10257.0,10198.5,variant surface glycoprotein (VSG)  frameshifted,G1
Tb927.11.17560,6361.5,4816.5,5728.0,4962.5,5064.5,variant surface glycoprotein (VSG)  frameshifted and point mutation,<2C (LG1)
Tb927.11.17570,1783.5,3872.5,2876.5,2756.0,915.0,variant surface glycoprotein (VSG)  frameshifted and degenerate,G1
Tb927.11.17580,612.5,1661.5,2219.0,2199.0,347.0,variant surface glycoprotein (VSG  atypical)  putative,S
Tb927.11.17590,4982.0,3950.5,3658.5,3785.5,6112.5,variant surface glycoprotein (VSG)  frameshifted and point mutation,>4C (GG2M)
Tb927.11.17600,8313.0,6813.0,5551.5,6831.0,5803.0,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb927.11.17610,11115.0,10225.5,9850.5,9762.5,9601.5,variant surface glycoprotein (VSG)  frameshifted and point mutation,<2C (LG1)
Tb927.11.17620,2406.5,1574.5,940.5,1110.5,433.0,variant surface glycoprotein (VSG)  fragment,<2C (LG1)
Tb927.11.17630,1783.5,6458.5,7235.5,6626.0,7847.5,variant surface glycoprotein (VSG)  frameshifted and degenerate,>4C (GG2M)
Tb927.11.17640,612.5,6650.5,7103.5,7119.0,5713.5,expression site-associated gene 3 (ESAG3)  frameshifted and degenerate,G2M
Tb927.11.17650,4339.5,2571.5,2738.5,3616.5,2495.0,variant surface glycoprotein (VSG)  frameshifted  interrupted and point mutation,<2C (LG1)
Tb927.11.17660,2886.0,1661.5,1938.0,1675.5,1027.5,variant surface glycoprotein (VSG)  frameshifted and degenerate fragment interrupted,<2C (LG1)
Tb927.11.17670,10182.5,3374.0,3930.5,4446.0,1860.5,variant surface glycoprotein (VSG)  degenerate,<2C (LG1)
Tb927.11.17680,8513.5,7487.0,6550.5,8319.0,6770.5,variant surface glycoprotein (VSG)  point mutation,<2C (LG1)
Tb927.11.17690,1783.5,1520.0,3658.5,2577.5,1944.0,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted fragment,S
Tb927.11.17700,2504.5,2000.5,1361.0,2264.5,1437.0,variant surface glycoprotein (VSG)  degenerate,<2C (LG1)
Tb927.11.17710,9120.5,3950.5,3308.0,4070.5,3323.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.11.17720,3358.0,1585.5,1886.0,3045.0,2505.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.17730,10081.0,6626.0,8015.5,7188.5,7161.5,variant surface glycoprotein (VSG)  frameshifted and degenerate,<2C (LG1)
Tb927.11.17740,612.5,2384.0,2389.0,1792.5,2647.0,variant surface glycoprotein (VSG)  degenerate fragment,>4C (GG2M)
Tb927.11.17750,612.5,40.5,210.0,111.0,86.0,variant surface glycoprotein (VSG)  fragment interrupted,<2C (LG1)
Tb927.11.17760,6479.5,5210.5,5962.0,5695.0,4276.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.17770,2481.0,2296.0,940.5,1792.5,213.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.17780,2504.5,709.0,1324.0,1805.5,1504.0,variant surface glycoprotein (VSG)  degenerate,<2C (LG1)
Tb927.11.17790,6052.0,7554.5,6577.0,7416.5,4541.5,variant surface glycoprotein (VSG)  degenerate and frameshifted,G1
Tb927.11.17800,612.5,4630.0,4758.5,2821.0,3950.0,variant surface glycoprotein (VSG)  degenerate,S
Tb927.11.17810,1914.0,4693.0,5469.5,3557.0,2898.5,variant surface glycoprotein (VSG)  frameshifted and degenerate,S
Tb927.11.17820,9288.0,7956.0,7520.5,8144.5,6826.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.11.17830,4480.0,2516.5,2369.0,2697.5,2884.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.17840,9357.0,9991.5,9464.0,9775.5,7704.5,retrotransposon hot spot protein (RHS)  degenerate,G1
Tb927.11.17850,2870.5,3407.5,2164.5,1430.0,3748.5,expression site-associated gene 9 (ESAG9)  fragment,>4C (GG2M)
Tb927.11.17860,8161.5,7776.0,8324.5,8144.5,7262.5,hypothetical protein  conserved,S
Tb927.11.17870,2780.5,4429.5,4632.5,4504.5,5379.5,variant surface glycoprotein (VSG)  interrupted,>4C (GG2M)
Tb927.11.17880,3785.5,5031.5,5276.5,3545.0,2631.5,expression site-associated gene 9 (ESAG9)  degenerate,S
Tb927.11.17890,9765.0,10299.5,9730.0,10358.5,8374.0,expression site-associated gene 1 (ESAG1) protein  putative,G2M
Tb927.11.17900,8002.0,5196.0,4316.5,4318.0,3386.5,Trypanosomal VSG domain containing protein  putative,<2C (LG1)
Tb927.11.17910,8423.0,8571.0,8105.0,8436.5,7725.5,hypothetical protein,G1
Tb927.11.17920,2047.0,2187.0,2182.5,2656.5,1027.5,variant surface glycoprotein (VSG)  frameshifted,G2M
Tb927.11.17930,1460.0,2601.0,3092.0,2999.5,2941.0,variant surface glycoprotein (VSG)  degenerate and frameshifted,S
Tb927.11.17940,6061.5,5416.0,4878.5,4252.5,4770.5,variant surface glycoprotein (VSG)  fragment,<2C (LG1)
Tb927.11.17950,612.5,5924.5,4622.0,2764.5,8048.5,variant surface glycoprotein (VSG)  degenerate and frameshifted,>4C (GG2M)
Tb927.11.17960,3478.0,867.5,778.0,989.0,697.5,variant surface glycoprotein (VSG)  degenerate,<2C (LG1)
Tb927.11.17970,612.5,96.0,130.5,82.5,213.0,expression site-associated gene 3 (ESAG3)  fragment,<2C (LG1)
Tb927.11.17980,1988.0,3586.5,4689.0,3418.5,1789.5,variant surface glycoprotein (VSG)  degenerate,S
Tb927.11.17990,7730.0,4838.0,5256.0,7009.0,6289.5,hypothetical protein  conserved  point mutation,<2C (LG1)
Tb927.11.18000,3261.0,1520.0,2023.5,2134.5,2283.5,variant surface glycoprotein (VSG)  frameshifted and point mutation,<2C (LG1)
Tb927.11.18010,2047.0,588.0,848.5,941.0,1717.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.11.18020,2047.0,2078.0,1989.5,1261.0,3741.0,variant surface glycoprotein (VSG)  fragment,>4C (GG2M)
Tb927.11.18030,612.5,358.0,520.0,592.5,915.0,variant surface glycoprotein (VSG)  fragment,>4C (GG2M)
Tb927.11.18040,5534.0,4181.5,5358.0,3737.0,3950.0,expression site-associated gene 3 (ESAG3)  frameshifted and degenerate,<2C (LG1)
Tb927.11.18050,9642.5,9570.0,8120.5,8695.0,8345.0,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb927.11.18060,4910.5,5446.5,4586.5,4476.0,4938.0,variant surface glycoprotein (VSG)  frameshifted,G1
Tb927.11.18070,612.5,3194.0,4069.0,4962.5,2231.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.18080,612.5,877.0,1361.0,1504.0,1582.0,variant surface glycoprotein (VSG)  frameshifted and point mutation,>4C (GG2M)
Tb927.11.18090,1460.0,3256.0,3051.5,1911.5,2039.0,variant surface glycoprotein (VSG)  frameshifted,G1
Tb927.11.18100,2637.5,3827.0,2207.0,3332.5,3185.0,expression site-associated gene 3 (ESAG3)  degenerate,G1
Tb927.11.18110,7935.5,5479.0,5696.5,6282.0,4617.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.18120,5573.5,3158.0,3420.5,2967.0,4517.5,variant surface glycoprotein (VSG)  frameshifted and degenerate,<2C (LG1)
Tb927.11.18130,3054.0,1982.5,2023.5,2483.5,672.0,hypothetical protein  conserved  frameshifted and point mutation,<2C (LG1)
Tb927.11.18140,11120.0,8429.0,8759.0,7592.5,6808.0,variant surface glycoprotein (VSG)  frameshifted and point mutation,<2C (LG1)
Tb927.11.18150,8961.5,6561.0,5736.5,5525.5,7226.0,variant surface glycoprotein (VSG)  frameshifted and degenerate,<2C (LG1)
Tb927.11.18160,8020.0,7998.5,8653.5,9140.5,9570.5,expression site-associated gene 3 (ESAG3)  degenerate,>4C (GG2M)
Tb927.11.18170,9553.5,8003.5,7498.5,7698.5,7816.0,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb927.11.18180,5428.0,2983.5,4411.0,3924.0,4158.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.11.18190,11207.0,7157.0,5817.5,7426.5,8048.5,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb927.11.18210,9078.0,7524.0,8023.0,7059.0,4874.0,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb927.11.18220,6308.5,3711.5,4758.5,4908.0,2463.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.18230,7277.5,5537.5,5315.0,5497.0,3794.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.18240,2357.5,4420.5,3464.5,4327.5,2928.5,variant surface glycoprotein (VSG)  pseudogene,G1
Tb927.11.18250,10307.0,11523.0,11534.0,11445.0,11421.5,variant surface glycoprotein (VSG)  putative,S
Tb927.11.18260,1988.0,2621.0,3633.5,3272.5,1676.0,variant surface glycoprotein (VSG)  putative,S
Tb927.11.18270,7591.5,3245.0,2827.0,3677.0,3386.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.18280,1783.5,1492.5,1679.0,1847.0,1392.5,ESAG7 (expression site associated protein 7)  putative (pseudogene),G2M
Tb927.11.18290,612.5,543.0,994.0,1374.0,1355.0,variant surface glycoprotein (VSG)  putative,G2M
Tb927.11.18300,612.5,2224.0,6495.5,5198.5,2857.0,variant surface glycoprotein (VSG)  putative (pseudogene),S
Tb927.11.18310,11599.0,11547.0,11570.0,11524.0,11500.0,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18320,612.5,398.0,832.0,382.0,1744.5,variant surface glycoprotein (VSG)  putative (pseudogene),>4C (GG2M)
Tb927.11.18330,7622.0,2232.0,3028.0,2554.0,3606.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.18340,612.5,2957.5,2488.5,2223.0,2671.5,variant surface glycoprotein (VSG)  putative (pseudogene),G1
Tb927.11.18350,5402.0,4172.0,3813.0,4486.5,3681.5,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18360,8689.5,4663.0,4823.0,4205.5,7834.0,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18370,6319.5,3747.5,4632.5,4699.5,5943.5,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18380,6372.0,3380.0,4662.5,4279.5,5788.5,variant surface glycoprotein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18390,612.5,438.0,717.5,483.0,86.0,Variant Surface Glycoprotein  putative,S
Tb927.11.18400,3550.5,1914.0,1783.0,1861.0,2336.0,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb927.11.18410,6042.0,4928.0,4271.0,4318.0,3861.0,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb927.11.18420,6714.0,3068.0,3364.5,3367.5,2692.0,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb927.11.18430,1460.0,1415.5,2023.5,2290.0,3323.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.18440,2637.5,1492.5,1111.5,1171.0,994.0,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb927.11.18450,9051.5,9146.0,9705.5,9482.5,9542.0,variant surface glycoprotein (VSG)  pseudogene,S
Tb927.11.18460,9424.0,10513.0,10653.5,10121.0,9714.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.18470,7023.5,1924.0,2262.5,2038.5,3110.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.11.18480,10883.0,9740.0,9099.5,9200.5,7944.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.11.18490,3341.5,747.5,685.0,610.5,778.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.11.18500,10749.0,9994.5,8863.5,9217.5,9511.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb927.11.18510,6080.5,8328.5,7283.5,7377.0,7681.5,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb927.11.18520,2870.5,600.0,233.5,204.0,505.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.18530,2436.0,1766.0,1909.5,1403.5,2563.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.11.18540,612.5,7818.0,8172.5,7361.0,7655.5,variant surface glycoprotein (VSG)  putative,S
Tb927.11.18550,4480.0,1789.5,2050.0,839.0,505.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.18560,3419.0,5798.0,6089.5,4542.0,4703.5,variant surface glycoprotein (VSG)  putative,S
Tb927.11.18570,1460.0,1838.0,1402.0,1329.0,2336.0,variant surface glycoprotein (VSG)  pseudogene,>4C (GG2M)
Tb927.11.18580,612.5,811.0,865.5,577.5,1842.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.18590,4163.5,5484.0,6192.0,5551.0,3386.5,variant surface glycoprotein (VSG)  putative,S
Tb927.11.18600,2700.0,5243.0,4680.0,3856.5,4403.5,variant surface glycoprotein (VSG)  putative,G1
Tb927.11.18610,8941.0,8176.0,9117.5,7426.5,7139.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,S
Tb927.11.18620,3964.5,2260.5,2050.0,1726.5,1878.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.18630,8572.5,8949.0,9612.0,8185.5,7465.5,ingi-related retroposon  putative (pseudogene),S
Tb927.11.18640,7157.5,4027.0,4529.5,3950.5,2609.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.1431,6402.5,4806.0,4518.5,4647.0,4440.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1441,612.5,413.0,562.5,557.5,584.5,variant surface glycoprotein (VSG  pseudogene)  fragment,<2C (LG1)
Tb11.1451,7436.0,5017.0,4790.5,5704.5,6253.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0111,612.5,799.5,1137.0,1299.0,213.0,variant surface protein (VSG)  putative,G2M
Tb11.v5.0112,3922.5,8137.5,7840.0,8498.5,9017.0,variant surface protein (VSG)  putative,>4C (GG2M)
Tb11.v5.0113,4972.0,8959.0,7953.5,8583.0,6006.0,variant surface protein (VSG)  putative,G1
Tb11.v5.0114,9440.0,7862.0,7865.5,7921.0,7782.5,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb11.v5.0115,6874.5,4920.0,4586.5,5198.5,5664.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0116,5386.5,5542.0,3127.0,5317.0,2647.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb11.v5.0117,8274.5,7787.0,6687.5,7557.0,6334.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0118,7173.0,4467.0,5208.5,3866.5,3399.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0119,5477.5,2490.5,1909.5,2642.5,1944.0,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb11.v5.0120,612.5,358.0,373.5,419.0,672.0,variant surface protein (VSG)  putative,>4C (GG2M)
Tb11.v5.0121,612.5,2839.5,2310.0,2009.0,915.0,variant surface protein (VSG)  putative,G1
Tb11.v5.0122,3041.5,3367.5,3578.0,4476.0,4266.0,variant surface protein (VSG)  putative,G2M
Tb11.v5.0123,612.5,1043.5,491.0,687.0,86.0,variant surface protein (VSG)  putative,G1
Tb11.v5.0124,5320.5,2429.0,4104.0,3216.0,1660.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0125,1460.0,700.5,865.5,592.5,818.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0126,612.5,1190.0,596.0,483.0,86.0,expression site-associated gene 3 (ESAG3) protein  putative,G1
Tb11.v5.0127,4594.0,1153.5,1700.5,1416.5,895.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0128,612.5,1171.5,1650.0,1572.5,1565.5,variant surface protein (VSG)  putative,S
Tb11.v5.0129,10055.5,11055.0,11078.5,10996.0,10458.5,variant surface protein (VSG)  putative,S
Tb11.v5.0130,4978.5,1492.5,1848.0,1391.5,1744.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0131,2956.5,1914.0,1311.0,1805.5,1304.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0132,8269.5,5585.0,5054.0,5148.0,3169.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0133,612.5,2106.0,2289.5,3666.5,1958.0,variant surface protein (VSG)  putative,G2M
Tb11.v5.0134,612.5,530.0,630.0,464.0,347.0,variant surface glycoprotein (VSG)  pseudogene,S
Tb11.v5.0135,5162.5,2808.0,2399.5,1888.0,3386.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0136,612.5,1437.5,1030.5,788.5,1304.5,variant surface protein (VSG)  putative,G1
Tb11.v5.0137,612.5,2687.5,2360.0,2788.5,3353.0,variant surface protein  atypical (VSG)  putative,>4C (GG2M)
Tb11.v5.0138,6080.5,2358.5,2653.0,3938.0,3295.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0139,612.5,2436.0,1945.0,1585.5,4967.0,variant surface protein (VSG)  putative,>4C (GG2M)
Tb11.v5.0140,4480.0,2964.5,3215.0,2422.0,4365.0,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb11.v5.0141,612.5,386.5,233.5,204.0,347.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0142,4905.0,2490.5,3009.0,3343.0,3576.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0143,8374.5,1476.5,1361.0,2058.5,672.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0144,612.5,2760.5,2351.5,3699.0,287.0,variant surface protein (VSG)  putative,G2M
Tb11.v5.0145,9480.5,6538.5,7736.0,7350.0,5972.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb11.v5.0146,3054.0,5095.5,4200.5,3815.5,4822.5,chaperone protein DnaJ  putative,G1
Tb11.v5.0147,8361.0,6890.0,6997.5,5838.5,6851.5,Calponin homology (CH) domain containing protein  putative,<2C (LG1)
Tb11.v5.0148,9195.5,9016.5,8863.5,9401.0,9983.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0149,6163.0,3711.5,4670.0,3826.0,3235.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0150,9677.5,7992.5,7568.0,7027.5,7077.0,J Biosynthesis Protein 2,<2C (LG1)
Tb11.v5.0151,612.5,5295.0,4662.5,4433.0,5034.5,hypothetical protein  conserved,G1
Tb11.v5.0152,11531.0,11130.0,10973.5,11019.0,10781.0,ribosomal RNA processing protein 4  putative,<2C (LG1)
Tb11.v5.0153,7185.0,7110.0,7265.0,7126.0,7169.5,BarP protein  putative,S
Tb11.v5.0154,4086.0,3900.0,2684.5,4908.0,6764.0,WD domain  G-beta repeat  putative,>4C (GG2M)
Tb11.v5.0155,8236.5,5355.0,5494.0,6045.0,7047.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0156,2956.5,4895.5,4388.0,4381.0,3235.0,hypothetical protein  conserved,G1
Tb11.v5.0157,6291.5,4406.0,3767.5,3282.0,3033.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0158,5709.5,4920.0,5015.0,5716.5,5745.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0159,7774.5,6001.5,5685.5,4782.0,6836.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0160,8009.5,5841.0,5315.0,4567.5,4508.5,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb11.v5.0161,1783.5,1220.5,1030.5,925.0,1078.0,conserved hypothetical protein  putative,<2C (LG1)
Tb11.v5.0162,5361.5,640.0,1831.0,3142.0,1120.5,proteasome beta 6 subunit,<2C (LG1)
Tb11.v5.0163,8448.5,6530.5,6178.5,5538.5,4022.0,HD domain containing protein  putative,<2C (LG1)
Tb11.v5.0164,1460.0,787.5,795.0,720.5,86.0,Trm112p-like protein  putative,<2C (LG1)
Tb11.v5.0165,6417.5,3206.5,2327.5,2735.0,3076.5,kinesin  putative,<2C (LG1)
Tb11.v5.0166,3701.5,5261.5,7269.0,6899.0,4645.0,hypothetical protein  conserved,S
Tb11.v5.0167,6248.5,1858.0,1999.5,2025.0,1531.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0168,4313.5,2652.5,2440.5,1980.0,2178.0,FHA domain containing protein  putative,<2C (LG1)
Tb11.v5.0169,7923.0,3273.5,3179.5,3677.0,3033.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0170,8105.0,6089.0,6066.5,6515.5,3752.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0171,9967.0,9501.0,8942.5,8921.0,7426.0,5'-3' exonuclease XRNA  putative,<2C (LG1)
Tb11.v5.0172,5120.0,4474.0,4550.5,4146.0,5824.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0173,5766.5,8259.5,7901.5,7410.0,7662.5,hypothetical protein  conserved,G1
Tb11.v5.0174,5511.0,3298.5,3688.0,3773.5,3335.5,ribonuclease H1  putative,<2C (LG1)
Tb11.v5.0175,612.5,7799.5,8552.5,6755.5,6096.5,oligopeptidase B protein  putative,S
Tb11.v5.0176,612.5,4242.0,3531.0,4126.5,4822.5,NAD(p)-dependent steroid dehydrogenase-like protein,>4C (GG2M)
Tb11.v5.0177,6980.0,4996.5,4695.5,4579.0,5898.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0178,11159.0,10336.5,10248.5,10232.0,9272.0,glutamine synthetase  putative,<2C (LG1)
Tb11.v5.0179,6339.0,2000.5,1938.0,1654.0,2376.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0180,2598.0,8070.5,8005.5,6683.5,6344.5,hypothetical protein  conserved,G1
Tb11.v5.0181,612.5,373.5,373.5,221.5,213.0,60S ribosomal protein L19  putative,<2C (LG1)
Tb11.v5.0182,612.5,1095.0,1078.0,1003.0,2297.5,60S ribosomal protein L19  putative,>4C (GG2M)
Tb11.v5.0183,5257.0,4287.0,4271.0,3677.0,2495.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0184,7054.5,3740.5,4462.5,7009.0,10545.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0185,612.5,1293.5,189.5,1097.5,10458.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0186,8386.5,5454.0,5919.0,5704.5,6826.5,CLN3 protein  putative,<2C (LG1)
Tb11.v5.0187,5413.5,1670.0,1041.5,1329.0,3576.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0188,6464.5,7226.5,7198.5,6573.5,4541.5,ATP-NAD kinase  putative,G1
Tb11.v5.0189,8408.0,5992.0,6678.0,6374.0,6890.0,condensin complex subunit 2  putative,<2C (LG1)
Tb11.v5.0190,6912.5,6265.5,5962.0,6171.5,4703.5,protein kinase  putative,<2C (LG1)
Tb11.v5.0191,612.5,1266.0,1226.0,1479.0,287.0,ELMO/CED-12 family  putative,G2M
Tb11.v5.0192,10188.0,9383.5,9238.0,9460.5,9907.0,B-box zinc finger  putative,<2C (LG1)
Tb11.v5.0193,4327.5,2820.5,3364.5,3216.0,2734.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0194,9751.0,6736.0,6712.5,6428.5,8020.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0195,8091.0,8086.5,8060.5,8172.5,9161.5,STAG domain containing protein  putative,>4C (GG2M)
Tb11.v5.0196,4496.5,1171.5,1179.5,1343.0,1647.0,Proteasome subunit A N-terminal signature/Proteasome subunit  putative,<2C (LG1)
Tb11.v5.0197,1783.5,588.0,596.0,577.5,744.5,clathrin heavy chain  putative,<2C (LG1)
Tb11.v5.0198,3054.0,867.5,1111.5,808.0,818.0,clathrin heavy chain  putative,<2C (LG1)
Tb11.v5.0199,7863.0,3900.0,4271.0,3393.5,3606.5,universal minicircle sequence binding protein  putative,<2C (LG1)
Tb11.v5.0200,612.5,471.5,615.0,444.5,86.0,proteasome beta 5 subunit  putative,S
Tb11.v5.0201,9779.0,7746.5,6744.5,7687.0,6173.5,tRNA pseudouridine synthase A  putative,<2C (LG1)
Tb11.v5.0202,7096.0,6229.5,6655.0,6009.0,6059.0,Protein of unknown function (DUF2419)  putative,<2C (LG1)
Tb11.v5.0203,612.5,3672.0,4069.0,3282.0,6491.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0204,8680.5,5039.5,5822.0,5159.0,6153.5,Peptidase M76 family  putative,<2C (LG1)
Tb11.v5.0205,5593.5,6373.5,5759.5,4542.0,6385.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0206,5450.0,5104.5,5097.0,3826.0,5772.0,phosphatidylinositolN-acetylglucosaminyltransferase  putative,>4C (GG2M)
Tb11.v5.0207,9396.5,11261.0,11177.0,11155.5,11094.0,neurobeachin/beige protein  putative,G1
Tb11.v5.0208,6552.0,5331.5,5452.0,4454.5,2661.5,invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0209,10440.0,9595.5,9382.0,9185.0,8814.0,Adenylate and Guanylate cyclase catalytic domain containing protein  putative,<2C (LG1)
Tb11.v5.0210,2780.5,4348.5,4271.0,4166.5,2389.0,adenosine transporter  putative,G1
Tb11.v5.0211,612.5,4188.5,3902.0,3463.5,2268.0,galactokinase-like protein  putative,G1
Tb11.v5.0212,9762.5,9342.5,9906.0,9793.5,10366.0,ribulose-phosphate 3-epimerase  putative,>4C (GG2M)
Tb11.v5.0213,11288.0,11518.0,11538.0,11514.0,11339.0,variant surface protein (VSG)  putative,S
Tb11.v5.0214,11702.0,11698.0,11694.0,11698.0,11680.0,retrotransposon hot spot (RHS) protein  putative,<2C (LG1)
Tb11.v5.0215,7396.5,5331.5,4607.0,5206.5,3144.5,iron/ascorbate oxidoreductase family protein  putative,<2C (LG1)
Tb11.v5.0216,3328.5,3526.0,3737.5,3356.0,2297.5,invariant surface glycoprotein  putative,S
Tb11.v5.0217,6976.5,4838.0,4598.0,4636.5,4560.5,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb11.v5.0218,10283.5,9302.5,9560.0,8952.0,8748.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0219,10003.0,10501.0,10362.0,10262.0,9978.5,methyltransferase  putative,G1
Tb11.v5.0220,3621.0,2326.0,1692.0,2506.5,2536.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0221,6487.5,7572.5,8026.5,8273.5,8184.5,transporter  putative,G2M
Tb11.v5.0222,2436.0,7451.5,7328.5,5592.0,9293.0,NADH dehydrogenase [ubiquinone] flavoprotein 1  mitochondrial  putative,>4C (GG2M)
Tb11.v5.0223,8729.0,8043.0,8226.0,7768.5,6535.5,BNR repeat-like domain/Concanavalin A-like lectin/glucanases superfamily  putative,<2C (LG1)
Tb11.v5.0224,7888.0,8466.5,8268.5,8052.5,9264.5,invariant surface glycoprotein  putative,>4C (GG2M)
Tb11.v5.0225,5897.5,4866.0,5559.0,5538.5,4849.5,invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0226,8894.0,8695.0,8705.5,8966.5,8553.5,invariant surface glycoprotein  putative,G2M
Tb11.v5.0227,6641.0,7897.5,8536.5,8230.5,7347.5,75 kDa invariant surface glycoprotein  putative,S
Tb11.v5.0228,10245.0,9757.5,9520.0,9242.0,8738.5,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0229,10033.5,5552.5,5325.5,5260.5,4451.0,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0230,3654.0,2975.0,3371.5,3295.5,1516.0,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0231,7911.0,8147.0,9027.5,8858.5,7900.0,75 kDa invariant surface glycoprotein  putative,S
Tb11.v5.0232,2504.5,4400.0,4200.5,4731.0,7930.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0233,11023.5,9841.5,9194.5,10640.0,11697.0,cyclic nucleotide-binding domain containing protein  putative,>4C (GG2M)
Tb11.v5.0234,9346.0,3827.0,3930.5,4146.0,3812.0,ADP-ribosylation factor-like protein  putative,<2C (LG1)
Tb11.v5.0235,6447.0,8827.5,9097.5,8752.5,9340.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0236,5036.5,4400.0,3969.5,3087.5,3596.5,transcription factor Tfb2  putative,<2C (LG1)
Tb11.v5.0237,7313.5,7237.5,7076.5,7167.0,6878.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0238,5902.5,7212.0,5469.5,6407.5,3847.5,Kinesin associated protein  putative,G1
Tb11.v5.0239,5139.0,2839.5,2075.5,4252.5,3693.0,TPR-repeat-containing chaperone protein DNAJ  putative,<2C (LG1)
Tb11.v5.0240,5457.5,3008.5,3464.5,3577.5,2991.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0241,612.5,1059.5,1237.5,1702.0,7147.0,dynein heavy chain  putative,>4C (GG2M)
Tb11.v5.0242,2137.5,5039.5,6296.0,7410.0,11204.0,dynein heavy chain  putative,>4C (GG2M)
Tb11.v5.1060,612.5,554.5,507.0,419.0,287.0,40S ribosomal protein S18  putative,<2C (LG1)
Tb11.v5.0243,612.5,1371.5,1008.5,788.5,1929.5,40S ribosomal protein S18  putative,>4C (GG2M)
Tb11.v5.0244,2826.5,6984.0,6603.0,7275.5,7518.0,RNA-editing complex protein  putative,>4C (GG2M)
Tb11.v5.0245,5766.5,7373.0,7662.0,8011.5,7614.5,protein kinase  putative,G2M
Tb11.v5.0246,4282.0,2498.0,2778.0,2656.5,3248.5,eukaryotic translation initiation factor 6  putative,<2C (LG1)
Tb11.v5.0247,4048.0,2376.0,1721.5,1805.5,1804.5,HIRA-interacting protein 5  putative,<2C (LG1)
Tb11.v5.0248,8925.0,7487.0,8497.0,7921.0,8273.0,pre-mRNA splicing factor ATP-dependent RNA helicase  putative,<2C (LG1)
Tb11.v5.0249,2855.0,5579.0,6055.5,5180.0,2351.0,protein kinase  putative,S
Tb11.v5.0250,612.5,978.5,1179.5,720.5,7624.5,C2 domain containing protein  putative,>4C (GG2M)
Tb11.v5.0251,3692.0,5221.5,4632.5,5517.5,4158.0,phosphatase  putative,G2M
Tb11.v5.0252,9344.0,7049.5,7115.5,6738.5,5266.5,RNA binding protein  putative,<2C (LG1)
Tb11.v5.0253,6498.0,4778.5,4938.0,5148.0,6183.0,major facilitator superfamily  putative,<2C (LG1)
Tb11.v5.0254,10111.0,9457.5,9560.0,9430.5,9337.5,pantothenate kinase subunit  putative,<2C (LG1)
Tb11.v5.0255,3606.0,600.0,615.0,577.5,3055.0,DNA-directed RNA polymerase II  subunit 9  putative,<2C (LG1)
Tb11.v5.0256,5521.0,1807.0,2586.5,2830.5,3812.0,proteasome beta 3 subunit  putative,<2C (LG1)
Tb11.v5.0257,7939.0,6824.0,7736.0,7078.5,8807.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0258,2047.0,664.5,907.5,1171.0,9458.0,Sperm tail/Sperm tail C-terminal domain containing protein  putative,>4C (GG2M)
Tb11.v5.0259,6701.0,7270.0,7934.5,7368.0,6426.0,DHHC palmitoyltransferase  putative,S
Tb11.v5.0260,3028.5,5953.5,6172.5,6465.0,5609.5,neurobeachin/beige protein  putative,G2M
Tb11.v5.0261,1914.0,2042.0,1489.0,1572.5,2231.5,adenosine 5'-monophosphoramidase  putative,>4C (GG2M)
Tb11.v5.0262,11267.5,10642.5,10715.5,10758.5,10446.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0263,5812.5,5867.5,6288.0,5850.0,4550.5,PX domain containing protein  putative,S
Tb11.v5.0264,6429.5,3806.5,3246.5,4742.5,9082.0,Domain of unknown function (DUF4201)  putative,>4C (GG2M)
Tb11.v5.0265,5379.0,2241.5,1923.0,2335.0,3144.5,Thioredoxin-like  putative,<2C (LG1)
Tb11.v5.0266,1460.0,7440.0,6460.5,6357.5,5978.5,hypothetical protein  conserved,G1
Tb11.v5.0267,8925.0,6319.0,5460.5,5069.5,3399.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0268,5435.0,3097.0,2858.0,3057.0,1266.0,60S ribosomal protein-like  putative,<2C (LG1)
Tb11.v5.0269,612.5,1961.5,2036.0,1745.0,672.0,histone acetyltransferase  putative,S
Tb11.v5.0270,2094.5,3407.5,2931.0,2907.5,4110.0,nucleoside hydrolase  putative,>4C (GG2M)
Tb11.v5.0271,612.5,1506.5,893.0,1261.0,8868.5,trypanin  putative,>4C (GG2M)
Tb11.v5.0272,5018.5,4745.0,4896.0,4872.5,9969.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0273,1914.0,1924.0,3599.5,5228.0,8566.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0274,7255.0,6916.5,7009.5,6414.0,7566.0,CBF/Mak21 family  putative,>4C (GG2M)
Tb11.v5.0275,4176.0,7146.5,7724.0,7662.5,5916.5,major vault protein  putative,S
Tb11.v5.0276,8470.0,3827.0,3969.5,4486.5,3669.0,Ribosomal protein S5  C-terminal domain containing protein  putative,<2C (LG1)
Tb11.v5.0277,612.5,158.5,130.5,182.5,347.0,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb11.v5.0278,612.5,345.0,233.5,534.5,672.0,N-terminal glutamine amidase  putative,>4C (GG2M)
Tb11.v5.0279,4680.0,2198.0,2477.5,2541.0,2589.5,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb11.v5.0280,6509.5,8992.0,8882.5,8541.0,8278.5,hypothetical protein  conserved,G1
Tb11.v5.0281,10822.0,10926.0,10721.5,10919.0,9797.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb11.v5.0282,612.5,1585.5,2154.5,1966.0,2964.0,expression site-associated gene (ESAG) protein  putative,>4C (GG2M)
Tb11.02.5050b,11014.0,11336.0,11268.0,11288.0,10735.0,protein kinase  putative,G1
Tb11.02.5060b,4776.0,6058.0,6429.5,5617.5,6575.5,SNF2 DNA repair protein  putative,>4C (GG2M)
Tb11.02.5070b,7658.5,3041.5,3542.0,3117.0,3733.0,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5080b,9530.0,5959.5,4559.5,5741.0,4874.0,Endoplasmic Reticulum-Golgi Intermediate Compartment (ERGIC)/Endoplasmic reticulum vesicle transporter  putative,<2C (LG1)
Tb11.02.5090b,612.5,612.5,685.0,464.0,213.0,proliferator-activated receptor-interacting protein (PRIP) interacting protein (PIMT)  putative  pseudogene,S
Tb11.02.5100b,3252.5,2934.5,1721.5,2223.0,1676.0,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5105b,3407.5,4663.0,3940.5,4446.0,3295.5,hypothetical protein  conserved,G1
Tb11.02.5110b,1988.0,484.0,596.0,419.0,505.0,origin recognition complex subunit 1 (ORC1)  putative,<2C (LG1)
Tb11.02.5120b,4010.5,2983.5,3335.0,2025.0,2977.5,mitochondrial edited mRNA stability factor 1 subunit  putative,<2C (LG1)
Tb11.02.5130b,3882.5,4872.5,4200.5,4464.5,5323.5,neurobeachin/beige protein  putative (fragment),>4C (GG2M)
Tb11.02.5360b,7682.5,5771.5,5519.5,5525.5,5432.0,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5370b,8386.5,4983.0,4139.5,5342.5,4975.5,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5380b,5630.0,5561.5,4767.5,4674.0,5834.5,exosome complex exonuclease RRP44p homologue  putative,>4C (GG2M)
Tb11.02.5390b,8137.0,6787.5,6308.5,5704.5,7638.0,mRNA processing protein  putative,<2C (LG1)
Tb11.02.5400b,8226.5,4172.0,4928.0,5190.5,6719.5,cystathionine beta-synthase  putative,<2C (LG1)
Tb11.02.5410b,612.5,398.0,471.5,248.0,874.5,ubiquitin activating enzyme  putative,>4C (GG2M)
Tb11.02.5420b,10674.0,8427.0,7797.5,7845.5,6878.5,NADPH-cytochrome p450 reductase  putative,<2C (LG1)
Tb11.02.5430b,8204.5,5435.5,6373.5,6935.5,5624.0,hypothetical protein  conserved,<2C (LG1)
Tb11.02.5440b,2258.5,8011.0,8172.5,7776.5,8048.5,SUMO-interacting motif-containing protein,S
Tb11.v5.0283,11725.0,11725.0,11725.0,11725.0,11725.0,variant surface glycoprotein (VSG) pseudogene  putative,<2C (LG1)
Tb11.v5.0284,4760.5,1807.0,2410.5,2058.5,3825.5,variant surface protein  atypical (VSG)  putative,<2C (LG1)
Tb11.v5.0285,612.5,40.5,99.0,111.0,86.0,variant surface protein  putative,<2C (LG1)
Tb11.v5.0286,3621.0,2444.5,2987.0,3992.5,2870.0,variant surface protein  atypical (VSG)  putative,G2M
Tb11.v5.0287,11710.0,11713.0,11711.0,11713.0,11708.0,variant surface protein  putative,G1
Tb11.v5.0288,10777.0,11607.0,11619.0,11578.0,11535.0,ribonucleoside-diphosphate reductase small chain  putative,S
Tb11.v5.0289,11387.0,9479.5,9780.0,9261.5,7431.5,ubiquitin ligase  putative,<2C (LG1)
Tb11.v5.0290,8236.5,3813.5,3039.5,3477.5,4222.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0291,612.5,498.0,818.5,737.0,1860.5,cleavage and polyadenylation specificity factor 30 kDa subunit  putative,>4C (GG2M)
Tb11.v5.0292,7090.5,7783.5,6849.0,7016.0,7077.0,hypothetical protein  conserved,G1
Tb11.1751,11717.0,11714.0,11714.0,11711.0,11713.0,hypothetical protein (pseudogene),<2C (LG1)
Tb11.1810b,7277.5,8789.0,9211.5,9323.0,9188.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,G2M
Tb11.v5.0294,11647.0,11649.0,11632.0,11656.0,11587.0,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0295,8294.0,10752.5,10769.0,10848.0,10205.5,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0296,7490.5,9709.0,9301.5,9951.0,8690.5,variant surface protein  atypical (VSG)  putative,G2M
Tb11.v5.0297,3142.5,1961.5,2275.0,1585.5,2178.0,variant surface protein  putative,<2C (LG1)
Tb11.v5.0298,3494.5,612.5,293.0,464.0,607.0,variant surface protein  putative,<2C (LG1)
Tb11.v5.0299,6980.0,8926.5,8492.0,8465.5,8731.0,variant surface protein  putative,G1
Tb11.v5.0300,612.5,335.0,532.5,501.5,433.0,variant surface protein  atypical (VSG)  putative,<2C (LG1)
Tb11.v5.0301,5844.5,6359.0,7005.5,6388.5,6369.5,glycerol uptake protein  putative,S
Tb11.v5.0302,3841.0,1766.0,1886.0,2321.5,2692.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0303,4580.0,2457.0,2310.0,1779.5,2661.5,pdz domain containing protein  putative,<2C (LG1)
Tb11.v5.0304,8012.0,8250.0,8345.0,7642.5,5647.5,cation transporter  putative,S
Tb11.v5.0305,6575.5,7392.0,7975.5,7410.0,6016.5,TFIID-like protein  putative,S
Tb11.v5.0306,3429.0,4357.5,3813.0,4394.5,3157.0,Triglyceride lipase  putative,G2M
Tb11.v5.0307,9430.0,8621.5,7692.5,8319.0,8840.5,THT1 - hexose transporter  putative,<2C (LG1)
Tb11.v5.0308,8316.0,6359.0,5792.5,5883.5,6826.5,THT1 - hexose transporter  putative,<2C (LG1)
Tb11.v5.0309,7627.5,6538.5,5838.5,6035.0,7002.5,THT1 - hexose transporter  putative,<2C (LG1)
Tb11.v5.0310,7614.0,6397.0,5930.5,5850.0,6670.0,THT1 - hexose transporter  putative,<2C (LG1)
Tb11.v5.0311,2747.5,1344.0,1536.0,1899.5,1958.0,variant surface protein  putative,<2C (LG1)
Tb11.v5.0312,10878.5,6967.5,6460.5,5883.5,5624.0,variant surface protein  putative,<2C (LG1)
Tb11.v5.0313,5870.0,3353.0,4857.0,3616.5,3638.0,variant surface protein  atypical (VSG)  putative,<2C (LG1)
Tb11.v5.0314,1460.0,8850.5,9911.5,9706.5,7655.5,variant surface protein  putative,S
Tb11.v5.0315,3272.0,4474.0,4380.5,5198.5,3199.5,hypothetical protein  conserved,G2M
Tb11.v5.0316,9318.0,10165.0,10770.0,10108.5,10034.5,variant surface protein  atypical (VSG)  putative,S
Tb11.v5.0317,6616.5,6890.0,7086.0,6657.5,6463.5,hypothetical protein  conserved,S
Tb11.v5.0318,4276.0,7422.5,7823.5,6417.5,5593.5,hypothetical protein  conserved,S
Tb11.v5.0319,4649.5,5166.0,6055.5,4205.5,4586.5,hypothetical protein  conserved,S
Tb11.v5.0320,3848.5,3457.0,4327.5,2869.0,2819.0,hypothetical protein  conserved,S
Tb11.v5.0321,8007.0,6745.0,7847.0,6573.5,5686.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0322,4034.5,3890.0,4398.0,3577.5,3586.0,hypothetical protein  conserved,S
Tb11.v5.0323,9632.0,10062.0,10469.5,10039.0,10164.0,hypothetical protein  conserved,S
Tb11.v5.0324,10497.5,7785.5,7782.0,8948.5,9358.0,variant surface protein  atypical (VSG)  putative,<2C (LG1)
Tb11.v5.0325,2982.0,2751.5,3189.5,3380.5,1608.0,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0326,11078.0,10388.0,10446.5,10186.5,10415.0,retrotransposon hot spot (RHS) protein  putative,<2C (LG1)
Tb11.v5.0327,7343.0,9085.0,9411.0,8379.0,8948.5,variant surface protein  putative,S
Tb11.v5.0328,2700.0,626.0,630.0,773.0,1582.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb11.v5.0329,6900.0,1371.5,1536.0,1140.0,347.0,variant surface protein  putative,<2C (LG1)
Tb11.v5.0330,8257.0,8265.0,7777.5,8116.5,6659.5,THT1 - hexose transporter  putative,G1
Tb11.v5.0331,6330.0,4838.0,5174.5,4612.5,5735.0,THT1 - hexose transporter  putative,<2C (LG1)
Tb11.v5.0332,7589.5,6403.5,6200.0,6501.0,7295.0,THT2A - glucose transporter  putative,<2C (LG1)
Tb11.v5.0333,4465.0,3687.0,3568.0,3627.0,3566.5,THT1 - hexose transporter  putative  fragment,<2C (LG1)
Tb11.v5.0334,4740.5,1257.5,1054.0,1228.0,1472.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0335,3701.5,438.0,532.5,352.0,559.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0336,10995.0,10935.0,10686.0,10961.0,10445.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0337,11657.0,11693.0,11704.0,11692.0,11703.0,hypothetical protein  conserved,S
Tb11.v5.0338,2381.5,3324.5,2887.5,2977.0,3825.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0339,10065.0,8827.5,8417.0,7119.0,8213.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0340,4626.0,2801.5,3009.0,1993.5,1608.0,ribonuclease HII  putative,<2C (LG1)
Tb11.v5.0341,612.5,5188.5,5460.5,4112.0,5165.5,Protein of unknown function (DUF3592)  putative,S
Tb11.v5.0342,612.5,4331.5,4235.0,3282.0,2550.0,chaperone protein DnaJ  putative,G1
Tb11.v5.0343,2295.5,4703.0,4550.5,3856.5,2786.0,BarP protein  putative,G1
Tb11.v5.0344,3202.0,2630.0,2551.0,2999.5,2231.5,BarP protein  putative,<2C (LG1)
Tb11.v5.0345,7206.0,5625.5,5808.0,6229.5,6319.0,BarP protein  putative,<2C (LG1)
Tb11.v5.0346,7363.0,7741.5,7930.0,8313.0,6826.5,BarP protein  putative,G2M
Tb11.15.0008b,11712.0,11712.0,11712.0,11714.0,11711.0,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,G2M
Tb11.15.0007b,2552.0,3890.0,3487.0,3319.0,3125.5,variant surface glycoprotein (VSG)  point mutation,G1
Tb11.15.0006b,7165.0,4034.0,2778.0,2940.5,2928.5,variant surface glycoprotein (VSG)  frameshifted,<2C (LG1)
Tb11.15.0005b,4288.5,1609.0,1977.0,2629.5,2834.5,hypothetical protein  conserved  degenerate,<2C (LG1)
Tb11.v5.0348,3179.0,3097.0,3398.5,4156.0,4391.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0349,11436.0,11680.0,11678.0,11679.0,11589.5,DNA-directed RNA polymerase II subunit 2  putative,G1
Tb11.v5.1061,612.5,1231.0,1164.0,1281.0,1179.0,hypothetical protein  conserved,G2M
Tb11.v5.0350,3166.5,690.0,391.5,366.5,433.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0351,1783.5,2326.0,1848.0,2009.0,2178.0,variant surface protein  atypical (VSG)  putative,G1
Tb11.v5.0353,11505.0,11558.0,11499.0,11505.0,11306.0,retrotransposon hot spot (RHS) protein  putative,G1
Tb11.v5.0354,612.5,484.0,233.5,366.5,637.0,TPR repeat  putative,>4C (GG2M)
Tb11.v5.0355,612.5,759.0,832.0,925.0,1504.0,TPR repeat  putative,>4C (GG2M)
Tb11.01.1680.v5,4403.5,5008.5,5286.0,5095.0,7154.5,polyubiquitin  putative,>4C (GG2M)
Tb11.v5.0356,5949.5,6650.5,7498.5,6262.0,8952.0,cytidine triphosphate synthase  putative,>4C (GG2M)
Tb11.v5.0357,3621.0,3436.5,2849.0,2686.0,2297.5,homocysteine S-methyltransferase  putative,<2C (LG1)
Tb11.v5.0358,11592.0,11661.0,11668.0,11634.0,11525.0,hypothetical protein  conserved,S
Tb11.v5.0359,8647.5,7682.5,8763.5,7384.5,6960.0,hypothetical protein  conserved,S
Tb11.v5.0360,10512.5,11452.5,11505.0,11440.0,11258.0,aminopeptidase  putative,S
Tb11.v5.0361,6973.0,6128.5,5135.0,6397.5,5953.5,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0362,1783.5,2839.5,3092.0,3356.0,3413.5,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb11.v5.0363,2221.0,294.5,448.0,382.0,433.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0364,11662.0,11683.0,11692.0,11669.0,11688.0,hypothetical protein  conserved,S
Tb11.v5.0365,8883.0,8942.0,8791.0,9249.5,7112.5,hypothetical protein  conserved,G2M
Tb11.v5.0366,11231.0,11217.5,11148.5,11215.0,10975.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0367,6029.0,4450.0,4518.5,3938.0,4571.0,expression site-associated gene (ESAG) protein  putative,<2C (LG1)
Tb11.v5.0368,9934.5,9713.0,9585.5,9363.0,9087.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0369,9985.5,10357.5,9895.0,9826.5,9857.0,hypothetical protein  conserved,G1
Tb11.v5.0371,612.5,1886.0,1742.5,1688.5,347.0,hypothetical protein  conserved,G1
Tb11.v5.0372,612.5,1602.5,1347.5,1585.5,994.0,hypothetical protein  conserved,G1
Tb11.v5.0373,6777.5,4719.0,3832.5,3272.5,4680.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0374,11679.0,11704.0,11706.0,11703.0,11696.0,hypothetical protein  conserved,S
Tb11.v5.0375,8415.5,7597.0,6873.5,7216.0,7968.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0376,5343.5,6698.0,7143.0,6407.5,4586.5,Trypanosomal VSG domain containing protein  putative,S
Tb11.v5.0377,7554.0,5344.0,5661.5,6183.0,8241.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0378,11716.0,11720.0,11721.0,11721.0,11721.0,hypothetical protein  conserved,S
Tb11.v5.0379,5270.0,5261.5,4832.0,5109.5,4635.5,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb11.v5.0380,10039.5,8039.5,8245.5,7460.5,6749.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0381,11105.5,11452.5,11479.5,11494.0,11270.0,hypothetical protein  conserved,G2M
Tb11.v5.0382,4865.5,3265.5,4577.0,3374.0,3214.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0383,7719.5,4056.0,4767.5,3897.5,5854.0,zeta tubulin  putative,<2C (LG1)
Tb11.v5.0384,4555.0,1704.5,2182.5,1391.5,2322.0,glycerol-3-phosphate dehydrogenase (FAD-dependent) putative,<2C (LG1)
Tb11.v5.0385,1783.5,811.0,410.0,483.0,213.0,expression site-associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb11.v5.0386,1460.0,40.5,40.0,33.5,86.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0387,9256.0,5929.0,6010.0,5741.0,5379.5,cell-division control protein 2 homolog 6  putative,<2C (LG1)
Tb11.v5.0388,7857.0,5612.5,5945.5,5838.5,4673.5,Ring finger domain/PHD-finger  putative,<2C (LG1)
Tb11.v5.0389,612.5,543.0,189.5,673.0,86.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0390,1460.0,2707.5,2717.5,2735.0,2463.0,serine/threonine protein phosphatase 2A regulatory subunit  putative,G2M
Tb11.v5.0391,9092.5,6745.0,7556.5,6567.0,6439.5,rRNA biogenesis protein  putative,<2C (LG1)
Tb11.v5.0392,8667.0,8417.0,9353.5,9261.5,8383.5,kinesin heavy chain  putative,S
Tb11.v5.0394,9502.5,7498.0,7426.0,7027.5,7778.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0395,11540.0,11682.0,11686.0,11673.0,11657.0,hypothetical protein  conserved,S
Tb11.v5.0396,5713.5,678.5,491.0,673.0,853.0,potassium voltage-gated channel  putative,<2C (LG1)
Tb11.v5.0397,11722.0,11719.0,11719.0,11719.0,11719.0,ATP-dependent zinc metallopeptidase  putative,<2C (LG1)
Tb11.v5.0399,11073.5,11207.0,11266.0,10967.5,11282.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0400,612.5,774.5,1549.5,1154.5,1504.0,Variant Surface Glycoprotein  putative,S
Tb11.v5.0401,9092.5,8629.0,8568.5,8628.5,5803.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0402,4346.0,1629.0,2251.5,2120.5,1162.5,BarP protein  putative,<2C (LG1)
Tb11.v5.0403,8972.0,6971.5,8138.0,7854.0,2442.5,BarP protein  putative,<2C (LG1)
Tb11.v5.0404,11482.0,11578.0,11578.5,11603.0,11467.0,hypothetical protein  conserved,G2M
Tb11.v5.0405,6546.5,1704.5,3079.0,2603.0,3494.0,50S ribosome-binding GTPase  putative,<2C (LG1)
Tb11.v5.0406,6330.0,5121.0,6469.0,6768.0,3413.5,glycerol uptake protein  putative,G2M
Tb11.v5.0407,10562.5,8839.0,8381.5,7987.5,9087.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0409,4721.0,5180.0,5208.5,5628.0,9803.5,guanine deaminase  putative,>4C (GG2M)
Tb11.v5.0410,10710.5,11322.0,11381.0,11005.0,10371.0,antigenic protein  conserved,S
Tb11.v5.0411,612.5,3961.0,4085.5,4318.0,6369.5,peptidylprolyl isomerase-like protein  putative,>4C (GG2M)
Tb11.v5.0412,4375.0,5115.0,4258.0,3393.5,4928.5,hypothetical protein  conserved,G1
Tb11.v5.0413,9608.5,8689.0,8803.0,8990.5,7959.5,expression site-associated gene 9 (ESAG9) protein,<2C (LG1)
Tb11.v5.0414,5863.0,1585.5,1416.0,2404.0,2153.5,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb11.v5.0415,11273.0,5883.0,6664.0,5949.0,6547.5,rRNA dimethyltransferase  putative,<2C (LG1)
Tb11.v5.0416,11345.0,11475.0,11553.0,11471.5,11343.0,Variant Surface Glycoprotein  putative,S
Tb11.v5.0417,11715.0,11715.0,11717.0,11716.0,11716.0,variant surface glycoprotein (atypical)  putative,S
Tb11.v5.0418,9125.5,4383.0,5164.0,3545.0,5174.5,AAA domain (dynein-related subfamily)  putative,<2C (LG1)
Tb11.v5.0419,9348.0,5625.5,4807.5,3866.5,5487.5,AAA domain (dynein-related subfamily)  putative,<2C (LG1)
Tb11.v5.0420,5235.0,3245.0,1757.0,2671.0,3693.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0421,5384.0,3961.0,3514.5,3616.5,3812.0,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0422,10867.0,8585.5,8621.0,8660.0,9001.5,SET domain containing protein  putative,<2C (LG1)
Tb11.v5.0423,3358.0,5057.5,5001.0,4623.0,6526.0,Plexin repeat  putative,>4C (GG2M)
Tb11.v5.0424,5218.0,6605.5,6452.5,6706.0,4550.5,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb11.v5.0425,8147.5,8560.5,8392.0,7517.0,8526.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb11.v5.0426,6904.0,4420.5,4790.5,3878.0,3741.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0427,3701.5,2551.0,1489.0,1626.0,3006.0,peroxisome assembly protein  putative,<2C (LG1)
Tb11.v5.0428,2137.5,6865.0,6568.5,6374.0,4418.5,hypothetical protein  conserved,G1
Tb11.v5.0429,10551.0,11208.5,11239.0,11256.5,10846.5,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb11.v5.0430,6106.5,4703.0,5512.0,5525.5,2692.0,ankyrin  putative,<2C (LG1)
Tb11.v5.0431,11324.0,11374.5,11321.0,11295.0,10945.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb11.v5.0432,10323.0,10473.0,10677.5,10761.0,9957.0,calpain-like cysteine peptidase  putative,G2M
Tb11.v5.0433,11506.5,11131.0,11158.5,10809.0,10908.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0434,10501.0,7459.0,6970.5,7308.0,6519.0,kinesin  putative,<2C (LG1)
Tb11.v5.0435,7236.5,7897.5,8185.0,8508.0,7060.5,adenylosuccinate synthetase  putative,G2M
Tb11.v5.0436,10499.0,10668.0,10781.0,10395.5,9983.5,Leucine Rich Repeat  putative,S
Tb11.v5.0437,8079.5,7479.0,7283.5,6955.0,9126.5,Mannosyltransferase (PIG-V))  putative,>4C (GG2M)
Tb11.v5.0438,612.5,4155.5,3578.0,2956.0,2747.0,hypothetical protein  conserved,G1
Tb11.v5.0439,11354.0,11570.0,11591.0,11580.0,11532.0,hypothetical protein  conserved,S
Tb11.v5.0440,4034.5,3680.0,4878.5,3429.5,4337.5,hypothetical protein  conserved,S
Tb11.v5.0442,9356.0,10127.5,10003.0,9882.0,8948.5,retrotransposon hot spot protein  RHS3  putative,G1
Tb11.v5.0444,8972.0,10720.5,10472.0,10561.5,10012.5,hypothetical protein  conserved,G1
Tb11.v5.0445,11390.5,11270.0,11306.0,11107.0,10993.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0446,10836.0,9410.0,9717.0,9523.5,7796.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0447,8952.5,7385.5,6942.5,6784.5,4860.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0448,10350.0,11444.0,11477.0,11469.0,11156.0,leucine-rich repeat protein (LRRP)  putative,S
Tb11.v5.0449,9457.0,11242.0,11223.0,11084.0,10733.5,Variant Surface Glycoprotein  putative,G1
Tb11.v5.0450,4594.0,4754.0,4868.0,4486.5,3929.5,hypothetical protein  conserved,S
Tb11.v5.0451,5379.0,7795.5,8138.0,7979.5,8831.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0452,1460.0,4719.0,4085.5,3343.0,4244.5,GTPase activating protein  putative,G1
Tb11.v5.0453,612.5,967.5,1124.0,705.5,86.0,hypothetical protein  conserved,S
Tb11.v5.0454,612.5,612.5,848.5,664.0,1213.5,GTPase activating protein  putative,>4C (GG2M)
Tb11.v5.1062,3828.5,1565.5,1791.5,1899.5,3836.0,chaperone protein DnaJ  putative,>4C (GG2M)
Tb11.v5.1063,7727.5,9742.5,9922.0,9908.5,10296.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0456,10671.0,10820.0,10909.0,10640.0,10119.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb11.v5.0458,6297.5,2214.5,2866.5,2150.0,2819.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0459,612.5,1068.5,940.5,974.5,2692.0,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb11.v5.0460,6513.0,2051.0,2164.5,2150.0,2550.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0461,612.5,458.5,491.0,592.5,86.0,Variant Surface Glycoprotein  putative,<2C (LG1)
Tb11.v5.0462,3848.5,2319.0,3127.0,2956.0,4525.5,Variant Surface Glycoprotein  putative,>4C (GG2M)
Tb11.v5.0463,3711.5,4251.5,4832.0,5024.0,5548.5,expression site-associated gene (ESAG) protein  putative,>4C (GG2M)
Tb11.v5.0464,2094.5,4596.5,3668.5,4004.5,6350.5,vesicular-fusion protein nsf  putative,>4C (GG2M)
Tb11.57.0047b,8470.0,10677.0,10767.5,10537.5,9626.0,variant surface glycoprotein (VSG)  point mutation,S
Tb11.v5.0465,11610.0,11590.0,11626.0,11562.0,11580.0,tRNA pseudouridine synthase A-like protein  putative,S
Tb11.v5.0467,6393.5,8223.0,8340.0,8282.5,10353.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0468,5339.5,1293.5,2790.5,2025.0,4988.5,alpha tubulin  putative,<2C (LG1)
Tb11.v5.0469,3494.5,1275.5,1428.0,1966.0,4607.0,beta tubulin  putative,>4C (GG2M)
Tb11.v5.0470,5042.0,5782.0,5097.0,5838.5,3596.5,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb11.v5.0471,5275.5,6500.0,6664.0,5325.0,6328.0,kelch motif containing protein  putative,S
Tb11.v5.0472,10792.5,11436.0,11367.0,11407.0,11383.0,hypothetical protein  conserved,G1
Tb11.v5.0474,9636.5,6324.0,5512.0,5109.5,6729.5,protein kinase  putative,<2C (LG1)
Tb11.v5.0476,11097.5,11501.0,11492.0,11532.0,11434.5,Variant Surface Glycoprotein  putative,G2M
Tb11.v5.0477,11642.0,11695.0,11698.0,11690.0,11683.0,TPR repeat  putative,S
Tb11.v5.0479,7698.5,3615.5,3028.0,2788.5,3960.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0480,612.5,4733.5,2919.0,2404.0,3271.5,DNA-directed RNA polymerase  alpha subunit  putative,G1
Tb11.v5.0481,2552.0,1875.5,1870.0,1441.0,2483.5,U3 snoRNA-associated protein UTP11  putative,<2C (LG1)
Tb11.v5.0482,6641.0,1653.5,1757.0,1792.5,2847.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0484,11486.0,11512.5,11429.0,11436.0,11299.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb11.v5.0485,4865.5,3542.5,4502.0,3429.5,3283.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0486,4655.5,2828.5,2378.0,2671.0,2483.5,katanin  putative,<2C (LG1)
Tb11.v5.0487,5298.5,1838.0,2410.5,2252.0,3586.0,Programmed cell death protein 2  C-terminal putative domain containing protein  putative,<2C (LG1)
Tb11.v5.0488,612.5,2011.0,1124.0,1243.0,697.5,hypothetical protein  conserved,G1
Tb11.v5.0489,9181.0,10477.0,10533.0,10652.0,9415.0,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0490,3191.0,3753.5,3568.0,3477.5,2203.5,hypothetical protein  conserved,G1
Tb11.v5.0491,9869.0,8634.5,8875.0,8798.5,8697.5,Serine hydrolase (FSH1)/RWD domain/50S ribosome-binding GTPase  putative,<2C (LG1)
Tb11.v5.0493,6918.0,11229.0,11404.5,11273.0,11236.5,kinesin K39  putative,S
Tb11.v5.0494,9314.5,10175.0,9691.0,9930.5,9866.5,RNA helicase  putative,G1
Tb11.v5.0495,10189.5,9971.5,10462.5,9915.0,9231.5,retrotransposon hot spot (RHS)  putative,S
Tb11.v5.0496,6521.5,7083.5,6630.0,6706.0,5906.5,sterol 24-c-methyltransferase  putative,G1
Tb11.v5.0497,3241.5,6858.5,7334.0,8567.5,11572.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb11.v5.0498,10488.0,11247.5,11214.5,11319.0,11148.0,lysosomal alpha-mannosidase precursor  putative,G2M
Tb11.v5.0499,3654.0,3646.5,2621.5,1993.5,2550.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0500,5053.5,4983.0,4990.5,6423.0,5803.0,2-oxoisovalerate dehydrogenase alpha subunit  putative,G2M
Tb11.v5.0501,2504.5,652.5,336.0,159.0,347.0,40S ribosomal protein S3A  putative,<2C (LG1)
Tb11.v5.0502,2714.5,4145.5,3755.0,3724.0,5110.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0504,10509.0,11036.0,10895.0,11143.5,10605.5,RNA polymerase IIA largest subunit  putative,G2M
Tb11.v5.0505,10980.5,11516.5,11476.0,11509.0,11230.0,hypothetical protein  conserved,G1
Tb11.v5.0506,6811.0,7927.5,8329.0,8436.5,7471.0,hypothetical protein  conserved,G2M
Tb11.v5.0507,2598.0,2457.0,3179.5,2603.0,3093.0,hypothetical protein  conserved,S
Tb11.v5.0508,10079.0,11062.5,10766.0,11072.0,10859.0,hypothetical protein  conserved,G2M
Tb11.v5.0509,9558.0,10047.5,10140.0,10234.5,10250.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0510,5496.0,7756.0,7498.5,8132.5,8083.5,Gp63-3 surface protease homolog  putative,G2M
Tb11.v5.0511,5393.5,7110.0,7861.0,7275.5,8719.5,Gp63-3 surface protease homolog  putative,>4C (GG2M)
Tb11.v5.0512,3283.5,5732.5,5728.0,5751.5,7213.0,Rtr1/RPAP2 family  putative,>4C (GG2M)
Tb11.v5.0513,11680.0,11676.0,11677.0,11663.0,11635.0,NLI interacting factor-like phosphatase  putative,<2C (LG1)
Tb11.v5.0514,11315.0,11275.0,10756.5,10287.5,10567.0,cation transporter  putative,<2C (LG1)
Tb11.v5.0515,8453.0,9245.0,9464.0,8611.5,6729.5,protein kinase  putative,S
Tb11.v5.0516,4698.0,7869.0,8176.5,7834.0,6344.5,glyceraldehyde 3-phosphate dehydrogenase  cytosolic  putative,S
Tb11.v5.0517,8695.0,10347.0,10325.5,10118.0,9036.0,hypothetical protein  conserved,G1
Tb11.v5.0518,10323.0,9910.5,9698.5,10419.5,8814.0,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0519,11661.0,11678.0,11682.0,11682.0,11656.0,hypothetical protein  conserved,S
Tb11.v5.0520,11319.0,11306.0,11219.0,11354.0,11173.0,acetyltransferase  putative,G2M
Tb11.v5.0522,5989.0,6804.5,7939.0,7479.0,9259.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0523,5955.0,4341.0,3487.0,2956.0,5943.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0524,11694.0,11708.0,11707.0,11708.0,11700.0,hypothetical protein  conserved,G1
Tb11.v5.0525,11161.0,11283.5,11276.0,11306.5,11022.0,hypothetical protein  conserved,G2M
Tb11.v5.0526,7704.5,6272.5,5752.5,6276.5,6356.5,DNA polymerase kappa  putative,<2C (LG1)
Tb11.1480b,5204.5,6963.0,7040.0,7236.0,7201.0,variant surface glycoprotein (VSG)  frameshifted,G2M
Tb11.v5.0527,4148.0,6199.5,5325.5,5949.0,6649.0,WD domain  G-beta repeat  putative,>4C (GG2M)
Tb11.v5.0528,7552.5,10455.0,10420.0,10198.0,10671.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0529,6828.0,7137.0,6236.5,6374.0,7699.0,ATP-dependent DEAD/H RNA helicase  putative,>4C (GG2M)
Tb11.v5.0530,3407.5,8165.5,7953.5,8070.5,6289.5,BSD domain containing protein  putative,G1
Tb11.v5.0531,2047.0,2283.0,994.0,534.5,3295.5,fructose-bisphosphate aldolase  glycosomal  putative,>4C (GG2M)
Tb11.v5.0532,9161.5,7886.5,8484.5,8739.0,7670.0,retrotransposon hot spot (RHS) protein  putative,<2C (LG1)
Tb11.v5.0533,10086.0,10700.0,10554.0,10636.0,9727.0,retrotransposon hot spot (RHS) protein  putative,G1
Tb11.v5.0534,3261.0,7914.5,7324.0,5530.5,3681.5,protein kinase  putative,G1
Tb11.v5.0535,6733.0,5331.5,5396.5,6240.5,5301.0,minichromosome maintenance (MCM) complex subunit  putative,<2C (LG1)
Tb11.v5.0536,6257.5,3476.5,3711.0,3264.5,3157.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0537,5593.5,7995.0,7823.5,8150.5,8401.0,polyubiquitin  putative,>4C (GG2M)
Tb11.v5.0538,4219.0,498.0,756.5,557.5,1622.5,69 kDa paraflagellar rod protein  putative,<2C (LG1)
Tb11.v5.0539,7242.5,4220.5,4732.5,4252.5,2110.0,Bardet-Biedl syndrome 4 protein  putative,<2C (LG1)
Tb11.v5.0540,6803.5,6683.5,6452.5,6892.0,6505.0,amino acid transporter 8  putative,G2M
Tb11.v5.0541,6728.0,7529.0,7773.5,6955.0,6206.0,amino acid transporter  putative,S
Tb11.v5.0542,9495.0,10574.0,10196.5,10820.5,10255.0,hypothetical protein  conserved,G2M
Tb11.v5.0543,4411.0,5243.0,4540.5,6009.0,6281.0,Heat shock protein 83  putative,>4C (GG2M)
Tb11.v5.0544,7892.5,7046.0,6821.0,6582.5,6143.5,methionyl-tRNA formyltransferase  putative,<2C (LG1)
Tb11.v5.0546,11437.0,11370.0,11458.0,11328.0,11265.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb11.v5.0547,11640.0,11644.0,11620.0,11629.0,11546.0,DNA mismatch repair protein  putative,G1
Tb11.v5.0550,9553.5,9565.5,9587.5,9264.5,9009.5,hypothetical protein  conserved,S
Tb11.v5.0551,10454.0,11391.0,11444.0,11460.0,11143.5,leucine-rich repeat protein (LRRP)  putative,G2M
Tb11.v5.0552,4642.5,2760.5,2812.5,2810.5,2153.5,75 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0553,10525.5,11425.0,11460.0,11536.0,11493.0,ubiquitin hydrolase  putative,G2M
Tb11.v5.0555,11063.5,11104.5,10964.0,10777.5,10814.0,hypothetical protein  conserved,G1
Tb11.v5.0556,11573.0,11619.0,11602.0,11621.0,11554.0,protein kinase  putative,G2M
Tb11.v4.0039b,10614.0,11111.0,10939.5,10923.5,10706.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb11.v5.0558,6607.5,5680.0,5838.5,5838.5,5713.5,oligosaccharyl transferase subunit  putative,<2C (LG1)
Tb11.v5.0559,6695.5,3336.0,3246.5,3393.5,2706.5,oligosaccharyl transferase subunit  putative,<2C (LG1)
Tb11.v5.0560,11440.0,11444.0,11420.5,11497.0,11340.5,leucine-rich repeat protein (LRRP)  putative,G2M
Tb11.v5.0561,4940.0,6386.5,6597.0,5850.0,4571.0,fatty acyl CoA synthetase  putative,S
Tb11.v5.0562,10493.0,9747.0,9497.0,9114.0,9657.0,Molybdopterin guanine dinucleotide synthesis protein B  putative,<2C (LG1)
Tb11.v5.0563,4691.0,5144.5,5408.5,4070.5,3994.5,periodic tryptophan protein 2  putative,S
Tb11.v5.0564,2826.5,5469.0,5875.5,5087.5,5014.5,protein kinase  putative,S
Tb11.v5.0565,8399.0,6874.5,8463.0,7871.0,6719.5,mitochondrial intermediate peptidase  putative,S
Tb11.v5.0566,7358.0,5287.0,4502.0,5087.5,4508.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0567,10662.5,11225.5,11284.5,11132.5,10746.0,retrotransposon hot spot (RHS) protein  putative,S
Tb11.v5.0568,11627.0,11617.0,11636.0,11576.0,11506.0,hypothetical protein  conserved,S
Tb11.v5.0569,11388.0,11161.0,10944.0,10750.0,10748.5,amino acid transporter  putative,<2C (LG1)
Tb11.v5.0570,6126.5,5888.5,5881.0,5206.5,5470.5,Zinc finger  C3HC4 type (RING finger)  putative,<2C (LG1)
Tb11.v5.0571,2995.0,4383.0,3618.0,4097.0,4244.5,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb11.v5.0572,9259.5,9734.0,9798.5,10191.5,10339.0,RAD50 DNA repair-like protein  putative,>4C (GG2M)
Tb11.v5.0573,8998.0,6664.0,4680.0,5342.5,5110.5,RAD50 DNA repair-like protein  putative,<2C (LG1)
Tb11.v5.0574,3166.5,5008.5,4711.5,5365.0,4365.0,Organic solute transport protein 1  putative,G2M
Tb11.v5.0575,7063.0,7176.5,6437.0,6637.0,4550.5,Coiled-coil domain-containing protein 40 homolog (fragment),G1
Tb11.v5.0576,11134.0,11450.0,11351.0,11463.0,11307.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb11.v5.0577,9468.0,10610.5,10936.5,10732.0,9589.0,casein kinase I  putative,S
Tb11.v5.0578,7987.0,8051.0,8763.5,7940.0,6994.0,Plasma-membrane choline transporter  putative,S
Tb11.v5.0579,7997.0,7128.5,8299.5,7631.5,9208.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0580,6929.5,5896.0,5174.5,5295.5,5014.5,delta-6 fatty acid desaturase  putative,<2C (LG1)
Tb11.v5.0581,11648.0,11653.0,11650.0,11662.0,11612.0,Sec8 exocyst complex component specific domain/Invariant surface glycoprotein  putative,G2M
Tb11.v5.0582,9531.5,9075.0,8878.5,8916.5,8943.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0583,3904.5,4630.0,3618.0,2120.5,4266.0,hypothetical protein  conserved,G1
Tb11.v5.0584,7763.5,6466.5,6495.5,5428.5,8838.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0585,11653.0,11674.0,11673.0,11670.0,11624.0,separase  putative,G1
Tb11.v5.0586,5588.5,6933.0,7359.5,7540.0,6535.5,hypothetical protein  conserved,G2M
Tb11.v5.0587,6131.0,5717.0,5054.0,4355.5,6229.0,protein kinase A regulatory subunit,>4C (GG2M)
Tb11.v5.0588,2714.5,4127.0,5372.0,4552.0,3906.0,AARP2CN (NUC121) domain containing protein  putative,S
Tb11.v5.0589,612.5,3526.0,4421.0,3642.0,7268.5,Clusterin-associated protein-1  putative,>4C (GG2M)
Tb11.v5.0590,2855.0,5269.5,5129.0,4918.5,7207.5,SET domain containing protein  putative,>4C (GG2M)
Tb11.v5.0591,4298.5,3658.5,3706.5,3307.0,6074.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0592,8105.0,10203.0,10286.5,10267.5,9194.5,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.0593,11488.0,11591.0,11592.0,11593.0,11516.0,hypothetical protein  conserved,G2M
Tb11.v5.0594,9578.0,9967.0,9709.5,10161.0,10050.0,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0595,612.5,1904.5,1721.5,1097.5,2336.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0596,4425.0,1482.5,1078.0,1140.0,1120.5,serine/threonine protein kinase  putative,<2C (LG1)
Tb11.v5.0597,10601.5,10932.0,11243.0,10795.0,10511.0,hypothetical protein  conserved,S
Tb11.v5.0598,3888.5,1838.0,1977.0,2025.0,5420.5,GIY-YIG catalytic domain containing protein  putative,>4C (GG2M)
Tb11.v5.0599,5981.0,3652.5,3275.0,3566.5,4065.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0600,5330.0,4119.5,4078.5,3319.0,1304.5,HIT zinc finger  putative,<2C (LG1)
Tb11.v5.0601,8800.5,9848.5,9903.0,9812.0,9475.5,major surface protease gp63  putative,S
Tb11.v5.0602,11489.0,11459.5,11456.0,11435.0,11321.5,leucine-rich repeat protein 1 (LRRP1)  putative,<2C (LG1)
Tb11.v5.0603,11669.0,11694.0,11693.0,11691.0,11655.0,hypothetical protein  conserved,G1
Tb11.v5.0604,9233.5,9501.0,9493.5,9572.0,7731.5,hypothetical protein  conserved,G2M
Tb11.v5.0605,5505.0,4341.0,3767.5,2869.0,2141.5,pyruvate kinase 1  putative,<2C (LG1)
Tb11.v5.0606,8857.0,9727.5,10358.0,9275.0,9052.0,hypothetical protein  conserved,S
Tb11.v5.0607,11416.0,11601.0,11644.0,11549.0,11517.0,hypothetical protein  conserved,S
Tb11.v5.0608,2221.0,6124.0,6114.0,5962.0,6363.0,DNA-directed RNA polymerase III largest subunit  putative,>4C (GG2M)
Tb11.v5.0609,3214.5,2544.5,2666.0,2617.5,4036.5,DNA-directed RNA polymerase III largest subunit  putative,>4C (GG2M)
Tb11.v5.0610,3407.5,7792.0,7736.0,7747.0,8862.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0611,7804.5,5829.5,5214.5,5716.5,7249.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0612,2406.5,3467.5,5239.0,5228.0,3693.0,MYND finger  putative,S
Tb11.v5.0613,10133.0,11356.0,11431.5,11342.0,11126.0,NADH-dependent fumarate reductase  putative,S
Tb11.v5.0614,8553.5,7789.0,6447.0,5662.0,3283.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0615,7717.0,6897.0,6866.5,6297.0,7008.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0616,11270.0,10868.0,11176.0,11341.0,11582.0,paraflagellar rod protein  putative,>4C (GG2M)
Tb11.v5.0617,11389.0,11234.0,11193.0,11045.5,11047.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0618,7387.5,7685.0,7404.5,6348.0,5174.5,hypothetical protein  conserved,G1
Tb11.v5.0619,11588.0,11594.0,11584.5,11607.0,11570.0,COG4 transport protein  putative,G2M
Tb11.v5.0620,6838.0,5315.0,5981.0,6374.0,7038.0,COG4 transport protein  putative,>4C (GG2M)
Tb11.v5.0621,9762.5,10098.0,9755.5,10031.0,10474.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0622,8321.0,10894.0,10569.0,10973.0,10260.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0623,612.5,1781.0,2541.5,2735.0,4051.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0624,10104.5,11245.0,11043.0,11219.0,10492.0,retrotransposon hot spot protein (PHS)  putative,G1
Tb11.v5.0625,6755.5,7660.0,7823.5,8445.5,6932.5,C-terminal motor kinesin  putative,G2M
Tb11.v5.0626,10155.0,10823.5,10426.5,10671.5,10882.0,protein kinase  putative,>4C (GG2M)
Tb11.v5.0627,10770.0,11382.0,11398.0,11335.0,10809.5,lipase domain protein  putative,S
Tb11.v5.0628,10554.0,11000.0,10378.5,10994.0,10899.0,tubulin binding cofactor c  putative,G1
Tb11.v5.0629,5247.5,6940.5,7622.5,7245.0,7406.5,fumarate hydratase  putative,S
Tb11.v5.0630,10593.0,7975.5,8953.0,8194.0,8360.5,SUMO-interacting motif-containing protein,<2C (LG1)
Tb11.v5.0631,6441.5,4481.0,2182.5,2746.5,3310.5,pre-mRNA processing factor 4 (PRP4) like/WD domain  G-beta repeat  putative,<2C (LG1)
Tb11.v5.0632,11329.0,11568.0,11502.0,11559.0,11413.5,Sel1 repeat  putative,G1
Tb11.v5.0633,9056.5,8459.0,9286.5,8397.0,7592.0,protein kinase  putative,S
Tb11.v5.0634,612.5,3407.5,3850.0,3130.0,5274.5,Uncharacterised ACR  YagE family COG1723  putative,>4C (GG2M)
Tb11.v5.0635,3456.5,5269.5,5704.5,4699.5,5240.0,tRNA modification enzyme  putative,S
Tb11.v5.0636,8330.5,6846.5,6480.0,7167.0,7406.5,C-terminal motor kinesin  putative,<2C (LG1)
Tb11.v5.0637,3951.0,3586.5,2154.5,2671.0,2941.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0638,5886.0,7006.0,6695.5,7236.0,4938.0,serine carboxypeptidase III precursor  putative,G2M
Tb11.v5.0639,4731.0,4317.5,3858.5,4235.5,9313.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0640,8823.5,8427.0,6764.0,6919.5,7478.0,minichromosome maintenance (MCM) complex subunit  putative,<2C (LG1)
Tb11.v5.0641,5209.5,3766.0,4462.5,3938.0,3939.5,major vault protein  putative,<2C (LG1)
Tb11.v5.0642,2552.0,5834.5,6108.0,6706.0,6485.0,hypothetical protein  conserved,G2M
Tb11.v5.0643,11015.5,11417.0,11347.0,11349.0,11441.0,dual specificity protein phosphatase  putative,>4C (GG2M)
Tb11.v5.0644,3987.5,3922.5,3779.5,4433.0,4145.0,serine/threonine-protein kinase  putative,G2M
Tb11.v5.0645,9736.0,10443.0,10626.0,11030.0,10278.0,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0646,9113.0,10771.0,10998.5,10854.0,9898.5,CYC2-like cyclin  putative,S
Tb11.v5.0647,612.5,1781.0,1091.0,1391.5,1010.0,hypothetical protein  conserved,G1
Tb11.v5.0648,7859.5,4574.0,4722.5,4112.0,3345.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0649,8998.0,5229.0,5408.5,5489.0,7304.0,serine palmitoyltransferase  putative,<2C (LG1)
Tb11.v5.0650,5844.5,3700.0,3487.0,3796.5,2870.0,enolase  putative,<2C (LG1)
Tb11.v5.0651,10184.5,10565.0,10926.0,10926.0,10728.0,Vps53-like  N-terminal  putative,S
Tb11.v5.0652,9006.5,7746.5,6883.0,7768.5,7685.0,protein kinase  putative,<2C (LG1)
Tb11.v5.0653,5393.5,2851.5,2238.0,2686.0,2550.0,trypanothione synthetase  putative,<2C (LG1)
Tb11.v5.0654,7148.0,8921.0,8411.5,9196.5,7304.0,receptor-type adenylate cyclase  putative,G2M
Tb11.v5.0655,11167.0,11468.5,11453.0,11534.0,11234.5,trypanosome RHS family  putative,G2M
Tb11.v5.0656,3680.5,3827.0,5577.5,5353.5,5311.0,hypothetical protein  conserved,S
Tb11.v5.0657,10916.0,11402.0,11302.0,11302.0,11196.5,hypothetical protein  conserved,G1
Tb11.v5.0658,11177.0,11497.0,11582.0,11455.0,11456.0,hypothetical protein  conserved,S
Tb11.v5.0659,4505.5,4540.5,4271.0,5215.5,4988.5,Eukaryotic translation initiation factor 4 gamma 3  putative,G2M
Tb11.v5.0660,10149.0,6595.5,6518.0,5775.5,6793.5,histone deacetylase  putative,<2C (LG1)
Tb11.v5.0661,10169.5,10077.5,10259.0,9990.5,9584.5,DNA polymerase kappa  putative,S
Tb11.v5.0662,10222.5,7142.0,7856.0,9821.0,11489.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0663,4384.0,5484.0,4038.0,5517.5,7662.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0664,2329.5,5675.0,5856.5,6706.0,9004.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0665,10568.0,10852.0,10608.0,11197.5,11498.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0666,4859.0,2638.5,2499.0,2940.5,2834.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0667,612.5,799.5,1054.0,592.5,836.0,poly(A) polymerase  putative,S
Tb11.v5.0668,6372.0,6039.0,5728.0,5824.5,5567.0,protein disulfide isomerase,<2C (LG1)
Tb11.v5.0669,5747.0,6905.5,6893.0,6706.0,5266.5,zinc carboxypeptidase  putative,G1
Tb11.v5.0670,6721.0,9963.0,10205.0,10460.5,9419.0,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0671,9921.5,10590.5,10500.0,10928.0,10711.5,protein kinase A catalytic subunit  putative,G2M
Tb11.v5.0672,9458.5,7355.0,6718.0,7327.0,5675.0,cardiolipin synthetase  putative,<2C (LG1)
Tb11.v5.0673,7696.0,9419.0,9515.5,9048.5,7510.5,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.0674,9312.0,7539.0,6568.5,7495.5,10086.0,protein phosphatase 2A regulatory subunit  putative,>4C (GG2M)
Tb11.v5.0675,3937.0,3542.5,2812.5,2840.5,5362.5,ubiquitin-activating enzyme E1  putative,>4C (GG2M)
Tb11.v5.0676,7747.0,6418.0,6831.5,6774.5,9504.0,expression site-associated gene 2 (ESAG2) protein  putative,>4C (GG2M)
Tb11.v5.0677,8328.0,8349.5,7802.5,8560.0,7811.5,expression site-associated gene 11 (ESAG11) protein  putative,G2M
Tb11.v5.0678,10580.5,8724.5,8303.0,7809.5,7847.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0679,4333.5,3625.0,4372.0,3557.0,5953.5,transporter  putative,>4C (GG2M)
Tb11.v5.0680,9956.5,10062.0,9658.0,9035.0,8590.5,hypothetical protein  conserved,G1
Tb11.v5.0681,6904.0,9248.0,9097.5,9014.0,8310.5,hypothetical protein  conserved,G1
Tb11.v5.0682,1460.0,867.5,1335.0,1572.5,933.5,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0683,10929.0,9913.0,9740.5,8691.0,7592.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0684,612.5,1108.0,1164.0,1228.0,347.0,eukaryotic translation initiation factor 5  putative,G2M
Tb11.v5.0685,8180.5,3758.0,4283.5,3374.0,5624.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0686,5718.0,5136.0,4586.5,5428.5,2364.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0687,4834.5,7665.0,8019.0,5741.0,7573.0,Pescadillo N-terminus/BRCA1 C Terminus (BRCT) domain containing protein  putative,S
Tb11.v5.0688,6415.0,7508.0,7490.0,7167.0,6903.0,tRNA pseudouridine synthase D (TruD)  putative,G1
Tb11.v5.0689,3937.0,1190.0,865.5,849.0,1407.5,NOT2 / NOT3 / NOT5 family  putative,<2C (LG1)
Tb11.v5.0690,3214.5,1661.5,1848.0,1171.0,1120.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0691,2180.0,1635.5,1692.0,1745.0,1842.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0692,6572.0,5488.5,6352.5,6452.5,6420.0,Thiopurine S-methyltransferase (TPMT)  putative,<2C (LG1)
Tb11.v5.0693,10574.5,11435.0,11415.0,11465.0,11058.0,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0694,6422.0,6605.5,7442.5,6276.5,6699.0,glycosyltransferase  putative,S
Tb11.v5.0695,9588.5,8144.0,7086.0,8250.0,5463.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0696,3895.5,2170.0,907.5,1171.0,6917.0,TerD domain containing protein  putative,>4C (GG2M)
Tb11.v5.0697,9992.5,9922.5,9446.5,9460.5,7537.5,Xaa-Pro aminopeptidase  putative,<2C (LG1)
Tb11.v5.0698,2436.0,612.5,1078.0,957.5,4607.0,dynein heavy chain  putative,>4C (GG2M)
Tb11.v5.0699,5989.0,6922.5,6495.5,6899.0,8103.5,Trypanosomal VSG domain containing protein  putative,>4C (GG2M)
Tb11.v5.0700,7110.5,3380.0,2196.0,2506.5,1582.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0701,11638.5,11546.0,11539.0,11560.0,11561.0,ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb11.v5.0702,11541.0,11652.0,11653.0,11671.0,11659.0,calpain-like cysteine peptidase  putative,G2M
Tb11.v5.0703,11096.0,11502.5,11507.0,11555.0,11377.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb11.v5.0704,5955.0,700.5,685.0,313.5,461.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0705,6672.0,4214.5,4341.0,4097.0,10077.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0706,10982.0,10744.0,10367.5,10429.5,9816.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0707,6137.0,6193.5,5372.0,6009.0,4337.5,hypothetical protein  conserved,G1
Tb11.v5.0708,8911.0,5789.5,5265.0,6098.5,5934.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0709,7086.0,2701.5,2023.5,1626.0,1896.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0710,5257.0,8051.0,7760.5,9445.0,9368.5,Gp63-1 surface protease homolog  putative,G2M
Tb11.v5.0711,7032.0,5172.5,4956.5,5137.0,4883.5,DNA polymerase kappa  putative,<2C (LG1)
Tb11.v5.0712,11364.0,11595.0,11511.0,11592.0,11575.0,calcium-transporting ATPase  putative,G1
Tb11.v5.0713,8077.0,9415.5,8709.0,9445.0,9090.0,Retrotransposon hot spot protein 6 (RHS6)  putative,G2M
Tb11.v5.0714,2258.5,10087.5,9066.5,9134.0,9062.0,RNA-binding protein  putative,G1
Tb11.v5.0715,5729.0,1758.0,743.0,1056.5,1099.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0716,8039.5,7610.0,8145.5,8348.5,8338.0,hypothetical protein  conserved,G2M
Tb11.v5.0717,9199.0,10593.0,10728.0,10871.5,10348.5,hypothetical protein  conserved,G2M
Tb11.v5.0718,4040.0,2106.0,2112.5,2150.0,1239.0,protein kinase  putative,<2C (LG1)
Tb11.v5.0719,2436.0,1322.5,1665.0,1187.5,1047.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0720,7337.0,9631.0,9189.0,8981.0,9390.0,hypothetical protein  conserved,G1
Tb11.v5.0721,10952.5,11329.0,11281.0,11297.0,10667.5,hypothetical protein  conserved,G1
Tb11.v5.0722,8534.5,6561.0,6788.5,6562.0,7541.0,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb11.v5.0723,4817.0,5384.5,4246.0,5215.5,8374.0,DNA-directed rna polymerase I largest subunit  putative,>4C (GG2M)
Tb11.v5.0724,5349.0,7073.0,7143.0,8309.0,8042.0,hypothetical protein  conserved,G2M
Tb11.v5.0725,6441.5,6391.5,6385.5,6262.0,5083.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0726,10120.5,9812.5,9863.0,9893.5,10106.5,WD domain  G-beta repeat/Utp13 specific WD40 associated domain containing protein  putative,<2C (LG1)
Tb11.v5.0727,5099.5,2214.5,1574.0,1899.5,1120.5,flagellum transition zone component  putative,<2C (LG1)
Tb11.v5.0728,612.5,40.5,40.0,33.5,86.0,14-3-3 protein  putative,<2C (LG1)
Tb11.v5.0729,612.5,40.5,40.0,33.5,86.0,ribokinase  putative,<2C (LG1)
Tb11.v5.0730,10706.5,7647.5,7549.5,7617.5,9678.0,pumillio RNA binding protein 4  putative,<2C (LG1)
Tb11.v5.0731,10888.0,10027.0,10412.5,10608.0,10068.0,65 kDa invariant surface glycoprotein  putative,<2C (LG1)
Tb11.v5.0732,10898.0,11006.0,10988.0,11102.5,10959.5,hexokinase  putative,G2M
Tb11.v5.0733,8391.5,9142.5,9866.0,10080.0,9925.5,dynein heavy chain  cytosolic  putative,G2M
Tb11.v5.0734,8244.5,6683.5,7706.0,6955.0,6774.5,multidrug resistance-associated protein  putative,<2C (LG1)
Tb11.v5.0735,4930.5,1747.5,1446.0,720.5,3235.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0736,4810.5,2170.0,3009.0,3228.0,1816.5,ABC1 family  putative,<2C (LG1)
Tb11.v5.0737,9632.0,3265.5,3441.0,3773.5,1676.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0738,6291.5,3073.0,3246.5,2956.0,2218.5,thymidylate kinase  putative,<2C (LG1)
Tb11.v5.0739,5174.0,6525.5,6664.0,6663.0,7775.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb11.v5.0740,612.5,1415.5,1808.5,1125.0,10988.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0741,8313.0,5675.0,5945.5,5891.5,7147.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0742,612.5,664.5,893.0,1343.0,1676.0,proteasome beta-1 subunit  putative,>4C (GG2M)
Tb11.v5.0743,5870.0,4636.0,5135.0,4290.5,6526.0,Mitochondrial ribosomal death-associated protein 3  putative,>4C (GG2M)
Tb11.v5.0744,9038.0,3806.5,4181.0,5168.5,2310.0,phosphatidylinositol 3-kinase tor  putative,<2C (LG1)
Tb11.v5.0745,7232.0,8114.0,6538.0,6863.0,8852.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0746,2930.5,6447.0,5981.0,6809.0,7377.0,tatD related deoxyribonuclease  putative,>4C (GG2M)
Tb11.v5.0747,612.5,3740.5,2977.0,3029.0,4121.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0748,7215.5,9764.5,9619.0,9732.5,11072.5,ABC transporter  putative,>4C (GG2M)
Tb11.v5.0749,5740.0,2062.0,1489.0,2850.5,5542.5,structural maintenance of chromosome 4  putative,<2C (LG1)
Tb11.v5.0750,5920.5,5344.0,5286.0,4882.0,3775.0,dual specificity protein phosphatase  putative,<2C (LG1)
Tb11.v5.0751,9568.0,10626.0,10302.0,10550.5,9655.0,dual specificity protein phosphatase  putative,G1
Tb11.v5.0752,10083.5,7110.0,7055.0,7308.0,9256.5,expression site-associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb11.v5.0753,7929.5,9139.5,9560.0,9766.0,9552.5,hypothetical protein  conserved,G2M
Tb11.v5.0754,11696.0,11705.0,11705.0,11705.0,11698.0,variant surface glycoprotein (VSG)  putative,G1
Tb11.v5.0755,11604.0,11692.0,11690.0,11683.0,11670.0,variant surface glycoprotein (VSG)  putative,G1
Tb11.v5.0756,7627.5,10357.5,10154.0,10112.0,9983.5,DNA polymerase kappa  putative,G1
Tb11.v5.0757,2504.5,1797.0,1335.0,1542.0,2039.0,stress-inducible protein STI1-like  putative,<2C (LG1)
Tb11.v5.0758,6607.5,4745.0,5590.5,3724.0,4967.0,Protein of unknown function (DUF1448)  putative,<2C (LG1)
Tb11.v5.0759,9570.5,11112.0,10754.0,11200.0,11157.5,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0760,8494.0,2741.5,2902.0,2321.5,2125.5,RNA polymerase III transcription factor (TF)IIIC subunit  putative,<2C (LG1)
Tb11.v5.0761,6649.0,7024.5,6178.5,6423.0,5470.5,proteasome activator protein pa26  putative,G1
Tb11.v5.0762,7380.5,9603.0,10007.0,9609.5,10442.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0763,2180.0,3700.0,3843.5,3588.0,1453.5,Eukaryotic translation initiation factor 4 gamma 5  putative,S
Tb11.v5.0764,7602.5,5315.0,5015.0,4790.0,4541.5,DNA polymerase kappa  putative,<2C (LG1)
Tb11.v5.0765,8811.0,8111.5,7782.0,8323.5,8137.0,N-acetylglucosaminyl-phosphatidylinositol biosynthetic protein  putative,<2C (LG1)
Tb11.v5.0766,9019.5,8762.0,8407.5,9386.0,8353.5,folate transporter  putative,G2M
Tb11.v5.0767,10853.0,10130.0,9725.0,9706.5,8802.0,pumillo RNA binding protein PUF1  putative,<2C (LG1)
Tb11.v5.0768,7484.0,3120.0,3051.5,3065.5,2376.0,aspartyl aminopeptidase  putative,<2C (LG1)
Tb11.v5.0769,1988.0,1275.5,1665.0,1861.0,1162.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0770,2406.5,2646.0,2866.5,2357.0,2747.0,hypothetical protein  conserved,S
Tb11.v5.0771,612.5,600.0,336.0,313.5,86.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0772,612.5,1542.0,532.5,673.0,531.0,expression site-associated gene 9 (ESAG9) protein  putative,G1
Tb11.v5.0773,7810.0,7310.0,6879.0,6663.0,11106.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0774,2855.0,2160.0,2360.0,2252.0,2505.5,dihydrolipoamide acetyltransferase precursor  putative,<2C (LG1)
Tb11.v5.0775,2840.5,2983.5,3297.5,3737.0,5963.0,methyltransferase domain containing protein  putative,>4C (GG2M)
Tb11.v5.0776,2714.5,3680.0,3051.5,3463.5,4490.0,variant surface glycoprotein (VSG) pseudogene  putative,>4C (GG2M)
Tb11.v5.0777,6072.0,6199.5,6393.0,6955.0,6820.0,paraflagellar rod protein  putative,G2M
Tb11.v5.0778,7880.0,2808.0,3260.0,3356.0,2671.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb11.v5.0779,11028.0,11253.0,11098.0,11179.5,10846.5,hypothetical protein  conserved,G1
Tb11.v5.0780,7471.5,7883.0,7767.5,7826.0,6955.0,ABC transporter  putative,G1
Tb11.v5.0781,6334.0,5771.5,4029.0,4166.5,4418.5,MIZ/SP-RING zinc finger  putative,<2C (LG1)
Tb11.v5.0782,4360.0,6605.5,6821.0,6969.0,4967.0,hypothetical protein  conserved,G2M
Tb11.v5.0783,8431.0,10751.0,10713.5,10504.0,10844.0,methionine aminopeptidase 2  putative,>4C (GG2M)
Tb11.v5.0784,10118.5,10791.5,10288.0,10510.5,10057.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb11.v5.0785,7643.0,9198.0,8547.5,8746.5,7459.5,variant surface glycoprotein (VSG)  putative,G1
Tb11.v5.0786,2094.5,130.0,1067.0,1031.0,531.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0787,4219.0,3344.5,4271.0,4137.0,3950.0,kinesin  putative,S
Tb11.v5.0788,2767.0,4429.5,5345.0,6035.0,5117.5,expression site-associated gene 2 (ESAG2) protein  putative,G2M
Tb11.v5.0789,3734.0,2272.0,2510.5,2801.0,5014.5,expression site-associated gene 2 (ESAG2) protein  putative,>4C (GG2M)
Tb11.v5.0790,8415.5,3485.5,4577.0,3408.0,3125.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0791,9064.5,4521.5,3233.0,3965.5,2857.0,ABC transporter  putative,<2C (LG1)
Tb11.v5.0792,9733.5,10675.5,10851.0,10956.0,10346.5,DNA polymerase theta (helicase domain only)  putative,G2M
Tb11.v5.0793,7516.0,3705.0,3224.5,3649.5,4005.5,FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase  putative,<2C (LG1)
Tb11.v5.0794,5588.5,5236.0,4815.0,5228.0,5034.5,PHD-zinc-finger like domain containing protein  putative,<2C (LG1)
Tb11.v5.0795,9541.5,4693.0,4653.0,4623.0,6670.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0796,6021.5,1078.5,1742.5,1792.5,3658.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0797,8718.5,9718.0,9105.0,9529.5,9264.5,flagellar calcium-binding protein,G1
Tb11.v5.0798,6389.5,4268.0,3940.5,3178.5,5125.0,flagellar calcium-binding protein,<2C (LG1)
Tb11.v5.0799,4080.0,2149.5,1945.0,1003.0,584.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0800,11154.5,11280.0,10771.0,11359.0,11228.5,retrotransposon hot spot (RHS) protein  putative,G2M
Tb11.v5.0801,3341.5,335.0,357.5,419.0,607.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0802,9990.0,10940.0,10707.0,10921.0,9998.5,hypothetical protein  conserved,G1
Tb11.v5.0803,612.5,3606.5,2876.5,3228.0,2389.0,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb11.v5.0804,5058.0,4348.5,5084.5,4940.5,6206.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0805,8120.0,8581.5,9072.5,8583.0,7585.5,hypothetical protein  conserved,S
Tb11.v5.0806,9220.5,9136.0,9286.5,9023.0,8037.5,hypothetical protein  conserved,S
Tb11.v5.0807,7876.0,4838.0,5631.0,5782.0,4617.5,ribonuclease  putative,<2C (LG1)
Tb11.v5.0808,7371.0,6260.0,6095.5,5704.5,4947.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0809,10766.5,11292.0,11352.5,11158.0,11187.0,TPR repeat  putative,S
Tb11.v5.0810,8047.5,5689.0,7013.5,5342.5,5854.0,glutamyl-tRNA synthetase  putative,<2C (LG1)
Tb11.v5.0811,7272.5,4849.5,5838.5,5215.5,4459.5,structural maintenance of chromosome 2  putative,<2C (LG1)
Tb11.v5.0812,6949.5,7233.0,7291.0,6706.0,7052.0,signal recognition particle protein  putative,S
Tb11.v5.0813,612.5,1095.0,1237.5,1125.0,1676.0,expression site-associated gene 3 (ESAG3)-like protein,>4C (GG2M)
Tb11.v5.0814,2826.5,2272.0,2262.5,2893.5,1789.5,expression site-associated gene 3 (ESAG3)-like protein,G2M
Tb11.v5.0815,10060.5,10902.0,10864.5,10596.0,10612.0,hypothetical protein  conserved,G1
Tb11.v5.0816,8236.5,9580.5,9255.0,9653.5,7236.5,expression site-associated gene 2 (ESAG2) protein  putative,G2M
Tb11.v5.0817,10203.0,11406.0,11417.5,11375.0,11031.5,ubiquitin-protein ligase  putative,S
Tb11.v5.0818,6238.5,3187.0,3260.0,3711.5,2574.5,Peroxisome biogenesis protein 2  putative,<2C (LG1)
Tb11.v5.0819,6037.5,9163.5,9460.5,9495.5,8480.0,kinesin  putative,G2M
Tb11.v5.0820,11504.0,11616.0,11571.0,11625.0,11577.0,branched-chain amino acid aminotransferase  putative,G2M
Tb11.v5.0821,4196.0,7689.5,8097.5,8000.5,6878.5,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb11.v5.0822,7709.5,5888.5,6447.0,5775.5,7125.0,ATP synthase  putative,<2C (LG1)
Tb11.v5.0823,10901.0,11200.5,11314.0,11147.0,11274.0,hypothetical protein  conserved,S
Tb11.v5.0824,10764.5,8605.5,7890.5,8361.0,8116.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0825,8105.0,9075.0,9823.0,9010.5,10436.0,fatty acyl CoA synthetase  putative,>4C (GG2M)
Tb11.v5.0826,7790.0,6339.0,6997.5,6748.5,7392.0,expression site-associated gene (ESAG) protein  putative,<2C (LG1)
Tb11.v5.0827,3468.5,1653.5,1124.0,2520.5,1304.5,NUP-1 protein  putative,<2C (LG1)
Tb11.v5.0828,6896.5,5442.5,4078.5,4711.5,4231.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0829,5897.5,5115.0,4577.0,5505.5,4794.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0830,9116.5,9223.5,9537.5,8993.5,9059.5,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb11.v5.0831,9663.5,9793.0,9780.0,9864.5,8789.0,kinesin motor domain containing protein  putative,G2M
Tb11.v5.0832,2813.0,3476.5,3649.5,3649.5,6679.0,methyltransferase domain containing protein  putative,>4C (GG2M)
Tb11.v5.0833,5751.0,6550.5,8066.5,7460.5,7328.5,kinesin  putative,S
Tb11.v5.0834,3429.0,2652.5,2961.0,2494.5,2427.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0835,6942.0,1466.5,2764.5,2389.0,6857.0,kinesin  putative,<2C (LG1)
Tb11.v5.0836,4972.0,1875.5,3737.5,3178.5,2283.5,metal-ion transporter  putative,<2C (LG1)
Tb11.v5.0837,10122.0,10408.0,10237.0,10208.0,10002.0,importin beta-1 subunit  putative,G1
Tb11.v5.0838,11589.0,11505.0,11490.5,11493.0,11466.0,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb11.v5.0839,10590.5,7716.0,7291.0,8082.0,7708.5,retrotransposon hot spot (RHS) protein  putative,<2C (LG1)
Tb11.v5.0840,6706.0,7931.0,7291.0,7547.0,6234.5,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb11.v5.0841,2357.5,3973.5,4224.5,5037.0,4306.0,hypothetical protein  conserved,G2M
Tb11.v5.0842,7455.5,5909.5,6961.0,6475.5,8638.0,Vesicle coat protein involved in Golgi to plasma membrane transport  putative,>4C (GG2M)
Tb11.v5.0843,3550.5,1362.5,1886.0,1888.0,6511.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0844,612.5,130.0,99.0,82.5,461.5,ATP-dependent DEAH-box RNA helicase  putative,<2C (LG1)
Tb11.v5.0845,1988.0,2896.5,2425.0,2404.0,2941.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0846,612.5,588.0,1650.0,687.0,86.0,hypothetical protein  conserved,S
Tb11.v5.0847,10525.5,10758.5,11012.0,10852.5,10761.0,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.0848,4801.0,3997.5,5526.0,6507.5,10738.0,gamma-tubulin complex subunit  putative,>4C (GG2M)
Tb11.v5.0849,3937.0,1961.5,1989.5,1936.0,2747.0,kinesin motor domain containing protein  putative,<2C (LG1)
Tb11.v5.0850,612.5,2881.5,3609.0,3216.0,1647.0,Trypanosomal VSG domain/Trypanosome variant surface glycoprotein C-terminal domain containing protein  putative,S
Tb11.v5.0851,4655.5,2011.0,2378.0,2869.0,1325.5,ribonuclease HII  putative,<2C (LG1)
Tb11.v5.0852,8756.5,4531.5,4689.0,4798.0,1919.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0853,6470.0,4096.5,5358.0,5087.5,5567.0,Vacuolar sorting protein 9 (VPS9) domain containing protein  putative,<2C (LG1)
Tb11.v5.0854,10385.0,8704.0,9055.5,9161.5,8679.5,NLI interacting factor-like phosphatase  putative,<2C (LG1)
Tb11.v5.0855,8504.5,6804.5,6379.0,5949.0,6307.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0856,6822.0,2772.5,2551.0,2893.5,3144.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0857,6441.5,4155.5,5025.0,4097.0,4284.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0858,4403.5,6824.0,7676.5,6784.5,9930.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0859,8423.0,7707.5,8386.0,7577.0,8424.5,N-myristoyl transferase  putative,>4C (GG2M)
Tb11.v5.0860,9507.5,9406.0,10127.0,9495.5,9723.0,endonuclease G  putative,S
Tb11.v5.0861,1460.0,1773.5,1650.0,1451.5,1489.0,hypothetical protein  conserved,G1
Tb11.v5.0862,3670.5,5301.5,5505.0,5342.5,4187.0,hypothetical protein  conserved,S
Tb11.v5.0863,9930.0,11086.0,10919.0,10947.5,9948.0,hypothetical protein  conserved,G1
Tb11.v5.0864,5625.5,6670.0,6961.0,7144.0,6917.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb11.v5.0865,8598.0,9484.0,8857.5,9350.5,8165.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb11.v5.0866,5349.0,2814.0,3092.0,2775.0,2231.5,major vault protein  putative,<2C (LG1)
Tb11.v5.0867,612.5,2429.0,2196.0,1805.5,3606.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0868,11173.5,11399.0,11452.0,11329.0,11208.0,mitotubule-associated protein Gb4  putative,S
Tb11.v5.0869,9539.0,11053.0,10901.0,11100.0,10454.0,cystathione gamma lyase  putative,G2M
Tb11.v5.0870,612.5,1817.5,2612.0,1558.5,1531.5,variant surface glycoprotein (VSG  atypical)  putative,S
Tb11.v5.0871,5053.5,2250.0,1149.5,1299.0,2514.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0872,7520.5,5804.5,6288.0,6899.0,6479.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0873,6858.5,7862.0,7249.5,7368.0,5686.0,variant surface glycoprotein (VSG)  putative,G1
Tb11.v5.0874,11182.0,11495.0,11518.0,11539.0,11552.0,protein kinase  putative,>4C (GG2M)
Tb11.v5.0875,1783.5,2516.5,1237.5,1343.0,2661.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0876,9401.0,8265.0,8794.5,9253.0,7725.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0877,2504.5,1609.0,778.0,757.5,1010.0,eukaryotic translation initiation factor 3 subunit 8  putative,<2C (LG1)
Tb11.v5.0878,10743.5,8758.5,8722.0,8602.5,8553.5,DNA polymerase kappa  putative,<2C (LG1)
Tb11.v5.0879,10457.5,10316.0,10479.5,10626.5,10844.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0880,7292.0,8970.5,8676.5,8235.0,7592.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,G1
Tb11.v5.0881,10868.0,11572.0,11549.0,11454.0,11402.5,antigenic protein  putative,G1
Tb11.v5.0882,11711.0,11716.0,11715.0,11715.0,11715.0,hypothetical protein  conserved,G1
Tb11.v5.0883,6344.5,1405.5,1446.0,875.0,1732.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0884,9310.0,11094.0,10559.5,11139.0,10771.0,hypothetical protein  conserved,G2M
Tb11.v5.0885,5167.5,6193.5,7644.0,6304.5,7510.5,amino acid transporter  putative,S
Tb11.v5.0886,4086.0,7711.0,7131.5,6531.0,5780.5,hypothetical protein  conserved,G1
Tb11.v5.0887,9495.0,9699.5,9497.0,9710.5,9991.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0888,8634.0,6818.5,6475.0,7137.5,7147.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0889,10306.0,11089.0,11087.5,11089.5,10869.0,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0890,2826.5,1371.5,2092.5,1430.0,1717.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0891,3283.5,5295.0,4878.5,4731.0,4320.5,variant surface glycoprotein (VSG)-related  putative,G1
Tb11.v5.0892,10478.5,10623.5,10677.5,10660.5,9891.0,hypothetical protein  conserved,S
Tb11.v5.0893,3013.5,3023.5,3531.0,4464.5,6522.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0894,10666.0,10491.5,9908.0,10330.5,9550.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0895,7824.5,8540.5,8398.0,9001.5,9472.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0896,6811.0,7444.0,7572.0,7016.0,6074.0,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.0897,8850.0,5426.5,6815.5,6728.0,5906.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0898,612.5,1609.0,1446.0,1228.0,461.5,variant surface glycoprotein (VSG)  putative,G1
Tb11.v5.0899,2436.0,896.0,1446.0,1479.0,1304.5,tRNA-dihydrouridine synthase 2  putative,<2C (LG1)
Tb11.v5.0900,612.5,413.0,907.5,292.5,213.0,hypothetical protein  conserved,S
Tb11.v5.0901,8466.0,1220.5,1860.0,1861.0,2442.5,tubulin-tyrsoine ligase-like protein  putative,<2C (LG1)
Tb11.v5.0902,3443.0,3941.5,4550.5,4808.0,7236.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0903,11330.0,11260.0,11101.0,11365.0,11331.0,S-adenosylmethionine decarboxylase proenzyme  putative,G2M
Tb11.v5.0904,4947.5,2350.5,2533.0,2977.0,1789.5,glutaredoxin-like protein  putative,<2C (LG1)
Tb11.v5.0905,8403.5,6148.5,5570.5,6219.5,6229.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0906,7063.0,4008.0,4341.0,4084.0,7244.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0907,1783.5,3201.0,3633.5,3909.0,1804.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0908,612.5,176.5,210.0,248.0,86.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0909,2840.5,2187.0,1428.0,1542.0,1281.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0910,612.5,7137.0,6961.0,6774.5,6006.0,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb11.v5.0911,612.5,823.0,313.0,534.5,347.0,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb11.v5.0912,6616.5,6922.5,7204.0,7710.0,5972.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0913,3380.0,2034.0,2011.5,2025.0,3494.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0914,5308.5,2296.0,2075.5,2335.0,3658.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0915,7655.5,7128.5,7098.0,7605.5,4783.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0916,6772.0,1747.5,2717.5,2184.5,4703.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0917,612.5,40.5,99.0,33.5,86.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0918,6447.0,3187.0,3179.5,3878.0,4036.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0919,612.5,279.5,410.0,136.5,461.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0920,5078.5,2934.5,3745.0,2801.0,3794.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0921,612.5,40.5,233.5,82.5,637.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0922,1988.0,1747.5,1700.5,1609.0,1531.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb11.v5.0923,4449.5,4675.5,4878.5,5883.5,4345.5,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0924,4910.5,1211.0,1300.0,1202.5,2601.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0925,6207.5,1961.5,3420.5,2869.0,3235.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0926,11103.0,11277.5,11011.0,11372.0,10636.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0927,8303.0,9367.5,9032.0,9261.5,9173.5,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb11.v5.0928,2901.0,7795.5,7689.5,8338.0,7981.0,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0929,7007.0,3747.5,3832.5,4409.0,3733.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0930,8992.0,5829.5,6055.5,6129.0,6123.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0931,6106.5,6838.5,7634.5,6706.0,6356.5,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.0932,3095.0,2808.0,1731.5,1228.0,2574.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0933,4411.0,3457.0,3801.5,3319.0,4693.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0934,1460.0,2731.0,2103.5,3241.5,2218.5,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0935,612.5,640.0,778.0,737.0,397.5,variant surface glycoprotein (VSG  atypical)  putative,S
Tb11.v5.0936,612.5,294.5,520.0,444.5,1213.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0937,10267.0,9861.0,10107.0,10360.5,10000.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0938,5915.0,3499.5,3344.0,3866.5,3871.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0939,5692.0,2296.0,2327.5,2184.5,3606.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0940,4282.0,2086.0,1909.5,1875.5,1374.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0941,10228.0,10023.0,10059.5,10398.5,10149.5,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0942,5876.5,3485.5,3398.5,3965.5,3906.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0943,4626.0,518.0,313.0,334.5,778.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0944,4034.5,1087.5,1692.0,1329.0,1437.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0945,5030.5,4331.5,4840.5,4235.5,5420.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0946,612.5,2839.5,2318.5,2716.0,2991.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0947,612.5,626.0,703.0,849.0,1878.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0948,612.5,1171.5,1030.5,862.0,505.0,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb11.v5.0949,7086.0,2731.0,1254.0,1466.0,3669.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0950,4721.0,1476.5,1536.0,1980.0,1195.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0951,3214.5,1026.5,1192.0,1654.0,1516.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0952,612.5,1026.5,1164.0,925.0,836.0,variant surface glycoprotein (VSG  atypical)  putative,S
Tb11.v5.0953,5058.0,4849.5,4448.0,5728.5,5092.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0954,612.5,40.5,40.0,82.5,86.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0955,6528.0,7992.5,8759.0,7740.5,8137.0,variant surface glycoprotein (VSG  atypical)  putative,S
Tb11.v5.0956,5766.5,3492.0,2996.5,4011.0,4276.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0957,4048.0,4967.0,5218.0,5087.5,6420.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0958,4523.5,4331.5,4046.5,5497.0,5702.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb11.v5.0959,5048.0,6561.0,6568.5,7111.0,8865.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0960,7935.5,7512.0,7158.0,6205.5,8053.5,tRNA-dihydrouridine synthase 4  putative,>4C (GG2M)
Tb11.v5.0961,5457.5,5267.0,6226.5,5873.0,5824.0,hypothetical protein  conserved,S
Tb11.v5.0962,612.5,4413.0,3668.5,3513.0,7154.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0963,8886.5,5552.5,6893.0,6491.0,3794.0,Uncharacterised ACR  YggU family COG1872  putative,<2C (LG1)
Tb11.v5.0964,5557.5,4590.5,3626.0,4654.5,2203.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0965,8502.5,10557.0,10431.5,10523.5,10711.5,ATP-dependent DEAH-box RNA helicase  putative,>4C (GG2M)
Tb11.v5.0966,7134.5,2741.5,2778.0,2821.0,2536.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0967,10449.0,7331.5,7658.5,5716.5,6216.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0968,5817.0,8336.5,7450.0,6790.5,7169.5,hypothetical protein  conserved,G1
Tb11.v5.0969,3341.5,2785.5,3868.5,3909.0,3541.0,hypothetical protein  conserved,G2M
Tb11.v5.0970,2995.0,4669.0,2666.0,3045.0,1789.5,chaperone protein DnaJ  putative,G1
Tb11.v5.0971,9526.5,7024.5,6695.5,7744.5,5675.0,mitochondrial DNA polymerase I protein A  putative,<2C (LG1)
Tb11.v5.0972,2258.5,1838.0,1446.0,875.0,761.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0973,612.5,664.5,507.0,577.5,672.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.0974,7747.0,7656.0,5981.0,7126.0,6307.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0975,2619.0,1975.0,1465.0,1430.0,1896.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb11.v5.0976,612.5,640.0,767.0,1031.0,778.5,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.0977,3794.5,3766.0,2790.5,2977.0,2914.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0978,4094.5,2436.0,2172.5,2506.5,2089.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.0979,2598.0,716.5,925.0,647.5,2039.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb11.v5.0980,3638.0,3961.0,4258.0,4327.5,2574.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.0981,8787.5,9192.5,8290.5,8688.0,8374.0,variant surface glycoprotein (VSG)  putative,G1
Tb11.v5.0982,2619.0,759.0,907.5,737.0,948.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0983,3314.5,2422.5,3167.0,1966.0,4051.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.1320,4544.0,4056.0,5358.0,3965.5,4170.0,hypothetical protein,S
Tb11.1330,3370.5,1303.5,1489.0,1299.0,1912.0,hypothetical protein,<2C (LG1)
Tb11.1340,3370.5,1619.0,2092.5,1329.0,1984.0,hypothetical protein,<2C (LG1)
Tb11.1350,3524.0,2392.5,2541.5,1745.0,1984.0,hypothetical protein,<2C (LG1)
Tb11.1360,4411.0,3008.5,3727.5,2746.5,3044.5,hypothetical protein,<2C (LG1)
Tb11.v4.0042,5218.0,1982.5,3009.0,2389.0,2941.0,variant surface glycoprotein (VSG  pseudogene)  fragment,<2C (LG1)
Tb11.v4.0043,2943.0,1220.5,1783.0,1299.0,1595.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.v4.0044,11461.0,11379.0,11401.0,11371.0,11378.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.v5.0984,6190.5,5002.0,4977.5,4928.5,5788.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0985,8188.0,7939.0,8759.0,9048.5,8367.0,variant surface glycoprotein (VSG)-related  putative,G2M
Tb11.v5.0986,612.5,40.5,40.0,33.5,86.0,sugar transporter  putative,<2C (LG1)
Tb11.v5.0987,4490.0,3606.5,4372.0,3577.5,3086.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0988,4225.5,2887.5,2931.0,2470.5,3586.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0989,4721.0,4008.0,4749.0,4112.0,3474.5,hypothetical protein  conserved,S
Tb11.v5.0990,10478.5,11472.0,11607.0,11391.5,11503.0,hypothetical protein  conserved,S
Tb11.v5.0991,8253.0,9557.0,8921.0,9143.0,7295.0,protein phosphatase 2C  putative,G1
Tb11.1410,8928.5,5530.5,4680.0,5307.5,5394.5,Ring finger domain containing protein  putative,<2C (LG1)
Tb11.1400,8875.5,6352.5,7372.0,6637.0,7125.0,hypothetical protein  conserved (pseudogene),<2C (LG1)
Tb11.1390,6286.5,7343.5,5817.5,6024.5,5861.5,hypothetical protein  conserved,G1
Tb11.1380,612.5,208.5,336.0,182.5,672.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.1370,6967.0,3615.5,4104.0,4027.5,3669.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.1064,5036.5,2106.0,2453.0,2184.5,2254.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0992,3794.5,2296.0,3079.0,1626.0,2243.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.0993,3598.0,2908.0,3767.5,2566.5,1912.0,hypothetical protein  conserved,S
Tb11.v5.0994,2813.0,1394.5,1977.0,1514.5,1595.5,hypothetical protein  conserved,<2C (LG1)
Tb11.1430,6459.5,4879.0,4398.0,4522.0,4468.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1440,612.5,498.0,562.5,464.0,778.5,variant surface glycoprotein (VSG  pseudogene)  fragment,>4C (GG2M)
Tb11.1450,7267.0,5077.5,4493.5,5862.5,6270.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.1780,9973.0,10432.5,10646.5,10339.5,10016.5,retrotransposon hot spot protein 1 (RHS1  pseudogene)  putative,S
Tb11.1790,7007.0,7857.5,7786.5,8089.5,8948.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,>4C (GG2M)
Tb11.v5.0995,612.5,1747.5,1278.5,1626.0,1453.5,hypothetical protein  conserved,G1
Tb11.v5.0996,612.5,398.0,336.0,534.5,3474.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0997,612.5,3284.0,3487.0,3154.0,8667.5,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.0998,8262.0,7049.5,6961.0,6262.0,7880.5,methionine aminopeptidase  putative,<2C (LG1)
Tb11.v5.0999,6334.0,5104.5,5777.0,5454.0,8933.0,Domain of Unknown Function (DUF1042)  putative,>4C (GG2M)
Tb11.v5.1000,11460.0,11548.0,11588.0,11422.0,11324.0,hypothetical protein  conserved,S
Tb11.v5.1001,2982.0,2086.0,2949.5,1382.0,2016.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.1002,3394.0,2062.0,2612.0,1779.5,1660.5,hypothetical protein  conserved,<2C (LG1)
Tb11.1540,4122.5,2751.5,4104.0,2589.0,2747.0,hypothetical protein,<2C (LG1)
Tb11.v5.1003,4978.5,2358.5,2894.5,2290.0,2514.5,hypothetical protein  conserved,<2C (LG1)
Tb11.1550,4776.0,3723.5,5164.0,4662.5,5003.0,hypothetical protein,S
Tb11.v5.1004,11718.0,11718.0,11716.0,11718.0,11717.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.1005,11630.0,11647.0,11634.0,11631.0,11581.0,hypothetical protein  conserved,G1
Tb11.v5.1006,4439.5,3120.0,3626.0,2977.0,2550.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.1007,4626.0,2479.0,3246.5,2530.5,2505.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.1008,8756.5,9980.5,10450.0,9820.0,9827.0,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.1009,612.5,2731.0,2790.5,2168.5,2190.0,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.1010,8657.0,4960.0,6302.0,4841.0,5657.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.1011,11405.0,11642.0,11646.0,11646.0,11621.0,calpain-like cysteine peptidase  putative,S
Tb11.v5.1012,612.5,4560.0,5419.0,4908.0,4096.5,2-oxoisovalerate dehydrogenase beta subunit  mitochondrial precursor  putative,S
Tb11.v5.1013,6116.5,4373.5,5044.5,4394.5,4266.0,Protein prenyltransferase alpha subunit repeat  putative,<2C (LG1)
Tb11.v5.1014,5981.0,5344.0,4977.5,4962.5,5075.5,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.1015,9652.5,9296.5,9931.0,10106.0,9983.5,expression site-associated gene 4 (ESAG4) protein  putative,G2M
Tb11.v5.1016,8318.0,10897.5,10956.0,11009.0,10620.0,receptor-type adenylate cyclase GRESAG 4 (pseudogene)  putative,G2M
Tb11.v5.1017,612.5,1115.5,1692.0,1479.0,874.5,variant surface glycoprotein (VSG)  putative,S
Tb11.v5.1018,5682.0,6255.5,5479.0,5042.5,6499.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.1019,3462.5,1059.5,1502.0,1391.5,1213.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.1020,10712.0,11416.0,11425.0,11379.0,10577.0,retrotransposon hot spot (RHS) protein  putative,S
Tb11.v5.1021,9666.5,8431.0,9457.0,8328.0,9068.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.1022,5369.0,9505.5,9332.5,9695.5,9259.5,protein kinase  putative,G2M
Tb11.v5.1023,6464.5,3336.0,4117.0,3216.0,6749.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.1024,10497.5,10786.0,11254.5,11134.0,11157.5,variant surface glycoprotein (VSG  atypical)  putative,S
Tb11.v5.1025,9681.0,11049.5,11116.0,10855.5,10411.0,variant surface glycoprotein (VSG)  putative,S
Tb11.01.6241,7260.0,2534.5,3157.0,3332.5,2631.5,expression site-associated gene (ESAG) protein  putative,<2C (LG1)
Tb11.01.6251,7282.0,8259.5,7372.0,7902.5,7494.0,expression site-associated gene 11 (ESAG11) protein  putative,G1
Tb11.v5.1026,5105.0,10009.0,10697.5,10619.0,10313.0,procyclin-associated gene 2-like protein  putative,S
Tb11.v5.1027,1783.5,4365.0,3503.0,3065.5,4498.5,procyclin-associated gene 2-like protein  putative,>4C (GG2M)
Tb11.v5.1028,4104.0,2581.5,2036.0,2237.0,3185.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v5.1029,8723.0,10659.5,10599.0,10016.5,9668.5,variant surface glycoprotein (VSG)  putative,G1
Tb11.v5.1030,4465.0,2358.5,2251.5,2058.5,3586.0,hypothetical protein  conserved,<2C (LG1)
Tb11.v5.1031,8742.0,9994.5,9790.0,9916.0,9200.0,hypothetical protein  conserved,G1
Tb11.v5.1032,11081.0,11498.0,11392.0,11596.0,11330.0,variant surface glycoprotein (VSG)  putative,G2M
Tb11.1620,11720.0,11721.0,11720.0,11720.0,11720.0,variant surface glycoprotein (VSG  pseudogene)  fragment,G1
Tb11.1610,612.5,2760.5,3344.0,2686.0,3021.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb11.v5.1033,2180.0,2839.5,4364.5,4598.0,2203.5,variant surface glycoprotein (VSG)  putative,G2M
Tb11.v5.1034,2221.0,1043.5,832.0,1003.0,697.5,heat shock protein 70 (hsp70)  putative,<2C (LG1)
Tb11.v5.1035,2943.0,3361.0,2764.5,3642.0,2050.0,heat shock protein 70 (hsp70)  putative,G2M
Tb11.v5.1036,10583.5,8031.0,7536.0,7027.5,8420.5,gamma-tubulin complex subunit  putative,<2C (LG1)
Tb11.v5.1037,4411.0,8496.0,7969.5,8676.0,9009.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.v5.1038,11663.0,11688.0,11691.0,11689.0,11661.0,calpain-like cysteine peptidase  putative,S
Tb11.v5.1039,8128.5,9713.0,9960.0,9681.0,9173.5,nuclear cap binding complex subunit CBP110  putative,S
Tb11.v5.1040,5090.0,6897.0,7377.0,7099.5,5145.5,mismatch repair protein  putative,S
Tb11.v5.1041,612.5,3367.5,3197.0,3319.0,6038.0,hypothetical protein  conserved,>4C (GG2M)
Tb11.v5.1042,5379.0,4145.5,1848.0,3380.5,2884.5,RNA-editing complex protein  putative,<2C (LG1)
Tb11.v5.1043,9134.0,7167.0,6900.0,7365.0,6917.0,nucleobase/nucleoside transporter 8.1  putative,<2C (LG1)
Tb11.v5.1044,10973.5,11124.0,11260.0,11050.0,11067.0,nucleobase/nucleoside transporter 8.1  putative,S
Tb11.v5.1045,9592.0,10695.5,10516.5,10279.5,10411.0,protein kinase  putative,G1
Tb11.v5.1046,7564.5,8160.0,7297.0,8219.0,8125.0,elongation factor 1-alpha  putative,G2M
Tb11.v5.1047,2180.0,2206.0,2144.5,2617.5,1338.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb11.v5.1048,2574.5,543.0,778.0,517.0,531.0,protein kinase  putative,<2C (LG1)
Tb11.v5.1049,6066.0,4560.0,5044.5,4552.0,4330.5,nucleobase/nucleoside transporter 8.1  putative,<2C (LG1)
Tb11.v5.1050,6216.0,5196.0,4722.5,4674.0,6659.5,DNA polymerase kappa  putative,>4C (GG2M)
Tb11.v5.1051,7352.5,6265.5,5898.0,6755.5,5526.5,nucleobase/nucleoside transporter 8.1  putative,<2C (LG1)
Tb11.v5.1052,8347.5,6561.0,6664.0,7167.0,6199.5,nucleobase/nucleoside transporter 8.1  putative,<2C (LG1)
Tb11.v5.1053,1914.0,3120.0,2750.5,3909.0,3812.0,DIS3-like exonuclease  putative,G2M
Tb11.v5.1054,8529.0,6754.0,6469.0,7426.5,6836.0,nucleobase/nucleoside transporter 8.1  putative,<2C (LG1)
Tb11.v5.1055,2180.0,176.5,210.0,204.0,397.5,73 kDa paraflagellar rod protein  putative,<2C (LG1)
Tb11.v5.1056,11277.0,11529.0,11430.0,11611.0,11457.0,DNA polymerase kappa  putative,G2M
Tb11.v5.1057,9757.0,4684.0,4200.5,5273.5,5248.0,protein kinase  putative,<2C (LG1)
Tb11.v5.1058,9692.0,7493.5,7098.0,8379.0,7419.5,DNA polymerase kappa  putative,<2C (LG1)
Tb11.v5.1059,612.5,554.5,293.0,82.5,213.0,40S ribosomal protein S4  putative,<2C (LG1)
Tb927.1.05,1988.0,2581.5,3678.5,3264.5,3510.5,variant surface glycoprotein (VSG)  putative,S
Tb927.1.10,9025.5,4719.0,5256.0,4636.5,3335.5,hypothetical protein,<2C (LG1)
Tb927.1.20,10200.5,10883.0,10951.5,11245.0,10767.0,expression site-associated gene 3 (ESAG3)  pseudogene,G2M
Tb927.1.30,9833.5,10452.0,10057.5,10219.5,10119.0,hypothetical protein,G1
Tb927.1.40,11723.0,11723.0,11723.0,11723.0,11723.0,hypothetical protein,<2C (LG1)
Tb927.1.60,11335.0,11552.0,11530.0,11533.0,11274.0,RNA polymerase (pseudogene)  putative,G1
Tb927.1.70,9245.0,10428.0,10569.0,10525.0,9852.0,retrotransposon hot spot protein 4 (RHS4)  putative,S
Tb927.1.90,10547.0,11298.5,11242.0,11164.5,10664.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,G1
Tb927.1.100,11619.0,11673.0,11667.0,11688.0,11614.0,RNA polymerase (pseudogene)  putative,G2M
Tb927.1.110,4916.5,5144.5,4857.0,4973.5,3248.5,hypothetical protein  conserved,G1
Tb927.1.120,10273.0,11407.0,11384.0,11381.0,11206.0,retrotransposon hot spot protein 4 (RHS4)  putative,G1
Tb927.1.180,10934.0,11232.0,11185.0,11178.0,11201.0,retrotransposon hot spot protein 1 (RHS1)  putative,G1
Tb927.1.190,11487.0,11249.0,11132.0,11363.0,11279.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb927.1.220,10565.5,11152.0,11191.0,11118.5,11200.0,retrotransposon hot spot protein 1 (RHS1)  putative,>4C (GG2M)
Tb927.1.240,11703.0,11702.0,11700.0,11696.0,11682.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb927.1.270,10327.0,10906.0,10900.0,10991.0,9916.5,hypothetical protein,G2M
Tb927.1.275,10688.0,11408.0,11465.0,11424.5,11239.5,expression site-associated gene 4 (ESAG4)  pseudogene,S
Tb927.1.280,10142.0,9081.5,9761.0,9217.5,8922.5,Protein of unknown function (DUF1181)  putative,<2C (LG1)
Tb927.1.290,11667.0,11706.0,11703.0,11709.0,11693.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.1.300,11701.0,11679.0,11689.0,11684.0,11668.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb927.1.320,4563.0,6282.5,6923.0,7212.0,8273.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,>4C (GG2M)
Tb927.1.330,6492.0,6901.5,8427.5,8520.5,8624.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,>4C (GG2M)
Tb927.1.350,11290.0,11361.0,11423.0,11443.0,11241.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,G2M
Tb927.1.370,11577.0,11656.0,11647.0,11666.0,11555.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.1.380,6680.5,9705.5,9192.0,9882.0,9095.5,Protein of unknown function (DUF1181)  putative,G2M
Tb927.1.400,10380.0,10760.5,10082.5,10556.5,9711.5,hypothetical protein  conserved,G1
Tb927.1.410,7980.5,10634.0,10668.0,10626.5,10705.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,>4C (GG2M)
Tb927.1.420,10454.0,9982.0,9755.5,10490.5,9056.0,retrotransposon hot spot protein 5 (RHS5)  putative,G2M
Tb927.1.430,11682.0,11677.0,11688.0,11677.0,11649.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,S
Tb927.1.450,11672.0,11668.0,11675.0,11645.0,11617.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,S
Tb927.1.470,6042.0,10513.0,10328.5,10556.5,9696.5,Protein of unknown function (DUF1181)  putative,G2M
Tb927.1.480,11643.0,11670.0,11656.0,11676.0,11564.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.1.490,5756.5,6595.5,6134.0,7710.0,6377.5,hypothetical protein,G2M
Tb927.1.500,11551.0,11640.0,11648.0,11619.0,11549.0,retrotransposon hot spot protein (RHS  pseudogene)  putative,S
Tb927.1.520,11187.0,8216.0,7562.5,6850.0,7161.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.1.530,9951.0,8895.0,8968.5,9039.0,9126.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.540,8094.0,10972.0,11223.0,11063.0,10935.0,DNA-directed RNA polymerase III  putative,S
Tb927.1.560,8502.5,8649.0,8523.0,8735.0,6960.0,WD domain  G-beta repeat  putative,G2M
Tb927.1.570,612.5,6235.0,6976.0,5917.0,4231.5,Histone-lysine N-methyltransferase  H3 lysine-76 specific,S
Tb927.1.580,9058.5,9326.0,8921.0,9722.5,9313.0,phosphate-repressible phosphate permease  putative,G2M
Tb927.1.600,6324.5,8857.0,8116.5,8720.5,8667.5,phosphate-repressible phosphate permease  putative,G1
Tb927.1.610,1460.0,5979.5,4990.5,6470.5,8409.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.1.630,4810.5,3799.0,3626.0,3545.0,3586.0,histone chaperone ASF1A,<2C (LG1)
Tb927.1.640,7587.0,9347.5,10649.5,10721.0,10090.0,BRCA2,G2M
Tb927.1.650,7130.0,3753.5,4462.5,4252.5,3214.5,conserved protein  unknown function,<2C (LG1)
Tb927.1.670,2682.0,5295.0,6334.0,6229.5,6334.5,conserved protein  unknown function,>4C (GG2M)
Tb927.1.690,6724.5,6016.0,5898.0,6996.5,8286.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.1.700,7301.5,6186.0,4224.5,2840.5,4703.5,phosphoglycerate kinase,<2C (LG1)
Tb927.1.710,8466.0,5561.5,4540.5,4112.0,2786.0,phosphoglycerate kinase,<2C (LG1)
Tb927.1.720,9988.0,6595.5,3127.0,3992.5,3021.0,phosphoglycerate kinase,<2C (LG1)
Tb927.1.730,1460.0,4341.0,3697.0,2456.5,6917.0,NADH-ubiquinone oxidoreductase complex I subunit  putative,>4C (GG2M)
Tb927.1.740,612.5,2392.5,4293.5,2102.5,2819.0,phosphatidylinositol-4-phosphate 5-kinase related,S
Tb927.1.750,9736.0,11153.5,10671.0,10718.0,11238.0,Metal-binding domain-containing protein,>4C (GG2M)
Tb927.1.760,11194.0,10793.0,11022.0,11206.5,10714.0,wd40 repeat domain-containing protein,G2M
Tb927.1.780,7469.0,7293.5,6022.5,4882.0,7770.5,leucine-rich repeat-containing protein,>4C (GG2M)
Tb927.1.790,3261.0,8680.5,8775.5,8709.5,9438.0,hypothetical transmembrane protein  conserved,>4C (GG2M)
Tb927.1.800,612.5,4373.5,2858.0,3295.5,5640.0,hypothetical transmembrane protein,>4C (GG2M)
Tb927.1.820,10093.0,10741.5,10773.5,10977.0,9696.5,kelch domain-containing protein,G2M
Tb927.1.830,9522.0,9793.0,9838.5,9275.0,9156.5,hypothetical protein  conserved,S
Tb927.1.840,3726.5,2516.5,2949.5,2311.0,4158.0,transmembrane protein  putative,>4C (GG2M)
Tb927.1.860,8745.0,7676.5,7098.0,8334.0,6096.5,transmembrane protein  putative,<2C (LG1)
Tb927.1.870,9256.0,7578.5,7466.5,7179.5,8198.0,deoxyhypusine synthase,<2C (LG1)
Tb927.1.880,11432.0,11545.0,11576.0,11473.5,11418.0,Midasin  putative,S
Tb927.1.890,612.5,130.0,161.0,82.5,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.990,4801.0,1961.5,2196.0,3045.0,2110.0,Enkuring domain-containig protein,<2C (LG1)
Tb927.1.1000,1460.0,3441.5,2182.5,2686.0,2125.5,developmentally regulated phosphoprotein,G1
Tb927.1.1010,7819.0,9557.0,9497.0,9426.0,8508.5,E3 ubiquitin-protein ligase KCMF1  putative,G1
Tb927.1.1020,8436.0,7036.0,5962.0,5850.0,8396.5,leucine-rich repeat-containing protein,<2C (LG1)
Tb927.1.1025,6890.5,1619.0,1008.5,1861.0,1636.0,conserved protein  unknown function,<2C (LG1)
Tb927.1.1030,4728.0,7549.0,7158.0,6873.5,4212.0,Nucleolar protein 49,G1
Tb927.1.1050,10051.5,9591.0,9565.5,9554.0,7120.0,Metallo-dependent phosphatase-like domain-containing protein,<2C (LG1)
Tb927.1.1060,10163.0,9927.5,9826.0,9678.0,10356.5,Cell cycle checkpoint protein RAD1-like  putative,>4C (GG2M)
Tb927.1.1080,1988.0,4287.0,3542.0,4070.5,2413.0,TFIIH basal transcription factor subunit  putative,G1
Tb927.1.1090,612.5,543.0,373.5,647.5,697.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.1.1100,3630.5,3900.0,5298.0,6157.0,9966.0,Basal body protein,>4C (GG2M)
Tb927.1.1120,8361.0,4574.0,4316.5,2999.5,3375.0,ribosomal RNA-processing protein 8  putative,<2C (LG1)
Tb927.1.1130,4989.5,1220.5,1989.5,989.0,1878.0,glycerol-3-phosphate dehydrogenase (FAD-dependent)  putative,<2C (LG1)
Tb927.1.1140,612.5,700.5,547.0,444.5,836.0,Transmembrane protein 231  putative,>4C (GG2M)
Tb927.1.1150,7727.5,5725.5,7033.5,6138.0,8254.5,zeta tubulin,>4C (GG2M)
Tb927.1.1160,7387.5,6690.5,7115.5,7153.5,7008.5,kinetoplast ribosomal PPR-repeat containing protein 3,<2C (LG1)
Tb927.1.1170,6365.5,4567.5,5229.5,5069.5,5664.0,DNA-directed RNA polymerase 2  RPB12 subunit,<2C (LG1)
Tb927.1.1175,5718.0,6782.5,6636.5,7119.0,7230.5,hypothetical protein,>4C (GG2M)
Tb927.1.1200,7250.0,3967.5,5222.0,3866.5,4975.5,Mitochondrial ribosomal protein S15,<2C (LG1)
Tb927.1.1210,1783.5,904.0,1008.5,664.0,3033.0,conserved protein  unknown function,>4C (GG2M)
Tb927.1.1220,6599.0,5267.0,5469.5,5463.0,4560.5,RWD domain-containing protein,<2C (LG1)
Tb927.1.1230,9731.0,9036.5,7638.5,8144.5,8536.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.1.1240,6955.5,7208.0,7552.5,6676.5,9246.5,cytidine triphosphate synthase  putative,>4C (GG2M)
Tb927.1.1270,3478.0,3138.5,2577.0,2735.0,2483.5,homocysteine S-methyltransferase  putative,<2C (LG1)
Tb927.1.1300,6718.5,4823.5,4046.5,3295.5,4737.0,hypothetical transmembrane protein  conserved,<2C (LG1)
Tb927.1.1310,1460.0,1506.5,1612.0,1187.5,874.5,transmembrane protein  conserved,S
Tb927.1.1330,612.5,1982.5,1977.0,1352.5,505.0,Mitochondrial Editosome-like Complex TUTase,G1
Tb927.1.1340,7770.5,7237.5,6923.0,5648.5,5509.0,Quinonprotein alcohol dehydrogenase-like protein  putative,<2C (LG1)
Tb927.1.1350,8667.0,9570.0,9705.5,8682.5,10140.0,kinesin heavy chain  putative,>4C (GG2M)
Tb927.1.1370,9082.5,7065.5,7474.5,6591.5,6588.5,rRNA biogenesis protein  putative,<2C (LG1)
Tb927.1.1380,7470.0,5625.5,5007.0,5285.0,5174.5,serine/threonine protein phosphatase 2A regulatory subunit  putative,<2C (LG1)
Tb927.1.1390,4346.0,4859.5,4559.5,4808.0,3733.0,hypothetical protein  conserved,G1
Tb927.1.1400,9106.0,5494.5,3912.5,4754.5,5102.5,Overproducer of inositol protein 10 homolog  putative,<2C (LG1)
Tb1.NT.24,1460.0,2795.0,3167.0,1792.5,86.0,Noncoding RNA  putative,S
Tb927.1.1420,4563.0,10065.5,8606.0,6657.5,9882.0,conserved protein  unknown function,G1
Tb927.1.1470,3443.0,4268.0,4388.0,5014.5,3144.5,conserved protein  unknown function,G2M
Tb927.1.1500,9195.5,8569.0,8222.0,8896.5,9347.0,conserved protein  unknown function,>4C (GG2M)
Tb1.NT.25,612.5,335.0,293.0,366.5,559.5,Noncoding RNA  putative,<2C (LG1)
Tb927.1.1530,7173.0,10628.5,10498.5,10370.0,10551.5,STE group serine/threonine-protein kinase  putative,G1
Tb927.1.1540,11356.0,9472.0,9630.5,9834.0,8998.0,Tubulin/FtsZ family  putative,<2C (LG1)
Tb927.1.1550,2956.5,8031.0,9012.5,8970.0,8905.0,tubulin-tyrosine ligase  putative,S
Tb927.1.1560,2137.5,7561.5,7246.0,7502.0,8872.5,vesicular-fusion protein nsf  putative,>4C (GG2M)
Tb927.1.1580,4327.5,6591.5,7278.0,7845.5,7525.0,electron transport protein SCO1/2  putative,G2M
Tb927.1.1600,7195.5,10472.0,10874.0,10725.0,10627.5,pseudouridine synthase TruD  putative,S
Tb927.1.1610,7507.5,2964.5,2750.5,2840.5,1636.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.1620,10126.5,10211.0,9730.0,9343.0,10145.0,ATP-dependent DEAD/H RNA helicase  putative,G1
Tb927.1.1630,7635.5,6727.5,6072.0,5981.0,6369.5,transcription elongation factor 1 homolog,<2C (LG1)
Tb927.1.1640,6185.5,2630.0,3441.0,2919.0,2898.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.1650,4176.0,2011.0,1860.0,1479.0,1374.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.1660,6264.0,3150.0,1324.0,2237.0,2442.5,ESCO acetyltransferase domain-containing protein,<2C (LG1)
Tb927.1.1670,8820.5,10570.0,10158.5,10469.0,10285.5,ARM-like helical domain-containing protein,G1
Tb927.1.1680,4555.0,4305.0,1956.0,2506.5,1878.0,Transcription elongation factor 1 domain-containing protein,<2C (LG1)
Tb927.1.1690,8614.5,11057.0,10783.0,10897.0,10578.5,RNA-editing nuclease 1,G1
Tb927.1.1700,7830.0,7285.5,6603.0,5862.5,5509.0,AATF protein  putative,<2C (LG1)
Tb927.1.1710,11252.5,11240.0,11196.5,11148.5,11363.0,transmembrane protein  conserved,>4C (GG2M)
Tb927.1.1720,11485.0,11015.0,11196.5,11085.0,8519.0,cyclophilin 15  putative,<2C (LG1)
Tb927.1.1730,9876.0,11164.0,11101.0,11287.0,10759.0,Polyadenylation mediator complex protein PAMC1  putative,G2M
Tb927.1.1740,11336.0,11687.0,11681.0,11672.0,11636.0,Microtubule-associated protein futsch  putative,G1
Tb927.1.1750,1460.0,3138.5,2750.5,3282.0,4883.5,conserved protein  unknown function,>4C (GG2M)
Tb927.1.1760,3937.0,2638.5,2510.5,3029.0,4928.5,hypothetical transmembrane protein,>4C (GG2M)
Tb927.1.1770,1783.5,799.5,1067.0,907.5,978.0,Dithiol glutaredoxin 2,<2C (LG1)
Tb927.1.1790,3166.5,3467.5,3779.5,4221.0,4145.0,hypothetical PIN domain-containing protein  conserved,G2M
Tb927.1.1820,612.5,2358.5,2023.5,1950.5,1717.0,hypothetical PIN domain-containing protein,G1
Tb927.1.1840,5817.0,8748.0,8392.0,8454.0,7219.5,conserved protein  unknown function,G1
Tb927.1.1850,3063.5,7893.5,8125.5,8239.5,7545.5,hypothetical protein  conserved,G2M
Tb927.1.1860,612.5,307.0,427.0,334.5,915.0,Uncharacterized protein,>4C (GG2M)
Tb927.1.1880,6847.0,6792.5,7334.0,6955.0,7610.5,WD40 repeat-containing protein,>4C (GG2M)
Tb927.1.1890,11381.0,9188.0,8558.0,8896.5,9757.5,Replication Factor C Subunit 1-related protein,<2C (LG1)
Tb927.1.1910,7991.5,10347.0,10163.0,10389.5,11181.0,MORN repeat-containing protein,>4C (GG2M)
Tb927.1.1920,9743.5,8869.0,8857.5,9457.0,8530.0,conserved protein  unknown function,<2C (LG1)
Tb927.1.1930,11495.0,11587.0,11550.0,11520.0,11443.5,phosphatidylinositol 3-kinase  putative,G1
Tb927.1.1960,7892.5,7578.5,8459.5,7839.5,6164.0,chaperone protein DnaJ  putative,S
Tb927.1.1980,7110.5,6048.0,5120.0,5728.5,6664.5,protein transport protein YIF1  putative,<2C (LG1)
Tb927.1.1990,7236.5,6179.5,5429.5,5695.0,4244.5,Pre-mRNA-splicing factor 38  putative,<2C (LG1)
Tb927.1.2000,7426.0,3596.0,2919.0,3205.5,3283.5,hypothetical protein,<2C (LG1)
Tb927.1.2040,7596.5,8555.5,7668.0,7605.5,6088.5,expression site-associated gene 2 (ESAG2) protein  putative,G1
Tb927.1.2060,612.5,1384.0,1489.0,1382.0,1179.0,expression site-associated gene 11 (ESAG11)  fragment,S
Tb927.1.2070,2221.0,5854.0,7301.0,6573.5,6206.0,expression site-associated gene 11 (ESAG11)  fragment,S
Tb927.1.2100,9983.5,11437.0,11443.0,11419.0,11112.0,Calpain-like protein 1.1,S
Tb927.1.2110,11044.0,10974.0,11156.0,11278.0,11347.0,Calpain-like protein 1.2,>4C (GG2M)
Tb927.1.2120,8645.0,10483.0,10512.5,10730.5,9950.5,Calpain-like protein CALP1.3,G2M
Tb927.1.2150,10083.5,7137.0,6200.0,7479.0,8020.0,Small kinetoplastid calpain-related protein 1-4,<2C (LG1)
Tb927.1.2160,1988.0,1838.0,1771.5,2025.0,1141.0,Small kinetoplastid calpain-related protein 1-5,G2M
Tb927.1.2190,10519.0,11219.0,10813.0,10842.5,10433.0,Raptor N-terminal CASPase like domain containing protein  putative,G1
Tb927.1.2200,5457.5,3164.5,2134.0,2058.5,3669.0,zinc finger protein family member  putative,<2C (LG1)
Tb927.1.2210,2221.0,6413.0,5728.0,5120.0,7236.5,nucleosome assembly protein (NAP)  putative,>4C (GG2M)
Tb927.1.2230,7143.0,2498.0,2360.0,3856.5,2463.0,small myristoylated protein 1-1,<2C (LG1)
Tb927.1.2260,2658.5,2664.0,1938.0,2211.5,3169.5,small myristoylated protein 1-2,>4C (GG2M)
Tb927.1.2310,3120.5,967.5,471.5,808.0,486.0,hypothetical protein,<2C (LG1)
Tb927.1.2320,2295.5,5717.0,4887.0,4612.5,7015.5,hypothetical protein  conserved,>4C (GG2M)
Tb1.NT.27,612.5,678.5,562.5,941.0,1062.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.1.2330,3589.5,1240.5,1388.5,1726.5,4110.0,beta tubulin,>4C (GG2M)
Tb927.1.2340,2637.5,626.0,658.5,862.0,4975.5,alpha tubulin,>4C (GG2M)
Tb927.1.2350,3502.5,1332.5,1465.0,1626.0,4760.0,beta tubulin,>4C (GG2M)
Tb927.1.2360,2460.0,612.5,717.5,989.0,4693.0,alpha tubulin,>4C (GG2M)
Tb927.1.2370,3478.0,1362.5,1665.0,1763.5,4831.5,beta tubulin,>4C (GG2M)
Tb927.1.2380,2406.5,413.0,731.0,875.0,4508.5,alpha tubulin,>4C (GG2M)
Tb927.1.2390,3534.0,1018.0,1347.5,1713.0,5953.5,beta tubulin,>4C (GG2M)
Tb927.1.2400,2598.0,652.5,578.5,907.5,4680.5,alpha tubulin,>4C (GG2M)
Tb927.1.2410,612.5,978.5,1041.5,957.5,4051.0,beta tubulin  pseudogene,>4C (GG2M)
Tb927.1.2420,10248.0,8352.5,8726.0,8773.0,8273.0,hypothetical protein,<2C (LG1)
Tb927.1.2430,8353.5,9136.0,9832.5,9261.5,10371.0,histone H3  putative,>4C (GG2M)
Tb927.1.2450,7940.0,9023.0,9211.5,8798.5,9852.0,histone H3  putative,>4C (GG2M)
Tb927.1.2470,8839.0,8677.0,9646.5,8909.5,10075.5,histone H3  putative,>4C (GG2M)
Tb927.1.2490,9816.5,10565.0,10932.0,10572.5,11111.0,histone H3  putative,>4C (GG2M)
Tb927.1.2510,9548.0,9956.5,10318.0,9900.5,10702.0,histone H3  putative,>4C (GG2M)
Tb927.1.2530,8124.5,9016.5,9528.0,8955.0,10119.0,histone H3  putative,>4C (GG2M)
Tb927.1.2550,8408.0,7830.5,8340.0,7571.0,9107.0,histone H3  putative,>4C (GG2M)
Tb927.1.2570,612.5,5261.5,4038.0,3737.0,1392.5,coatomer beta subunit,G1
Tb927.1.2580,9011.0,5992.0,5771.0,5808.5,5487.5,exosome-associated protein 1,<2C (LG1)
Tb927.1.2600,8196.5,2335.0,3420.5,3699.0,4005.5,pumilio/PUF RNA binding protein 9,<2C (LG1)
Tb927.1.2640,4248.0,4603.5,3703.5,4862.5,4915.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.1.2670,2995.0,678.5,547.0,464.0,2525.0,paralyzed flagella 16,<2C (LG1)
Tb927.1.2700,9463.5,4242.0,4224.5,4394.5,5342.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.2710,10809.5,9072.0,9202.0,9671.0,9068.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.2730,8918.0,8796.0,7823.5,8235.0,4975.5,conserved protein  unknown function,<2C (LG1)
Tb927.1.2740,7660.5,8216.0,4732.5,7087.0,4957.5,lipase-like protein  putative,G1
Tb927.1.2750,2767.0,1670.0,1710.5,2150.0,4748.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.1.2760,2870.5,944.0,1324.0,862.0,1565.5,hypothetical protein,<2C (LG1)
Tb927.1.2770,7063.0,6852.0,6185.0,6919.5,9798.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.1.2780,11422.0,11259.0,11317.0,11326.5,11136.0,hypothetical protein,<2C (LG1)
Tb927.1.2820,10490.0,10363.0,10118.0,10099.0,9113.0,pteridine transporter  putative,<2C (LG1)
Tb927.1.2850,9974.0,10614.0,10490.5,10393.0,10191.0,pteridine transporter  putative,G1
Tb927.1.2880,9123.0,9016.5,8600.5,8848.5,7478.0,pteridine transporter  putative,<2C (LG1)
Tb927.1.2970,1460.0,1171.5,1254.0,907.5,559.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.2980,7433.0,10324.0,10234.5,10061.0,7968.5,hypothetical protein  conserved,G1
Tb927.1.2985,6624.0,2296.0,1585.5,2603.0,2483.5,ER protein Pkr1  putative,<2C (LG1)
Tb927.1.2990,9082.5,10545.0,10528.5,10663.0,7775.0,kinetoplast ribosomal PPR-repeat containing protein 2,G2M
Tb927.1.3000,3095.0,5946.5,3868.5,5024.0,7624.5,amidohydrolase  putative,>4C (GG2M)
Tb927.1.3010,7396.5,2887.5,2778.0,1936.0,4231.5,mRNA processing protein  putative,<2C (LG1)
Tb927.1.3030,9210.5,6347.0,5445.5,6738.5,4480.5,KREL2,<2C (LG1)
Tb927.1.3040,10116.0,9202.0,9268.0,9300.0,9461.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3050,10171.5,9968.5,9816.5,10022.5,10405.0,tRNA (Uracil-5-)-methyltransferase  putative,>4C (GG2M)
Tb927.1.3070,3295.0,5236.0,5938.0,4731.0,4468.5,hypothetical protein  conserved,S
Tb927.1.3110,5111.0,8302.5,8436.5,7910.0,6016.5,soluble N-ethylmaleimide sensitive factor (NSF) attachment protein  putative,S
Tb927.1.3120,10967.0,10125.5,10127.0,10087.0,9911.0,Peptidase C50 separase  putative,<2C (LG1)
Tb927.1.3130,8769.0,9433.5,9702.5,9317.0,10619.0,AGC/RSK family serine/threonine kinase  putative,>4C (GG2M)
Tb927.1.3150,8147.5,9113.0,8646.5,9412.5,9386.5,hypothetical protein  conserved,G2M
Tb927.1.3170,8491.0,9875.0,9642.0,9900.5,7806.0,CHORD  putative,G2M
Tb927.1.3180,612.5,96.0,40.0,136.5,213.0,40S ribosomal protein S11  putative,<2C (LG1)
Tb927.1.3200,3996.0,3693.0,3755.0,3557.0,3541.0,Suppressor of G2 allele of SKP1  putative,<2C (LG1)
Tb927.1.3220,7503.5,7783.5,8368.0,8406.5,9940.5,TBC1 domain family member 20/GTPase  putative,>4C (GG2M)
Tb927.1.3230,6844.0,9282.0,9388.5,8036.0,9131.0,cell division cycle protein  putative,S
Tb927.1.3250,6264.0,10425.0,10599.0,10133.0,11178.5,Domain of unknown function (DUF4456)  putative,>4C (GG2M)
Tb927.1.3260,11478.0,11142.0,11319.0,11181.0,10674.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3270,10820.0,9413.0,8318.5,8688.0,8420.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3280,2221.0,3050.5,3745.0,4267.0,3648.5,septum formation protein MAF homologue  putative,G2M
Tb927.1.3290,5718.0,8985.5,9598.0,9035.0,9827.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.1.3300,2357.5,8755.5,9863.0,9383.5,8291.0,Myotubularin-related protein  putative,S
Tb927.1.3310,9265.0,5804.5,5144.0,6774.5,6432.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3320,9516.5,9399.5,9346.0,9464.5,9289.0,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.1.3350,2682.0,9944.0,10232.5,9837.0,10449.5,hypothetical protein,>4C (GG2M)
Tb927.1.3360,9068.5,9529.0,9306.5,8743.5,10499.0,hypothetical protein,>4C (GG2M)
Tb927.1.3390,1460.0,471.5,1731.5,941.0,853.0,Eukaryotic protein of unknown function (DUF866)  putative,S
Tb927.1.3400,3013.5,4879.0,5001.0,4598.0,4330.5,hypothetical protein  conserved,S
Tb927.1.3410,10058.5,8733.0,8867.5,9075.5,7356.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3450,6888.0,9181.5,9211.5,9540.0,8883.5,hypothetical protein  conserved,G2M
Tb927.1.3550,11010.0,11414.0,11417.5,11482.0,11479.5,hypothetical protein,G2M
Tb927.1.3560,9482.5,8642.5,9563.5,9816.0,9325.0,Centrosomal protein of 164 kDa  putative,G2M
Tb927.1.3670,11534.0,11645.0,11623.0,11600.0,11470.0,expression site-associated gene 8 (ESAG8) protein  putative,G1
tmp.1.100,10757.5,11054.0,11048.0,11122.5,10871.5,rRNA cluster,G2M
tmp.1.10,612.5,40.5,40.0,33.5,86.0,18S ribosomal RNA,<2C (LG1)
tmp.1.30,612.5,40.5,40.0,33.5,86.0,5.8S ribosomal RNA,<2C (LG1)
tmp.1.40,612.5,40.5,40.0,33.5,86.0,28S alpha ribosomal RNA,<2C (LG1)
tmp.1.50,612.5,40.5,40.0,33.5,86.0,M1 ribosomal RNA,<2C (LG1)
tmp.1.60,612.5,40.5,40.0,33.5,86.0,28S beta ribosomal RNA,<2C (LG1)
tmp.1.70,612.5,40.5,40.0,33.5,86.0,M2 ribosomal RNA,<2C (LG1)
tmp.1.80,612.5,40.5,40.0,33.5,86.0,M6 ribosomal RNA,<2C (LG1)
tmp.1.90,612.5,40.5,40.0,33.5,86.0,M4 ribosomal RNA,<2C (LG1)
Tb927.1.3750,10796.0,9767.5,10114.0,10477.5,9876.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3760,10849.0,11359.0,11436.0,11427.0,11193.5,hypothetical protein  conserved,S
Tb927.1.3800,612.5,3747.5,3410.0,2707.0,3021.0,Present in the outer mitochondrial membrane proteome 18,G1
Tb927.1.3810,2047.0,1180.5,1731.5,1572.5,505.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3820,7481.0,2392.5,3649.5,4464.5,5332.5,ATP synthase subunit  putative,<2C (LG1)
Tb927.1.3830,1460.0,2457.0,1721.5,2085.0,1195.0,glucose-6-phosphate isomerase  glycosomal,G1
Tb927.1.3840,7455.5,7065.5,6587.5,6694.0,7396.5,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3850,8060.0,5063.5,5102.5,5789.5,5135.5,Sec61beta family  putative,<2C (LG1)
Tb927.1.3860,11075.0,8433.5,9415.5,9103.5,8638.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.3880,10173.0,11461.0,11442.0,11491.0,11178.5,Fusaric acid resistance protein-like  putative,G2M
Tb927.1.3890,1460.0,3245.0,3420.5,3924.0,2884.5,hypothetical protein,G2M
Tb927.1.3910,5944.5,8020.5,9218.0,8652.5,6405.0,Anaphase-promoting complex subunit CDC23,S
Tb927.1.3940,10470.5,10708.5,10663.5,10545.0,9519.5,hypothetical protein  conserved,G1
Tb927.1.3950,4066.0,7310.0,7115.5,6827.0,7112.5,alanine aminotransferase,G1
Tb927.1.4010,9897.0,9626.0,10144.0,8900.0,7649.5,primase 2,S
Tb927.1.4020,3142.5,6992.5,5577.5,6955.0,6164.0,hypothetical protein,G1
Tb927.1.4040,5209.5,8440.0,7556.5,7350.0,8424.5,hypothetical protein  conserved,G1
Tb927.1.4050,11205.0,11021.5,11093.5,10911.0,10496.0,ser/thr protein phosphatase  putative,<2C (LG1)
Tb927.1.4100,6257.5,8287.5,8245.5,9060.0,8724.0,cytochrome oxidase subunit IV,G2M
Tb927.1.4140,6429.5,4348.5,4334.5,3307.0,4725.0,Bardet-Biedl syndrome 5 protein,<2C (LG1)
Tb927.1.4160,1460.0,877.0,1300.0,1665.0,1392.5,hypothetical protein  conserved,G2M
Tb927.1.4180,1460.0,3842.0,3344.0,4421.5,3760.5,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.1.4220,8157.0,7549.0,6929.5,7564.0,3169.5,Ydr279p protein family (RNase H2 complex component)  putative,<2C (LG1)
Tb927.1.4230,9855.5,9560.0,8692.5,9430.5,9689.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.4250,5320.5,9146.0,8060.5,7710.0,7816.0,hypothetical protein  conserved,G1
Tb927.1.4280,11496.5,10505.0,10402.5,10437.0,10962.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.4300,11007.0,7818.0,8489.5,8704.5,8237.5,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.1.4310,1988.0,967.5,1388.5,1403.5,11059.0,Flagellum attachment zone protein 2,>4C (GG2M)
Tb927.1.4340,11154.5,10481.0,10023.0,10526.0,10676.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.4370,6624.0,8358.5,8261.5,7719.0,7268.5,Putative integral membrane protein conserved region (DUF2404)  putative,G1
Tb927.1.4380,9873.0,8846.5,9329.5,8762.0,8486.0,Putative integral membrane protein conserved region (DUF2404)  putative,<2C (LG1)
Tb927.1.4400,612.5,2422.5,1886.0,1713.0,1120.5,hypothetical protein  conserved,G1
Tb927.1.4410,5490.5,4373.5,5486.5,4183.0,4957.5,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.1.4420,9758.0,10797.0,10709.5,10768.0,10416.5,ABC transporter  putative,G1
Tb927.1.4450,10822.0,10455.0,10343.0,10013.0,9427.0,calcium-activated potassium channel  putative,<2C (LG1)
Tb927.1.4470,7734.0,7630.5,8676.5,7931.0,8169.0,hypothetical protein  conserved,S
Tb927.1.4480,5090.0,10295.5,10431.5,9726.5,9435.5,WD repeat and HMG-box DNA-binding protein  putative,S
Tb927.1.4490,3841.0,5530.5,5325.5,4674.0,3494.0,acetyltransferase  putative,G1
Tb927.1.4500,4569.0,2772.5,2630.0,2302.0,6690.0,SNARE associated Golgi protein  putative,>4C (GG2M)
Tb927.1.4520,9436.5,10032.5,10054.0,9803.0,8303.5,Zinc finger  C3HC4 type (RING finger)  putative,S
Tb927.1.4540,8790.0,7731.5,7108.0,7285.0,11051.0,cyclin-like F-box protein 1A,>4C (GG2M)
Tb927.1.4560,4721.0,2671.0,2300.0,2716.0,9830.5,cyclin-like F-box protein 1B,>4C (GG2M)
Tb927.1.4580,4849.5,3187.0,2987.0,3642.0,10314.0,cyclin-like F-box protein 1C,>4C (GG2M)
Tb927.1.4600,4608.5,2795.0,2621.5,2541.0,9319.0,cyclin-like F-box protein 1D,>4C (GG2M)
Tb927.1.4630,5530.5,3293.0,3323.5,3205.5,10407.5,cyclin-like F-box protein 1E,>4C (GG2M)
Tb927.1.4650,5534.0,2367.5,2522.5,3724.0,7313.0,cyclin-like F-box protein 2,>4C (GG2M)
Tb927.1.4680,6185.5,4624.0,4046.5,3616.5,8516.0,Kinetochore interacting protein 6,>4C (GG2M)
Tb927.1.4690,8595.0,9858.0,10007.0,9955.5,8662.0,Protein arginine N-methyltransferase 1 catalytic subunit,S
Tb927.1.4700,7892.5,8887.5,8441.0,8172.5,7988.0,hypothetical protein  conserved,G1
Tb927.1.4710,612.5,4127.0,3079.0,3635.0,1355.0,hypothetical protein  conserved,G1
Tb927.1.4720,10558.5,6984.0,7359.5,8126.5,8151.0,SET domain containing protein  putative,<2C (LG1)
Tb927.1.4730,8124.5,8149.5,7979.5,7776.5,6074.0,Ribonuclease H2 non-catalytic subunit (Ylr154p-like)  putative,G1
Tb927.1.4740,11011.0,10599.5,10939.5,10910.0,10897.5,FAM91 N-terminus/FAM91 C-terminus  putative,<2C (LG1)
Tb927.1.4760,9639.0,10312.0,9878.5,9942.0,8943.0,Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2  putative,G1
Tb927.1.4780,10366.0,7851.5,7532.5,7789.5,7880.5,Alpha/beta hydrolase domain-containing protein,<2C (LG1)
Tb927.1.4800,4721.0,6319.0,5670.5,8391.0,5983.0,hypothetical protein  conserved,G2M
Tb927.1.4810,2920.5,3201.0,3288.0,2907.5,5092.0,hypothetical protein  conserved (pseudogene),>4C (GG2M)
Tb927.1.4830,6990.0,1132.5,2598.5,3307.0,3970.0,phospholipase A1,<2C (LG1)
Tb927.1.4860,3957.5,1240.5,1164.0,1726.5,2734.0,expression site-associated gene 11 (ESAG11)  pseudogene,<2C (LG1)
Tb927.1.4870,5174.0,7897.5,7069.0,7809.5,5379.5,expression site-associated gene 1 (ESAG1) protein  putative,G1
Tb927.1.4890,3558.0,6363.5,6000.0,7040.5,6096.5,expression site-associated gene 2 (ESAG2) protein  putative,G2M
Tb927.1.4900,6066.0,8916.0,8295.5,9001.5,7356.5,expression site-associated gene 11 (ESAG11) protein  putative,G2M
Tb927.1.4910,6137.0,6928.5,6236.5,7285.0,3950.0,expression site-associated gene 1 (ESAG1) protein  putative,G2M
Tb927.1.4920,5829.0,5822.5,5808.0,4894.5,7104.0,hypothetical protein,>4C (GG2M)
Tb927.1.4970,5876.5,7380.0,7773.5,6434.5,8071.5,hypothetical protein,>4C (GG2M)
Tb927.1.5000,6649.0,5243.0,5001.0,5004.5,6080.0,hypothetical protein  conserved,<2C (LG1)
Tb927.1.5030,6777.5,10945.0,10797.0,11051.0,10711.5,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.1.5060,8124.5,7433.5,8071.0,8176.5,7207.5,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.1.5080,3437.5,1437.5,1237.5,1017.0,2039.0,expression site-associated gene 9 (ESAG9) protein  putative,<2C (LG1)
Tb927.1.5090,612.5,835.5,471.5,647.5,637.0,expression site-associated gene 1(ESAG1)  pseudogene,G1
Tb927.1.5100,3272.0,5416.0,7018.5,6525.0,4938.0,expression site-associated gene 2 (ESAG2) protein  putative,S
Tb927.1.5110,8825.5,8625.5,7515.5,8179.5,6878.5,expression site-associated gene 11 (ESAG11) protein  putative,<2C (LG1)
Tb927.1.5120,7608.0,9433.5,8964.5,9775.5,7644.0,expression site-associated gene 1 (ESAG1) protein  putative,G2M
Tb927.1.5150,5876.5,7317.5,8842.5,8554.0,5117.5,hypothetical protein,S
Tb927.1.5160,612.5,158.5,99.0,136.5,86.0,hypothetical protein,<2C (LG1)
Tb927.1.5170,6741.5,3467.5,3609.0,3117.0,3431.5,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.1.5180,612.5,811.0,1574.0,974.5,86.0,hypothetical protein,S
Tb927.1.5200,4094.5,8619.0,9004.5,9900.5,8338.0,expression site-associated gene 1 (ESAG1) protein  putative,G2M
Tb927.1.5220,612.5,2592.5,2378.0,2881.0,1912.0,expression site-associated gene 9 (ESAG9) protein  putative,G2M
Tb927.1.5235,612.5,40.5,40.0,111.0,86.0,expression site-associated gene 1 (ESAG1)  fragment,<2C (LG1)
Tb927.1.5240,4048.0,2983.5,5439.0,5120.0,1162.5,expression site-associated gene 1 (ESAG1) protein  putative,S
Tb927.1.5250,612.5,40.5,40.0,33.5,86.0,hypothetical protein,<2C (LG1)
Tb927.1.5260,5779.0,3586.5,4258.0,4409.0,3638.0,hypothetical protein,<2C (LG1)
Tb927.1.5280,3996.0,4849.5,4356.5,4512.5,7994.5,expression site-associated gene 3 (ESAG3)  pseudogene,>4C (GG2M)
Tb927.1.5300,1783.5,1108.0,925.0,1228.0,2619.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.1.5320,2357.5,5185.0,4246.0,5095.0,7426.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.1.5330,612.5,2949.5,3642.0,4070.5,4292.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.1.5340,2221.0,498.0,313.0,419.0,559.5,expression site-associated gene 3 (ESAG3)  pseudogene,<2C (LG1)
Tb927.11.18690,7589.5,6386.5,5494.0,5638.0,5230.0,expression site-associated gene 4 (ESAG4) protein  putative,<2C (LG1)
Tb927.11.18700,4480.0,7146.5,7115.5,6647.5,9084.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.11.18710,7324.0,6750.5,6022.5,6647.5,4831.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.18720,11086.5,10642.5,10660.5,10519.5,9052.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb927.11.18730,612.5,307.0,532.5,273.5,86.0,variant surface protein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18740,2767.0,6940.5,5604.5,6340.0,6965.5,variant surface protein (VSG)  putative,>4C (GG2M)
Tb927.11.18750,8274.5,3032.5,1831.0,2025.0,2389.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb927.11.18760,1914.0,279.5,293.0,248.0,347.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb927.11.18770,2637.5,3596.0,2876.5,2335.0,2243.5,variant surface protein (VSG)  putative,G1
Tb927.11.18780,4354.0,1171.5,1278.5,1110.5,2029.5,hypothetical protein  conserved,<2C (LG1)
Tb927.11.18790,612.5,246.5,410.0,382.0,1078.0,variant surface protein (VSG)  putative,>4C (GG2M)
Tb927.11.18800,2381.5,438.0,293.0,517.0,818.0,expression site-associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb927.11.18810,6429.5,1124.5,2465.5,2735.0,2231.5,variant surface protein (VSG  atypical)  putative (pseudogene),<2C (LG1)
Tb927.11.18820,4708.0,7600.0,7836.0,8834.0,6737.5,variant surface protein (VSG  atypical)  putative,G2M
Tb927.11.18830,4840.5,2367.5,1402.0,1466.0,3638.0,variant surface protein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.18840,1460.0,919.5,743.0,501.5,637.0,variant surface protein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18850,612.5,919.5,658.5,673.0,853.0,variant surface protein (VSG)  putative,G1
Tb927.11.18860,8742.0,6516.5,5120.0,5799.5,7913.5,variant surface protein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18870,612.5,2350.5,1030.5,1763.5,2351.0,variant surface protein (VSG)  putative (pseudogene),>4C (GG2M)
Tb927.11.18880,9707.5,7602.0,7744.5,6892.0,4915.5,variant surface protein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18890,6767.0,3235.0,2653.0,3057.0,2402.0,variant surface protein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.18900,3534.0,2561.0,3379.0,2830.5,3144.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb927.11.18910,5588.5,6139.5,5752.5,5325.0,5024.5,variant surface protein (VSG)  putative (pseudogene),G1
Tb927.11.18920,2523.0,978.5,848.5,673.0,994.0,variant surface protein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.18930,6357.5,5647.0,4928.0,5454.0,4737.0,variant surface protein (VSG)  putative,<2C (LG1)
Tb927.11.18940,612.5,96.0,40.0,33.5,397.5,variant surface protein (VSG)  putative,<2C (LG1)
Tb927.11.18950,612.5,1797.0,1536.0,2211.5,1338.5,variant surface protein (VSG)  putative (pseudogene),G2M
Tb927.11.18960,9969.5,11109.0,10832.5,10696.0,10342.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.18970,3179.0,1161.5,1091.0,1071.0,1141.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.18980,10655.5,10724.0,10814.5,10805.0,9214.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.18990,1914.0,1492.5,1650.0,1609.0,2125.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19000,5686.0,2864.5,2164.5,1966.0,2402.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19010,2221.0,1101.5,1164.0,1110.5,3044.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.19020,3937.0,2392.5,4568.5,4267.0,4199.0,hypothetical protein (pseudogene),S
Tb927.11.19030,4309.5,2871.5,3215.0,3815.5,3628.5,expression site-associated gene 1 (ESAG1) protein  putative (pseudogene),<2C (LG1)
Tb927.11.19040,10220.0,5301.5,3609.0,4464.5,4928.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19050,612.5,2241.5,3398.5,3102.5,3185.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.19060,4745.5,9509.0,9551.5,9620.0,9816.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19100,4266.5,1293.5,2050.0,1888.0,721.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19110,612.5,2896.5,2251.5,2642.5,2773.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.19120,2094.5,716.5,644.5,826.5,1422.0,expression site-associated gene 3 (ESAG3) protein  putative (pseudogene),<2C (LG1)
Tb927.11.19130,5938.5,2106.0,2692.0,2977.0,1944.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.19140,10604.5,10487.0,10694.0,9893.5,10063.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.19150,4826.0,3705.0,4356.5,3616.5,1878.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19160,612.5,373.5,271.5,221.5,287.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19170,1460.0,978.5,767.0,610.5,584.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19180,8042.0,6329.5,6504.5,5079.0,5542.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.19190,6684.5,1736.5,1416.0,1665.0,1453.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19200,612.5,709.0,848.5,1140.0,1304.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19210,8236.5,7676.5,7773.5,7021.5,4770.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19220,6853.5,4348.5,3912.5,4336.5,5092.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19240,2047.0,2313.0,1634.5,2085.0,1582.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.19270,11491.0,11592.0,11609.0,11546.0,11476.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.19290,4849.5,4393.0,3578.0,4112.0,3065.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.v4.0062,612.5,944.0,880.5,925.0,1099.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.1720,5831.5,4041.5,3578.0,3897.5,2472.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.19350,1783.5,2051.0,2289.5,2321.5,1608.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.19380,6154.5,4460.5,3779.5,5206.5,5174.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.19390,6179.5,5095.5,4783.5,4512.5,4065.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19400,6684.5,2505.5,1923.0,2264.5,2442.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.19410,612.5,678.5,391.5,419.0,1929.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb11.57.0047,4313.5,3436.5,3717.5,3566.5,3431.5,variant surface glycoprotein (VSG)  point mutation,<2C (LG1)
Tb927.11.19420,1460.0,235.5,253.5,313.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19430,5230.5,1585.5,1585.5,1833.5,1772.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19440,7430.0,3507.5,2522.5,2940.5,2079.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19450,4122.5,3693.0,4807.5,3264.5,5064.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.19460,4211.5,3194.0,3066.0,3065.5,2647.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19470,11291.0,11358.0,11348.0,11386.0,11239.5,expression site-associated gene 3 (ESAG3)  frameshifted and degenerate,G2M
Tb927.11.19480,4667.5,5717.0,5609.0,4940.5,3658.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.19490,612.5,2034.0,1650.0,1202.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.19500,2221.0,4281.0,2425.0,3699.0,1304.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.19510,7873.0,5180.0,4246.0,4057.0,3510.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19520,2406.5,1565.5,2522.5,2058.5,86.0,variant surface glycoprotein (VSG)  putative,S
Tb927.11.19530,6344.5,811.0,658.5,483.0,721.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19540,4233.5,2138.5,2262.5,2347.0,2231.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.19550,612.5,2534.5,2389.0,1950.5,2125.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb11.57.0050,1460.0,1716.0,1446.0,1329.0,2454.0,expression site-associated gene 3 (ESAG3)  frameshifted and degenerate,>4C (GG2M)
Tb11.57.0049,4066.0,2402.0,1923.0,2102.5,2734.0,variant surface glycoprotein (VSG  pseudogene)  degenerate,<2C (LG1)
Tb927.11.19560,612.5,2540.0,3969.5,2275.5,2914.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.19570,4364.5,935.5,578.5,862.0,1355.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19580,9078.0,7110.0,8206.5,7350.0,6924.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19590,612.5,2687.5,3224.5,3847.5,2376.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb11.15.0005,4375.0,1704.5,2036.0,2686.0,2819.0,hypothetical protein  conserved  degenerate,<2C (LG1)
Tb11.15.0006,7007.0,7792.0,7416.0,6927.5,5943.5,variant surface glycoprotein (VSG)  frameshifted,G1
Tb11.15.0007,2682.0,3561.5,3398.5,3087.5,3447.0,variant surface glycoprotein (VSG)  point mutation,G1
Tb11.15.0008,7459.5,5355.0,5239.0,5873.0,5064.5,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,<2C (LG1)
Tb927.11.19600,612.5,2469.5,3108.5,3367.5,4096.5,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,>4C (GG2M)
Tb927.11.19610,6582.0,3138.5,4411.0,2821.0,1758.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19620,1460.0,4313.0,4246.0,4346.0,4687.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19630,612.5,1240.5,1278.5,1763.5,1929.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19640,1460.0,877.0,756.5,292.5,1647.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19650,2995.0,1384.0,1402.0,1363.5,1772.5,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,<2C (LG1)
Tb927.11.19660,612.5,6798.0,5276.5,7398.5,9996.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19670,2982.0,1240.5,1771.5,890.0,486.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19680,2700.0,1643.5,1254.0,1816.5,1772.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19690,612.5,1018.0,980.0,849.0,3310.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.19700,3478.0,4630.0,4540.5,3950.5,5102.5,hypothetical protein  conserved  degenerate,>4C (GG2M)
Tb927.11.19710,7188.0,9124.0,8574.0,8715.0,7944.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.19720,6021.5,9408.5,8741.5,8356.0,9169.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.19730,3937.0,1394.5,1388.5,1542.0,1453.5,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,<2C (LG1)
Tb927.11.19740,4309.5,1466.5,1324.0,1688.5,1758.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19750,5799.0,4227.0,3452.0,3649.5,2706.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19760,3524.0,2581.5,2011.5,1491.0,2000.0,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,<2C (LG1)
Tb927.11.19770,4122.5,1275.5,1054.0,941.0,1582.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19780,2094.5,1143.0,865.5,1451.5,531.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19790,11148.0,11175.0,11265.0,11326.5,11166.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.19800,4066.0,3646.5,3157.0,4252.5,4459.5,hypothetical protein,>4C (GG2M)
Tb927.11.19810,7067.0,1506.5,1710.5,1726.5,2773.0,hypothetical protein,<2C (LG1)
Tb927.11.19820,5477.5,6874.5,8044.5,6177.5,6028.0,hypothetical protein,S
Tb927.11.19830,4900.0,5746.5,7242.0,5215.5,5332.5,hypothetical protein,S
Tb927.11.19840,4260.5,3457.0,4010.5,3393.5,3741.0,hypothetical protein,<2C (LG1)
Tb927.11.19850,11269.0,11224.0,11332.0,11015.0,10728.0,hypothetical protein (pseudogene),S
Tb927.11.19870,2460.0,967.5,1574.0,2085.0,1027.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.19880,10807.5,10176.5,9342.5,10096.5,9185.0,variant surface glycoprotein (VSG)  point mutation,<2C (LG1)
Tb927.11.19890,7923.0,4590.5,4493.5,4035.5,6314.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19900,3810.5,4145.5,5182.0,4772.5,5003.0,expression site-associated gene 3 (ESAG3)  degenerate and frameshifted,S
Tb927.11.19910,4389.0,4406.0,5298.0,2919.0,2297.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.19920,4900.0,3740.5,3051.5,3924.0,1732.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19930,1783.5,386.5,658.5,673.0,287.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19940,2995.0,1266.0,1870.0,1542.0,1703.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19950,3751.5,4653.0,4448.0,4918.5,4867.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.19960,9849.5,9699.5,9185.0,9018.0,9811.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.19970,10283.5,10765.5,10929.0,10466.0,10189.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.19990,2552.0,774.5,756.5,647.5,761.5,variant surface protein (VSG)  putative (pseudogene),<2C (LG1)
Tb927.11.20010,612.5,3740.5,3745.0,4940.5,5117.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.20020,1988.0,4547.5,5286.0,5037.0,836.0,variant surface glycoprotein (VSG)  frameshifted and point mutation,S
Tb927.11.20030,2747.5,7087.5,6460.5,7034.0,7459.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.20040,8337.0,10052.0,10110.0,9926.0,10054.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.20050,5462.0,978.5,1549.5,1642.5,3825.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20060,8709.5,4578.5,3197.0,3566.5,3606.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.20070,6397.5,5963.0,5429.5,5917.0,5934.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.11.20080,3429.0,3171.5,3940.5,3545.0,874.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.20090,3502.5,2485.0,1938.0,2335.0,1422.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.20100,2747.5,7252.5,6953.0,7296.0,5188.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.11.20110,8698.0,7355.0,6288.0,6525.0,7356.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20120,5598.0,7012.5,7040.0,7083.0,5795.0,variant surface glycoprotein (VSG)  frameshifted and degenerate,G2M
Tb927.11.20130,7682.5,2106.0,3148.0,3057.0,2376.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20140,6145.5,2609.5,2410.5,2801.0,1660.5,variant surface glycoprotein (VSG)  frameshifted and degenerate,<2C (LG1)
Tb927.11.20150,2137.5,1059.5,1008.5,1125.0,2495.0,expression site-associated gene 3 (ESAG3)  frameshifted and degenerate,>4C (GG2M)
Tb927.11.20160,612.5,823.0,1324.0,1281.0,397.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.20170,612.5,192.5,40.0,273.5,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20180,612.5,1059.5,1818.0,1031.0,347.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.20190,2047.0,3922.5,3323.5,4045.0,5548.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.11.20200,7317.0,8887.5,8726.0,9177.5,7631.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.20210,3945.0,7871.5,8627.0,8578.5,9423.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.20220,2436.0,5261.5,6360.5,6434.5,5153.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.20230,5241.5,5499.5,5885.0,6098.5,4418.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.20240,8257.0,6313.0,7490.0,6331.5,3950.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.20250,9853.0,6922.5,5867.0,8273.5,5432.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20260,9729.0,7092.0,7869.0,7560.5,7573.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20270,8796.5,8481.5,8646.5,8536.0,6994.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20280,10738.0,9497.5,9342.5,9965.0,9548.5,variant surface glycoprotein (VSG)  degenerate and frameshifted,<2C (LG1)
Tb927.11.20290,6724.5,1924.0,1446.0,1514.5,1804.5,variant surface glycoprotein (VSG)  degenerate,<2C (LG1)
Tb927.11.20300,2295.5,2160.0,2238.0,2506.5,1549.5,variant surface glycoprotein (VSG)  putative,G2M
Tb927.11.20310,612.5,5568.0,5902.5,6120.5,5888.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.20320,3734.0,4242.0,4950.0,5551.0,4065.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.20330,612.5,4711.5,5214.5,7009.0,3733.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.20340,4740.5,1789.5,1574.0,1745.0,1929.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20350,3589.5,600.0,703.0,444.5,531.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.11.20360,9663.5,5971.0,6000.0,6549.5,6006.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20370,4375.0,3579.0,2894.5,3666.5,2125.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20380,4817.0,2957.5,2341.0,2120.5,1732.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20390,7465.0,9634.5,9016.0,9366.0,9519.5,variant surface glycoprotein (VSG)  putative,G1
Tb927.11.20400,3041.5,4072.5,4896.0,3142.0,1691.0,variant surface glycoprotein (VSG)  putative,S
Tb927.11.20410,1783.5,1585.5,1549.5,2058.5,1304.5,hypothetical protein,G2M
Tb927.11.20420,612.5,1394.5,1300.0,1228.0,1842.0,hypothetical protein,>4C (GG2M)
Tb927.11.20430,10588.0,10852.0,10464.0,10300.5,10356.5,variant surface glycoprotein (VSG)  putative,G1
Tb927.11.20470,6828.0,1945.5,2112.5,1702.0,2898.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.20480,4142.5,4574.0,4711.5,4558.5,7280.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.20490,2381.5,1838.0,1783.0,1642.5,1929.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.v4.0039,10360.0,11005.0,11006.5,10566.5,10673.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.20500,612.5,3086.5,3891.5,3272.5,531.0,variant surface glycoprotein (VSG)  putative,S
Tb11.v4.0041,612.5,1670.0,954.0,1003.0,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb11.09.0001,612.5,3632.0,2738.5,2656.5,2050.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.20530,6088.5,4596.5,4160.5,4699.5,7731.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.20540,612.5,373.5,271.5,221.5,287.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20550,7108.5,3179.0,2410.5,3087.5,1213.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.20560,8177.0,8565.0,6821.0,8414.0,6984.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G1
Tb927.11.20570,9540.0,6763.0,7328.5,7740.5,8310.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.20580,6931.5,7195.5,6055.5,5765.5,7015.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.20590,612.5,2795.0,2112.5,2470.5,1195.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb927.11.20600,2047.0,1914.0,1416.0,1491.0,1804.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20610,612.5,426.0,547.0,647.5,559.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb927.11.20620,612.5,3988.0,5091.5,4446.0,4860.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb927.11.20630,1460.0,877.0,966.5,826.5,1565.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.20640,10287.0,8470.5,8661.5,8303.0,7551.5,variant surface glycoprotein (VSG)  interrupted,<2C (LG1)
Tb927.11.20650,11150.0,7059.0,7018.5,6996.5,8146.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20660,5658.5,2881.5,2522.5,2988.5,2773.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.11.20670,10902.0,8611.0,7934.5,7586.5,7855.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.11.20680,612.5,576.5,596.0,788.5,721.5,variant surface glycoprotein (VSG)  fragment and point mutation,G2M
Tb927.11.20690,4010.5,1108.0,1254.0,1228.0,1227.0,variant surface glycoprotein (VSG)  fragment degenerate and frameshifted,<2C (LG1)
Tb927.11.20700,1460.0,3138.5,2533.0,3075.0,3055.0,variant surface glycoprotein (VSG  atypical)  putative,G1
Tb927.11.20710,3419.0,2516.5,2703.5,2422.0,4725.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.11.20720,10235.0,10922.5,11066.5,10456.5,10613.0,variant surface glycoprotein (VSG)  putative,S
Tb927.6.100,4642.5,7909.0,7793.5,7144.0,9578.0,receptor-type adenylate cyclase GRESAG 4  pseudogene  putative,>4C (GG2M)
Tb927.6.110,10510.5,9574.5,10032.5,9888.5,10439.0,hypothetical protein,<2C (LG1)
Tb927.6.120,6689.0,7879.0,7727.5,7959.5,6112.5,Protein of unknown function (DUF1181)  putative,G2M
Tb927.6.130,11707.0,11699.0,11702.0,11706.0,11676.0,hypothetical leucine-rich repeat protein 1 (LRRP1),<2C (LG1)
Tb927.6.140,8805.0,10740.0,10556.5,10719.0,10034.5,retrotransposon hot spot protein 5 (RHS5)  putative,G1
Tb927.6.150,11379.0,11614.0,11608.0,11651.0,11585.0,retrotransposon hot spot protein 3 (RHS3)  frameshift,G2M
Tb927.6.160,10941.0,11308.0,11237.0,11235.0,10990.5,retrotransposon hot spot protein 1 (RHS1)  putative,G1
Tb927.6.170,11658.0,11663.0,11663.0,11664.0,11595.0,receptor-type adenylate cyclase GRESAG 4  putative,G2M
Tb927.6.180,10177.5,9577.5,9846.5,9357.0,8789.0,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.6.181,3770.5,3900.0,3260.0,3282.0,2297.5,M4 ribosomal RNA,G1
Tb927.6.182,2658.5,471.5,357.5,444.5,531.0,M6 ribosomal RNA,<2C (LG1)
Tb927.6.183,3868.5,787.5,925.0,757.5,486.0,M2 ribosomal RNA,<2C (LG1)
Tb927.6.184,6718.5,5675.0,5298.0,5353.5,4883.5,28S beta ribosomal RNA (fragment),<2C (LG1)
Tb927.6.185,8282.0,8850.5,7756.0,8026.5,6195.0,28S beta ribosomal RNA (fragment),G1
Tb927.6.186,4685.0,3304.0,3079.0,3429.5,3185.0,M1 ribosomal RNA,<2C (LG1)
Tb927.6.187,4313.5,2871.5,2154.5,2716.0,2692.0,28S alpha ribosomal RNA (fragment),<2C (LG1)
Tb927.6.190,10596.0,11144.5,11269.0,11201.5,11080.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.6.200,11377.0,10980.5,11145.0,10615.5,10911.0,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.6.210,11689.0,11626.0,11611.0,11632.0,11511.0,leucine-rich repeat protein (LRRP  pseudogene)  putative,<2C (LG1)
Tb927.6.220,11128.5,11104.5,11030.0,10997.5,10433.0,purine nucleoside transporter,<2C (LG1)
Tb927.6.230,1460.0,588.0,253.5,557.5,721.5,expression site-associated gene 1 (ESAG1)  fragment,<2C (LG1)
Tb927.6.240,8961.5,8259.5,8913.5,8259.5,8380.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.250,3785.5,2250.0,1612.0,1763.5,1758.0,hypothetical protein,<2C (LG1)
Tb927.6.260,8702.0,9091.5,8000.5,8547.5,8116.0,hypothetical protein,G1
Tb927.6.270,9151.0,10255.0,10489.0,10586.5,9308.5,receptor-type adenylate cyclase GRESAG 4  pseudogene  putative,G2M
Tb927.6.280,6870.5,9363.5,9441.0,9533.0,9732.0,receptor-type adenylate cyclase GRESAG 4  putative,>4C (GG2M)
Tb927.6.290,7143.0,9372.5,10180.5,10311.5,9655.0,receptor-type adenylate cyclase GRESAG 4  pseudogene  putative,G2M
Tb927.6.300,9840.0,10737.0,10894.0,10593.0,10255.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.6.310,8572.5,10349.5,10203.0,9988.5,10004.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.6.320,11517.0,11557.0,11547.0,11522.5,11398.0,receptor-type adenylate cyclase GRESAG 4  pseudogene  putative,G1
Tb927.6.330,9878.0,10599.5,10840.5,10643.5,10534.0,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.6.340,11622.0,11632.0,11638.0,11644.0,11484.0,receptor-type adenylate cyclase GRESAG 4  pseudogene  putative,G2M
Tb927.6.350,612.5,3813.5,3858.5,1875.5,3825.5,hypothetical protein  conserved,S
Tb927.6.360,8567.5,9773.0,9889.5,8892.5,8437.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,S
Tb927.6.370,8188.0,4127.0,4334.5,4552.0,5577.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.380,9360.5,5561.5,5670.5,6465.0,6479.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.390,11611.0,11556.0,11523.0,11570.0,11356.0,adenylyl cyclase  pseudogene  putative,<2C (LG1)
Tb927.6.400,6939.5,9797.5,10011.0,9726.5,10083.5,peptidase M20/M25/M40  putative,>4C (GG2M)
Tb927.6.410,8542.5,9546.0,9674.0,9740.5,9885.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.430,8386.5,11476.0,11386.0,11403.0,11102.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.6.440,5423.5,1934.0,1446.0,2168.5,2254.0,haptoglobin-hemoglobin receptor,<2C (LG1)
Tb927.6.450,3964.5,5664.0,6166.0,5873.0,5841.5,procyclin PARP A,S
Tb927.6.460,6047.5,4590.5,3868.5,5120.0,4903.0,procyclin associated gene 3 (PAG3) protein,<2C (LG1)
Tb927.6.470,11360.0,11140.0,11187.0,11027.5,10320.0,gene related to expression site-associated gene 2 (GRESAG2)  putative,<2C (LG1)
Tb927.6.480,3252.5,5280.5,5340.0,5148.0,5499.0,surface protein EP3-2 procyclin precursor,>4C (GG2M)
Tb927.6.490,6339.0,4653.0,4372.0,5392.0,4957.5,procyclin associated gene 3 (PAG3) protein,<2C (LG1)
Tb927.6.500,11300.0,11189.0,11191.0,11049.0,10401.5,gene related to expression site-associated gene 2 (GRESAG2)  putative,<2C (LG1)
Tb927.6.510,8395.5,8789.0,9001.0,8916.5,9621.0,GPEET procyclin,>4C (GG2M)
Tb927.6.520,8964.0,9484.0,9233.0,8786.5,8993.5,EP3-2 procyclin,G1
Tb927.6.530,6145.5,5185.0,4857.0,6056.0,5647.5,procyclin associated gene 3 (PAG3) protein,<2C (LG1)
Tb927.6.540,11089.0,9589.0,9468.0,9281.5,7236.5,gene related to expression site-associated gene 2 (GRESAG2)  putative,<2C (LG1)
Tb927.6.550,11439.0,11263.0,11160.0,11122.5,10490.5,hypothetical protein,<2C (LG1)
Tb927.6.560,612.5,1858.0,1679.0,1833.5,3981.5,cysteine peptidase C (CPC),>4C (GG2M)
Tb927.6.570,1460.0,4675.5,5386.5,4981.0,7084.5,conserved protein,>4C (GG2M)
Tb927.6.580,9253.0,7689.5,6246.0,6946.0,5927.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.590,5620.5,6352.5,7183.5,6694.0,6547.5,hypothetical protein  conserved,S
Tb927.6.600,1783.5,2638.5,2122.5,2237.0,4893.5,ccr4-not transcription complex subunit,>4C (GG2M)
Tb927.6.610,6349.0,8279.5,8054.5,8427.5,7060.5,kinetoplast ribosomal PPR-repeat containing protein 18,G2M
Tb927.6.620,10289.0,11512.5,11563.0,11552.0,11603.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.630,4916.5,6504.5,4990.5,4987.0,6706.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.640,11230.0,10795.5,10520.0,10877.5,10237.0,ApaH-like phosphatase ALPH1,<2C (LG1)
Tb927.6.650,11566.0,11352.0,11406.0,11258.5,11476.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.660,8671.5,7704.0,8771.5,8328.0,6398.5,hypothetical protein  conserved,S
Tb927.6.670,3711.5,8031.0,7622.5,6501.0,8367.0,exosome complex component RRP45,>4C (GG2M)
Tb927.6.680,11537.0,8550.0,9551.5,9743.5,9203.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.690,9700.0,9922.5,9548.0,10204.0,10504.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.700,1783.5,8379.0,7930.0,7188.5,8389.0,alanyl-tRNA synthetase  putative,>4C (GG2M)
Tb927.6.710,612.5,3060.0,2522.5,1363.5,1565.5,dephospho-CoA kinase  putative,G1
Tb927.6.720,612.5,96.0,130.5,111.0,287.0,40S ribosomal protein L14  putative,<2C (LG1)
Tb927.6.730,10686.5,10401.5,10892.5,10619.0,10134.0,hypothetical protein  conserved,S
Tb927.6.740,5511.0,10233.5,9721.0,9627.0,8789.0,ATP-dependent DEAH-box RNA helicase  putative,G1
Tb927.6.750,6559.0,3304.0,3028.0,3295.5,2413.0,kinetoplastid-specific phospho-protein phosphatase  putative,<2C (LG1)
Tb927.6.760,10316.0,10153.5,10279.0,9882.0,9164.5,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb927.6.770,10690.0,10710.0,10588.5,10129.0,10029.0,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.6.780,10385.0,10803.5,10776.5,10360.5,10356.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb927.6.790,8738.0,10686.5,10943.0,10400.5,9683.5,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.6.800,10633.0,11009.0,11182.0,10917.5,10428.5,receptor-type adenylate cyclase GRESAG 4  putative,S
Tb927.6.810,11431.0,10228.5,9922.0,9923.0,9692.0,hypothetical protein,<2C (LG1)
Tb927.6.815,5428.0,6690.5,6788.5,7268.5,6994.0,hypothetical protein,G2M
Tb927.6.820,11143.0,9358.5,9634.0,9715.0,10907.0,Pumilio homology domain family member 4,<2C (LG1)
Tb927.6.830,7664.5,6977.5,7098.0,8205.0,8893.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.840,4418.5,2128.0,3642.0,3477.5,8937.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.850,4900.0,8086.5,6844.5,6271.5,7890.5,ccr4-not transcription complex subunit 2,G1
Tb927.6.860,11254.0,10774.5,10460.5,10561.5,10191.0,hypothetical protein,<2C (LG1)
Tb927.6.870,8785.5,11176.0,11210.0,11150.5,10808.0,myotubularin  putative,S
Tb927.6.880,8972.0,7923.0,8968.5,7819.0,7649.5,conserved protein,<2C (LG1)
Tb927.6.890,11128.5,9999.0,10531.0,10146.0,11507.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.900,6915.5,7622.0,6900.0,5862.5,4231.5,Substrate of Polo-like kinase in the basal body 1,G1
Tb927.6.910,10910.0,6306.5,6821.0,5862.5,7422.5,SET domain containing protein  putative,<2C (LG1)
Tb06.3A7.270,5792.5,9479.5,9934.0,9579.5,3365.0,hypothetical protein  conserved,S
Tb927.6.920,1460.0,5822.5,7151.0,5505.5,4938.0,helicase  putative,S
Tb927.6.930,3550.5,4181.5,4434.0,4623.0,3658.5,metacaspase MCA3,G2M
Tb927.6.940,2682.0,4019.0,4271.0,4279.5,5034.5,metacaspase MCA2,>4C (GG2M)
Tb927.6.950,8192.5,6804.5,4740.5,6289.0,6799.5,cysteinyl-tRNA synthetase  putative,<2C (LG1)
Tb927.6.960,10187.0,10497.5,10640.5,10402.5,9847.0,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.970,10892.5,10915.0,11083.0,10900.5,10563.0,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.980,10473.0,10435.0,10758.0,10564.5,10281.5,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.990,8988.0,8866.0,9047.0,8909.5,7342.0,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.1000,8952.5,8674.0,8980.5,8756.0,7134.0,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.1010,10364.0,10503.0,10729.5,10286.0,10000.5,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.1020,10919.0,11010.0,11128.5,11043.0,10728.0,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.1030,8842.5,8961.5,8852.0,8743.5,7406.5,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,G1
Tb927.6.1040,8735.0,8503.5,8556.0,8505.0,7023.0,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,<2C (LG1)
Tb927.6.1050,8434.0,8370.0,8172.5,8018.0,6878.5,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,<2C (LG1)
Tb927.6.1060,9558.0,9776.5,9856.5,9699.0,8332.5,cysteine peptidase  Clan CA  family C1  Cathepsin L-like,S
Tb927.6.1070,6528.0,8716.0,9259.0,9149.5,8286.5,hypothetical protein  conserved,S
Tb927.6.1080,5393.5,5031.5,5598.0,5505.5,7347.5,hydroxyacylglutathione hydrolase  putative,>4C (GG2M)
Tb927.6.1090,6590.0,3109.0,4038.0,4981.0,4813.5,proteasome regulatory ATPase subunit 3,<2C (LG1)
Tb927.6.1100,10410.0,9390.0,9730.0,9173.0,9156.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.1110,9991.0,10571.0,10847.0,10782.0,10838.0,ubiquitin carboxyl-terminal hydrolase  putative,S
Tb927.6.1120,10811.0,8611.0,8407.5,7883.0,7125.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.1130,612.5,2250.0,1634.5,2671.0,1732.0,hypothetical protein  conserved,G2M
Tb927.6.1140,612.5,7862.0,7578.5,7111.0,7811.5,dolichyl-P-Man:GDP-Man5GlcNAc2-PP-dolichyl alpha-1 2-mannosyltransferase  putative,G1
Tb927.6.1150,4810.5,9045.5,8730.5,8250.0,8264.0,hypothetical protein,G1
Tb927.6.1160,11393.0,9033.5,9622.0,9930.5,9928.0,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.6.1170,4792.5,2561.0,1199.5,1745.0,2463.0,Aph-1 protein  putative,<2C (LG1)
Tb927.6.1180,2406.5,8107.0,7540.5,9181.5,11198.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.1190,10840.0,8400.5,7578.5,9281.5,7610.5,Plus-3 domain/Zinc finger  C3HC4 type (RING finger)  putative,<2C (LG1)
Tb927.6.1200,612.5,1961.5,2238.0,1980.0,1970.0,Polyadenylation mediator complex protein PAMC2  putative,S
Tb927.6.1210,612.5,4796.5,4078.5,4623.0,6016.5,kinetoplastid kinetochore protein 6,>4C (GG2M)
Tb927.6.1220,3680.5,2224.0,1989.5,1950.5,3365.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.1230,1783.5,5717.0,4181.0,4019.0,2977.5,kinetoplastid-specific phospho-protein phosphatase,G1
Tb927.6.1240,612.5,2260.5,2630.0,2223.0,86.0,hypothetical protein  conserved,S
Tb927.6.1250,8288.5,6449.5,6346.0,6452.5,8037.5,Mitochondrial SSU ribosomal protein 29,<2C (LG1)
Tb927.6.1260,612.5,449.0,907.5,808.0,1422.0,proteasome beta-1 subunit  putative,>4C (GG2M)
Tb927.6.1270,612.5,738.5,778.0,1261.0,1120.5,PITH domain-containing protein,G2M
Tb927.6.1280,612.5,2106.0,1731.5,1675.5,818.0,translation initiation factor EIF-2b alpha subunit  putative,G1
Tb927.6.1290,612.5,3060.0,3962.5,3785.5,10911.0,hypothetical protein  conserved,>4C (GG2M)
Tb06.3A7.960,9329.5,7223.0,7061.5,7227.0,5135.5,hypothetical protein,<2C (LG1)
Tb927.6.1300,4637.0,6702.5,7457.0,7119.0,5780.5,hypothetical protein,S
Tb927.6.1310,10729.5,7890.5,6854.5,7455.0,7541.0,Trypanosomal VSG domain containing protein  putative,<2C (LG1)
Tb927.6.1320,8042.0,5384.5,5153.5,5109.5,4839.5,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.6.1330,7121.0,9546.0,9050.5,9079.0,8420.5,Trypanosomal VSG domain containing protein  putative,G1
Tb927.6.1340,7236.5,6115.0,4462.5,4674.0,4645.0,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.6.1350,9436.5,7694.0,7965.0,9226.5,6412.5,Trypanosomal VSG domain containing protein  putative,<2C (LG1)
Tb927.6.1360,7759.0,6530.5,6134.0,6219.5,6729.5,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.6.1370,4900.0,4429.5,4411.0,4612.5,5125.0,Trypanosomal VSG domain containing protein  putative,>4C (GG2M)
Tb927.6.1380,7807.5,6363.5,5570.5,5628.0,5311.0,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.6.1390,5058.0,5924.5,5728.0,6417.5,7304.0,Trypanosomal VSG domain containing protein  putative,>4C (GG2M)
Tb927.6.1400,8330.5,7825.0,6831.5,6515.5,6164.0,cyclophilin-type peptidyl-prolyl cis-trans isomerase  putative,<2C (LG1)
Tb927.6.1410,2747.5,3842.0,3441.0,4057.0,3465.5,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,G2M
Tb927.6.1420,1460.0,3782.0,2996.5,3909.0,3100.5,Uncharacterised protein family (UPF0220)  putative,G2M
Tb927.6.1430,9533.5,8361.5,7896.0,8773.0,9239.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.1440,612.5,1736.5,1932.0,1154.5,2427.0,LSU ribosomal protein  mitochondrial  putative,>4C (GG2M)
Tb927.6.1450,5521.0,5104.5,6302.0,5728.5,5847.0,hypothetical protein  conserved,S
Tb927.6.1460,10298.0,3606.5,5265.0,4346.0,3825.5,cyclin 3,<2C (LG1)
Tb927.6.1470,6450.5,5967.0,6991.5,5407.5,3618.5,hypothetical protein  conserved,S
Tb927.6.1480,10957.5,11314.0,11175.0,11266.0,10930.0,hypothetical protein  conserved,G1
Tb927.6.1490,10419.0,10191.5,10481.0,10504.0,8193.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.6.1500,1460.0,3447.0,4783.5,4476.0,1027.5,alkyl-dihydroxyacetone phosphate synthase,S
Tb927.6.1510,8643.5,6890.0,6636.5,6873.5,5647.5,lysyl-tRNA synthetase  putative,<2C (LG1)
Tb927.6.1520,3751.5,6429.5,5460.5,7059.0,4822.5,Aquaglyceroporin 1,G2M
Tb927.6.1530,1460.0,1455.0,1067.0,788.5,948.5,Glutamine amidotransferase class-I  putative,<2C (LG1)
Tb927.6.1540,9806.5,9747.0,8309.5,8607.5,9358.0,Yip1 domain containing protein  putative,<2C (LG1)
Tb927.6.1550,2295.5,1924.0,3832.5,3577.5,1789.5,Leucine-rich repeat  ribonuclease inhibitor subtype domain-containing protein,S
Tb927.6.1560,5856.0,8259.5,8578.0,8615.0,7800.0,hypothetical protein  conserved,G2M
Tb927.6.1570,6628.0,4583.0,4364.5,4279.5,4065.0,2-hydroxy-3-oxopropionate reductase  putative,<2C (LG1)
Tb927.6.1580,3543.0,5883.0,5084.5,5569.0,5640.0,polynucleotide kinase 3'-phosphatase  putative,G1
Tb927.6.1590,9488.0,7622.0,7731.0,7356.0,7401.0,conserved protein,<2C (LG1)
Tb927.6.1600,6422.0,1171.5,940.5,464.0,1162.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.1610,8288.5,8578.5,8257.5,7719.0,7736.0,ribosomal RNA adenine dimethylase family protein  conserved,G1
Tb927.6.1620,6464.5,7875.0,8466.5,8909.5,9402.5,Zn-finger in Ran binding protein and others  putative,>4C (GG2M)
Tb927.6.1630,2258.5,5789.5,4293.5,3264.5,7069.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.1640,6361.5,4872.5,4848.5,4496.5,3618.5,single strand-specific nuclease  putative,<2C (LG1)
Tb927.6.1650,7903.5,5647.0,4476.0,5883.5,5323.5,single strand-specific nuclease  putative,<2C (LG1)
Tb6.NT.39,612.5,130.0,161.0,204.0,1266.0,Noncoding RNA  putative,>4C (GG2M)
Tb927.6.1660,2329.5,3380.0,3275.0,4476.0,8132.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.1670,7994.5,10319.0,10498.5,10042.5,9568.5,PAB-dependent poly(A)-specific ribonuclease subunit PAN2 (pseudogene),S
Tb927.6.1680,10921.0,9134.0,8517.0,9264.5,5516.0,mitochondrial RNA binding protein 1,<2C (LG1)
Tb927.6.1690,4354.0,8231.5,7103.5,8391.0,2505.5,cysteine peptidase  Clan CA  family C54  putative,G2M
Tb927.6.1700,612.5,2871.5,4568.5,3241.5,1437.0,hypothetical protein  conserved,S
Tb927.6.1710,5643.5,6289.0,6838.0,6883.0,5368.0,hypothetical protein  conserved,G2M
Tb927.6.1720,7400.5,9256.0,9221.0,8773.0,9001.5,hypothetical protein  conserved,G1
Tb927.6.1730,10789.0,10064.0,10335.0,10149.0,9711.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.1740,5330.0,7290.5,6900.0,7245.0,7459.5,Sad1 / UNC-like C-terminal  putative,>4C (GG2M)
Tb927.6.1750,8992.0,7226.5,7137.0,7227.0,8249.0,Rab-GTPase-TBC domain containing protein  putative,<2C (LG1)
Tb927.6.1760,1460.0,5656.0,4749.0,5728.5,6699.0,KU80 protein,>4C (GG2M)
Tb927.6.1770,3314.5,2160.0,3323.5,6827.0,7826.5,kinesin  putative,>4C (GG2M)
Tb6.NT.40,5981.0,3000.5,1999.5,3658.0,6143.5,Noncoding RNA  putative,>4C (GG2M)
Tb927.6.1780,4661.0,3324.5,2638.5,4112.0,1453.5,mitogen activated protein kinase 4  putative,<2C (LG1)
Tb927.6.1790,5068.5,5426.5,3246.5,5069.5,3939.5,hypothetical protein,G1
Tb927.6.1800,1460.0,5953.5,5239.0,6612.5,4179.0,protein phosphatase 2C  putative,G2M
Tb927.6.1810,3803.0,6955.0,4598.0,3897.5,4617.5,Alpha/beta hydrolase family  putative,G1
Tb927.6.1820,2047.0,1969.0,2011.5,2801.0,4874.0,dolichyl pyrophosphate phosphatase  putative,>4C (GG2M)
Tb927.6.1830,4293.0,10415.0,9931.0,10032.5,10657.0,Cleavage stimulation factor subunit 50  putative,>4C (GG2M)
Tb927.6.1840,7287.5,6023.5,5938.0,6192.0,4257.0,Diacylglycerol kinase catalytic domain containing protein  putative,<2C (LG1)
Tb927.6.1850,8865.0,9688.5,8917.0,8348.5,9820.5,quiescin sulfhydryl oxidase,>4C (GG2M)
Tb927_06_v4.snoRNA.0033,2747.5,458.5,448.0,483.0,744.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0034,2747.5,554.5,448.0,483.0,559.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0018,3468.5,1034.0,743.0,808.0,584.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0007,3191.0,678.5,532.5,826.5,797.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0012,3013.5,1817.5,1041.5,1071.0,1958.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0023,4074.0,1934.0,1650.0,1403.5,1816.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0005,5068.5,1697.0,1612.0,1675.5,1472.0,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0028,4354.0,1124.5,1008.5,957.5,895.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0035,2637.5,322.0,532.5,382.0,397.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0019,3283.5,787.5,448.0,557.5,486.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0008,2481.0,518.0,233.5,382.0,397.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0013,3964.5,1115.5,658.5,1215.5,978.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0027,3726.5,2051.0,2790.5,2577.5,1691.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0002,2870.5,1115.5,1179.5,907.5,1047.0,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0029,2930.5,1275.5,1207.5,1261.0,1120.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0036,2700.0,458.5,520.0,517.0,637.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0020,3621.0,664.5,507.0,419.0,461.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0009,3295.0,565.0,391.5,419.0,433.0,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0014,3778.0,1101.5,717.5,1017.0,721.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0024,4490.0,1797.0,1757.0,2150.0,1549.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0003,2886.0,1124.5,1278.5,925.0,1253.0,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0030,3142.5,1143.0,1041.5,974.5,1281.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0037,2637.5,952.0,630.0,647.5,461.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0017,3429.0,1466.5,1137.0,1281.0,933.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0010,2221.0,373.5,336.0,397.5,287.0,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0015,2094.5,1161.5,743.0,890.0,1099.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0025,3654.0,2367.5,2154.5,2494.5,2098.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0004,3606.0,1858.0,1650.0,1609.0,1744.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0031,3241.5,1476.5,1402.0,1352.5,1744.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0038,2504.5,664.5,547.0,501.5,637.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0021,3078.5,690.0,410.0,501.5,433.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0011,2180.0,449.0,410.0,419.0,433.0,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0016,2047.0,944.0,578.5,705.5,964.0,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0026,3295.0,1437.5,1347.5,1261.0,1392.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0006,4439.5,1466.5,1347.5,1514.5,1582.0,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0032,2504.5,1425.5,1388.5,1154.5,1304.5,C/D snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0039,1914.0,1322.5,1446.0,1642.5,1531.5,H/ACA-like snoRNA,<2C (LG1)
Tb927_06_v4.snoRNA.0022,2901.0,700.5,520.0,757.5,1595.5,H/ACA-like snoRNA,<2C (LG1)
Tb927.6.1860,7121.0,5361.5,6159.0,7719.0,5003.0,conserved protein,G2M
Tb927.6.1870,4865.5,4486.5,4840.5,4367.0,2000.0,Eukaryotic translation initiation factor 4E-4,<2C (LG1)
Tb927.6.1880,5181.0,6636.5,5736.5,6322.0,5487.5,aspartyl-tRNA synthetase  putative,G1
Tb927.6.1890,8015.0,7763.5,8705.5,9217.5,7169.5,hypothetical protein  conserved,G2M
Tb927.6.1900,4327.5,3138.5,3157.0,2617.5,2254.0,essential nuclear protein 1  putative,<2C (LG1)
Tb927.6.1910,6666.0,8107.0,9032.0,9086.5,9637.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.1920,9995.0,9396.5,8935.0,9060.0,7541.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.1930,6112.0,4008.0,4398.0,4421.5,2442.5,SAM domain (Sterile alpha motif)  putative,<2C (LG1)
Tb927.6.1940,6319.5,9799.5,9008.0,9111.5,9194.5,leucine-rich repeat protein (LRRP)  putative,G1
Tb927.6.1950,9711.5,10905.0,10892.5,10838.0,10630.0,N-acetyltransferase B complex (NatB) non catalytic subunit  putative,G1
Tb927.6.1960,9159.5,9450.5,9968.5,10016.5,9744.5,glycosyltransferase family 28 protein  putative,G2M
Tb927.6.1970,3510.0,4902.5,5783.0,6313.0,4737.0,nuclear cap binding protein,G2M
Tb927.6.1980,8883.0,4305.0,4878.5,3596.5,6499.0,LMBR1-like membrane protein  putative,<2C (LG1)
Tb927.6.1990,1460.0,1858.0,1574.0,2335.0,1565.5,hypothetical protein  conserved,G2M
Tb927.6.2000,10506.5,8560.5,7158.0,6883.0,8602.0,spliceosome-associated protein  putative,<2C (LG1)
Tb927.6.2010,11192.0,11051.0,11338.0,11418.0,11011.5,acyl-CoA synthetase  putative,G2M
Tb927.6.2020,11132.0,10588.5,10561.0,10445.5,10031.0,Bardet-Biedl syndrome 2 protein,<2C (LG1)
Tb927.6.2030,9181.0,10505.0,10429.5,10725.0,10037.0,STE/STE11 serine/threonine-protein kinase  putative,G2M
Tb927.6.2040,10510.5,7524.0,3452.0,7053.0,8088.0,nitrate reductase  putative,<2C (LG1)
Tb927.6.2050,7086.0,7919.0,7259.5,7474.0,6699.0,ribosome biogenesis regulatory protein (RRS1)  putative,G1
Tb927.6.2060,6301.5,8996.0,5618.5,4686.5,7134.0,histidyl-tRNA synthetase,G1
Tb927.6.2070,6238.5,4084.5,2778.0,2038.5,2928.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2080,10881.5,9129.5,9192.0,9858.5,10073.0,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.6.2090,3645.5,5378.0,7676.5,6657.5,8249.0,pdz domain containing protein  putative,>4C (GG2M)
Tb927.6.2100,612.5,458.5,507.0,419.0,607.0,40S ribosomal protein S30  putative,<2C (LG1)
Tb927.6.2110,612.5,208.5,130.5,159.0,86.0,40S ribosomal protein S30  putative,<2C (LG1)
Tb927.6.2120,8190.0,5384.5,6000.0,2858.5,5963.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2130,6483.0,3665.0,2488.5,2373.0,1896.5,nuclear movement protein  putative,<2C (LG1)
Tb927.6.2140,6701.0,7948.5,8517.0,7642.5,7699.0,hypothetical protein  conserved,S
Tb927.6.2150,7581.5,6488.0,6134.0,7275.5,4849.5,cell division cycle protein 16 homolog  putative,<2C (LG1)
Tb927.6.2160,2137.5,3068.0,3745.0,2707.0,4967.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.2170,612.5,4268.0,6495.5,4433.0,8332.5,co-chaperone GrpE  putative,>4C (GG2M)
Tb927.6.2180,10909.0,10497.5,10502.0,10647.5,9655.0,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.6.2190,5186.0,2714.5,2812.5,3463.5,4266.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2200,7358.0,8487.5,7269.0,6683.5,9286.0,DJ-1 family protein  putative,>4C (GG2M)
Tb927.6.2210,10984.0,10130.0,10415.5,10513.5,9119.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2220,2970.5,3705.0,3930.5,3117.0,2794.5,hypothetical protein  conserved,S
Tb927.6.2230,2901.0,11125.0,11246.0,11195.0,10342.0,RGG protein,S
Tb927.6.2240,612.5,2034.0,2488.5,3374.0,4257.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.2250,9187.0,10772.0,10482.0,10739.0,9430.5,rac serine-threonine kinase  putative,G1
Tb927.6.2260,6883.0,5604.5,5969.0,5273.5,5735.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2270,9016.0,7716.0,7578.5,6598.5,6016.5,AdoMet dependent proline di-methyltransferase  putative,<2C (LG1)
Tb927.6.2280,3751.5,1643.5,3335.0,3130.0,3482.5,prefoldin subunit  putative,<2C (LG1)
Tb927.6.2290,1783.5,11074.5,10991.0,10959.5,10637.5,50S ribosome-binding GTPase  putative,G1
Tb927.6.2300,8365.0,9445.0,8998.0,8728.0,9236.5,adenosine kinase  putative,G1
Tb927.6.2310,3720.0,2741.5,3009.0,3847.5,1789.5,hypothetical protein  conserved,G2M
Tb927.6.2320,6921.5,5592.5,6360.5,5690.0,5432.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2330,8578.0,7524.0,6936.0,5981.0,5788.5,RGG protein,<2C (LG1)
Tb927.6.2340,3987.5,1619.0,3275.0,3241.5,3110.0,prefoldin subunit  putative,<2C (LG1)
Tb927.6.2350,1988.0,10835.0,10767.5,10756.0,10356.5,50S ribosome-binding GTPase  putative,G1
Tb927.6.2360,9773.5,9902.0,9565.5,9313.0,9637.5,adenosine kinase  putative,G1
Tb927.6.2370,10255.5,9983.5,10507.0,10274.0,9355.5,ubiquitin-protein ligase  putative,S
Tb927.6.2380,10335.0,8857.0,9730.0,9396.0,8245.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2390,6967.0,3429.0,2909.0,4267.0,2898.5,conserved hypothetical protein  putative,<2C (LG1)
Tb927.6.2400,4270.5,6890.0,7433.0,7448.0,7649.5,Gamma-tubulin complex component 4,>4C (GG2M)
Tb927.6.2410,7413.5,5974.5,6226.5,5215.5,6405.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2420,10083.5,6530.5,6142.0,6790.5,6463.5,p22 protein precursor,<2C (LG1)
Tb927.6.2430,6521.5,5407.0,5908.5,5850.0,3310.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2440,5462.0,6804.5,6815.5,5932.0,9605.0,Mo25-like  putative,>4C (GG2M)
Tb927.6.2450,8915.0,9205.5,8771.5,9740.5,10210.5,Protein kinase B  putative,>4C (GG2M)
Tb927.6.2460,11321.0,10062.0,10519.0,10623.0,10389.5,ubiquitin fusion degradation protein 2  putative,<2C (LG1)
Tb927.6.2470,5099.5,8866.0,7813.0,8168.5,5064.5,hypothetical protein  conserved,G1
Tb927.6.2480,2137.5,855.5,1207.5,1313.5,3465.5,chaperone protein DnaJ  putative,>4C (GG2M)
Tb927.6.2490,2535.5,5069.5,3994.5,3847.5,5963.0,succinate dehydrogenase subunit 7,>4C (GG2M)
Tb927.6.2500,612.5,1068.5,596.0,1171.0,287.0,RF-1 domain containing protein  putative,G2M
Tb927.6.2510,9006.5,8192.0,6796.5,7144.0,7369.5,Succinate dehydrogenase assembly factor 2  mitochondrial,<2C (LG1)
Tb927.6.2520,8411.5,8839.0,10163.0,9438.0,8703.0,hypothetical protein  conserved,S
Tb927.6.2530,8725.5,3109.0,2684.5,4367.0,3658.5,hypothetical protein,<2C (LG1)
Tb927.6.2540,8300.0,7406.5,7584.0,8391.0,4794.5,DREV methyltransferase  putative,G2M
Tb927.6.2550,5450.0,7110.0,6997.5,7642.5,7736.0,RNA-binding protein  putative,>4C (GG2M)
Tb927.6.2560,3028.5,912.5,907.5,826.5,1437.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2570,11094.0,8946.0,8924.0,9604.0,8409.5,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.6.2580,10728.0,9554.0,8783.0,7675.5,7904.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2590,1460.0,5045.5,4502.0,3393.5,2857.0,hypothetical protein  conserved,G1
Tb927.6.2600,1460.0,3050.5,3920.5,3658.0,2016.0,Protein of unknown function (DUF1077)  putative,S
Tb927.6.2610,1460.0,130.0,795.0,808.0,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2620,6413.0,2609.5,2134.0,2756.0,5916.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2630,2137.5,6992.5,6923.0,6348.0,8254.5,Hsp33 protein  putative,>4C (GG2M)
Tb927.6.2640,11247.0,6500.0,5938.0,6067.5,7038.0,importin alpha subunit  putative,<2C (LG1)
Tb927.6.2650,9472.0,11236.0,11258.0,11263.5,10943.5,nucleolar mif4g domain-containing protein 1,G2M
Tb927.6.2660,11245.0,10859.5,10812.0,10633.5,11056.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2670,9800.5,7208.0,6900.0,6969.0,7740.0,Nudix hydrolase 4,<2C (LG1)
Tb927.6.2680,2221.0,5778.0,7151.0,6205.5,6298.5,transmembrane protein  putative,S
Tb927_06_v4.snoRNA.0040,612.5,896.0,818.5,1003.0,213.0,C/D snoRNA,G2M
Tb927_06_v4.snoRNA.0041,612.5,1108.0,865.5,687.0,287.0,H/ACA-like snoRNA,G1
Tb927_06_v4.snoRNA.0001,612.5,626.0,1254.0,737.0,994.0,C/D snoRNA,S
Tb927.6.2690,8938.5,7493.5,6796.5,6867.5,5927.0,ubiquitin carboxyl-terminal hydrolase  putative,<2C (LG1)
Tb927.6.2700,5330.0,4019.0,3388.5,3295.5,2720.5,small nuclear ribonucleoprotein Sm-E,<2C (LG1)
Tb927.6.2710,10617.0,10881.5,10965.0,10930.0,10068.0,hypothetical protein  conserved,S
Tb927.6.2720,3762.0,6199.5,7151.0,6969.0,4306.0,calcium-binding protein  putative,S
Tb927.6.2730,5955.0,11090.0,11049.5,11056.5,11011.5,hypothetical protein  conserved,G1
Tb927.6.2740,4544.0,3872.5,6134.0,4552.0,5282.0,pyridoxal kinase,S
Tb927.6.2750,2826.5,2731.0,3868.5,3513.0,2483.5,hypothetical protein  conserved,S
Tb927.6.2760,612.5,2772.5,4364.5,8159.0,11568.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.2770,8800.5,11153.5,11225.0,11428.0,11295.0,Vacuolar assembly protein vps41,G2M
Tb927.6.2780,3107.5,4693.0,4662.5,3737.0,3310.5,U3 small nuclear ribonucleoprotein (snRNP)  putative,G1
Tb927.6.2790,7785.0,4481.0,4258.0,4567.5,4760.0,L-threonine 3-dehydrogenase,<2C (LG1)
Tb927.6.2800,10390.5,11304.0,11252.0,11258.5,11146.0,hypothetical protein  conserved,G1
Tb927.6.2810,2901.0,5151.5,4680.0,3773.5,2525.0,ABC transporter  putative,G1
Tb927.6.2820,2258.5,1585.5,1149.5,1125.0,1281.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.2830,9858.5,10377.0,10389.5,10687.5,9957.0,GTPase activating protein  conserved,G2M
Tb927.6.2840,10402.0,6971.5,6185.0,8198.0,8776.5,Serine/threonine-protein kinase RIO2  putative,<2C (LG1)
Tb927.6.2850,6973.0,7505.5,7177.0,8076.5,9730.5,ESAG8-associated protein  putative,>4C (GG2M)
Tb927.6.2860,7459.5,7979.0,9014.0,9563.5,9134.5,WD domain  G-beta repeat  putative,G2M
Tb927.6.2870,1783.5,7032.0,6991.5,6873.5,7465.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.2880,9656.5,10105.5,10090.5,10130.5,8221.5,kinesin  putative,G2M
Tb927.6.2890,4767.5,4796.5,5752.5,5592.0,5362.5,single strand-specific nuclease  putative,S
Tb927.6.2900,8294.0,7362.0,7103.5,8239.5,5824.0,dendritic cell-derived IFNG-induced protein,<2C (LG1)
Tb927.6.2910,1783.5,4242.0,4341.0,5407.5,2977.5,RNA pseudouridylate synthase  putative,G2M
Tb927.6.2920,9153.5,11052.0,10969.0,11052.5,11171.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.2930,6864.5,8571.0,6929.5,7809.5,7618.0,ATPase family associated with various cellular activities (AAA)  putative,G1
Tb927.6.2940,8110.5,6019.0,5783.0,5198.5,4170.0,phosphopantothenoylcysteine decarboxylase  putative,<2C (LG1)
Tb927.6.2950,2436.0,5077.5,4540.5,6304.5,5354.0,hypothetical protein,G2M
Tb927.6.2960,8866.5,11026.0,11045.0,11109.0,10464.0,epsilon-adaptin  putative,G2M
Tb927.6.2970,2886.0,6772.0,7736.0,6626.0,7716.0,pseudouridine synthase A-like protein  putative,S
Tb927.6.2980,2840.5,8170.0,8145.5,8385.0,3825.5,Eukaryotic translation initiation factor 2-alpha kinase 3  putative,G2M
Tb927.6.2990,2523.0,5530.5,6437.0,6761.5,4617.5,Putative papain-like cysteine peptidase (DUF1796)  putative,G2M
Tb927.6.3000,6528.0,6905.5,7411.0,7642.5,4170.0,sphingolipid delta 4 desaturase  putative,G2M
Tb927.6.3010,612.5,2601.0,1679.0,2788.5,2016.0,PH domain containing protein  putative,G2M
Tb927.6.3020,3822.0,7355.0,8348.0,8348.5,7092.0,hypothetical protein  conserved,G2M
Tb927.6.3030,6116.5,8127.5,7151.0,8268.0,7008.5,hypothetical protein  conserved,G2M
Tb927.6.3040,3692.0,4207.5,5439.0,3992.5,4508.5,small GTP-binding protein Rab28  putative,S
Tb927.6.3050,3654.0,7493.5,7588.0,8465.5,7624.5,Aldehyde dehydrogenase 3  putative,G2M
Tb927.6.3060,6741.5,6073.0,5765.5,5342.5,3386.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3070,7352.5,7079.5,6315.0,5538.5,5240.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3080,2137.5,1982.5,2541.5,2566.5,1691.0,hypothetical protein,G2M
Tb927.6.3090,11660.0,10648.5,11047.0,11116.5,11667.0,microtubule associated protein xmap215,>4C (GG2M)
Tb927.6.3100,4225.5,2457.0,3323.5,2725.0,8590.5,Intraflagellar transport complex B protein 46 C terminal  putative,>4C (GG2M)
Tb927.6.3110,4080.0,5479.0,5408.5,6470.5,6038.0,cdc2-related protein kinase 11  putative,G2M
Tb927.6.3120,7037.0,7544.0,7947.5,8445.5,7092.0,chaperone protein DnaJ  putative,G2M
Tb927.6.3130,9151.0,6626.0,5717.5,5042.5,3353.0,queuine tRNA-ribosyltransferase  putative,<2C (LG1)
Tb927.6.3140,4333.5,6115.0,6826.5,6979.0,8303.5,Ubiquitin-like protein 11,>4C (GG2M)
Tb927.6.3150,9280.0,4975.5,3801.5,4486.5,11565.0,Hydin,>4C (GG2M)
Tb927.6.3160,10720.0,9317.5,8955.5,9471.5,10785.5,splicing factor 3a  putative,>4C (GG2M)
Tb927.6.3170,5467.5,5372.5,5097.0,5137.0,6491.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3180,10143.5,3997.5,4181.0,5538.5,5092.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3190,7352.5,6858.5,6108.0,7199.5,6123.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3200,612.5,1924.0,1831.0,1056.5,86.0,hypothetical protein  conserved,G1
Tb927.6.3210,8267.0,5121.0,6495.5,5551.0,3125.5,Adenylate kinase  nuclear,<2C (LG1)
Tb927.6.3220,7162.5,8540.5,8285.0,8496.0,7890.5,hypothetical protein  conserved,G1
Tb927.6.3230,5354.0,5896.0,6630.0,4994.0,7720.0,RNA pseudouridylate synthase  putative,>4C (GG2M)
Tb927.6.3240,9769.0,8540.5,8268.5,8492.5,8602.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3250,4527.5,6977.5,7183.5,7783.5,6679.0,C2H2 type zinc-finger (2 copies)  putative,G2M
Tb927.6.3260,612.5,6286.0,5704.5,4764.5,8111.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3270,2406.5,7216.5,7291.0,7675.5,9940.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3280,10740.0,10672.5,10478.0,10611.5,10137.5,cyclosome subunit 1  putative,<2C (LG1)
Tb927.6.3290,1783.5,1585.5,1923.0,2440.0,2805.5,intraflagellar transport protein 20,>4C (GG2M)
Tb927.6.3300,10050.0,8565.0,9281.5,8529.5,6173.5,GPI alpha-mannosyltransferase I,<2C (LG1)
Tb927.6.3310,10192.5,10505.0,10259.0,10703.0,9395.0,cysteine peptidase  Clan CA  family C2  putative,G2M
Tb927.6.3320,6803.5,9002.0,8484.5,9370.5,8526.5,ferric reductase transmembrane protein  putative,G2M
Tb927.6.3330,9142.5,5854.0,7404.5,5463.0,7299.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3340,6330.0,4163.0,4189.0,4558.5,6240.0,Domain of unknown function (DUF814)  putative,<2C (LG1)
Tb927.6.3350,9138.0,10484.5,10764.0,10434.0,9885.5,hypothetical protein  conserved,S
Tb927.6.3360,2047.0,1415.5,1446.0,1626.0,397.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3380,10553.0,11113.5,11293.0,11262.0,10081.5,expression site-associated gene 1 (ESAG1)  degenerate,S
Tb927.6.3390,10824.0,10360.0,9850.5,10362.0,9378.5,expression site-associated gene 2 (ESAG2)  frameshift,<2C (LG1)
Tb927.6.3400,10461.5,11574.0,11615.0,11567.0,11407.0,hypothetical protein  conserved,S
Tb927.6.3410,8625.0,7087.5,7143.0,6850.0,8433.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3420,5257.0,2679.0,2839.0,1805.5,2747.0,Oligomerisation domain containing protein  putative,<2C (LG1)
Tb927.6.3430,11310.0,10324.0,10363.5,10667.5,10514.0,Serine/threonine-protein kinase NEK10  putative,<2C (LG1)
Tb927.6.3440,2180.0,738.5,756.5,647.5,1062.5,NUDIX hydrolase domain-like domain-containing protein,<2C (LG1)
Tb927.6.3450,9972.0,8654.5,9202.0,8909.5,9126.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3460,2658.5,4567.5,3930.5,4252.5,5332.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3470,1914.0,438.0,615.0,534.5,213.0,hypothetical protein  conserved,<2C (LG1)
Tb6.NT.65,612.5,40.5,40.0,82.5,213.0,Noncoding RNA  putative,<2C (LG1)
Tb927.6.3480,2094.5,2034.0,1679.0,2483.5,2671.5,RNA-binding protein  putative,>4C (GG2M)
Tb6.NT.66,612.5,40.5,40.0,82.5,86.0,Noncoding RNA  putative,<2C (LG1)
Tb927.6.3490,10342.5,9977.5,8917.0,9222.5,7913.5,zinc finger protein 1,<2C (LG1)
Tb927.6.3500,9613.0,10537.0,10310.5,11246.0,11302.0,endosomal trafficking protein RME-8  putative,>4C (GG2M)
Tb927.6.3510,4470.5,8265.0,7831.0,8036.0,9122.0,tRNA modification enzyme  putative,>4C (GG2M)
Tb927.6.3520,5393.5,6636.5,7607.0,7144.0,9701.5,Uncharacterised ACR  YagE family COG1723  putative,>4C (GG2M)
Tb927.6.3530,5625.5,6190.5,6236.5,6837.5,7573.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3540,4339.5,5039.5,4200.5,4908.0,4257.0,zinc-finger protein  conserved,G1
Tb927.6.3550,9049.0,10554.0,10098.5,9966.0,11086.5,phospholipid-translocating P-type ATPase (flippase)  putative,>4C (GG2M)
Tb927.6.3560,6995.5,7879.0,7490.0,9285.5,11631.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3570,6594.5,8607.0,9358.5,9309.0,8264.0,tubulin-tyrosine ligase-like protein  conserved,S
Tb927.6.3580,9632.0,9893.5,10484.5,9946.5,9606.5,ATP-dependent DEAD/H DNA helicase recQ  putative,S
Tb927.6.3590,2795.5,6380.0,5898.0,6289.0,6392.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3600,6243.0,5309.0,5798.5,4504.5,5064.5,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.6.3610,10108.5,9858.0,10047.5,9810.0,10116.0,SET domain containing protein  putative,>4C (GG2M)
Tb927.6.3620,9187.0,10140.0,10246.0,10158.5,8685.5,zinc finger protein  putative,S
Tb927.6.3630,4533.5,8684.5,7607.0,8593.5,4860.0,sphingosine 1-phosphate lyase  putative,G1
Tb927.6.3640,7455.5,8144.0,7384.0,7093.5,6028.0,zinc finger of C3HC4-type  RING/B-box zinc finger  putative,G1
Tb927.6.3650,8562.5,6475.0,5962.0,5648.5,2953.5,ADP-ribosylation factor-like protein 3C  putative,<2C (LG1)
Tb927.6.3660,9620.5,8587.5,8318.5,8649.5,6945.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3670,6984.5,10847.0,10836.0,10858.5,11613.0,paraflagellar rod component  putative,>4C (GG2M)
Tb927.6.3680,3095.0,678.5,578.5,557.5,978.0,Present in the outer mitochondrial membrane proteome 31,<2C (LG1)
Tb927.6.3690,10004.5,2887.5,4807.5,2956.0,6799.5,pre-mRNA cleavage complex II Clp1-like  conserved,<2C (LG1)
Tb927.6.3700,6158.0,2000.5,1311.0,1597.5,874.5,peptidyl-tRNA hydrolase PTH2  putative,<2C (LG1)
Tb927.6.3710,5428.0,5494.5,5919.0,6276.5,4703.5,hypothetical protein  conserved,G2M
Tb927.6.3720,9843.0,10698.0,10798.5,10865.0,9659.5,hypothetical protein  conserved,G2M
Tb927.6.3730,4691.0,2942.5,2902.0,2150.0,1608.0,chaperone protein DnaJ  putative,<2C (LG1)
Tb927.6.3740,7007.0,5111.5,4559.5,2999.5,3812.0,heat shock 70 kDa protein  mitochondrial precursor  putative,<2C (LG1)
Tb927.6.3750,6257.5,6272.5,5070.5,4464.5,4199.0,heat shock 70 kDa protein  mitochondrial precursor  putative,G1
Tb927.6.3755,612.5,1747.5,1848.0,2199.0,1407.5,hypothetical protein,G2M
Tb927.6.3760,612.5,5454.0,5771.0,6322.0,4988.5,kinetoplastid kinetochore protein 15,G2M
Tb927.6.3770,612.5,4242.0,3940.5,3866.5,4560.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3780,2943.0,6319.0,6296.0,6192.0,6770.5,E3 ubiquitin-protein ligase  putative,>4C (GG2M)
Tb927.6.3790,8947.5,8571.0,6587.5,7557.0,8071.5,valosin-containing protein homolog  putative,<2C (LG1)
Tb927.6.3800,8686.0,6408.0,5512.0,3332.5,5075.5,heat shock 70 kDa protein  mitochondrial precursor  putative,<2C (LG1)
Tb927.6.3810,6173.0,6295.0,5419.0,4409.0,3044.5,hypothetical protein  conserved,G1
Tb927.6.3820,6900.0,6824.0,7259.5,8011.5,11000.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3830,10520.0,9573.0,8968.5,9840.0,10100.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3840,7906.5,6554.5,6544.0,8567.5,6405.0,reticulon domain protein,G2M
Tb927.6.3850,4104.0,5798.0,6095.5,6694.0,6808.0,chaperone protein DnaJ  putative,>4C (GG2M)
Tb927.6.3860,8079.5,6599.5,5728.0,7752.0,7644.0,leucyl/phenylalanyl-tRNA protein transferase  putative,<2C (LG1)
Tb927.6.3870,7496.0,5946.5,3578.0,5285.0,5110.5,RNA-binding protein  putative,<2C (LG1)
Tb927.6.3880,9790.5,8349.5,8994.0,9405.0,9286.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3890,5870.0,7310.0,7342.5,7681.5,5780.5,replication factor C  subunit 2  putative,G2M
Tb927.6.3900,8288.5,4287.0,4740.5,3950.5,3981.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3910,5500.5,2283.0,1860.0,2893.5,4244.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3920,612.5,3041.5,3138.0,2404.0,3566.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.3930,5994.0,7303.5,6905.5,7179.5,5752.5,LSU ribosomal protein  mitochondrial  putative,G1
Tb927.6.3940,612.5,5049.5,5208.5,5180.0,7525.0,Autophagy-related protein 27  putative,>4C (GG2M)
Tb927.6.3950,10361.5,8066.0,7421.5,9149.5,8627.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.3960,8099.0,9043.0,8167.5,8786.5,8327.5,Nucleotide sugar transporter 4,G1
Tb927.6.3970,612.5,877.0,994.0,628.0,559.5,SH3 domain protein  conserved,S
Tb927.6.3980,4459.5,5104.5,5570.5,7236.0,4693.0,hypothetical protein  conserved,G2M
Tb927.6.3990,2795.5,7162.0,6702.5,7859.5,11574.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4000,10304.5,10176.5,10094.5,10222.5,10753.5,small glutamine-rich tetratricopeptide repeat protein  putative,>4C (GG2M)
Tb927.6.4010,5413.5,3298.5,3197.0,3744.5,3413.5,Translation machinery associated TMA7  putative,<2C (LG1)
Tb927.6.4020,2295.5,260.0,40.0,136.5,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4030,4490.0,4413.0,3531.0,3677.0,3457.5,superoxide dismutase  putative,<2C (LG1)
Tb927.6.4040,8297.0,1653.5,1078.0,1542.0,1325.5,mitochondrial ribosomal protein L28,<2C (LG1)
Tb927.6.4050,1460.0,3665.0,3260.0,3254.5,3271.5,zinc finger ccch domain-containing protein 14,G1
Tb927.6.4060,612.5,823.0,1561.5,664.0,2720.5,Eukaryotic protein of unknown function (DUF872)  putative,>4C (GG2M)
Tb927.6.4070,612.5,7585.5,8091.5,7651.5,5230.0,hypothetical protein  conserved,S
Tb927.6.4080,5561.0,6066.5,5717.5,5638.0,3586.0,ribosomal protein  putative,G1
Tb927.6.4090,7453.0,9658.5,9504.5,9454.0,8460.5,chaperonin HSP60  mitochondrial precursor  putative,G1
Tb927.6.4100,3448.5,7310.0,6780.0,7906.5,9829.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4120,2552.0,5172.5,5752.5,6067.5,6392.5,GTPase activating protein  putative,>4C (GG2M)
Tb927.6.4130,9312.0,4615.5,5340.0,4309.5,6048.5,succinate dehydrogenase subunit 3,<2C (LG1)
Tb927.6.4140,612.5,1727.5,1416.0,2589.0,7038.0,paraflagellar rod component  putative,>4C (GG2M)
Tb927.6.4150,5756.5,8077.5,7188.5,8264.5,9644.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4160,9278.5,5180.0,6000.0,6850.0,8522.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4170,7614.0,4745.0,4680.0,4981.0,3704.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4180,2930.5,7049.5,6648.5,6120.5,4645.0,FUN14 family  putative,G1
Tb927.6.4190,8908.0,9327.5,7836.0,8100.0,8118.5,Pentatricopeptide repeat protein (PPR)  putative,G1
Tb927.6.4200,612.5,6159.0,5120.0,4464.5,3628.5,LSU ribosomal protein  mitochondrial  putative,G1
Tb927.6.4210,1783.5,8699.5,8470.0,8323.5,6764.0,aldehyde dehydrogenase  putative,G1
Tb927.6.4220,2406.5,3041.5,4722.5,3545.0,2427.0,mitogen-activated protein kinase 5,S
Tb927.6.4230,8832.5,6870.0,6593.0,7391.0,7909.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4240,612.5,3792.0,5164.0,3477.5,4222.5,hypothetical protein  conserved,S
Tb927.6.4250,612.5,4281.0,5537.0,4598.0,4257.0,hypothetical protein  conserved,S
Tb927.6.4260,2840.5,8491.0,9185.0,9164.5,8731.0,hypothetical protein  conserved,S
Tb927.6.4270,2729.0,2232.0,3354.5,3102.5,1549.5,hypothetical protein  conserved,S
Tb927.6.4280,4364.5,2034.0,1091.0,1416.5,1078.0,glyceraldehyde 3-phosphate dehydrogenase  glycosomal,<2C (LG1)
Tb927.6.4290,7516.0,7216.5,5645.0,5206.5,6804.0,hypothetical protein  conserved (pseudogene),<2C (LG1)
Tb927.6.4300,5190.5,1542.0,795.0,1171.0,1141.0,glyceraldehyde 3-phosphate dehydrogenase  glycosomal,<2C (LG1)
Tb927.6.4310,6733.0,7338.0,6288.0,5926.0,8206.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4320,4756.0,7962.0,7259.5,7350.0,5927.0,Protein of unknown function (DUF2817)  putative,G1
Tb927.6.4330,1460.0,7065.5,6360.5,6374.0,5323.5,telomere-associated protein,G1
Tb927.6.4340,7121.0,3835.5,3205.5,4156.0,5927.0,small nuclear ribonucleoprotein  putative,<2C (LG1)
Tb927.6.4350,6937.0,3235.0,2564.5,3343.0,4480.5,ribosomal RNA assembly protein  putative,<2C (LG1)
Tb927.6.4360,6672.0,2839.5,2703.5,2907.5,3794.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4370,5251.5,3086.5,2839.0,2494.5,3704.0,eukaryotic translation initiation factor 3 subunit d,<2C (LG1)
Tb927.6.4380,8976.0,9342.5,9030.0,8144.5,9706.0,Protein of unknown function (DUF544)  putative,>4C (GG2M)
Tb927.6.4390,11313.0,9920.0,9838.5,10000.5,9616.5,kinesin  putative,<2C (LG1)
Tb927.6.4400,7870.5,8270.0,7692.5,8126.5,5752.5,Pentatricopeptide repeat protein (PPR)  putative,G1
Tb927.6.4410,6641.0,5057.5,4002.0,4112.0,3100.5,S-adenosylmethionine decarboxylase,<2C (LG1)
Tb927.6.4420,5774.0,6452.5,4977.5,4027.5,287.0,tRNA (Guanine-1)-methyltransferase  putative,G1
Tb927.6.4430,3778.0,5136.0,5350.5,4512.5,6844.5,homoserine kinase,>4C (GG2M)
Tb927.6.4440,5799.0,5499.5,4758.5,5728.5,6216.5,RNA-binding protein 42 (RNA-binding motif protein 42),>4C (GG2M)
Tb927.6.4450,6264.0,6170.0,5696.5,6515.5,3606.5,Pentatricopeptide repeat protein (PPR)  putative,G2M
Tb927.6.4460,7317.0,7983.0,8044.5,7692.0,8937.5,S-adenosylmethionine decarboxylase,>4C (GG2M)
Tb927.6.4470,1783.5,2078.0,1237.5,1313.5,1970.0,S-adenosylmethionine decarboxylase proenzyme,G1
Tb927.6.4480,11426.0,10988.0,10585.0,10010.5,9963.0,valyl-tRNA synthetase  putative,<2C (LG1)
Tb927.6.4490,1460.0,1619.0,1416.0,1110.5,1676.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4500,4894.5,2206.0,1465.0,1675.5,1531.5,conserved repeat domain containing protein  putative,<2C (LG1)
Tb927.6.4510,9097.0,5841.0,4966.0,4894.5,4081.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4520,1783.5,3872.5,5777.0,5392.0,5266.5,Tumour suppressor  Mitostatin  putative,S
Tb927.6.4530,612.5,8015.5,7718.5,7809.5,5499.0,RNA-binding protein  putative,G1
Tb927.6.4540,1783.5,8081.0,8368.0,7422.0,7453.0,3-hydroxy-3-methylglutaryl-CoA reductase  putative,S
Tb927.6.4550,6632.0,8955.0,8949.5,8525.0,7274.5,hypothetical protein  conserved,G1
Tb927.6.4560,4182.0,4034.0,3801.5,4512.5,3566.5,Mitochondrial SSU ribosomal protein  putative,G2M
Tb927.6.4570,612.5,1257.5,2949.5,2404.0,505.0,hypothetical protein  conserved,S
Tb927.6.4580,5981.0,5701.0,6089.5,6738.5,5117.5,Mitochondrial SSU ribosomal protein  putative,G2M
Tb927.6.4590,7090.5,4990.0,6603.0,4973.5,5898.0,glutamyl-tRNA synthetase  putative,<2C (LG1)
Tb927.6.4600,1783.5,4008.0,5736.5,3785.5,4560.5,pre-mRNA splicing factor ATP-dependent RNA helicase  putative,S
Tb927.6.4610,11031.0,8774.5,8492.0,7258.0,10482.0,Ankyrin repeats (3 copies)  putative,<2C (LG1)
Tb927.6.4620,612.5,4341.0,5059.5,3888.5,4276.5,hypothetical protein  conserved,S
Tb927.6.4630,6607.5,7152.0,6966.5,6357.5,5209.5,kinetoplastid-specific phospho-protein phosphatase  putative,G1
Tb927.6.4640,10031.5,10238.0,10405.5,10431.0,10887.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4650,1460.0,8998.5,8420.5,8858.5,8317.5,UV excision repair RAD23 protein  putative,G1
Tb927.6.4660,3272.0,9358.5,9126.0,9649.0,8161.0,cationic amino acid transporter  putative,G2M
Tb927.6.4670,612.5,1009.0,1179.5,2810.5,4110.0,MORN repeat-containing protein 1,>4C (GG2M)
Tb927.6.4680,9769.0,6058.0,6577.0,7586.5,4244.5,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4690,2637.5,260.0,520.0,483.0,397.5,60S ribosomal protein L9  putative,<2C (LG1)
Tb927.6.4700,10573.0,10246.5,9420.0,9111.5,10740.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4710,3155.0,4902.5,4887.0,5538.5,4988.5,calmodulin  putative,G2M
Tb927.6.4720,7358.0,5159.5,5645.0,4290.5,4597.5,zinc finger CCCH domain-containing protein 15,<2C (LG1)
Tb927.6.4730,612.5,2444.5,2050.0,1888.0,1647.0,hypothetical protein,G1
Tb927.6.4740,10755.0,9646.5,10332.0,10592.0,10379.5,importin-alpha re-exporter protein  putative,<2C (LG1)
Tb927.6.4750,612.5,4703.0,5298.0,4808.0,8057.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4760,9011.0,9913.0,9880.5,9014.0,9302.5,T-complex protein 11  putative,G1
Tb927.6.4770,1460.0,1353.5,1502.0,2321.5,5354.0,protein mkt1  putative,>4C (GG2M)
Tb927.6.4780,2619.0,5641.5,5792.5,6056.0,9609.5,DNA ligase I  putative,>4C (GG2M)
Tb927.6.4790,1460.0,3950.5,4148.5,3677.0,4490.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.4800,8015.0,5454.0,5609.0,6815.5,7192.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.4810,7635.5,7297.5,6078.5,7336.5,7471.0,zinc-binding protein (Yippee)  putative,<2C (LG1)
Tb927.6.4820,612.5,927.5,2410.5,5095.0,10045.5,chromosomal passenger complex protein 1,>4C (GG2M)
Tb927.6.4830,7101.5,5746.5,6568.5,6067.5,3812.0,MIZ/SP-RING zinc finger  putative,<2C (LG1)
Tb927.6.4840,10361.5,9398.0,9423.0,9267.0,8993.5,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4850,10114.0,9266.0,9165.5,8645.0,8260.0,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4860,10076.0,8765.0,8842.5,8245.0,7866.0,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4870,10542.0,9631.0,9713.0,9097.0,8805.0,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4880,9996.5,9016.5,9169.5,8414.0,8674.0,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4890,10555.5,9646.5,9653.5,9285.5,8817.0,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4900,10718.5,10001.5,10144.0,9678.0,9138.0,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4910,10638.0,9658.5,9675.5,9157.5,8860.0,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4920,10042.5,8796.0,9010.5,8036.0,7924.5,S-adenosylmethionine synthetase,<2C (LG1)
Tb927.6.4930,612.5,4317.5,5685.5,5939.0,3981.5,thiosulfate sulfurtransferase  mitochondrial  putative,G2M
Tb927.6.4940,7034.0,5765.0,6708.5,6304.5,6038.0,RF-1 domain containing protein  putative,<2C (LG1)
Tb927.6.4950,9199.0,7927.5,7634.5,8191.0,9308.5,Protein mago nashi homolog,>4C (GG2M)
Tb927.6.4960,612.5,2714.5,3431.0,3319.0,2914.5,Zinc finger CCCH domain-containing protein 47,S
Tb927.6.4970,11025.0,10274.5,9765.5,9939.0,10895.5,serine/arginine-rich protein specific kinase SRPK  putative,<2C (LG1)
Tb927.6.4980,2574.5,1180.5,1124.0,1154.5,1422.0,40S ribosomal protein S14,<2C (LG1)
Tb927.6.4990,612.5,2671.0,2621.5,2483.5,672.0,mitochondrial ATP synthase delta chain,G1
Tb927.6.5000,8606.5,10069.0,9823.0,9666.0,9467.0,Protein of unknown function (DUF773)  putative,G1
Tb927.6.5010,5314.0,6429.5,8120.5,6873.5,5075.5,hypothetical protein  conserved,S
Tb927.6.5020,2780.5,1353.5,1289.5,1597.5,2495.0,cyclin 7  putative,<2C (LG1)
Tb927.6.5030,3095.0,1143.0,1379.5,1609.0,10923.5,Component of motile flagella protein 46,>4C (GG2M)
Tb927.6.5040,1460.0,2505.5,2839.0,3531.5,2589.5,ribosomal protein L15  putative,G2M
Tb927.6.5050,3166.5,5834.5,6368.5,5958.0,5379.5,V-type ATPase  C subunit  putative,S
Tb927.6.5060,2406.5,1827.5,1650.0,1609.0,3076.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.5070,2137.5,1520.0,2238.0,2629.5,8748.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.6.5080,7550.0,5637.5,4758.5,4674.0,5861.5,Protein of unknown function (DUF3808)  putative,<2C (LG1)
Tb927.6.5090,9776.5,11093.0,10776.5,11066.0,9948.0,hypothetical protein  conserved,G1
Tb927.6.5095,612.5,823.0,818.5,1243.0,895.5,hypothetical protein,G2M
Tb927.6.5100,9499.5,9153.0,9922.0,9540.0,8748.0,polo-like protein kinase  putative,S
Tb927.6.5110,7520.5,11403.0,11402.0,11274.0,11128.0,damage-specific DNA binding protein  putative,G1
Tb927.6.5120,2901.0,1455.0,2092.5,1936.0,2098.0,60S acidic ribosomal protein P2  putative,<2C (LG1)
Tb927.6.5130,3937.0,2920.5,3727.5,3763.0,2442.5,60S acidic ribosomal protein P2  putative,<2C (LG1)
Tb927.6.5140,9556.0,8373.5,9066.5,8997.0,8137.0,ribosomal P protein AGP2beta-1  putative,<2C (LG1)
Tb927.6.5150,11615.0,11462.0,11481.0,11502.0,11370.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.5160,11553.0,11697.0,11685.0,11693.0,11660.0,retrotransposon hot spot protein 3 (RHS3)  point mutation,G1
Tb927.6.5170,10257.0,7403.5,7909.5,7687.0,7192.0,retrotransposon hot spot protein 4 (RHS4)  interrupted,<2C (LG1)
Tb927.6.5180,11331.0,10212.5,10034.0,10051.0,10578.5,retrotransposon hot spot protein 4 (RHS4)  interrupted,<2C (LG1)
Tb927.6.5190,7611.5,10619.0,10638.0,10673.5,8630.0,DNA-directed RNA polymerase III  pseudogene  putative,G2M
Tb927.6.5200,8647.5,8270.0,6917.0,8536.0,6757.0,hypothetical protein  conserved,<2C (LG1)
Tb927.6.5210,10278.0,10910.0,10690.0,10707.0,10534.0,variant surface glycoprotein  frameshift,G1
Tb927.6.5220,4027.5,2093.5,2653.0,2577.5,2679.0,variant surface glycoprotein  fragment  degenerate,<2C (LG1)
Tb927.6.5230,3987.5,3256.0,3066.0,2940.5,5745.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.6.5240,7100.0,8086.5,9452.0,9457.0,8910.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.6.5250,612.5,3050.5,3920.5,3429.5,2454.0,variant surface glycoprotein  fragment,S
Tb927.6.5260,2137.5,246.5,471.5,577.5,461.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.6.5270,1783.5,999.0,1021.0,1171.0,1062.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.6.5280,10381.5,6344.0,5164.0,5307.5,3888.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5290,1460.0,626.0,313.0,444.5,347.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5300,6190.5,1961.5,2399.5,2881.0,3310.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5310,5133.0,5069.5,5144.0,5295.5,4813.5,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,G2M
Tb927.6.5320,8115.5,7184.0,7484.0,6676.5,8374.0,variant surface glycoprotein  frameshift,>4C (GG2M)
Tb927.6.5330,3630.5,1437.5,1021.0,1202.5,531.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5350,3394.0,999.0,1124.0,1031.0,797.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5360,3888.5,5188.5,5645.0,5148.0,4967.0,variant surface glycoprotein  degenerate,S
Tb927.6.5370,10194.5,11277.5,11334.5,11114.0,10426.5,variant surface glycoprotein (VSG)  putative,S
Tb927.6.5380,2460.0,1536.0,2425.0,2335.0,2050.0,variant surface glycoprotein  truncated,<2C (LG1)
Tb927.6.5390,612.5,4331.5,5919.0,6728.0,4915.5,variant surface glycoprotein  degenerate,G2M
Tb927.6.5400,1460.0,4103.5,5358.0,5662.0,5526.5,expression site-associated gene 3 (ESAG3)  degenerate,G2M
Tb927.6.5410,3078.5,3217.5,3021.0,3950.5,4664.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.6.5420,8619.0,7410.0,6849.0,7675.5,7130.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5430,6151.5,7585.5,5945.5,7009.0,3375.0,variant surface glycoprotein  degenerate,G1
Tb927.6.5440,612.5,192.5,233.5,382.0,505.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5450,1783.5,7637.0,7283.5,7656.5,7437.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb927.6.5460,8120.0,1275.5,743.0,1003.0,86.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5470,8638.0,10281.0,10547.5,10069.0,9231.5,variant surface glycoprotein  degenerate,S
Tb927.6.5480,612.5,4531.5,3930.5,3429.5,3055.0,variant surface glycoprotein  degenerate,G1
Tb927.6.5490,6120.0,6132.0,5345.0,5497.0,3260.0,expression site-associated gene 3 (ESAG3)  degenerate,G1
Tb927.6.5500,1914.0,4072.5,4586.5,4112.0,2322.0,variant surface glycoprotein  degenerate,S
Tb927.6.5510,5012.0,1482.5,1650.0,1491.0,1392.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.6.5520,612.5,4429.5,4776.0,6683.5,4158.0,variant surface glycoprotein  degenerate,G2M
Tb927.6.5530,3214.5,4027.0,3354.5,2850.5,7855.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.6.5540,10153.0,4908.0,4139.5,5517.5,6557.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5550,7741.0,2384.0,3009.0,2940.5,1338.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.6.5560,11168.0,10182.5,9816.5,10258.0,8685.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5570,9231.5,10186.5,10658.0,9848.5,10170.5,variant surface glycoprotein  fragment  degenerate,S
Tb927.6.5580,5817.0,4467.0,5867.0,6475.5,6123.0,expression site-associated gene 3 (ESAG3)  degenerate,G2M
Tb927.6.5590,6080.5,4996.5,5408.5,5159.0,4831.5,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.6.5600,612.5,386.5,848.5,313.5,86.0,variant surface glycoprotein  degenerate,S
Tb927.6.5610,5546.0,5344.0,3969.5,5850.0,3950.0,variant surface glycoprotein  degenerate,G2M
Tb927.6.5620,1783.5,1747.5,717.5,1071.0,397.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5630,612.5,530.0,980.0,720.5,721.5,variant surface glycoprotein  frameshift,S
Tb927.6.5640,2826.5,1249.0,2289.5,2520.5,1816.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5650,7282.0,6132.0,5153.5,6452.5,4391.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5660,5186.0,3407.5,3323.5,4045.0,3474.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5670,5241.5,5521.0,5460.5,5862.5,6955.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.6.5680,612.5,40.5,99.0,82.5,86.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5690,612.5,335.0,357.5,444.5,721.5,variant surface glycoprotein  fragment,>4C (GG2M)
Tb927.6.5700,2258.5,438.0,336.0,273.5,559.5,variant surface glycoprotein  fragment  degenerate,<2C (LG1)
Tb927.6.5710,3241.5,2086.0,1956.0,2746.5,1141.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.6.5720,2221.0,484.0,703.0,610.5,697.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.6.5730,1460.0,5192.0,4598.0,5037.0,7597.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.6.5740,612.5,1455.0,2778.0,2168.5,4005.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.6.5750,612.5,279.5,357.5,334.5,637.0,variant surface glycoprotein  fragment,>4C (GG2M)
Tb927.6.5760,5204.5,4785.0,5153.5,4301.0,6444.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.6.5770,2094.5,2469.5,1771.5,2840.5,2029.5,expression site-associated gene 3 (ESAG3)  degenerate,G2M
Tb927.6.5780,612.5,2638.5,4246.0,4409.0,4073.0,variant surface glycoprotein  point mutation,G2M
Tb927.6.5790,3524.0,4119.5,5358.0,5648.5,4440.0,variant surface glycoprotein  frameshift,G2M
Tb927.6.5800,2180.0,1231.0,1692.0,2120.5,2178.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.6.5810,612.5,208.5,40.0,33.5,86.0,transposase of Tn10,<2C (LG1)
Tb927.6.5820,2047.0,96.0,99.0,159.0,433.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb927.6.5830,612.5,260.0,756.5,808.0,1958.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.3.100,2637.5,2260.5,2488.5,2656.5,1919.5,hypothetical protein  pseudogene,G2M
Tb927.3.110,6207.5,4859.5,5396.5,4662.5,5795.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.3.120,7933.0,6984.0,7802.5,7783.5,5479.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb927.3.130,7167.0,4547.5,5340.0,5050.5,5772.0,variant surface glycoprotein  truncated,<2C (LG1)
Tb927.3.140,612.5,3419.0,2488.5,2589.0,3494.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.3.150,612.5,3201.0,2764.5,2168.5,8057.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb927.3.160,2295.5,3353.0,3633.5,3441.0,1504.0,expression site-associated gene 3 (ESAG3)  degenerate,S
Tb927.3.170,612.5,130.0,130.5,136.5,86.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.180,7080.5,7851.5,8193.5,8070.5,4748.5,variant surface glycoprotein (VSG  atypical)  putative,S
Tb927.3.190,5490.5,6247.5,6278.0,5551.0,5064.5,variant surface glycoprotein (VSG)  putative,S
Tb927.3.200,1460.0,1143.0,1446.0,989.0,584.5,variant surface glycoprotein  truncated  degenerate,<2C (LG1)
Tb927.3.210,11510.0,11097.0,10992.0,10621.0,9674.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb927.3.220,7299.0,5953.5,5637.0,6452.5,6557.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.230,612.5,4937.5,4029.0,3878.0,2773.0,variant surface glycoprotein  degenerate,G1
Tb927.3.240,7250.0,4675.5,4304.0,5050.5,3335.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.250,3041.5,1405.5,1475.5,1299.0,994.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.3.260,3142.5,3000.5,3789.5,2893.5,2079.5,variant surface glycoprotein  fragment,S
Tb927.3.270,1460.0,3201.0,2839.0,3588.0,4073.0,variant surface glycoprotein  frameshift,>4C (GG2M)
Tb927.3.280,1460.0,6998.0,6393.0,6525.0,6137.0,variant surface glycoprotein  degenerate,G1
Tb927.3.290,7723.0,2687.5,4293.5,3130.0,5516.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.3.300,4321.0,5322.5,4807.5,5445.5,7077.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.3.310,7906.5,6380.0,6114.0,7208.0,6190.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.320,2094.5,7041.5,5034.0,5695.0,4418.5,variant surface glycoprotein  point mutation,G1
Tb927.3.330,8738.0,4950.0,6152.5,5704.5,4089.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.340,1460.0,3050.5,2604.0,1847.0,637.0,variant surface glycoprotein (VSG)  putative,G1
Tb927.3.350,9590.5,9266.0,8502.5,8921.0,7670.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.360,3341.5,2106.0,1848.0,2697.5,1531.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.370,1460.0,1153.5,532.5,2456.5,3335.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb927.3.380,1914.0,458.5,313.0,397.5,948.5,variant surface glycoprotein  truncated  degenerate,<2C (LG1)
Tb927.3.390,1914.0,3806.5,2440.5,1922.5,2098.0,variant surface glycoprotein  degenerate,G1
Tb927.3.400,5505.0,4383.0,4749.0,4754.5,4199.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.410,3720.0,3336.0,3308.0,4166.5,4645.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.3.420,612.5,3700.0,3127.0,3343.0,2098.0,variant surface glycoprotein  degenerate,G1
Tb927.3.430,5620.5,2621.0,2075.5,2821.0,3375.0,expression site-associated gene 3 (ESAG3)  truncated,<2C (LG1)
Tb927.3.440,2329.5,7436.5,8796.5,7854.0,6670.0,variant surface glycoprotein (VSG)  putative,S
Tb927.3.450,4233.5,2785.5,2717.5,2554.0,3704.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.460,5557.5,5592.5,6917.0,7398.5,5664.0,expression site-associated gene 3 (ESAG3)  degenerate,G2M
Tb927.3.470,7964.5,6347.0,6744.5,7227.0,5003.0,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.3.480,1460.0,4806.0,4170.0,3463.5,1549.5,variant surface glycoprotein  degenerate,G1
Tb927.3.490,1460.0,4393.0,3431.0,3477.5,3825.5,variant surface glycoprotein (VSG)  putative,G1
Tb927.3.500,5402.0,3916.0,3189.5,4112.0,2589.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.3.510,9666.5,9997.5,9906.0,9686.5,8807.5,hypothetical protein  conserved,G1
Tb927.3.520,4233.5,3665.0,4783.5,4205.5,4306.0,expression site-associated gene 1 (ESAG1) protein  putative,S
Tb927.3.530,4574.0,4624.0,4235.0,3130.0,1407.5,expression site-associated gene 11 (ESAG11)  degenerate,G1
Tb927.3.540,4922.5,576.5,848.5,483.0,895.5,expression site-associated gene 1 (ESAG1)  truncated,<2C (LG1)
Tb927.3.550,5740.0,4214.5,3288.0,4790.0,5996.5,expression site-associated gene 1 (ESAG1)  degenerate,>4C (GG2M)
Tb927.3.560,3429.0,2178.5,2522.5,2589.0,3929.5,expression site-associated gene 11 (ESAG11) protein  putative,>4C (GG2M)
Tb927.3.570,9166.0,9685.0,9353.5,9683.0,8872.5,expression site-associated gene 2 (ESAG2) protein  putative,G1
Tb927.3.580,11641.0,11629.0,11635.0,11637.0,11586.0,leucine-rich repeat protein (LRRP)  putative,<2C (LG1)
Tb927.3.585,612.5,5992.0,6648.5,7034.0,5803.0,hypothetical protein,G2M
Tb927.3.590,3502.5,2679.0,3464.5,3577.5,4550.5,adenosine transporter  putative,>4C (GG2M)
Tb927.3.600,8969.0,10116.5,10332.0,10216.5,10582.5,hypothetical protein,>4C (GG2M)
Tb927.3.610,3358.0,2551.0,3441.0,2290.0,1304.5,N-acetyltransferase complex ARD1 subunit  putative,S
Tb927.3.620,9672.5,8878.5,8547.5,8176.5,8508.5,ATP-dependent DEAD/H RNA helicase  putative,<2C (LG1)
Tb927.3.630,3543.0,3086.5,3642.0,3711.5,2098.0,hypothetical protein  conserved,G2M
Tb927.3.640,9307.5,6229.5,7049.5,7681.5,6463.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.650,612.5,1394.5,1371.0,1609.0,2029.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.660,5257.0,2658.5,2289.5,1626.0,4158.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.670,3972.0,2224.0,1679.0,1922.5,4244.5,hypothetical protein,>4C (GG2M)
Tb927.3.680,3904.5,5104.5,5325.5,3577.5,1565.5,cytochrome P450  putative,S
Tb927.3.690,612.5,1969.0,2593.5,4367.0,9628.5,CMGC/RCK protein kinase  putative,>4C (GG2M)
Tb927.3.700,612.5,518.0,448.0,444.5,347.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.710,9190.0,7059.0,7209.5,6112.5,7699.0,RING-variant domain containing protein  putative,<2C (LG1)
Tb927.3.720,2598.0,5338.5,3801.5,2850.5,6719.5,zinc finger protein 3,>4C (GG2M)
Tb927.3.730,10532.0,7897.5,7177.0,8254.5,9504.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.740,6088.5,999.0,1428.0,1779.5,7369.5,ZFP family member  putative,>4C (GG2M)
Tb927.3.750,4661.0,4838.0,6034.5,5342.5,2953.5,SET domain containing protein  putative,S
Tb927.3.760,8247.0,8357.0,8809.0,8168.5,9741.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.770,6649.0,2571.5,1870.0,2199.0,2016.0,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.3.780,5528.0,2367.5,2144.5,2134.5,4121.5,proteasome alpha 7 subunit,<2C (LG1)
Tb927.3.790,8553.5,4065.5,3051.5,4579.0,5624.0,zinc finger CCCH domain-containing protein 6  putative,<2C (LG1)
Tb927.3.800,7734.0,4675.5,5379.0,5561.5,3896.5,Vacuolar iron transporter 1  putative,<2C (LG1)
Tb927.3.810,7667.0,5322.5,6393.0,5958.0,6038.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.820,8391.5,3579.0,4711.5,4522.0,3157.0,LSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.3.830,7774.5,6698.0,7562.5,7078.5,7047.0,flap endonuclease-1 (FEN-1)  putative,<2C (LG1)
Tb927.3.840,5944.5,7285.5,7474.5,6919.5,6890.0,hypothetical protein  conserved,S
Tb927.3.850,7682.5,9587.5,8552.5,9157.5,10182.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.860,4674.5,1697.0,1679.0,1261.0,1984.0,Acyl carrier protein  mitochondrial,<2C (LG1)
Tb927.3.870,6909.0,2621.0,3503.0,3924.0,1970.0,Histone RNA hairpin-binding protein RNA-binding domain containing protein  putative,<2C (LG1)
Tb927.3.880,2137.5,3723.5,3354.5,3087.5,1929.5,Ankyrin repeats (3 copies)  putative,G1
Tb927.3.890,1460.0,6494.5,6577.0,7340.5,5780.5,hypothetical protein  conserved,G2M
Tb927.3.900,612.5,2069.5,2327.5,2956.0,213.0,PUB domain containing protein  putative,G2M
Tb927.3.910,4233.5,8325.5,7652.5,8921.0,11168.0,tubulin gamma chain,>4C (GG2M)
Tb927.3.920,9669.5,11170.0,11162.0,11094.0,10795.0,hypothetical protein  conserved,G1
Tb927.3.930,1988.0,2808.0,3009.0,3228.0,8103.5,dynein heavy chain  putative,>4C (GG2M)
Tb927.3.940,612.5,6890.0,6544.0,6899.0,6398.5,Complex 1 protein (LYR family)  putative,G2M
Tb927.3.945,4563.0,5612.5,4518.5,4782.0,3606.5,hypothetical protein,G1
Tb927.3.950,11480.0,11412.0,11361.0,11504.0,11338.0,2OG-Fe(II) oxygenase superfamily  putative,G2M
Tb927.3.960,4887.0,3235.0,2949.5,2788.5,2389.0,protein transport protein Sec61 gamma subunit  putative,<2C (LG1)
Tb927.3.970,612.5,3526.0,3589.5,2656.5,3157.0,Mitochondrial SSU ribosomal protein  putative,S
Tb927.3.980,3524.0,7358.5,7049.5,7789.5,4988.5,hypothetical protein  conserved,G2M
Tb927.3.990,2700.0,10096.0,9889.5,9544.5,10423.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.1000,5593.5,3625.0,3275.0,3477.5,4320.5,frataxin-like  mitochondrial precursor  putative,<2C (LG1)
Tb927.3.1010,8988.0,6830.0,6226.5,6056.0,10353.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.1020,1460.0,130.0,189.5,273.5,86.0,Flagellum attachment zone protein 13,<2C (LG1)
Tb927.3.1030,8706.0,5088.5,3755.0,3826.0,7334.5,RNA-binding protein,<2C (LG1)
Tb927.3.1060,10388.0,9337.5,8214.0,8868.0,7974.5,cAMP Response Protein 4,<2C (LG1)
Tb927.3.1050,612.5,40.5,40.0,33.5,86.0,transposase of Tn10,<2C (LG1)
Tb927.3.1070,7847.5,6928.5,7304.5,6507.5,5880.0,Peptide chain release factor 1  mitochondrial  putative,<2C (LG1)
Tb927.3.1080,9543.5,10452.0,9816.5,9913.5,8401.0,Present in the outer mitochondrial membrane proteome 23,G1
Tb927.3.1085,4910.5,1858.0,1634.5,1702.0,1239.0,hypothetical protein,<2C (LG1)
Tb927.3.1090,9373.5,8000.5,8610.0,8277.5,6878.5,U1 small nuclear ribonucleoprotein 24 kDa,<2C (LG1)
Tb927.3.1100,5550.0,3973.5,4776.0,5375.0,3006.0,exonuclease  putative,<2C (LG1)
Tb927.3.1110,612.5,3632.0,4214.0,3847.5,7280.5,Putative intraflagellar transport protein A1,>4C (GG2M)
Tb927.3.1120,1460.0,40.5,99.0,419.0,2463.0,GTP-binding nuclear protein rtb2  putative,>4C (GG2M)
Tb927.3.1130,2619.0,2871.5,4170.0,4156.0,7704.5,DNA polymerase delta subunit 2  putative,>4C (GG2M)
Tb927.3.1140,612.5,7395.0,7515.5,7314.0,5282.0,Surp module  putative,S
Tb927.3.1150,5762.0,5287.0,5429.5,3878.0,4355.0,Conserved hypothetical ATP binding protein  putative,<2C (LG1)
Tb927.3.1160,1460.0,2469.5,2564.5,2009.0,1472.0,hypothetical protein  conserved,S
Tb927.3.1170,1460.0,6229.5,5222.0,5530.5,2747.0,TAP42-like family  putative,G1
Tb927.3.1180,8188.0,8512.5,7741.0,7327.0,8703.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.1190,11498.0,10538.0,10794.0,10801.5,11615.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.1200,9297.0,11031.0,10617.0,10335.0,10694.5,hypothetical protein  conserved,G1
Tb927.3.1210,1914.0,8707.5,6893.0,7987.5,7328.5,protein transport protein Sec24,G1
Tb927.3.1220,3645.5,1716.0,1818.0,1875.5,3524.0,GIY-YIG catalytic domain containing protein  putative,<2C (LG1)
Tb927.3.1230,9396.5,11334.0,11303.0,11384.0,11006.0,Dicer-like protein 2,G2M
Tb927.3.1240,612.5,386.5,253.5,501.5,1304.5,Serine/threonine-protein phosphatase 2A  putative,>4C (GG2M)
Tb927.3.1250,1460.0,2051.0,2510.5,2940.5,3413.5,DNA-directed RNA polymerase I subunit RPB10,>4C (GG2M)
Tb927.3.1260,10037.5,1914.0,3379.0,1558.5,3345.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1270,1783.5,7041.5,6308.5,6001.0,5934.5,PRP38 family  putative,G1
Tb927.3.1280,6955.5,5963.0,7638.5,6802.5,7930.5,NPL4 family  putative,>4C (GG2M)
Tb927.3.1290,4655.5,6216.5,4896.0,5569.0,6679.0,cullin 4B  putative,>4C (GG2M)
Tb927.3.1300,8995.0,10050.0,9159.5,9189.5,9515.5,hypothetical protein  conserved,G1
Tb927.3.1310,11479.0,10626.0,10346.5,9478.0,9450.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1320,5973.5,10221.0,10606.5,9729.5,9568.5,hypothetical protein  conserved,S
Tb927.3.1330,10777.0,9372.5,8664.5,8348.5,9551.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1340,11261.0,9055.5,9415.5,9579.5,8499.5,Nuclear cap-binding protein subunit 66,<2C (LG1)
Tb927.3.1350,5078.5,5656.0,5445.5,5069.5,2870.0,hypothetical protein  conserved,G1
Tb927.3.1360,2221.0,4172.0,3930.5,3924.0,5258.0,cytosine-specific DNA methylase  putative,>4C (GG2M)
Tb927.3.1370,3794.5,1766.0,1137.0,1097.5,1717.0,40S ribosomal protein S25  putative,<2C (LG1)
Tb927.3.1380,7790.0,6058.0,5962.0,6250.0,6588.5,ATP synthase subunit beta  mitochondrial,<2C (LG1)
Tb927.3.1390,3041.5,7591.5,5919.0,7372.5,4480.5,LMBR1-like membrane protein  putative,G1
Tb927.3.1400,4947.5,10162.0,9672.0,9357.0,9295.5,alpha-tubulin N-acetyltransferase  putative,G1
Tb927.3.1410,1460.0,3499.5,2310.0,3815.5,6712.0,cytochrome oxidase subunit VII,>4C (GG2M)
Tb927.3.1420,11446.0,11577.0,11584.5,11612.0,11277.0,hypothetical protein  conserved,G2M
Tb927.3.1430,2729.0,6079.5,4823.0,5437.0,6247.5,chaperone protein DnaJ  putative,>4C (GG2M)
Tb927.3.1440,9236.5,9997.5,9174.5,8728.0,8264.0,Spastin  putative,G1
Tb927.3.1450,2780.5,7886.5,8023.0,8048.0,7098.5,CorA-like Mg2+ transporter protein  putative,G2M
Tb927.3.1460,3191.0,5031.5,5197.0,5407.5,1660.5,hypothetical protein,G2M
Tb927.3.1470,5162.5,7897.5,6873.5,8488.5,7351.0,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.3.1480,1460.0,5115.0,4790.5,3452.5,6623.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.1490,6434.5,10734.0,10860.5,10949.5,10950.5,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.3.1500,3868.5,5656.0,6475.0,6112.5,3929.5,variant surface glycoprotein (VSG)-related  putative,S
Tb927.3.1510,5737.5,4859.5,6401.0,5824.5,5499.0,variant surface glycoprotein (VSG)-related  putative,S
Tb927.3.1520,5074.0,7331.5,6873.5,7979.5,7092.0,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.3.1525,2682.0,1240.5,1361.0,1542.0,213.0,hypothetical protein,<2C (LG1)
Tb927.3.1530,2901.0,8436.5,8145.5,8211.5,9119.5,CorA-like Mg2+ transporter protein  putative,>4C (GG2M)
Tb927.3.1540,2682.0,4510.5,3962.5,3897.5,4135.5,CAAX amino terminal protease  putative,G1
Tb927.3.1550,7140.0,8667.0,8703.5,8578.5,10232.5,Rab3 GTPase-activating protein catalytic subunit  putative,>4C (GG2M)
Tb927.3.1560,3770.5,5896.0,3737.5,4381.0,4550.5,TRF-Interacting Factor 2,G1
Tb927.3.1570,10430.0,10608.0,10400.0,10477.5,9361.0,Lapatinib-binding protein kinase 3,G1
Tb927.3.1580,2598.0,6916.5,6172.5,6229.5,6890.0,hypothetical protein  conserved,G1
Tb927.3.1590,10619.5,8733.0,8955.5,8900.0,7442.5,mitochondrial RNA binding complex 1 subunit,<2C (LG1)
Tb927.3.1600,5247.5,2701.5,2612.0,2357.0,1842.0,Mitochondrial import inner membrane translocase subunit 10,<2C (LG1)
Tb927.3.1610,6942.0,7746.5,9035.5,8211.5,6639.5,CMGC/CLK family protein kinase  putative,S
Tb927.3.1620,8085.0,10986.0,10932.0,10888.0,10557.5,ER-golgi trafficking TRAPP I complex 85 kDa subunit  putative,G1
Tb927.3.1630,9805.0,7875.0,8398.0,8809.5,6535.5,casein kinase 1  putative,<2C (LG1)
Tb927.3.1640,612.5,345.0,293.0,352.0,672.0,hypothetical protein,>4C (GG2M)
Tb927.3.1650,4159.0,1425.5,966.5,808.0,1374.5,hypothetical protein,<2C (LG1)
Tb927.3.1660,3041.5,9440.5,9181.0,9876.5,10580.5,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.3.1670,11204.0,10057.0,9977.0,10293.0,11300.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.1680,5542.0,3078.5,2360.0,3897.5,3323.0,Eukaryotic translation initiation factor 3 subunit F,<2C (LG1)
Tb927.3.1690,612.5,2093.5,2389.0,2085.0,4081.5,Mitochondrial ATP synthase subunit  putative,>4C (GG2M)
Tb927.3.1700,5822.0,5746.5,6854.5,5628.0,4403.5,diacylglycerol acyltransferase  putative,S
Tb927.3.1710,8073.0,6708.5,8329.0,8259.5,7256.0,mitochondrial ribosomal protein l24,S
Tb927.3.1720,612.5,235.5,99.0,397.5,486.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1730,9837.0,9322.0,9940.5,9601.5,8327.5,hypothetical protein  conserved,S
Tb927.3.1740,1460.0,988.5,880.5,957.5,1099.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1750,7747.0,8118.0,7884.0,8633.0,8221.5,Mad2-like HORMA domain containing protein,G2M
Tb927.3.1760,6470.0,6830.0,6648.5,5079.0,3921.0,chaperone protein DnaJ  putative,G1
Tb927.3.1770,5235.0,7487.0,8332.5,6719.5,10278.0,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.3.1780,1460.0,1789.5,3354.5,2577.5,2190.0,U6 snRNA-associated Sm-like protein LSm8p,S
Tb927.3.1790,6816.5,5725.5,5759.5,4674.0,7147.0,pyruvate dehydrogenase E1 beta subunit  putative,>4C (GG2M)
Tb927.3.1800,5086.5,8133.5,8235.0,7757.0,7236.5,hypothetical protein  conserved,S
Tb927.3.1810,8647.5,4838.0,4235.0,2697.5,2514.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1820,11035.5,10330.5,10190.0,10451.5,9969.0,mitochondrial RNA binding complex 1 subunit,<2C (LG1)
Tb927.3.1830,2094.5,1240.5,2075.5,1888.0,1828.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1840,7173.0,3492.0,2738.5,2470.5,3413.5,3-oxo-5-alpha-steroid 4-dehydrogenase  putative,<2C (LG1)
Tb927.3.1850,2658.5,6220.0,7013.5,6647.5,8057.5,CMGC/MAPK protein kinase  putative,>4C (GG2M)
Tb927.3.1860,9214.0,11080.0,11115.0,11183.0,10936.0,ATP-grasp domain containing protein  putative,G2M
Tb927.3.1870,8622.5,4531.5,4348.0,3992.5,2884.5,CHAP domain containing protein  putative,<2C (LG1)
Tb927.3.1880,7671.0,5876.0,6200.0,5873.0,4320.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1890,4879.5,6101.0,5661.5,6969.0,4813.5,cytochrome c oxidase assembly protein  putative,G2M
Tb927.3.1900,3419.0,7704.0,7793.5,8978.0,11175.0,conserved protein  unknown function,>4C (GG2M)
Tb927.3.1891,612.5,40.5,40.0,33.5,86.0,C/D snoRNA  TB3C2C1,<2C (LG1)
Tb927.3.1892,612.5,40.5,40.0,33.5,86.0,C/D snoRNA  TB3C2C1,<2C (LG1)
Tb927.3.1893,612.5,40.5,40.0,33.5,86.0,C/D snoRNA  TB3C2C1,<2C (LG1)
Tb927.3.1894,612.5,40.5,40.0,33.5,86.0,C/D snoRNA  TB3C2C1,<2C (LG1)
Tb927.3.1895,612.5,40.5,40.0,33.5,86.0,C/D snoRNA  TB3C2C1,<2C (LG1)
Tb927.3.1896,612.5,40.5,40.0,33.5,86.0,C/D snoRNA  TB3C2C1,<2C (LG1)
Tb927.3.1905,612.5,40.5,40.0,33.5,86.0,C/D snoRNA  TB3C2C1,<2C (LG1)
Tb927.3.1910,5511.0,10179.0,9339.0,9930.5,9361.0,Histone RNA hairpin-binding protein RNA-binding domain containing protein  putative,G1
Tb3.NT.21,6145.5,1378.0,1446.0,1281.0,1472.0,Noncoding RNA  putative,<2C (LG1)
Tb927.3.1920,6528.0,9049.0,8960.0,9138.0,9741.5,General negative regulator of transcription subunit 5,>4C (GG2M)
Tb927.3.1930,11188.0,8970.5,9749.0,9554.0,9934.5,pre-mrna-processing factor 17,<2C (LG1)
Tb927.3.1940,8777.5,4456.0,4316.5,4567.5,3375.0,TLP18.3  Psb32 and MOLO-1 founding proteins of phosphatase  putative,<2C (LG1)
Tb927.3.1955,2481.0,1143.0,848.5,1261.0,2153.5,Vacuolar protein sorting-associated protein 55 homolog,<2C (LG1)
Tb927.3.1960,8324.0,7503.0,5710.5,6827.0,6016.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.1970,5120.0,6193.5,5486.5,6748.5,3386.5,phosphopantothenoylcysteine synthetase  putative,G2M
Tb927.3.1980,5413.5,5391.0,5144.0,5307.5,6448.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.1990,3598.0,7190.0,8200.0,8682.5,7788.0,Tetratricopeptide repeat  putative,G2M
Tb927.3.2000,612.5,4967.0,4104.0,3711.5,3431.5,RNA-binding protein  putative,G1
Tb927.3.2010,5542.0,7243.0,7547.0,7651.5,7534.5,hypothetical protein  conserved,G2M
Tb927.3.2020,7451.0,8528.5,9513.0,9103.5,9036.0,kinesin  putative,S
Tb927.3.2030,7801.0,5711.0,5034.0,4394.5,3939.5,acylphosphatase  putative,<2C (LG1)
Tb927.3.2040,8199.5,9334.0,9906.0,8254.5,7069.0,kinesin  putative,S
Tb927.3.2050,11415.0,10682.5,11070.0,11106.0,11294.0,Minicircle replication factor 172,<2C (LG1)
Tb927.3.2060,8830.0,6205.5,5469.5,6171.5,6719.5,STE20-like serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.3.2070,10627.0,6750.5,8008.5,9213.0,8466.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2080,11111.0,7912.0,6886.5,7850.0,8121.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2090,5428.0,4816.5,3779.5,3616.5,4714.5,Xaa-Pro aminopeptidase  putative,<2C (LG1)
Tb927.3.2100,4242.0,5121.0,5229.5,5419.5,5432.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2110,9011.0,4135.5,3668.5,3429.5,5479.5,Mitochondrial import inner membrane translocase subunit TIM50,<2C (LG1)
Tb927.3.2120,3041.5,8103.5,6469.0,6821.5,7871.0,hypothetical protein  conserved,G1
Tb927.3.2130,6131.0,4653.0,5365.5,4531.5,2734.0,RNA pseudouridylate synthase  putative,<2C (LG1)
Tb927.3.2140,3987.5,8081.0,7584.0,6183.0,6864.5,transcription activator  putative,G1
Tb927.3.2150,6264.0,5031.5,4434.0,4531.5,994.0,protein phosphatase 2C  putative,<2C (LG1)
Tb927.3.2160,7880.0,7285.5,8235.0,8652.5,8582.0,Rieske-like [2Fe-2S] domain containing protein  putative,G2M
Tb927.3.2170,10098.5,10087.5,10512.5,10102.0,10086.0,translation elongation factor EF-2  putative,S
Tb927.3.2180,7919.0,5811.0,7033.5,7053.0,5301.0,Mitochondrial ATP synthase subunit  putative,<2C (LG1)
Tb927.3.2190,5393.5,3855.5,4181.0,4019.0,3586.0,Capping enzyme RNA triphosphatase 1,<2C (LG1)
Tb927.3.2200,1460.0,6901.5,7049.5,6452.5,6679.0,TPR repeat  putative,S
Tb927.3.2210,8183.5,8694.0,8911.5,8623.5,7890.5,KIF-1 binding protein C terminal  putative,S
Tb927.3.2220,6504.0,8408.5,7896.0,6845.5,5988.0,eukaryotic translation initiation factor 3 subunit j,G1
Tb927.3.2230,4397.0,4111.5,5908.5,4327.5,4680.5,succinyl-CoA synthetase alpha subunit  putative,S
Tb927.3.2240,612.5,3023.5,3233.0,2988.5,1355.0,BRO1-like domain containing protein  putative,S
Tb927.3.2250,612.5,2839.5,3079.0,2389.0,2483.5,hypothetical protein  conserved,S
Tb927.3.2260,6349.0,3596.0,3642.0,3577.5,3871.0,Mitochondrial SSU ribosomal protein  putative,<2C (LG1)
Tb927.3.2270,9998.5,9322.0,8510.0,8511.5,8674.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2280,2295.5,5656.0,5885.0,5673.5,2914.5,vacuolar sorting protein 33   putative,S
Tb927.3.2290,3564.0,5384.5,5829.0,5969.0,6420.0,chaperone protein DnaJ  putative,>4C (GG2M)
Tb927.3.2300,612.5,1378.0,547.0,773.0,6412.5,DNL zinc finger  putative,>4C (GG2M)
Tb927.3.2310,2137.5,1132.5,615.0,875.0,6878.5,parkin coregulated gene protein,>4C (GG2M)
Tb927.3.2320,5330.0,8147.0,7777.5,8348.5,7471.0,COP9 signalosome complex subunit 2  putative,G2M
Tb927.3.2330,10866.0,10494.0,10604.5,10347.5,9991.5,kinetoplastid kinetochore protein 17,<2C (LG1)
Tb927.3.2340,7019.5,4235.0,4200.5,4235.5,2953.5,Peroxisome biogenesis protein 2,<2C (LG1)
Tb927.3.2350,4989.5,3766.0,3344.0,3075.0,3144.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2360,5920.5,8645.0,8290.5,7592.5,9409.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2370,7780.5,3407.5,4160.5,3557.0,2000.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2380,4134.0,4663.0,4614.0,5437.0,7084.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2390,6509.5,8141.0,7994.5,7547.0,7015.5,hypothetical protein  conserved,G1
Tb927.3.2400,7948.0,3922.5,3079.0,3837.0,3431.5,palmitoyl acyltransferase 10  putative,<2C (LG1)
Tb927.3.2410,8438.0,6550.5,7532.5,6927.5,8754.0,Peroxisome biogenesis factor 10,>4C (GG2M)
Tb927.3.2420,612.5,799.5,1371.0,1110.5,1896.5,Microsomal signal peptidase 12 kDa subunit (SPC12)  putative,>4C (GG2M)
Tb927.3.2430,1460.0,9287.5,8819.5,9468.5,6088.5,Alsin  putative,G2M
Tb927.3.2440,3598.0,6115.0,5856.5,6950.5,10379.5,AGC essential kinase 1,>4C (GG2M)
Tb927.3.2450,1460.0,2592.5,2894.5,3264.5,3214.5,hypothetical protein  conserved,G2M
Tb927.3.2460,7593.5,8176.0,8200.0,8194.0,7585.5,hypothetical protein  conserved,S
Tb927.3.2470,5257.0,5811.0,5885.0,6219.5,5675.0,Pumilio homology domain family member 8,G2M
Tb927.3.2475,3778.0,4294.5,3531.0,3699.0,3125.5,hypothetical protein,G1
Tb927.3.2477,4956.5,1736.5,1679.0,1726.5,933.5,hypothetical protein,<2C (LG1)
Tb927.3.2480,1460.0,1275.5,1111.5,1542.0,1489.0,Arv1-like family  putative,G2M
Tb927.3.2490,10805.0,9871.5,9691.0,9736.5,10591.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2500,10468.0,10685.0,10116.0,10339.5,8428.5,Trypanosomal VSG domain containing protein  putative,G1
Tb927.3.2510,10295.5,8869.0,9004.5,9408.5,7762.5,expression site-associated gene 2 (ESAG2) protein  putative,<2C (LG1)
Tb927.3.2520,612.5,279.5,391.5,204.0,213.0,expression site-associated gene 1 (ESAG1) protein  putative,<2C (LG1)
Tb927.3.2530,2258.5,2272.0,2876.5,2404.0,1896.5,expression site-associated gene 11 (ESAG11)  degenerate,S
Tb927.3.2540,7631.0,8716.0,7991.5,9200.5,6938.5,variant surface glycoprotein (VSG)-related  putative,G2M
Tb927.3.2550,4626.0,6012.0,6772.0,7285.0,6153.5,hypothetical protein  conserved,G2M
Tb927.3.2560,4767.5,1747.5,2226.5,2038.5,2231.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2570,6301.5,4796.5,5256.0,4951.0,4135.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2580,2901.0,1285.0,2564.5,2058.5,672.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2590,9300.0,11298.5,11240.0,11310.5,11031.5,hypothetical protein,G2M
Tb927.3.2600,9208.5,11323.0,11345.0,11031.5,10155.0,ATP-dependent DEAD/H RNA helicase  putative,S
Tb927.3.2610,10116.0,11132.0,10755.0,10709.0,10538.5,GPI inositol deacylase 2,G1
Tb927.3.2620,7547.0,10977.0,11135.5,11250.0,11290.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2630,8785.5,10276.0,9662.0,9703.0,10323.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2640,7540.5,8063.0,8290.5,9043.0,8471.0,hypothetical protein  conserved,G2M
Tb927.3.2650,9240.5,7024.5,7027.5,7631.5,5735.0,cytochrome c oxidase copper chaperone  putative,<2C (LG1)
Tb927.3.2660,7540.5,8878.5,9093.5,8948.5,8088.0,TatD related DNase  putative,S
Tb927.3.2670,1460.0,4859.5,4348.0,5079.0,6224.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2680,7426.0,5088.5,4823.0,6024.5,6334.5,Ubiquitin-like domain containing protein  putative,<2C (LG1)
Tb927.3.2690,5281.0,11035.0,11106.0,10981.0,10759.0,AGC/RSK family serine/threonine kinase  putative,S
Tb927.3.2700,4916.5,7465.5,6953.0,7525.5,9835.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2710,11179.0,10157.0,10243.5,9997.0,9957.0,6-phosphofructo-2-kinase 2,<2C (LG1)
Tb927.3.2720,4745.5,8534.5,8489.5,7776.5,9322.0,hypothetical protein,>4C (GG2M)
Tb927.3.2730,10414.0,11272.0,11331.0,11456.0,11465.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.3.2740,6072.0,1982.5,2465.5,2025.0,2870.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2750,2137.5,7216.5,6339.5,6105.5,4849.5,hypothetical protein  conserved,G1
Tb927.3.2760,9812.5,6998.0,8536.5,8583.0,11483.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2770,9702.0,9897.0,9771.5,9614.0,7356.5,Mitochondrial processome subunit 3,G1
Tb927.3.2780,8027.0,10074.5,9745.5,10134.0,9239.0,hypothetical protein  conserved,G2M
Tb927.3.2790,3341.5,9786.0,10077.0,10858.5,10966.5,leucine-rich repeat protein (LRRP)  putative,>4C (GG2M)
Tb927.3.2800,5490.5,6884.0,6178.5,6428.5,7963.5,hypothetical protein,>4C (GG2M)
Tb927.3.2810,5837.5,10518.5,10540.0,10534.5,10605.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2820,2047.0,5426.5,2876.5,3888.5,3960.5,TFIIF-stimulated CTD phosphatase  putative,G1
Tb927.3.2830,2094.5,1875.5,2341.0,1745.0,2427.0,brix domain containing protein  putative,>4C (GG2M)
Tb927.3.2840,5933.5,5469.0,6339.5,5899.5,3648.5,inorganic pyrophosphatase  putative,S
Tb927.3.2850,10147.0,6767.5,5365.5,6465.0,4110.0,Got1/Sft2-like family  putative,<2C (LG1)
Tb927.3.2860,612.5,2160.0,4010.5,4205.5,4036.5,hypothetical protein  conserved,G2M
Tb927.3.2870,9488.0,10532.0,10352.5,10152.5,9256.5,multicopper oxidase  putative,G1
Tb927.3.2880,3692.0,4866.0,5460.5,5497.0,7551.5,Mitochondrial ATP synthase subunit  putative,>4C (GG2M)
Tb927.3.2890,9103.0,4242.0,4848.5,6255.5,9788.5,radial spoke protein RSP10  putative,>4C (GG2M)
Tb927.3.2900,3922.5,2551.0,2289.5,2577.5,1531.5,eukaryotic translation initiation factor 2 subunit alpha,<2C (LG1)
Tb927.3.2910,7709.5,5236.0,6016.0,5050.5,3076.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2920,2943.0,6363.5,5822.0,6637.0,7256.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.2930,7462.5,8424.0,6976.0,9226.5,5888.5,RNA-binding protein RBP6  putative,G2M
Tb927.3.2940,7967.5,9804.0,9451.0,9959.0,9386.5,hypothetical protein  conserved,G2M
Tb927.3.2950,8036.0,6568.0,5875.5,7296.0,10079.5,ribonuclease inhibitor- like protein,>4C (GG2M)
Tb927.3.2960,10457.5,7277.5,6788.5,6348.0,5240.0,inosine-adenosine-guanosine-nucleosidehydrolase,<2C (LG1)
Tb927.3.2970,4728.0,2214.5,2310.0,3045.0,1253.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.2980,8095.5,5782.0,6200.0,6381.0,4231.5,mitochondrial carrier protein,<2C (LG1)
Tb927.3.2990,1460.0,2376.0,3021.0,2869.0,3704.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.3000,2780.5,4429.5,2931.0,3216.0,11548.0,Putative intraflagellar transport protein C3,>4C (GG2M)
Tb927.3.3010,9485.5,5669.5,5486.5,6534.5,7112.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3020,7812.0,3060.0,3108.5,3185.0,4451.0,actin-like protein  putative,<2C (LG1)
Tb927.3.3030,1460.0,2814.0,4807.5,2470.5,8483.0,phosphatidylcholine transfer protein  putative,>4C (GG2M)
Tb927.3.3040,2552.0,8753.5,8091.5,9010.5,9801.5,Right handed beta helix region  putative,>4C (GG2M)
Tb927.3.3050,8334.0,9337.5,10228.5,9473.5,8570.5,kinetoplast ribosomal PPR-repeat containing protein 20,S
Tb927.3.3060,6521.5,6176.0,4341.0,4720.5,4028.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3070,9685.0,8601.0,7752.0,8511.5,8237.5,3'  5'-cyclic nucleotide phosphodiesterase  putative,<2C (LG1)
Tb927.3.3080,9036.0,7121.0,6929.5,7194.0,5593.5,Serine/threonine-protein kinase NEK6  putative,<2C (LG1)
Tb927.3.3090,2729.0,7736.5,8362.5,7469.0,6857.0,helicase  putative,S
Tb927.3.3100,4459.5,4937.5,4776.0,4446.0,4822.5,peptidyl-prolyl cis-trans isomerase NIMA-interacting 4  putative,G1
Tb927.3.3110,2943.0,8846.5,9789.0,9786.5,9741.5,Condensin complex subunit 3  putative,S
Tb927.3.3120,2840.5,7578.5,7269.0,7854.0,9214.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.3130,8738.0,10548.5,10922.0,10746.0,10637.5,Present in the outer mitochondrial membrane proteome 24,S
Tb927.3.3140,7032.0,3932.0,3308.0,4336.5,6719.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3150,10129.5,10059.0,9962.5,10177.5,10752.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.3160,3621.0,7756.0,7685.0,7275.5,5379.5,Nuclear poly(A) polymerase 1,G1
Tb927.3.3170,6752.5,9276.0,10212.5,9245.5,10421.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.3.3180,6616.5,7036.0,7259.5,7065.0,10310.0,Nucleoporin NUP98,>4C (GG2M)
Tb927.3.3190,11202.0,6391.5,6695.5,8150.5,4988.5,Serine/threonine-protein kinase NEK7  putative,<2C (LG1)
Tb3.NT.36,4601.0,1285.0,1199.5,1675.5,1239.0,Noncoding RNA  putative,<2C (LG1)
Tb927.3.3200,9615.0,8813.0,9639.5,9771.5,7762.5,Domain of unknown function (DUF4586)  putative,G2M
Tb927.3.3210,6509.5,5561.5,4348.0,4720.5,4607.0,hypothetical protein,<2C (LG1)
Tb927.3.3220,7448.5,7436.5,6788.5,6105.5,6319.0,RNA polymerase-associated protein CTR9  putative,<2C (LG1)
Tb927.3.3230,7016.5,8046.5,8466.5,9079.0,7437.0,NOL1/NOP2/sun family  putative,G2M
Tb927.3.3240,8595.0,2326.0,1783.0,1374.0,1622.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3250,7173.0,4317.5,3832.5,4699.5,4525.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3260,2523.0,1838.0,1402.0,2275.5,1099.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3270,4859.0,358.0,336.0,159.0,347.0,ATP-dependent 6-phosphofructokinase  glycosomal,<2C (LG1)
Tb927.3.3280,9804.0,6418.0,5315.0,5992.0,7861.0,vacuolar protein sorting-associated protein 4  putative,<2C (LG1)
Tb927.3.3290,9905.0,7325.0,6509.5,5583.5,7689.0,protein kinase  putative,<2C (LG1)
Tb927.3.3300,2504.5,7524.0,7278.0,6657.5,7139.0,Flagellum attachment zone protein 19,G1
Tb927.3.3310,1460.0,96.0,99.0,136.5,86.0,60S ribosomal protein L13  putative,<2C (LG1)
Tb927.3.3320,1460.0,716.5,253.5,334.5,287.0,60S ribosomal protein L13  putative,<2C (LG1)
Tb927.3.3330,3794.5,3568.0,2134.0,1688.5,2589.5,heat shock protein 20  putative,<2C (LG1)
Tb927.3.3340,11603.0,11440.0,11447.0,11501.0,11472.0,3'  5'-cyclic nucleotide phosphodiesterase  putative,<2C (LG1)
Tb927.3.3350,10772.5,8522.0,8000.5,8070.5,8477.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3360,11006.0,10553.0,10262.0,10093.0,8868.5,acyltransferase  putative,<2C (LG1)
Tb927.3.3370,9655.0,5746.5,7040.0,5683.5,8345.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3380,9240.5,8059.5,8791.0,8205.0,9279.0,TFIIF-stimulated CTD phosphatase  putative,>4C (GG2M)
Tb927.3.3390,7667.0,6723.5,6630.0,6892.0,4957.5,kinesin  putative,<2C (LG1)
Tb927.3.3400,8450.5,8015.5,8309.5,8356.0,6917.0,kinesin  putative,<2C (LG1)
Tb927.3.3410,7503.5,2851.5,2692.0,2566.5,2039.0,aspartyl aminopeptidase  putative,<2C (LG1)
Tb927.3.3420,9848.0,11203.0,11146.0,11031.5,10767.0,hypothetical protein  point mutation,G1
Tb927.3.3421,11633.0,11561.0,11560.0,11513.0,11451.5,18S ribosomal RNA,<2C (LG1)
Tb927.3.3422,5844.5,4305.0,3649.5,4019.0,4617.5,5.8S ribosomal RNA,<2C (LG1)
Tb927.3.3423,10336.0,10732.5,10571.0,10227.0,9272.0,28S alpha ribosomal RNA,G1
Tb927.3.3424,6014.5,2571.5,2011.5,1816.5,2495.0,M1 ribosomal RNA,<2C (LG1)
Tb927.3.3425,10491.0,10171.5,9870.0,9784.0,8682.5,28S beta ribosomal RNA,<2C (LG1)
Tb927.3.3426,2840.5,835.5,427.0,862.0,874.5,M2 ribosomal RNA,<2C (LG1)
Tb927.3.3427,3841.0,1394.5,1446.0,1861.0,1789.5,M6 ribosomal RNA,<2C (LG1)
Tb927.3.3428,4182.0,2851.5,2144.5,2046.5,2322.0,M4 ribosomal RNA,<2C (LG1)
Tb927.3.3429,11635.0,11564.5,11565.0,11499.0,11437.0,18S ribosomal RNA,<2C (LG1)
Tb927.3.3431,5822.0,4305.0,4235.0,4662.5,5145.5,5.8S ribosomal RNA,<2C (LG1)
Tb927.3.3432,10229.5,10749.0,10490.5,10152.5,9358.0,28S alpha ribosomal RNA,G1
Tb927.3.3433,5973.5,2534.5,2207.0,2199.0,2427.0,M1 ribosomal RNA,<2C (LG1)
Tb927.3.3434,10570.0,10293.0,9978.0,10019.0,9149.0,28S beta ribosomal RNA,<2C (LG1)
Tb927.3.3435,3314.5,1180.5,731.0,1085.0,1099.0,M2 ribosomal RNA,<2C (LG1)
Tb927.3.3436,3711.5,2621.0,1977.0,2656.5,2661.5,M6 ribosomal RNA,<2C (LG1)
Tb927.3.3437,4233.5,2160.0,1561.5,2058.5,2065.0,M4 ribosomal RNA,<2C (LG1)
Tb927.3.3438,11632.0,11566.0,11562.0,11487.0,11430.0,18S ribosomal RNA,<2C (LG1)
Tb927.3.3439,5604.0,3909.5,3464.5,4097.0,4292.0,5.8S ribosomal RNA,<2C (LG1)
Tb927.3.3441,10342.5,10701.5,10483.0,10259.5,9399.0,28S alpha ribosomal RNA,G1
Tb927.3.3442,6080.5,2609.5,2050.0,2085.0,2141.5,M1 ribosomal RNA,<2C (LG1)
Tb927.3.3443,10595.0,10295.5,10196.5,9988.5,8943.0,28S beta ribosomal RNA,<2C (LG1)
Tb927.3.3444,3252.5,1052.0,596.0,1243.0,1195.0,M2 ribosomal RNA,<2C (LG1)
Tb927.3.3445,3654.0,1530.0,1612.0,1847.0,1732.0,M6 ribosomal RNA,<2C (LG1)
Tb927.3.3446,4196.0,2000.5,1757.0,2134.5,1984.0,M4 ribosomal RNA,<2C (LG1)
Tb927.3.3447,11612.0,11549.0,11548.0,11488.0,11390.0,18S ribosomal RNA,<2C (LG1)
Tb927.3.3448,5897.5,4806.0,4540.5,5050.5,5780.5,5.8S ribosomal RNA,<2C (LG1)
Tb927.3.3449,10295.5,10765.5,10573.5,10237.5,9286.0,28S alpha ribosomal RNA,G1
Tb927.3.3451,5891.0,2551.0,1808.5,2009.0,2706.5,M1 ribosomal RNA,<2C (LG1)
Tb927.3.3452,10538.5,10019.5,9743.5,9401.0,8685.5,28S beta ribosomal RNA,<2C (LG1)
Tb927.3.3453,3013.5,1124.5,703.0,1202.5,1253.0,M2 ribosomal RNA,<2C (LG1)
Tb927.3.3454,3828.5,2920.5,2207.0,2725.0,2351.0,M6 ribosomal RNA,<2C (LG1)
Tb927.3.3455,4276.0,2942.5,2134.0,2541.0,2679.0,M4 ribosomal RNA,<2C (LG1)
Tb927.3.3430,10930.0,11373.0,11395.0,11322.0,11161.0,hypothetical protein  conserved,S
Tb927.3.3440,3028.5,4553.0,5710.5,5428.5,5248.0,phytanoyl-CoA dioxygenase (PhyH)  putative,S
Tb927.3.3450,612.5,1425.5,1595.5,2756.0,9319.0,ADP-ribosylation factor-like protein 3  putative,>4C (GG2M)
Tb927.3.3460,7759.0,6179.5,6334.0,6407.5,5953.5,succinate dehydrogenase flavoprotein subunit  putative,<2C (LG1)
Tb927.3.3470,2504.5,3872.5,1808.5,3687.5,1141.0,cytochrome b5  putative,G1
Tb927.3.3480,4439.5,6631.0,6550.5,6604.0,8078.0,U2 small nuclear ribonucleoprotein B  putative,>4C (GG2M)
Tb927.3.3490,612.5,2402.0,3197.0,2275.5,6289.5,High mobility group protein TDP1,>4C (GG2M)
Tb927.3.3500,1783.5,1553.5,3568.0,2422.0,1078.0,hypothetical protein  conserved,S
Tb927.3.3510,1914.0,3863.5,5744.0,4686.5,5174.5,hypothetical protein  conserved,S
Tb927.3.3520,4211.5,5273.0,5991.0,5060.5,7334.5,Present in the outer mitochondrial membrane proteome 25,>4C (GG2M)
Tb927.3.3530,8185.5,6494.5,6119.5,6935.5,6281.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3540,612.5,2344.0,3599.5,4221.0,4680.5,Nucleoporin NUP53b,>4C (GG2M)
Tb927.3.3550,6586.0,10035.5,10415.5,10144.0,10553.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.3560,10002.0,8625.5,8356.0,9438.0,9538.0,U-box domain containing protein  putative,<2C (LG1)
Tb927.3.3570,2700.0,774.5,893.0,1430.0,874.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3580,9846.0,9067.5,9001.0,7789.5,7236.5,heat shock protein 90  putative,<2C (LG1)
Tb927.3.3590,1914.0,10262.5,10314.5,10078.0,9652.5,U3 small nucleolar ribonucleoprotein protein MPP10  putative,S
Tb927.3.3600,1914.0,3256.0,2931.0,3332.5,5064.5,hypothetical protein,>4C (GG2M)
Tb927.3.3610,5682.0,4467.0,3599.5,5190.5,1549.5,peroxisomal targeting signal 2 receptor  putative,<2C (LG1)
Tb927.3.3620,3261.0,1405.5,1428.0,1451.5,1860.5,SUMO-interacting motif-containing protein,<2C (LG1)
Tb927.3.3630,612.5,6727.5,6624.0,6883.0,4065.0,Elongation factor Ts  mitochondrial  putative,G2M
Tb927.3.3640,1460.0,10980.5,10851.0,10689.0,10866.0,bardet-biedl syndrome 7 protein,G1
Tb927.3.3650,5339.5,9617.5,8502.5,9063.5,8303.5,hypothetical protein  conserved,G1
Tb927.3.3660,6238.5,7167.0,5892.0,6591.5,7439.5,NADH-ubiquinone oxidoreductase complex I subunit  putative,>4C (GG2M)
Tb927.3.3670,7790.0,7482.5,5885.0,5808.5,4806.5,Triple RNA binding domain protein 3,<2C (LG1)
Tb927.3.3680,1988.0,3890.0,2389.0,1847.0,4687.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.3690,1988.0,3129.0,2586.5,3492.0,8111.0,flagellar radial spoke protein-like  putative,>4C (GG2M)
Tb927.3.3700,612.5,5378.0,4411.0,6083.5,3760.5,hypothetical protein,G2M
Tb927.3.3710,1460.0,2693.0,2750.5,2788.5,2692.0,Scavenger mRNA decapping enzyme C-term binding  putative,G2M
Tb927.3.3720,612.5,2760.5,3868.5,4174.5,4266.0,Golgi vesicular membrane trafficking protein  putative,>4C (GG2M)
Tb927.3.3730,11466.0,11342.0,11389.0,11368.0,9840.0,ABC transporter  putative,<2C (LG1)
Tb927.3.3740,11613.0,11202.0,11191.0,11226.0,11305.0,Zinc-finger double-stranded RNA-binding  putative,<2C (LG1)
Tb927.3.3750,1460.0,1220.5,2050.0,1374.0,2427.0,paraflagellar rod component  putative,>4C (GG2M)
Tb927.3.3760,7496.0,2992.5,4093.0,4084.0,2203.5,tryparedoxin 1b  putative,<2C (LG1)
Tb927.3.3770,9689.5,8156.5,7384.0,8121.5,9972.5,paraflagellar rod component  putative,>4C (GG2M)
Tb927.3.3780,6811.0,2983.5,4093.0,3763.0,2550.0,tryparedoxin 1a  putative,<2C (LG1)
Tb927.3.3790,6847.0,4547.5,3994.5,4531.5,6679.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3800,10890.0,11362.0,11315.5,11313.5,10785.5,hypothetical protein  conserved,G1
Tb927.3.3810,1460.0,4194.0,4868.0,4894.5,3541.0,Etoposide-induced protein 2.4 (EI24)  putative,G2M
Tb927.3.3820,4205.0,5063.5,5334.5,4221.0,4440.0,hypothetical protein  conserved,S
Tb927.3.3830,9536.5,9186.5,8886.0,9426.0,9082.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3840,6504.0,4331.5,4711.5,2967.0,6749.5,Family of unknown function (DUF572)  putative,>4C (GG2M)
Tb927.3.3850,11511.0,11427.0,11253.0,11145.0,11318.0,COPII coat assembly protein sec16,<2C (LG1)
Tb927.3.3860,8196.5,9646.5,10073.5,9451.0,9182.0,triacylglycerol lipase  putative,S
Tb927.3.3870,6963.5,9546.0,9945.5,9328.0,10113.5,lipase domain protein  putative,>4C (GG2M)
Tb927.3.3880,6470.0,3179.0,3920.5,4174.5,5220.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3890,6492.0,5192.0,6055.5,5862.5,6259.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3900,3751.5,7610.0,8637.5,8834.0,8883.5,carnitine O-palmitoyltransferase II  putative,>4C (GG2M)
Tb927.3.3910,612.5,4429.5,4662.5,4045.0,3214.5,DNA-directed RNA polymerase III subunit RPC6,S
Tb927.3.3920,3224.0,7704.0,6981.5,7204.5,5153.5,Aurora kinase 2  putative,G1
Tb927.3.3930,7507.5,8160.0,6527.5,7356.0,7644.0,RNA-binding protein,G1
Tb927.3.3940,9100.0,10774.5,10068.5,10352.0,9800.0,RNA-binding protein  putative,G1
Tb927.3.3950,2406.5,5151.5,5340.0,3878.0,3125.5,hypothetical protein  conserved,S
Tb927.3.3960,4354.0,6019.0,4356.5,5095.0,4586.5,Double RNA binding domain protein 6A,G1
Tb927.3.3970,8567.5,6776.5,6315.0,7662.5,7280.5,Cell growth-regulating nucleolar protein  putative,<2C (LG1)
Tb927.3.3980,6533.5,5251.5,6437.0,5908.5,2472.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.3990,4048.0,6079.5,6725.0,5751.5,5888.5,KREPB6,S
Tb927.3.4000,6594.5,2913.5,2164.5,2120.5,4051.0,clathrin coat assembly protein ap19  putative,<2C (LG1)
Tb927.3.4005,2221.0,1384.0,2653.0,2199.0,2898.5,hypothetical protein,>4C (GG2M)
Tb927.3.4010,5001.5,4111.5,6339.5,4355.5,5834.5,hypothetical protein,S
Tb927.3.4020,11000.5,11488.5,11478.0,11316.0,11185.0,phosphatidylinositol 4-kinase alpha  putative,G1
Tb927.3.4030,10714.5,9358.5,9713.0,8809.5,8088.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4040,10013.5,10776.0,10577.5,10779.0,10323.0,Ankyrin repeats (3 copies)  putative,G2M
Tb927.3.4050,5457.5,6525.5,6236.5,6452.5,5024.5,hypothetical protein  conserved,G1
Tb927.3.4060,5006.5,10680.5,10583.0,10761.0,9905.0,asparagine synthetase domain-containing protein 1,G2M
Tb927.3.4070,5663.0,6676.0,6452.5,5428.5,4096.5,Pyruvate transporter  putative,G1
Tb927.3.4080,6264.0,6723.5,5867.0,4951.0,6298.5,Pyruvate transporter  putative,G1
Tb927.3.4090,8562.5,8039.5,8303.0,7194.0,7274.5,Pyruvate transporter  putative,<2C (LG1)
Tb927.3.4100,4425.0,7505.5,6142.0,4772.5,5252.5,Pyruvate transporter  putative,G1
Tb927.3.4110,4034.5,5822.5,5064.5,4409.0,5664.0,Pyruvate transporter  putative,G1
Tb927.3.4120,4698.0,9886.5,10573.5,9984.5,10224.0,hypothetical protein  conserved,S
Tb927.3.4130,5369.0,6958.5,7220.5,6470.5,6432.5,hypothetical protein  conserved,S
Tb927.3.4140,4339.5,5701.0,5829.0,5342.5,5135.5,hypothetical protein  conserved,S
Tb927.3.4150,1460.0,7348.0,6776.0,6423.0,8968.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.4160,7640.5,9990.0,9454.0,9642.5,9601.5,XPC-binding domain/UBA/TS-N domain containing protein  putative,G1
Tb927.3.4170,5625.5,3734.0,3521.5,3477.5,4737.0,CRK9-associated protein,<2C (LG1)
Tb927.3.4180,10643.0,8996.0,9194.5,9390.5,9737.5,hypothetical protein,<2C (LG1)
Tb927.3.4190,7074.5,8152.5,7115.5,7486.0,8651.0,endosomal integral membrane protein  putative,>4C (GG2M)
Tb927.3.4200,6912.5,3273.5,2399.5,3194.5,3365.0,Integral membrane protein S linking to the trans Golgi network  putative,<2C (LG1)
Tb927.3.4210,9205.0,10360.0,10588.5,10161.0,8260.0,hypothetical protein  conserved,S
Tb927.3.4220,9727.0,8127.5,9356.5,9617.0,9283.0,Zn-finger domain protein  putative,<2C (LG1)
Tb927.3.4230,10939.0,11166.0,10935.0,11009.0,11020.0,serine peptidase  clan SB  family S8-like protein,G1
Tb927.3.4240,5078.5,1747.5,3589.5,3319.0,3939.5,thioredoxin  putative,<2C (LG1)
Tb927.3.4250,3972.0,2138.5,2275.0,2290.0,505.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4260,10054.0,7726.5,8632.5,7398.5,8842.5,Acetyl-CoA hydrolase,<2C (LG1)
Tb927.3.4270,7888.0,5506.0,7227.5,6250.0,3669.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4280,11287.0,10308.0,10748.0,10508.0,9334.0,mismatch repair protein MSH5  putative,<2C (LG1)
Tb927.3.4290,2180.0,322.0,391.5,444.5,797.5,Paraflagellar rod protein 1-1,<2C (LG1)
Tb927.3.4300,2094.5,222.0,161.0,182.5,287.0,Paraflagellar rod protein 1-2,<2C (LG1)
Tb927.3.4310,2137.5,176.5,233.5,221.5,213.0,Paraflagellar rod protein 1-3,<2C (LG1)
Tb927.3.4320,2221.0,192.5,253.5,248.0,397.5,Paraflagellar rod protein 1-4,<2C (LG1)
Tb927.3.4330,2221.0,235.5,233.5,273.5,397.5,Paraflagellar rod protein 1-5,<2C (LG1)
Tb927.3.4340,4655.5,6466.5,7235.5,7625.0,7740.0,diphthamide synthesis protein  putative,>4C (GG2M)
Tb927.3.4350,9830.0,8231.5,8160.5,8155.0,8835.5,twin BRCT domain containing protein  putative,<2C (LG1)
Tb927.3.4360,1914.0,600.0,596.0,366.5,559.5,40S ribosomal protein S15A  putative,<2C (LG1)
Tb927.3.4370,1460.0,5689.0,5838.5,5758.0,7951.5,Vesicle coat protein involved in Golgi to plasma membrane transport  putative,>4C (GG2M)
Tb927.3.4380,11213.5,8741.5,8945.5,8816.0,8852.5,sorting assembly machinery 50 kDa subunit  putative,<2C (LG1)
Tb927.3.4390,6831.5,5656.0,6360.5,6423.0,6455.5,dihydrolipoamide dehydrogenase,<2C (LG1)
Tb927.3.4393,3013.5,1026.5,1021.0,826.5,1179.0,tRNA Serine,<2C (LG1)
Tb927.3.4396,4708.0,1415.5,1595.5,1017.0,2016.0,tRNA Leucine,<2C (LG1)
Tb927.3.4399,6372.0,1231.0,1549.5,1056.5,2050.0,tRNA Serine,<2C (LG1)
Tb927.3.4400,6257.5,8813.0,8632.5,8547.5,8738.5,basal body component  putative,G1
Tb927.3.4410,612.5,3457.0,3487.0,3045.0,2141.5,pre-RNA processing PIH1/Nop17  putative,S
Tb927.3.4420,10133.0,9217.0,9066.5,8848.5,6764.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4430,3078.5,10191.5,10349.5,10790.5,8570.5,hypothetical protein  conserved,G2M
Tb927.3.4440,2747.5,4383.0,4896.0,5489.0,5861.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.4450,7224.0,6647.0,6089.5,6289.0,3716.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4460,1783.5,1807.0,2092.5,2058.5,1078.0,hypothetical protein  conserved,S
Tb927.3.4470,612.5,10123.0,10066.0,10330.5,9918.5,hypothetical protein  conserved,G2M
Tb927.3.4480,6319.5,2920.5,3885.0,3057.0,4418.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4490,2295.5,7351.0,6368.5,5799.5,8733.0,protein farnesyltransferase alpha subunit  putative,>4C (GG2M)
Tb927.3.4500,6759.0,8507.5,8960.0,8793.0,9430.5,Fumarate hydratase class I  cytosolic,>4C (GG2M)
Tb927.3.4510,8242.0,9950.5,10263.5,10344.5,10886.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.4520,6295.0,4450.0,4224.5,2025.0,86.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4530,6470.0,5002.0,6006.0,6018.0,4893.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4540,3429.0,5841.0,5222.0,3909.0,2794.5,NOL1/NOP2/sun family  putative,G1
Tb927.3.4550,9504.5,10022.0,9886.0,9684.0,9879.5,kinetoplast ribosomal PPR-repeat containing protein 6,G1
Tb927.3.4560,9595.5,10429.5,10688.0,10539.0,10597.5,5'-AMP-activated protein kinase catalytic subunit alpha  putative,S
Tb927.3.4570,10104.5,7806.5,8226.0,7285.0,6719.5,N-acetylglucosamyl transferase component GPI1  putative,<2C (LG1)
Tb927.3.4580,6270.5,10189.5,10918.0,10365.0,11181.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.4590,4211.5,1132.5,848.5,1430.0,397.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4600,11546.0,11515.0,11522.0,11563.0,11486.0,hypothetical protein  conserved,G2M
Tb927.3.4610,11506.5,11584.0,11559.0,11554.0,11526.0,Right handed beta helix region  putative,G1
Tb927.3.4620,7096.0,8784.5,9517.0,8720.5,9134.5,AAA domain containing protein  putative,S
Tb927.3.4630,8042.0,11221.0,10809.5,10673.5,10570.5,UDP-glucose:glycoprotein glucosyltransferase  putative,G1
Tb927.3.4640,1988.0,373.5,210.0,382.0,461.5,VIT family  putative,<2C (LG1)
Tb927.3.4650,612.5,2469.5,3711.0,3992.5,2141.5,C-8 sterol isomerase  putative,G2M
Tb927.3.4660,612.5,6664.0,6016.0,6663.0,3950.0,WD domain  G-beta repeat  putative,G1
Tb927.3.4670,7884.0,7105.0,7209.5,7642.5,5600.5,cdc2-related kinase 10  putative,<2C (LG1)
Tb927.3.4680,5148.5,7642.0,6544.0,6045.0,5906.5,RAB GDP dissociation inhibitor alpha  putative,G1
Tb927.3.4690,5441.0,7667.5,8523.0,7350.0,6581.0,DTW domain containing protein  putative,S
Tb927.3.4700,7115.0,6154.5,6308.5,5569.0,6199.5,Domain of unknown function (DUF4379)  putative,<2C (LG1)
Tb927.3.4710,11102.0,9002.0,9272.5,9055.5,9720.5,Flagellum attachment zone protein 23,<2C (LG1)
Tb927.3.4720,9872.0,2864.5,2717.5,2977.0,4440.0,dynamin-1-like protein,<2C (LG1)
Tb927.3.4730,2682.0,5854.0,4956.5,5939.0,6216.5,leucine-rich repeat-containing protein,>4C (GG2M)
Tb927.3.4740,612.5,5782.0,4258.0,5325.0,7038.0,NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus  putative,>4C (GG2M)
Tb927.3.4750,11042.0,9909.0,10201.0,9708.0,9239.0,Aminopeptidase M1  putative,<2C (LG1)
Tb927.3.4760,7090.5,6313.0,5696.5,5386.0,4480.5,dynamin-1-like protein,<2C (LG1)
Tb927.3.4770,2682.0,4895.5,3978.5,4579.0,5609.5,leucine-rich repeat-containing protein,>4C (GG2M)
Tb927.3.4780,1460.0,5883.0,4586.5,5249.5,7363.0,NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus  putative,>4C (GG2M)
Tb927.3.4790,11080.0,9968.5,9975.0,9769.0,9313.0,Aminopeptidase M1  putative,<2C (LG1)
Tb927.3.4800,6995.5,6032.5,5885.0,5215.5,4957.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4810,10637.0,2795.0,4868.0,4409.0,2991.5,dna replication complex gins protein sld5,<2C (LG1)
Tb927.3.4820,8630.0,8881.5,9515.5,8834.0,9852.0,acyltransferase  putative,>4C (GG2M)
Tb927.3.4830,5747.0,6955.0,6417.0,6598.5,4451.0,hypothetical protein,G1
Tb927.3.4840,7210.5,8388.5,7622.5,7132.0,7201.0,ubiquitin carboxyl-terminal hydrolase  putative,G1
Tb927.3.4850,9971.0,9615.0,9227.0,8660.0,7861.0,enoyl-CoA hydratase  mitochondrial precursor  putative,<2C (LG1)
Tb927.3.4860,1460.0,1758.0,1692.0,1261.0,1078.0,mitogen-activated protein kinase kinase 1,G1
Tb927.3.4870,612.5,1394.5,1226.0,1056.5,213.0,hypothetical protein  conserved,G1
Tb927_03_v4.snoRNA.0100,612.5,40.5,40.0,33.5,86.0,unspecified product,<2C (LG1)
Tb927.3.4880,9617.5,2741.5,3464.5,3492.0,2203.5,nucleosome assembly protein (NAP)  putative,<2C (LG1)
Tb927.3.4890,5186.0,3407.5,2453.0,4841.0,933.5,ubiquinone biosynthesis protein COQ7 homolog  putative,<2C (LG1)
Tb927.3.4900,10951.0,9532.5,9433.0,9177.5,9330.5,tRNA isopentenyltransferase  putative,<2C (LG1)
Tb927.3.4910,9019.5,7916.5,7712.0,7877.0,6945.5,signal peptide peptidase  putative,<2C (LG1)
Tb927.3.4920,9407.5,6928.5,7124.5,6567.0,4748.5,LETM1 and EF-hand domain-containing protein 1  putative,<2C (LG1)
Tb927.3.4930,612.5,1574.5,1254.0,1281.0,778.5,hypothetical protein  conserved,G1
Tb927.3.4940,612.5,9562.5,9755.5,9357.0,9609.5,5-histidylcysteine sulfoxide synthase  putative,S
Tb927.3.4950,7866.0,5637.5,6417.0,5342.5,3681.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.4960,10716.0,11002.0,10796.0,10484.0,10489.0,kinesin  putative,G1
Tb927.3.4970,5734.0,6643.5,7124.5,6452.5,2389.0,hypothetical protein  conserved,S
Tb927.3.4980,7180.5,9378.0,9129.5,8793.0,10449.5,hypothetical protein  conserved  frameshift,>4C (GG2M)
Tb927.3.4990,4505.5,7847.5,8261.5,8695.0,8585.5,oxidoreductase  putative,G2M
Tb927.3.5000,10567.0,7778.5,7834.0,7252.0,7134.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5010,612.5,5530.5,3779.5,4647.0,3110.0,hypothetical protein  conserved,G1
Tb927.3.5020,11069.0,11283.5,11055.0,11115.0,9989.0,Flagellar Member 6,G1
Tb927.3.5030,8029.0,10257.0,10054.0,9802.0,9487.0,KU70 protein,G1
Tb927.3.5040,8282.0,4510.5,3503.0,3699.0,1878.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5050,1460.0,759.0,1111.5,647.5,1929.5,60S ribosomal protein L4,>4C (GG2M)
Tb927.3.5060,3516.5,6039.0,4977.5,5638.0,6664.5,Ankyrin repeats (many copies)/Ankyrin repeats (3 copies)  putative,>4C (GG2M)
Tb3.NT.66,612.5,40.5,99.0,204.0,559.5,Noncoding RNA  putative,<2C (LG1)
Tb927.3.5070,3534.0,3507.5,3978.5,4987.0,4626.5,hypothetical protein  conserved,G2M
Tb927.3.5080,6563.5,9759.5,9513.0,9722.5,8428.5,PSP1 C-terminal conserved region  putative,G1
Tb927.3.5090,10636.0,10813.0,10392.5,10914.0,10021.5,tryparedoxin 2  putative,G2M
Tb927.3.5100,6767.0,8133.5,8193.5,8270.5,6699.0,tfiih basal transcription factor complex helicase xpb subunit,G2M
Tb927.3.5110,5012.0,7487.0,8015.5,7340.5,6938.5,hypothetical protein  conserved,S
Tb927.3.5120,10355.0,11101.0,11229.0,11283.5,10306.5,Ankyrin repeats (3 copies)  putative,G2M
Tb927.3.5130,4879.5,8287.5,8324.5,8061.0,6960.0,exonuclease  putative,S
Tb927.3.5140,4756.0,8721.5,8167.5,8296.5,7753.0,exonuclease  putative,G1
Tb927.3.5150,612.5,3922.5,6346.0,5365.0,1804.5,exonuclease  putative,S
Tb927.3.5160,11358.0,10983.0,11005.0,11211.0,10134.0,Basal body protein,<2C (LG1)
Tb927.3.5170,2047.0,3507.5,6513.5,4882.0,7192.0,mediator of rna polymerase ii transcription subunit 3,>4C (GG2M)
Tb927.3.5180,1460.0,4849.5,5214.5,4962.5,6229.0,ADF/Cofilin,>4C (GG2M)
Tb927.3.5190,8063.0,8671.0,9286.5,8913.5,6143.5,hypothetical protein  conserved,S
Tb927.3.5200,9286.0,4047.5,5652.5,5617.5,8093.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5210,8023.5,7746.5,7916.5,8793.0,3648.5,hypothetical protein  conserved,G2M
Tb927.3.5220,2460.0,8730.5,7595.0,6612.5,9075.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5230,8748.0,9562.5,9749.0,9790.5,9399.0,DNA repair protein  putative,G2M
Tb927.3.5240,10577.0,9457.5,8627.0,9370.5,6917.0,kinetoplast ribosomal PPR-repeat containing protein 8,<2C (LG1)
Tb927.3.5250,7573.5,8560.5,8303.0,8637.5,9134.5,Zinc finger CCCH domain-containing protein 8,>4C (GG2M)
Tb927.3.5260,3120.5,6458.5,7377.0,7320.0,6137.0,hypothetical protein  conserved,S
Tb927.3.5270,9163.5,6079.5,6328.0,4686.5,8817.0,DNA-directed RNA polymerases II subunit  putative,<2C (LG1)
Tb927.3.5280,7898.5,5469.0,4214.0,3677.0,5624.0,spliceosome-associated protein 49  putative,<2C (LG1)
Tb927.3.5290,10949.5,10169.5,10094.5,9695.5,11021.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5300,612.5,2206.0,1278.5,1763.5,2834.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5310,7444.0,9621.0,10064.0,10013.0,11358.5,paraflagellar rod protein,>4C (GG2M)
Tb927.3.5320,7677.5,7047.0,6942.5,7826.0,8235.0,UBX domain-containing protein,>4C (GG2M)
Tb927.3.5330,4010.5,3313.0,2827.0,2440.0,3353.0,centaurin beta 5,<2C (LG1)
Tb927.3.5340,2295.5,7975.5,7939.0,7199.5,5713.5,Hsc70-interacting protein (Hip)  putative,G1
Tb927.3.5350,4563.0,3615.5,4085.5,5180.0,4533.5,hypothetical protein  conserved,G2M
Tb927.3.5360,6434.5,3665.0,3912.5,4742.5,4748.5,FHA domain containing protein  putative,<2C (LG1)
Tb927.3.5370,612.5,2609.5,4235.0,5838.5,2050.0,hypothetical protein  conserved,G2M
Tb927.3.5380,8842.5,9378.0,9581.5,9362.0,9763.0,Tubulin-tyrosine ligase family  putative,>4C (GG2M)
Tb927.3.5390,2535.5,5634.0,3626.0,3130.0,4957.5,Ring finger domain containing protein  putative,G1
Tb927.3.5400,9210.5,9287.5,10098.5,10256.0,9766.5,serine/threonine protein kinase RIO1  putative,G2M
Tb927.3.5410,6572.0,4096.5,4462.5,4662.5,2283.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5420,5120.0,9826.0,10070.5,10241.0,10373.0,protein transport protein Sec24,>4C (GG2M)
Tb927.3.5430,4792.5,4975.5,5276.5,3557.0,3110.0,hypothetical protein  conserved,S
Tb927.3.5440,11402.0,11551.0,11536.0,11585.0,11528.0,SNF2 DNA repair protein  putative,G2M
Tb927.3.5450,10565.5,10054.0,10146.5,10183.5,10664.0,Basal body protein,>4C (GG2M)
Tb927.3.5460,4617.0,8133.5,9133.5,9297.0,6526.0,RNA-binding protein  putative,G2M
Tb927.3.5470,612.5,1904.5,1612.0,1609.0,2153.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5480,5275.5,5985.5,7061.5,5949.0,5745.0,hypothetical protein  conserved,S
Tb927.3.5490,1783.5,2581.5,3832.5,5069.5,10342.0,Putative intraflagellar transport protein B2,>4C (GG2M)
Tb927.3.5500,2357.5,1293.5,1008.5,1688.5,4988.5,DNA-directed RNA polymerase II subunit 3  putative,>4C (GG2M)
Tb927.3.5510,9588.5,5967.0,5298.0,4193.5,1676.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5520,3751.5,3515.0,3167.0,3117.0,3225.0,26S proteasome regulatory non-ATPase subunit,<2C (LG1)
Tb927.3.5530,11219.5,11433.0,11501.0,11535.0,11375.5,Tb-292 membrane associated protein,G2M
Tb927.3.5540,1460.0,1405.5,2182.5,2656.5,10396.0,dynein intermediate chain WDRD34  putative,>4C (GG2M)
Tb927.3.5550,612.5,2741.5,2621.5,3796.5,8797.0,intraflagellar transport protein 27,>4C (GG2M)
Tb927.3.5560,5120.0,3206.5,4398.0,4542.0,3994.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5570,6453.0,3397.0,3239.0,3635.0,2563.0,syntaxin  putative,<2C (LG1)
Tb927.3.5580,6365.5,5914.5,4670.0,3616.5,8367.0,tryptophanyl-tRNA synthetase,>4C (GG2M)
Tb927.3.5590,2767.0,6525.5,6917.0,6205.5,7494.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5600,5534.0,5479.0,5307.5,4754.5,2525.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5610,9161.5,7406.5,8190.0,7797.0,8449.0,Mitochondrial ribosomal protein L3,<2C (LG1)
Tb927.3.5620,3534.0,5205.5,5919.0,8607.5,8466.5,Facilitates chromatin transcription complex subunit spt16,G2M
Tb927.3.5630,612.5,6164.0,5685.5,6414.0,4725.0,3 2-trans-enoyl-CoA isomerase  mitochondrial precursor  putative,G2M
Tb927.3.5640,10670.0,10432.5,10834.0,10598.0,10524.5,nuclear transcription factor  putative,S
Tb927.3.5650,10657.0,10113.0,10494.5,9837.0,9889.0,STE group serine/threonine-protein kinase  putative,<2C (LG1)
Tb927.3.5660,5891.0,2927.0,2919.0,4486.5,2065.0,UDP-GlcNAc:alpha3-D-mannoside beta-1 2-N-acetylglucosaminyltransferase I,<2C (LG1)
Tb927.3.5670,9380.5,7190.0,7505.5,8482.5,8016.5,hypothetical protein,<2C (LG1)
Tb927.3.5680,9265.0,4056.0,3688.0,2775.0,2631.5,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.3.5690,10895.0,10675.5,10731.5,10820.5,10848.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5700,7991.5,7243.0,7676.5,8094.5,8132.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5710,8619.0,7879.0,7962.5,8422.5,8367.0,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5720,5709.5,5675.0,5396.5,5260.5,8129.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5730,7892.5,6605.5,6385.5,7047.0,7112.5,hypothetical protein  conserved,<2C (LG1)
Tb927.3.5740,6095.5,4251.5,4614.0,4084.0,3836.0,hypothetical protein,<2C (LG1)
Tb927.3.5750,7622.0,8147.0,7923.5,8385.0,8206.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,G2M
Tb927.3.5760,4276.0,3881.5,3717.5,4862.5,4915.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.3.5770,8438.0,9529.0,9035.5,8773.0,9582.0,hypothetical protein,>4C (GG2M)
Tb927.3.5780,8724.0,10655.0,10914.5,10943.0,11016.0,hypothetical protein,>4C (GG2M)
Tb927.3.5790,3179.0,4287.0,4518.5,4205.5,3465.5,expression site-associated gene 9 (ESAG9) (pseudogene),S
Tb927.3.5800,7195.5,5024.5,6831.5,6883.0,6398.5,expression site-associated gene 1 (ESAG1)  degenerate,<2C (LG1)
Tb927.3.5810,3680.5,2326.0,2866.5,2756.0,1732.0,expression site-associated gene 2 (ESAG2) (pseudogene),<2C (LG1)
Tb927.3.5820,4266.5,4047.5,4224.5,4918.5,3704.0,expression site-associated gene 11 (ESAG11)  degenerate,G2M
Tb927.3.5830,1988.0,2241.5,1848.0,1993.5,1984.0,expression site-associated gene 1 (ESAG1) protein  putative,G1
Tb927.3.5850,1460.0,3419.0,4944.0,5949.0,6247.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb927.3.5860,1783.5,1520.0,1536.0,1626.0,1453.5,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.3.5870,612.5,2785.5,1799.0,1626.0,1860.5,variant surface glycoprotein  fragment,G1
Tb927.3.5880,6955.5,8292.0,9105.0,9485.0,9989.0,variant surface glycoprotein  point mutation,>4C (GG2M)
Tb927.3.5890,1783.5,235.5,980.0,1085.0,836.0,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.3.5900,4066.0,1257.5,980.0,974.5,1758.0,variant surface glycoprotein  frameshift,<2C (LG1)
Tb09.v4.0162,9044.5,7277.5,6695.5,7275.5,9458.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0163,7876.0,9160.5,9008.0,8765.0,7334.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0164,5762.0,5513.5,6089.5,4852.5,5274.5,variant surface glycoprotein  fragment,S
Tb09.v4.0165,1988.0,1506.5,1446.0,1363.5,1027.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0166,4517.0,5315.0,5372.0,5445.5,4806.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb09.v4.0167,2381.5,3711.5,2551.0,3577.5,3086.0,hypothetical protein  pseudogene,G1
Tb09.v4.0168,8706.0,6104.0,6078.5,5775.5,6363.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0169,5408.0,1653.5,2196.0,2150.0,2402.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0170,5682.0,2490.5,2598.5,2335.0,2016.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0171,10317.5,10662.0,10825.0,10316.0,10264.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0172,3224.0,5573.0,5953.5,5838.5,5664.0,expression site-associated gene 3 (ESAG3)  pseudogene,S
Tb09.v4.0173,9185.0,5506.0,4614.0,4409.0,2914.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0174,7481.0,7414.5,6288.0,7003.0,5220.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0175,6123.0,6095.5,6442.0,6366.5,3474.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0176,612.5,1211.0,1710.5,1382.0,2472.5,variant surface glycoprotein  fragment,>4C (GG2M)
Tb09.v4.0177,8087.0,8137.5,8603.5,7877.0,8789.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb09.v4.0178,8791.5,9220.5,9394.0,10169.5,9305.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb2.NT.1,10894.0,10811.0,10248.5,10575.0,9820.5,Noncoding RNA  putative,<2C (LG1)
Tb927.2.100,11449.0,11305.0,11305.0,11424.5,10860.5,retrotransposon hot spot protein 1 (RHS1)  putative,<2C (LG1)
Tb927.2.160,6112.0,11171.0,11081.0,11157.0,10456.0,Protein of unknown function (DUF1181)  putative,G1
Tb927.2.170,11684.0,11700.0,11696.0,11700.0,11678.0,leucine-rich repeat protein 1 (LRRP1)  putative,G1
Tb927.2.200,11109.0,11542.0,11535.0,11602.0,11485.0,expression site-associated gene 3 (ESAG3)  degenerate,G2M
Tb927.2.220,8105.0,6838.5,7556.5,7725.0,7510.5,retrotransposon hot spot protein 2 (RHS2)  interrupted  degenerate,<2C (LG1)
Tb927.2.240,11257.0,11039.0,10934.0,11076.0,10547.0,retrotransposon hot spot protein 5 (RHS5)  putative,<2C (LG1)
Tb927.2.270,10906.0,10857.5,10924.0,10927.0,10548.0,retrotransposon hot spot protein 3 (RHS3)  frameshift,G2M
Tb927.2.280,10381.5,10801.5,10680.0,10610.0,10045.5,retrotransposon hot spot protein 2 (RHS2)  putative,G1
Tb927.2.300,11373.0,11396.0,11416.0,11397.0,11137.0,DNA-directed RNA polymerase  pseudogene  putative,S
Tb927.2.340,10225.5,9833.5,9734.0,10099.0,9041.0,retrotransposon hot spot protein 4 (RHS4)  putative,<2C (LG1)
Tb927.2.370,10899.0,11309.5,11283.0,11280.0,11161.0,retrotransposon hot spot protein 1 (RHS1)  putative,G1
Tb927.2.380,10696.5,11199.0,11270.0,11321.0,10772.0,retrotransposon hot spot protein 2 (RHS2)  putative,G2M
Tb927.2.400,10632.0,10653.5,10787.0,10736.5,10054.5,retrotransposon hot spot protein 2 (RHS2)  putative,S
Tb927.2.420,11547.0,11522.0,11537.0,11571.5,11400.0,DNA-directed RNA polymerase  pseudogene  putative,G2M
Tb927.2.450,9880.5,11302.0,11390.0,11293.5,11025.0,retrotransposon hot spot protein 4 (RHS4)  putative,S
Tb927.2.460,11099.0,11246.0,11362.0,11438.0,10764.5,DNA-directed RNA polymerase  pseudogene  putative,G2M
Tb927.2.470,10962.0,10371.0,10389.5,10528.0,8893.0,retrotransposon hot spot protein 4 (RHS4)  putative,<2C (LG1)
Tb927.2.480,10859.0,10695.5,10440.0,10683.5,9454.0,retrotransposon hot spot protein 2 (RHS2)  degenerate,<2C (LG1)
Tb927.2.490,10243.5,10866.0,10908.0,10699.0,10353.0,DNA-directed RNA polymerase  pseudogene  putative,S
Tb927.2.510,10098.5,10841.0,10704.5,10935.5,10332.5,retrotransposon hot spot protein 4 (RHS4)  putative,G2M
Tb927.2.540,10692.0,11539.0,11556.0,11542.0,11268.0,DNA-directed RNA polymerase  pseudogene  putative,S
Tb927.2.560,11117.0,11296.5,11259.0,11289.0,10538.5,retrotransposon hot spot protein 4 (RHS4)  putative,G1
Tb927.2.650,11023.5,11191.0,11101.0,11118.5,10514.0,hypothetical protein,G1
Tb927.2.660,11481.0,11597.0,11604.0,11601.0,11543.0,expression site-associated gene 4 (ESAG4)  degenerate,S
Tb927.2.680,5863.0,9971.5,9873.0,10152.5,9708.0,Protein of unknown function (DUF1181)  putative,G2M
Tb927.2.690,11606.0,11662.0,11654.0,11685.0,11634.0,leucine-rich repeat protein (LRRP)  putative,G2M
Tb927.2.720,11618.0,11681.0,11679.0,11687.0,11646.0,retrotransposon hot spot protein 5 (RHS5)  degenerate,G2M
Tb927.2.820,11196.0,11332.0,11308.0,11370.0,10986.5,retrotransposon hot spot protein 1 (RHS1)  interrupted,G2M
Tb927.2.830,8489.0,8755.5,9035.5,8715.0,6463.5,retrotransposon hot spot protein 1 (RHS1)  interrupted,S
Tb927.2.900,11406.0,11441.0,11356.0,11400.5,11203.0,hypothetical protein,G1
Tb927.2.910,9931.5,11457.0,11514.0,11448.5,11421.5,expression site-associated gene 4 (ESAG4)  degenerate,S
Tb927.2.940,6721.0,8625.5,8513.5,8465.5,6314.0,Protein of unknown function (DUF1181)  putative,G1
Tb927.2.950,11361.0,11665.0,11666.0,11665.0,11604.0,paraflagellar rod component  putative,S
Tb927.2.960,5807.0,8620.0,8362.5,9646.5,8449.0,hypothetical protein,G2M
Tb927.2.980,11676.0,11696.0,11687.0,11697.0,11664.0,retrotransposon hot spot protein 5 (RHS5)  degenerate,G2M
Tb927.2.1050,10978.0,10738.5,10668.0,10572.5,10632.0,retrotransposon hot spot protein 1 (RHS1)  interrupted,<2C (LG1)
Tb927.2.1060,4496.5,6804.5,6533.5,6262.0,4673.5,retrotransposon hot spot protein 1 (RHS1)  interrupted,G1
Tb927.2.1080,10174.0,10437.5,10079.0,10579.0,9573.0,retrotransposon hot spot protein 5 (RHS5)  putative,G2M
Tb927.2.1100,9250.0,10960.0,10743.5,10957.0,10600.0,retrotransposon hot spot protein 3 (RHS3)  degenerate,G1
Tb927.2.1110,10590.5,11486.0,11543.0,11517.0,11333.0,DNA-directed RNA polymerase III subunit 2  pseudogene  putative,S
Tb927.2.1120,10580.5,11309.5,11065.0,11229.0,10901.0,retrotransposon hot spot protein 4 (RHS4)  point mutation,G1
Tb927.2.1130,10588.0,11268.0,11014.5,11380.0,10905.0,retrotransposon hot spot protein 3 (RHS3)  interrupted  degenerate,G2M
Tb927.2.1140,7774.5,8160.0,8108.5,7871.0,7566.0,retrotransposon hot spot protein 3 (RHS3)  interrupted,G1
Tb927.2.1150,9229.0,10012.0,9370.0,10130.5,10077.5,retrotransposon hot spot protein 2 (RHS2)  interrupted  degenerate,G2M
Tb927.2.1160,9318.0,9415.5,9873.0,10198.0,8898.5,retrotransposon hot spot protein 2 (RHS2)  interrupted  degenerate,G2M
Tb927.2.1170,8321.0,10621.0,10864.5,10861.0,10980.0,retrotransposon hot spot protein 5 (RHS5)  putative,>4C (GG2M)
Tb927.2.1180,11535.0,11550.0,11532.0,11586.0,11462.5,retrotransposon hot spot protein 3 (RHS3)  putative,G2M
Tb927.2.1200,11375.0,11581.0,11583.0,11613.0,11461.0,DNA-directed RNA polymerase III subunit 2  pseudogene  putative,G2M
Tb927.2.1210,11424.5,11600.0,11569.0,11622.0,11513.0,retrotransposon hot spot protein 4 (RHS4)  putative,G2M
Tb927.2.1250,9134.0,8630.5,8529.5,9149.5,7988.0,hypothetical protein,G2M
Tb927.2.1260,11538.0,11525.0,11516.0,11512.0,11367.0,expression site-associated gene 4 (ESAG4)  degenerate,<2C (LG1)
Tb927.2.1290,6612.5,6958.5,6910.5,7126.0,7295.0,hypothetical protein,>4C (GG2M)
Tb927.2.1310,11502.5,11659.0,11651.0,11658.5,11594.0,leucine-rich repeat protein (LRRP  pseudogene)  putative,G1
Tb927.2.1330,9908.0,10031.0,9672.0,9903.0,8549.5,retrotransposon hot spot protein 6 (RHS6)  degenerate,G1
Tb927.2.1344,5174.0,2751.5,2666.0,2928.0,2941.0,retrotransposon hot spot protein 1 (RHS1)  interrupted,<2C (LG1)
Tb927.2.1350,7960.5,9171.0,8563.0,9140.5,8638.0,retrotransposon hot spot protein 1 (RHS1)  interrupted,G1
Tb927.2.1380,11296.5,11540.0,11515.0,11526.0,11395.0,leucine-rich repeat protein (LRRP)  putative,G1
Tb927.2.1389,4767.5,2429.0,1899.0,1875.5,2413.0,M4 ribosomal RNA,<2C (LG1)
Tb927.2.1398,3638.0,1101.5,1124.0,1281.0,994.0,M6 ribosomal RNA,<2C (LG1)
Tb927.2.1407,3328.5,1332.5,1054.0,1281.0,1213.5,M2 ribosomal RNA,<2C (LG1)
Tb927.2.1416,10847.0,11021.5,10949.0,10827.5,10188.0,28S beta ribosomal RNA,G1
Tb927.2.1425,5241.5,2992.5,2275.0,2788.5,3169.5,M1 ribosomal RNA,<2C (LG1)
Tb927.2.1434,11035.5,11411.0,11408.0,11352.0,10831.5,28S alpha ribosomal RNA,G1
Tb927.2.1443,6862.0,5738.0,4938.0,5816.0,5379.5,5.8S ribosomal RNA,<2C (LG1)
Tb927.2.1452,11673.0,11671.0,11672.0,11654.0,11618.0,18S ribosomal RNA,<2C (LG1)
Tb927.2.1460,11026.5,11563.0,11586.0,11557.0,11496.5,hypothetical protein  conserved,S
Tb927.2.1470,10963.5,10953.0,11006.5,10889.0,10762.0,hypothetical protein  conserved,S
Tb927.2.1480,4894.5,2751.5,2134.0,2290.0,2268.0,M4 ribosomal RNA,<2C (LG1)
Tb927.2.1490,3645.5,1043.5,1179.5,1097.5,964.0,M6 ribosomal RNA,<2C (LG1)
Tb927.2.1500,3230.0,1180.5,818.5,1299.0,1162.5,M2 ribosomal RNA,<2C (LG1)
Tb927.2.1510,10723.0,10900.5,10800.0,10699.0,10050.0,28S beta ribosomal RNA,G1
Tb927.2.1520,5162.5,2949.5,2533.0,2956.0,3076.5,M1 ribosomal RNA,<2C (LG1)
Tb927.2.1530,11072.0,11464.0,11438.5,11396.0,10914.0,28S alpha ribosomal RNA,G1
Tb927.2.1540,6737.5,6186.0,5218.0,6282.0,5813.0,5.8S ribosomal RNA,<2C (LG1)
Tb927.2.1550,11678.0,11669.0,11676.0,11661.0,11625.0,18S ribosomal RNA,<2C (LG1)
Tb927.2.1560,1783.5,5309.0,6278.0,5628.0,6173.5,peptidyl-prolyl cis-trans isomerase  putative,S
Tb927.2.1600,8921.0,9329.5,10224.0,10248.5,9564.5,invariant surface glycoprotein  putative,G2M
Tb927.2.1680,612.5,4719.0,5829.0,4711.5,4673.5,peptidyl-prolyl cis-trans isomerase  putative,S
Tb2.NT.3,2295.5,759.0,293.0,501.5,1647.0,Noncoding RNA  putative,<2C (LG1)
Tb927.2.1700,9715.5,7731.5,8892.5,8885.0,8910.5,Enriched in surface-labeled proteome protein 10,<2C (LG1)
Tb927.2.1720,7343.0,1727.5,1536.0,1847.0,1531.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.1730,7622.0,7529.0,6664.0,6090.0,6096.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.1740,8794.0,8863.0,8031.0,8061.0,9491.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.1760,9525.0,6095.5,7359.5,7188.5,5014.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.1770,3283.5,1362.5,966.5,1003.0,1595.5,hypothetical protein  conserved  truncated,<2C (LG1)
Tb927.2.1780,9783.0,9724.5,9533.0,10263.0,9760.0,GlcNAc-PI synthesis protein,G2M
Tb927.2.1790,5154.5,4481.0,5187.5,4862.5,6164.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.1800,6834.0,9977.5,10612.0,10589.0,11246.0,DNA polymerase delta catalytic subunit  putative,>4C (GG2M)
Tb927.2.1810,10506.5,10897.5,10434.0,10352.0,11025.0,chromatin-remodeling complex atpase chain iswi,>4C (GG2M)
Tb927.2.1820,10010.0,7626.5,8000.5,7465.0,7385.0,CAMK/CAMKL family protein kinase  putative,<2C (LG1)
Tb927.2.1850,4170.0,4521.5,5307.5,5120.0,7459.5,Tetratricopeptide repeat  putative,>4C (GG2M)
Tb927.2.1860,9919.0,11220.0,11178.0,11170.0,10883.0,RNA editing mediator complex protein 2,G1
Tb927.2.1890,1460.0,774.5,562.5,592.5,721.5,E2-like ubiquitin-conjugation enzyme,<2C (LG1)
Tb2.NT.8,612.5,158.5,161.0,182.5,213.0,Noncoding RNA  putative,<2C (LG1)
Tb927.2.1920,5369.0,8025.0,7614.0,7495.5,8291.0,expression site-associated gene 5 (ESAG5) protein  putative,>4C (GG2M)
Tb927.2.1931,11617.0,11564.5,11567.0,11489.0,11420.0,18S ribosomal RNA,<2C (LG1)
Tb927.2.1942,8134.5,6636.5,6808.5,6837.5,6690.0,5.8S ribosomal RNA,<2C (LG1)
Tb927.2.1953,10629.0,10873.0,10634.0,10533.0,9733.5,28S alpha ribosomal RNA,G1
Tb927.2.1964,5063.0,2551.0,1710.5,2134.5,2153.5,M1 ribosomal RNA,<2C (LG1)
Tb927.2.1975,11091.0,10269.5,10020.0,10188.5,9427.0,28S beta ribosomal RNA,<2C (LG1)
Tb927.2.1986,3107.5,978.5,615.0,957.5,1239.0,M2 ribosomal RNA,<2C (LG1)
Tb927.2.1997,3914.0,1542.0,1700.5,2025.0,1504.0,M6 ribosomal RNA,<2C (LG1)
Tb927.2.2008,5573.5,2571.5,2182.5,2357.0,2402.0,M4 ribosomal RNA,<2C (LG1)
Tb927.2.2015,2813.0,4041.5,4799.0,4174.5,3110.0,hypothetical protein,S
Tb927.2.2020,2406.5,2913.5,3364.5,2347.0,1422.0,expression site-associated gene 3 (ESAG3) protein  putative,S
Tb927.2.2029,10096.0,5442.5,4643.0,5648.5,6234.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.2.2060,3380.0,1275.5,1226.0,2977.0,2110.0,variant surface glycoprotein (VSG)-related  putative,<2C (LG1)
Tb927.2.2070,5856.0,4521.5,4568.5,4464.5,3157.0,hypothetical protein,<2C (LG1)
Tb927.2.2090,10420.0,10735.5,10601.0,11029.0,11088.0,SUMO-interacting motif-containing protein,>4C (GG2M)
Tb927.2.2120,1460.0,3909.5,4085.5,4235.5,5470.5,Serine/threonine-protein kinase NEK22  putative,>4C (GG2M)
Tb927.2.2130,612.5,5431.5,4790.5,5850.0,8781.0,small GTP-binding protein RAB6  putative,>4C (GG2M)
Tb927.2.2140,4010.5,2444.5,2389.0,2746.5,2563.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2160,4104.0,3646.5,4711.5,4647.0,4212.0,paraflagellar rod component  putative,S
Tb927.2.2180,2504.5,2992.5,3233.0,3319.0,3981.5,ribosomal RNA processing protein 41B,>4C (GG2M)
Tb927.2.2190,9575.5,6278.5,6475.0,4882.0,7778.0,histone deacetylase 3,<2C (LG1)
Tb927.2.2200,5981.0,3872.5,4568.5,4476.0,3906.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2210,10647.5,10780.0,10565.0,10796.5,9766.5,hypothetical protein  conserved,G2M
Tb927.2.2220,8721.5,4895.5,4364.5,4951.0,6581.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2230,4849.5,5431.5,6055.5,5463.0,5209.5,hypothetical protein  conserved,S
Tb927.2.2240,7267.0,9948.5,10133.0,10451.5,8063.0,exportin-T  putative,G2M
Tb927.2.2260,11339.5,11560.0,11612.0,11598.0,11591.0,phosphatidylinositol kinase related protein  putative,S
Tb927.2.2270,5291.5,3273.5,3420.5,3677.0,1828.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2320,2180.0,260.0,293.0,248.0,287.0,hypothetical protein,<2C (LG1)
Tb927.2.2340,11651.0,10944.0,11056.5,10846.0,11175.0,Glycerophosphoryl diester phosphodiesterase family  putative,<2C (LG1)
Tb927.2.2360,7037.0,8887.5,8324.5,7768.5,9857.0,Ankyrin repeats (3 copies)/Zinc finger  C3HC4 type (RING finger)  putative,>4C (GG2M)
Tb927.2.2370,8847.5,10416.5,10474.0,10761.0,11248.0,Vps51/Vps67  putative,>4C (GG2M)
Tb927.2.2380,10426.5,8741.5,8752.5,8492.5,8042.0,glycosyltransferase (GlcNAc)  putative,<2C (LG1)
Tb927.2.2390,8947.5,7512.0,7797.5,7093.5,7944.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2400,6029.0,6520.5,6583.0,7752.0,4883.5,glycosyltransferase (GlcNAc)  putative,G2M
Tb927.2.2410,8559.0,9284.0,7259.5,7220.0,8502.5,hypothetical protein  conserved,G1
Tb927.2.2430,6106.5,10338.5,10360.5,10067.0,9330.5,casein kinase II  alpha chain,S
Tb927.2.2440,2870.5,904.0,1008.5,1215.5,1608.0,proteasome regulatory non-ATPase subunit 6,<2C (LG1)
Tb927.2.2450,8015.0,8331.5,8417.0,8779.5,8516.0,ribosomal RNA methyltransferase  putative,G2M
Tb927.2.2460,7046.0,8187.5,7562.5,7495.5,8198.0,ubiquitin-conjugating enzyme E2  putative,>4C (GG2M)
Tb927.2.2470,8224.0,6373.5,7086.0,6562.0,7704.5,Kinetoplastid RNA editing protein 1,<2C (LG1)
Tb927.2.2490,8288.5,4733.5,7763.5,7877.0,6511.5,hypothetical protein,<2C (LG1)
Tb927.2.2500,10814.5,7220.5,8463.0,8138.5,7184.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2510,5643.5,2402.0,2977.0,2483.5,1703.0,Mitochondrial outer membrane protein porin 1,<2C (LG1)
Tb927.2.2520,7096.0,4041.5,3727.5,3492.0,2389.0,Mitochondrial outer membrane protein porin 2,<2C (LG1)
Tb927.2.2530,7157.5,7041.5,6246.0,6706.0,4525.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2540,612.5,2858.5,3441.0,3216.0,2283.5,Ribosome biogenesis protein SLX9  putative,S
Tb927.2.2550,10676.0,9069.5,8167.5,7734.5,9084.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2570,4910.5,7711.0,6561.5,6331.5,4680.5,hypothetical protein  conserved,G1
Tb927.2.2580,10907.0,10515.5,10487.0,10713.0,9962.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2590,612.5,2178.5,2738.5,2506.5,584.5,hypothetical protein  conserved,S
Tb927.2.2650,11597.0,11510.0,11387.0,11337.0,10793.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2670,3888.5,3374.0,4200.5,4183.0,2550.0,histone H4 variant,S
Tb927.2.2720,9073.0,10798.0,9442.0,10308.0,10831.5,STE/STE7 protein kinase  putative,>4C (GG2M)
Tb927.2.2770,612.5,413.0,756.5,628.0,347.0,hypothetical protein  conserved,S
Tb927.2.2830,5561.0,2820.5,3952.0,4798.0,4607.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2860,9370.0,6568.0,7018.5,6591.5,7681.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.2880,8063.0,8704.0,8249.5,8798.5,10790.5,TPR repeat/Tetratricopeptide repeat  putative,>4C (GG2M)
Tb927.2.2900,612.5,6568.0,4304.0,5407.5,5735.0,ARP2/3 complex subunit  putative,G1
Tb927.2.2910,8898.5,7615.0,8060.5,7921.0,9075.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.2920,2956.5,4547.5,5120.0,6388.5,1929.5,UAA transporter family  putative,G2M
Tb927.2.2940,5965.0,5979.5,6981.5,6098.5,5252.5,MICOS complex subunit 32,S
Tb927.2.2950,8313.0,8869.0,9169.5,9020.0,9581.0,Nop14-like family  putative,>4C (GG2M)
Tb927.2.2970,5262.5,4785.0,5379.0,5148.0,4760.0,mitochondrial carrier protein,S
Tb927.2.2990,5477.5,8942.0,7939.0,8328.0,5675.0,hypothetical protein  conserved,G1
Tb927.2.3000,10263.0,3561.5,3589.5,4504.5,4345.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.3020,4792.5,2429.0,818.5,1779.5,8914.5,Component of motile flagella 76,>4C (GG2M)
Tb927.2.3030,7933.0,10355.0,10098.5,10436.0,10617.0,ATP-dependent Clp protease subunit  heat shock protein 78 (HSP78)  putative,>4C (GG2M)
Tb927.2.3055,612.5,96.0,99.0,33.5,86.0,hypothetical protein,<2C (LG1)
Tb927.2.3080,6349.0,9869.5,7763.5,9568.5,8727.5,cytochrome b5-dependent oleate desaturase,G1
Tb927.2.3090,3120.5,3201.0,2182.5,3531.5,3981.5,hypothetical protein  conserved,>4C (GG2M)
Tb927_02_v4.snoRNA.0100,2460.0,358.0,271.5,136.5,505.0,unspecified product,<2C (LG1)
Tb927.2.3160,6080.5,7857.5,8356.0,9119.5,9994.0,Gar1/Naf1 RNA binding region  putative,>4C (GG2M)
Tb927.2.3180,9927.5,11113.5,11216.0,11253.0,10971.5,kinetoplast polyadenylation/uridylation factor 1,G2M
Tb927.2.3190,10838.0,8807.0,8451.0,10007.0,9628.5,Got1/Sft2-like family  putative,<2C (LG1)
Tb927.2.3270,11237.0,11233.0,11251.0,11193.5,10697.5,65 kDa invariant surface glycoprotein,S
Tb927.2.3280,7723.0,6928.5,7188.5,7208.0,5354.0,65 kDa invariant surface glycoprotein,<2C (LG1)
Tb927.2.3290,7285.0,8392.0,8497.0,8749.0,7662.5,65 kDa invariant surface glycoprotein,G2M
Tb927.2.3300,4972.0,5746.5,6346.0,5690.0,4145.0,65 kDa invariant surface glycoprotein,S
Tb927.2.3310,9524.0,10120.0,10135.5,10057.0,9641.5,65 kDa invariant surface glycoprotein,S
Tb927.2.3320,10772.5,7451.5,7614.0,7628.5,7077.0,65 kDa invariant surface glycoprotein,<2C (LG1)
Tb927.2.3330,4703.5,2609.5,3197.0,2707.0,4051.0,hypothetical protein,<2C (LG1)
Tb927.2.3340,612.5,1322.5,1428.0,1792.5,1944.0,hypothetical protein,>4C (GG2M)
Tb927.2.3370,7730.0,7385.5,6936.0,5949.0,7052.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase  putative,<2C (LG1)
Tb927.2.3390,7106.5,7568.5,6308.5,6863.0,4760.0,hypothetical protein  conserved,G1
Tb927.2.3400,5281.0,7321.0,6905.5,6205.5,6639.5,hypothetical protein  conserved,G1
Tb927.2.3420,2329.5,4096.5,3832.5,4531.5,4550.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.3440,4375.0,2772.5,3503.0,3796.5,4377.5,cysteine peptidase  Clan CA  family C51  putative,>4C (GG2M)
Tb927.2.3460,8009.5,5251.5,4990.5,4279.5,3125.5,cysteine peptidase  Clan CA  family C51  putative,<2C (LG1)
Tb927.2.3480,7405.5,4812.5,5064.5,5004.5,3199.5,transcription elongation factor s-II  putative,<2C (LG1)
Tb927.2.3580,10522.5,9467.5,9189.0,9858.5,7530.0,transcription elongation factor s-II  putative,<2C (LG1)
Tb927.2.3610,6173.0,7325.0,6682.5,8105.0,9269.0,Mitochondrial ATP synthase subunit  putative,>4C (GG2M)
Tb927.2.3620,9073.0,8750.5,8130.5,8224.5,9368.5,GTP-binding elongation factor Tu family  putative,>4C (GG2M)
Tb927.2.3660,10095.0,11385.0,11459.0,11373.0,11436.0,paraflagellar rod component  putative,S
Tb927.2.3720,2826.5,3008.5,2369.0,3154.0,3457.5,ubiquitin-conjugating enzyme  putative,>4C (GG2M)
Tb927.2.3730,4134.0,7277.5,7905.5,8974.0,8173.5,hypothetical protein  conserved,G2M
Tb927.2.3750,11410.0,11235.0,11148.5,11297.0,10865.0,Domain of unknown function (DUF4520)  putative,<2C (LG1)
Tb927.2.3780,6042.0,7622.0,7706.0,7111.0,5394.5,translation initiation factor IF-2  putative,S
Tb927.2.3800,6692.5,4019.0,3452.0,3503.0,3447.0,guide RNA associated protein 1,<2C (LG1)
Tb2.NT.37,612.5,260.0,130.5,182.5,213.0,Noncoding RNA  putative,<2C (LG1)
Tb927.2.3880,10664.5,7539.0,7905.5,7027.5,5301.0,heterogeneous nuclear ribonucleoproteins F/H homologue,<2C (LG1)
Tb927.2.3910,7478.0,7418.0,9027.5,9048.5,9308.5,beta-ketoacyl-ACP synthase,>4C (GG2M)
Tb927.2.3920,8002.0,3872.5,4695.5,4872.5,5577.5,Complex 1 protein (LYR family)  putative,<2C (LG1)
Tb927.2.3930,7960.5,2026.5,1977.0,3168.0,3836.0,dna replication licensing factor mcm3,<2C (LG1)
Tb927.2.3960,2826.5,3932.0,2251.5,2603.0,1842.0,chaperone protein DnaJ  putative,G1
Tb927.2.3970,1460.0,5309.0,4703.0,5307.5,5702.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.3990,10366.0,9863.5,9948.5,10291.0,7840.5,GRIP-related Arf-binding domain containing protein  putative,<2C (LG1)
Tb927.2.4000,9604.0,8310.5,8574.0,8848.5,8910.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.4020,8351.0,8176.0,7770.5,7931.0,8475.0,NEDD8-activating enzyme E1 regulatory subunit  putative,>4C (GG2M)
Tb927.2.4050,9683.5,9977.5,9936.0,10809.0,11443.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.4060,1460.0,944.0,2310.0,3045.0,11297.0,Dynein intermediate chain 138,>4C (GG2M)
Tb927.2.4090,6509.5,3723.5,3051.5,3452.5,4403.5,signal recognition particle receptor beta subunit  putative,<2C (LG1)
Tb927.2.4110,8007.0,4642.5,5728.0,5365.0,3628.5,Mitochondrial-processing peptidase subunit alpha,<2C (LG1)
Tb927.2.4130,9475.0,7866.5,7607.0,7596.5,6945.5,enoyl-CoA hydratase/Enoyl-CoA isomerase/3-hydroxyacyl-CoA dehydrogenase  putative,<2C (LG1)
Tb927.2.4140,11579.0,11468.5,11431.5,11492.0,11385.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.4150,6029.0,6289.0,5759.5,4183.0,5199.0,hypothetical protein  conserved,G1
Tb927.2.4160,11279.0,9051.5,9411.0,9381.5,9316.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.4200,7438.5,10888.5,10649.5,10824.0,10167.0,CMGC/CLK family protein kinase  putative,G1
Tb927.2.4210,4965.0,7414.5,8138.0,8250.0,9458.0,Phosphoenolpyruvate carboxykinase [ATP]  glycosomal,>4C (GG2M)
Tb927.2.4230,11262.5,8455.5,8836.5,8422.5,9704.0,NUP-1 protein  putative,<2C (LG1)
Tb927.2.4240,5929.5,5368.5,6429.5,6205.5,6328.0,GTP binding protein  putative,S
Tb927.2.4280,10125.0,8621.5,8335.5,8628.5,8914.5,kinetoplastid-specific dual specificity phosphatase  putative,<2C (LG1)
Tb927.2.4330,10341.0,6272.5,6041.0,6515.5,8213.5,paraflagellar rod protein 5  putative,<2C (LG1)
Tb927.2.4340,4580.0,9347.5,9490.0,9900.5,8597.0,hypothetical protein  conserved,G2M
Tb927.2.4370,9617.5,5359.5,4316.5,4882.0,4222.5,trypanothione synthetase,<2C (LG1)
Tb927.2.4380,2329.5,5039.5,5645.0,5190.5,2065.0,NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit  putative,S
Tb927.2.4390,10968.0,10045.0,10007.0,10083.0,10728.0,double-strand break repair protein MRE11,<2C (LG1)
Tb927.2.4400,10045.5,9394.5,9569.0,9287.5,9246.5,SSU ribosomal protein  mitochondrial  putative,<2C (LG1)
Tb927.2.4410,9092.5,6216.5,5945.5,6591.5,6229.0,Eukaryotic protein of unknown function (DUF846)  putative,<2C (LG1)
Tb927.2.4420,10486.0,10246.5,9898.0,10335.0,9866.5,MIZ/SP-RING zinc finger  putative,<2C (LG1)
Tb927.2.4440,7971.0,1940.0,1603.5,1823.5,2141.5,hypothetical protein,<2C (LG1)
Tb927.2.4445,3550.5,1875.5,1402.0,2810.5,948.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.4460,2535.5,2957.5,2275.0,3627.0,2647.0,Kinetoplast ribosomal PPR-repeat containing protein 21,G2M
Tb927.2.4470,10090.5,5909.5,4711.5,5120.0,4607.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.4480,3654.0,6148.5,5445.5,6821.5,5735.0,hypothetical protein  conserved,G2M
Tb927.2.4510,4389.0,10617.0,10098.5,10016.5,10829.0,cdc2-related kinase 9,>4C (GG2M)
Tb927.2.4520,3972.0,4567.5,5135.0,4587.0,10879.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.4530,5969.0,5128.0,5070.5,6112.5,8998.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.4540,5266.0,5431.5,5015.0,4146.0,7201.0,Small nuclear ribonucleoprotein-associated protein B (snRNP-B) (Sm protein B) (Sm-B) (SmB)  putative,>4C (GG2M)
Tb927.2.4550,6746.5,6278.5,5129.0,3897.5,4988.5,2'-O-ribose RNA methyltransferase SPB1 homolog,<2C (LG1)
Tb927.2.4560,2535.5,7685.0,6028.0,5497.0,8404.5,Rab-GTPase-TBC domain containing protein  putative,>4C (GG2M)
Tb927.2.4580,9051.5,9806.0,9016.0,10954.0,9114.5,UNC119,G2M
Tb2.NT.41,4555.0,2051.0,1510.5,1585.5,3065.0,Noncoding RNA  putative,<2C (LG1)
Tb927.2.4590,7465.0,6115.0,6521.5,5317.0,5555.0,branched-chain amino acid aminotransferase  putative,<2C (LG1)
Tb927.2.4610,9562.0,8122.5,8803.0,7422.0,8202.0,branched-chain amino acid aminotransferase  putative,<2C (LG1)
Tb927.2.4620,9718.5,8750.5,8882.5,8802.5,7356.5,Transmembrane adaptor Erv26  putative,<2C (LG1)
Tb927.2.4650,3191.0,5935.5,6108.0,4522.0,4110.0,hypothetical protein  conserved,S
Tb927.2.4670,9546.0,6329.5,6185.0,6304.5,8048.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.4680,9274.0,9440.5,8809.0,8328.0,9500.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.4700,8572.5,5196.0,4181.0,4662.5,4110.0,succinate dehydrogenase subunit,<2C (LG1)
Tb927.2.4710,6009.5,2934.5,2653.0,2907.5,6240.0,RNA-binding protein  putative,>4C (GG2M)
Tb927.2.4720,10066.5,10436.0,10438.0,10486.5,9142.0,dolichyl-P-Man:GDP-Man7GlcNAc2-PP-dolichyl alpha-1 6-mannosyltransferase  putative,G2M
Tb927.2.4740,6297.5,9345.5,9306.5,9518.5,10021.5,mitochondrial ribosomal protein l11,>4C (GG2M)
Tb927.2.4750,6925.5,8279.5,7334.0,7710.0,6614.5,hypothetical protein  conserved,G1
Tb927.2.4760,8209.5,10628.5,10662.0,10754.0,10470.0,hypothetical protein  conserved,G2M
Tb927.2.4780,9983.5,10420.5,10512.5,10896.0,11599.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.4795,2381.5,484.0,471.5,334.5,397.5,hypothetical protein,<2C (LG1)
Tb927.2.4800,3785.5,7073.0,5822.0,5285.0,5647.5,hypothetical protein  conserved,G1
Tb927.2.4810,2552.0,6339.0,5102.5,6491.0,11448.0,Component of motile flagella 5,>4C (GG2M)
Tb927.2.4830,612.5,7243.0,8023.0,7531.5,8158.5,TFIIF-stimulated CTD phosphatase  putative,>4C (GG2M)
Tb927.2.4840,612.5,176.5,130.5,159.0,213.0,Vitamin K epoxide reductase family  putative,<2C (LG1)
Tb927.2.4850,5213.5,3827.0,3323.5,4381.0,8674.0,Phosducin  putative,>4C (GG2M)
Tb927.2.4870,6281.5,4684.0,4966.0,5939.0,5282.0,kinetoplastid-specific dual specificity phosphatase  putative,<2C (LG1)
Tb927.2.4890,6862.0,10085.5,10114.0,10248.5,10557.5,mitochondrial ribosomal protein l11,>4C (GG2M)
Tb927.2.4900,6106.5,7663.0,7131.5,7801.5,5870.5,hypothetical protein  conserved,G2M
Tb927.2.4920,9041.0,10670.0,10092.0,10556.5,9225.0,hypothetical protein  conserved,G1
Tb927.2.4925,5154.5,4235.0,5685.5,5419.5,5282.0,hypothetical protein,S
Tb927.2.4930,6116.5,7731.5,6838.0,7651.5,7924.5,esterase  putative,>4C (GG2M)
Tb927.2.4950,10618.0,10507.0,10567.0,10335.0,9965.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.4970,9570.5,8068.5,7629.0,7925.5,8762.0,UV radiation resistance protein and autophagy-related subunit 14  putative,<2C (LG1)
Tb927.2.4980,7046.0,6500.0,6246.0,6979.0,4915.5,EMG1/NEP1 methyltransferase  putative,<2C (LG1)
Tb927.2.4990,7074.5,9809.0,10089.0,10115.5,9872.5,hypothetical protein  conserved,G2M
Tb927.2.5000,10698.0,7518.0,7756.0,7434.0,7762.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5010,612.5,2260.5,994.0,2725.0,2218.5,Meiotic cell cortex C-terminal pleckstrin homology  putative,G2M
Tb927.2.5020,8453.0,6599.5,7629.0,7495.5,7826.5,acyl-CoA oxidase  putative,<2C (LG1)
Tb927.2.5030,2747.5,5104.5,5396.5,6525.0,4418.5,transcription elongation factor SPT5  putative,G2M
Tb927.2.5040,2956.5,4913.5,4510.0,4558.5,1929.5,MORN repeat  putative,G1
Tb927.2.5050,9393.5,6946.0,7165.0,8082.0,7369.5,protein phosphatase 2C  putative,<2C (LG1)
Tb927.2.5060,6409.5,6936.0,6803.5,5386.0,5963.0,GTP binding protein  putative,G1
Tb927.2.5070,612.5,222.0,189.5,159.0,213.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5080,9449.0,7810.0,8763.5,8470.0,7676.5,hypothetical protein  conserved,<2C (LG1)
Tb2.NT.50,1460.0,554.5,427.0,610.5,1374.5,Noncoding RNA  putative,<2C (LG1)
Tb927.2.5120,1783.5,1405.5,3737.5,1702.0,2679.0,Vesicle-associated membrane protein 7,S
Tb927.2.5130,8325.5,2828.5,2703.5,2150.0,3310.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5140,3494.5,2828.5,3441.0,2058.5,2574.5,hypothetical protein  conserved,<2C (LG1)
Tb2.NT.51,6251.5,2384.0,1757.0,2211.5,2364.5,Noncoding RNA  putative,<2C (LG1)
Tb927.2.5150,7717.0,4920.0,6442.0,6434.5,4498.5,TPR-repeat protein  putative,<2C (LG1)
Tb927.2.5160,2552.0,3890.0,2440.5,2671.0,3716.5,chaperone protein DnaJ  putative,G1
Tb927.2.5180,6684.5,4603.5,5618.5,6171.5,4831.5,aldo-keto reductase  putative,<2C (LG1)
Tb927.2.5190,10047.0,5871.0,5109.5,5583.5,5916.5,Homologous-pairing protein 2 homolog,<2C (LG1)
Tb927.2.5200,9064.5,6782.5,6460.5,6582.5,7201.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5210,7640.5,6951.0,7896.0,7199.5,7280.5,beta-ketoacyl-ACP reductase,S
Tb927.2.5220,2094.5,4181.5,5015.0,4486.5,5761.0,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.5230,8073.0,3922.5,4214.0,3332.5,1266.0,CAMK family pseudokinase  putative,<2C (LG1)
Tb927.2.5240,1783.5,5416.0,5084.5,7264.0,10193.0,pre-mRNA splicing factor 19,>4C (GG2M)
Tb927.2.5250,1460.0,3799.0,5054.0,4267.0,7299.5,tubulin-tyrosine ligase  putative,>4C (GG2M)
Tb927.2.5260,5423.5,1437.5,1791.5,1374.0,2141.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5270,2329.5,3217.5,4887.0,5260.5,11496.5,dynein heavy chain  putative,>4C (GG2M)
Tb927.2.5280,3882.5,7430.0,6495.5,6014.5,4051.0,Enriched in surface-labeled proteome protein 1,G1
Tb927.2.5290,7130.0,10243.0,10090.5,10052.0,8703.0,hypothetical protein  conserved,G1
Tb927.2.5300,5286.0,6690.5,6826.5,6883.0,5609.5,hypothetical protein  conserved,G2M
Tb927.2.5310,10189.5,10870.5,10474.0,10550.5,8291.0,hypothetical protein  conserved,G1
Tb927.2.5320,7617.0,8096.5,7505.5,8155.0,6083.5,hypothetical protein  conserved,G2M
Tb927.2.5330,9731.0,11264.0,11295.0,11303.5,11209.0,hypothetical protein  conserved,G2M
Tb927.2.5340,7380.5,10533.0,10460.5,11012.5,9872.5,hypothetical protein  conserved,G2M
Tb927.2.5350,7987.0,9875.0,9368.0,9622.0,8773.5,hypothetical protein  conserved,G1
Tb927.2.5360,8932.0,10555.5,10398.0,10145.0,9149.0,hypothetical protein  conserved,G1
Tb927.2.5384,8919.5,8189.5,8813.0,7915.5,7951.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb927.2.5410,9404.0,10509.5,10822.5,10564.5,10990.5,ABC transporter family-like protein,>4C (GG2M)
Tb927.2.5440,11594.0,11216.0,11346.0,11313.5,10360.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5480,11172.0,10965.0,10843.5,10327.0,10113.5,hypothetical protein  conserved,<2C (LG1)
Tb2.NT.57,3358.0,4928.0,4327.5,4174.5,3628.5,Noncoding RNA  putative,G1
Tb927.2.5500,6602.0,7985.5,8157.5,7830.0,5354.0,hypothetical protein  conserved,S
Tb927.2.5530,11399.0,10949.5,10976.5,10799.0,9454.0,Present in the outer mitochondrial membrane proteome 22-1,<2C (LG1)
Tb2.NT.58,1460.0,1904.5,1799.0,1936.0,559.5,Noncoding RNA  putative,G2M
Tb927.2.5540,7193.0,11369.0,11315.5,11285.0,11315.0,hypothetical protein  conserved,G1
Tb927.2.5600,7260.0,11376.0,11341.5,11260.0,11256.0,hypothetical protein  conserved,G1
Tb2.NT.61,1460.0,1934.0,1799.0,2252.0,637.0,Noncoding RNA  putative,G2M
Tb927.2.5610,11442.5,11070.0,11168.0,11077.0,10194.0,Present in the outer mitochondrial membrane proteome 22B,<2C (LG1)
Tb927.2.5630,7285.0,8899.0,9137.5,8928.5,7112.5,hypothetical protein  conserved,S
Tb2.NT.63,1460.0,3447.0,2692.0,2893.5,1717.0,Noncoding RNA  putative,G1
Tb927.2.5650,11138.0,11144.5,10983.0,10697.0,10522.0,hypothetical protein  conserved,G1
Tb927.2.5660,612.5,1747.5,2684.5,2494.5,2884.5,adenylate kinase  putative,>4C (GG2M)
Tb927.2.5680,1460.0,5513.5,6226.5,5481.5,7676.5,U2 small nuclear RNA,>4C (GG2M)
Tb927.2.5710,7377.0,6471.5,6556.0,7236.0,6028.0,hypothetical protein,<2C (LG1)
Tb927.2.5720,2137.5,8020.5,7850.5,7871.0,7092.0,hypothetical protein,G1
Tb927.2.5750,10214.0,8451.5,9032.0,8642.0,8559.0,tyrosyl-DNA Phosphodiesterase (Tdp1)  putative,<2C (LG1)
Tb927.2.5760,11623.0,11555.0,11555.0,11561.0,11387.0,Flagellar Member 8,<2C (LG1)
Tb927.2.5800,6137.0,6429.5,6046.5,6348.0,7494.0,sedoheptulose-1 7-bisphosphatase,>4C (GG2M)
Tb927.2.5810,9009.0,8908.0,8249.5,8529.5,5834.5,Holliday-junction resolvase-like of SPT6/SH2 domain containing protein  putative,<2C (LG1)
Tb927.2.5820,10010.0,10414.0,10385.5,10488.5,10517.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.5830,3013.5,5128.0,4160.5,5392.0,4680.5,hypothetical protein  conserved,G2M
Tb927.2.5850,4792.5,2707.5,3009.0,3045.0,3760.5,small nuclear ribonucleoprotein SmD2,<2C (LG1)
Tb927.2.5860,11142.0,10319.0,10184.5,9416.5,9298.5,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5870,11550.0,11654.0,11670.0,11640.0,11597.0,hypothetical protein  conserved,S
Tb927.2.5890,1783.5,5397.5,5084.5,6790.5,3970.0,hypothetical protein  conserved,G2M
Tb927.2.5900,8692.5,8832.5,8683.0,9217.5,8549.5,hypothetical protein  conserved,G2M
Tb927.2.5910,612.5,158.5,130.5,182.5,347.0,40S ribosomal protein S13  putative,<2C (LG1)
Tb927.2.5930,1460.0,8007.5,7947.5,9081.5,6143.5,hypothetical protein  conserved,G2M
Tb927.2.5950,6620.5,8964.0,8703.5,9495.5,8690.5,hypothetical protein  conserved,G2M
Tb927.2.5970,9647.0,5136.0,4857.0,4567.5,4073.0,hypothetical protein  conserved,<2C (LG1)
Tb927.2.5980,3726.5,10007.0,9971.5,9434.0,8254.5,chaperone protein ClpB1  putative,G1
Tb927.2.6000,4995.5,6792.5,5919.0,6761.5,6950.5,glycosylphosphatidylinositol-specific phospholipase C,>4C (GG2M)
Tb927.2.6050,3494.5,4393.0,3813.0,5109.5,5209.5,beta prime COP protein,>4C (GG2M)
Tb927.2.6070,6552.0,5789.5,6469.0,5240.0,6535.5,mitochondrial RNA binding complex 1 subunit,<2C (LG1)
Tb927.2.6080,6762.5,7208.0,6942.5,7236.0,7299.5,hypothetical protein  conserved,>4C (GG2M)
Tb927.2.6090,5281.0,2561.0,1574.0,957.5,1828.0,60S ribosomal protein L44,<2C (LG1)
Tb927.2.6100,4527.5,5172.5,4911.0,5333.0,4839.5,hypothetical protein  conserved,G2M
Tb927.2.6130,8687.5,9980.5,10163.0,9408.5,9681.0,ABC transporter  putative,S
Tb927.2.6150,8777.5,9132.0,8627.0,9493.0,8505.0,adenosine transporter 2,G2M
Tb927.2.6180,3882.5,8664.0,7484.0,8728.0,6298.5,iron/ascorbate oxidoreductase family protein  putative,G2M
Tb927.2.6200,11332.0,11363.0,11475.0,11537.0,11319.0,adenosine transporter 2  putative,G2M
Tb927.2.6210,6528.0,6437.0,5265.0,5190.5,4635.5,iron/ascorbate oxidoreductase family protein  putative,<2C (LG1)
Tb927.2.6220,2329.5,7716.0,7416.0,8026.5,6499.0,adenosine transporter 2  putative,G2M
Tb927.2.6230,11012.0,11380.0,11377.0,11394.0,11150.0,iron/ascorbate oxidoreductase family protein  putative,G2M
Tb927.2.6240,11508.0,11509.0,11441.0,11518.0,11446.0,adenosine transporter 2,G2M
Tb927.2.6270,11554.0,11182.0,11121.0,11111.0,10923.5,iron/ascorbate oxidoreductase family protein  putative,<2C (LG1)
Tb927.2.6280,11224.0,11490.0,11451.0,11538.0,11401.0,adenosine transporter 2  putative,G2M
Tb927.2.6310,11397.0,11190.0,11090.0,11244.0,10963.0,iron/ascorbate oxidoreductase family protein  putative,<2C (LG1)
Tb927.2.6320,10211.5,11060.0,10719.0,11000.5,10738.0,adenosine transporter 2  putative,G1
Tb927.2.6350,9352.0,6870.0,7009.5,6962.0,6870.5,variant surface glycoprotein  point mutation,<2C (LG1)
Tb927.2.6372,11557.0,11285.0,11008.0,11205.0,10798.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb927.2.6375,7660.5,6181.5,7227.5,6112.5,7662.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb927.2.6380,612.5,2416.5,2499.0,3087.5,2254.0,variant surface glycoprotein  frameshift,G2M
Tb927.2.6390,8030.5,5180.0,5792.5,6796.5,5317.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb927.2.6400,7652.5,5738.0,5144.0,6626.0,7453.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb927.2.6404,8981.5,6615.5,5829.0,7873.5,6836.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,<2C (LG1)
Tb927.2.6410,7200.5,6830.0,7744.5,6573.5,6405.0,variant surface glycoprotein (VSG  atypical)  putative,S
Tb927.2.6430,7843.5,4642.5,5015.0,5307.5,5024.5,variant surface glycoprotein  frameshift,<2C (LG1)
Tb927.2.6435,4947.5,4276.0,2679.5,3075.0,5301.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb05.5K5.10,612.5,40.5,40.0,33.5,86.0,conserved hypothetical protein  conserved (fragment),<2C (LG1)
Tb05.5K5.20,5441.0,6344.0,5867.0,6555.5,6131.0,hypothetical protein  conserved,G2M
Tb05.5K5.30,6126.5,8248.0,8455.5,8888.0,9609.5,serine/threonine protein phosphatase  putative,>4C (GG2M)
Tb05.5K5.40,2982.0,1766.0,1226.0,1391.5,3185.0,hypothetical protein  conserved,>4C (GG2M)
Tb05.5K5.50,612.5,4950.0,5486.5,5816.0,6878.5,hypothetical protein  conserved,>4C (GG2M)
Tb05.5K5.60,612.5,438.0,1388.5,1281.0,3741.0,hypothetical protein  conserved,>4C (GG2M)
Tb05.5K5.70,8667.0,7208.0,7171.5,7506.5,4635.5,nucleolar RNA helicase II  putative,<2C (LG1)
Tb05.5K5.80,6009.5,6211.0,5875.5,7344.0,6281.0,calcium/calmodulin-dependent protein kinase  putative,G2M
Tb05.5K5.90,2619.0,222.0,427.0,313.5,287.0,dynein light chain  putative,<2C (LG1)
Tb05.5K5.100,4956.5,2020.5,2465.5,2373.0,2631.5,hypothetical protein  conserved,<2C (LG1)
Tb05.5K5.110,9948.0,6736.0,5408.5,6322.0,5479.5,major vault protein  putative,<2C (LG1)
Tb05.5K5.120,6733.0,9142.5,7601.0,8749.0,8582.0,hypothetical protein  conserved,G1
Tb05.5K5.130,4505.5,2839.5,3940.5,3627.0,3510.5,paraflagellar rod component par4  putative,<2C (LG1)
Tb05.5K5.140,6047.5,2785.5,4160.5,3763.0,4860.0,Trypanosoma specific protein  unknown function,<2C (LG1)
Tb05.5K5.150,4982.0,2232.0,2717.5,2199.0,4199.0,small GTP-binding protein  putative,<2C (LG1)
Tb05.5K5.160,7366.5,3032.5,3767.5,3627.0,6253.5,hypothetical protein  conserved,<2C (LG1)
Tb05.5K5.170,4122.5,1303.5,685.0,610.5,1099.0,elongation of very long chain fatty acids protein  putative,<2C (LG1)
Tb05.5K5.180,8546.0,8964.0,8433.5,8868.0,8409.5,receptor-type adenylate cyclase GRESAG 4  putative,G1
Tb05.5K5.190,10966.0,10794.0,10708.0,10617.0,10793.5,receptor-type adenylate cyclase GRESAG 4  putative,<2C (LG1)
Tb05.5K5.200,4680.0,3753.5,3858.5,3521.5,5752.5,guanine deaminase  putative,>4C (GG2M)
Tb05.5K5.210,7822.5,6977.5,7873.0,8520.5,11652.0,hypothetical protein,>4C (GG2M)
Tb05.5K5.220,7830.0,9542.0,9524.0,9426.0,11481.5,hypothetical protein,>4C (GG2M)
Tb05.5K5.230,9626.0,9205.5,8610.0,9149.5,9036.0,RAB GTP-binding protein  degenerate,<2C (LG1)
Tb05.5K5.240,7915.5,6306.5,6134.0,5799.5,5647.5,expression site-associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb05.5K5.250,3863.0,4348.5,3832.5,4647.0,2619.0,hypothetical protein,G2M
Tb05.5K5.260,5137.0,4260.5,3288.0,3724.0,4337.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb05.5K5.270,5635.5,3950.5,3308.0,3319.0,2079.5,expression site-associated gene 9 (ESAG9)  frameshift,<2C (LG1)
Tb05.5K5.280,9743.5,9611.5,9365.5,9955.5,9564.5,expression site-associated gene 1 (ESAG1)  point mutation,G2M
Tb05.5K5.290,3252.5,1969.0,1783.0,1779.5,1860.5,hypothetical protein,<2C (LG1)
Tb05.5K5.300,3078.5,4103.5,3051.5,3805.5,4626.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb05.5K5.310,5598.0,5077.5,4104.0,4137.0,4187.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb05.5K5.320,2574.5,3680.0,1791.5,1966.0,1717.0,variant surface glycoprotein (VSG)  putative,G1
Tb05.5K5.330,612.5,3758.0,2164.5,2999.5,1027.5,variant surface glycoprotein  point mutation,G1
Tb05.5K5.340,7465.0,3211.5,2564.5,2134.5,3494.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb05.5K5.350,6737.5,3109.0,3609.0,4486.5,2231.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb05.5K5.360,3166.5,2707.5,2207.0,2554.0,2322.0,variant surface glycoprotein  point mutation,<2C (LG1)
Tb05.5K5.370,5686.0,8955.0,8676.5,8602.5,7551.5,variant surface glycoprotein  degenerate,G1
Tb05.5K5.380,612.5,3344.5,4117.0,3627.0,5014.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb05.5K5.390,8513.5,9081.5,8749.5,8091.5,5332.5,variant surface glycoprotein  degenerate,G1
Tb05.5K5.400,8361.0,4181.5,3779.5,3521.5,2847.0,variant surface glycoprotein  interrupted,<2C (LG1)
Tb05.5K5.410,612.5,3499.5,3205.5,2373.0,3260.0,variant surface glycoprotein  degenerate,G1
Tb05.5K5.420,2481.0,5592.5,5460.5,5538.5,4822.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb05.5K5.430,7646.5,1670.0,1679.0,1936.0,2914.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb05.5K5.440,3834.5,5355.0,5025.0,4754.5,3310.5,variant surface glycoprotein  point mutation,G1
Tb05.5K5.450,7446.5,1697.0,1465.0,1572.5,2647.0,variant surface glycoprotein  frameshift,<2C (LG1)
Tb05.5K5.460,3606.0,5261.5,5265.0,4579.0,3295.5,variant surface glycoprotein (VSG)  pseudogene,S
Tb05.5K5.470,1460.0,2106.0,2630.0,3605.5,1608.0,variant surface glycoprotein  frameshift,G2M
Tb05.5K5.480,1460.0,678.5,966.5,907.5,584.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb05.5K5.490,3241.5,4172.0,4293.5,4221.0,4345.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb05.5K5.500,3645.5,2544.5,2300.0,3117.0,2297.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb05.5K5.510,4587.0,4603.5,4029.0,5333.0,3447.0,phosphoglycan beta 1 3 galactosyltransferase  degenerate,G2M
Tb05.5K5.520,6308.5,3646.5,4200.5,4464.5,1239.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb05.5K5.530,1460.0,4474.0,5736.5,4772.5,7201.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb05.5K5.540,612.5,5431.5,6262.0,6024.5,5943.5,variant surface glycoprotein  degenerate,S
Tb09.v4.0179,7804.5,6084.5,5717.5,5470.0,6631.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0180,6455.0,4287.0,6236.5,4699.5,4748.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0181,612.5,904.0,1347.5,1441.0,721.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G2M
Tb09.v4.0182,3875.5,5454.0,3410.0,3185.0,2720.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0183,5374.5,1643.5,1956.0,1763.5,3939.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0184,7558.5,7479.0,6410.0,7495.5,7442.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0185,1988.0,4574.0,3994.5,3992.5,5110.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb09.v4.0186,2481.0,1684.5,1237.5,907.5,874.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0187,4433.0,2934.5,3051.5,2440.0,3144.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0188,612.5,759.0,1149.5,773.0,1860.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0088,3810.5,2457.0,1886.0,1922.5,1732.0,variant surface glycoprotein (VSG),<2C (LG1)
Tb09.v4.0089,7050.5,4913.5,4904.5,4355.5,3524.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0090,6037.5,4838.0,4124.0,4394.5,4187.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0091,8374.5,6963.0,6577.0,7040.5,5870.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb09.v4.0092,5467.5,6128.5,4767.5,5148.0,5153.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0093,612.5,664.5,880.5,788.5,1407.5,variant surface glycoprotein  fragment,>4C (GG2M)
Tb09.v4.0094,612.5,1018.0,907.5,687.0,1195.0,variant surface glycoprotein  fragment,>4C (GG2M)
Tb09.v4.0095,3131.5,855.5,1067.0,1110.5,1355.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb09.v4.0096,4834.5,2540.0,2887.5,2671.0,4158.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0097,5706.0,2128.0,2275.0,2290.0,1141.0,hypothetical protein  pseudogene,<2C (LG1)
Tb09.v4.0098,3202.0,2714.5,2876.5,2840.5,2254.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0099,5105.0,3419.0,4749.0,4166.5,5188.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0100,8105.0,3429.0,3503.0,2956.0,4517.5,expression site-associated gene 3 (ESAG3)  fragment,<2C (LG1)
Tb09.v4.0101,6980.0,6260.0,6147.0,6452.5,5044.5,hypothetical protein  pseudogene,<2C (LG1)
Tb09.v4.0102,6080.5,5997.0,5543.5,5662.0,3169.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb09.v4.0103,612.5,2983.5,2050.0,2810.5,2525.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0104,4533.5,6159.0,5656.5,5079.0,4783.5,leucine-rich repeat protein 1 (LRRP1)  fragment,G1
Tb09.v4.0105,2682.0,2814.0,4046.5,3205.5,3199.5,hypothetical protein,S
Tb09.v4.0106,10476.5,10837.0,10466.5,10482.0,11121.0,nucleoside transporter 1  putative,>4C (GG2M)
Tb09.v4.0107,7646.5,5331.5,5962.0,7696.0,7712.5,expression site-associated gene 5 (ESAG5) protein  putative,>4C (GG2M)
Tb09.v4.0108,6672.0,2214.5,2327.5,2025.0,2463.0,expression site-associated gene 8 (ESAG8)  pseudogene,<2C (LG1)
Tb09.v4.0109,1460.0,5695.5,5981.0,6562.0,5725.5,hypothetical protein,G2M
Tb09.v4.0110,4153.0,2232.0,2310.0,2058.5,2389.0,hypothetical protein,<2C (LG1)
Tb09.v4.0111,2180.0,4008.0,3858.5,3658.0,3006.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0112,7232.0,9446.5,8746.5,9878.0,8898.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb09.v4.0113,7484.0,5717.0,6055.5,5437.0,5686.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb09.v4.0114,7080.5,3799.0,3371.5,3254.5,4893.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb09.v4.0115,3524.0,3625.0,3952.0,3699.0,5174.5,expression site-associated gene 3 (ESAG3)  pseudogene,>4C (GG2M)
Tb09.v4.0116,6980.0,5953.5,5981.0,6304.5,4490.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0117,7191.0,4669.0,5084.5,4279.5,5354.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0118,5886.0,3979.0,3308.0,2801.0,5379.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0119,2700.0,7810.0,8892.5,8578.5,8807.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0120,1460.0,1455.0,1324.0,1215.5,1027.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0121,4122.5,2592.5,2621.5,2919.0,2454.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0122,3107.5,3625.0,3503.0,3418.5,3733.0,expression site-associated gene 3 (ESAG3)  fragment,>4C (GG2M)
Tb09.v4.0123,4930.5,3747.5,4388.0,4336.5,4867.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0124,7016.5,1823.0,1848.0,1922.5,3033.0,hypothetical protein,<2C (LG1)
Tb09.v4.0125,7851.0,10072.0,10011.0,10295.5,10095.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb09.v4.0126,612.5,4079.5,2801.5,4004.5,5332.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0127,5915.0,3436.5,4928.0,3965.5,1266.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0128,5524.5,5530.5,4200.5,5137.0,4089.5,variant surface glycoprotein  fragment,G1
Tb09.v4.0129,612.5,652.5,848.5,687.0,1195.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0130,8614.5,3485.5,3288.0,3924.0,3006.0,expression site-associated gene 3 (ESAG3)  fragment,<2C (LG1)
Tb09.v4.0131,8236.5,7447.5,6393.0,6549.5,7112.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0132,4327.5,5301.5,4848.5,5365.0,4703.5,expression site-associated gene 2/3 (ESAG2/ESAG3)  pseudogene,G2M
Tb09.v4.0133,612.5,458.5,410.0,557.5,874.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0134,4810.5,2034.0,2112.5,2134.5,2706.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0135,5844.5,2652.5,2154.5,3130.0,3386.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0136,7564.5,3747.5,4380.5,3978.5,2706.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb09.v4.0137,10243.5,11179.5,11323.0,10962.5,10721.5,variant surface glycoprotein  fragment,S
Tb09.v4.0138,10514.5,7694.0,7249.5,7208.0,5963.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0139,7371.0,6683.5,6730.0,6357.5,6048.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0140,3979.5,988.5,1909.5,907.5,1374.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb09.v4.0141,5275.5,1303.5,3179.5,1847.0,3915.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0142,6405.5,4317.5,5120.0,5728.5,5266.5,variant surface glycoprotein,<2C (LG1)
Tb09.v4.0143,10104.5,11255.5,11359.5,11054.0,10541.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0144,2956.5,2078.0,2764.5,2788.5,2268.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0145,4449.5,3813.5,3260.0,2907.5,4725.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0061,10780.5,7605.0,7676.5,7698.5,6131.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0062,1460.0,1894.5,1522.0,1899.5,1472.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G2M
Tb09.v4.0063,7880.0,10194.5,10290.5,10445.5,10881.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0064,10514.5,10586.0,11018.0,10935.5,10679.5,hypothetical protein,S
Tb09.v4.0065,4859.0,5757.0,6010.0,5765.5,5044.5,expression site-associated gene 1 (ESAG 1)  putative,S
Tb11.0290,1460.0,307.0,253.5,248.0,584.5,chrXI additional  unordered contigs,<2C (LG1)
Tb11.0300,1783.5,2128.0,2023.5,2275.5,1842.0,hypothetical protein,G2M
Tb11.0310,5762.0,3900.0,4224.5,4327.5,2884.5,hypothetical protein,<2C (LG1)
Tb11.0320,5361.5,6437.0,7823.5,7314.0,5585.0,hypothetical protein,S
Tb11.0330,1460.0,1940.0,1522.0,1726.5,2609.5,Cornifin (SPRR) family  putative,>4C (GG2M)
Tb11.0340,4002.5,3447.0,3308.0,3566.5,3021.0,hypothetical protein,<2C (LG1)
Tb11.0350,6684.5,2206.0,1870.0,1609.0,2819.0,hypothetical protein,<2C (LG1)
Tb11.0360,4190.5,2828.5,3755.0,4504.5,2125.5,chrXI additional  unordered contigs,G2M
Tb11.0370,8236.5,7195.5,6593.0,6582.5,5394.5,chrXI additional  unordered contigs,<2C (LG1)
Tb11.0380,6695.5,4420.5,3891.5,3724.0,2964.0,chrXI additional  unordered contigs,<2C (LG1)
Tb11.0390,1460.0,130.0,130.5,705.5,213.0,chrXI additional  unordered contigs,<2C (LG1)
Tb11.0400,4182.0,3171.5,3021.0,3380.5,3716.5,P27 protein  putative,<2C (LG1)
Tb11.0410,5920.5,3941.5,4462.5,4367.0,3447.0,hypothetical protein,<2C (LG1)
Tb11.0420,6308.5,4420.5,5551.5,4841.0,4703.5,hypothetical protein,<2C (LG1)
Tb09.v4.0021,4260.5,8103.5,8038.5,8454.0,7401.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb09.v4.0022,3261.0,2949.5,2092.5,2788.5,5657.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0023,4298.5,4928.0,5144.0,4623.0,7930.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb09.v4.0024,4965.0,3150.0,3969.5,3752.5,4081.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb09.v4.0025,11349.0,11426.0,11355.0,11303.5,11018.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0026,5082.5,3313.0,3215.0,3596.5,2050.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb09.v4.0027,1914.0,3217.5,3167.0,2869.0,2928.5,expression site-associated gene 3 (ESAG3)  degenerate,G1
Tb09.v4.0028,1460.0,1875.5,1860.0,3264.5,1608.0,variant surface glycoprotein  fragment,G2M
Tb09.v4.0029,4134.0,3293.0,4046.5,4097.0,4440.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0030,7421.0,3596.0,4283.5,4279.5,3006.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb09.v4.0031,9975.0,8118.0,7562.5,7801.5,7369.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb09.v4.0032,612.5,192.5,130.5,136.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0033,7210.5,6591.5,6360.5,7839.5,6737.5,expression site-associated gene 3 (ESAG3)  fragment,G2M
Tb09.v4.0034,1783.5,4583.0,3843.5,4531.5,2525.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0035,612.5,1466.5,1848.0,1585.5,1842.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0036,3078.5,1574.5,1237.5,737.0,1162.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0150,1460.0,4590.5,5531.5,4841.0,4860.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0151,8462.5,10163.5,9556.0,9547.5,9442.5,hypothetical protein,G1
Tb09.v4.0152,8507.0,10756.0,10504.0,10510.5,10488.0,hypothetical protein,G1
Tb09.v4.0153,10736.0,10667.0,10874.0,10804.0,10383.0,hypothetical protein,S
Tb09.v4.0154,7906.5,7770.5,7614.0,7692.0,8151.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0155,10522.5,7343.5,6642.0,7099.5,6938.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0232,4163.5,1332.5,1956.0,2642.5,2941.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0233,612.5,3758.0,2275.0,3254.5,3076.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,G1
Tb10.v4.0234,4587.0,2283.0,2075.5,3075.0,1842.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb10.v4.0235,1460.0,4034.0,4316.5,4772.5,5252.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,>4C (GG2M)
Tb10.v4.0236,2381.5,458.5,703.0,464.0,778.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0237,9318.0,7549.0,8356.0,8048.0,7154.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0238,11079.0,9157.5,9276.0,10072.0,7770.5,variant surface glycoprotein (VSG  pseudogene)  fragment,<2C (LG1)
Tb10.v4.0239,612.5,5711.0,5208.5,5042.5,6439.5,variant surface glycoprotein (VSG)  pseudogene,>4C (GG2M)
Tb10.v4.0240,9478.5,10862.0,10655.0,10335.0,9659.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,G1
Tb11.0660,5534.0,4348.5,3877.5,4252.5,3086.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.0670,1783.5,2920.5,2577.0,2025.0,2427.0,variant surface glycoprotein (VSG)  putative,G1
Tb11.0680,7682.5,2344.0,2827.0,2577.5,3457.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.0690,612.5,530.0,818.5,248.0,1392.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.0430,3762.0,2214.5,2679.5,2302.0,1896.5,hypothetical protein,<2C (LG1)
Tb11.0440,4205.0,3639.0,4421.0,3194.5,3921.0,hypothetical protein,S
Tb11.0450,4225.5,2490.5,2977.0,2072.5,2322.0,hypothetical protein,<2C (LG1)
Tb11.0460,3785.5,1266.0,1289.5,849.0,1355.0,hypothetical protein,<2C (LG1)
Tb11.0470,4470.5,3032.5,3821.0,2506.5,2472.5,hypothetical protein,<2C (LG1)
Tb11.0480,4806.0,2908.0,3388.5,2357.0,1660.5,hypothetical protein,<2C (LG1)
Tb09.v4.0037,7260.0,4849.5,5164.0,4647.0,3981.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0038,2094.5,438.0,336.0,313.5,637.0,UDP-Gal or UDP-GlcNAc-dependent glycosyltransferase (pseudogene)  putative,<2C (LG1)
Tb09.v4.0039,10942.0,3447.0,3618.0,3805.5,3044.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0040,612.5,40.5,40.0,33.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0203,4633.0,3447.0,4057.0,3503.0,4014.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0204,6185.5,5407.0,4476.0,3837.0,3618.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0205,5663.0,2416.5,3987.0,2168.5,4737.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0206,5944.5,1643.5,1300.0,2168.5,1804.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb09.v4.0207,7345.5,3397.0,3521.5,3429.5,3510.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0208,3041.5,2232.0,2103.5,1980.0,2505.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0209,7602.5,8056.5,7813.0,7912.0,7834.0,chrIX additional  unordered contigs,G1
Tb11.1090,612.5,438.0,795.0,862.0,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb11.1100,5923.0,3150.0,4148.5,4166.5,4947.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1110,8625.0,4373.5,4868.0,4587.0,7885.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0054,1460.0,96.0,1923.0,1187.5,86.0,variant surface glycoprotein  fragment,S
Tb09.v4.0055,612.5,158.5,189.5,221.5,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0056,10794.5,7992.5,7578.5,6531.0,7501.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0057,4411.0,2785.5,2750.5,1558.5,607.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0131,3407.5,835.5,795.0,808.0,607.0,hypothetical protein,<2C (LG1)
Tb10.v4.0132,5915.0,7032.0,7091.5,6669.5,5542.5,variant surface glycoprotein (VSG)  putative,S
Tb10.v4.0133,6233.5,10395.0,10628.5,10180.0,9126.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,S
Tb10.v4.0134,2137.5,8310.5,7319.5,7455.0,8744.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb10.v4.0135,1783.5,3711.5,3398.5,4290.5,4874.0,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb10.v4.0136,9886.0,6936.0,6780.0,8000.5,8230.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0137,3283.5,3419.0,3398.5,4045.0,3541.0,expression site-associated gene 3 (ESAG3)  degenerate,G2M
Tb10.v4.0138,5925.5,3526.0,3642.0,3154.0,4036.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb10.v4.0139,7272.5,7002.0,7700.5,7617.5,7377.0,variant surface glycoprotein (VSG)  putative,S
Tb10.v4.0140,6896.5,3235.0,2969.0,1936.0,3271.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0141,6207.5,6205.5,7131.5,6837.5,2297.5,expression site-associated gene 3 (ESAG3)  degenerate,S
Tb10.v4.0142,9697.0,4684.0,2341.0,3909.0,778.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0143,6223.5,5261.5,3364.5,4336.5,4468.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0042,3394.0,3129.0,3157.0,2589.0,2218.5,hypothetical protein,<2C (LG1)
Tb10.v4.0043,612.5,4796.5,5325.5,4962.5,3748.5,chrX additional  unordered contigs,S
Tb10.v4.0044,8196.5,5804.5,4823.0,4882.0,5824.0,hypothetical protein  conserved,<2C (LG1)
Tb10.v4.0045,612.5,2170.0,1561.5,2102.5,1860.5,prohibitin  putative,G1
Tb10.v4.0046,5616.0,4895.5,6401.0,6540.5,6377.5,transporter  putative,G2M
Tb10.v4.0032,7873.0,6504.5,6767.0,7137.5,4158.0,expression site- associated gene 3 (ESAG3) protein  putative,<2C (LG1)
Tb10.v4.0033,10408.0,7630.5,7879.0,6962.0,7981.0,pumillo RNA binding protein PUF1,<2C (LG1)
Tb10.v4.0034,3589.5,944.0,562.5,737.0,1758.0,SAP domain containing protein  putative,<2C (LG1)
Tb10.v4.0035,2460.0,1858.0,1371.0,1572.5,2000.0,stress-inducible protein STI1-like  putative,<2C (LG1)
Tb10.v4.0036,3131.5,5612.5,5717.5,6381.0,7236.5,leucine carboxyl methyltransferase  putative,>4C (GG2M)
Tb10.v4.0037,7157.5,9378.0,10038.0,8997.0,9889.0,hypothetical protein  conserved,S
Tb10.v4.0038,3041.5,6418.0,5704.5,6388.5,3335.5,chrX additional  unordered contigs,G1
Tb10.v4.0039,4745.5,5592.5,5661.5,6157.0,8071.5,hypothetical protein  conserved,>4C (GG2M)
Tb10.v4.0040,5235.0,4181.5,4170.0,4166.5,5463.0,mRNA capping methyltransferase  putative,>4C (GG2M)
Tb10.v4.0041,612.5,4920.0,4607.0,3380.5,4839.5,PUB domain containing protein  putative,G1
Tb09.v4.0156,612.5,3138.5,2564.5,2373.0,3566.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0157,9593.0,4207.5,5197.0,5939.0,4571.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0158,7301.5,3353.0,3108.5,2530.5,1453.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0159,4523.5,4096.5,4019.5,3878.0,4468.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0160,6361.5,6265.5,6041.0,6229.5,5640.0,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb09.v4.0161,2481.0,1171.5,1067.0,1391.5,1531.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0490,3419.0,530.0,1207.5,1215.5,697.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0500,4411.0,2561.0,1808.5,1922.5,1407.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0510,612.5,978.5,1311.0,1416.5,637.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb11.1490,1460.0,855.5,1549.5,1171.0,1472.0,variant surface glycoprotein (VSG)  putative,S
Tb11.1500,5653.0,2701.5,1977.0,1745.0,2427.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1510,2258.5,640.0,717.5,664.0,1789.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1520,3828.5,2335.0,4104.0,4252.5,3704.0,hypothetical protein  conserved,G2M
Tb11.1530,4248.0,3284.0,3618.0,4112.0,3929.5,expression site-associated gene 1 (ESAG1)  degenerate,<2C (LG1)
Tb09.v4.0009,3904.5,3313.0,4246.0,3752.5,3199.5,receptor-type adenylate cyclase  putative,S
Tb09.v4.0010,9823.0,7864.0,8249.5,7834.0,8879.5,variant surface glycoprotein (VSG)  pseudogene,<2C (LG1)
Tb09.v4.0011,3929.5,5225.5,4840.5,4552.0,5694.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb09.v4.0012,4074.0,5914.5,5097.0,4355.5,5916.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb09.v4.0013,9894.0,10995.0,10867.0,10982.5,10573.0,retrotransposon hot spot (RHS) protein  putative,G1
Tb09.v4.0014,5343.5,2011.0,2023.5,2404.0,1732.0,hypothetical protein,<2C (LG1)
Tb09.v4.0015,612.5,1231.0,1886.0,1441.0,2000.0,hypothetical protein,>4C (GG2M)
Tb11.1740,11275.0,11282.0,11411.0,10975.5,11051.0,hypothetical protein,S
Tb11.1750,11652.0,11636.0,11658.0,11583.0,11607.0,hypothetical protein,S
Tb11.1760,11026.5,10789.0,11109.0,10222.5,10700.0,hypothetical protein,S
Tb11.1770,11666.0,11635.0,11655.0,11588.0,11609.0,hypothetical protein,<2C (LG1)
Tb10.v4.0251,4661.0,7002.0,9162.5,8414.0,7951.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0252,2598.0,2671.0,2011.5,2422.0,4199.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0253,6037.5,1052.0,1311.0,1140.0,2310.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0254,5573.5,5438.5,4653.0,5638.0,6836.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0255,4170.0,5811.0,5613.5,6738.5,4081.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,G2M
Tb10.v4.0256,5997.5,4194.0,3969.5,4841.0,5516.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0257,7459.5,3429.0,3678.5,2275.5,4306.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0258,8998.0,9030.5,9464.0,9253.0,9538.0,hypothetical protein,>4C (GG2M)
Tb10.v4.0259,612.5,5664.0,6226.5,5992.0,6965.5,Endonuclease-reverse transcriptase  putative,>4C (GG2M)
Tb10.v4.0260,4182.0,1266.0,1489.0,1626.0,1338.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0261,6960.0,787.5,1008.5,483.0,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0262,4397.0,2969.5,3678.5,4531.5,4418.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0263,612.5,1574.5,2036.0,2520.5,3125.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb10.v4.0264,8638.0,10166.5,10224.0,9968.5,9686.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0091,5094.0,4145.5,2987.0,4409.0,3596.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0092,1460.0,1078.5,1311.0,1416.5,1504.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0093,8897.0,3515.0,2801.5,3013.0,1407.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0094,612.5,413.0,373.5,313.5,397.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0095,6009.5,4816.5,3379.0,3557.0,778.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0096,11239.5,11168.0,11301.0,11058.0,10800.5,variant surface glycoprotein (VSG)  putative,S
Tb10.v4.0097,9385.5,8699.5,9792.5,9196.5,8026.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,S
Tb10.v4.0098,1460.0,1565.5,1966.5,1504.0,86.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,S
Tb10.v4.0099,3448.5,5172.5,4372.0,5704.5,5824.0,hypothetical protein,>4C (GG2M)
Tb11.0790,6680.5,6705.5,8206.5,6177.5,7120.0,hypothetical protein,S
Tb11.0800,8772.0,9661.0,10484.5,9536.5,8984.0,hypothetical protein,S
Tb11.0810,11700.0,11707.0,11713.0,11707.0,11704.0,hypothetical protein,S
Tb11.0090,4734.5,2042.0,1791.5,2788.5,1929.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0100,2094.5,471.5,471.5,501.5,1010.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0110,612.5,2896.5,2389.0,1888.0,915.0,hypothetical protein,G1
Tb11.0120,2780.5,716.5,1522.0,1542.0,1027.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0130,612.5,999.0,532.5,687.0,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb11.0140,5829.0,2664.0,4224.5,3356.0,1744.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0150,612.5,96.0,161.0,33.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0160,3895.5,1619.0,1149.5,1313.5,778.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb11.0170,4649.5,1332.5,1665.0,1451.5,853.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.0180,4840.5,3032.5,3542.0,3343.0,3447.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0190,612.5,2561.0,3079.0,2830.5,4244.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0105,5450.0,2498.0,3560.0,3635.0,1453.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0106,5747.0,2969.5,1731.5,2810.5,2164.5,hypothetical protein  conserved (pseudogene),<2C (LG1)
Tb10.v4.0107,3534.0,1542.0,1289.5,1675.5,3994.5,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb10.v4.0108,5213.5,4937.5,3688.0,3605.5,3076.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0109,612.5,4441.0,4434.0,4252.5,3271.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0110,2619.0,3535.0,3858.5,4070.5,4391.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0111,7780.5,3158.0,2399.5,2629.5,3915.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0112,612.5,96.0,130.5,111.0,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0113,2047.0,4008.0,5015.0,5716.5,2589.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0114,9388.5,5732.5,3858.5,4754.5,4654.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0115,1460.0,1353.5,925.0,1261.0,2218.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0116,3230.0,2814.0,1932.0,1911.5,3871.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0117,3328.5,1643.5,3079.0,2440.0,3960.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb10.v4.0118,612.5,1124.5,1041.5,1281.0,1437.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0119,1460.0,3872.5,4085.5,4156.0,5075.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0120,6602.0,5725.5,6764.0,5190.5,5813.0,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0121,2523.0,3000.5,3167.0,2988.5,2364.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0122,1460.0,4207.5,4448.0,4764.5,6836.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb10.v4.0123,612.5,3973.5,4160.5,3924.0,3847.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0124,4142.5,5229.0,5848.5,5228.0,3044.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0125,612.5,176.5,210.0,248.0,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0840,3598.0,896.0,644.5,890.0,1516.0,hypothetical protein,<2C (LG1)
Tb11.0845,1460.0,727.0,743.0,647.5,2692.0,dynein light chain LC8  putative,>4C (GG2M)
Tb11.0850,7007.0,5706.5,5861.5,6240.5,5014.5,SCAMP family  putative,<2C (LG1)
Tb11.0860,4142.5,4089.5,2977.0,3029.0,1691.0,hypothetical protein,<2C (LG1)
Tb11.0870,3914.0,4790.0,4476.0,4994.0,2631.5,hypothetical protein,G2M
Tb11.0880,2504.5,208.5,233.5,292.5,744.5,chrXI additional  unordered contigs,<2C (LG1)
Tb11.0890,4555.0,3016.0,2839.0,2907.5,2141.5,epsin  putative,<2C (LG1)
Tb10.v4.0126,5550.0,6792.5,6452.5,7479.0,6096.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,G2M
Tb10.v4.0127,8952.5,5573.0,5564.0,5365.0,6038.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0128,4956.5,4574.0,4956.5,5891.5,4292.0,hypothetical protein,G2M
Tb10.v4.0129,2995.0,576.5,644.5,1085.0,347.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb08.27P2.50,2221.0,3672.0,2987.0,3513.0,2805.5,hypothetical protein,G1
Tb08.27P2.60,3701.5,3390.0,2987.0,3938.0,3794.0,hypothetical protein,G2M
Tb08.27P2.70,1988.0,4610.5,3930.5,5260.5,4893.5,hypothetical protein,G2M
Tb08.27P2.80,3726.5,3097.0,3224.5,3878.0,3044.5,hypothetical protein,G2M
Tb08.27P2.90,612.5,386.5,271.5,159.0,287.0,hypothetical protein,<2C (LG1)
Tb08.27P2.110,6492.0,8601.0,8834.5,9014.0,8651.0,PAP2 superfamily  putative,G2M
Tb08.27P2.120,2840.5,1231.0,1149.5,1171.0,486.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.140,8473.5,4072.5,5435.0,4381.0,5014.5,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb08.27P2.150,5181.0,4493.5,4462.5,2184.5,1565.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.160,3751.5,3485.5,2949.5,3888.5,4212.0,expression site-associated gene 3 (ESAG3)  degenerate,>4C (GG2M)
Tb08.27P2.165,10814.5,9088.0,8661.5,8878.0,8831.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb08.27P2.190,2436.0,2260.5,3487.0,2025.0,1437.0,variant surface glycoprotein  degenerate,S
Tb08.27P2.210,1914.0,4251.5,2790.5,3013.0,2413.0,variant surface glycoprotein  degenerate,G1
Tb08.27P2.220,9789.0,2128.0,1574.0,1763.5,2098.0,variant surface glycoprotein (VSG  atypical)  putative,<2C (LG1)
Tb08.27P2.230,612.5,5397.5,5077.0,4973.5,6083.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb08.27P2.240,612.5,1969.0,3009.0,3087.5,1970.0,variant surface glycoprotein (VSG)  putative,G2M
Tb08.27P2.250,6393.5,1704.5,2172.5,2264.5,1878.0,expression site-associated gene 3 (ESAG3)  frameshift,<2C (LG1)
Tb08.27P2.260,1988.0,2779.0,2410.5,3013.0,1281.5,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb08.27P2.270,4480.0,4155.5,5064.5,5109.5,3144.5,variant surface glycoprotein  frameshift,G2M
Tb08.27P2.290,4995.5,5236.0,3902.0,5260.5,6699.0,variant surface glycoprotein (VSG  atypical)  putative,>4C (GG2M)
Tb08.27P2.310,9851.5,3967.5,3850.0,5353.5,2661.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.330,2970.5,1827.5,1489.0,1675.5,637.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb08.27P2.340,4740.5,2062.0,2801.5,2697.5,3681.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.370,7400.5,6095.5,5765.5,5489.0,8401.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb08.27P2.380,2729.0,3206.5,3697.0,3477.5,6639.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb08.27P2.390,4708.0,2551.0,1808.5,2102.5,2536.0,variant surface glycoprotein  frameshift,<2C (LG1)
Tb08.27P2.400,612.5,5521.0,5174.5,5505.5,672.0,expression site-associated gene 3 (ESAG3)  degenerate,G1
Tb08.27P2.410,10465.0,10959.0,10970.0,10606.0,10505.0,variant surface glycoprotein  degenerate  interrupted,S
Tb08.27P2.435,8091.0,5008.5,5208.5,4754.5,5110.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb08.27P2.460,2357.5,2376.0,1289.5,2038.5,697.5,variant surface glycoprotein (VSG)  putative,G1
Tb08.27P2.480,4972.0,3766.0,3920.5,3356.0,3716.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.490,612.5,1394.5,2630.0,2184.5,2283.5,variant surface glycoprotein  degenerate,S
Tb08.27P2.510,4397.0,6181.5,6469.0,5576.5,4081.5,variant surface glycoprotein  degenerate,S
Tb08.27P2.520,7843.5,5196.0,5334.5,5765.5,3021.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb08.27P2.530,2619.0,855.5,1217.0,1110.5,1099.0,variant surface glycoprotein  point mutation,<2C (LG1)
Tb08.27P2.550,4580.0,6235.0,6159.0,6515.5,6623.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb08.27P2.565,3241.5,426.0,293.0,334.5,433.0,variant surface glycoprotein  fragment,<2C (LG1)
Tb08.27P2.580,7377.0,1716.0,2717.5,1202.5,818.0,variant surface glycoprotein  frameshift,<2C (LG1)
Tb08.27P2.610,1460.0,7303.5,6860.0,6940.5,7579.5,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb08.27P2.620,9329.5,7009.0,5229.5,6434.5,5609.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.630,4242.0,2723.0,1742.5,1763.5,1703.0,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.640,3341.5,6683.5,6016.0,6738.5,5555.0,variant surface glycoprotein  degenerate,G2M
Tb08.27P2.555,2574.5,1619.0,2134.0,2617.5,3295.5,phosphoglycan beta 1 3 galactosyltransferase  degenerate,>4C (GG2M)
Tb08.27P2.650,612.5,40.5,161.0,664.0,213.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb08.27P2.660,2913.0,3827.0,3127.0,2357.0,5567.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb08.27P2.670,7475.0,10486.0,9900.5,10546.5,10260.0,variant surface glycoprotein (VSG  atypical)  putative,G2M
Tb08.27P2.680,2295.5,4008.0,5276.5,4318.0,4170.0,variant surface glycoprotein  degenerate,S
Tb08.27P2.690,2840.5,1747.5,2351.5,2656.5,4170.0,variant surface glycoprotein  degenerate,>4C (GG2M)
Tb08.27P2.710,10640.0,2187.0,1254.0,1479.0,1660.5,variant surface glycoprotein  degenerate,<2C (LG1)
Tb08.27P2.720,8575.5,2020.5,3066.0,2656.5,697.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0204,7058.0,6295.0,5728.0,6001.0,3704.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0205,10241.0,7422.5,6346.0,7053.0,5463.0,variant surface glycoprotein (VSG  pseudogene)  fragment,<2C (LG1)
Tb10.v4.0206,6450.5,3060.0,2499.0,2009.0,2631.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0207,5030.5,5136.0,5298.0,5716.5,4096.5,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0208,612.5,322.0,99.0,501.5,637.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,>4C (GG2M)
Tb10.v4.0209,612.5,1052.0,994.0,757.5,964.0,variant surface glycoprotein (VSG)  putative,G1
Tb10.v4.0210,2295.5,1969.0,1808.5,1950.5,2310.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,>4C (GG2M)
Tb10.v4.0211,5030.5,5883.0,6460.5,5228.0,5248.0,variant surface glycoprotein (VSG)  putative,S
Tb11.0610,2982.0,1629.0,1475.5,1823.5,1374.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.0620,3358.0,959.0,925.0,849.0,964.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1630,4685.0,2350.5,2182.5,1950.5,1099.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1640,612.5,40.5,40.0,33.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.1650,2406.5,2170.0,2653.0,2373.0,4867.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.1660,5158.5,3324.5,2949.5,3605.5,2203.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0200,4048.0,1043.5,1465.0,2009.0,744.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0210,2137.5,3256.0,2360.0,2530.5,2773.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb11.0220,2295.5,835.5,703.0,890.0,1195.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb11.0230,5960.5,2214.5,2653.0,2881.0,2098.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.0240,9615.0,10465.0,10746.0,10198.0,10812.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.0250,8716.0,7157.0,7782.0,5683.5,2734.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0260,6636.0,1838.0,1549.5,1654.0,1437.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0270,612.5,877.0,717.5,989.0,1374.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.0280,7919.0,5506.0,6754.0,5129.0,3794.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0054,5441.0,4135.5,4790.5,4327.5,4703.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0055,7306.5,5841.0,6126.5,5489.0,6096.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0056,5682.0,2652.5,4124.0,3513.0,5258.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0057,2747.5,1249.0,1428.0,1056.5,1531.5,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb11.0700,5804.0,6251.0,5598.0,5260.5,4391.0,expression site-associated gene 3 (ESAG3)  degenerate,G1
Tb11.0710,2295.5,1807.0,1510.5,1202.5,1239.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.0720,5343.5,6583.5,6616.5,6863.0,7431.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.0730,3680.5,1789.5,1585.5,1609.0,1717.0,hypothetical protein,<2C (LG1)
Tb11.0740,3214.5,1018.0,1124.0,1382.0,1772.5,hypothetical protein,<2C (LG1)
Tb11.0750,6777.5,1934.0,2075.5,1702.0,2773.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.1140,2943.0,664.5,644.5,907.5,1010.0,expression site-associated gene 3 (ESAG3)  degenerate,<2C (LG1)
Tb11.1150,612.5,307.0,293.0,483.0,1120.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.1160,4242.0,1161.5,1103.0,1085.0,2065.0,hypothetical protein,<2C (LG1)
Tb11.1170,2682.0,3579.0,3323.5,2335.0,2364.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb11.1180,9511.5,4199.5,2551.0,3102.5,3248.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0063,612.5,3293.0,4518.5,1626.0,1120.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb10.v4.0064,3107.5,3353.0,3920.5,3724.0,1860.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,S
Tb10.v4.0065,3261.0,7524.0,7644.0,8076.5,5199.0,variant surface glycoprotein (VSG)  putative,G2M
Tb10.v4.0066,6984.5,4413.0,4214.0,3503.0,3658.5,expression site-associated gene 3 (ESAG3  pseudogene)  putative,<2C (LG1)
Tb10.v4.0067,2295.5,222.0,410.0,397.5,86.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb11.0570,6315.5,4251.5,4155.0,5381.0,5230.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0580,5012.0,4089.5,3308.0,3319.0,2847.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb11.0590,6672.0,2609.5,2122.5,1833.5,2514.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb11.0600,612.5,664.5,99.0,334.5,1407.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb11.0060,3822.0,3723.5,4732.5,3503.0,2964.0,hypothetical protein,S
Tb11.0070,4339.5,2864.5,3431.0,2530.5,2376.0,hypothetical protein,<2C (LG1)
Tb11.0080,2970.5,3806.5,3503.0,3117.0,4571.0,hypothetical protein,>4C (GG2M)
Tb10.v4.0212,2970.5,2128.0,2075.5,1726.5,2351.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0213,2598.0,6782.5,6873.5,6909.0,4714.5,expression site-associated protein 1 (ESAG1)  putative,G2M
Tb10.v4.0214,5281.0,2505.5,2134.0,1922.5,1717.0,expression site-associated gene 9 (ESAG9 pseudogene)  putative,<2C (LG1)
Tb10.v4.0215,9274.0,11135.0,11141.0,11255.0,10454.0,hypothetical protein,G2M
Tb10.v4.0216,9499.5,6578.0,6226.5,7194.0,7192.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0217,6339.0,2630.0,2327.5,2483.5,86.0,hypothetical protein,<2C (LG1)
Tb10.v4.0218,11156.0,11088.0,11054.0,11279.0,11227.0,expression site-associated gene 3 (ESAG3) protein  putative,G2M
Tb10.v4.0219,8766.5,8292.0,7540.5,8759.0,5943.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb10.v4.0220,5689.5,4603.5,4529.5,4994.0,5135.5,retrotransposon hot spot protein (RHS  pseudogene)  putative,<2C (LG1)
Tb10.v4.0221,9265.0,7813.5,7301.0,8126.5,6706.0,hypothetical protein,<2C (LG1)
Tb10.v4.0084,2180.0,2128.0,3678.5,2199.0,5054.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0085,2381.5,4357.5,3912.5,4409.0,4391.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0086,612.5,1211.0,1008.5,1514.5,1281.5,variant surface glycoprotein (VSG  pseudogene)  putative /product,G2M
Tb10.v4.0087,3751.5,4481.0,4896.0,4711.5,6059.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb10.v4.0088,1460.0,1313.5,668.5,974.5,1179.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0089,4066.0,6380.0,5953.5,6240.5,7015.5,variant surface glycoprotein (VSG)  putative,>4C (GG2M)
Tb10.v4.0090,7301.5,4950.0,4928.0,4486.5,4051.0,expression site-associated gene 3 (ESAG3  pseudogene)  degenerate,<2C (LG1)
Tb09.v4.0066,11357.0,10955.0,10649.5,10709.0,9674.0,hypothetical protein,<2C (LG1)
Tb09.v4.0067,7520.5,6858.5,7283.5,8303.0,7147.0,retrotransposon hot spot protein  pseudogene,G2M
Tb09.v4.0068,1988.0,471.5,391.5,517.0,461.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb09.v4.0069,9086.5,8918.5,7969.5,7675.5,7112.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0070,7622.0,6403.5,7171.5,7460.5,6334.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0071,5554.0,4553.0,5930.5,5673.5,3125.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0072,612.5,4441.0,5144.0,4137.0,4276.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0073,6797.0,4610.5,4170.0,4720.5,4330.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb09.v4.0074,10762.5,8400.5,8927.5,7931.0,6485.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0075,11311.0,11608.0,11594.0,11553.0,11455.0,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0076,10279.0,4365.0,3618.0,3847.5,4725.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0077,3078.5,10437.5,10551.0,10591.0,10024.5,variant surface glycoprotein (VSG)  putative,G2M
Tb09.v4.0078,3510.0,3068.0,3364.5,3965.5,3125.5,variant surface glycoprotein (VSHG  pseudogene)  putative,G2M
Tb09.v4.0079,10325.5,7694.0,9321.0,7940.0,6729.5,variant surface glycoprotein  fragment,<2C (LG1)
Tb09.v4.0080,3054.0,2581.5,2341.0,3393.5,1944.0,hypothetical protein  conserved,G2M
Tb09.v4.0081,5133.0,8982.0,8430.5,9189.5,7530.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb09.v4.0082,4346.0,7756.0,7040.0,7625.0,8111.0,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0083,8470.0,8317.0,8015.5,9107.0,8032.5,expression site-associated gene 3 (ESAG3)  pseudogene,G2M
Tb09.v4.0084,612.5,4227.0,3717.5,3503.0,2977.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0085,3638.0,1781.0,3531.0,3216.0,2283.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0086,2180.0,2149.5,1124.0,2150.0,2505.5,hypothetical protein  conserved,>4C (GG2M)
Tb09.v4.0087,7462.5,9155.0,8285.0,8368.0,6356.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0068,5230.5,2444.5,2638.5,2589.0,3775.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,<2C (LG1)
Tb10.v4.0069,4667.5,260.0,336.0,182.5,347.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0070,9882.5,6239.5,3688.0,3950.5,4158.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb10.v4.0071,6357.5,5537.5,5829.0,5899.5,9242.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,>4C (GG2M)
Tb10.v4.0072,612.5,3419.0,2969.0,3418.5,3541.0,variant surface glycoprotein (VSG  pseudogene)  putative /product,>4C (GG2M)
Tb10.v4.0047,5012.0,3457.0,3521.5,3463.5,2442.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0048,612.5,2250.0,2533.0,3075.0,2525.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb10.v4.0049,5929.5,2469.5,2327.5,2999.5,2720.5,hypothetical protein,<2C (LG1)
Tb10.v4.0050,2970.5,1285.0,1731.5,1329.0,397.5,hypothetical protein,<2C (LG1)
Tb10.v4.0051,3063.5,3073.0,3452.0,3178.5,4459.5,hypothetical protein,>4C (GG2M)
Tb09.v4.0189,612.5,1574.5,2425.0,2211.5,1453.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0190,3179.0,1670.0,1489.0,1171.0,964.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0191,6413.0,2801.5,2440.5,1451.5,2283.5,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb09.v4.0192,3701.5,1679.0,1324.0,1763.5,1253.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb09.v4.0193,8559.0,5426.5,5930.5,5899.5,5888.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0194,6612.5,5236.0,5744.0,5638.0,5870.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0195,4587.0,1466.5,1966.5,2311.0,1691.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb09.v4.0196,4375.0,6148.5,5973.0,6979.0,5988.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb09.v4.0197,6783.5,5573.0,6597.0,6831.0,6323.0,variant surface glycoprotein (VSG  pseudogene)  putative,G2M
Tb09.v4.0198,10146.0,10870.5,10626.0,10468.0,9316.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb10.v4.0228,2047.0,1766.0,1446.0,1899.5,1772.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0229,4048.0,1704.5,1700.5,1861.0,3457.5,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0230,7967.5,5236.0,3618.0,4476.0,4429.0,variant surface glycoprotein (VSG  pseudogene)  putative,<2C (LG1)
Tb10.v4.0231,612.5,4287.0,4614.0,4084.0,4036.5,variant surface glycoprotein (VSG  pseudogene)  putative,S
Tb09.v4.0047,10311.5,10907.0,10878.5,10373.0,9628.5,variant surface glycoprotein (VSG  pseudogene)  putative,G1
Tb09.v4.0048,2137.5,4041.5,5584.0,5260.5,5694.5,variant surface glycoprotein (VSG  pseudogene)  putative,>4C (GG2M)
Tb09.v4.0049,3314.5,2376.0,4258.0,4027.5,3375.0,variant surface glycoprotein  degenerate,S
Tb09.v4.0050,9549.5,6073.0,6066.5,6340.0,6649.0,variant surface glycoprotein (VSG)  putative,<2C (LG1)
Tb09.v4.0051,4626.0,4089.5,3969.5,5381.0,3494.0,variant surface glycoprotein (VSG)  putative,G2M
